0001755672-21-000012.txt : 20210505 0001755672-21-000012.hdr.sgml : 20210505 20210505162746 ACCESSION NUMBER: 0001755672-21-000012 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 124 CONFORMED PERIOD OF REPORT: 20210331 FILED AS OF DATE: 20210505 DATE AS OF CHANGE: 20210505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Corteva, Inc. CENTRAL INDEX KEY: 0001755672 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE PRODUCTION - CROPS [0100] IRS NUMBER: 824979096 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38710 FILM NUMBER: 21893803 BUSINESS ADDRESS: STREET 1: 974 CENTRE ROAD STREET 2: BUILDING 735 CITY: WILMINGTON STATE: DE ZIP: 19805 BUSINESS PHONE: (302) 485-3000 MAIL ADDRESS: STREET 1: 974 CENTRE ROAD STREET 2: BUILDING 735 CITY: WILMINGTON STATE: DE ZIP: 19805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DUPONT E I DE NEMOURS & CO CENTRAL INDEX KEY: 0000030554 STANDARD INDUSTRIAL CLASSIFICATION: PLASTIC MATERIAL, SYNTH RESIN/RUBBER, CELLULOS (NO GLASS) [2820] IRS NUMBER: 510014090 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-00815 FILM NUMBER: 21893804 BUSINESS ADDRESS: STREET 1: 974 CENTRE ROAD STREET 2: BUILDING 735 CITY: WILMINGTON STATE: DE ZIP: 19805 BUSINESS PHONE: (302) 485-3000 MAIL ADDRESS: STREET 1: 974 CENTRE ROAD STREET 2: BUILDING 735 CITY: WILMINGTON STATE: DE ZIP: 19805 10-Q 1 dd-20210331.htm 10-Q dd-20210331
3/31/20213/31/202110-Q10-QfalsefalseMarch 31, 2021March 31, 202100017556720000030554December 31December 3120212021Q1Q1Large Accelerated FilerNon-Accelerated FilerFalseFalseFalseFalseFalseTrue0.010.010.011,666,667,0001,666,667,0001,666,667,000738,321,000743,458,000748,369,0003,8743,8573,4060.130.13833854000000410000005002.3011712012012010210210223,00023,0001,6731,67370070023,00023,00023,0000.300.300.301,800,000,0001,800,000,0001,800,000,00020020020023,000,00023,000,00023,000,0001,673,0001,673,0001,673,00012012012023,000,00023,000,00023,000,000700,000700,000700,0001021021023,8743,8573,4061.1251.1250.8750.8751.629200017556722021-01-012021-03-310001755672dd:EIDMember2021-01-012021-03-310001755672us-gaap:CommonStockMember2021-01-012021-03-310001755672dd:EIDMemberdd:A3.50SeriesPreferredStockMember2021-01-012021-03-310001755672dd:EIDMemberdd:A4.50SeriesPreferredStockMember2021-01-012021-03-31xbrli:shares00017556722021-04-30iso4217:USDxbrli:shares0001755672dd:EIDMember2021-04-30iso4217:USD00017556722020-01-012020-03-310001755672us-gaap:PensionPlansDefinedBenefitMember2021-01-012021-03-310001755672us-gaap:PensionPlansDefinedBenefitMember2020-01-012020-03-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-03-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-01-012020-03-3100017556722021-03-3100017556722020-12-3100017556722020-03-310001755672dd:TotalcompanyMember2021-01-012021-03-310001755672dd:TotalcompanyMember2020-01-012020-03-3100017556722019-12-310001755672us-gaap:CommonStockMember2019-12-310001755672us-gaap:AdditionalPaidInCapitalMember2019-12-310001755672us-gaap:RetainedEarningsMember2019-12-310001755672us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001755672us-gaap:NoncontrollingInterestMember2019-12-310001755672us-gaap:RetainedEarningsMember2020-01-012020-03-310001755672us-gaap:NoncontrollingInterestMember2020-01-012020-03-310001755672us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-03-310001755672us-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-310001755672us-gaap:CommonStockMember2020-03-310001755672us-gaap:AdditionalPaidInCapitalMember2020-03-310001755672us-gaap:RetainedEarningsMember2020-03-310001755672us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-310001755672us-gaap:NoncontrollingInterestMember2020-03-310001755672us-gaap:CommonStockMember2020-12-310001755672us-gaap:AdditionalPaidInCapitalMember2020-12-310001755672us-gaap:RetainedEarningsMember2020-12-310001755672us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001755672us-gaap:NoncontrollingInterestMember2020-12-310001755672us-gaap:RetainedEarningsMember2021-01-012021-03-310001755672us-gaap:NoncontrollingInterestMember2021-01-012021-03-310001755672us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310001755672us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001755672us-gaap:CommonStockMember2021-03-310001755672us-gaap:AdditionalPaidInCapitalMember2021-03-310001755672us-gaap:RetainedEarningsMember2021-03-310001755672us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310001755672us-gaap:NoncontrollingInterestMember2021-03-310001755672dd:InternalReorganizationMember2020-01-012020-03-31xbrli:pure0001755672dd:AccountsandNotesReceivableMemberdd:DuPontdeNemoursMember2021-03-310001755672dd:DuPontdeNemoursMemberus-gaap:OtherAssetsMember2021-03-310001755672dd:DuPontdeNemoursMemberus-gaap:OtherNoncurrentLiabilitiesMember2021-03-310001755672dd:AccruedandOtherCurrentLiabilitiesMemberdd:DowMember2021-03-310001755672dd:DowMemberus-gaap:OtherNoncurrentLiabilitiesMember2021-03-310001755672dd:AccountsandNotesReceivableMemberdd:PerformanceChemicalsMember2021-03-310001755672us-gaap:OtherAssetsMemberdd:PerformanceChemicalsMember2021-03-310001755672dd:AccruedandOtherCurrentLiabilitiesMemberdd:PerformanceChemicalsMember2021-03-310001755672us-gaap:OtherNoncurrentLiabilitiesMemberdd:PerformanceChemicalsMember2021-03-310001755672dd:PerformanceChemicalsMember2021-01-012021-03-310001755672srt:MinimumMember2021-03-310001755672srt:MaximumMember2021-03-310001755672dd:AccruedandOtherCurrentLiabilitiesMember2021-03-310001755672dd:AccruedandOtherCurrentLiabilitiesMember2020-12-310001755672dd:AccruedandOtherCurrentLiabilitiesMember2020-03-310001755672us-gaap:OtherNoncurrentLiabilitiesMember2021-03-310001755672us-gaap:OtherNoncurrentLiabilitiesMember2020-12-310001755672us-gaap:OtherNoncurrentLiabilitiesMember2020-03-310001755672dd:MajorProductLineMember2021-01-012021-03-310001755672dd:CornMemberdd:SeedMember2021-01-012021-03-310001755672dd:CornMemberdd:SeedMember2020-01-012020-03-310001755672dd:SoybeanMemberdd:SeedMember2021-01-012021-03-310001755672dd:SoybeanMemberdd:SeedMember2020-01-012020-03-310001755672dd:OtheroilseedsMemberdd:SeedMember2021-01-012021-03-310001755672dd:OtheroilseedsMemberdd:SeedMember2020-01-012020-03-310001755672dd:SeedMemberdd:OtherMember2021-01-012021-03-310001755672dd:SeedMemberdd:OtherMember2020-01-012020-03-310001755672dd:SeedMember2021-01-012021-03-310001755672dd:SeedMember2020-01-012020-03-310001755672dd:CropProtectionMemberdd:HerbicidesMember2021-01-012021-03-310001755672dd:CropProtectionMemberdd:HerbicidesMember2020-01-012020-03-310001755672dd:InsecticidesMemberdd:CropProtectionMember2021-01-012021-03-310001755672dd:InsecticidesMemberdd:CropProtectionMember2020-01-012020-03-310001755672dd:FungicidesMemberdd:CropProtectionMember2021-01-012021-03-310001755672dd:FungicidesMemberdd:CropProtectionMember2020-01-012020-03-310001755672dd:CropProtectionMemberdd:OtherMember2021-01-012021-03-310001755672dd:CropProtectionMemberdd:OtherMember2020-01-012020-03-310001755672dd:CropProtectionMember2021-01-012021-03-310001755672dd:CropProtectionMember2020-01-012020-03-310001755672dei:LocationDomain2021-01-012021-03-310001755672srt:NorthAmericaMemberdd:SeedMember2021-01-012021-03-310001755672srt:NorthAmericaMemberdd:SeedMember2020-01-012020-03-310001755672us-gaap:EMEAMemberdd:SeedMember2021-01-012021-03-310001755672us-gaap:EMEAMemberdd:SeedMember2020-01-012020-03-310001755672srt:LatinAmericaMemberdd:SeedMember2021-01-012021-03-310001755672srt:LatinAmericaMemberdd:SeedMember2020-01-012020-03-310001755672srt:AsiaPacificMemberdd:SeedMember2021-01-012021-03-310001755672srt:AsiaPacificMemberdd:SeedMember2020-01-012020-03-310001755672srt:NorthAmericaMemberdd:CropProtectionMember2021-01-012021-03-310001755672srt:NorthAmericaMemberdd:CropProtectionMember2020-01-012020-03-310001755672us-gaap:EMEAMemberdd:CropProtectionMember2021-01-012021-03-310001755672us-gaap:EMEAMemberdd:CropProtectionMember2020-01-012020-03-310001755672srt:LatinAmericaMemberdd:CropProtectionMember2021-01-012021-03-310001755672srt:LatinAmericaMemberdd:CropProtectionMember2020-01-012020-03-310001755672srt:AsiaPacificMemberdd:CropProtectionMember2021-01-012021-03-310001755672srt:AsiaPacificMemberdd:CropProtectionMember2020-01-012020-03-310001755672srt:MinimumMemberdd:A2021RestructuringActionsDomain2021-03-310001755672dd:A2021RestructuringActionsDomainsrt:MaximumMember2021-03-310001755672srt:MinimumMemberdd:A2021RestructuringActionsDomainus-gaap:EmployeeSeveranceMember2021-03-310001755672dd:A2021RestructuringActionsDomainsrt:MaximumMemberus-gaap:EmployeeSeveranceMember2021-03-310001755672srt:MinimumMemberdd:A2021RestructuringActionsDomaindd:AssetRelatedChargesMember2021-03-310001755672dd:A2021RestructuringActionsDomainsrt:MaximumMemberdd:AssetRelatedChargesMember2021-03-310001755672srt:MinimumMemberdd:A2021RestructuringActionsDomainus-gaap:AssetRetirementObligationCostsMember2021-03-310001755672dd:A2021RestructuringActionsDomainsrt:MaximumMemberus-gaap:AssetRetirementObligationCostsMember2021-03-310001755672srt:MinimumMemberdd:A2021RestructuringActionsDomainus-gaap:ContractTerminationMember2021-03-310001755672dd:A2021RestructuringActionsDomainus-gaap:ContractTerminationMembersrt:MaximumMember2021-03-310001755672dd:A2021RestructuringActionsDomaindd:SeedMember2021-01-012021-03-310001755672dd:A2021RestructuringActionsDomaindd:CropProtectionMember2021-01-012021-03-310001755672us-gaap:CorporateMemberdd:A2021RestructuringActionsDomain2021-01-012021-03-310001755672dd:A2021RestructuringActionsDomain2021-01-012021-03-310001755672dd:A2021RestructuringActionsDomainus-gaap:EmployeeSeveranceMember2020-12-310001755672dd:A2021RestructuringActionsDomaindd:AssetRelatedChargesMember2020-12-310001755672dd:A2021RestructuringActionsDomaindd:CostsRelatedToContractTerminationMember2020-12-310001755672dd:A2021RestructuringActionsDomain2020-12-310001755672dd:A2021RestructuringActionsDomainus-gaap:EmployeeSeveranceMember2021-01-012021-03-310001755672dd:A2021RestructuringActionsDomaindd:AssetRelatedChargesMember2021-01-012021-03-310001755672dd:A2021RestructuringActionsDomaindd:CostsRelatedToContractTerminationMember2021-01-012021-03-310001755672dd:A2021RestructuringActionsDomainus-gaap:EmployeeSeveranceMember2021-03-310001755672dd:A2021RestructuringActionsDomaindd:AssetRelatedChargesMember2021-03-310001755672dd:A2021RestructuringActionsDomaindd:CostsRelatedToContractTerminationMember2021-03-310001755672dd:A2021RestructuringActionsDomain2021-03-310001755672dd:ExecutetoWinProductivityProgramDomain2020-01-012021-03-310001755672dd:ExecutetoWinProductivityProgramDomaindd:AssetRelatedChargesMember2020-01-012021-03-310001755672dd:ExecutetoWinProductivityProgramDomainus-gaap:EmployeeSeveranceMember2020-01-012021-03-310001755672dd:ExecutetoWinProductivityProgramDomain2021-01-012021-03-310001755672dd:ExecutetoWinProductivityProgramDomaindd:SeedMember2021-01-012021-03-310001755672dd:ExecutetoWinProductivityProgramDomaindd:SeedMember2020-01-012020-03-310001755672dd:ExecutetoWinProductivityProgramDomaindd:CropProtectionMember2021-01-012021-03-310001755672dd:ExecutetoWinProductivityProgramDomaindd:CropProtectionMember2020-01-012020-03-310001755672dd:ExecutetoWinProductivityProgramDomainus-gaap:CorporateNonSegmentMember2021-01-012021-03-310001755672dd:ExecutetoWinProductivityProgramDomainus-gaap:CorporateNonSegmentMember2020-01-012020-03-310001755672dd:ExecutetoWinProductivityProgramDomain2020-01-012020-03-310001755672dd:ExecutetoWinProductivityProgramDomainus-gaap:EmployeeSeveranceMember2021-01-012021-03-310001755672dd:ExecutetoWinProductivityProgramDomainus-gaap:EmployeeSeveranceMember2020-01-012020-03-310001755672dd:ExecutetoWinProductivityProgramDomaindd:AssetRelatedChargesMember2021-01-012021-03-310001755672dd:ExecutetoWinProductivityProgramDomaindd:AssetRelatedChargesMember2020-01-012020-03-310001755672dd:ExecutetoWinProductivityProgramDomainus-gaap:EmployeeSeveranceMember2020-12-310001755672dd:ExecutetoWinProductivityProgramDomaindd:AssetRelatedChargesMember2020-12-310001755672dd:ExecutetoWinProductivityProgramDomain2020-12-310001755672dd:ExecutetoWinProductivityProgramDomainus-gaap:EmployeeSeveranceMember2021-03-310001755672dd:ExecutetoWinProductivityProgramDomaindd:AssetRelatedChargesMember2021-03-310001755672dd:ExecutetoWinProductivityProgramDomain2021-03-310001755672dd:ExecutetoWinProductivityProgramDomainsrt:MinimumMember2021-01-012021-03-310001755672dd:ExecutetoWinProductivityProgramDomainsrt:MaximumMember2021-01-012021-03-310001755672dd:OtherAssetRelatedMember2021-01-012021-03-310001755672dd:OtherAssetRelatedMember2020-01-012020-03-310001755672dd:CropProtectionMemberus-gaap:MaterialReconcilingItemsMember2021-01-012021-03-310001755672dd:ArgentinePesoDevaluationMemberdd:HedgingProgramMember2021-01-012021-03-310001755672dd:ArgentinePesoDevaluationMemberdd:HedgingProgramMember2020-01-012020-03-310001755672srt:SubsidiariesMember2021-01-012021-03-310001755672srt:SubsidiariesMember2020-01-012020-03-310001755672dd:HedgingProgramMember2021-01-012021-03-310001755672dd:HedgingProgramMember2020-01-012020-03-310001755672us-gaap:OtherCurrentAssetsMember2021-03-310001755672us-gaap:OtherCurrentAssetsMember2020-12-310001755672us-gaap:OtherCurrentAssetsMember2020-03-310001755672dd:FactoringAgreementMember2021-01-012021-03-310001755672dd:FactoringAgreementMember2020-01-012020-03-310001755672dd:FactoringAgreementMember2021-03-310001755672dd:FactoringAgreementMember2020-12-310001755672dd:FactoringAgreementMember2020-03-310001755672dd:GermplasmMember2021-03-310001755672dd:GermplasmMember2020-12-310001755672dd:GermplasmMember2020-03-310001755672us-gaap:CustomerRelatedIntangibleAssetsMember2021-03-310001755672us-gaap:CustomerRelatedIntangibleAssetsMember2020-12-310001755672us-gaap:CustomerRelatedIntangibleAssetsMember2020-03-310001755672us-gaap:DevelopedTechnologyRightsMember2021-03-310001755672us-gaap:DevelopedTechnologyRightsMember2020-12-310001755672us-gaap:DevelopedTechnologyRightsMember2020-03-310001755672us-gaap:TrademarksAndTradeNamesMember2021-03-310001755672us-gaap:TrademarksAndTradeNamesMember2020-12-310001755672us-gaap:TrademarksAndTradeNamesMember2020-03-310001755672dd:FavorableSupplyContractMember2021-03-310001755672dd:FavorableSupplyContractMember2020-12-310001755672dd:FavorableSupplyContractMember2020-03-310001755672us-gaap:OtherIntangibleAssetsMember2021-03-310001755672us-gaap:OtherIntangibleAssetsMember2020-12-310001755672us-gaap:OtherIntangibleAssetsMember2020-03-310001755672us-gaap:InProcessResearchAndDevelopmentMember2021-03-310001755672us-gaap:InProcessResearchAndDevelopmentMember2020-12-310001755672us-gaap:InProcessResearchAndDevelopmentMember2020-03-310001755672us-gaap:TradeNamesMember2020-03-310001755672us-gaap:SegmentContinuingOperationsMember2021-03-310001755672us-gaap:CommercialPaperMember2021-03-310001755672us-gaap:CommercialPaperMember2020-12-310001755672us-gaap:CommercialPaperMember2020-03-310001755672us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMemberus-gaap:RepurchaseAgreementsMember2021-03-310001755672us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMemberus-gaap:RepurchaseAgreementsMember2020-12-310001755672us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMemberus-gaap:RepurchaseAgreementsMember2020-03-310001755672dd:OtherloansvariouscurrenciesMember2021-03-310001755672dd:OtherloansvariouscurrenciesMember2020-12-310001755672dd:OtherloansvariouscurrenciesMember2020-03-310001755672us-gaap:FairValueInputsLevel2Member2021-03-310001755672us-gaap:FairValueInputsLevel2Member2020-12-310001755672us-gaap:FairValueInputsLevel2Member2020-03-310001755672us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember2021-02-090001755672dd:AccountsandNotesReceivableMemberus-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMemberus-gaap:RepurchaseAgreementsMember2021-03-310001755672dd:RevolvingCreditFacilitiesdue2024Member2018-11-130001755672srt:ScenarioForecastMemberdd:RevolvingCreditFacilitiesdue2024Member2018-11-132023-11-130001755672dd:RevolvingCreditFacilitiesdue2022Member2018-11-130001755672dd:RevolvingCreditFacilitiesdue2022Membersrt:ScenarioForecastMember2018-11-132021-11-130001755672dd:RevolvingCreditFacilitiesdue2022Member2018-11-130001755672dd:RevolvingCreditFacilitiesdue2022Member2020-03-310001755672dd:RevolvingCreditFacilitiesdue2022Member2021-03-310001755672dd:NotesMaturing2030Domainus-gaap:LoansPayableMember2021-03-310001755672dd:FactoringAgreementMember2021-03-310001755672dd:FactoringAgreementMember2020-12-310001755672dd:AgreementswithlenderstoprovidefinancingforselectcustomersMember2021-03-310001755672dd:AgreementswithlenderstoprovidefinancingforselectcustomersMember2020-12-310001755672dd:AgreementswithlenderstoprovidefinancingforselectcustomersMember2020-03-310001755672dd:CortevaMemberdd:DuPontdeNemoursMemberdd:PFOAMattersMultiDistrictLitigationMember2017-04-012017-06-30dd:lawsuits0001755672dd:PFOAMattersMultiDistrictLitigationMember2017-12-310001755672dd:PFOAMattersDrinkingWaterActionsMemberdd:ScheduledfortrialMemberdd:PostMDLSettlementPFOAPersonalInjuryClaimsDomain2021-03-310001755672srt:MaximumMemberdd:PFASMember2021-01-012021-03-310001755672srt:MaximumMemberdd:PFASMember2021-03-310001755672dd:CortevaMemberdd:PFASMemberdd:DuPontdeNemoursMember2021-03-310001755672dd:CortevaMembersrt:MaximumMemberdd:PFASMemberdd:DuPontdeNemoursMember2021-03-310001755672dd:DuPontdeNemoursMember2021-03-310001755672dd:DuPontdeNemoursMember2021-03-310001755672dd:CortevaMember2021-03-310001755672dd:ChemoursMemberdd:PFASMember2022-09-300001755672dd:CortevaMemberdd:PFASMemberdd:DuPontdeNemoursMember2022-09-300001755672dd:ChemoursMemberdd:PFASMember2028-09-300001755672dd:CortevaMemberdd:PFASMemberdd:DuPontdeNemoursMember2028-09-300001755672srt:MaximumMemberdd:ChemoursMemberdd:PFASMember2028-09-300001755672dd:CortevaMembersrt:MaximumMemberdd:PFASMemberdd:DuPontdeNemoursMember2028-09-300001755672dd:PFASMember2028-12-310001755672dd:ChemoursMemberdd:PFASMember2021-03-310001755672dd:DuPontdeNemoursMemberdd:DuPontdeNemoursMember2021-03-310001755672dd:CortevaMemberdd:DuPontdeNemoursMember2021-03-310001755672dd:CortevaMemberdd:PFASMember2021-03-310001755672dd:PFASMemberdd:DuPontdeNemoursMember2021-03-310001755672srt:MinimumMemberdd:PFASMember2021-03-310001755672srt:MinimumMemberdd:Once300millionthresholdismetMemberdd:PFASMember2021-03-310001755672dd:ChemoursMemberdd:PFOAMattersMember2021-03-310001755672dd:PFOAMattersDrinkingWaterActionsMember2004-01-012004-12-310001755672dd:PFOAMattersDrinkingWaterActionsMember2012-01-010001755672dd:PFOAMattersDrinkingWaterActionsMember2004-12-310001755672dd:PFOAMattersDrinkingWaterActionsMember2012-01-012020-09-300001755672dd:PFOAMattersDrinkingWaterActionsMember2021-03-310001755672dd:PFOAMattersMultiDistrictLitigationMember2021-03-310001755672dd:PFOAMattersMultiDistrictLitigationMember2017-10-012017-12-310001755672dd:PFOAMattersDrinkingWaterActionsMemberdd:CompensatorydamagesMemberdd:PostMDLSettlementPFOAPersonalInjuryClaimsDomain2021-01-012021-03-310001755672dd:PFOAMattersDrinkingWaterActionsMemberdd:LossofconsortiumMemberdd:PostMDLSettlementPFOAPersonalInjuryClaimsDomain2021-01-012021-03-310001755672us-gaap:SettledLitigationMemberdd:PFOAMattersDrinkingWaterActionsMemberdd:PostMDLSettlementPFOAPersonalInjuryClaimsDomain2021-01-012021-03-310001755672dd:MDLSettlementMember2021-01-012021-03-310001755672dd:ChemoursContributionToMDLSettlementMember2021-01-012021-03-310001755672dd:DuPontDeNemoursAndCortevaContributionToMDLSettlementMember2021-01-012021-03-310001755672dd:PFOAMattersDrinkingWaterActionsMemberstpr:NY2021-03-310001755672dd:PFOAMattersDrinkingWaterActionsMemberstpr:NJ2021-03-310001755672dd:NaturalResourcesDamagesMemberstpr:NJ2021-03-310001755672dd:PFOAMattersDrinkingWaterActionsMemberstpr:OH2021-03-310001755672dd:FirefightingFoamMember2021-03-310001755672dd:FirefightingFoamMemberdd:PersonalinjurycasesMember2021-03-310001755672stpr:NCdd:PFOAMattersDrinkingWaterActionsMember2021-01-012021-03-310001755672dd:SuperfundSitesMember2021-03-310001755672dd:ChemoursrelatedobligationsubjecttoindemnificationMember2021-03-310001755672us-gaap:SegmentDiscontinuedOperationsMember2021-03-310001755672dd:OtherdiscontinuedordivestedbusinessobligationsMember2021-03-310001755672dd:EnvironmentalremediationliabilitiesprimarilyrelatedtoDuPontsubjecttoindemnityfromDuPontMember2021-03-310001755672dd:NotsubjecttoindemnificationMember2021-03-310001755672dd:ChemoursMemberdd:SuperfundSitesMemberus-gaap:IndemnificationGuaranteeMember2021-03-310001755672dd:PerformanceChemicalsMember2021-03-310001755672dd:NaturalResourcesDamagesMemberdd:AlabamaWaterUtilityMember2021-03-310001755672dd:FactoringAgreementMember2020-03-3100017556722019-06-260001755672dd:CortevaMember2019-06-260001755672dd:CortevaMember2021-01-012021-03-310001755672dd:CortevaMember2020-01-012020-03-310001755672dd:EIDMemberdd:CortevaMember2021-01-012021-03-310001755672dd:EIDMemberdd:A4.50SeriesPreferredStockMember2021-03-310001755672dd:EIDMemberdd:A3.50SeriesPreferredStockMember2021-03-310001755672us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310001755672us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2019-12-310001755672us-gaap:PensionPlansDefinedBenefitMember2019-12-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2019-12-310001755672us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-12-310001755672us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-03-310001755672us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-01-012020-03-310001755672us-gaap:PensionPlansDefinedBenefitMember2020-01-012020-03-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-01-012020-03-310001755672us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-01-012020-03-310001755672us-gaap:AccumulatedTranslationAdjustmentMember2020-03-310001755672us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-03-310001755672us-gaap:PensionPlansDefinedBenefitMember2020-03-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-03-310001755672us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-03-310001755672us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310001755672us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-12-310001755672us-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-12-310001755672us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-12-310001755672us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-03-310001755672us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-01-012021-03-310001755672us-gaap:PensionPlansDefinedBenefitMember2021-01-012021-03-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-03-310001755672us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-01-012021-03-310001755672us-gaap:AccumulatedTranslationAdjustmentMember2021-03-310001755672us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-03-310001755672us-gaap:PensionPlansDefinedBenefitMember2021-03-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-03-310001755672us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-03-310001755672us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMemberus-gaap:PensionPlansDefinedBenefitMember2021-01-012021-03-310001755672us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMemberus-gaap:PensionPlansDefinedBenefitMember2020-01-012020-03-310001755672us-gaap:PensionPlansDefinedBenefitMemberdd:AccumulatedDefinedBenefitPlansAdjustmentSettlementGainLossMember2021-01-012021-03-310001755672us-gaap:PensionPlansDefinedBenefitMemberdd:AccumulatedDefinedBenefitPlansAdjustmentSettlementGainLossMember2020-01-012020-03-310001755672us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:PensionPlansDefinedBenefitMember2021-01-012021-03-310001755672us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:PensionPlansDefinedBenefitMember2020-01-012020-03-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2021-01-012021-03-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2020-01-012020-03-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-03-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-01-012020-03-310001755672dd:EIDMemberdd:A4.50SeriesPreferredStockMember2020-12-310001755672dd:EIDMemberdd:A4.50SeriesPreferredStockMember2020-03-310001755672dd:EIDMemberdd:A3.50SeriesPreferredStockMember2020-12-310001755672dd:EIDMemberdd:A3.50SeriesPreferredStockMember2020-03-310001755672us-gaap:CashEquivalentsMember2021-03-310001755672us-gaap:CashEquivalentsMember2020-12-310001755672us-gaap:CashEquivalentsMember2020-03-310001755672dd:MarketableSecuritiesMember2021-03-310001755672dd:MarketableSecuritiesMember2020-12-310001755672dd:MarketableSecuritiesMember2020-03-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2021-03-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2020-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2020-03-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMember2021-03-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMember2020-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMember2020-03-310001755672us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2021-03-310001755672us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2020-12-310001755672us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2020-03-310001755672us-gaap:NondesignatedMemberus-gaap:CommodityContractMember2021-03-310001755672us-gaap:NondesignatedMemberus-gaap:CommodityContractMember2020-12-310001755672us-gaap:NondesignatedMemberus-gaap:CommodityContractMember2020-03-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMember2021-01-012021-03-310001755672us-gaap:CommodityContractMember2021-01-012021-03-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMember2019-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMember2020-01-012020-03-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2021-01-012021-03-310001755672us-gaap:ForeignExchangeContractMember2021-01-012021-03-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2019-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2020-01-012020-03-31iso4217:EUR0001755672us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMember2021-03-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2021-03-310001755672us-gaap:OtherCurrentAssetsMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2021-03-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberdd:AccruedandOtherCurrentLiabilitiesMemberus-gaap:ForeignExchangeContractMember2021-03-310001755672dd:AccruedandOtherCurrentLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2021-03-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2020-12-310001755672us-gaap:OtherCurrentAssetsMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2020-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberdd:AccruedandOtherCurrentLiabilitiesMemberus-gaap:ForeignExchangeContractMember2020-12-310001755672dd:AccruedandOtherCurrentLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2020-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2020-03-310001755672us-gaap:OtherCurrentAssetsMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2020-03-310001755672dd:AccruedandOtherCurrentLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2020-03-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMember2021-01-012021-03-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMember2020-01-012020-03-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2021-01-012021-03-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2020-01-012020-03-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMember2021-01-012021-03-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMember2020-01-012020-03-310001755672us-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-03-310001755672us-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-03-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2021-01-012021-03-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2020-01-012020-03-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMemberus-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMember2021-01-012021-03-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMemberus-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMember2020-01-012020-03-310001755672us-gaap:NondesignatedMemberus-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeContractMember2021-01-012021-03-310001755672us-gaap:NondesignatedMemberus-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeContractMember2020-01-012020-03-310001755672us-gaap:NondesignatedMemberus-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2021-01-012021-03-310001755672us-gaap:NondesignatedMemberus-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2020-01-012020-03-310001755672us-gaap:NondesignatedMemberus-gaap:CostOfSalesMemberus-gaap:CommodityContractMember2021-01-012021-03-310001755672us-gaap:NondesignatedMemberus-gaap:CostOfSalesMemberus-gaap:CommodityContractMember2020-01-012020-03-310001755672us-gaap:NondesignatedMember2021-01-012021-03-310001755672us-gaap:NondesignatedMember2020-01-012020-03-310001755672us-gaap:AvailableforsaleSecuritiesMember2021-01-012021-03-310001755672us-gaap:USTreasurySecuritiesMember2021-03-310001755672us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-03-310001755672us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:USTreasurySecuritiesMember2021-03-310001755672us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMember2021-03-310001755672us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-03-310001755672us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001755672us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:USTreasurySecuritiesMember2020-12-310001755672us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMember2020-12-310001755672us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2020-12-310001755672us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2020-03-310001755672us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMember2020-03-310001755672dd:SeedMember2021-03-310001755672dd:CropProtectionMember2021-03-310001755672dd:SeedMember2020-03-310001755672dd:CropProtectionMember2020-03-310001755672dd:SeedMember2020-12-310001755672dd:CropProtectionMember2020-12-310001755672us-gaap:MaterialReconcilingItemsMember2021-01-012021-03-310001755672us-gaap:MaterialReconcilingItemsMember2020-01-012020-03-310001755672dd:SeedMemberus-gaap:MaterialReconcilingItemsMember2021-01-012021-03-310001755672us-gaap:CorporateNonSegmentMemberus-gaap:MaterialReconcilingItemsMember2021-01-012021-03-310001755672dd:SeedMemberus-gaap:MaterialReconcilingItemsMember2020-01-012020-03-310001755672dd:CropProtectionMemberus-gaap:MaterialReconcilingItemsMember2020-01-012020-03-310001755672us-gaap:CorporateNonSegmentMemberus-gaap:MaterialReconcilingItemsMember2020-01-012020-03-310001755672dd:CropProtectionMemberdd:LaPorteMemberus-gaap:MaterialReconcilingItemsMember2020-01-012020-03-310001755672dd:LaPorteMemberus-gaap:MaterialReconcilingItemsMember2020-01-012020-03-310001755672dd:EIDMember2020-01-012020-03-310001755672dd:EIDMemberus-gaap:PensionPlansDefinedBenefitMember2021-01-012021-03-310001755672dd:EIDMemberus-gaap:PensionPlansDefinedBenefitMember2020-01-012020-03-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberdd:EIDMember2021-01-012021-03-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberdd:EIDMember2020-01-012020-03-310001755672dd:EIDMember2021-03-310001755672dd:EIDMember2020-12-310001755672dd:EIDMember2020-03-310001755672dd:EIDMemberdd:TotalcompanyMember2021-01-012021-03-310001755672dd:EIDMemberdd:TotalcompanyMember2020-01-012020-03-310001755672dd:EIDMember2019-12-310001755672dd:EIDMemberus-gaap:PreferredStockMember2019-12-310001755672dd:EIDMemberus-gaap:CommonStockMember2019-12-310001755672dd:EIDMemberus-gaap:AdditionalPaidInCapitalMember2019-12-310001755672dd:EIDMemberus-gaap:RetainedEarningsMember2019-12-310001755672dd:EIDMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001755672dd:EIDMemberus-gaap:NoncontrollingInterestMember2019-12-310001755672dd:EIDMemberus-gaap:RetainedEarningsMember2020-01-012020-03-310001755672dd:EIDMemberus-gaap:NoncontrollingInterestMember2020-01-012020-03-310001755672dd:EIDMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-03-310001755672dd:EIDMemberus-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-310001755672dd:EIDMemberus-gaap:PreferredStockMember2020-03-310001755672dd:EIDMemberus-gaap:CommonStockMember2020-03-310001755672dd:EIDMemberus-gaap:AdditionalPaidInCapitalMember2020-03-310001755672dd:EIDMemberus-gaap:RetainedEarningsMember2020-03-310001755672dd:EIDMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-310001755672dd:EIDMemberus-gaap:NoncontrollingInterestMember2020-03-310001755672dd:EIDMemberus-gaap:PreferredStockMember2020-12-310001755672dd:EIDMemberus-gaap:CommonStockMember2020-12-310001755672dd:EIDMemberus-gaap:AdditionalPaidInCapitalMember2020-12-310001755672dd:EIDMemberus-gaap:RetainedEarningsMember2020-12-310001755672dd:EIDMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001755672dd:EIDMemberus-gaap:NoncontrollingInterestMember2020-12-310001755672dd:EIDMemberus-gaap:RetainedEarningsMember2021-01-012021-03-310001755672dd:EIDMemberus-gaap:NoncontrollingInterestMember2021-01-012021-03-310001755672dd:EIDMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310001755672dd:EIDMemberus-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001755672dd:EIDMemberus-gaap:PreferredStockMember2021-03-310001755672dd:EIDMemberus-gaap:CommonStockMember2021-03-310001755672dd:EIDMemberus-gaap:AdditionalPaidInCapitalMember2021-03-310001755672dd:EIDMemberus-gaap:RetainedEarningsMember2021-03-310001755672dd:EIDMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310001755672dd:EIDMemberus-gaap:NoncontrollingInterestMember2021-03-310001755672dd:EIDMemberdd:A4.50SeriesPreferredStockMember2020-01-012020-03-310001755672dd:EIDMemberdd:A3.50SeriesPreferredStockMember2020-01-012020-03-310001755672dd:CortevaMember2021-03-310001755672dd:EIDMemberdd:CortevaMember2021-03-310001755672dd:EIDMemberdd:CortevaMember2020-03-310001755672dd:EIDMemberdd:CortevaMember2021-01-012021-03-310001755672dd:EIDMemberdd:CortevaMember2020-01-012020-03-310001755672dd:EIDMemberdd:CortevaMemberdd:AccruedandOtherCurrentLiabilitiesMember2021-03-310001755672dd:EIDMemberdd:CortevaMemberus-gaap:OtherNoncurrentLiabilitiesMember2021-03-310001755672dd:EIDMemberdd:CortevaMemberdd:AccruedandOtherCurrentLiabilitiesMember2020-12-310001755672dd:EIDMemberdd:CortevaMemberdd:AccruedandOtherCurrentLiabilitiesMember2020-03-310001755672dd:EIDMemberdd:CortevaMemberus-gaap:OtherNoncurrentLiabilitiesMember2020-03-310001755672dd:EIDMemberdd:CortevaMember2020-12-310001755672dd:EIDMemberdd:CortevaMemberus-gaap:OtherNoncurrentLiabilitiesMember2020-12-310001755672dd:EIDMemberus-gaap:MaterialReconcilingItemsMember2021-01-012021-03-310001755672dd:EIDMemberus-gaap:MaterialReconcilingItemsMember2020-01-012020-03-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549 
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2021
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number 001-38710
Corteva, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Delaware 82-4979096
(State or other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.)
974 Centre Road,Wilmington,Delaware19805 (302)485-3000
(Address of Principal Executive Offices) (Zip Code)(Registrant’s Telephone Number, including area code)
Commission File Number 1-815
E. I. du Pont de Nemours and Company
(Exact Name of Registrant as Specified in Its Charter)
Delaware 51-0014090
(State or other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.)
974 Centre Road,Wilmington,Delaware19805 (302)485-3000
(Address of Principal Executive Offices) (Zip Code)(Registrant’s Telephone Number, including area code)


Securities registered pursuant to Section 12(b) of the Act for Corteva, Inc.:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareCTVANew York Stock Exchange

Securities registered pursuant to Section 12(b) of the Act for E. I. du Pont de Nemours and Company:
Title of each classTrading Symbol(s)Name of each exchange on which registered
$3.50 Series Preferred Stock CTAPrANew York Stock Exchange
$4.50 Series Preferred StockCTAPrBNew York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  
Corteva, Inc.                                          Yes  x   No  o
E. I. du Pont de Nemours and Company                          Yes  x   No  o


 Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files.)  
Corteva, Inc.                                       Yes  x   No  o
E. I. du Pont de Nemours and Company                           Yes  x   No  o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.  See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Corteva, Inc.
Large Accelerated Filerx
Accelerated Filer o
Non-Accelerated Filero
Smaller reporting company o
Emerging growth company o
E. I. du Pont de Nemours and Company
Large Accelerated Filero
Accelerated Filer o
Non-Accelerated Filer
x

Smaller reporting company o
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 
Corteva, Inc.                                                 
E. I. du Pont de Nemours and Company                                  

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). 
Corteva, Inc.                                          Yes     No  x
E. I. du Pont de Nemours and Company                          Yes     No  x

Corteva, Inc. had 737,101,000 shares of common stock, par value $0.01 per share, outstanding at April 30, 2021.
E. I. du Pont de Nemours and Company had 200 shares of common stock, par value $0.30 per share, outstanding at April 30, 2021, all of which are held by Corteva, Inc.    

E. I. du Pont de Nemours and Company meets the conditions set forth in General Instruction H(1)(a) and (b) of Form 10-Q (as modified by a grant of no-action relief dated February 12, 2018) and is therefore filing this form with reduced disclosure format.


CORTEVA, INC.
E. I. DU PONT DE NEMOURS AND COMPANY

Table of Contents
  Page
 
   
 
 
 
 
 
   
 
 
 
 
 
   
   
 
   
 
 

1

Explanatory Note

Corteva owns 100% of the outstanding common stock of EID (defined below), and EID owns, directly or indirectly, 100% of DAS (defined below). EID is a subsidiary of Corteva, Inc. and continues to be a reporting company, subject to the requirements of the Securities Exchange Act of 1934, as amended.

Unless otherwise indicated or the context otherwise requires, references in this Quarterly Report on Form 10-Q to:

    • "Corteva" or "the company" refers to Corteva, Inc. and its consolidated subsidiaries (including EID);
• "EID" refers to E. I. du Pont de Nemours and Company and its consolidated subsidiaries or E. I. du Pont de Nemours and Company excluding its consolidated subsidiaries, as the context may indicate;
    • "DowDuPont" refers to DowDuPont Inc., and its subsidiaries prior to the Separation of Corteva (defined below);
• "Historical Dow" refers to the Dow Chemical Company and its consolidated subsidiaries prior to the Internal Reorganization (defined below);
    • "Historical DuPont" refers to EID prior to the Internal Reorganization (defined below);
• "Internal Reorganizations" refers to the series of internal reorganization and realignment steps undertaken by Historical DuPont and Historical Dow to realign its business into three groups: agriculture, materials science and specialty products.  These steps include:
1.the April 1, 2019 transfer of the assets and liabilities aligned with EID’s material science businesses including EID’s ethylene and ethylene copolymers business, excluding its ethylene acrylic elastomers business, (“EID ECP”) to DowDuPont, which were ultimately conveyed by DowDuPont to Dow;
2.the May 1, 2019 distribution of EID legal entities containing the assets and liabilities of EID’s specialty products business (the “EID Specialty Products Entities”) to DowDuPont;
3.the May 2, 2019 conveyance of Historical Dow's agriculture business ("Dow Ag Entities") to EID; and
4.the May 31, 2019 contribution of EID to Corteva, Inc.  Refer to the company’s Annual Report on Form 10-K for the year ended December 31, 2020 for further information.
• "Dow Distribution" refers to the separation of DowDuPont's materials science business into a separate and independent public company, effective as of 5:00 pm ET on April 1, 2019, by way of a distribution of Dow Inc. through a pro rata dividend in-kind of all of the then-issued and outstanding shares of Dow’s common stock, par value $0.01 per share, to holders of DowDuPont's common stock, as of the close of business on March 21, 2019;
    • "Distributions" refers to the Dow Distribution and the Corteva Distribution;
• "Merger” refers to the all-stock merger of equals strategic combination between Historical Dow and Historical DuPont;
• "Merger Effectiveness Time” refers to August 31, 2017 at 11:59 pm ET;
    • "Dow" refers to Dow Inc. after the Dow Distribution;
    • "DuPont" refers to DuPont de Nemours, Inc. after the Separation of Corteva (on June 1, 2019, DowDuPont Inc. changed its registered name to DuPont de Nemours, Inc.);
    • "DAS" refers to the agriculture business of Historical Dow AgroSciences; and
• "Separation" or "Separation of Corteva" refers to June 1, 2019, when Corteva, Inc. became an independent, publicly
    traded company.

This Quarterly Report on Form 10-Q is a combined report being filed separately by Corteva, Inc. and EID.  The information in this Quarterly Report on Form 10-Q is equally applicable to Corteva, Inc. and EID, except where otherwise indicated.

The separate EID financial statements and footnotes for areas that differ from Corteva, are included within this Quarterly Report on Form 10-Q and begin on page 61. Footnotes of EID that are identical to that of Corteva are cross-referenced accordingly.
2

PART I.  FINANCIAL INFORMATION 

Item 1.CONSOLIDATED FINANCIAL STATEMENTS

Corteva, Inc.
Consolidated Statements of Operations (Unaudited)
(In millions, except per share amounts) Three Months Ended
March 31,
20212020
Net sales$4,178 $3,956 
Cost of goods sold
2,420 2,269 
Research and development expense
281 280 
Selling, general and administrative expenses
733 757 
Amortization of intangibles
183 163 
Restructuring and asset related charges - net
100 70 
Other income - net337 1 
Interest expense
7 10 
Income from continuing operations before income taxes791 408 
Provision for income taxes on continuing operations178 127 
Income from continuing operations after income taxes613 281 
(Loss) income from discontinued operations after income taxes(10)1 
Net income603 282 
Net income attributable to noncontrolling interests3 10 
Net income attributable to Corteva$600 $272 
Basic earnings per share of common stock:
Basic earnings per share of common stock from continuing operations$0.82 $0.36 
Basic loss per share of common stock from discontinued operations(0.01) 
Basic earnings per share of common stock$0.81 $0.36 
Diluted earnings per share of common stock:
Diluted earnings per share of common stock from continuing operations$0.81 $0.36 
Diluted loss per share of common stock from discontinued operations(0.01) 
Diluted earnings per share of common stock$0.80 $0.36 

See Notes to the interim Consolidated Financial Statements beginning on page 8.
3

Corteva, Inc.
Consolidated Statements of Comprehensive (Loss) Income (Unaudited)
(In millions) Three Months Ended
March 31,
20212020
Net income $603 $282 
Other comprehensive income (loss) - net of tax:
Cumulative translation adjustments
(403)(672)
Adjustments to pension benefit plans
8  
Adjustments to other benefit plans
(157)3 
Unrealized gain on investments10  
Derivative instruments
65 6 
Total other comprehensive loss(477)(663)
Comprehensive income (loss) 126 (381)
Comprehensive income attributable to noncontrolling interests - net of tax3 10 
Comprehensive income (loss) attributable to Corteva$123 $(391)

See Notes to the interim Consolidated Financial Statements beginning on page 8.

4

Corteva, Inc.
Condensed Consolidated Balance Sheets (Unaudited)
(In millions, except share amounts)March 31, 2021December 31, 2020March 31, 2020
Assets  
Current assets  
Cash and cash equivalents$2,404 $3,526 $1,963 
Marketable securities114 269 10 
Accounts and notes receivable - net6,792 4,926 6,775 
Inventories4,321 4,882 4,401 
Other current assets1,405 1,165 1,530 
Total current assets15,036 14,768 14,679 
Investment in nonconsolidated affiliates64 66 64 
Property, plant and equipment - net of accumulated depreciation (March 31, 2021 - $3,874; December 31, 2020 - $3,857; March 31, 2020 - $3,406)4,299 4,396 4,358 
Goodwill10,146 10,269 10,027 
Other intangible assets10,584 10,747 11,241 
Deferred income taxes433 464 273 
Other assets1,987 1,939 2,336 
Total Assets$42,549 $42,649 $42,978 
Liabilities and Equity  
Current liabilities  
Short-term borrowings and finance lease obligations$1,250 $3 $1,996 
Accounts payable3,098 3,615 3,021 
Income taxes payable165 123 143 
Deferred revenue2,247 2,662 1,996 
Accrued and other current liabilities2,239 2,145 2,043 
Total current liabilities8,999 8,548 9,199 
Long-Term Debt1,102 1,102 614 
Other Noncurrent Liabilities
Deferred income tax liabilities902 893 911 
Pension and other post employment benefits - noncurrent4,954 5,176 6,186 
Other noncurrent obligations1,814 1,867 1,989 
Total noncurrent liabilities8,772 9,038 9,700 
Commitments and contingent liabilities
Stockholders’ equity  
Common stock, $0.01 par value; 1,666,667,000 shares authorized;
issued at March 31, 2021 - 738,321,000; December 31, 2020 - 743,458,000; and March 31, 2020 - 748,369,000
7 7 7 
Additional paid-in capital27,630 27,707 27,906 
Retained earnings / (accumulated deficit)268  (155)
Accumulated other comprehensive loss(3,367)(2,890)(3,933)
Total Corteva stockholders’ equity24,538 24,824 23,825 
Noncontrolling interests240 239 254 
Total equity24,778 25,063 24,079 
Total Liabilities and Equity$42,549 $42,649 $42,978 
See Notes to the interim Consolidated Financial Statements beginning on page 8.
5

Corteva, Inc.
Consolidated Statements of Cash Flows (Unaudited)
(In millions)Three Months Ended
March 31,
20212020
Operating activities
Net income$603 $282 
Adjustments to reconcile net income to cash used for operating activities:
Depreciation and amortization304 283 
Provision for deferred income tax47 26 
Net periodic pension and OPEB benefit, net(318)(85)
Pension and OPEB contributions(84)(95)
Net loss on sales of property, businesses, consolidated companies and investments 46 
Restructuring and asset related charges - net100 70 
Other net loss54 138 
Changes in assets and liabilities, net
Accounts and notes receivable(2,012)(1,685)
Inventories467 398 
Accounts payable(448)(557)
Deferred revenue(401)(575)
Other assets and liabilities(262)(176)
Cash used for operating activities(1,950)(1,930)
Investing activities 
Capital expenditures(137)(128)
Proceeds from sales of property, businesses and consolidated companies - net of cash divested20 11 
Purchases of investments(40)(67)
Proceeds from sales and maturities of investments194 58 
Other investing activities - net(1)(4)
Cash provided by (used for) investing activities36 (130)
Financing activities 
Net change in borrowings (less than 90 days)828 1,619 
Proceeds from debt419 875 
Payments on debt (1)
Repurchase of common stock(350)(50)
Proceeds from exercise of stock options38 14 
Dividends paid to stockholders(97)(97)
Other financing activities(17)(16)
Cash provided by financing activities821 2,344 
Effect of exchange rate changes on cash, cash equivalents and restricted cash(50)(117)
(Decrease)/increase in cash, cash equivalents and restricted cash(1,143)167 
Cash, cash equivalents and restricted cash at beginning of period3,873 2,173 
Cash, cash equivalents and restricted cash at end of period1
$2,730 $2,340 
1. See page 15 for reconciliation of cash and cash equivalents and restricted cash presented in interim Condensed Consolidated Balance Sheets to total cash, cash equivalents and restricted cash presented in the interim Consolidated Statements of Cash Flows.

See Notes to the interim Consolidated Financial Statements beginning on page 8.
6

Corteva, Inc.
Consolidated Statements of Equity (Unaudited)
(In millions, except per share amounts)Common StockAdditional Paid-in Capital "APIC"(Accumulated deficit) Retained EarningsAccumulated Other Comp (Loss) IncomeTreasury StockNon-controlling InterestsTotal Equity
2020
Balance at January 1, 2020$7 $27,997 $(425)$(3,270)$— $246 $24,555 
Net income
272 10 282 
Other comprehensive loss
(663)(663)
Common dividends ($.13 per share)(97)(97)
Issuance of Corteva stock14 14 
Share-based compensation
2 2 
Repurchase of common stock(50)(50)
Other - net
40 (2)(2)36 
Balance at March 31, 2020$7 $27,906 $(155)$(3,933)$— $254 $24,079 
(In millions, except per share amounts)Common StockAdditional Paid-in Capital "APIC"(Accumulated deficit) Retained EarningsAccumulated Other Comp (Loss) IncomeTreasury StockNon-controlling InterestsTotal Equity
2021
Balance at January 1, 2021$7 $27,707 $ $(2,890)$— $239 $25,063 
Net income
600 3 603 
Other comprehensive loss
(477)(477)
Common dividends ($0.13 per share)
(97)(97)
Issuance of Corteva stock
38 38 
Repurchase of common stock(18)(332)(350)
Other - net
(2)(2)
Balance at March 31, 2021$7 $27,630 $268 $(3,367)$— $240 $24,778 


See Notes to the interim Consolidated Financial Statements beginning on page 8.
7

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

Corteva, Inc.
Notes to the Consolidated Financial Statements (Unaudited)


Table of Contents



8

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation
The accompanying unaudited interim Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included.  Results for interim periods should not be considered indicative of results for a full year.  These interim Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2020, collectively referred to as the “2020 Annual Report.”  The interim Consolidated Financial Statements include the accounts of the company and all of its subsidiaries in which a controlling interest is maintained.

Certain reclassifications of prior year's data have been made to conform to current year's presentation.

During the first quarter 2020, the company recorded an increase of $40 million to APIC relating to net assets recorded as transferred as part of the 2019 Internal Reorganizations that were retained. 

Since 2018, Argentina has been considered a hyper-inflationary economy under U.S. GAAP and therefore the U.S. Dollar (“USD”) is the functional currency for our related subsidiaries. We remeasure the net monetary assets utilizing the official Argentine Peso (“Peso”) to USD exchange rate. The devaluation of the Peso relative to the USD over the last several years has resulted in the recognition of exchange losses (refer to Note 6 of these financial statements and Note 9 of the 2020 financial statements included in the Company's Annual Report on Form 10-K). As of March 31, 2021, a further 10% deterioration in the official Peso to USD exchange rate would reduce the USD value of our net monetary assets and negatively impact pre-tax earnings by approximately $20 million.

NOTE 2 - RECENT ACCOUNTING GUIDANCE

Recently Adopted Accounting Guidance
In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which was part of the FASB’s Simplification Initiative to identify, evaluate, and improve areas of U.S. GAAP for which cost and complexity can be reduced, while maintaining or improving the usefulness of the information provided to users of financial statements. This ASU amends ASC 740, Income Taxes, by removing certain exceptions to the general principles, and clarifying and amending current guidance. The new standard is effective for fiscal years, and periods within those fiscal years, beginning after December 15, 2020. The company adopted this guidance on January 1, 2021 and it did not have a material impact on the company’s financial position, results of operation or cash flows.

NOTE 3 - DIVESTITURES AND OTHER TRANSACTIONS

Separation Agreements
In connection with the Distributions, DuPont, Corteva, and Dow (together, the “Parties” and each a “Party”) have entered into certain agreements to effect the Separation, provide for the allocation of DowDuPont’s assets, employees, liabilities and obligations (including its investments, property and employee benefits and tax-related assets and liabilities) among the Parties, and provide a framework for Corteva's relationship with Dow and DuPont following the separations and Distributions (collectively, the "Separation Agreements"). For additional information see Note 13 - Commitments and Contingent Liabilities.

DuPont
Pursuant to the Separation Agreements, DuPont and Corteva indemnifies the other against certain litigation, environmental, tax, workers' compensation and other liabilities that arose prior to the Corteva Distribution. The term of this indemnification is generally indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. At March 31, 2021, the indemnification assets are $28 million within accounts and notes receivable - net and $51 million within other assets in the interim Condensed Consolidated Balance Sheet. At March 31, 2021, the indemnification liabilities are $77 million within other noncurrent obligations in the interim Condensed Consolidated Balance Sheet.

Dow
Pursuant to the Separation Agreements, Dow and Corteva indemnifies the other against certain litigation, environmental, tax and other liabilities that arose prior to the Corteva Distribution. The term of this indemnification is generally indefinite and
9

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. At March 31, 2021, the indemnification liabilities are $52 million within accrued and other current liabilities and $14 million within other noncurrent obligations in the interim Condensed Consolidated Balance Sheet.

Performance Chemicals
On July 1, 2015, Historical DuPont completed the separation of its Performance Chemicals segment through the spin-off of all of the issued and outstanding stock of The Chemours Company (the "Chemours Separation"). In connection with the Chemours Separation, Historical DuPont and The Chemours Company ("Chemours") entered into a Separation Agreement (as amended, the "Chemours Separation Agreement"), discussed below, a Tax Matters Agreement and certain ancillary agreements, including an employee matters agreement, agreements related to transition and site services, and intellectual property cross licensing arrangements. In addition, the companies entered into certain supply agreements.

Separation Agreement
The Chemours Separation Agreement sets forth, among other things, the agreements between the company and Chemours regarding the principal transactions necessary to effect the Chemours Separation and also sets forth ancillary agreements that govern certain aspects of the company’s relationship with Chemours after the separation. Among other matters, the Chemours Separation Agreement and the ancillary agreements provide for the allocation between Historical DuPont and Chemours of assets, employees, liabilities and obligations (including investments, property and employee benefits and tax-related assets and liabilities) attributable to periods prior to, at and after the completion of the Chemours Separation.

Pursuant to the Chemours Separation Agreement, Chemours indemnifies the company against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the distribution. The term of this indemnification is generally indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In 2017, EID and Chemours amended the Chemours Separation Agreement ("2017 Amendment") to provide for a limited sharing of potential future perfluorooctanoic acid (“PFOA”) liabilities for a period of five years beginning July 6, 2017. In January 2021, Chemours, DuPont and Corteva entered into a binding memorandum of understanding ("MOU") amending the Chemours Separation Agreement, and thereby replacing the 2017 Amendment.

In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. At March 31, 2021, the indemnification assets are $63 million within accounts and notes receivable - net and $259 million within other assets (along with the corresponding liabilities within accrued and other current liabilities and other noncurrent obligations in the interim Condensed Consolidated Balance Sheet.) Additionally, at March 31, 2021 indemnification liabilities related to the MOU, primarily associated with environmental remediation related to PFAS, were $10 million within accrued and other current liabilities and $44 million within other noncurrent obligations in the interim Condensed Consolidated Balance Sheet. During the three months ended March 31, 2021, the company recorded a charge of $3 million to (loss) income from discontinued operations after income taxes, related to the MOU.

See Note 13 - Commitments and Contingent Liabilities, to the interim Consolidated Financial Statements, for further discussion of the amendment to the Chemours Separation Agreement, MOU, and environmental matters indemnified by Chemours.


NOTE 4 - REVENUE

Revenue Recognition
Products
Substantially all of Corteva's revenue is derived from product sales. Product sales consist of sales of Corteva's products to farmers, distributors, and manufacturers. Corteva considers purchase orders, which in some cases are governed by master supply agreements, to be a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year. However, the company has some long-term contracts which can span multiple years.

Revenue from product sales is recognized when the customer obtains control of the company's product, which occurs at a point in time according to shipping terms. Payment terms are generally less than one year from invoicing. The company elected the practical expedient and does not adjust the promised amount of consideration for the effects of a significant financing component when the company expects it will be one year or less between when a customer obtains control of the company's product and when payment is due. The company has elected to recognize shipping and handling activities when control has transferred to the customer as an expense in cost of goods sold. Taxes collected from customers relating to product sales and
10

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

remitted to governmental authorities are excluded from revenues. In addition, the company elected the practical expedient to expense any costs to obtain contracts as incurred, as the amortization period for these costs would have been one year or less.

The transaction price includes estimates of variable consideration, such as rights of return, rebates, and discounts, that are reductions in revenue. All estimates are based on the company's historical experience, anticipated performance, and the company's best judgment at the time the estimate is made. Estimates of variable consideration included in the transaction price utilize either the expected value method or most likely amount depending on the nature of the variable consideration. These estimates are reassessed each reporting period and are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur upon resolution of uncertainty associated with the variable consideration. The majority of contracts have a single performance obligation satisfied at a point in time and the transaction price is stated in the contract, usually as quantity times price per unit. For contracts with multiple performance obligations, the company allocates the transaction price to each performance obligation based on the relative standalone selling price. The standalone selling price is the observable price which depicts the price as if sold to a similar customer in similar circumstances.

Licenses of Intellectual Property
Corteva enters into licensing arrangements with customers under which it licenses its intellectual property. Revenue from the majority of intellectual property licenses is derived from sales-based royalties. Revenue for licensing agreements that contain sales-based royalties is recognized at the later of (i) when the subsequent sale occurs or (ii) when the performance obligation to which some or all of the royalty has been allocated is satisfied.

Remaining Performance Obligations
Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. The company applies the practical expedient to disclose the transaction price allocated to the remaining performance obligations for only those contracts with an original duration of one year or more. The transaction price allocated to remaining performance obligations with an original duration of more than one year related to material rights granted to customers for contract renewal options were $113 million at March 31, 2021 ($115 million and $106 million at December 31, 2020 and March 31, 2020, respectively). The company expects revenue to be recognized for the remaining performance obligations over the next 1 year to 6 years.

Contract Balances
Contract liabilities primarily reflect deferred revenue from prepayments under contracts with customers where the company receives advance payments for products to be delivered in future periods. Corteva classifies deferred revenue as current or noncurrent based on the timing of when the company expects to recognize revenue. Contract assets primarily include amounts related to contractual rights to consideration for completed performance not yet invoiced. Accounts receivable are recorded when the right to consideration becomes unconditional.
Contract BalancesMarch 31, 2021December 31, 2020March 31, 2020
(In millions)
Accounts and notes receivable - trade1
$5,764 $3,917 $5,779 
Contract assets - current2
$22 $22 $20 
Contract assets - noncurrent3
$53 $54 $49 
Deferred revenue - current$2,247 $2,662 $1,996 
Deferred revenue - noncurrent4
$111 $116 $104 
1.Included in accounts and notes receivable - net in the interim Condensed Consolidated Balance Sheets.
2.Included in other current assets in the interim Condensed Consolidated Balance Sheets.
3.Included in other assets in the interim Condensed Consolidated Balance Sheets.
4.Included in other noncurrent obligations in the interim Condensed Consolidated Balance Sheets.

Revenue recognized during the three months ended March 31, 2021 from amounts included in deferred revenue at the beginning of the period was $924 million ($822 million in the three months ended March 31, 2020).


11

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


Disaggregation of Revenue
Corteva's operations are classified into two reportable segments: Seed and Crop Protection. The company disaggregates its revenue by major product line and geographic region, as the company believes it best depicts the nature, amount and timing of its revenue and cash flows. Net sales by major product line are included below:
Three Months Ended
March 31,
(In millions)20212020
    Corn$1,888 $1,864 
    Soybean177 181 
    Other oilseeds296 248 
    Other131 162 
Seed2,492 2,455 
    Herbicides986 823 
    Insecticides385 378 
    Fungicides261 229 
    Other54 71 
Crop Protection1,686 1,501 
Total$4,178 $3,956 
.

Sales are attributed to geographic regions based on customer location. Net sales by geographic region and segment are included below:
SeedThree Months Ended
March 31,
(In millions)20212020
North America1
$1,210 $1,290 
EMEA2
947 881 
Latin America274 216 
Asia Pacific61 68 
Total$2,492 $2,455 
Crop ProtectionThree Months Ended
March 31,
(In millions)20212020
North America1
$533 $475 
EMEA2
655 586 
Latin America244 218 
Asia Pacific254 222 
Total$1,686 $1,501 
1.Represents U.S. & Canada.
2.Europe, Middle East, and Africa ("EMEA").

12

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 5 - RESTRUCTURING AND ASSET RELATED CHARGES - NET

2021 Restructuring Actions
As discussed in the 2020 Annual Report, on February 1, 2021, Corteva approved restructuring actions designed to right-size and optimize its footprint and organizational structure according to the business needs in each region with the focus on driving continued cost improvement and productivity. As a result of these actions, the company expects to record total pre-tax restructuring charges of approximately $130 million to $170 million, comprised of approximately $40 million to $50 million of severance and related benefit costs, $40 million to $60 million of asset related charges, $10 million to $15 million of asset retirement obligations and $40 million to $45 million of costs related to contract terminations (contract terminations includes early lease terminations). Future cash payments related to this charge are anticipated to be approximately $80 million to $100 million, primarily related to the payment of severance and related benefits, asset retirement obligations, and costs related to contract terminations. The restructuring actions associated with this charge are expected to be substantially complete in 2021.

The charges related to the 2021 Restructuring Actions related to the segments, as well as corporate expenses, were as follows:
Three Months Ended March 31,
(In millions)2021
Seed$14 
Crop Protection28 
Corporate expenses47 
Total$89 

A reconciliation of the December 31, 2020 to the March 31, 2021 liability balances related to the 2021 Restructuring Actions is summarized below:
(In millions)Severance and Related Benefit Costs
Asset Related1
Contract Termination2
Total
Balance at December 31, 2020   $ 
Charges to income from continuing operations for the three months ended March 31, 202139 13 37 89 
Payments(1) (6)(7)
Asset write-offs (13) (13)
Balance at March 31, 2021$38 $ $31 $69 
1.In addition, the Company has a liability recorded for asset retirement obligations of $6 million as of March 31, 2021.
2.The liability for contract terminations includes lease obligations. The cash impact of these obligations will be substantially complete by 2022.

Execute to Win Productivity Program
During the first quarter of 2020, Corteva approved restructuring actions designed to improve productivity through optimizing certain operational and organizational structures primarily related to the Execute to Win Productivity Program. Through the first quarter of 2021, the company recorded net pre-tax restructuring charges of $180 million inception-to-date under the Execute to Win Program, consisting of $117 million of asset related charges and $63 million of severance and related benefit costs. The company does not anticipate any additional material charges from the Execute to Win Program as actions associated with this charge were substantially complete by the end of 2020.

The Execute to Win Productivity Program charges related to the segments, as well as corporate expenses, were as follows:
Three Months Ended March 31,
(In millions)20212020
Seed$ $3 
Crop Protection4 18 
Corporate expenses 42 
Total$4 $63 

13

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

The below is a summary of charges incurred related to the Execute to Win Productivity Program for the three months ended March 31, 2021 and 2020:
Three Months Ended March 31,
(In millions)20212020
Severance and related benefit costs$ $42 
Asset related charges4 21 
Total restructuring and asset related charges - net$4 $63 

A reconciliation of the December 31, 2020 to the March 31, 2021 liability balances related to the Execute to Win Productivity Program is summarized below:
(In millions)Severance and Related Benefit CostsAsset RelatedTotal
Balance at December 31, 2020$53 $3 $56 
Charges to income from continuing operations for the three months ended March 31, 2021 4 4 
Payments(11)(3)(14)
Asset write-offs (4)(4)
Balance at March 31, 2021$42 $ $42 

In addition to the above, the company has a liability recorded for asset retirement obligations of $20 million as of March 31, 2021. The asset retirement obligations relate to the company’s required demolition and removal for buildings and equipment at third party leased sites and will be recognized as asset related charges over the remaining useful lives of the related assets.  The company’s leases require these assets be removed from leased land within 12-24 months of operations being ceased. The company ceased substantially all operations in 2020 and the assets are expected to be removed within the contractual timeframe.

Other Asset Related Charges
During the three months ended March 31, 2021 and 2020, the company recognized $7 million and $10 million, respectively, in restructuring and asset related charges, net in the interim Consolidated Statement of Operations, from non-cash accelerated prepaid royalty amortization expense related to Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits.

NOTE 6 - SUPPLEMENTARY INFORMATION
Other Income - NetThree Months Ended
March 31,
(In millions)20212020
Interest income$21 $18 
Equity in earnings / (losses) of affiliates - net3 (1)
Net loss on sales of businesses and other assets1
 (46)
Net exchange losses2
(35)(61)
Non-operating pension and other post employment benefit credit3
325 91 
Miscellaneous income - net4
23  
Other income - net$337 $1 
 
1.The three months ended March 31, 2020 includes a loss of $(53) million relating to the sale of the La Porte site, for which the company signed an agreement in 2020, and closed during the first quarter of 2021.
2.Includes net pre-tax exchange losses of $(23) million and $(9) million associated with the devaluation of the Argentine peso for the three months ended March 31, 2021 and 2020, respectively.
3.Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement loss).
4.Miscellaneous income - net, includes a gain from a remeasurement of an equity investment, losses on sale of available-for-sale securities, tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont, losses on sale of receivables, and other items.
14

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

The following table summarizes the impacts of the company's foreign currency hedging program on the company's results of operations. The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The hedging program gains (losses) are largely taxable (tax deductible) in the U.S., whereas the offsetting exchange gains (losses) on the remeasurement of the net monetary asset positions are often not taxable (tax deductible) in their local jurisdictions. The net pre-tax exchange gains (losses) are recorded in other income - net and the related tax impact is recorded in provision for (benefit from) income taxes on continuing operations in the interim Consolidated Statement of Operations.
(In millions)Three Months Ended
March 31,
20212020
Subsidiary Monetary Position (Losses) Gains
Pre-tax exchange losses$(51)$(226)
Local tax (expenses) / benefits(1)23 
Net after-tax impact from subsidiary exchange losses$(52)$(203)
Hedging Program Gains
Pre-tax exchange gains$16 $165 
Tax expenses(4)(40)
Net after-tax impact from hedging program exchange gains$12 $125 
Total Exchange Losses
Pre-tax exchange losses$(35)$(61)
Tax expenses(5)(17)
Net after-tax exchange losses$(40)$(78)
Cash, cash equivalents and restricted cash
The following table provides a reconciliation of cash and cash equivalents and restricted cash (included in other current assets) presented in the interim Condensed Consolidated Balance Sheets to the total cash, cash equivalents and restricted cash presented in the interim Consolidated Statements of Cash Flows.
(In millions)March 31, 2021December 31, 2020March 31, 2020
Cash and cash equivalents$2,404 $3,526 $1,963 
Restricted cash326 347 377 
Total cash, cash equivalents and restricted cash$2,730 $3,873 $2,340 

EID entered into a trust agreement in 2013 (as amended and restated in 2017), establishing and requiring EID to fund a trust (the "Trust") for cash obligations under certain non-qualified benefit and deferred compensation plans upon a change in control event as defined in the Trust agreement. Under the Trust agreement, the consummation of the Merger was a change in control event. Restricted cash at March 31, 2021, December 31, 2020, and March 31, 2020 is related to the Trust.

15

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 7 - INCOME TAXES

For periods between the Merger Effectiveness Time and the Corteva Distribution, Corteva and its subsidiaries were included in DowDuPont's consolidated federal income tax group and consolidated tax return.  Generally, the consolidated tax liability of the DowDuPont U.S. tax group for each year was apportioned among the members of the consolidated group based on each member’s separate taxable income.  Corteva, DuPont and Dow intend that to the extent Federal and/or State corporate income tax liabilities are reduced through the utilization of tax attributes of the other, settlement of any receivable and payable generated from the use of the other party’s sub-group attributes will be in accordance with a tax matters agreement. See Note 3 - Divestitures and Other Transactions, for further information related to indemnifications between Corteva, Dow and DuPont.

Each year the company files hundreds of tax returns in the various national, state and local income taxing jurisdictions in which it operates. These tax returns are subject to examination and possible challenge by the tax authorities. Positions challenged by the tax authorities may be settled or appealed by the company. As a result, there is an uncertainty in income taxes recognized in the company's financial statements in accordance with accounting for income taxes and accounting for uncertainty in income taxes. The ultimate resolution of such uncertainties is not expected to have a material impact on the company's results of operations.

The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of the program, which resides in the U.S., is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions, which can drive material impacts on the company's effective tax rate. For further discussion of pre-tax and after-tax impacts of the company's foreign currency hedging program and net monetary asset programs, refer to Note 6 - Supplementary Information.

16

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 8 - EARNINGS PER SHARE OF COMMON STOCK

The following tables provide earnings per share calculations for the periods indicated below:
Net Income for Earnings Per Share Calculations - Basic and DilutedThree Months Ended
March 31,
(In millions)20212020
Income from continuing operations after income taxes$613 $281 
Net income attributable to continuing operations noncontrolling interests3 10 
Income from continuing operations available to Corteva common stockholders610 271 
(Loss) income from discontinued operations available to Corteva common stockholders(10)1 
Net income available to common stockholders$600 $272 
Earnings Per Share Calculations - BasicThree Months Ended
March 31,
(Dollars per share)20212020
Earnings per share of common stock from continuing operations
$0.82 $0.36 
Loss per share of common stock from discontinued operations(0.01) 
Earnings per share of common stock$0.81 $0.36 
Earnings Per Share Calculations - DilutedThree Months Ended
March 31,
(Dollars per share)20212020
Earnings per share of common stock from continuing operations$0.81 $0.36 
Loss per share of common stock from discontinued operations (0.01) 
Earnings per share of common stock$0.80 $0.36 
Share Count InformationThree Months Ended
March 31,
(Shares in millions)20212020
Weighted-average common shares - basic743.4 749.9 
Plus dilutive effect of equity compensation plans1
6.2 2.6 
Weighted-average common shares - diluted749.6 752.5 
Potential shares of common stock excluded from EPS calculations2
2.9 9.1 
1.Diluted earnings per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.
2.These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been anti-dilutive.
17

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 9 - ACCOUNTS AND NOTES RECEIVABLE - NET
(In millions)March 31, 2021December 31, 2020March 31, 2020
Accounts receivable – trade1
$5,231 $3,754 $5,367 
Notes receivable – trade1,2
533 163 412 
Other3
1,028 1,009 996 
Total accounts and notes receivable - net$6,792 $4,926 $6,775 
1.Accounts receivable – trade and notes receivable - trade are net of allowances of $203 million at March 31, 2021, $208 million at December 31, 2020, and $203 million at March 31, 2020. Allowances are equal to the estimated uncollectible amounts and are based on the expected credit losses and were developed using a loss-rate method.
2.Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid pre-approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of March 31, 2021, December 31, 2020, and March 31, 2020 there were no significant impairments related to current loan agreements.
3.Other includes receivables in relation to indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than 10 percent of total receivables. In addition, Other includes amounts due from nonconsolidated affiliates of $115 million, $106 million, and $140 million as of March 31, 2021, December 31, 2020, and March 31, 2020, respectively.

Accounts and notes receivable are carried at the expected amount to be collected, which approximates fair value. The company establishes the allowance for doubtful receivables using a loss-rate method where the loss rate is developed using past events, historical experience, current conditions and forecasts that affect the collectability of the financial assets.

The following table summarizes changes in the allowance for doubtful receivables for the three months ended March 31, 2021 and 2020:
(In millions)
2020
Balance at December 31, 2019$174 
Net provision for credit losses60 
Write-offs charged against allowance(1)
Recoveries collected(30)
Balance at March 31, 2020
$203 
2021
Balance at December 31, 2020$208 
Net benefit for credit losses(5)
Balance at March 31, 2021
$203 

The company enters into various factoring agreements with third-party financial institutions to sell its trade receivables under both recourse and non-recourse agreements in exchange for cash proceeds. These financing arrangements result in a transfer of the company's receivables and risks to the third-party. As these transfers qualify as true sales under the applicable accounting guidance, the receivables are derecognized from the interim Condensed Consolidated Balance Sheets upon transfer, and the company receives a payment for the receivables from the third-party within a mutually agreed upon time period. For arrangements involving an element of recourse, which is typically provided through a guarantee of accounts in the event of customer default, the guarantee obligation is measured using market data from similar transactions and reported as a current liability in the interim Condensed Consolidated Balance Sheets.

Trade receivables sold under these agreements were $11 million and $15 million for the three months ended March 31, 2021 and March 31, 2020, respectively. The trade receivables sold that remained outstanding under these agreements which include an element of recourse as of March 31, 2021, December 31, 2020, and March 31, 2020 were $128 million, $157 million, and $43 million, respectively. The net proceeds received are included in cash provided by operating activities in the interim Consolidated Statements of Cash Flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of receivables in other income - net in the Consolidated Statements of Operations. Loss on sale of receivables for the three months ended March 31, 2021 and 2020 were not material. The guarantee obligations recorded as of March 31, 2021, December 31, 2020, and March 31, 2020 in the interim Condensed Consolidated Balance Sheets were not material. See Note 13 - Commitments and Contingent Liabilities for additional information on the company’s guarantees.
18

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 10 - INVENTORIES
(In millions)March 31, 2021December 31, 2020March 31, 2020
Finished products$2,508 $2,584 $2,721 
Semi-finished products1,386 1,813 1,260 
Raw materials and supplies427 485 420 
Total inventories$4,321 $4,882 $4,401 



NOTE 11 - OTHER INTANGIBLE ASSETS

The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows: 
(In millions)March 31, 2021December 31, 2020March 31, 2020
 GrossAccumulated
Amortization
NetGrossAccumulated
Amortization
NetGrossAccumulated
Amortization
Net
Intangible assets subject to amortization (Definite-lived):
      
Germplasm$6,265 $(380)$5,885 $6,265 $(317)$5,948 $6,265 $(126)$6,139 
Customer-related
1,956 (404)1,552 1,984 (380)1,604 1,956 (293)1,663 
Developed technology
1,485 (565)920 1,451 (525)926 1,463 (409)1,054 
Trademarks/trade names1
2,013 (112)1,901 2,019 (99)1,920 166 (88)78 
Favorable supply contracts
475 (326)149 475 (302)173 475 (231)244 
Other2
405 (238)167 405 (239)166 400 (218)182 
Total other intangible assets with finite lives
12,599 (2,025)10,574 12,599 (1,862)10,737 10,725 (1,365)9,360 
Intangible assets not subject to amortization (Indefinite-lived):
      
IPR&D10 — 10 10 — 10 10 — 10 
Trade name1
1,871 — 1,871 
Total other intangible assets10 — 10 10 — 10 1,881 — 1,881 
Total$12,609 $(2,025)$10,584 $12,609 $(1,862)$10,747 $12,606 $(1,365)$11,241 
1.Beginning on October 1, 2020, the company changed its indefinite life assertion of its trade name asset to definite lived with a useful life of 25 years. This change is the result of the launch of BrevantTM seed in the retail channel in the U.S. Prior to changing the useful life of the trade name asset, the company tested the asset for the impairment under ASC 350- Intangibles, Goodwill and Other, concluding the asset was not impaired.
2.Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.

The aggregate pre-tax amortization expense from continuing operations for definite-lived intangible assets was $183 million and $163 million for the three months ended March 31, 2021 and 2020, respectively. The current estimated aggregate pre-tax amortization expense from continuing operations for the remainder of 2021 and each of the next five years is approximately $537 million, $700 million, $620 million, $606 million, $569 million and $555 million, respectively.


19

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


NOTE 12 - SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES

The following tables summarize Corteva's short-term borrowings and finance lease obligations:
Short-term borrowings and finance lease obligations
(In millions)March 31, 2021December 31, 2020March 31, 2020
Commercial paper$1,218 $ $1,918 
Repurchase facility30  30 
Other loans - various currencies 1 45 
Long-term debt payable within one year1 1 1 
Finance lease obligations payable within one year1 1 2 
Total short-term borrowings and finance lease obligations$1,250 $3 $1,996 

The estimated fair value of the company's short-term borrowings, including interest rate financial instruments, was determined using Level 2 inputs within the fair value hierarchy. Based on quoted market prices for the same or similar issues, or on current rates offered to the company for debt of the same remaining maturities, the fair value of the company's short-term borrowings and finance lease obligations was approximately carrying value.

The fair value of the company’s long-term borrowings, including debt due within one year, was $1,121 million, $1,168 million, and $612 million as of March 31, 2021, December 31, 2020, and March 31, 2020, respectively, and was determined using quoted market prices for the same or similar issues, or current rates offered to the company for debt of the same remaining maturities (Level 2 inputs).

Repurchase Facility
In February 2021, the company entered into a new committed receivable repurchase facility of up to $1 billion (the "2021 Repurchase Facility") which expires in December 2021. Under the 2021 Repurchase Facility, Corteva may sell a portfolio of available and eligible outstanding customer notes receivables to participating institutions and simultaneously agree to repurchase at a future date. The 2021 Repurchase Facility is considered a secured borrowing with the customer notes receivables inclusive of those that are sold and repurchased, equal to 105 percent of the outstanding amounts borrowed utilized as collateral. Borrowings under the 2021 Repurchase Facility have an interest rate of LIBOR+0.85 percent.

As of March 31, 2021, $32 million of notes receivable, recorded in accounts and notes receivable - net, were pledged as collateral against outstanding borrowings under the 2021 Repurchase Facility of $30 million, recorded in short-term borrowings and finance lease obligations on the interim Condensed Consolidated Balance Sheet.

Revolving Credit Facilities
In November 2018, EID entered into a $3.0 billion 5-year revolving credit facility and a $3.0 billion 3-year revolving credit facility (the “Revolving Credit Facilities”). The Revolving Credit Facilities became effective May 2019. Corteva, Inc. became a party at the time of the Corteva Distribution. The Revolving Credit Facilities may serve as a substitute to the company's commercial paper program, and can be used, from time to time, for general corporate purposes including, but not limited to, the funding of seasonal working capital needs. The Revolving Credit Facilities contain customary representations and warranties, affirmative and negative covenants and events of default that are typical for companies with similar credit ratings. Additionally, the Revolving Credit Facilities contain a financial covenant requiring that the ratio of total indebtedness to total capitalization for Corteva and its consolidated subsidiaries not exceed 0.60.

In March 2020, the company drew down $500 million under the $3.0 billion 3-year revolving credit facility as a result of the volatility and increased borrowing costs of commercial paper resulting from the unstable market conditions caused by the COVID-19 pandemic and repaid that borrowing in full in June 2020. There were no additional borrowings and the unused commitments under the 3-year revolving credit facility were $3.0 billion as of March 31, 2021.


20

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 13 - COMMITMENTS AND CONTINGENT LIABILITIES

Guarantees
Indemnifications
In connection with acquisitions and divestitures as of March 31, 2021, the company has indemnified respective parties against certain liabilities that may arise in connection with these transactions and business activities prior to the completion of the transactions. The term of these indemnifications, which typically pertain to environmental, tax and product liabilities, is generally indefinite. In addition, the company indemnifies its duly elected or appointed directors and officers to the fullest extent permitted by Delaware law, against liabilities incurred as a result of their activities for the company, such as adverse judgments relating to litigation matters. If the indemnified party were to incur a liability or have a liability increase as a result of a successful claim, pursuant to the terms of the indemnification, the company would be required to reimburse the indemnified party. The maximum amount of potential future payments is generally unlimited. See pages 9 and 22 for additional information relating to the indemnification obligations under the Chemours Separation Agreement and the Corteva Separation Agreement.

Obligations for Customers and Other Third Parties
The company has directly guaranteed various debt obligations under agreements with third parties related to customers and other third parties. At March 31, 2021, December 31, 2020 and March 31, 2020, the company had directly guaranteed $108 million, $94 million, and $90 million, respectively, of such obligations. These amounts represent the maximum potential amount of future (undiscounted) payments that the company could be required to make under the guarantees in the event of default by the guaranteed party. All of the maximum future payments at March 31, 2021 had terms less than one year. The maximum future payments include $23 million at March 31, 2021 and $17 million at December 31, 2020 and March 31, 2020, respectively, of guarantees related to the various factoring agreements that the company enters into with third-party financial institutions to sell its trade receivables. See Note 9 - Accounts and Notes Receivable, Net, for additional information.

The maximum future payments also include agreements with lenders to establish programs that provide financing for select customers. The terms of the guarantees are equivalent to the terms of the customer loans that are primarily made to finance customer invoices. The total amounts owed from customers to the lenders relating to these agreements was $178 million, $16 million and $125 million at March 31, 2021, December 31, 2020 and March 31, 2020, respectively.

The company assesses the payment/performance risk by assigning default rates based on the duration of the guarantees. These default rates are assigned based on the external credit rating of the counterparty or through internal credit analysis and historical default history for counterparties that do not have published credit ratings. For counterparties without an external rating or available credit history, a cumulative average default rate is used.

Litigation
The company is subject to various legal proceedings, including, but not limited to, product liability, intellectual property, antitrust, commercial, property damage, personal injury, environmental and regulatory matters arising out of the normal course of its current businesses or legacy EID businesses unrelated to Corteva’s current businesses but allocated to Corteva as part of the separation of Corteva from DuPont. It is not possible to predict the outcome of these various proceedings, as considerable uncertainty exists.  However, the ultimate liabilities could be material to results of operations and the cash flows in the period recognized.

Indemnifications under Separation Agreements
The company has entered into various agreements where the company is indemnified for certain liabilities. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. See Note 3 - Divestitures and Other Transactions, to the interim Consolidated Financial Statements for additional information related to indemnifications.

Chemours/Performance Chemicals
Refer to Note 3 - Divestitures and Other Transactions, to the interim Consolidated Financial Statements for additional discussion of the Chemours Separation Agreement.

In 2017, EID and Chemours amended the Chemours Separation Agreement to provide for a limited sharing of potential future liabilities related to alleged historical releases of perfluorooctanoic acids and its ammonium salts (“PFOA”) for a five-year period that began on July 6, 2017. In addition, in 2017, Chemours and EID each paid $335 million to settle multi-district litigation in the U.S. District Court for the Southern District of Ohio (“Ohio MDL”), thereby resolving claims of about 3,550 plaintiffs alleging injury from exposure to PFOA in drinking water as a result of the historical manufacture or use of PFOA at the Washington Works plant outside Parkersburg, West Virginia. This plant was previously owned and/or operated by the performance chemicals segment of EID and is now owned and/or operated by Chemours. The 2017 settlement did not resolve
21

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

claims of certain class members who did not have claims in the Ohio MDL or whose claims are based on diseases first diagnosed after February 11, 2017. About 96 claims alleging personal injury were filed in the Ohio MDL since the 2017 settlement and a number of additional pre-suit claims for personal injury were asserted.

On May 13, 2019, Chemours filed suit in the Delaware Court of Chancery against DuPont, EID, and Corteva, seeking, among other things, to limit its responsibility for the litigation and environmental liabilities allocated to and assumed by Chemours under the Chemours Separation Agreement (the “Delaware Litigation”). On March 30, 2020, the Court of Chancery granted a motion to dismiss. On December 15, 2020, the Delaware Supreme Court affirmed the judgment of the Court of Chancery. Meanwhile, a confidential arbitration process regarding the same and other claims had proceeded (the “Pending Arbitration”).

For additional information regarding environmental indemnification, see discussion on page 25.

On January 22, 2021, Chemours, DuPont, Corteva and EID entered into a binding memorandum of understanding containing a settlement to resolve legal disputes originating from the Delaware Litigation and Pending Arbitration, and to establish a cost sharing arrangement and escrow account to be used to support and manage potential future legacy per- and polyfluoroalkyl substances (“PFAS”) liabilities arising out of pre-July 1, 2015 conduct (the “MOU”). The MOU replaces the 2017 amendment to the Chemours Separation Agreement. According to the terms of the cost sharing arrangement within the MOU, Corteva and DuPont together, on one hand, and Chemours, on the other hand, agreed to a 50-50 split of certain qualified expenses related to PFAS liabilities incurred over a term not to exceed twenty years or $4 billion of qualified spend and escrow account contributions (see below for discussion of escrow account) in the aggregate. DuPont’s and Corteva’s 50% share under the MOU will be limited to $2 billion, including qualified expenses and escrow contributions. These expenses and escrow account contributions will be subject to the existing Letter Agreement, under which DuPont and Corteva will each bear 50% of the first $300 million (up to $150 million each), and thereafter DuPont bears 71% and Corteva bears the remaining 29%.

In order to support and manage any potential future PFAS liabilities, the parties have also agreed to establish an escrow account. The MOU provides that (1) no later than each of September 30, 2021 and September 30, 2022, Chemours shall deposit $100 million into an escrow account and DuPont and Corteva shall together deposit $100 million in the aggregate into an escrow account and (2) no later than September 30 of each subsequent year through and including 2028, Chemours shall deposit $50 million into an escrow account and DuPont and Corteva shall together deposit $50 million in the aggregate into an escrow account. Subject to the terms and conditions set forth in the MOU, each party may be permitted to defer funding in any year (excluding 2021). Over this period, Chemours will deposit a total of $500 million in the account and DuPont and Corteva will deposit an additional $500 million pursuant to the terms of the Letter Agreement. Additionally, if on December 31, 2028, the balance of the escrow account (including interest) is less than $700 million, Chemours will make 50% of the deposits and DuPont and Corteva together will make 50% of the deposits necessary to restore the balance of the escrow account to $700 million. Such payments will be made in a series of consecutive annual equal installments commencing on September 30, 2029 pursuant to the escrow account replenishment terms as set forth in the MOU.

After the term of this arrangement, Chemours’ indemnification obligations under the original 2015 Chemours Separation Agreement, would continue unchanged, subject in each case to certain exceptions set out in the MOU. Under the MOU, Chemours waived specified claims regarding the construct of its 2015 spin-off transaction, and the parties will dismiss the pending arbitration regarding those claims (as discussed below). Additionally, the parties have agreed to resolve the Ohio MDL PFOA personal injury litigation (as discussed below). The parties are expected to cooperate in good faith to enter into additional agreements reflecting the terms set forth in the MOU.

Corteva Separation Agreement
On April 1, 2019, in connection with the Dow Distribution, Corteva, DuPont and Dow entered into the Corteva Separation Agreement, the Tax Matters Agreement, the Employee Matters Agreement, and certain other agreements (collectively, the “Corteva Separation Agreements”). The Corteva Separation Agreements allocate among Corteva, DuPont and Dow certain liabilities and obligations among the parties and provides for indemnification obligation among the parties. Under the Corteva Separation Agreements, DuPont will indemnify Corteva against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the Corteva Distribution and (ii) Dow indemnifies Corteva against certain litigation and other liabilities that relate to the Historical Dow business, but were transferred over as part of the common control combination with DAS, and Corteva indemnifies DuPont and Dow for certain liabilities. The term of this indemnification is generally indefinite with exceptions, and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. See Note 3 - Divestitures and Other Transactions, to the interim Consolidated Financial Statements for additional information relating to the Separation.


22

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

DuPont
Under the Corteva Separation Agreement, certain legacy EID liabilities from discontinued and/or divested operations and businesses of EID (including Performance Chemicals) (a “stray liability”) were allocated to Corteva or DuPont. For those stray liabilities allocated to Corteva (which may include a specified amount of liability associated with that liability), Corteva is responsible for liabilities in an amount up to that specified amount plus an additional $200 million and, for those stray liabilities allocated to DuPont (which may include a specified amount of liability associated with that liability), DuPont is responsible for liabilities up to a specified amount plus an additional $200 million. Once each company has met the $200 million threshold, Corteva and DuPont will share future liabilities proportionally on the basis of 29% and 71%, respectively; provided, however, that for PFAS, DuPont will manage such liabilities with Corteva and DuPont sharing the costs on a 50% - 50% basis starting from $1 and up to $300 million (with such amount, up to $150 million, to be credited to each company’s $200 million threshold) and once the $300 million threshold is met, then the companies will share proportionally on the basis of 29% and 71% respectively, subject to a $1 million de minimis requirement.

Litigation related to legacy EID businesses unrelated to Corteva’s current businesses

PFAS, PFOA, PFOS and Other Related Liabilities
For purposes of this report, the term PFOA means collectively perfluorooctanoic acid and its salts, including the ammonium salt and does not distinguish between the two forms, and PFAS, which means per- and polyfluoroalkyl substances, including PFOA, PFOS (perfluorooctanesulfonic acid), GenX and other perfluorinated chemicals and compounds ("PFCs").

EID is a party to various legal proceedings relating to the use of PFOA by its former Performance Chemicals segment for which potential liabilities would be subject to the cost sharing arrangement under the MOU as long as it remains effective. Management believes that it is reasonably possible that EID could incur liabilities related to PFOA in excess of amounts accrued. However, any such losses are not estimable at this time due to various reasons, including, among others, that the underlying matters are in their early stages and have significant factual issues to be resolved. The company has recorded a liability of $21 million and an indemnification asset of $16 million at March 31, 2021, related to testing drinking water in and around certain former EID sites and offering treatment or an alternative supply of drinking water if tests indicate the presence of PFOA in drinking water at or greater than the national health advisory level established from time to time by the EPA.

Leach Settlement and Ohio MDL Settlement
EID has residual liabilities under its 2004 settlement of a West Virginia state court class action, Leach v. EID, which alleged that PFOA from EID’s former Washington Works facility had contaminated area drinking water supplies and affected the health of area residents. The settlement class has about 80,000 members. In addition to relief that was provided to class members years ago, the settlement requires EID to continue providing PFOA water treatment to six area water districts and private well users and to fund, through an escrow account, up to $235 million for a medical monitoring program for eligible class members. As of March 31, 2021, approximately $2 million had been disbursed from the account since its establishment in 2012 and the remaining balance is approximately $1 million.

The Leach settlement permits class members to pursue personal injury claims for six health conditions (and no others) that an expert panel appointed under the settlement reported in 2012 had a “probable link” (as defined in the settlement) with PFOA: pregnancy-induced hypertension, including preeclampsia; kidney cancer; testicular cancer; thyroid disease; ulcerative colitis; and diagnosed high cholesterol. After the panel reported its findings, approximately 3,550 personal injury lawsuits were filed in federal and state courts in Ohio and West Virginia and consolidated in multi-district litigation in the U.S. District Court for the Southern District of Ohio (“Ohio MDL”). The Ohio MDL was settled in early 2017 for $670.7 million in cash, with Chemours and EID (without indemnification from Chemours) each paying half.

Post-MDL Settlement PFOA Personal Injury Claims
The 2017 Ohio MDL settlement did not resolve claims of plaintiffs who did not have claims in the Ohio MDL or whose claims are based on diseases first diagnosed after February 11, 2017. The first trial for these claims, a kidney cancer case, resulted in a hung jury, while the second, Travis and Julie Abbot v. E.I du Pont de Nemours and Company (the “Abbot Case”), a testicular cancer case, resulted in a jury verdict of $40 million in compensatory damages and $10 million for loss of consortium. Following entry of the judgment by the court, EID filed post-trial motions to reduce the verdict, and to appeal the verdict on the basis of procedural and substantive legal errors made by the trial court. The trial court recently granted EID’s motion to reduce the loss of consortium award to conform with state tort reform laws limiting these damages to $250,000. The company is continuing its other appeals to reduce the jury verdict or eliminate its liability, in whole or part.

In January 2021, Chemours, DuPont and Corteva agreed to settle the remaining approximately 95 matters, as well as unfiled matters, remaining in the Ohio MDL, with the exception of the Abbot case, for $83 million, with Chemours contributing $29 million to the settlement, and DuPont and Corteva contributing $27 million each. The company recorded a liability for its share
23

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

of the settlement, with a charge to (loss) income from discontinued operations after income taxes, during the year ended December 31, 2020, and paid $16 million during the three months ended March 31, 2021. Following this settlement, the parties have agreed to petition the court for the dissolution of the MDL.

Other PFOA Matters
EID is a party to other PFOA lawsuits that do not involve claims for personal injury. Defense costs and any future liabilities that may arise out of these lawsuits are subject to the MOU and the cost sharing arrangement disclosed above. Under the MOU, fraudulent conveyance claims associated with these matters are not qualified expenses, unless Corteva, Inc. and EID would prevail on the merits of these claims.

New York. EID is a defendant in about 50 lawsuits, including a putative class action, brought by persons who live in and around Hoosick Falls, New York. These lawsuits assert claims for medical monitoring and property damage based on alleged PFOA releases from manufacturing facilities owned and operated by co-defendants in Hoosick Falls and allege that EID and 3M supplied some of the materials used at these facilities. EID is also one of more than ten defendants in a lawsuit brought by the Town of East Hampton, New York alleging PFOA and PFOS contamination of the town’s well water. Additionally, EID, along with 3M, Chemours and Dyneon, have been named defendants in complaints filed by eight water districts in Nassau County, New York alleging that the drinking water they provide to customers is contaminated with PFAS and seeking reimbursement for clean-up costs. The water district complaints also include allegations of fraudulent transfer.

New Jersey. At March 31, 2021, two lawsuits were pending, one brought by a local water utility and the second a putative class action, against EID alleging that PFOA from EID’s former Chambers Works facility contaminated drinking water sources. The putative class action was voluntarily dismissed without prejudice by the plaintiff.

In late March of 2019, the New Jersey State Attorney General filed four lawsuits against EID, Chemours, 3M and others alleging that operations at and discharges from former EID sites in New Jersey (Chambers Works, Pompton Lakes, Parlin and Repauno) damaged the State’s natural resources. Two of these lawsuits (those involving the Chambers Works and Parlin sites) allege contamination from PFAS. The Ridgewood Water District in New Jersey filed suit in the first quarter 2019 against EID, 3M, Chemours, and Dyneon alleging losses related to the investigation, remediation and monitoring of polyfluorinated surfactants, including PFOA, in water supplies. DuPont and Corteva were subsequently added as defendants to these lawsuits.

Alabama / Others. EID is one of more than thirty defendants in a lawsuit by the Alabama water utility alleging contamination from PFCs, including PFOA, used by co-defendant carpet manufacturers to make their products more stain and grease resistant. In addition, the states of Alaska, Michigan, Mississippi, New Hampshire, South Dakota, and Vermont recently filed lawsuits against EID, Chemours, 3M and others, claiming, among other things, PFC (including PFOA) contamination of groundwater and drinking water. The complaints seek reimbursement for past and future costs to investigate and remediate the alleged contamination and compensation for the loss of value and use of the state’s natural resources. Motions to dismiss the Michigan, Vermont and New Hampshire cases have been denied. Additionally, the State of Delaware has indicated it may file a similar natural resource claim related to alleged PFAS contamination and other contaminants.

Ohio. EID is a defendant in three lawsuits: an action by the State of Ohio based on alleged damage to natural resources, a putative nationwide class action brought on behalf of anyone who has detectable levels of PFAS in their blood serum, and an action by the City of Dayton claiming losses related to the investigation, remediation and monitoring of PFAS in water supplies.

Aqueous Firefighting Foams. Approximately 985 cases have been filed against 3M and other defendants, including EID and Chemours, and more recently also including Corteva and DuPont, alleging PFOS or PFOA contamination of soil and groundwater from the use of aqueous firefighting foams. Most of those cases claim some form of property damage and seek to recover the costs of responding to this contamination and damages for the loss of use and enjoyment of property and diminution in value. Most of these cases have been transferred to a multidistrict litigation proceeding in federal district court in South Carolina. Approximately 910 of these cases were filed on behalf of firefighters who allege personal injuries (primarily kidney and testicular cancer) as a result of aqueous firefighting foams. Most of these recent cases assert claims that the EID and Chemours separation constituted a fraudulent conveyance. A schedule of initial trials is expected to be established in the second quarter of 2021.

EID did not make firefighting foams, PFOS, or PFOS products. While EID made surfactants and intermediaries that some manufacturers used in making foams, which may have contained PFOA as an unintended byproduct or an impurity, EID’s
24

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

products were not formulated with PFOA, nor was PFOA an ingredient of these products. EID has never made or sold PFOA as a commercial product.

Fayetteville Works Facility, North Carolina
Prior to the separation of Chemours, EID introduced GenX as a polymerization processing aid and a replacement for PFOA at the Fayetteville Works facility in Bladen County, North Carolina. The facility is now owned and operated by Chemours, which continues to manufacture and use GenX.

At March 31, 2021, several actions are pending in federal court against Chemours and EID relating to PFC discharges from the Fayetteville Works facility. One of these is a consolidated putative class action that asserts claims for medical monitoring and property damage on behalf of putative classes of property owners and residents in areas near or who draw drinking water from the Cape Fear River. Another action is a consolidated action brought by various North Carolina water authorities, including the Cape Fear Public Utility Authority and Brunswick County, that seek actual and punitive damages as well as injunctive relief. In another action over approximately 100 property owners near the Fayetteville Works facility filed a complaint against Chemours and EID in May 2020. The plaintiffs seek compensatory and punitive damages for their claims of private nuisance, trespass, and negligence allegedly caused by release of PFAS.

In addition to the federal court actions, there is an action on behalf of about 100 plaintiffs who own wells and property near the Fayetteville Works facility. The plaintiffs seek damages for nuisance allegedly caused by releases of certain PFCs from the site. The plaintiffs’ claims for medical monitoring, punitive damages, public nuisance, trespass, unjust enrichment, failure to warn, and negligent manufacture were dismissed.

Generally, site-related expenses related GenX claims are subject to the cost sharing arrangements as defined in the MOU.

Environmental
Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on current law and existing technologies. At March 31, 2021, the company had accrued obligations of $333 million for probable environmental remediation and restoration costs, including $56 million for the remediation of Superfund sites. These obligations are included in accrued and other current liabilities and other noncurrent obligations in the interim Condensed Consolidated Balance Sheet. This is management’s best estimate of the costs for remediation and restoration with respect to environmental matters for which the company has accrued liabilities, although it is reasonably possible that the ultimate cost with respect to these particular matters could range up to $577 million above the amount accrued at March 31, 2021. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the company’s results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration.

For a discussion of the allocation of environmental liabilities under the Chemours Separation Agreement and the Corteva Separation Agreement, see the previous discussion on page 22.

25

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

The above noted $333 million accrued obligations includes the following:
As of March 31, 2021
(In millions)Indemnification Asset
Accrual balance3,4
Potential exposure above amount accrued3
Environmental Remediation Stray Liabilities
Chemours related obligations - subject to indemnity1,2
$152 $152 $280 
Other discontinued or divested businesses obligations1
 78 177 
Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont2
34 34 65 
Environmental remediation liabilities not subject to indemnity 69 55 
Total$186 $333 $577 
1.Represents liabilities that are subject to the $200 million thresholds and sharing arrangements as discussed on page 22, under Corteva Separation Agreement.
2.The company has recorded an indemnification asset related to these accruals, including $30 million related to the Superfund sites.
3.Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates
4.Accrual balance excludes indemnification liabilities of $54 million to Chemours, related to the cost sharing arrangement under the MOU (see page 10).


NOTE 14 - STOCKHOLDERS' EQUITY

Share Buyback Plan
On June 26, 2019, Corteva, Inc. announced that the Board of Directors of Corteva, Inc. authorized a $1 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date. The timing, price and volume of purchases will be based on market conditions, relevant securities laws and other factors.

During the three months ended March 31, 2021, the company purchased and retired 7,646,000 shares in the open market for a total cost of $350 million. During the three months ended March 31, 2020, the company purchased and retired 1,865,000 shares in the open market for a total cost of $50 million.

Shares repurchased pursuant to Corteva's share buyback plan are immediately retired upon purchase. Repurchased common stock is reflected as a reduction of stockholders' equity. The company's accounting policy related to its share repurchases is to reduce its common stock based on the par value of the shares and to reduce its retained earnings for the excess of the repurchase price over the par value. When Corteva has an accumulated deficit balance, the excess over the par value is applied to additional paid-in capital. When Corteva has retained earnings, the excess is charged entirely to retained earnings.

Noncontrolling Interest
Corteva, Inc. owns 100% of the outstanding common shares of EID. However, EID has preferred stock outstanding to third parties which is accounted for as a non-controlling interest in Corteva's interim Condensed Consolidated Balance Sheets. Each share of EID Preferred Stock - $4.50 Series and EID Preferred Stock - $3.50 Series issued and outstanding at the effective date of the Corteva Distribution remains issued and outstanding as to EID and was unaffected by the Corteva Distribution.

Below is a summary of the EID Preferred Stock at March 31, 2021, December 31, 2020, and March 31, 2020, which is classified as noncontrolling interests in Corteva's interim Condensed Consolidated Balance Sheets.
Shares in thousandsNumber of Shares
Authorized23,000
$4.50 Series, callable at $1201,673
$3.50 Series, callable at $102700

26

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

Other Comprehensive (Loss) Income
The changes and after-tax balances of components comprising accumulated other comprehensive loss are summarized below:
(In millions)
Cumulative Translation Adjustment1
Derivative InstrumentsPension Benefit PlansOther Benefit PlansUnrealized Gain (Loss) on InvestmentsTotal
2020
Balance January 1, 2020$(1,944)$2 $(1,247)$(81)$ $(3,270)
Other comprehensive (loss) income before reclassifications
(672)1 (2)3  (670)
Amounts reclassified from accumulated other comprehensive loss
 5 2   7 
Net other comprehensive (loss) income
(672)6  3  (663)
Balance March 31, 2020$(2,616)$8 $(1,247)$(78)$ $(3,933)
2021     
Balance January 1, 2021$(1,970)$(67)$(1,433)$590 $(10)$(2,890)
Other comprehensive (loss) income before reclassifications
(403)71 (4)1 4 (331)
Amounts reclassified from accumulated other comprehensive loss
 (6)12 (158)6 (146)
Net other comprehensive (loss) income
(403)65 8 (157)10 (477)
Balance March 31, 2021$(2,373)$(2)$(1,425)$433 $ $(3,367)
1.The cumulative translation adjustment loss for the three months ended March 31, 2020 was primarily driven by the strengthening of the USD against the Brazilian Real (“BRL”) and the South African Rand ("ZAR"). The cumulative translation adjustment loss for the three months ended March 31, 2021 was primarily driven by strengthening of the USD against the Swiss Franc ("CHF"), Brazilian Real ("BRL") and European Euro.

The tax benefit (expense) on the net activity related to each component of other comprehensive (loss) income was as follows:
(In millions)Three Months Ended
March 31,
20212020
Derivative instruments$(18)$5 
Pension benefit plans - net(2)(4)
Other benefit plans - net49  
Benefit from income taxes related to other comprehensive (loss) income items$29 $1 


27

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

A summary of the reclassifications out of accumulated other comprehensive loss is provided as follows:
(In millions)Three Months Ended
March 31,
20212020
Derivative Instruments1:
$(5)$7 
Tax benefit2
(1)(2)
After-tax$(6)$5 
Amortization of pension benefit plans:
  Actuarial losses3,4
$14 $1 
  Settlement loss3,4
1 2 
Total before tax$15 $3 
Tax benefit2
(3)(1)
After-tax$12 $2 
Amortization of other benefit plans:
  Prior service benefit3,4
$(230)$ 
  Actuarial gains3,4
23  
Total before tax$(207)$ 
Tax benefit2
49  
After-tax$(158)$ 
Unrealized Loss on Investments4
$6 $ 
Tax benefit2
  
After-tax$6 $ 
Total reclassifications for the period, after-tax$(146)$7 
1.Reflected in cost of goods sold.
2.Reflected in provision for (benefit from) income taxes from continuing operations.
3.These accumulated other comprehensive (loss) income components are included in the computation of net periodic benefit credit of the company's pension and other benefit plans. See Note 15 - Pension Plans and Other Post Employment Benefits, for additional information.
4.Reflected in other income - net.

28

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 15 - PENSION PLANS AND OTHER POST EMPLOYMENT BENEFITS

The following sets forth the components of the company's net periodic benefit (credit) cost for defined benefit pension plans and other post employment benefits:
Three Months Ended
March 31,
(In millions)20212020
Defined Benefit Pension Plans:
Service cost$7 $5 
Interest cost91 141 
Expected return on plan assets(230)(251)
Amortization of unrecognized loss14 1 
Settlement loss1 2 
Net periodic benefit credit$(117)$(102)
Other Post Employment Benefits:
Service cost$ $1 
Interest cost6 16 
Amortization of unrecognized loss23  
Amortization of prior service benefit(230) 
Net periodic benefit (credit) cost$(201)$17 

NOTE 16 - FINANCIAL INSTRUMENTS

At March 31, 2021, the company had $1,602 million ($2,511 million and $1,536 million at December 31, 2020 and March 31, 2020, respectively) of held-to-maturity securities (primarily time deposits and money market funds) classified as cash equivalents, as these securities had maturities of three months or less at the time of purchase; and $49 million ($43 million and $10 million at December 31, 2020 and March 31, 2020, respectively) of held-to-maturity securities (primarily time deposits) classified as marketable securities as these securities had maturities of more than three months to less than one year at the time of purchase. The company’s investments in held-to-maturity securities are held at amortized cost, which approximates fair value. Additionally, at March 31, 2021, the company had $65 million ($226 million at December 31, 2020) of available-for-sale securities. The above noted securities are included in cash and cash equivalents, marketable securities, and other current assets in the interim Condensed Consolidated Balance Sheets.

Derivative Instruments
Objectives and Strategies for Holding Derivative Instruments
In the ordinary course of business, the company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency and commodity price risks. The company has established a variety of derivative programs to be utilized for financial risk management. These programs reflect varying levels of exposure coverage and time horizons based on an assessment of risk.

Derivative programs have procedures and controls and are approved by the Corporate Financial Risk Management Committee, consistent with the company's financial risk management policies and guidelines. Derivative instruments used are forwards, options, futures and swaps. The company has not designated any non-derivatives as hedging instruments.

The company's financial risk management procedures also address counterparty credit approval, limits and routine exposure monitoring and reporting. The counterparties to these contractual arrangements are major financial institutions and major commodity exchanges, and multinational grain exporters. The company is exposed to credit loss in the event of nonperformance by these counterparties. The company utilizes collateral support annex agreements with certain counterparties to limit its exposure to credit losses. The company anticipates performance by counterparties to these contracts and therefore no material loss is expected. Market and counterparty credit risks associated with these instruments are regularly reported to management.


29

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

The notional amounts of the company's derivative instruments were as follows:
Notional Amounts
(In millions)
March 31, 2021December 31, 2020March 31, 2020
Derivatives designated as hedging instruments:
Foreign currency contracts
$1,030 $1,164 $751 
Commodity contracts
$239 $383 $418 
Derivatives not designated as hedging instruments:
Foreign currency contracts$715 $647 $644 
Commodity contracts$154 $ $59 

Foreign Currency Risk
The company's objective in managing exposure to foreign currency fluctuations is to reduce earnings and cash flow volatility associated with foreign currency rate changes and to mitigate the exposure of certain investments in foreign subsidiaries against changes in the Euro/USD exchange rate. Accordingly, the company enters into various contracts that change in value as foreign exchange rates change to protect the value of its existing foreign currency-denominated assets, liabilities, commitments, investments and cash flows.

The company uses foreign exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The primary business objective of this hedging program is to maintain an approximately balanced position in foreign currencies so that exchange gains and losses resulting from exchange rate changes, after related tax effects, are minimized. The company also uses foreign currency exchange contracts to offset a portion of the company’s exposure to certain forecasted transactions as well as the translation of foreign currency-denominated earnings. The company also uses commodity contracts to offset risks associated with foreign currency devaluation in certain countries.

Commodity Price Risk
Commodity price risk management programs serve to reduce exposure to price fluctuations on purchases of inventory such as corn and soybeans. The company enters into over-the-counter and exchange-traded derivative commodity instruments to hedge the commodity price risk associated with agricultural commodity exposures.

Derivatives Designated as Cash Flow Hedges
Commodity Contracts
The company enters into over-the-counter and exchange-traded derivative commodity instruments, including options, futures and swaps, to hedge the commodity price risk associated with agriculture commodity exposures.

While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two years. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is not probable of occurring.

The following table summarizes the after-tax effect of commodity contract cash flow hedges on accumulated other comprehensive loss:
Three Months Ended
March 31,
(In millions)20212020
Beginning balance$(16)$2 
Additions and revaluations of derivatives designated as cash flow hedges30 (22)
Clearance of hedge results to earnings(4)5 
Ending balance$10 $(15)

At March 31, 2021, an after-tax net loss of $8 million is expected to be reclassified from accumulated other comprehensive loss into earnings over the next twelve months.

Foreign Currency Contracts
The company enters into forward contracts to hedge the foreign currency risk associated with forecasted transactions within certain foreign subsidiaries.
30

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two years. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is not probable of occurring.

The following table summarizes the after-tax effect of foreign currency cash flow hedges on accumulated other comprehensive loss:
Three Months Ended
March 31,
(In millions)20212020
Beginning balance$(17)$ 
Additions and revaluations of derivatives designated as cash flow hedges25 16 
Clearance of hedge results to earnings(2) 
Ending balance$6 $16 

At March 31, 2021, an after-tax net gain of $6 million is expected to be reclassified from accumulated other comprehensive loss into earnings over the next twelve months.

Derivatives Designated as Net Investment Hedges
Foreign Currency Contracts
The company has designated €450 million of forward contracts to exchange EUR as net investment hedges. The purpose of these forward contracts is to mitigate FX exposure related to a portion of the company’s Euro net investments in certain foreign subsidiaries against changes in Euro/USD exchange rates. These hedges will expire and be settled in 2023, unless terminated early at the discretion of the company.

The company elected to apply the spot method in testing for effectiveness of the hedging relationship.

Derivatives not Designated in Hedging Relationships
Foreign Currency Contracts
The company uses foreign exchange contracts to reduce its net exposure, by currency, related to foreign currency-denominated monetary assets and liabilities of its operations so that exchange gains and losses resulting from exchange rate changes are minimized. The netting of such exposures precludes the use of hedge accounting; however, the required revaluation of the forward contracts and the associated foreign currency-denominated monetary assets and liabilities intends to achieve a minimal earnings impact, after taxes. The company also uses foreign currency exchange contracts to offset a portion of the company’s exposure to the translation of certain foreign currency-denominated earnings so that gains and losses on the contracts offset changes in the USD value of the related foreign currency-denominated earnings over the relevant aggregate period.

Commodity Contracts
The company utilizes options, futures and swaps that are not designated as hedging instruments to reduce exposure to commodity price fluctuations on purchases of inventory such as corn and soybeans. The company uses forward agreements, with durations less than one year, to buy and sell USD priced commodities in order to reduce its exposure to currency devaluation for a portion of its local currency cash balances. Counterparties to the forward sales agreements are multinational grain exporters and subject to the company’s financial risk management procedures.


31

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

Fair Value of Derivative Instruments
Asset and liability derivatives subject to an enforceable master netting arrangement with the same counterparty are presented on a net basis in the interim Condensed Consolidated Balance Sheets. The presentation of the company's derivative assets and liabilities is as follows:
March 31, 2021
(In millions)Balance Sheet LocationGross
Counterparty and Cash Collateral Netting1
Net Amounts Included in the interim Condensed Consolidated Balance Sheet
Asset derivatives:   
Derivatives designated as hedging instruments:
Foreign currency contracts
Other current assets$38 $ $38 
Derivatives not designated as hedging instruments:
  
Foreign currency contractsOther current assets52(32)20 
Total asset derivatives
 $90 $(32)$58 
Liability derivatives:  
Derivatives designated as hedging instruments:
Foreign currency contractsAccrued and other current liabilities$16 $ $16 
Derivatives not designated as hedging instruments:
  
Foreign currency contractsAccrued and other current liabilities46(30)16 
Total liability derivatives
 $62 $(30)$32 

32

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

December 31, 2020
(In millions)Balance Sheet LocationGross
Counterparty and Cash Collateral Netting1
Net Amounts Included in the Condensed Consolidated Balance Sheet
Asset derivatives:   
Derivatives designated as hedging instruments:
Foreign currency contractsOther current assets$15 $ $15 
Derivatives not designated as hedging instruments:
  
Foreign currency contracts
Other current assets40 (40) 
Total asset derivatives
 $55 $(40)$15 
Liability derivatives:  
Derivatives designated as hedging instruments:
Foreign currency contractsAccrued and other current liabilities$38 $ $38 
Derivatives not designated as hedging instruments:
  
Foreign currency contracts
Accrued and other current liabilities97 (40)57 
Total liability derivatives
 $135 $(40)$95 
March 31, 2020
(In millions)Balance Sheet LocationGross
Counterparty and Cash Collateral Netting1
Net Amounts Included in the interim Condensed Consolidated Balance Sheet
Asset derivatives:   
Derivatives designated as hedging instruments:
Foreign currency contracts
Other current assets$36 $ $36 
Derivatives not designated as hedging instruments:
  
Foreign currency contracts
Other current assets230 (110)120 
Total asset derivatives
 $266 $(110)$156 
Liability derivatives:  
Derivatives not designated as hedging instruments:
  
Foreign currency contracts
Accrued and other current liabilities$108 $(103)$5 
Total liability derivatives
 $108 $(103)$5 
1.    Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.


33

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

Effect of Derivative Instruments
Amount of (Loss) Gain Recognized in OCI1 - Pre-Tax
Three Months Ended
March 31,
(In millions)20212020
Derivatives designated as hedging instruments:
Net investment hedges:
Foreign currency contracts
$21 $9 
Cash flow hedges:
Foreign currency contracts
31 19 
 Commodity contracts36 (34)
Total derivatives designated as hedging instruments$88 $(6)
1.OCI is defined as other comprehensive income (loss).
Amount of Gain (Loss) Recognized in Income - Pre-Tax1
Three Months Ended
March 31,
(In millions)20212020
Derivatives designated as hedging instruments:
Cash flow hedges:
Foreign currency contracts2
$1 $ 
 Commodity contracts2
4 (7)
Total derivatives designated as hedging instruments
$5 $(7)
Derivatives not designated as hedging instruments:
Foreign currency contracts3
$16 $165 
Foreign currency contracts2
2  
Commodity contracts2
(12)9 
Total derivatives not designated as hedging instruments
6 174 
Total derivatives$11 $167 
1.For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period.
2.Recorded in cost of goods sold.
3.Gain recognized in other income (expense) - net was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 6 - Supplementary Information, for additional information.

Debt Securities
The company's investment in debt securities are classified as available-for-sale. At March 31, 2021, the fair value and amortized cost of the company's investments in debt securities with contractual maturities within one to five years was $65 million.

The estimated fair value of the available-for-sale securities as of March 31, 2021 and December 31, 2020 was determined using Level 1 inputs within the fair value hierarchy. Level 1 measurements were based on quoted market prices in active markets for identical assets and liabilities. The available-for-sale securities as of March 31, 2021 and December 31, 2020 are held by certain foreign subsidiaries in which the USD is not the functional currency. The fluctuations in foreign exchange are recorded in accumulated other comprehensive loss within the interim Consolidated Statements of Equity. These fluctuations are subsequently reclassified from accumulated other comprehensive loss to earnings in the period in which the marketable securities are sold and the gains and losses on these securities offset a portion of the foreign exchange fluctuations in earnings for the company.

34

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


The following table provides the investing results from available-for-sale securities for the three months ended March 31, 2021:
Investing ResultsThree Months Ended
 March 31,
(In millions)2021
Proceeds from sales of available-for-sale securities$161 
Gross realized losses(6)
Total$155 

The following table provides the fair value and gross unrealized losses of the company's investments in debt securities at March 31, 2021, aggregated by investment category:
March 31, 202112 months or more
(In millions)Fair valueGross unrealized losses
U.S. Treasuries$65 $ 


NOTE 17 - FAIR VALUE MEASUREMENTS

The following tables summarize the basis used to measure certain assets and liabilities at fair value on a recurring basis:
March 31, 2021Significant Other Observable Inputs
(In millions)Level 1Level 2
Assets at fair value:
Marketable securities
$— $49 
Debt securities:
U.S. treasuries1
65— 
Derivatives relating to:2
Foreign currency
— 90 
Total assets at fair value$65 $139 
Liabilities at fair value:
Derivatives relating to:2
Foreign currency
— 62 
Total liabilities at fair value$— $62 
December 31, 2020Significant Other Observable Inputs
(In millions)Level 1Level 2
Assets at fair value:
Marketable securities
$— $43 
Debt securities:
U.S. treasuries1
226— 
Derivatives relating to:2
Foreign currency
— 55 
Total assets at fair value$226 $98 
Liabilities at fair value:
Derivatives relating to:2
Foreign currency
— 135 
Total liabilities at fair value$— $135 
35

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

March 31, 2020Significant Other Observable Inputs (Level 2)
(In millions)
Assets at fair value:
Marketable securities
$10 
Derivatives relating to:2
Foreign currency
266 
Total assets at fair value$276 
Liabilities at fair value:
Derivatives relating to:2
Foreign currency
108 
Total liabilities at fair value$108 
1.    The company's investments in debt securities, which are available-for-sale, are included in "marketable securities" in the interim Condensed Consolidated Balance Sheets.
2. See Note 16 - Financial Instruments for the classification of derivatives in the interim Condensed Consolidated Balance Sheets.



NOTE 18 - SEGMENT INFORMATION
Corteva’s reportable segments reflects the manner in which its chief operating decision maker ("CODM") allocates resources and assesses performance, which is at the operating segment level (seed and crop protection). For purposes of allocating resources to the segments and assessing segment performance, segment operating EBITDA is the primary measure used by Corteva’s CODM. The company defines segment operating EBITDA as earnings (i.e., income (loss) from continuing operations before income taxes) before interest, depreciation, amortization, corporate expenses, non-operating (benefits) costs - net, foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items. Effective January 1, 2021, on a prospective basis, the company excludes from segment operating EBITDA net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. Non-operating (benefits) costs - net consists of non-operating pension and other post-employment benefit (OPEB) costs, tax indemnification adjustments and environmental remediation and legal costs associated with legacy EID businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense.

As of and for the Three Months Ended March 31,
(In millions)
SeedCrop ProtectionTotal
2021   
Net sales$2,492 $1,686 $4,178 
Segment operating EBITDA$617 $321 $938 
Segment assets1
$24,799 $13,349 $38,148 
2020   
Net sales$2,455 $1,501 $3,956 
Segment operating EBITDA$581 $238 $819 
Segment assets1
$25,857 $13,251 $39,108 
1.    Segment assets at December 31, 2020 were $23,751 million and $13,099 million for Seed and Crop Protection, respectively.

 
36

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


Reconciliation to interim Consolidated Financial Statements
Income from continuing operations after income taxes to segment operating EBITDA


(In millions)
Three Months Ended
March 31,
20212020
Income from continuing operations after income taxes$613 $281 
Provision for income taxes on continuing operations178 127 
Income from continuing operations before income taxes791 408 
Depreciation and amortization304 283 
Interest income(21)(18)
Interest expense7 10 
Exchange losses - net35 61 
Non-operating benefits - net(311)(73)
Mark-to-market gains on certain foreign currency contracts not designated as hedges1
(1)
Significant items100 123 
Corporate expenses34 25 
Segment operating EBITDA$938 $819 
1.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There was no activity in the three months ended March 31, 2020. Refer to page 48 for further discussion of the company’s Non-GAAP financial measures.

Segment assets to total assets (in millions)
March 31, 2021December 31, 2020March 31, 2020
Total segment assets$38,148 $36,850 $39,108 
Corporate assets4,401 5,799 3,870 
Total assets$42,549 $42,649 $42,978 

Significant Pre-tax (Charges) Benefits Not Included in Segment Operating EBITDA
The three months ended March 31, 2021 and 2020, respectively, included the following significant pre-tax (charges) benefits which are excluded from segment operating EBITDA:
(In millions)SeedCrop ProtectionCorporateTotal
For the Three Months Ended March 31, 2021
Restructuring and Asset Related Charges - Net 1
$(21)$(32)$(47)$(100)
Total$(21)$(32)$(47)$(100)
(In millions)SeedCrop ProtectionCorporateTotal
For the Three Months Ended March 31, 2020
Restructuring and Asset Related Charges - Net 1
$(10)$(18)$(42)$(70)
Loss on Divestiture2
— (53)— (53)
Total$(10)$(71)$(42)$(123)
1.Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements for additional information.
2.Includes a loss recorded in other income - net related to the sale of the La Porte site.
.






37

Item 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Cautionary Statements About Forward-Looking Statements

This report contains certain estimates and forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and may be identified by their use of words like “plans,” “expects,” “will,” “anticipates,” “believes,” “intends,” “projects,” “estimates,” "outlook," or other words of similar meaning. All statements that address expectations or projections about the future, including statements about Corteva’s strategy for growth, product development, regulatory approval, market position, liquidity, anticipated benefits of recent acquisitions, timing of anticipated benefits from restructuring actions, outcome of contingencies, such as litigation and environmental matters, expenditures, and financial results, as well as its expectations related to its separation of Corteva from DowDuPont and the agreements related thereto, are forward-looking statements.

Forward-looking statements and other estimates are based on certain assumptions and expectations of future events which may not be accurate or realized. Forward-looking statements and other estimates also involve risks and uncertainties, many of which are beyond Corteva’s control. While the list of factors presented below is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on Corteva’s business, results of operations and financial condition. Some of the important factors that could cause Corteva’s actual results to differ materially from those projected in any such forward-looking statements include: (i) failure to obtain or maintain the necessary regulatory approvals for some of Corteva’s products; (ii) failure to successfully develop and commercialize Corteva’s pipeline; (iii) effect of the degree of public understanding and acceptance or perceived public acceptance of Corteva’s biotechnology and other agricultural products; (iv) effect of changes in agricultural and related policies of governments and international organizations; (v) effect of competition and consolidation in Corteva’s industry; (vi) effect of competition from manufacturers of generic products; (vii) costs of complying with evolving regulatory requirements and the effect of actual or alleged violations of environmental laws or permit requirements; (viii) effect of climate change and unpredictable seasonal and weather factors; (ix) risks related to oil and commodity markets; (x) competitor’s establishment of an intermediary platform for distribution of Corteva's products; (xi) impact of Corteva's dependence on third parties with respect to certain of its raw materials or licenses and commercialization; (xii) effect of industrial espionage and other disruptions to Corteva’s supply chain, information technology or network systems; (xiii) effect of volatility in Corteva’s input costs; (xiv) failure to realize the anticipated benefits of the internal reorganizations taken by DowDuPont in connection with the spin-off of Corteva and other cost savings initiatives; (xv) failure to raise capital through the capital markets or short-term borrowings on terms acceptable to Corteva; (xvi) failure of Corteva’s customers to pay their debts to Corteva, including customer financing programs; (xvii) increases in pension and other post-employment benefit plan funding obligations; (xviii) risks related to the indemnification obligations of legacy EID liabilities in connection with the separation of Corteva; (xix) effect of compliance with laws and requirements and adverse judgments on litigation; (xx) risks related to Corteva’s global operations; (xxi) failure to effectively manage acquisitions, divestitures, alliances and other portfolio actions; (xxii) risks related to COVID-19; (xxiii) risks related to activist stockholders; (xxiv) Corteva’s intellectual property rights or defend against intellectual property claims asserted by others; (xxv) effect of counterfeit products; (xxvi) Corteva’s dependence on intellectual property cross-license agreements; and (xxvii) other risks related to the separation from DowDuPont.

Additionally, there may be other risks and uncertainties that Corteva is unable to currently identify or that Corteva does not currently expect to have a material impact on its business. Where, in any forward-looking statement or other estimate, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of Corteva’s management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. Corteva disclaims and does not undertake any obligation to update or revise any forward-looking statement, except as required by applicable law. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements or other estimates is included in the “Risk Factors” section of Corteva’s Annual Report on Form 10-K, as modified by subsequent Quarterly Reports on Forms 10-Q and Current Reports on Form 8-K.



38

Recent Developments

COVID-19 Pandemic
On March 11, 2020, the World Health Organization (“WHO”) declared the novel coronavirus disease (“COVID-19”) a pandemic. The global health crisis caused by COVID-19 and the related government actions and stay at home orders have negatively impacted economic activity and increased political instability across the globe. Since the crisis began Corteva has engaged its global Integrated Health Services Pandemic & Infectious Disease Team to take actions and implement guidelines and protocols in response to the COVID-19 pandemic described in its 2020 Annual Report, Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations, COVID-19 Pandemic.

When COVID-19 is demonstrably contained, the company anticipates a rebound in economic activity, depending on the rate, pace, and effectiveness of the containment efforts deployed by various national, state, and local governments, vaccination rates, and the ability of COVD-19 variants to overcome containment efforts, available vaccines, and medical treatments. Corteva will continue to actively monitor the situation and may take further actions altering its business operations that it determines are in the best interests of its stakeholders, or as required by federal, state, or local authorities. It is not clear what the potential effects any such alterations or modifications may have on the company's business, including the effects on its customers, employees, and prospects, or on its financial results for 2021 and beyond. With the ongoing volatility in global markets, the company will continue to monitor various factors that could impact earnings and cash flows of the business, including, but not limited to the inflation of, or unavailability of raw material inputs and transportation and logistics services, currency fluctuations, expectations of future planted area (as influenced by consumer demand, ethanol markets and government policies and regulations), trade and purchasing of commodities globally and relative commodity prices.

2021 Restructuring Actions
On February 1, 2021, Corteva approved restructuring actions designed to right-size and optimize footprint and organizational structure according to the business needs in each region with the focus on driving continued cost improvement and productivity. As a result of these actions, the company expects to record total pre-tax restructuring charges of approximately $130 million to $170 million, comprised of approximately $40 million to $50 million of severance and related benefit costs, $40 million to $60 million of asset related charges, $10 million to $15 million of asset retirement obligations and $40 million to $45 million of costs related to contract terminations (contract terminations includes early lease terminations). Future cash payments related to this charge are anticipated to be approximately $80 million to $100 million, primarily related to the payment of severance and related benefits, asset retirement obligations, and costs related to contract terminations. The restructuring actions associated with this charge are expected to be substantially complete in 2021.

During the three months ended March 31, 2021, the company recorded pre-tax charges of $89 million, recognized in restructuring and asset related charges - net in the company's interim Consolidated Statement of Operations, primarily related to the payment of severance and related benefits and contract termination charges.

The 2021 Restructuring Actions are expected to contribute to the company’s ongoing cost and productivity improvement efforts through achieving an estimated $70 million of savings on a run rate basis by 2023. See Note 5 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements for additional information.

Share Buyback Plan
On June 26, 2019, Corteva, Inc. announced that its Board of Directors authorized a $1 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date. The company expects to complete the share repurchase program in 2021. The timing, price and volume of purchases will be based on market conditions, relevant securities laws and other factors. During the three months ended March 31, 2021, the company purchased and retired 7,646,000 shares in the open market for a total cost of $350 million. During the three months ended March 31, 2020, the company purchased and retired 1,865,000 shares in the open market for a total cost of $50 million.

39

Overview

The following is a summary of results from continuing operations for the three months ended March 31, 2021:

The company reported net sales of $4,178 million, up 6 percent versus the same quarter last year, reflecting a 3 percent increase in volume and a 3 percent increase in price. Volume and price gains were driven by continued penetration of new products, coupled with favorable overall market fundamentals.

Cost of goods sold ("COGS") totaled $2,420 million in the first quarter of 2021, up from $2,269 million in the first quarter of 2020, primarily driven by increased volumes and higher input costs, partially offset by ongoing cost and productivity actions.

Restructuring and asset related charges - net were $100 million in the first quarter of 2021, an increase from $70 million in the first quarter of 2020. The charges in the first quarter of 2021 primarily relate to severance and related benefit costs, asset related charges, and contract termination charges associated with 2021 Restructuring Actions.

Income from continuing operations after income taxes was $613 million, as compared to $281 million in the same quarter last year.

Operating EBITDA was $904 million for the three months ended March 31, 2021, up from $794 million for the three months ended March 31, 2020, primarily driven by strong price execution and volume gains, which collectively more than offset cost headwinds. The company experienced market-driven cost headwinds in the quarter, including cost increases in freight and logistics, as well as raw materials. These headwinds were partially offset by the company’s ongoing execution on its productivity programs. Refer to page 48 for further discussion of the company's Non-GAAP financial measures.

In addition to the financial highlights above, the following events occurred during or subsequent to the three months ended March 31, 2021:

The company returned approximately $450 million to shareholders during the three months ended March 31, 2021 under its previously announced share repurchase program and through common stock dividends.






40

Selected Financial Data
In millions, except per share amountsThree Months Ended
March 31,
20212020
Net sales$4,178 $3,956 
Cost of goods sold$2,420 $2,269 
Percent of net sales58 %57 %
Research and development expense$281 $280 
Percent of net sales%%
Selling, general and administrative expenses$733 $757 
Percent of net sales18 %19 %
Effective tax rate on continuing operations22.5 %31.1 %
Income from continuing operations after income taxes$613 $281 
Income from continuing operations available to Corteva common stockholders$610 $271 
Basic earnings per share of common stock from continuing operations$0.82 $0.36 
Diluted earnings per share of common stock from continuing operations$0.81 $0.36 

41

Results of Operations

Net Sales
Net sales were $4,178 million and $3,956 million for the three months ended March 31, 2021 and 2020, respectively. Volume and local price both increased 3 percent versus the prior-year period, primarily driven by the ongoing penetration of new products coupled with favorable overall market fundamentals. Gains were reported in most regions, led by double-digit growth in Latin America.

 Three Months Ended
March 31,
20212020
Net Sales
($ Millions)
%Net Sales
($ Millions)
%
Worldwide$4,178 100 %$3,956 100 %
North America1
1,743 42 %1,765 45 %
EMEA2
1,602 38 %1,467 37 %
Latin America
518 12 %434 11 %
Asia Pacific
315 %290 %
Q1 2021 vs. Q1 2020Percent Change Due To:
Net Sales ChangeLocal Price &Portfolio /
$ In millions$%Product MixVolumeCurrencyOther
North America1
$(22)(1)%%(3)%%— %
EMEA2
135 %%%%— %
Latin America84 19 %14 %24 %(19)%— %
Asia Pacific25 %%%%(4)%
Total$222 %%%— %— %
1.Represents U.S. & Canada.
2.Europe, Middle East, and Africa ("EMEA").

Cost of Goods Sold
COGS was $2,420 million (58 percent of net sales) and $2,269 million (57 percent of net sales) for the three months ended March 31, 2021 and 2020, respectively. The increase was primarily driven by higher input costs in both crop protection and seed. Also, the company experienced higher seed freight costs due to lower service capacity combined with an increase in volumes, all partially offset by ongoing cost and productivity actions.

Research and Development Expense
R&D expense was $281 million (7 percent of net sales) and $280 million (7 percent of net sales) for the three months ended March 31, 2021 and 2020, respectively. R&D expense was essentially flat, as compared to prior year, as increases in spending to support new product launches were offset by ongoing cost and productivity actions.

Selling, General and Administrative Expenses
SG&A expenses were $733 million (18 percent of net sales) and $757 million (19 percent of net sales) for the three months ended March 31, 2021 and 2020, respectively. The decrease was primarily driven by lower bad debt expense due to a reduction in the reserve percentage used based on improvements in the loss history, lower travel expense due to COVID-19 related restrictions put into place late in the first quarter of 2020, and favorable currency, partially offset by higher commission expense due to an increase in sales.

Amortization of Intangibles
Intangible asset amortization was $183 million and $163 million for the three months ended March 31, 2021 and 2020, respectively. The increase was primarily driven by amortization of the trade name asset that was changed from indefinite lived intangible asset to definite lived in the fourth quarter of 2020. See Note 11 - Other Intangible Assets, to the interim Consolidated Financial Statements for additional information.



42

Restructuring and Asset Related Charges - Net
Restructuring and asset related charges - net were $100 million and $70 million for the three months ended March 31, 2021 and 2020, respectively. The charges in the first quarter of 2021 primarily relate to severance and related benefit costs, contract termination charges, and asset related charges associated with 2021 Restructuring Actions. The charges in the first quarter of 2020 primarily relate to severance and related benefit costs and asset related charges under the Execute to Win Productivity Program.

In addition, during the three months ended March 31, 2021 and 2020, the company recognized $7 million and $10 million, respectively, in restructuring and asset related charges, net in the interim Consolidated Statement of Operations, from non-cash accelerated prepaid royalty amortization expense related to Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits.

See Note 5 - Restructuring and Asset Related Charges, Net, to the interim Consolidated Financial Statements for additional information.

Other Income - Net
Other income - net was $337 million and $1 million for the three months ended March 31, 2021 and 2020, respectively. The increase was primarily due to an increase in non-operating pension and other post employment benefit credit, driven by the December 2020 OPEB plan amendments as discussed in the 2020 Annual Report. In addition, Other income - net for the quarter ended March 31, 2020 includes a $(53) million loss on the sale of the La Porte site. See Note 6 - Supplementary Information, to the interim Consolidated Financial Statements for additional information.

Pre-tax net exchange losses were $35 million and $61 million for the three months ended March 31, 2021 and 2020, respectively. The company routinely uses forward exchange contracts to offset its net exposures, by currency denominated monetary assets and liabilities of its operations. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes. The net pre-tax exchange gains and losses are recorded in other income - net and the related tax impact is recorded in provision for (benefit from) income taxes on continuing operations in the interim Consolidated Statement of Operations.

Interest Expense
Interest expense was $7 million and $10 million for the three months ended March 31, 2021 and 2020, respectively. The change was primarily driven by lower average commercial paper balances and lower interest rates, partially offset by higher average long-term borrowings.

Provision for Income Taxes on Continuing Operations
The company’s provision for income taxes on continuing operations was $178 million for the three months ended March 31, 2021 on pre-tax income from continuing operations of $791 million, resulting in an effective tax rate of 22.5 percent. The effective tax rate was unfavorably impacted by the tax impact of certain net exchange losses recognized on the re-measurement of the net monetary asset positions which were not tax-deductible in their local jurisdictions, as well as geographic mix of earnings. Those unfavorable impacts were partially offset by $(7) million of net tax benefits associated with changes in accruals for certain prior year tax positions in various jurisdictions, as well as tax benefits related to the issuance of stock-based compensation.
The company’s provision for income taxes on continuing operations was $127 million for the three months ended March 31, 2020 on pre-tax income from continuing operations of $408 million, resulting in an effective tax rate of 31.1 percent. The effective tax rate was unfavorably impacted by the tax impact of certain net exchange losses recognized on the re-measurement of the net monetary asset positions which were not tax-deductible in their local jurisdictions, as well as tax charges related to the issuance of stock-based compensation.

EID Analysis of Operations
As discussed in Note 1 - Basis of Presentation, to the EID Consolidated Financial Statements, EID is a subsidiary of Corteva, Inc. and continues to be a reporting company, subject to the requirements of the Exchange Act. The below relates to EID only and is presented to provide an Analysis of Operations, only for the differences between EID and Corteva, Inc.


43

Interest Expense
EID’s interest expense was $22 million and $42 million for the three months ended March 31, 2021 and 2020, respectively. The change was primarily driven by the items noted on page 43, under the header "Interest Expense," and by lower interest expense incurred on the related party loan between EID and Corteva, Inc. See Note 2 - Related Party Transactions, to the EID Consolidated Financial Statements for further information.

Provision for Income Taxes on Continuing Operations
EID’s provision for income taxes on continuing operations was $174 million for three months ended March 31, 2021 on pre-tax income from continuing operations of $776 million, resulting in an effective tax rate of 22.4 percent. EID’s provision for income taxes on continuing operations was $119 million for the three months ended March 31, 2020 on pre-tax income from continuing operations of $376 million, resulting in an effective tax rate of 31.6 percent.

EID’s effective tax rates for the three months ended March 31, 2021 and 2020 were driven by the items noted on page 43, under the header “Provision for Income Taxes on Continuing Operations” and a tax benefit related to the interest expense incurred on the related party loan between EID and Corteva, Inc. See Note 2 - Related Party Transactions, to the EID Consolidated Financial Statements for further information.

Corporate Outlook
The company is increasing its net sales outlook for 2021, and expects an approximate 3 – 4 percent increase in net sales. Additionally, the company is reaffirming its previous 2021 Corporate Outlook on Operating EBITDA and Operating Earnings Per Share, refer to the 2020 Annual Report, and expects an increase of approximately 15 - 20 percent and 23 - 30 percent, respectively.

Corteva is not able to reconcile its forward-looking non-GAAP financial measures to its most comparable U.S. GAAP financial measures, as it is unable to predict with reasonable certainty items outside of the company’s control, such as Significant Items, without unreasonable effort (refer to page 49 for Significant Items recorded in the three months ended March 31, 2021 and 2020). During 2021, the company expects to record $130 million to $170 million for the 2021 Restructuring Actions and approximately $130 million for non-cash accelerated prepaid royalty amortization expense as restructuring and asset related charges. See Note 5 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements for additional information on the company’s 2021 Restructuring Actions and accelerated prepaid royalty amortization.


Recent Accounting Pronouncements
See Note 2 - Recent Accounting Guidance, to the interim Consolidated Financial Statements for a description of recent accounting pronouncements.


44

Segment Reviews
The company operates in two reportable segments: Seed and Crop Protection.

Seed
The company’s seed segment is a global leader in developing and supplying advanced germplasm and traits that produce optimum yield for farms around the world. The segment is a leader in many of the company’s key seed markets, including North America corn and soybeans, Europe corn and sunflower, as well as Brazil, India, South Africa and Argentina corn. The segment offers trait technologies that improve resistance to weather, disease, insects and herbicides used to control weeds, and trait technologies that enhance food and nutritional characteristics. In addition, the segment provides digital solutions that assist farmer decision-making with a view to optimize product selection and, ultimately, help maximize yield and profitability.

Crop Protection
The crop protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The segment offers crop protection solutions that provide farmers the tools they need to improve productivity and profitability, and help keep fields free of weeds, insects and diseases. The segment is a leader in global herbicides, insecticides, nitrogen stabilizers and pasture and range management herbicides.

Summarized below are comments on individual segment net sales and segment operating EBITDA for the three months ended March 31, 2021 compared with the same period in 2020. The company defines segment operating EBITDA as earnings (i.e., income from continuing operations before income taxes) before interest, depreciation, amortization, corporate expenses, non-operating costs-net, foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items. Non-operating costs-net consists of non-operating pension and other post-employment benefit (OPEB) credits, tax indemnification adjustments and environmental remediation and legal costs associated with legacy EID businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense. Beginning January 1, 2021, the company excludes net unrealized gains or losses from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. See Note 18 - Segment Information, to the interim Consolidated Financial Statements for details related to significant pre-tax benefits (charges) excluded from segment operating EBITDA. All references to prices are based on local price unless otherwise specified.

A reconciliation of segment operating EBITDA to income from continuing operations after income taxes for the three months ended March 31, 2021 and 2020 is included in Note 18 - Segment Information, to the interim Consolidated Financial Statements.
SeedThree Months Ended
March 31,
In millions20212020
Net sales$2,492 $2,455 
Segment operating EBITDA
$617 $581 
SeedQ1 2021 vs. Q1 2020Percent Change Due To:
Net Sales Change Local Price &Portfolio /
$ In millions$%Product MixVolumeCurrencyOther
North America$(80)(6)%(1)%(6)%%— %
EMEA66 %%%%— %
Latin America58 27 %%39 %(21)%— %
Asia Pacific(7)(10)%%(12)%(3)%— %
Total$37 %%%(1)%— %
45

SeedQ1 2021 vs. Q1 2020Percent Change Due To:
Net Sales Change Local Price &Portfolio /
$ In millions$%Product MixVolumeCurrencyOther
Corn$24 %%— %(1)%— %
Soybeans(4)(2)%(4)%— %%— %
Other oilseeds48 19 %%18 %(3)%— %
Other(31)(19)%(5)%(12)%(2)%— %
Total $37 %%%(1)%— %

Seed
Seed net sales were $2,492 million in the first quarter of 2021, up 2 percent from $2,455 million in the first quarter of 2020. Gains were driven by a 2 percent increase in local price and a 1 percent increase in volume, partially offset by a 1 percent impact from currency.

Pricing gains were driven by strong adoption of new Seed technology, including price execution in EMEA and Latin America, with corn price up 2% globally. Volume growth was driven by record corn and sunflower volume in EMEA due to a shift in customer demand on local supply concerns and an early start to the spring, coupled with strong Safrinha sales in Brazil and early demand in other parts of Latin America. Gains were partially offset by impact of seasonal timing of deliveries in North America. Unfavorable currency impacts, led by the Brazilian Real, were partially offset by favorable impacts from the Euro.

Segment operating EBITDA was $617 million in the first quarter of 2021, up 6 percent from $581 million in the first quarter of 2020. Price execution, lower SG&A driven by an improvement in bad debt, a gain on the remeasurement of an equity investment and ongoing cost and productivity actions more than offset higher input costs from unfavorable yields on European corn, higher freight costs and the unfavorable impact of currency. Segment operating EBITDA margin improved by more than 100 basis points versus the prior-year period.

Crop ProtectionThree Months Ended
March 31,
In millions20212020
Net sales$1,686 $1,501 
Segment Operating EBITDA
$321 $238 
Crop ProtectionQ1 2021 vs. Q1 2020Percent Change Due To:
Net Sales Change Local Price &Portfolio /
$ In millions$%Product MixVolumeCurrencyOther
North America
$58 12 %%%%— %
EMEA
69 12 %%%%— %
Latin America
26 12 %18 %10 %(16)%— %
Asia Pacific
32 14 %%12 %%(5)%
Total$185 12 %%%%(1)%
Crop ProtectionQ1 2021 vs. Q1 2020Percent Change Due To:
Net Sales ChangeLocal Price &Portfolio /
$ In millions$%Product MixVolumeCurrencyOther
Herbicides$163 20 %%12 %%— %
Insecticides%%(4)%(2)%— %
Fungicides32 14 %%14 %(1)%(4)%
Other(17)(24)%(1)%(19)%(4)%— %
Total$185 12 %%%%(1)%


46


Crop Protection
Crop protection net sales were $1,686 million in the first quarter of 2021, up 12 percent from $1,501 million in the first quarter of 2020. Gains were driven by 6 percent increases in volume and price, respectively, and a 1 percent favorable impact from currency, partially offset by a 1 percent impact from portfolio.

Volume gains were driven by strong demand for new products globally, including ArylexTM, EnlistTM, and RinskorTM herbicides and IsoclastTM and PyraxaltTM insecticides. These volume gains were partially offset by an approximate $70 million impact from the company's decision to phase out select low-margin, generic products. Local price rose due to increases in Latin America, coupled with favorable product mix globally and strategic price increases in North America. Favorable currency impacts primarily from the Euro more than offset unfavorable impacts from the Brazilian Real. The portfolio impact was driven by prior-year divestitures in Asia Pacific.

Segment operating EBITDA was $321 million in the first quarter of 2021, up 35 percent from $238 million in the first quarter of 2020. Price and volume gains and ongoing cost and productivity actions more than offset higher input costs, including raw materials costs. Segment operating EBITDA margin improved by more than 300 basis points versus prior-year.

While the company has experienced some supply chain challenges and higher costs during the quarter ended March 31, 2021, as a result of freight and logistic service capacities remaining contracted and not yet having returned to pre-pandemic levels and weather-related events in the Gulf Coast, its supply chain strategies have to-date largely enabled availability of product and deliveries to customers.

47

Non-GAAP Financial Measures
The company presents certain financial measures that do not conform to U.S. GAAP and are considered non-GAAP measures. These measures include Operating EBITDA and operating earnings per share. Management uses these measures internally for planning and forecasting, including allocating resources and evaluating incentive compensation. Management believes that these non-GAAP measures best reflect the ongoing performance of the company during the periods presented and provide more relevant and meaningful information to investors as they provide insight with respect to ongoing operating results of the company and a more useful comparison of year over year results. These non-GAAP measures supplement the company's U.S. GAAP disclosures and should not be viewed as an alternative to U.S. GAAP measures of performance. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. Reconciliations for these non-GAAP measures to U.S. GAAP are provided below.

Operating EBITDA is defined as earnings (i.e., income from continuing operations before income taxes) before interest, depreciation, amortization, non-operating (benefits) costs - net, foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items. Non-operating (benefits) costs - net consists of non-operating pension and OPEB credits, tax indemnification adjustments and environmental remediation and legal costs associated with legacy businesses and sites of Historical DuPont. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense. Operating earnings per share is defined as "Earnings per common share from continuing operations - diluted" excluding the after-tax impact of significant items, the after-tax impact of non-operating (benefits) costs - net, the after-tax impact of amortization expense associated with intangible assets existing as of the Separation from DowDuPont, and the after-tax impact of net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. Although amortization of the company's intangible assets is excluded from these non-GAAP measures, management believes it is important for investors to understand that such intangible assets contribute to revenue generation. Amortization of intangible assets that relate to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Any future acquisitions may result in amortization of additional intangible assets. Net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting represents the non-cash net gain (loss) from changes in fair value of certain undesignated foreign currency derivative contracts. Upon settlement, which is within the same calendar year of execution of the contract, the realized gain (loss) from the changes in fair value of the non-qualified foreign currency derivative contracts will be reported in the relevant non-GAAP financial measures, allowing quarterly results to reflect the economic effects of the foreign currency derivative contracts without the resulting unrealized mark to fair value volatility.

Reconciliation of Income from Continuing Operations after Income Taxes to Operating EBITDA
Three Months Ended
March 31,
(In millions)20212020
Income from continuing operations after income taxes (GAAP)
$613 $281 
Provision for income taxes on continuing operations178 127 
Income from continuing operations before income taxes (GAAP)791 408 
Depreciation and amortization304 283 
Interest income(21)(18)
Interest expense10 
Exchange losses - net
35 61 
Non-operating benefits - net(311)(73)
Mark-to-market gains on certain foreign currency contracts not designated as hedges1
(1)
Significant items charge100 123 
Operating EBITDA (Non-GAAP)$904 $794 
1.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There was no activity in the three months ended March 31, 2020.


48

Significant Items
Three Months Ended
March 31,
(In millions)20212020
Restructuring and asset related charges - net$(100)$(70)
Loss on divestiture— (53)
Total pretax significant items charge(100)(123)
Total tax benefit impact of significant items1
23 23 
Tax only significant item benefit2
— (19)
Total significant items charge, after tax$(77)$(119)
1.Unless specifically addressed above, the income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
2.The three months ended March 31, 2020 includes an after tax charge related to the impact of a state tax valuation allowance in the U.S. based on a change in judgment about the realizability of a deferred tax asset.

Reconciliation of Income from Continuing Operations Attributable to Corteva and Earnings Per Share of Common Stock from Continuing Operations - Diluted to Operating Earnings and Operating Earnings Per Share
Three Months Ended
March 31,
(In millions)20212020
Income from continuing operations attributable to Corteva (GAAP)
$610 $271 
Less: Non-operating benefits - net, after tax237 57 
Less: Amortization of intangibles (existing as of Separation), after tax(143)(114)
Less: Mark-to-market gains on certain foreign currency contracts not designated as hedges, after tax1
Less: Significant items charge, after tax(77)(119)
Operating Earnings (Non-GAAP)$592 $447 
Three Months Ended
March 31,
20212020
Earnings per share of common stock from continuing operations - diluted (GAAP)
$0.81 $0.36 
Less: Non-operating benefits - net, after tax0.31 0.08 
Less: Amortization of intangibles (existing as of Separation), after tax(0.19)(0.15)
Less: Mark-to-market gains on certain foreign currency contracts not designated as hedges, after tax1
— 
Less: Significant items charge, after tax(0.10)(0.16)
Operating Earnings Per Share (Non-GAAP)$0.79 $0.59 
Diluted Shares Outstanding (in millions)
749.6 752.5 
1.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There was no activity in the three months ended March 31, 2020.

49

Liquidity and Capital Resources
Information related to the company's liquidity and capital resources can be found in the company’s 2020 Annual Report, Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations, Liquidity & Capital Resources. The discussion below provides the updates to this information for the three months ended March 31, 2021.
(In millions)March 31, 2021December 31, 2020March 31, 2020
Cash, cash equivalents and marketable securities$2,518 $3,795 $1,973 
Total debt$2,352 $1,105 $2,610 

The company's cash, cash equivalents and marketable securities at March 31, 2021, December 31, 2020, and March 31, 2020 were $2,518 million, $3,795 million and $1,973 million, respectively. Total debt at March 31, 2021, December 31, 2020, and March 31, 2020 was $2,352 million, $1,105 million, and $2,610 million, respectively. The increase in debt balances from December 31, 2020 was primarily due to funding the company’s seasonal working capital needs. See further information in Note 12 - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities, to the interim Consolidated Financial Statements.

The company believes its ability to generate cash from operations and access to capital markets and commercial paper markets will be adequate to meet anticipated cash requirements to fund its operations, including seasonal working capital, capital spending and pension obligations. Corteva's strong financial position, liquidity and credit ratings will provide access as needed to capital markets and commercial paper markets to fund seasonal working capital needs. The company's liquidity needs can be met through a variety of sources, including cash provided by operating activities, commercial paper, syndicated credit lines, bilateral credit lines, long-term debt markets, bank financing and committed receivable repurchase facilities. Corteva considers the borrowing costs and lending terms when selecting the source to fund its operations and working capital needs. During the three months ended March 31, 2021, the company has experienced increased costs for steel and other materials used in various capital expenditures and capacity expansion projects, and expects this trend to continue. This has been due, in part to, rising demand from the economic recovery from the lifting of COVID-19 pandemic restrictions and government stimulus in some regions, while the supply for certain materials have not returned to pre-pandemic levels.

The company had access to approximately $6.4 billion at March 31, 2021 and December 31, 2020, respectively and $5.8 billion at March 31, 2020, in committed and uncommitted unused credit lines. In addition to the unused credit facilities, the company has a $1 billion 2021 Repurchase Facility (as defined below). These facilities provide support to meet the company’s short-term liquidity needs and for general corporate purposes which may include funding of discretionary and nondiscretionary contributions to certain benefit plans, severance payments, repayment and refinancing of debt, working capital, capital expenditures, repurchases and redemptions of securities, and funding Corteva's costs and expenses.

In March 2020, the company drew down $500 million under the three year revolving credit facility to finance its short term liquidity needs as a result of the volatility and increased borrowing costs of commercial paper resulting from the unstable market conditions caused by the COVID-19 pandemic, and repaid that borrowing in full in June 2020. The Revolving Credit Facilities contain customary representations and warranties, affirmative and negative covenants and events of default that are typical for companies with similar credit ratings. The Revolving Credit Facilities also contain a financial covenant requiring that the ratio of total indebtedness to total capitalization for Corteva and its consolidated subsidiaries not exceed 0.60. At March 31, 2021 the company was in compliance with these covenants.

The company's indenture covenants include customary limitations on liens, sale and leaseback transactions, and mergers and consolidations affecting manufacturing plants, mineral producing properties or research facilities located in the U.S. and the consolidated subsidiaries owning such plants, properties and facilities subject to certain limitations. The outstanding long-term debt also contains customary default provisions.
The company has meaningful seasonal working capital needs based in part on providing financing to its customers. Working capital is funded through multiple methods including cash, commercial paper, the 2021 Repurchase Facility, the Revolving Credit Facilities, and factoring.

In February 2021, in line with seasonal working capital requirements, the company entered into a committed receivable repurchase agreement of up to $1.0 billion (the "2021 Repurchase Facility") which expires in December 2021. Under the 2021 Repurchase Facility, Corteva may sell a portfolio of available and eligible outstanding customer notes receivables to participating institutions and simultaneously agree to repurchase at a future date. See further discussion of this facility in Note 12 - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities, to the interim Consolidated Financial Statements.

50

The company has factoring agreements with third-party financial institutions to sell its trade receivables under both recourse and non-recourse agreements in exchange for cash proceeds in an effort to reduce its receivables risk. For arrangements that include an element of recourse, the company provides a guarantee of the trade receivables in the event of customer default. Refer to Note 9 - Accounts and Notes Receivable, Net, to the interim Consolidated Financial Statements for more information.
The company also organizes agreements with third-party financial institutions who directly provide financing for select customers of the company's seed and crop protection products in each region. Terms of the third-party loans are less than a year and programs are renewed on an annual basis. In some cases, the company guarantees a portion of the extension of such credit to such customers. Refer to Note 13 - Commitments and Contingent Liabilities, to the interim Consolidated Financial Statements for more information on the company’s guarantees.

The company's cash, cash equivalents and marketable securities at March 31, 2021, December 31, 2020, and March 31, 2020 are $2.5 billion, $3.8 billion, and $2.0 billion respectively, of which $2.4 billion at March 31, 2021, $3.1 billion at December 31, 2020, and $1.5 billion at March 31, 2020 was held by subsidiaries in foreign countries, including United States territories. The 2017 Tax Cuts and Jobs Act ("The Act") required companies to pay a one-time transition tax on the untaxed earnings of foreign subsidiaries. Upon actual repatriation, such earnings could be subject to withholding taxes, foreign and/or U.S. state income taxes, and taxes resulting from the impact of foreign currency movements. The Act also introduced a 100 percent dividends received deduction regarding earnings of foreign subsidiaries. The cash held by foreign subsidiaries is generally used to finance the subsidiaries' operational activities and future foreign investments. At March 31, 2021, management believed that sufficient liquidity is available in the U.S. with global operating cash flows, borrowing capacity from existing committed credit facilities, and access to capital markets and commercial paper markets.

Summary of Cash Flows
Cash used for operating activities was $1,950 million for the three months ended March 31, 2021 compared to $1,930 million for the three months ended March 31, 2020. The change in cash used for operating activities was driven by an increase in working capital requirements.

Cash provided by (used for) investing activities was $36 million for the three months ended March 31, 2021 compared to $(130) million for the three months ended March 31, 2020. The change was primarily due to higher net proceeds from investments in available-for-sale securities, partly offset by higher capital expenditures.

Cash provided by financing activities was $0.8 billion for the three months ended March 31, 2021 compared to $2.3 billion for the three months ended March 31, 2020. The change was primarily due to lower borrowings partially offset by higher repurchases of Corteva common stock.

In January 2021, the Company's Board of Directors authorized a common stock dividend of $0.13 per share, payable on March 15, 2021, to the shareholders of record on March 1, 2021.

On June 26, 2019, the company's Board of Directors authorized a $1 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date. The company repurchased $650 million under its share buyback plan since the Corteva Distribution and expects to repurchase the remaining $350 million in 2021. The timing, price and volume of purchases will be based on market conditions, relevant securities laws and other factors.

During the three months ended March 31, 2021, the company purchased and retired 7,646,000 shares in the open market for a total cost of $350 million. During the three months ended March 31, 2020, the company purchased and retired 1,865,000 shares for a total cost of $50 million. See Note 14 - Stockholders' Equity, to the interim Consolidated Financial Statements for additional information related to the share buyback plan.

EID Liquidity Discussion
As discussed in Note 1 - Basis of Presentation, to the EID Consolidated Financial Statements, EID is a subsidiary of Corteva, Inc. and continues to be a reporting company, subject to the requirements of the Exchange Act. The below relates to EID only and is presented to provide a Liquidity discussion for the differences between EID and Corteva, Inc.

Cash used for operating activities
EID’s cash used for operating activities was $1.9 billion for the three months ended March 31, 2021 and 2020, respectively. The change was primarily driven by the items above under the header, "Summary of Cash Flow".


51

Cash provided by financing activities
EID’s cash provided by financing activities was $0.8 billion for the three months ended March 31, 2021 compared to $2.3 billion for the three months ended March 31, 2020. The change was primarily driven by lower borrowings and higher payments on related party debt.

See Note 2 - Related Party Transactions, to the EID Consolidated Financial Statements for further information on the related party loan between EID and Corteva, Inc.

Guarantees and Off-Balance Sheet Arrangements
For detailed information related to Guarantees, Indemnifications, and Obligations for Equity Affiliates and Others, see the company’s 2020 Annual Report, Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations, Off-Balance Sheet Arrangements and Note 13 - Commitments and Contingent Liabilities, to the interim Consolidated Financial Statements.


Contractual Obligations

Information related to the company's contractual obligations at December 31, 2020 can be found on page 73 of the company's 2020 Annual Report.  There have been no material changes to the company’s contractual obligations outside the ordinary course of business from those reported in the company’s 2020 Annual Report.


Item 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 

See Note 16 - Financial Instruments, to the interim Consolidated Financial Statements. See also Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk, of the company's 2020 Annual Report, for information on the company's utilization of financial instruments and an analysis of the sensitivity of these instruments.

52

Item 4.  CONTROLS AND PROCEDURES 

Corteva, Inc.

a)        Evaluation of Disclosure Controls and Procedures
 
The company maintains a system of disclosure controls and procedures to give reasonable assurance that information required to be disclosed in the company's reports filed or submitted under the Securities Exchange Act of 1934 ("Exchange Act") is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission. These controls and procedures also give reasonable assurance that information required to be disclosed in such reports is accumulated and communicated to management to allow timely decisions regarding required disclosures.

As of March 31, 2021, the company's Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), together with management, conducted an evaluation of the effectiveness of the company's disclosure controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Based on that evaluation, the CEO and CFO concluded that these disclosure controls and procedures are effective.
 
b)                         Changes in Internal Control over Financial Reporting
 
There have been no changes in the company's internal control over financial reporting that occurred during the quarter ended March 31, 2021 that have materially affected, or are reasonably likely to materially affect, the company's internal control over financial reporting.

E. I. du Pont de Nemours and Company

a)        Evaluation of Disclosure Controls and Procedures
 
EID maintains a system of disclosure controls and procedures to give reasonable assurance that information required to be disclosed in their reports filed or submitted under the Securities Exchange Act of 1934 ("Exchange Act") is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission. These controls and procedures also give reasonable assurance that information required to be disclosed in such reports is accumulated and communicated to management to allow timely decisions regarding required disclosures.

As of March 31, 2021, EID's CEO and CFO, together with management, conducted an evaluation of the effectiveness of EID's disclosure controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Based on that evaluation, the CEO and CFO concluded that these disclosure controls and procedures are effective.
 
b)                         Changes in Internal Control over Financial Reporting
 
There have been no changes in EID's internal control over financial reporting that occurred during the quarter ended March 31, 2021 that have materially affected, or are reasonably likely to materially affect, EID's internal control over financial reporting.
53

PART II.  OTHER INFORMATION


Item 1.LEGAL PROCEEDINGS
The company is subject to various legal proceedings, including, but not limited to, product liability, intellectual property, antitrust, commercial, property damage, personal injury, environmental and regulatory matters arising out of the normal course of its current businesses or legacy EID businesses unrelated to Corteva’s current businesses but allocated to Corteva as part of the Separation of Corteva from DuPont. Information regarding certain of these matters is set forth below and in Note 13 - Commitments and Contingent Liabilities, to the interim Consolidated Financial Statements. Even when the Company believes liabilities are not expected to be material or the probability of loss or of an adverse unappealable final judgment is remote, the Company may consider settlement of these matters, and may enter into settlement agreements, if it believes settlement is in the best interest of the Company, including avoidance of future distraction and litigation defense cost, and its shareholders.

Litigation related to Corteva’s current businesses
Canadian Competition Bureau Formal Inquiry
On January 30, 2020, the Canadian Competition Bureau (the “Bureau”) filed a court order for the company to produce records and information as part of a formal inquiry under civil sections of Canada’s competition laws. The inquiry is in response to allegations by the Farmers Business Network ("FBN") that Corteva and other seeds and crop protection manufacturers and wholesalers unilaterally or in coordination refused, restricted and/or impaired supply of products to FBN in western Canada. This inquiry follows an informal request for information from the Bureau pursuant to which the company voluntarily provided documents and engaged in discussions with the Bureau outlining how its conduct was and continues to be compliant with Canadian competition laws. Corteva continues to cooperate with the Bureau’s inquiries, but believes the likelihood of material liability is remote.

Federal Trade Commission Investigation
On May 26, 2020, Corteva received a subpoena from the Federal Trade Commission (“FTC”) directing it to submit documents pertaining to its crop protection products generally, as well as business plans, rebate programs, offers, pricing and marketing materials specifically related to its acetochlor, oxamyl and rimsulfuron and other related products in order to determine whether Corteva engaged in unfair methods of competition through anticompetitive conduct. Corteva has cooperated with the FTC’s subpoena, and continues to believe the likelihood of material liability is remote.

Litigation related to legacy EID businesses unrelated to Corteva’s current businesses
As discussed below and in Note 13 - Commitments and Contingent Liabilities, to the interim Consolidated Financial Statements, certain of the environmental proceedings and litigation allocated to Corteva as part of the Separation from DuPont relate to the legacy EID businesses, including their use of PFOA, which, for purposes of this report, means collectively perfluorooctanoic acid and its salts, including the ammonium salt and does not distinguish between the two forms, and PFAS, which means per- and polyfluoroalkyl substances, including PFOA, PFOS (perfluorooctanesulfonic acid), GenX and other perfluorinated chemicals and compounds ("PFCs"). Management believes that it is reasonably possible that EID could incur liabilities related to PFOA in excess of amounts accrued. However, any such losses are not estimable at this time due to various reasons, including, among others, that the underlying matters are in their early stages and have significant factual issues to be resolved.

On May 13, 2019, Chemours filed suit in the Delaware Court of Chancery against DuPont, EID, and Corteva, seeking, among other things, to limit its responsibility for the litigation and environmental liabilities allocated to and assumed by Chemours under the Chemours Separation Agreement (the “Delaware Litigation”). On March 30, 2020, the Court of Chancery granted a motion to dismiss. On December 15, 2020, the Delaware Supreme Court affirmed the judgment of the Court of Chancery. Meanwhile, a confidential arbitration process regarding the same and other claims has proceeded (the “Pending Arbitration”). On January 22, 2021, Chemours, DuPont, Corteva and EID entered into a binding memorandum of understanding containing a settlement to resolve legal disputes originating from the Delaware Litigation and Pending Arbitration, and to establish a cost sharing arrangement and escrow account to be used to support and manage potential future legacy per- and polyfluoroalkyl substances (“PFAS”) liabilities arising out of pre-July 1, 2015 conduct (the “MOU”). See Note 13 - Commitments and Contingent Liabilities, to the interim Consolidated Financial Statements for further discussion.

Environmental Proceedings
The company believes it is remote that the following matters will have a material impact on its financial position, liquidity or results of operations. The matters below involve the potential for $1 million or more in monetary fines and are included per Item 103(3)(c)(iii) of Regulation S-K of the Securities Exchange Act of 1934, as amended.
54


Related to Corteva's current businesses

La Porte Plant, La Porte, Texas - Crop Protection - Release Incident Investigations
On November 15, 2014, there was a release of methyl mercaptan at EID's La Porte, Texas, facility. The release occurred at the site’s crop protection unit resulting in four employee fatalities inside the unit. The Chemical Safety Board (“CSB”) issued its final report on June 18, 2019, which included recommendations related to the emergency response program at La Porte. Corteva responded to the CSB on September 30, 2019 outlining the actions it has taken to date to address the recommendations for the site and providing its plan to address the CSB’s remaining recommendations. After the conclusion of the CSB investigation, criminal U.S. Environmental Protection Agency ("EPA") and the Department of Justice ("DOJ") investigations related to the incident continued. On January 8, 2021, EID and the facility's former unit operations leader were indicted by the DOJ on two felony and one misdemeanor charges of violations of the Clean Air Act related to the release. The maximum statutory penalties per charge are $500,000, or twice the gross gain or loss derived from the incident, as well as up to three years of probation and related ongoing reporting obligations. Corteva cooperated fully with the government’s investigation and will vigorously defend against these charges. The trial is currently scheduled for March 2022.

Related to legacy EID businesses unrelated to Corteva’s current businesses

Sabine Plant, Orange, Texas - EPA Multimedia Inspection
In June 2012, EID began discussions with the EPA and the DOJ related to a multimedia inspection that the EPA conducted at the Sabine facility in March 2009 and December 2015. The discussions involve the management of materials in the facility's wastewater treatment system, hazardous waste management, flare and air emissions, including leak detection and repair. These discussions continue. Under the Separation Agreement, Corteva and DuPont will share any future liabilities proportionally on the basis of 29% and 71%, respectively.

Divested Neoprene Facility, La Place, Louisiana - EPA Compliance Inspection
In 2016, the EPA conducted a focused compliance investigation at the Denka Performance Elastomer LLC (“Denka”) neoprene manufacturing facility in La Place, Louisiana. EID sold the neoprene business, including this manufacturing facility, to Denka in the fourth quarter of 2015. In the spring of 2017, the EPA, the DOJ, the Louisiana Department of Environmental Quality, EID and Denka began discussions relating to the inspection conclusions and allegations of noncompliance arising under the Clean Air Act, including leak detection and repair. These discussions, which include potential settlement options, continue. Under the Separation Agreement, DuPont is defending and indemnifying the company in this matter.

New Jersey Directive PFAS
On March 25, 2019, the New Jersey Department of Environmental Protection (“NJDEP”) issued a Statewide PFAS Directive to several companies, including Chemours, DuPont, and EID. The Directive seeks information relating to the use and environmental release of PFAS and PFAS-replacement chemicals at and from two former EID sites in New Jersey, Chambers Works and Parlin, and a funding source for costs related to the NJDEP’s investigation of PFAS issues and PFAS testing and remediation.

New Jersey Directive Pompton Lakes
On March 27, 2019, the NJDEP issued to Chemours and EID a Natural Resource Damages Directive relating to chemical contamination (non-PFAS) at and around EID’s former Pompton Lakes facility in New Jersey. The Directive alleges that this contamination has harmed the natural resources of New Jersey. It seeks $125,000 as reimbursement for the cost of preparing a natural resource damages assessment, which the State will use to determine the extent of such damage and the amount it expects to seek to restore the affected natural resources to their pre-damage state.

Natural Resource Damage Cases
Since May 2017, several municipal water districts and state attorneys general have filed lawsuits against EID, Corteva, Chemours, 3M, and others, claiming contamination of public water systems by PFCs, including but not limited to PFOA. These actions with the municipalities and states seeking economic impact damages for alleged harm to natural resources, punitive damages, present and future costs to cleanup PFOA contamination and the abatement of alleged nuisance with filtration systems. Further information with respect to these proceedings is set forth under "Other PFOA Matters" in Note 13 - Commitments and Contingent Liabilities, to the interim Consolidated Financial Statements.

55

Item 1A. RISK FACTORS

There have been no material changes in the company's risk factors discussed in Part I, Item 1A, Risk Factors, in the company's most recently filed annual report on Form 10-K.

56

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Issuer Purchases of Equity Securities
The following table summarizes information with respect to the company's purchase of its common stock during the three months ended March 31, 2021:
MonthTotal Number of Shares PurchasedAverage Price
Paid per Share
Total Number of
Shares Purchased as Part of the Company's Publicly Announced Share Buyback Program1
Approximate Value
of Shares that May
Yet Be Purchased
Under the Programs(1) (Dollars in millions)
February 20212,530,263 $44.78 2,530,263 $587 
March 20215,116,171 46.27 5,116,171 350
Total7,646,434 $45.77 7,646,434 $350 
1.    On June 26, 2019, Corteva, Inc. announced that its Board of Directors authorized a $1 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date. The timing, price and volume of purchases will be based on market conditions, relevant securities laws and other factors.

57


Item 5. OTHER INFORMATION

None.
58

Item 6.EXHIBITS

Exhibit
Number
 Description
   
Separation and Distribution Agreement by and among DuPont Inc., Dow Inc. and Corteva, Inc. (incorporated by reference to Exhibit No. 2.1 to Amendment 3 to Corteva’s Registration Statement on Form 10 (Commission file number 001-38710), filed on April 16, 2019).
   
 Amended and Restated Certificate of Incorporation of Corteva, Inc. (incorporated by reference to Exhibit No. 3.1 to Corteva’s Current Report on Form 8-K (Commission file number 001-38710), filed on June 3, 2019.
   
 Amended and Restated Bylaws of Corteva, Inc. (incorporated by reference to Exhibit No. 3.1 to Corteva’s Current Report on Form 8-K (Commission file number 001-38710), filed on October 10, 2019.
   
Amended and Restated Certificate of Incorporation of E.I. du Pont de Nemours and Company (incorporated by reference to Exhibit 3.1 to E.I. du Pont de Nemours and Company’s Current Report on Form 8-K (Commission file number 1-815) dated September 1, 2017).
Amended and Restated Bylaws of E.I. du Pont de Nemours and Company (incorporated by reference to Exhibit 3.2 to E.I. du Pont de Nemours and Company's Current Report on Form 8-K (Commission file number 1-815) dated September 1, 2017).
4 Corteva agrees to provide the Commission, on request, copies of instruments defining the rights of holders of long-term debt of Corteva and its subsidiaries.
Master Repurchase Agreement by and among Coöperatieve Rabobank, U.A. (New York Branch), MUFG Bank, Ltd. (New York Branch), Standard Chartered Bank (New York Branch), HSBC Bank USA, N.A., and PHI Financial Services, Inc. dated as of February 9, 2021.
Master Framework Agreement by and among Coöperatieve Rabobank, U.A. (New York Branch), MUFG Bank, Ltd. (New York Branch), Standard Chartered Bank (New York Branch), HSBC Bank USA, N.A., and PHI Financial Services, Inc. dated as of February 9, 2021.
Memorandum of Understanding, dated January 22, 2021, by and among The Chemours Company, Corteva, Inc., E. I. du Pont de Nemours and Company and DuPont de Nemours, Inc. (incorporated by reference from the Form 8-K (Commission file number 001-38710) filed January 22, 2021)
Agreement dated March 18, 2021, among Corteva, Inc., Starboard Value LP and certain of its affiliates (incorporated by reference from the Form 8-K (Commission file number 001-38710) filed March 19, 2021).
   
 Rule 13a-14(a)/15d-14(a) Certification of the company’s and EID’s Principal Executive Officer.
   
 Rule 13a-14(a)/15d-14(a) Certification of the company’s and EID’s Principal Financial Officer.
  
 Section 1350 Certification of the company’s and EID’s Principal Executive Officer. The information contained in this Exhibit shall not be deemed filed with the Securities and Exchange Commission nor incorporated by reference in any registration statement filed by the registrant under the Securities Act of 1933, as amended.
   
 Section 1350 Certification of the company’s and EID’s Principal Financial Officer. The information contained in this Exhibit shall not be deemed filed with the Securities and Exchange Commission nor incorporated by reference in any registration statement filed by the registrant under the Securities Act of 1933, as amended.
101.INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
   
101.SCH Inline XBRL Taxonomy Extension Schema Document
   
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
   
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document
   
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document
   
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
104Cover Page Interactive Data File – The Cover Page XBRL tags are embedded within the Inline XBRL document (included in Exhibit 101.INS)
59

SIGNATURE

Corteva, Inc. 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
CORTEVA, INC.
(Registrant)
  
Date:May 5, 2021
  
  
By:/s/ Brian Titus
 
 Brian Titus
 Vice President, Controller
 (Principal Accounting Officer)

E. I. du Pont de Nemours and Company

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
E. I. du Pont de Nemours and Company
(Registrant)
  
Date:May 5, 2021
  
  
By:/s/ Brian Titus
 
 Brian Titus
 Vice President, Controller
 (Principal Accounting Officer)


60

CONSOLIDATED FINANCIAL STATEMENTS OF E. I. DU PONT DE NEMOURS AND COMPANY

E. I. du Pont de Nemours and Company
Consolidated Statements of Operations (Unaudited) 
Three Months Ended
March 31,
(In millions, except per share amounts) 20212020
Net sales$4,178 $3,956 
Cost of goods sold
2,420 2,269 
Research and development expense
281 280 
Selling, general and administrative expenses
733 757 
Amortization of intangibles
183 163 
Restructuring and asset related charges - net
100 70 
Other income - net
337 1 
Interest expense
22 42 
Income from continuing operations before income taxes776 376 
Provision for income taxes on continuing operations174 119 
Income from continuing operations after income taxes602 257 
(Loss) income from discontinued operations after income taxes(10)1 
Net income592 258 
Net income attributable to noncontrolling interests1 8 
Net income attributable to E. I. du Pont de Nemours and Company$591 $250 

See Notes to the Consolidated Financial Statements beginning on page 66.


61

E. I. du Pont de Nemours and Company
Consolidated Statements of Comprehensive Income (Loss) (Unaudited)
Three Months Ended
March 31,
(In millions) 20212020
Net income$592 $258 
Other comprehensive loss - net of tax:
Cumulative translation adjustments
(403)(672)
Adjustments to pension benefit plans
8  
Adjustments to other benefit plans
(157)3 
Unrealized gain on investments10  
Derivative instruments
65 6 
Total other comprehensive loss(477)(663)
Comprehensive income (loss)115 (405)
Comprehensive income attributable to noncontrolling interests - net of tax1 8 
Comprehensive income (loss) attributable to E. I. du Pont de Nemours and Company$114 $(413)

See Notes to the Consolidated Financial Statements beginning on page 66.

62

E. I. du Pont de Nemours and Company
Condensed Consolidated Balance Sheets (Unaudited)
(In millions, except share amounts)March 31, 2021December 31, 2020March 31, 2020
Assets  
Current assets  
Cash and cash equivalents$2,404 $3,526 $1,963 
Marketable securities114 269 10 
Accounts and notes receivable - net6,792 4,926 6,775 
Inventories4,321 4,882 4,401 
Other current assets1,405 1,165 1,530 
Total current assets15,036 14,768 14,679 
Investment in nonconsolidated affiliates64 66 64 
Property, plant and equipment - net of accumulated depreciation (March 31, 2021 - $3,874; December 31, 2020 - $3,857; March 31, 2020 - $3,406)4,299 4,396 4,358 
Goodwill10,146 10,269 10,027 
Other intangible assets10,584 10,747 11,241 
Deferred income taxes433 464 273 
Other assets1,987 1,939 2,336 
Total Assets
$42,549 $42,649 $42,978 
Liabilities and Equity  
Current liabilities  
Short-term borrowings and finance lease obligations$1,250 $3 $1,996 
Accounts payable3,098 3,615 3,021 
Income taxes payable165 123 143 
Deferred revenue2,247 2,662 1,996 
Accrued and other current liabilities2,257 2,148 2,083 
Total current liabilities
9,017 8,551 9,239 
Long-Term Debt1,102 1,102 614 
Long-Term Debt - Related Party3,012 3,459 3,872 
Other Noncurrent Liabilities
Deferred income tax liabilities
902 893 911 
Pension and other post employment benefits - noncurrent
4,954 5,176 6,186 
Other noncurrent obligations
1,814 1,867 1,989 
Total noncurrent liabilities
11,784 12,497 13,572 
Commitments and contingent liabilities
Stockholders’ equity  
Preferred stock, without par value – cumulative; 23,000,000 shares authorized;
     issued at March 31, 2021, December 31, 2020, and March 31, 2020:
$4.50 Series – 1,673,000 shares (callable at $120)
169 169 169 
$3.50 Series – 700,000 shares (callable at $102)
70 70 70 
Common stock, $0.30 par value; 1,800,000,000 shares authorized; 200 issued at March 31, 2021, December 31, 2020, and March 31, 2020   
Additional paid-in capital24,083 24,049 24,004 
Retained earnings / (accumulated deficit)792 203 (158)
Accumulated other comprehensive loss(3,367)(2,890)(3,933)
Total E. I. du Pont de Nemours and Company stockholders’ equity
21,747 21,601 20,152 
Noncontrolling interests
1  15 
Total equity
21,748 21,601 20,167 
Total Liabilities and Equity
$42,549 $42,649 $42,978 

See Notes to the Consolidated Financial Statements beginning on page 66.

63

E. I. du Pont de Nemours and Company
Consolidated Statements of Cash Flows (Unaudited)
Three Months Ended
March 31,
(In millions)20212020
Operating activities
Net income$592 $258 
Adjustments to reconcile net income to cash used for operating activities:
Depreciation and amortization304 283 
Provision for deferred income tax47 26 
Net periodic pension and OPEB benefit, net(318)(85)
Pension and OPEB contributions(84)(95)
Net loss on sales of property, businesses, consolidated companies, and investments 46 
Restructuring and asset related charges - net100 70 
Other net loss54 138 
Changes in assets and liabilities, net
Accounts and notes receivable(2,012)(1,685)
Inventories467 398 
Accounts payable(448)(557)
Deferred revenue(401)(575)
Other assets and liabilities(247)(144)
Cash used for operating activities(1,946)(1,922)
Investing activities 
Capital expenditures(137)(128)
Proceeds from sales of property, businesses, and consolidated companies - net of cash divested20 11 
Purchases of investments(40)(67)
Proceeds from sales and maturities of investments194 58 
Other investing activities - net(1)(4)
Cash provided by (used for) investing activities36 (130)
Financing activities 
Net change in borrowings (less than 90 days)828 1,619 
Payments on related party debt(447)(148)
Proceeds from debt419 875 
Payments on debt (1)
Proceeds from exercise of stock options38 14 
Other financing activities(21)(23)
Cash provided by financing activities817 2,336 
Effect of exchange rate changes on cash, cash equivalents and restricted cash(50)(117)
(Decrease) / increase in cash, cash equivalents and restricted cash(1,143)167 
Cash, cash equivalents and restricted cash at beginning of period3,873 2,173 
Cash, cash equivalents and restricted cash at end of period$2,730 $2,340 
See Notes to the Consolidated Financial Statements beginning on page 66.
64

E. I. du Pont de Nemours and Company
Consolidated Statements of Equity (Unaudited)
(In millions)Preferred StockCommon StockAdd. Paid-in Capital "APIC"Retained Earnings (Accumulated deficit)Accum. Other Comp LossTreasury StockNon-controlling InterestsTotal Equity
2020
Balance at January 1, 2020$239 $ $23,958 $(406)$(3,270)$— $7 $20,528 
Net income
250 8 258 
Other comprehensive loss
(663)(663)
Preferred dividends ($4.50 Series - $1.125 per share, $3.50 Series - $0.875 per share)(2)(2)
Issuance of Corteva stock14 14 
Share-based compensation
2 2 
Other - net
32 (2)30 
Balance at March 31, 2020$239 $ $24,004 $(158)$(3,933)$— $15 $20,167 
(In millions)Preferred StockCommon StockAdd. Paid-in Capital "APIC"Retained Earnings (Accumulated deficit)Accum. Other Comp LossTreasury StockNon-controlling InterestsTotal Equity
2021
Balance at January 1, 2021$239 $ $24,049 $203 $(2,890)$— $ $21,601 
Net income591 1 592 
Other comprehensive loss(477)(477)
Preferred dividends ($4.50 Series - $1.125 per share, $3.50 Series - $0.875 per share)(2)(2)
Issuance of Corteva stock38 38 
Other - net(4)(4)
Balance at March 31, 2021$239 $ $24,083 $792 $(3,367)$— $1 $21,748 

See Notes to the Consolidated Financial Statements beginning on page 66.
65

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

E. I. du Pont de Nemours and Company
Notes to the Consolidated Financial Statements (Unaudited)


Table of Contents

66

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 1 - BASIS OF PRESENTATION

As a result of the Business Realignment and the Internal Reorganization, Corteva, Inc. owns 100% of the outstanding common stock of EID. EID is a subsidiary of Corteva, Inc. and continues to be a reporting company, subject to the requirements of the Exchange Act. The primary differences between Corteva, Inc. and EID are outlined below:

Preferred Stock - EID has preferred stock outstanding to third parties which is accounted for as a non-controlling interest at the Corteva, Inc. level. Each share of EID Preferred Stock - $4.50 Series and EID Preferred Stock - $3.50 Series issued and outstanding at the effective date of the Corteva Distribution remains issued and outstanding as to EID and was unaffected by the Corteva Distribution.
Related Party Loan - EID engaged in a series of debt redemptions during the second quarter of 2019 that were partially funded through an intercompany loan from Corteva, Inc. This was eliminated in consolidation at the Corteva, Inc. level but remains on EID's financial statements at the standalone level (including the associated interest).
Capital Structure - At March 31, 2021, Corteva, Inc.'s capital structure consists of 738,321,000 issued shares of common stock, par value $0.01 per share.

The accompanying footnotes relate to EID only, and not to Corteva, Inc., and are presented to show differences between EID and Corteva, Inc.

For the footnotes listed below, refer to the following Corteva, Inc. footnotes:
Note 1 - Summary of Significant Accounting Policies - refer to page 9 of the Corteva, Inc. interim Consolidated Financial Statements
Note 2 - Recent Accounting Guidance - refer to page 9 of the Corteva, Inc. interim Consolidated Financial Statements
Note 3 - Divestitures and Other Transactions - refer to page 9 of the Corteva, Inc. interim Consolidated Financial Statements
Note 4 - Revenue - refer to page 10 of the Corteva, Inc. interim Consolidated Financial Statements
Note 5 - Restructuring and Asset Related Charges - Net - refer to page 13 of the Corteva, Inc. interim Consolidated Financial Statements
Note 6 - Supplementary Information - refer to page 14 of the Corteva, Inc. interim Consolidated Financial Statements
Note 7 - Income Taxes - refer to page 16 of the Corteva, Inc. interim Consolidated Financial Statements
Note 8 - Earnings Per Share of Common Stock - Not applicable for EID
Note 9 - Accounts and Notes Receivable - Net - refer to page 18 of the Corteva, Inc. interim Consolidated Financial Statements
Note 10 - Inventories - refer to page 19 of the Corteva, Inc. interim Consolidated Financial Statements
Note 11 - Other Intangible Assets - refer to page 19 of the Corteva, Inc. interim Consolidated Financial Statements
Note 12 - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities - refer to page 20 of the Corteva, Inc. interim Consolidated Financial Statements. In addition, EID has a related party loan payable to Corteva, Inc.; refer to EID Note 2 - Related Party Transactions, below
Note 13 - Commitments and Contingent Liabilities - refer to page 21 of the Corteva, Inc. interim Consolidated Financial Statements
Note 14 - Stockholders' Equity - refer to page 26 of the Corteva, Inc. interim Consolidated Financial Statements
Note 15 - Pension Plans and Other Post Employment Benefits - refer to page 29 of the Corteva, Inc. interim Consolidated Financial Statements
Note 16 - Financial Instruments - refer to page 29 of the Corteva, Inc. interim Consolidated Financial Statements
Note 17 - Fair Value Measurements - refer to page 35 of the Corteva, Inc. interim Consolidated Financial Statements
Note 18 - Segment Information - Differences exist between Corteva, Inc. and EID; refer to EID Note 3 - Segment Information, below


67

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 2 - RELATED PARTY TRANSACTIONS

Transactions with Corteva
In the second quarter of 2019, EID entered into a related party revolving loan from Corteva, Inc., with a maturity date in 2024. As of March 31, 2021, December 31, 2020, and March 31, 2020, the outstanding related party loan balance was $3,012 million, $3,459 million, and $3,872 million respectively (which approximates fair value), with interest rates of 1.62% at March 31, 2021 and December 31, 2020, respectively, and 3.27% at March 31, 2020, and is reflected as long-term debt - related party in EID's interim Condensed Consolidated Balance Sheets. Additionally, EID has incurred tax deductible interest expense of $15 million and $32 million for the three months ended March 31, 2021 and 2020, respectively, associated with the related party loan from Corteva, Inc.

As of March 31, 2021, EID had payables to Corteva, Inc., of $55 million and $91 million included in accrued and other current liabilities and other noncurrent obligations, respectively, $92 million at December 31, 2020 included in both accrued and other current liabilities and other noncurrent obligations, respectively, and $166 million and $82 million at March 31, 2020, included in accrued and other current liabilities and other noncurrent obligations, respectively, in the interim Condensed Consolidated Balance Sheets related to Corteva's indemnification liabilities to Dow and DuPont per the Separation Agreements (refer to page 9 of the Corteva, Inc. interim Consolidated Financial Statements for further details of the Separation Agreements).

NOTE 3 - SEGMENT INFORMATION

There are no differences in reporting structure or segments between Corteva, Inc. and EID. In addition, there are no differences between Corteva, Inc. and EID segment net sales, segment operating EBITDA, segment assets, or significant items by segment; refer to page 36 of the Corteva, Inc. interim Consolidated Financial Statements for background information on the segments as well as further details regarding segment metrics. The tables below reconcile income from continuing operations after income taxes to segment operating EBITDA, as differences exist between Corteva, Inc. and EID.

Reconciliation to interim Consolidated Financial Statements
Income from continuing operations after income taxes to segment operating EBITDA


(In millions)
Three Months Ended
March 31,
20212020
Income from continuing operations after income taxes$602 $257 
Provision for income taxes on continuing operations174 119 
Income from continuing operations before income taxes776 376 
Depreciation and amortization304 283 
Interest income(21)(18)
Interest expense22 42 
Exchange losses - net35 61 
Non-operating benefits - net(311)(73)
Mark-to-market gains on certain foreign currency contracts not designated as hedges1
(1)
Significant items100 123 
Corporate expenses34 25 
Segment operating EBITDA$938 $819 
1.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There was no activity in the three months ended March 31, 2020.

68
EX-10.1 2 a101.htm EX-10.1 Document

Master Repurchase
Agreement
_____________________________
September 1996 Version

Dated as of    February 9, 2021
_____________________________________________________________________________________________________________________
Between: Coöperatieve Rabobank, U.A., New York Branch, MUFG Bank, Ltd., New York Branch, Standard Chartered Bank, acting through its New York branch, HSBC Bank USA, N.A.
_____________________________________________________________________________________________________________________
and    PHI Financial Services, Inc.

1.Applicability
From time to time the parties hereto may enter into transactions in which one party (“Seller”) agrees to transfer to the other (“Buyer”) securities or other assets (“Securities”) against the transfer of funds by Buyer, with a simultaneous agreement by Buyer to transfer to Seller such Securities at a date certain or on demand, against the transfer of funds by Seller. Each such transaction shall be referred to herein as a “Transaction” and, unless otherwise agreed in writing, shall be governed by this Agreement, including any supplemental terms or conditions contained in Annex I hereto and in any other annexes identified herein or therein as applicable hereunder.


2. Definitions
(a) “Act of Insolvency”, with respect to any party, (i) the commencement by such party as debtor of any case or proceeding under any bankruptcy, insolvency, reorganization, liquidation, moratorium, dissolution, delinquency or similar law, or such party seeking the appointment or election of a receiver, conservator, trustee, custodian or similar official for such party or any substantial part of its property, or the convening of any meeting of creditors for purposes of commencing any such case or proceeding or seeking such an appointment or election, (ii) the commencement of any such case or proceeding against such party, or another seeking such an appointment or election, or the filing against a party of an application for a protective decree under the provisions of the Securities Investor Protection Act of 1970, which (A) is consented to or not timely contested by such party, (B) results in the entry of an order for relief, such an appointment or election, the issuance of such a protective decree or the entry of an order having a similar effect, or (C) is not dismissed within 15 days, (iii) the making by such party of a general assignment for the benefit of creditors, or (iv) the admission in writing by such party of such party’s inability to pay such party’s debts as they become due;




(b)    “Additional Purchased Securities”, Securities provided by Seller to Buyer pursuant to Paragraph 4(a) hereof;
(c)    “Buyer’s Margin Amount”, with respect to any Transaction as of any date, the amount obtained by application of the Buyer’s Margin Percentage to the Repurchase Price for such Transaction as of such date;

(d)    “Buyer’s Margin Percentage”, with respect to any Transaction as of any date, a percentage (which may be equal to the Seller’s Margin Percentage) agreed to by Buyer and Seller or, in the absence of any such agreement, the percentage obtained by dividing the Market Value of the Purchased Securities on the Purchase Date by the Purchase Price on the Purchase Date for such Transaction;

(e)    “Confirmation”, the meaning specified in Paragraph 3(b) hereof;

(f)    “Income”, with respect to any Security at any time, any principal thereof and all interest, dividends or other distributions thereon;

(g)    “Margin Deficit”, the meaning specified in Paragraph 4(a) hereof;

(h)    “Margin Excess”, the meaning specified in Paragraph 4(b) hereof;

(i)    “Margin Notice Deadline”, the time agreed to by the parties in the relevant Confirmation, Annex I hereto or otherwise as the deadline for giving notice requiring same-day satisfaction of margin maintenance obligations as provided in Paragraph 4 hereof (or, in the absence of any such agreement, the deadline for such purposes established in accordance with market practice);

(j)    “Market Value”, with respect to any Securities as of any date, the price for such Securities on such date obtained from a generally recognized source agreed to by the parties or the most recent closing bid quotation from such a source, plus accrued Income to the extent not included therein (other than any Income credited or transferred to, or applied to the obligations of, Seller pursuant to Paragraph 5 hereof) as of such date (unless contrary to market practice for such Securities);

(k)    “Price Differential”, with respect to any Transaction as of any date, the aggregate amount obtained by daily application of the Pricing Rate for such Transaction to the Purchase Price for such Transaction on a 360 day per year basis for the actual number of days during the period commencing on (and including) the Purchase Date for such Transaction and ending on (but excluding) the date of determination (reduced by any amount of such Price Differential previously paid by Seller to Buyer with respect to such Transaction);

(l)    “Pricing Rate”, the per annum percentage rate for determination of the Price Differential;




(m)    “Prime Rate”, the prime rate of U.S. commercial banks as published in The Wall Street Journal (or, if more than one such rate is published, the average of such rates);

(n)    “Purchase Date”, the date on which Purchased Securities are to be transferred by Seller to Buyer;
(o)    “Purchase Price”, (i) on the Purchase Date, the price at which Purchased Securities are transferred by Seller to Buyer, and (ii) thereafter, except where Buyer and Seller agree otherwise, such price increased by the amount of any cash transferred by Buyer to Seller pursuant to Paragraph 4(b) hereof and decreased by the amount of any cash transferred by Seller to Buyer pursuant to Paragraph 4(a) hereof or applied to reduce Seller’s obligations under clause (ii) of Paragraph 5 hereof;

(p)    “Purchased Securities”, the Securities transferred by Seller to Buyer in a Transaction here- under, and any Securities substituted therefor in accordance with Paragraph 9 hereof. The term “Purchased Securities” with respect to any Transaction at any time also shall include Additional Purchased Securities delivered pursuant to Paragraph 4(a) hereof and shall exclude Securities returned pursuant to Paragraph 4(b) hereof;

(q)    “Repurchase Date”, the date on which Seller is to repurchase the Purchased Securities from Buyer, including any date determined by application of the provisions of Paragraph 3(c) or 11 hereof;

(r)    “Repurchase Price”, the price at which Purchased Securities are to be transferred from Buyer to Seller upon termination of a Transaction, which will be determined in each case (including Transactions terminable upon demand) as the sum of the Purchase Price and the Price Differential as of the date of such determination;

(s)    “Seller’s Margin Amount”, with respect to any Transaction as of any date, the amount obtained by application of the Seller’s Margin Percentage to the Repurchase Price for such Transaction as of such date;

(t)    “Seller’s Margin Percentage”, with respect to any Transaction as of any date, a percentage (which may be equal to the Buyer’s Margin Percentage) agreed to by Buyer and Seller or, in the absence of any such agreement, the percentage obtained by dividing the Market Value of the Purchased Securities on the Purchase Date by the Purchase Price on the Purchase Date for such Transaction.


3.    Initiation; Confirmation; Termination
(a)    An agreement to enter into a Transaction may be made orally or in writing at the initiation of either Buyer or Seller. On the Purchase Date for the Transaction, the Purchased Securities shall be transferred to Buyer or its agent against the transfer of the Purchase Price to an account of Seller.




(b)    Upon agreeing to enter into a Transaction hereunder, Buyer or Seller (or both), as shall be agreed, shall promptly deliver to the other party a written confirmation of each Transaction (a “Confirmation”). The Confirmation shall describe the Purchased Securities (including CUSIP number, if any), identify Buyer and Seller and set forth (i) the Purchase Date, (ii) the Purchase Price, (iii) the Repurchase Date, unless the Transaction is to be terminable on demand, (iv) the Pricing Rate or Repurchase Price applicable to the Transaction, and (v) any additional terms or conditions of the Transaction not inconsistent with this Agreement. The Confirmation, together with this Agreement, shall constitute conclusive evidence of the terms agreed between Buyer and Seller with respect to the Transaction to which the Confirmation relates, unless with
respect to the Confirmation specific objection is made promptly after receipt thereof. In the event of any conflict between the terms of such Confirmation and this Agreement, this Agreement shall prevail.

(c)    In the case of Transactions terminable upon demand, such demand shall be made by Buyer or Seller, no later than such time as is customary in accordance with market practice, by telephone or otherwise on or prior to the business day on which such termination will be effective. On the date specified in such demand, or on the date fixed for termination in the case of Transactions having a fixed term, termination of the Transaction will be effected by transfer to Seller or its agent of the Purchased Securities and any Income in respect thereof received by Buyer (and not previously credited or transferred to, or applied to the obligations of, Seller pursuant to Paragraph 5 hereof) against the transfer of the Repurchase Price to an account of Buyer.


4.    Margin Maintenance
(a)    If at any time the aggregate Market Value of all Purchased Securities subject to all Transactions in which a particular party hereto is acting as Buyer is less than the aggregate Buyer’s Margin Amount for all such Transactions (a “Margin Deficit”), then Buyer may by notice to Seller require Seller in such Transactions, at Seller’s option, to transfer to Buyer cash or additional Securities reasonably acceptable to Buyer (“Additional Purchased Securities”), so that the cash and aggregate Market Value of the Purchased Securities, including any such Additional Purchased Securities, will thereupon equal or exceed such aggregate Buyer’s Margin Amount (decreased by the amount of any Margin Deficit as of such date arising from any Transactions in which such Buyer is acting as Seller).

(b)    If at any time the aggregate Market Value of all Purchased Securities subject to all Transactions in which a particular party hereto is acting as Seller exceeds the aggregate Seller’s Margin Amount for all such Transactions at such time (a “Margin Excess”), then Seller may by notice to Buyer require Buyer in such Transactions, at Buyer’s option, to transfer cash or Purchased Securities to Seller, so that the aggregate Market Value of the Purchased Securities, after deduction of any such cash or any Purchased Securities so transferred, will thereupon not exceed such aggregate Seller’s Margin Amount (increased



by the amount of any Margin Excess as of such date arising from any Transactions in which such Seller is acting as Buyer).

(c)    If any notice is given by Buyer or Seller under subparagraph (a) or (b) of this Paragraph at or before the Margin Notice Deadline on any business day, the party receiving such notice shall transfer cash or Additional Purchased Securities as provided in such subparagraph no later than the close of business in the relevant market on such day. If any such notice is given after the Margin Notice Deadline, the party receiving such notice shall transfer such cash or Securities no later than the close of business in the relevant market on the next business day following such notice.

(d)    Any cash transferred pursuant to this Paragraph shall be attributed to such Transactions as shall be agreed upon by Buyer and Seller.
(e)    Seller and Buyer may agree, with respect to any or all Transactions hereunder, that the respective rights of Buyer or Seller (or both) under subparagraphs (a) and (b) of this Paragraph may be exercised only where a Margin Deficit or Margin Excess, as the case may be, exceeds a specified dollar amount or a specified percentage of the Repurchase Prices for such Transactions (which amount or percentage shall be agreed to by Buyer and Seller prior to entering into any such Transactions).

(f)    Seller and Buyer may agree, with respect to any or all Transactions hereunder, that the respective rights of Buyer and Seller under subparagraphs (a) and (b) of this Paragraph to require the elimination of a Margin Deficit or a Margin Excess, as the case may be, may be exercised whenever such a Margin Deficit or Margin Excess exists with respect to any single Transaction hereunder (calculated without regard to any other Transaction outstanding under this Agreement).


5.    Income Payments
Seller shall be entitled to receive an amount equal to all Income paid or distributed on or in respect of the Securities that is not otherwise received by Seller, to the full extent it would be so entitled if the Securities had not been sold to Buyer. Buyer shall, as the parties may agree with respect to any Transaction (or, in the absence of any such agreement, as Buyer shall reasonably determine in its discretion), on the date such Income is paid or distributed either (i) transfer to or credit to the account of Seller such Income with respect to any Purchased Securities subject to such Transaction or (ii) with respect to Income paid in cash, apply the Income payment or payments to reduce the amount, if any, to be transferred to Buyer by Seller upon termination of such Transaction. Buyer shall not be obligated to take any action pursuant to the preceding sentence (A) to the extent that such action would result in the creation of a Margin Deficit, unless prior thereto or simultaneously therewith Seller transfers to Buyer cash or Additional Purchased Securities sufficient to eliminate such Margin Deficit, or (B) if an Event of Default with respect to Seller has occurred and is then continuing at the time such Income is paid or distributed.





6.    Security Interest
Although the parties intend that all Transactions hereunder be sales and purchases and not loans, in the event any such Transactions are deemed to be loans, Seller shall be deemed to have pledged to Buyer as security for the performance by Seller of its obligations under each such Transaction, and shall be deemed to have granted to Buyer a security interest in, all of the Purchased Securities with respect to all Transactions hereunder and all Income thereon and other proceeds thereof.


7.    Payment and Transfer
Unless otherwise mutually agreed, all transfers of funds hereunder shall be in immediately available funds. All Securities transferred by one party hereto to the other party (i) shall be in suitable form for transfer or shall be accompanied by duly executed instruments of transfer or assignment in blank and such other documentation as the party receiving possession may reasonably request, (ii) shall be transferred on the book-entry system of a Federal Reserve Bank, or (iii) shall be transferred by any other method mutually acceptable to Seller and Buyer.
8.    Segregation of Purchased Securities
To the extent required by applicable law, all Purchased Securities in the possession of Seller shall be segregated from other securities in its possession and shall be identified as subject to this Agreement. Segregation may be accomplished by appropriate identification on the books and records of the holder, including a financial or securities intermediary or a clearing corporation. All of Seller’s interest in the Purchased Securities shall pass to Buyer on the Purchase Date and, unless otherwise agreed by Buyer and Seller, nothing in this Agreement shall preclude Buyer from engaging in repurchase transactions with the Purchased Securities or other- wise selling, transferring, pledging or hypothecating the Purchased Securities, but no such transaction shall relieve Buyer of its obligations to transfer Purchased Securities to Seller pursuant to Paragraph 3, 4 or 11 hereof, or of Buyer’s obligation to credit or pay Income to, or apply Income to the obligations of, Seller pursuant to Paragraph 5 hereof.




requireddislcosure1.gif



9.    Substitution
(a)    Seller may, subject to agreement with and acceptance by Buyer, substitute other Securities for any Purchased Securities. Such substitution shall be made by transfer to Buyer of such other Securities and transfer to Seller of such Purchased Securities. After substitution, the substituted Securities shall be deemed to be Purchased Securities.

(b)    In Transactions in which Seller retains custody of Purchased Securities, the parties expressly agree that Buyer shall be deemed, for purposes of subparagraph (a) of this Paragraph, to have agreed to and accepted in this Agreement substitution by Seller of other Securities for Purchased Securities; provided, however, that such other Securities shall have a Market Value at least equal to the Market Value of the Purchased Securities for which they are substituted.
10. Representations
Each of Buyer and Seller represents and warrants to the other that (i) it is duly authorized to execute and deliver this Agreement, to enter into Transactions contemplated hereunder and to perform its obligations hereunder and has taken all necessary action to authorize such execution, delivery and performance, (ii) it will engage in such Transactions as principal (or, if agreed in writing, in the form of an annex hereto or otherwise, in advance of any Transaction by the other party hereto, as agent for a disclosed principal), (iii) the person signing this Agreement on its behalf is duly authorized to do so on its behalf (or on behalf of any such disclosed principal), (iv) it has obtained all authorizations of any governmental body



required in connection with this Agreement and the Transactions hereunder and such authorizations are in full force and effect and (v) the execution, delivery and performance of this Agreement and the Transactions hereunder will not violate any law, ordinance, charter, by- law or rule applicable to it or any agreement by which it is bound or by which any of its assets are affected. On the Purchase Date for any Transaction Buyer and Seller shall each be deemed to repeat all the foregoing representations made by it.


11.    Events of Default
In the event that (i) Seller fails to transfer or Buyer fails to purchase Purchased Securities upon the applicable Purchase Date, (ii) Seller fails to repurchase or Buyer fails to transfer Purchased Securities upon the applicable Repurchase Date, (iii) Seller or Buyer fails to com- ply with Paragraph 4 hereof, (iv) Buyer fails, after one business day’s notice, to comply with Paragraph 5 hereof, (v) an Act of Insolvency occurs with respect to Seller or Buyer, (vi) any representation made by Seller or Buyer shall have been incorrect or untrue in any material respect when made or repeated or deemed to have been made or repeated, or (vii) Seller or Buyer shall admit to the other its inability to, or its intention not to, perform any of its obligations hereunder (each an “Event of Default”):

(a)    The nondefaulting party may, at its option (which option shall be deemed to have been exercised immediately upon the occurrence of an Act of Insolvency), declare an Event of Default to have occurred hereunder and, upon the exercise or deemed exercise of such option, the Repurchase Date for each Transaction hereunder shall, if it has not already occurred, be deemed immediately to occur (except that, in the event that the Purchase Date for any Transaction has not yet occurred as of the date of such exercise or deemed exercise, such Transaction shall be deemed immediately canceled). The nondefaulting party shall (except upon the occurrence of an Act of Insolvency) give notice to the defaulting party of the exercise of such option as promptly as practicable.

(b)    In all Transactions in which the defaulting party is acting as Seller, if the nondefaulting party exercises or is deemed to have exercised the option referred to in subparagraph (a) of this Paragraph, (i) the defaulting party’s obligations in such Transactions to repurchase all Purchased Securities, at the Repurchase Price therefor on the Repurchase Date deter- mined in accordance with subparagraph (a) of this Paragraph, shall thereupon become immediately due and payable, (ii) all Income paid after such exercise or deemed exercise shall be retained by the nondefaulting party and applied to the aggregate unpaid Repurchase Prices and any other amounts owing by the defaulting party hereunder, and
(iii) the defaulting party shall immediately deliver to the nondefaulting party any Purchased Securities subject to such Transactions then in the defaulting party’s possession or control.
(c)    In all Transactions in which the defaulting party is acting as Buyer, upon tender by the nondefaulting party of payment of the aggregate Repurchase Prices for all such Transactions, all right, title and interest in and entitlement to all Purchased Securities



subject to such Transactions shall be deemed transferred to the nondefaulting party, and the defaulting party shall deliver all such Purchased Securities to the nondefaulting party.

(d)    If the nondefaulting party exercises or is deemed to have exercised the option referred to in subparagraph (a) of this Paragraph, the nondefaulting party, without prior notice to the defaulting party, may:

(i)    as to Transactions in which the defaulting party is acting as Seller, (A) immediately sell, in a recognized market (or otherwise in a commercially reasonable manner) at such price or prices as the nondefaulting party may reasonably deem satisfactory, any or all Purchased Securities subject to such Transactions and apply the proceeds thereof to the aggregate unpaid Repurchase Prices and any other amounts owing by the defaulting party hereunder or (B) in its sole discretion elect, in lieu of selling all or a portion of such Purchased Securities, to give the defaulting party credit for such Purchased Securities in an amount equal to the price therefor on such date, obtained from a generally recognized source or the most recent closing bid quotation from such a source, against the aggregate unpaid Repurchase Prices and any other amounts owing by the defaulting party hereunder; and

(ii)    as to Transactions in which the defaulting party is acting as Buyer, (A) immediately purchase, in a recognized market (or otherwise in a commercially reasonable manner) at such price or prices as the nondefaulting party may reasonably deem satisfactory, securities (“Replacement Securities”) of the same class and amount as any Purchased Securities that are not delivered by the defaulting party to the nondefaulting party as required hereunder or (B) in its sole discretion elect, in lieu of purchasing Replacement Securities, to be deemed to have purchased Replacement Securities at the price therefor on such date, obtained from a generally recognized source or the most recent closing offer quotation from such a source.

Unless otherwise provided in Annex I, the parties acknowledge and agree that (1) the Securities subject to any Transaction hereunder are instruments traded in a recognized market, (2) in the absence of a generally recognized source for prices or bid or offer quotations for any Security, the nondefaulting party may establish the source therefor in its sole discretion and (3) all prices, bids and offers shall be determined together with accrued Income (except to the extent contrary to market practice with respect to the relevant Securities).

(e)    As to Transactions in which the defaulting party is acting as Buyer, the defaulting party shall be liable to the nondefaulting party for any excess of the price paid (or deemed paid) by the nondefaulting party for Replacement Securities over the Repurchase Price for the Purchased Securities replaced thereby and for any amounts payable by the defaulting party under Paragraph 5 hereof or otherwise hereunder.

(f)    For purposes of this Paragraph 11, the Repurchase Price for each Transaction hereunder in respect of which the defaulting party is acting as Buyer shall not increase above the



amount of such Repurchase Price for such Transaction determined as of the date of the exercise or deemed exercise by the nondefaulting party of the option referred to in sub- paragraph (a) of this Paragraph.

(g)    The defaulting party shall be liable to the nondefaulting party for (i) the amount of all reasonable legal or other expenses incurred by the nondefaulting party in connection with or as a result of an Event of Default, (ii) damages in an amount equal to the cost (including all fees, expenses and commissions) of entering into replacement transactions and entering into or terminating hedge transactions in connection with or as a result of an Event of Default, and (iii) any other loss, damage, cost or expense directly arising or resulting from the occurrence of an Event of Default in respect of a Transaction.

(h)    To the extent permitted by applicable law, the defaulting party shall be liable to the non- defaulting party for interest on any amounts owing by the defaulting party hereunder, from the date the defaulting party becomes liable for such amounts hereunder until such amounts are (i) paid in full by the defaulting party or (ii) satisfied in full by the exercise of the nondefaulting party’s rights hereunder. Interest on any sum payable by the defaulting party to the nondefaulting party under this Paragraph 11(h) shall be at a rate equal to the greater of the Pricing Rate for the relevant Transaction or the Prime Rate.

(i)    The nondefaulting party shall have, in addition to its rights hereunder, any rights other- wise available to it under any other agreement or applicable law.


12.    Single Agreement
Buyer and Seller acknowledge that, and have entered hereinto and will enter into each Transaction hereunder in consideration of and in reliance upon the fact that, all Transactions hereunder constitute a single business and contractual relationship and have been made in consideration of each other. Accordingly, each of Buyer and Seller agrees (i) to perform all of its obligations in respect of each Transaction hereunder, and that a default in the performance of any such obligations shall constitute a default by it in respect of all Transactions hereunder, (ii) that each of them shall be entitled to set off claims and apply property held by them in respect of any Transaction against obligations owing to them in respect of any other Transactions hereunder and (iii) that payments, deliveries and other transfers made by either of them in respect of any Transaction shall be deemed to have been made in consideration of payments, deliveries and other transfers in respect of any other Transactions hereunder, and the obligations to make any such payments, deliveries and other transfers may be applied against each other and netted.


13.    Notices and Other Communications
Any and all notices, statements, demands or other communications hereunder may be given by a party to the other by mail, facsimile, telegraph, messenger or otherwise to the address specified in Annex II hereto, or so sent to such party at any other place specified in a notice of



change of address hereafter received by the other. All notices, demands and requests hereunder may be made orally, to be confirmed promptly in writing, or by other communication as specified in the preceding sentence.
14.    Entire Agreement; Severability
This Agreement shall supersede any existing agreements between the parties containing general terms and conditions for repurchase transactions. Each provision and agreement herein shall be treated as separate and independent from any other provision or agreement herein and shall be enforceable notwithstanding the unenforceability of any such other provision or agreement.


15.    Non-assignability; Termination
(a)    The rights and obligations of the parties under this Agreement and under any Transaction shall not be assigned by either party without the prior written consent of the other party, and any such assignment without the prior written consent of the other party shall be null and void. Subject to the foregoing, this Agreement and any Transactions shall be binding upon and shall inure to the benefit of the parties and their respective successors and assigns. This Agreement may be terminated by either party upon giving written notice to the other, except that this Agreement shall, notwithstanding such notice, remain applicable to any Transactions then outstanding.

(b)    Subparagraph (a) of this Paragraph 15 shall not preclude a party from assigning, charging or otherwise dealing with all or any part of its interest in any sum payable to it under Paragraph 11 hereof.


16.    Governing Law
This Agreement shall be governed by the laws of the State of New York without giving effect to the conflict of law principles thereof.


17.    No Waivers, Etc.
No express or implied waiver of any Event of Default by either party shall constitute a waiver of any other Event of Default and no exercise of any remedy hereunder by any party shall constitute a waiver of its right to exercise any other remedy hereunder. No modification or waiver of any provision of this Agreement and no consent by any party to a departure here- from shall be effective unless and until such shall be in writing and duly executed by both of the parties hereto. Without limitation on any of the foregoing, the failure to give a notice pursuant to Paragraph 4(a) or 4(b) hereof will not constitute a waiver of any right to do so at a later date.







18.    Use of Employee Plan Assets
(a)    If assets of an employee benefit plan subject to any provision of the Employee Retirement Income Security Act of 1974 (“ERISA”) are intended to be used by either party hereto (the “Plan Party”) in a Transaction, the Plan Party shall so notify the other party prior to the Transaction. The Plan Party shall represent in writing to the other party that the Transaction does not constitute a prohibited transaction under ERISA or is otherwise exempt therefrom, and the other party may proceed in reliance thereon but shall not be required so to proceed.
(b)    Subject to the last sentence of subparagraph (a) of this Paragraph, any such Transaction shall proceed only if Seller furnishes or has furnished to Buyer its most recent available audited statement of its financial condition and its most recent subsequent unaudited statement of its financial condition.

(c)    By entering into a Transaction pursuant to this Paragraph, Seller shall be deemed (i) to represent to Buyer that since the date of Seller’s latest such financial statements, there has been no material adverse change in Seller’s financial condition which Seller has not dis- closed to Buyer, and (ii) to agree to provide Buyer with future audited and unaudited statements of its financial condition as they are issued, so long as it is a Seller in any out- standing Transaction involving a Plan Party.


19.    Intent
(a)    The parties recognize that each Transaction is a “repurchase agreement” as that term is defined in Section 101 of Title 11 of the United States Code, as amended (except insofar as the type of Securities subject to such Transaction or the term of such Transaction would render such definition inapplicable), and a “securities contract” as that term is defined in Section 741 of Title 11 of the United States Code, as amended (except insofar as the type of assets subject to such Transaction would render such definition inapplicable).

(b)    It is understood that either party’s right to liquidate Securities delivered to it in connection with Transactions hereunder or to exercise any other remedies pursuant to Paragraph 11 hereof is a contractual right to liquidate such Transaction as described in Sections 555 and 559 of Title 11 of the United States Code, as amended.

(c)    The parties agree and acknowledge that if a party hereto is an “insured depository institution,” as such term is defined in the Federal Deposit Insurance Act, as amended (“FDIA”), then each Transaction hereunder is a “qualified financial contract,” as that term is defined in FDIA and any rules, orders or policy statements thereunder (except insofar as the type of assets subject to such Transaction would render such definition inapplicable).

(d)    It is understood that this Agreement constitutes a “netting contract” as defined in and subject to Title IV of the Federal Deposit Insurance Corporation Improvement Act of 1991 (“FDICIA”) and each payment entitlement and payment obligation under any Transaction hereunder shall constitute a “covered contractual payment entitlement” or “covered



contractual payment obligation”, respectively, as defined in and subject to FDI- CIA (except insofar as one or both of the parties is not a “financial institution” as that term is defined in FDICIA).


20.    Disclosure Relating to Certain Federal Protections
The parties acknowledge that they have been advised that:

(a)    in the case of Transactions in which one of the parties is a broker or dealer registered with the Securities and Exchange Commission (“SEC”) under Section 15 of the Securities Exchange Act of 1934 (“1934 Act”), the Securities Investor Protection Corporation has taken the position that the provisions of the Securities Investor Protection Act of 1970 (“SIPA”) do not protect the other party with respect to any Transaction hereunder;

(b)    in the case of Transactions in which one of the parties is a government securities broker or a government securities dealer registered with the SEC under Section 15C of the 1934 Act, SIPA will not provide protection to the other party with respect to any Transaction hereunder; and

(c)    in the case of Transactions in which one of the parties is a financial institution, funds held by the financial institution pursuant to a Transaction hereunder are not a deposit and therefore are not insured by the Federal Deposit Insurance Corporation or the National Credit Union Share Insurance Fund, as applicable.


[Signature Pages Follow]




Cooperatieve Rabobank, U.A., New York Branch


By: /s/ Vikram Malkani
Name: Vikram Malkani
Title: Managing Director



By: /s/ David Epstein
Name: David Epstein
Title: Vice President


[SIGNATURE PAGES CONTINUE ON FOLLOWING PAGE]




MUFG Bank, Ltd., New York Branch



By: /s/ Philippe Pepin     
Name: Philippe Pepin
Title: Director


[SIGNATURE PAGES CONTINUE ON FOLLOWING PAGE]




Standard Chartered Bank, acting through its New York branch



By: /s/ Anita Gray
Name: Anita Gray
Title: Executive Director


[SIGNATURE PAGES CONTINUE ON FOLLOWING PAGE]




HSBC Bank USA, N.A.



By: /s/ Adam Hendley     
Name: Adam Hendley
Title: Managing Director


[SIGNATURE PAGES CONTINUE ON FOLLOWING PAGE]




PHI Financial Services, Inc.


By: /s/ Timothy A. Johnson
Name:    Timothy A. Johnson
Title: Treasurer and Director


EX-10.2 3 a102.htm EX-10.2 Document

MASTER FRAMEWORK AGREEMENT

This MASTER FRAMEWORK AGREEMENT (this “Framework Agreement”), is made and entered into as of February 9, 2021 (the “Effective Date”), by and among:

Coöperatieve Rabobank, U.A., New York Branch, a Dutch coöperatieve acting through its New York Branch (“Rabobank”), MUFG Bank, Ltd., New York Branch, a Japanese banking corporation acting through its New York Branch (“MUFG”), Standard Chartered Bank, a bank organized and existing under the laws of England and Wales, acting through its New York branch, (“Standard Chartered”) and HSBC Bank USA, N.A., a national banking association organized under the laws of the United States (“HSBC”), as purchasers (collectively, the “Buyers”);

Rabobank and MUFG, as joint lead arrangers (each, in such capacity, a “Joint Lead Arranger”);

Rabobank, as Buyers’ agent (in such capacity, “Agent”); and

PHI Financial Services, Inc., an Iowa corporation (“Seller”).

Each of Agent, Buyers and Seller may also be referred to herein individually as a “Party”, and collectively as the “Parties”.

RECITALS

WHEREAS, Buyers have agreed to provide Seller with a facility under which Buyers and Seller will enter into certain sale and repurchase agreements with respect to Eligible Farmer Loans owned by Seller.
AGREEMENT

NOW, THEREFORE, in consideration of the mutual covenants, agreements and conditions set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

1.    Interpretation.

1.1    Definitions. All capitalized terms used in this Framework Agreement (including its recitals and Schedules) shall, unless defined herein, have the respective meanings set forth in Schedule 1 hereto.

1.2    Construction.

(a)    The headings and sub-headings in this Framework Agreement shall not affect its interpretation. References in this Framework Agreement to Sections and



Schedules shall, unless the context otherwise requires, be references to Sections of, and Schedules to, this Framework Agreement.

(b)    Words denoting the singular number only shall include the plural number also and vice versa; words denoting one gender only shall include the other genders and words denoting persons shall include firms and corporations and vice versa.

(c)    References to a Person are also to its permitted successors or assigns.

(d)    References in this Framework Agreement to any agreement or other document shall be deemed also to refer to such agreement or document as amended or varied or novated from time to time.

(e)    References to an amendment include a supplement, novation, restatement or re-enactment and amend and amended (or any of their derivative forms) will be construed accordingly.

(f)    Reference to a time of day is a reference to New York City time.    
    
(g)    “Include”, “includes” and “including” shall be deemed to be followed by the words “without limitation.”

(h)    “Hereof”, “hereto”, “herein” and “hereunder” and words of similar import when used in this Framework Agreement refer to this Framework Agreement as a whole and not to any particular provision of this Framework Agreement.

(i)    References to a “writing” or “written” include any text transmitted or made available on paper or through electronic means.

(j)    References to “$”, U.S. Dollars or otherwise to dollar amounts refer to the lawful currency of the United States.

(k)    References to a law include any amendment or modification to such law and any rules and regulations issued thereunder, whether such amendment or modification is made, or issuance of such rules and regulations occurs, before or after the Effective Date.

2.    Transaction Agreements.

2.1    Agreements to be Executed at the Closing. Concurrently with this Framework Agreement, the Parties intend to execute the following additional agreements (together with this Framework Agreement and each subsequent Confirmation entered into during the Facility Term subsequent to the Closing, the “Transaction Agreements”) to which they are party:

(a)    the Master Repurchase Agreement among Seller and the Buyers;




(b)    the Fee Letter among Seller and Buyers;

(c)    the Side Letter between Seller and Agent; and

(d)    the Guaranty.

2.2    Definitions. When used in any Transaction Agreement, capitalized terms not otherwise defined therein will, to the extent defined herein, have the meanings set forth in this Framework Agreement (including Schedule 1).

3.    Closing; Closing Deliveries.

3.1    Closing. Subject to the terms and conditions of this Framework Agreement, the transactions contemplated in this Framework Agreement to occur concurrently with the execution hereof (other than the entry into any Confirmations) will take place at a closing (the “Closing”) to be held on the Effective Date at a mutually agreeable location or by the exchange of electronic documentation.

3.2    Seller Closing Deliverables. At the Closing or prior to the Closing, Seller will deliver, or cause to be delivered, to each Buyer:

(a)    an executed counterpart to each of the Transaction Agreements (other than any Confirmations) to which it is a party;

(b)    executed counterparts of each of the Guarantors to the Guaranty;

(c)    a certificate of the Secretary or an Assistant Secretary of Seller, dated the Effective Date, certifying as to (i) the incumbency of the officers of Seller executing the Transaction Agreements, (ii) attached copies of Seller’s articles of incorporation and bylaws; and (iii) copies of all corporate approvals and consents of Seller that are required by it in connection with entering into, and the exercise of its rights and the performance of its obligations under, the Transaction Agreements;

(d)    a certificate of the Secretary or an Assistant Secretary of each Guarantor, dated the Effective Date, certifying as to (i) the incumbency of the officer(s) of each Guarantor executing the Guaranty, (ii) attached copies of each Guarantor’s certificate of incorporation and bylaws; and (iii) copies of all corporate approvals and consents of each Guarantor that are required by it in connection with entering into, and the exercise of its rights and the performance of its obligations under, the Guaranty;

(e)    a customary legal opinion or opinions with respect to Seller opining on existence, due authorization and execution, absence of conflicts with Organizational Documents, binding nature of obligations, absence of violations of Law and no consents under Law, and creation and perfection of security interests;




(f)    a customary legal opinion or opinions with respect to each Guarantor opining on existence, due authorization and execution, absence of conflicts with Organizational Documents, binding nature of obligations, absence of violations of Law and no consents under Law;

(g)    a duly completed Certification of Beneficial Owners(s) with respect to Seller;

(h)    results of a UCC lien search with respect to Seller for the State of Iowa as of a date not more than seven (7) days prior to the Closing; and

(i)    fully prepared UCC-1 financing statements reflecting the Security Interests granted by Seller under the Master Repurchase Agreement.

3.3    Buyer Closing Deliverables. At the Closing or prior to the Closing, each Buyer will deliver to Seller and each other Buyer an executed counterpart to each of the Transaction Agreements (other than any Confirmations) to which it is a party.

3.4    Agent Closing Deliverables. At the Closing or prior to the Closing, Agent shall provide to Seller, an executed copy of IRS Form W-8IMY, indicating on Part VI that Agent is a U.S. branch of a foreign bank described in United States Department of Treasury Regulations section 1.1441-1(b)(2)(iv)(A) agreeing to be treated as a U.S. person for purposes of withholding on payments under the Transaction Agreements.

4.    Transactions.

4.1    Requests for Transactions.

(a)    Transaction Notices. Seller may, from time to time during the Facility Term, deliver a written notice, substantially in the form attached hereto as Exhibit A and including a fully-completed proposed Portfolio Schedule (a “Transaction Notice”) to Agent requesting that Buyers enter into a Transaction on a Monthly Date (or, if Seller elects to terminate a Transaction pursuant to Paragraph 3(c)(ii) of Annex I to the Master Repurchase Agreement, on the effective date of such termination). Such notice shall be delivered to Agent not less than four (4) Business Days prior to the proposed Purchase Date for such proposed Transaction (or such later date as may be consented to by Agent, which consent may be conditioned on the consent of the Buyers). Subject to the terms and conditions set forth herein and in the other Transaction Agreements, each Buyer agrees severally, and not jointly, to enter into such Transactions with Seller up to its respective Individual Commitment Amount as of the applicable Purchase Date.

(b)    Confirmation Process. Within one (1) Business Day of its receipt of a Transaction Notice, Agent shall deliver a fully completed draft Confirmation with respect to the proposed Transaction, attaching the related proposed Portfolio Schedule provided



by Seller pursuant to Section 4.1(a). In the event Seller and Agent disagree with respect to any portion of the draft Confirmation or the proposed Portfolio Schedule or in the event Agent determines in good faith that any applicable Transaction Conditions are not, or will not be, satisfied as of the relevant Purchase Date, Seller or Agent (as applicable) shall promptly notify the other of the same, and Seller and Agent shall cooperate expeditiously and in good faith to resolve any such matters (to the extent the same are capable of being resolved). If the applicable Transaction Conditions are (or will be) satisfied as of the applicable Purchase Date, then Agent shall, on behalf of the Buyers and subject to the provisions of Section 4.5, enter into the proposed Transaction with Seller on the terms set forth in the draft Confirmation (as may be modified as agreed between Seller and Agent in accordance with the preceding sentence) by executing and delivering to Seller, on behalf of each such Buyer, a Confirmation evidencing such Transaction in accordance with the Master Repurchase Agreement.

(c)    Failed Closings. If, on any proposed Purchase Date, the entry into a proposed Transaction on such date would otherwise fail to occur due to:

(i)    any failure of Seller and Agent to agree on the Confirmation or the Portfolio Schedule for such proposed Transaction in accordance with the foregoing Section 4.1(b) on or before such proposed Purchase Date;

(ii)    any failure as of such proposed Purchase Date of any applicable Transaction Condition to be satisfied with respect to such proposed Transaction;

(iii)    any unforeseen circumstance or event, such as a disruption in wire transfers, power or other mechanical or technological failures or interruptions, computer viruses, communications disruptions, work stoppages, natural disasters, fire, war, terrorism, riots, rebellions, or any circumstance beyond the control of the Parties; or

(iv)    any other reason (other than the failure of a Deemed Roll-Over Condition to be satisfied);

then, notwithstanding any provision to the contrary in any Transaction Agreement,

(x)     if the proposed Purchase Date is not a Monthly Date and any Current Transaction was specified for early termination on such proposed Purchase Date pursuant to Paragraph 3(c)(ii) of Annex I to the Master Repurchase Agreement, then notwithstanding such specification, such Current Transaction shall continue without termination on such proposed Purchase Date and no new Transaction shall be entered into on such proposed Purchase Date, and

(y)    if the proposed Purchase Date is a Monthly Date, then so long as the Deemed Roll-Over Conditions are satisfied as of such Monthly Date, and



notwithstanding the failure of any Additional Funding Condition or Roll-Over Condition (which condition, in each case, is not also a Deemed Roll-Over Condition) to be satisfied as of such Monthly Date, Seller and Buyers shall be deemed to have entered into a new Roll-Over Transaction (a “Deemed Roll-Over Transaction”) on such Monthly Date in accordance with Section 4.1(d) below.

(d)    Deemed Roll-Over Transactions. In the event the Parties are deemed to have entered into a Deemed Roll-Over Transaction on any Monthly Date pursuant to the foregoing Section 4.1(c), such Deemed Roll-Over Transaction shall be deemed to be entered into on the same terms as those set forth in the final form of Confirmation (including the Portfolio Schedule thereto) governing the Transaction expiring on such Monthly Date, subject to the following modifications:

(A) the Purchase Date shall be the applicable Monthly Date on which such Deemed Roll-Over Transaction is deemed to have been entered into, and the applicable Pricing Rate shall be updated accordingly;

(B) the Repurchase Date shall be the earlier of the Facility Expiration Date or the next applicable Monthly Date following the Purchase Date;

(C) the Portfolio Schedule applicable to the Deemed Roll-Over Transaction shall be: (i) in the event Seller has delivered to Agent a Portfolio Schedule by such Purchase Date designated for use in connection with entry into a Transaction on such Purchase Date and which satisfies clauses (vi) through (ix) of Section 4.3(a), such delivered Portfolio Schedule; and (ii) otherwise, the Portfolio Schedule for the prior Transaction expiring on such Monthly Date (the Portfolio Schedule described in this clause (ii), a “Roll-Over Portfolio Schedule”);

(D) if the Purchase Price set forth in the Confirmation for the expiring Transaction exceeds the Aggregate Commitment Amount applicable to such Deemed Roll-Over Transaction, the Purchase Price for such Deemed Roll-Over Transaction shall be reduced so as to be equal to such applicable Aggregate Commitment Amount, and Seller shall pay to Agent for the account of the Buyers any Funded Repurchase Price required to be paid by it as a result of such reduction; and

(E) in addition to any Funded Repurchase Price required to be paid by Seller on such Monthly Date in accordance with the terms hereof, Seller may, at its election, pay to Agent for the account of the Buyers an additional amount by wire transfer of immediately available funds to the account of Agent specified in Schedule 2 by or before 5:00 p.m. on such Monthly Date, which additional payment shall (i) reduce the Purchase Price for such Deemed Roll-Over Transaction and (ii) be treated as the payment of additional Funded Repurchase Price for all purposes hereunder and under the other Transaction Agreements; provided, that the Price Differential through the first two (2) Business Days of the Transaction Period for such Deemed Roll-Over Transaction shall be calculated as though the corresponding reduction of Purchase Price did not occur.





Promptly after entry into any Deemed Roll-Over Transaction, Seller and Agent shall cooperate expeditiously and in good faith to prepare, execute and deliver a Confirmation and Portfolio Schedule which, if treated as having been delivered in a timely manner in connection with a proposed Roll-Over Transaction to be entered into on the Purchase Date for such Deemed Roll-Over Transaction, would satisfy the applicable Roll-Over Conditions (excluding the condition described in Section 4.3(a)(iii), which need not be satisfied for purposes of this paragraph) as of such Purchase Date, to evidence and definitively document such Deemed Roll-Over Transaction, with the terms of such Confirmation, and if applicable, updated Portfolio Schedule, amending, restating and superseding any deemed terms specified in the preceding sentence as of the applicable Purchase Date, notwithstanding such later execution and delivery of such definitive documentation.

4.2    Funding of Transaction Purchase Prices.

(a)    Funding Notices. In the event Agent receives a Transaction Notice for a proposed Transaction in accordance with Section 4.1(a), Agent shall deliver to each other Buyer a written notice concerning such Transaction (a “Funding Notice”) not later than 10:00 a.m. on the date that is two (2) Business Days prior to the date of the proposed Transaction. Such notice shall (i) set forth the Purchase Date for the proposed Transaction, the amount of any Funded Purchase Price anticipated to be paid or Funded Repurchase Price anticipated to be received in connection with such Transaction, any Funding Amount payable by or Distribution Amount anticipated to be distributed to each Buyer in connection with the Transaction, any adjustments and related calculations made pursuant to Section 4.5 and the anticipated Aggregate Buyer Balance after giving effect to such Transaction, and (ii) be accompanied by a copy of the substantially final form of Confirmation to be entered into in connection with such Transaction.

(b)    Funding of Purchase Prices. Following receipt of any Funding Notice concerning a proposed Transaction, each Buyer shall fund its respective Funding Amount (if any) for such proposed Transaction by wire transfer of immediately available funds to the account of Agent specified in Schedule 2 no later than 11:00 a.m. on the Purchase Date for such Transaction (or such later time as Agent may determine with the consent of Seller (such consent not to be unreasonably withheld so long as the Funded Purchase Price is received for value on such Purchase Date)). Agent shall, subject to satisfaction of the Additional Funding Conditions, use such funds to pay the Funded Purchase Price for the Transaction on behalf of each of the Buyers in accordance with terms of the Master Repurchase Agreement and applicable Confirmation, upon which Seller will sell and assign, and Buyers will purchase, the Transaction Portfolio for such Transaction, with each Buyer receiving a fractional undivided interest in such Transaction Portfolio in accordance with its respective Undivided Funding Percentage as of the time of such purchase (after giving effect to the funding of such Funding Amounts and payment of such Funded Purchase Price). The closing of such Transaction and payment of such Funded Purchase Price shall occur at 12:00 noon on the Purchase Date (or such later time



on such Purchase Date as Agent may determine with the consent of Seller (such consent not to be unreasonably withheld for so long as the Funded Purchase Price is received for value on such Purchase Date)).

(c)    Advance Payment of Funded Purchase Price. Notwithstanding the provisions of Section 4.2(b) above, Agent may, at its sole discretion, on any Purchase Date for a Transaction in respect of which it anticipates receiving Funding Amounts from Buyers, transfer in advance any Funded Purchase Price anticipated to be payable in respect of such Transaction to Seller on such Purchase Date prior to Agent’s actual receipt of such Funding Amounts; provided, that if Agent does not receive all such Funding Amounts from Buyers by or before 5:00 p.m. on such Purchase Date, then subject to and in accordance with Section 4.5(a)(iii), Seller and each applicable Defaulting Buyer severally agree to pay to Agent forthwith on demand the amount of Funded Purchase Price transferred in advance corresponding to the Funding Amounts not received, with interest thereon at a rate reasonably determined by Agent in accordance with banking industry rules on interbank compensation.

(d)    Return of Excess Funding Amounts. In the event any Buyer has funded its respective Funding Amount on any proposed Purchase Date for an Additional Funding Transaction in accordance with Section 4.2(b), and either (i) Seller and Buyers fail to enter into such Additional Funding Transaction on such proposed Purchase Date or (ii) Seller and Buyers enter into an Additional Funding Transaction on such Purchase Date with respect to which less than all of the amount funded by such Buyer is actually applied to the payment of Funded Purchase Price on such Purchase Date, then Agent shall, promptly following either such event, refund to such Buyer the unused portion of such funded amount.

4.3    Transaction Conditions.

(a)    The obligation of Buyers to enter into any Additional Funding Transaction shall be subject to satisfaction of the following conditions (in each case, as of the Purchase Date) (together, the “Additional Funding Conditions”):

(i)    with respect to the initial Transaction, each of the items required to be delivered by Seller at or prior to the Closing pursuant to Section 3.2 shall have been delivered in accordance with the terms hereof;

(ii)    all amounts then due and owing by Seller under Section 9.2, the Fee Letter and the Side Letter shall have been paid in full;

(iii)    the Transaction Notice, including the proposed Portfolio Schedule required to be attached thereto, shall have been delivered to Agent in accordance with Section 4.1;




(iv)    Seller shall have delivered to Agent a duly executed counterpart to the applicable Confirmation;

(v)    each of the representations and warranties of Seller and each Guarantor (as applicable) set forth in the Transaction Agreements (excluding any representations or warranties set forth in the Asset Representations, Warranties and Covenants) shall be true and correct in all material respects;

(vi)    the aggregate Market Value of the Transaction Portfolio for such Transaction (as set forth in the Portfolio Schedule to the Confirmation provided by Seller) shall be equal to or greater than 105% of the Purchase Price for such Transaction;

(vii)    all of the loans included in the Transaction Portfolio for such Transaction (as set forth in the Portfolio Schedule to the Confirmation provided by Seller) shall be Eligible Farmer Loans;

(viii)    the Weighted Average CBR Score with respect to the Transaction Portfolio for such Transaction shall be equal to or greater than 675;

(ix)    no less than seventy percent (70%) of the Eligible Farmer Loans comprising the Transaction Portfolio for such Transaction (based on their respective Book Values) shall have been made to Debtors that are natural persons;

(x)    the Purchase Date for such Transaction shall be at least ten (10) days prior to the Farmer Loan Maturity Date;

(xi)    the payment of the proposed Purchase Price would not cause (x) the Aggregate Buyer Balance (after giving effect to such payment) to exceed the Aggregate Commitment Amount applicable to such Transaction or (y) any Buyer’s Individual Buyer Balance (after giving effect to such payment) to exceed such Buyer’s applicable Individual Commitment Amount with respect to such Transaction;

(xii)    no Potential Event of Default or Event of Default shall have occurred and be continuing which has not been waived; and

(xiii)    no “Event of Default” shall have occurred and be continuing under the Corteva Revolver which has not been waived.

(b)    The obligation of Buyers to enter into any Roll-Over Transaction (other than a Deemed Roll-Over Transaction) shall be subject to satisfaction of the following conditions (in each case, as of the Purchase Date) (together, the “Roll-Over Conditions”):




(i)    each of the conditions set forth in clauses (iii), (iv), and (vi) through (xi) of Section 4.3(a) shall have been satisfied; and
(ii)    no Event of Default shall have occurred and be continuing which has not been waived.

(c)    The deemed entry by Buyers into any Deemed Roll-Over Transaction shall be subject to satisfaction of the following conditions (in each case, as of the Purchase Date) (together, the “Deemed Roll-Over Conditions”):

(i)    the aggregate Market Value of the Transaction Portfolio for such Deemed Roll-Over Transaction (as set forth in the applicable Portfolio Schedule for such Deemed Roll-Over Transaction determined in accordance with Section 4.1(d)(C)) shall be equal to or greater than (x) 100% of the Purchase Price for such Transaction, if the applicable Portfolio Schedule for such Deemed Roll-Over Transaction is a Roll-Over Portfolio Schedule, or (y) 105% of the Purchase Price for such Transaction, in all other cases;

(ii)    each of the conditions set forth in clauses (vii) through (xi) of Section 4.3(a), as applied mutatis mutandis to the applicable terms of such Deemed Roll-Over Transaction and to the Transaction Portfolio set forth on the Portfolio Schedule for such Deemed Roll-Over Transaction, shall have been satisfied;

(iii)    if the prior Transaction expiring on such Purchase Date is Deemed Roll-Over Transaction, Seller shall have executed and delivered definitive documentation evidencing such prior Deemed Roll-Over Transaction in accordance with the last sentence of Section 4.1(d) on or before the Business Day immediately preceding such Purchase Date; and

(iv)    no Event of Default shall have occurred and be continuing which has not been waived.

4.4    Funding of Transaction Repurchase Prices.

(a)    Seller’s Payment of Funded Repurchase Price. On each Repurchase Date for a Transaction on which Funded Repurchase Price (other than Funded Repurchase Price on account of accrued but unpaid Price Differential) is payable by Seller pursuant to the Transaction Agreements (including, for the avoidance of doubt, on the Facility Expiration Date and each Commitment Reduction Date), Seller shall fund the Funded Repurchase Price for such Transaction by wire transfer of immediately available funds to the account of Agent specified in Schedule 2, no later than 5:00 p.m. on such Repurchase Date (or such later time as Seller may determine with the consent of Agent (such consent not to be unreasonably withheld so long as such Funded Repurchase Price is received for value on such Repurchase Date)).




(b)    Distribution of Amounts Received by Agent. On any Business Day when Agent receives any Funded Repurchase Price or Margin Payment from Seller for any Transaction, Agent shall distribute to each Buyer such Buyer’s Distribution Amount in respect of such Funded Repurchase Price or Margin Payment by wire transfer of immediately available funds to the account of such Buyer set forth on Schedule 2 hereto or separately provided in writing to Agent (i) on the same Business Day if such Funded Repurchase Price or Margin Payment is received from Seller prior to 2:00 p.m. on such Business Day or (ii) otherwise, on the next succeeding Business Day.

(c)     Advances of Funded Repurchase Price. Notwithstanding the foregoing Section 4.4(b), Agent may, at its discretion, on any Repurchase Date when it anticipates receiving any Funded Repurchase Price from Seller, transfer in advance to each Buyer its anticipated Distribution Amount in respect of such anticipated Funded Repurchase Price on such Repurchase Date prior to Agent’s actual receipt of such Funded Repurchase Price; provided, that if Agent does not receive such Funded Repurchase Price from Seller by 5:00 p.m. on such Repurchase Date, each Buyer shall be required to promptly refund to Agent any such anticipated Distribution Amounts transferred in advance.

4.5    Defaulting Buyers.

(a)     Adjustment for Reduced Funding. Notwithstanding anything in this Article IV to the contrary, in the event that, on any Purchase Date on which Agent has entered into, or is obligated to enter into, an Additional Funding Transaction with respect to which any Funded Purchase Price is to be paid in accordance with Section 4.2(b), one or more Buyers (any such Buyer, a “Defaulting Buyer”) fails to fund its respective Funding Amount on such Purchase Date when and as required by Section 4.2(b), then Agent shall promptly give notice of such failure to Seller and each other Buyer. Upon Agent’s giving of such notice:

(i)    the Confirmation for such Additional Funding Transaction shall be amended (or, if already executed and delivered by Seller prior to Agent’s giving of such notice, shall be deemed to have been amended) so as to reduce the Purchase Price for such Additional Funding Transaction by the applicable Funding Amounts such Defaulting Buyers have failed to fund;

(ii)    when and as required pursuant to Section 4.2(b), and subject to the satisfaction of the Additional Funding Conditions otherwise applicable to such Additional Funding Transaction, Agent shall pay to Seller, on behalf of the Buyers (other than the Defaulting Buyer), any remaining unpaid Funded Purchase Price payable in respect of such Additional Funding Transaction (after giving effect to the reduction in Purchase Price pursuant to the foregoing Section 4.5(a)(i));

(iii)    to the extent Agent has advanced any amounts to Seller pursuant to Section 4.2(c) on such Purchase Date in excess of the Funded Purchase Price payable in respect of such Additional Funding Transaction (after giving effect to the reduction in Purchase Price pursuant to



the foregoing Section 4.5(a)(i)), Seller shall refund any such excess when and as required pursuant to Section 4.2(c);

(iv)    following such Purchase Date, Seller shall be entitled to exercise its rights under Paragraph 4(b) of Annex I to the Master Repurchase Agreement to address the excess Market Value of the Transaction Portfolio which may result from the failure of such Defaulting Buyer to fund.

(b)    Replacement of Buyers. Seller may, at its sole expense and effort, upon notice to any Defaulting Buyer and Agent, require such Defaulting Buyer to assign, without recourse, all of its rights and obligations under the Transaction Agreements (including its Individual Buyer Balance, Individual Commitment Amount and any undivided fractional interest it may own with respect to any Transaction Portfolio) to one or more existing Buyers or new Buyers that is willing to assume such obligations; provided that (i) Seller shall have received the prior written consent of Agent with respect to any new Buyer, which consent shall not unreasonably be withheld, (ii) such Defaulting Buyer shall have received payment of an amount equal to its Individual Buyer Balance and accrued and unpaid Price Differential, fees and all other amounts payable to it under the Transaction Agreements (which may be paid by the applicable assignee and/or by Seller) and (iii) such assignment does not conflict with applicable Law. No Buyer shall be required to make any such assignment if prior thereto, such Buyer shall have ceased to be a Defaulting Buyer in accordance with Section 4.5(c). Each Party agrees that an assignment required pursuant to this Section 4.5(b) may be effected pursuant to assignment documentation executed by Seller, Agent and the assignee and that the Defaulting Buyer required to make such assignment need not be a party thereto. In connection with any such assignment, each assignee of the Defaulting Buyer agrees to purchase (at par) Individual Buyer Balances of other non-Defaulting Buyers (together with corresponding portions of such other non-Defaulting Buyers’ undivided fractional interests in any Transaction Portfolio) as Agent may determine necessary to cause each non-Defaulting Buyer’s Undivided Funding Percentage in connection with the applicable Current Transaction to equal its Undivided Commitment Percentage with respect to such Current Transaction (in each case, after giving effect to such assignment and with such adjustments as Agent may deem appropriate to take into account any Buyers that remain Defaulting Buyers).

(c)    Reinstatement of Defaulting Buyers. In the event that Agent and Seller agree that a Defaulting Buyer has adequately remedied all matters that caused such Buyer to be a Defaulting Buyer, then such Buyer shall cease to be a Defaulting Buyer for all purposes hereof. In connection with any such reinstatement of a Defaulting Buyer, such Defaulting Buyer agrees to purchase (at par) Individual Buyer Balances of other non-Defaulting Buyers as Agent may determine necessary to cause each non-Defaulting Buyer’s Undivided Funding Percentage in connection with the applicable Current Transaction to equal its Undivided Commitment Percentage with respect to such Current Transaction (in each case, after giving effect to such reinstatement and with such



adjustments as Agent may deem appropriate to take into account any Buyers that remain Defaulting Buyers).

(d)    Replacement of Agent. In the event that Agent or any Affiliate thereof is a Defaulting Buyer, Required Buyers may, to the extent permitted by applicable law, by notice in writing to Seller and Agent, remove Agent in its capacity as such, and subject to Seller’s approval (not to be unreasonably withheld), appoint a successor. Upon the acceptance of its appointment as Agent hereunder by a successor, such successor shall succeed to and become vested with all the rights, powers, privileges and duties of the removed Agent and the removed Agent shall be discharged from its duties and obligations hereunder and under the other Transaction Agreements. The fees payable by Seller to a successor Agent shall be the same as those payable to its predecessor unless otherwise agreed between Seller and such successor. Removed Agent agrees to execute such additional documents and perform such further acts as may be reasonably required or desirable to carry out or perform the foregoing provisions of this Section; provided that, to the extent removed Agent fails to promptly execute such additional documents and or to perform such further acts, successor Agent may, on behalf of removed Agent, execute such additional documents or perform such further acts.

(e)    Calculations. All calculations with respect to adjustments in the Undivided Commitment Percentages and Undivided Funding Percentages of, Funding Amounts owed by, or Distribution Amounts payable to, any Buyers resulting from any Buyer becoming a Defaulting Buyer or any actions taken by Agent pursuant to this Section 4.5 shall be made by Agent and communicated to Buyers in appropriate Funding Notices or other written notices (in all cases, with copies to Seller).

5.    Representations and Warranties; Certain Covenants.

5.1    Representations and Warranties of Seller. Seller represents to Agent and each Buyer that:

(a)    Organization and Authority. Seller is a corporation duly organized, validly existing, and in good standing under the Laws of the State of Iowa. Seller has full corporate power and authority to enter into the Transaction Agreements to which it is a party, to carry out its obligations thereunder, and to consummate the transactions contemplated thereby. The execution and delivery by Seller of the Transaction Agreements to which it is a party and the performance by Seller of its obligations thereunder have been duly authorized by all requisite corporate action on the part of Seller. The Transaction Agreements to which Seller is a party have been duly executed and delivered by Seller, and (assuming due authorization, execution, and delivery by each other Party) the Transaction Agreements to which Seller is a party constitute a legal, valid, and binding obligation of Seller enforceable against Seller in accordance with their terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and similar Laws affecting creditors’ rights generally and subject, as to enforceability, to general principles of equity.




(b)    No Conflicts; Consents. The execution, delivery and performance by Seller of each of the Transaction Agreements and the consummation of the transactions contemplated by the Transaction Agreements do not and will not: (A) conflict with or result in a violation or breach of, or default under, any provision of the Organizational Documents of Seller; (B) conflict with or result in a violation or breach of any provision of any Law or Governmental Order applicable to Seller except as would not reasonably be expected to have a Material Adverse Effect; or (C) require the consent, notice or other action by any Person pursuant to, or result in a default or event of default under, any Contract to which Seller is a party, except: (1) as expressly set forth in the applicable Transaction Agreement, (2) as shall have been obtained by Seller as of the Effective Date or (3) as would not reasonably be expected to have a Material Adverse Effect. No consent, approval, Permit, Governmental Order, declaration or filing with, or notice to, any Governmental Authority is required by or with respect to Seller in connection with the execution and delivery of the Transaction Agreements and the consummation of the transactions contemplated by the Transaction Agreements except as shall have been obtained by Seller or except as would not reasonably be expected to have a Material Adverse Effect.

(c)    Legal Proceedings. There are no Actions pending or, to Seller’s knowledge, threatened against or by Seller or any Affiliate of Seller that challenge or seek to prevent, enjoin, or otherwise delay the transactions contemplated by the Transaction Agreements.

(d)    Compliance with Laws. Seller is in compliance with all applicable Laws in connection with the performance of obligations or exercise of rights under the Transaction Agreements, except where the failure to be so would not reasonably be expected to have a Material Adverse Effect.

(e)    No Defaults. No Event of Default under this Framework Agreement has occurred and is continuing that has not been waived. Except as disclosed to Agent, no Potential Event of Default under this Framework Agreement has occurred and is continuing that has not been waived.

(f)    Certification of Beneficial Owner. The information included in the Certification of Beneficial Owner(s) is true and correct in all respects as of the date of delivery thereof.

5.2    Asset Representations and Warranties. Seller represents or covenants, as applicable, to Agent and each Buyer with respect to each Eligible Farmer Loan included in the Transaction Portfolio for any outstanding Transaction that:

(a)    Accuracy of Information. The information regarding such Eligible Farmer Loan set forth on the Portfolio Schedule to the Confirmation for such Transaction (as corrected in accordance with Section 4.1(d), in the case of any Deemed Roll-Over



Transaction) is true and correct in all material respects as of the Purchase Date for such Transaction.

(b)    Form of Loan Agreement. The Loan Agreement for such Eligible Farmer Loan is substantially in the form of one of the Deferred Payment Loan Agreements attached to Schedule 3 hereto or any other form of Loan Agreement provided to and deemed satisfactory by Agent.

(c)    Enforceability. Such Eligible Farmer Loan and related Loan Agreement has been duly authorized, executed and delivered by all parties thereto, and constitutes a legal, valid, and binding obligation of each such party enforceable against such party in accordance with its terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and similar Laws affecting creditors’ rights generally and subject, as to enforceability, to general principles of equity.

(d)    No Conflicts; Consents. The execution, delivery and performance by Seller and each applicable Debtor under such Eligible Farmer Loan of the Loan Agreement and the consummation of the transactions contemplated thereby do not and will not conflict with or result in a violation or breach of any provision of any Law or Governmental Order applicable to Seller except as would not reasonably be expected to have a Material Adverse Effect, and no consent, approval, Permit, Governmental Order, declaration or filing with, or notice to, any Governmental Authority is required by or with respect to Seller or any Affiliate of Seller in connection with the execution and delivery of the Loan Agreement and the consummation of the transactions contemplated thereby except as shall have been obtained by Seller or such Affiliate as of the date of such Loan Agreement or except as would not reasonably be expected to have a Material Adverse Effect.

(e)    No Modifications. Except in accordance with its ordinary servicing practices (so long as the related modification, alteration or amendment would not (i) cause such loan to cease to be an Eligible Farmer Loan, (ii) breach any of the other Asset Representations, Warranties and Covenants, (iii) reduce the amount payable under the Eligible Farmer Loan (other than as a result of a prepayment), (iv) extend the stated maturity date of such Eligible Farmer Loan or (v) reasonably be expected to have a Material Adverse Effect) or as consented to by Agent, Seller is not a party to any Contract or other legally binding arrangement with any Debtor in relation to such Eligible Farmer Loan that modifies, alters or amends any of the terms in the related Loan Agreement.

(f)    Compliance with Laws.

(i)    Seller and its Affiliates are in compliance with all applicable Laws with respect to the making of such Eligible Farmer Loan (including all applicable “know your customer” Laws), except where the failure to be so would not reasonably be expected to have a Material Adverse Effect.




(ii)    Seller has implemented and maintain policies and procedures reasonably designed to promote compliance by Seller, its Subsidiaries and its Subsidiaries’ respective directors, officers, employees and, to the knowledge of Seller and to the extent commercially reasonable, agents with Anti-Corruption Laws and applicable Sanctions, and Seller, its Subsidiaries and their and its Subsidiaries’ respective directors, officers and employees and, to the knowledge of Seller, their agents, are in compliance with Anti-Corruption Laws and applicable Sanctions in all material respects. None of (x) Seller, any of its Subsidiaries or, to the knowledge of Seller, any of its and its Subsidiaries’ respective directors, officers or employees, or (y) to the knowledge of Seller, any agent of Seller or any of its Subsidiaries that will act in any capacity in connection with or benefit from the facility established hereby, is a Sanctioned Person. The use of proceeds of any Transaction will not violate Anti-Corruption Laws or applicable Sanctions, in each case, in any material respect.

(g)    Legal Proceedings. There is no Action pending or, to the knowledge of Seller, threatened against Seller relating to such Eligible Farmer Loan or which seeks the issuance of an order restraining, enjoining or otherwise prohibiting or making illegal the consummation of any of the transactions contemplated by the Loan Agreement, except as would not reasonably be expected to have a Material Adverse Effect.

    (h)    
Segregation of Eligible Farmer Loans. All Eligible Farmer Loans included in the Portfolio Schedule for the Current Transaction that are in the possession of Seller shall be segregated from other securities in its possession and shall be identified as subject to the Transaction Agreements. Segregation may be accomplished by appropriate identification on the books and records of Seller.

5.3    Certain Covenants. Seller covenants with Agent and each Buyer as follows:

(a)    Taxes. Subject to the provisions of Section 6.8 and the provision by each Buyer of any relevant IRS forms and related documentation confirming its exemption from withholding Taxes, Seller will pay all relevant Taxes and make all relevant returns in respect of Taxes in relation to any Purchased Securities and Seller shall indemnify and hold each Buyer harmless from and against any such Taxes. Without limiting the generality of the foregoing, Seller shall remit all Direct Taxes to the applicable Governmental Authority relating to the Purchased Securities as and when due and Seller shall indemnify and hold each Buyer harmless from and against any such Taxes.

(b)    Performance of Loan Agreements. Seller shall perform and comply with each Loan Agreement governing an Eligible Farmer Loan included in the Transaction Portfolio for the Current Transaction in such a way as would not (or would not reasonably be expected to) materially affect the entitlement and/or ability to receive and/or to recover and/or enforce and/or collect payment of the full amount of such Eligible



Farmer Loan, and the exercise by Agent of its rights under this Framework Agreement and the other Transaction Agreements shall not relieve Seller of such obligations.

(c)    Indemnification. Seller will indemnify and keep indemnified Agent, each Buyer, their Affiliates, and their respective officers, directors, employees and agents and their successors and assigns (each, an “Indemnified Party”) against any cost, claim, loss, expense, liability or damages (including reasonable legal costs and out-of-pocket expenses) arising out of or involving a claim or demand made by any Person (other than by Seller, any of its Affiliates or any Indemnified Party) against such Indemnified Party (each a “Claim”) and incurred or suffered by it in connection with:

(i)    any representation or warranty made by Seller under or in connection with any Transaction Agreement (including with respect to any Portfolio Schedule delivered by Seller pursuant hereto) that shall have been false or incorrect when made or deemed made (without regard to any knowledge, materiality or Material Adverse Effect qualifiers contained therein);

(ii)    the failure by Seller, to comply with any applicable Law with respect to any Eligible Farmer Loan included in any Transaction Portfolio, or the nonconformity of any such Eligible Farmer Loan included therein or any related Contract with any such applicable Law, rule or regulation or any failure of Seller to keep or perform any of its obligations, express or implied, with respect to any Contract;

(iii)    any failure of Seller to perform its duties, covenants or other obligations in accordance with the provisions of any Transaction Agreement;

(iv)    any products liability, personal injury or damage, suit or other similar claim arising out of or in connection with merchandise, insurance or services that are the subject of any Eligible Farmer Loan in which any Indemnified Party becomes involved as a result of any of the Transactions contemplated hereby;

(v)    any investigation, litigation or proceeding related to or arising from any Transaction Agreement, the Transactions contemplated hereby, Seller’s use of the proceeds of such Transactions, the ownership of the Eligible Farmer Loans originated by Seller or any other investigation, litigation or proceeding relating to Seller in which any Indemnified Party becomes involved as a result of any of the Transactions contemplated hereby;

(vi)    any action or omission by Seller which reduces or impairs the rights of any Buyer with respect to any Eligible Farmer Loan or the value of any such Eligible Farmer Loan; and

(vii)    any civil penalty or fine assessed by the Office of Foreign Assets Control of the U.S. Department of the Treasury or any other Governmental Authority administering any Sanctions Law or Anti-Corruption Law against, and all reasonable costs and expenses (including counsel fees and disbursements) incurred in connection with defense thereof by any Buyer as a result of any action of Seller;




provided, that notwithstanding the foregoing, in no event shall Seller be liable hereunder to any Indemnified Party or any other Person for (A) any special, indirect, consequential or punitive damages, even if Seller has been advised of the likelihood of such loss or damage and regardless of the form of action or (B) Claims to the extent arising from any Indemnified Party’s breach, bad faith, gross negligence or willful misconduct.

(d)    Approvals and Filings. Except as would not (or would not reasonably be expected to) materially affect the entitlement and/or ability to receive and/or to recover and/or enforce and/or collect payment of the full amount in the Eligible Farmer Loans, Seller shall maintain such Permits and make such filings, registrations and submissions as are necessary or advisable for the performance of its obligations under the Loan Agreements relating to the Eligible Farmer Loans.

(e)    Books and Records. Seller shall keep all its books, records and documents evidencing or relating to the Eligible Farmer Loans in accordance with its practice and procedures from time to time. Seller shall, but only upon Agent’s reasonable request in advance of the same, during normal business hours at reasonably accessible offices in the continental United States designated by Seller, and subject to Seller’s normal security and confidentiality procedures, permit Agent or any of its agents or representatives to examine and make copies of and abstracts from the records, books of account and documents (including computer tapes and disks) of Seller, visit the properties of Seller for the purpose of examining or obtaining access to such records, books of account and documents, and discuss the affairs, finances and accounts of Seller relating to the Eligible Farmer Loans with any of its officers, and Seller shall be obligated to reimburse Agent for the costs and expenses of one such examination during the Facility Term.

(f)    No Sales, Liens. Seller (i) shall not sell, assign or grant any Security Interest on or otherwise encumber any Eligible Farmer Loan subject to a Transaction or any Loan Agreement under which such Eligible Farmer Loan arises except as expressly contemplated by the Transaction Agreements, (ii) shall not permit any Security Interest to exist on or with respect to, any such Eligible Farmer Loan or Loan Agreement except as expressly contemplated by the Transaction Agreements, and (iii) will defend the right, title and interest of the Buyers in, to and under any of the foregoing.

(g)    No Waivers, Amendments. Except to the extent arising in the ordinary course of business and except as required by Section 5.3(h), Seller shall not (x) cancel, terminate, amend, modify or waive any term or condition of any Loan Agreement for an Eligible Farmer Loan subject to a Transaction (including reducing the amount of such Eligible Farmer Loan) or (y) take any other action that, in each case, may materially affect any entitlement and/or ability to receive and/or recover and/or enforce and/or collect payment in full of the full amount of the Eligible Farmer Loan, or otherwise prejudice any Buyer’s interest in any Eligible Farmer Loan in any material respect.

(h)    Ordinary Course. Seller shall follow its credit and collection procedures with respect to the Eligible Farmer Loans in accordance with its ordinary course of



dealing as in effect from time to time without regard to the Transactions contemplated hereby, and shall use the same standards it would follow with respect to Eligible Farmer Loans which are owned by Seller.

(i)    Notice of Certain Events. Seller shall provide Agent with prompt notice upon becoming aware of (x) any Event of Default or Potential Event of Default or (y) any Change of Control with respect to Seller or any Guarantor.

(j)    Changes in Credit and Collection Procedures. Seller shall provide Agent with prompt notice, and in all instances at least sixty (60) days prior to the effectiveness of any material change in or material amendment to the credit and collection procedures (other than any such change or amendment required by applicable Law, in which case Seller shall provide notice to Agent of such change or amendment as promptly as practicable), a copy of the credit and collection procedures then in effect and a notice indicating such proposed change or amendment.

(k)    Information Required by Governmental Authorities. Subject to applicable Laws prohibiting or limiting such disclosure or provision of such information, documents, records or reports, Seller shall provide each Buyer promptly, from time to time upon request, such information, documents, records or reports relating to the Eligible Farmer Loans or Seller as such Buyer (or its assigns) may be required by a Governmental Authority to obtain; provided, that each such Buyer shall use commercially reasonable efforts to maintain the confidentiality of such information, documents, records or reports to the extent consistent with applicable Law, Seller’s normal privacy and confidentiality procedures, the terms of the Data Transfer Agreement and any confidentiality provisions or restrictions contained therein.

(l)    Accounting. Seller shall comply with all required accounting and Tax disclosures related to the Transactions in accordance with GAAP and applicable Law, except where the failure to do so would not reasonably be expected to have a Material Adverse Effect.

(m)    Changes Concerning Seller. Seller will not undergo a Change of Control or change its (i) jurisdiction of organization, (ii) name, (iii) identity or structure (within the meaning of Article 9 of the UCC), unless it shall have notified Agent of the same and delivered to Agent all financing statement amendments and other documents necessary to maintain the perfection of the Security Interests granted by Seller under the Transaction Agreements in connection with such change, relocation or Change of Control.

(n)    Compliance. Seller will maintain in effect and enforce policies and procedures reasonably designed to promote compliance by Seller, its Subsidiaries and their and their Subsidiaries’ respective directors, officers, employees and, to the knowledge of Seller and to the extent commercially reasonable, agents with Anti-Corruption Laws and applicable Sanctions. Seller will not request that Buyers enter into any Transaction, and Seller shall not use, and shall not permit its Subsidiaries and their or



their Subsidiaries’ respective directors, officers, employees and, to the knowledge of Seller and to the extent commercially reasonable, agents to use, the proceeds of any Transaction (i) in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any Person in violation of any Anti-Corruption Laws, (ii) for the purpose of funding, financing or facilitating any activities, business or transaction of or with any Sanctioned Person, or in any Sanctioned Country or (iii) in any manner that would result in the violation in any material respect of any Sanctions applicable to any party hereto.

(o)    Margin Compliance During Final Two Months. On each Recalculation Date, Seller shall recalculate the aggregate Market Value of the Transaction Portfolio for the Current Transaction as of the close of business on the Business Day that is (x) three (3) Business Days before such Recalculation Date in the case of Recalculation Dates occurring prior to the Farmer Loan Maturity Date or (y) one (1) Business Day before such Recalculation Date in the case of Recalculation Dates occurring after the Farmer Loan Maturity Date, and based on such recalculations, shall notify Agent in writing (i) no later than the second Business Day following such Recalculation Date if the aggregate Market Value of such Transaction Portfolio decreases to an extent sufficient to result in a Margin Deficit exceeding fifty percent (50%) of the applicable threshold specified in Paragraph 4(e) of Annex I to the Master Repurchase Agreement and (ii) promptly if the aggregate Market Value of such Transaction Portfolio decreases to an extent sufficient to result in a Margin Deficit exceeding the applicable threshold specified in Paragraph 4(e) of Annex I to the Master Repurchase Agreement.

(p)    Servicing Information. In the event that Agent reasonably determines, with notice to Seller, that the likelihood of an Event of Default occurring has increased by an amount that it deems material, Seller shall within ten (10) Business Days following receipt of such notice, provide Agent with an updated Portfolio Schedule for the Current Transaction, which updated Portfolio Schedule shall include, for each Debtor with respect to each Eligible Farmer Loan listed on the Portfolio Schedule, the name, address, phone number, email address of, and principal contact at, each such Debtor and each Portfolio Schedule delivered hereunder thereafter shall contain such additional information; provided, that, for the avoidance of doubt, any removal by Seller of Eligible Farmer Loans from the applicable Transaction Portfolio prior to or in connection with the delivery of such updated Portfolio Schedule and other documents must comply with the applicable requirements of this Framework Agreement and the Master Repurchase Agreement. If an Event of Default shall have occurred and be continuing, Seller, upon a written request from Agent, provide to Agent (i) within ten (10) Business Days following receipt of such request with a list of all invoices provided to the Debtors under the Eligible Farmer Loans comprising the Transaction Portfolio, (ii) within four weeks following receipt of such request, copies of all Loan Agreements with and invoices pertaining to, such Debtors and corresponding Eligible Farmer Loans, which delivery shall be effected at an approximate rate of 25% of such Loan Agreements and invoices per week, it being understood that delivery at a faster rate in earlier weeks may result in a smaller percentage being delivered in later weeks and (iii) as promptly as practicable



following receipt of such request, any other documents which may be necessary or appropriate to enforce Seller’s rights in connection with such Eligible Farmer Loans.

(q)    Certification of Beneficial Owner. Promptly, following any change in the information included in the Certification of Beneficial Owner(s) that would result in a change to the exemption from the definition of “legal entity customer” (if any) specified as being applicable to Seller in such certification, or if no such exemption is applicable, a change in the list of beneficial owners or control party (if any) required to be identified in such certification, or a change in the address of any such beneficial owners or control party, Seller shall execute and deliver to Agent an updated Certification of Beneficial Owner(s).

6.    Agent.

6.1    Appointment and Authority.

(a)    Each of the Buyers hereby irrevocably appoints Rabobank to act on its behalf as Agent hereunder and under the other Transaction Agreements and authorizes Agent to take such actions on its behalf and to exercise such powers as are delegated to Agent by the terms hereof or thereof (including the power to execute and deliver Confirmations on behalf of such Buyer in accordance with Sections 4.1 and 4.5 of this Framework Agreement and the Master Repurchase Agreement), together with such actions and powers as are reasonably incidental thereto. The provisions of this Article VI (other than the proviso to the first sentence of Section 6.5) are solely for the benefit of Agent, and neither Seller nor any Guarantor shall have rights as a third party beneficiary of any of such provisions.

(b)    Each of the Buyers hereby irrevocably appoints and authorizes Agent to act as the agent of such Buyer for purposes of acquiring, holding and enforcing any and all Security Interests on Purchased Securities granted by Seller under the Transaction Agreements, including the filing in Agent’s name of any financing statements on behalf of Buyers, together with such powers and discretion as are reasonably incidental thereto. Each Buyer hereby authorizes Agent to exercise any rights and remedies on its behalf hereunder or under the other Transaction Agreements in respect of such Security Interests.

(c)    Agent hereby agrees that it will promptly deliver to each Buyer copies of each Confirmation and Portfolio Schedule and any notices or written information received by Agent from Seller or any Guarantor in connection with any Transaction Agreement (other than the Side Letter).

6.2    Rights as a Buyer. The Person serving as Agent hereunder shall have the same rights and powers in its capacity as a Buyer as any other Buyer and may exercise the same as though it were not Agent and the term “Buyer” or “Buyers” shall, unless otherwise expressly indicated or unless the context otherwise requires, include the Person serving as Agent hereunder in its individual capacity. Such Person and its Affiliates may accept deposits from, lend money to, act as the financial advisor or in any other advisory capacity for and generally engage in any



kind of business with Seller, any Guarantor or any of their Affiliates as if such Person were not Agent hereunder and without any duty to account therefor to the Buyers.

6.3    Exculpatory Provisions. The Agent shall not have any duties or obligations except those expressly set forth herein and in the other Transaction Agreements. Without limiting the generality of the foregoing, Agent:

(i)    shall not be subject to any fiduciary or other implied duties, regardless of whether an Event of Default has occurred and is continuing;

(ii)    shall not have any duty to take any discretionary action or exercise any discretionary powers; and

(iii)    shall not, except as expressly set forth herein or in the other Transaction Agreements, have any duty to disclose, and shall not be liable for the failure to disclose, any information relating to Seller, any Guarantor or any of their Affiliates that is communicated to or obtained by the Person serving as Agent or any of its Affiliates in any capacity.

Agent shall not be liable for any action taken or not taken by it in the absence of its own gross negligence or willful misconduct. Agent shall be deemed not to have knowledge of any Event of Default unless and until notice describing such Event of Default as such is given to Agent by Seller, a Guarantor or a Buyer.

Agent shall not be responsible for or have any duty to ascertain or inquire into (i) any statement, warranty or representation made in or in connection with this Framework Agreement or any other Transaction Agreement, (ii) the contents of any certificate, report or other document delivered hereunder or thereunder or in connection herewith or therewith, (iii) the performance or observance of any of the covenants, agreements or other terms or conditions set forth herein or therein or the occurrence of any Event of Default, (iv) the validity, enforceability, effectiveness or genuineness of this Framework Agreement, any other Transaction Agreement or any other agreement, instrument or document, (v) the value or the sufficiency of any Purchased Securities or (vi) the satisfaction of any condition set forth in Article III, Section 4.3 or elsewhere herein, other than to confirm receipt of items expressly required to be delivered to Agent.

6.4    Reliance by Agent. Agent shall be entitled to rely upon, and shall not incur any liability for relying upon, any notice, request, certificate, consent, statement, instrument, document or other writing (including any electronic message, Internet or intranet website posting or other distribution) believed by it to be genuine and to have been signed, sent or otherwise authenticated by the proper Person. Agent also may rely upon any statement made to it orally or by telephone and believed by it to have been made by the proper Person, and shall not incur any liability for relying thereon. Agent may consult with legal counsel, independent accountants and other experts selected by it, and shall not be liable for any action taken or not taken by it in accordance with the advice of any such counsel, accountants or experts.




6.5    Delegation of Duties. Agent may perform any and all of its duties and exercise its rights and powers hereunder or under any other Transaction Agreement by or through any one or more sub-agents appointed by Agent; provided, that with respect to any sub-agents taking actions with respect to, or receiving information in respect of, Eligible Farmer Loans that are not wholly-owned Subsidiaries of Agent and could reasonably be considered a competitor of Seller, but only insofar as no Event of Default has occurred and is continuing, Agent shall have first obtained the prior written consent of Seller. Agent and any such sub-agent may perform any and all of its duties and exercise its rights and powers by or through their respective Related Parties. The exculpatory provisions of this Article shall apply to any such sub-agent and to the Related Parties of Agent and any such sub-agent.

6.6    Non-Reliance on Agent and Other Buyers. Each Buyer acknowledges that it has, independently and without reliance upon Agent or any other Buyer or any of their Related Parties and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Framework Agreement and the other Transaction Agreements. Each Buyer also acknowledges that it will, independently and without reliance upon Agent or any other Buyer or any of their Related Parties and based on such documents and information as it shall from time to time deem appropriate, continue to make its own decisions in taking or not taking action under or based upon this Framework Agreement, any other Transaction Agreement or any related agreement or any document furnished hereunder or thereunder.

6.7    Agent May File Proofs of Claim. In case of the pendency of any proceeding under any bankruptcy or insolvency Law or any other judicial proceeding relative to Seller or any Guarantor, Agent shall be entitled and empowered, by intervention in such proceeding or otherwise:

(i)    to file and prove a claim for the whole amount of any amounts that are owing by Seller or any Guarantor under any Transaction Agreement and unpaid and to file such other documents as may be necessary or advisable in order to have the claims of the Buyers and Agent (including any claim for the reasonable compensation, expenses, disbursements and advances of the Buyers, Agent and their respective agents and counsel and all other amounts due to the Buyers and Agent under any Transaction Agreement) allowed in such judicial proceeding; and

(ii)    to collect and receive any monies or other property payable or deliverable on any such claims and to distribute the same;

and any custodian, curator, receiver, assignee, trustee, liquidator, sequestrator or other similar official in any such judicial proceeding is hereby authorized by each Buyer to make such payments to Agent and, in the event that Agent shall consent to the making of such payments directly to the Buyers, to pay to Agent any amount due for the reasonable compensation, expenses, disbursements and advances of Agents and their respective agents and counsel, and any other amounts due to Agent hereunder or under any Transaction Agreement.




Nothing contained herein shall be deemed to authorize Agent to authorize or consent to or accept or adopt on behalf of any Buyer any plan of reorganization, arrangement, adjustment or composition affecting the obligations of Seller or any Guarantor under any Transaction Agreement or the rights of any Buyer or to authorize Agent to vote in respect of the claim of any Buyer in any such proceeding.

6.8    Withholding Tax. To the extent required by any applicable Law, Agent may withhold from any payment to any Buyer an amount equal to any applicable withholding Tax; provided, that Agent shall ensure that the withholding does not exceed the minimum amount legally required and Agent shall pay the amount withheld to the relevant Governmental Authority in accordance with applicable law. If the IRS or any other authority of the United States or other jurisdiction asserts a claim that Agent did not properly withhold Tax from any amount paid to or for the account of any Buyer for any reason (including because the appropriate form was not delivered or was not properly executed, or because such Buyer failed to notify Agent of a change in circumstances that rendered the exemption from, or reduction of, withholding Tax ineffective), such Buyer shall indemnify and hold harmless Agent (to the extent that Agent has not already been reimbursed by Seller or any Guarantor and without limiting or expanding the obligation of Seller or any Guarantor to do so) for all amounts paid, directly or indirectly, by Agent as Tax or otherwise, including any penalties, additions to Tax or interest thereon, together with all expenses incurred, including legal expenses and any out-of-pocket expenses, whether or not such Tax was correctly or legally imposed or asserted by the relevant Governmental Authority; provided, that Buyer shall not be required to indemnify Agent for penalties, addition to Tax or interest thereon, or any expenses incurred, to the extent the failure to withhold results from Agent’s gross negligence or willful misconduct. A certificate as to the amount of such payment or liability delivered to any Buyer by Agent shall be conclusive absent manifest error. Each Buyer hereby authorizes Agent to set off and apply any and all amounts at any time owing to such Buyer under this Framework Agreement or any other Transaction Agreement against any amount due to Agent under this Article VI. The agreements in this Article VI shall survive any assignment of rights by, or the replacement of, a Buyer, the expiration of the Facility Term and the repayment, satisfaction or discharge of all obligations under this Framework Agreement and the other Transaction Agreements. Unless required by applicable Laws, at no time shall Agent have any obligation to file for or otherwise pursue on behalf of a Buyer any refund of Taxes withheld or deducted from funds paid for the account of such Buyer.

7.    Payment To Agent; Several Obligations And Certain Calculations.

7.1    Payments to Agent. Notwithstanding anything to the contrary contained herein, all amounts payable to any Buyer in connection with any Transaction shall be paid to Agent, and Agent shall distribute such payments to the Buyers in accordance with Section 4.4. As between Seller and the Buyers, any payment of such amounts to Agent shall be treated as payments to the Buyers and neither Seller nor any Guarantor shall have any liability for the failure of Agent to comply with the preceding sentence.




7.2    Several Obligations. The obligations of the Buyers hereunder are several, and no Buyer shall have any obligation or liability for the failure of any other Buyer to perform its obligations hereunder.

7.3    Certain Calculations. Agent shall calculate the Undivided Commitment Percentages, Undivided Funding Percentages, Funded Purchase Prices, Funding Amounts, Distribution Amounts, Aggregate Commitment Amount, Aggregate Buyer Balance, Individual Commitment Amounts, Individual Buyer Balances, Breakage Amounts, the amounts of any fees payable under the Fee Letter or the Side Letter and all other amounts to be calculated under the Transaction Agreements, as well as any adjustments thereto, which calculations shall be conclusive absent manifest error. Upon the reasonable request of Seller, any Buyer or any Guarantor for any such calculations, Agent shall promptly provide such calculations to such Person.

8.    Confidentiality.

8.1    Duty to Preserve Confidentiality. Except as otherwise provided herein, each Receiving Party agrees, for a period of two (2) years following the termination or expiration of this Framework Agreement, to hold in confidence all Confidential Information furnished by the Disclosing Party, to not disclose any Confidential Information to any third party, and to use Confidential Information solely for purposes of the transactions contemplated by this Framework Agreement and the other Transaction Agreements; provided, that such Confidential Information may be disclosed to Representatives of such Receiving Party as reasonably necessary in connection with the transactions contemplated by this Framework Agreement and the other Transaction Agreements, so long as such Representatives are similarly bound by an obligation of confidentiality (including by means of applicable policies of the Receiving Party).

8.2    Permitted Disclosure. Notwithstanding the foregoing Section, a Receiving Party shall be permitted to disclose Confidential Information of a Disclosing Party if the Receiving Party is required by applicable Law or other legal process or requested by any Governmental Authority asserting jurisdiction over the Receiving Party or its Affiliates, or as necessary or appropriate to enforce its rights under the Transaction Agreements. Such Receiving Party agrees that in the event of any such disclosure (other than as a result of an examination by a Governmental Authority or other regulatory authority), it will notify the Disclosing Party as soon as practicable, unless such notification shall be prohibited by applicable Law. Such Receiving Party shall disclose only that portion of the Confidential Information that, in the reasonable judgment of such Receiving Party and its Representatives, is legally required (or, in the case of request by a Governmental Authority or other regulatory authority, that portion ordinarily disclosed in accordance with the Receiving Party’s usual practice with respect to such requests) and shall disclose the Confidential Information in a manner reasonably designed to preserve its confidential nature.

8.3    Return of Confidential Information. Unless otherwise specified in writing, all Confidential Information shall remain the property of the Disclosing Party. Upon request of the Disclosing Party, the Receiving Party agrees to return or destroy all Confidential Information



received from the Disclosing Party; provided, that (i) the Receiving Party and its Representatives may retain Confidential Information to the extent required by any applicable Law, by any supervisory or regulatory body or by its internal record retention policy, and (ii) the Receiving Party and its Representatives shall in no event be required to erase, destroy or return any information from computer systems or hard drives, tapes, memory or other electronic forms of information retention processes, materials or equipment. All Confidential Information so retained shall remain subject to the confidentiality obligations set forth herein.

8.4    Data Transfer Agreement. In addition to the confidentiality provisions set forth in Section 8.1, but subject to the provisions of Sections 8.2 and 8.3 concerning permitted disclosures and retention, each Buyer agrees to be bound by the provisions of the Data Transfer Agreement that are applicable to the “Company” thereunder as though such Buyer were a signatory to such Data Transfer Agreement as the “Company” thereunder.

9.    Miscellaneous.

Except as otherwise expressly set forth in a Transaction Agreement, the following will apply to all Transaction Agreements:

9.1    Copies of Records; Further Assurances. Each Party will promptly provide, upon the other Party’s written request, copies of the other Party’s records in a Party’s or any of its Subsidiaries’ possession or control. Each Party will promptly execute, or cause its Subsidiaries to promptly execute, such other documents and instruments, and provide such other assurances, as reasonably necessary to carry out the purpose and intent of the Transaction Agreements.

9.2    Expenses. Upon and as a condition to the Closing, Seller shall reimburse Rabobank for all reasonable and sufficiently detailed documented out-of-pocket expenses (including fees, charges and disbursements of counsel) up to an aggregate of $125,000 incurred by Rabobank in connection with the negotiation, preparation, execution and delivery of the Transaction Agreements and any related documentation and the consummation of the transactions contemplated thereby. Except as otherwise set forth in the preceding sentence or in any Transaction Agreement, all costs and expenses, including fees and disbursements of counsel, financial advisors, and accountants, incurred in connection with any Transaction Agreement will be paid by the Party incurring those costs and expenses.

9.3    Entire Agreement. This Framework Agreement, together with the other Transaction Agreements, constitutes the entire agreement between the Parties and supersedes all prior oral and written negotiations, communications, discussions, and correspondence pertaining to the subject matter of the Transaction Agreements.

9.4    Order of Precedence. If there is a conflict between this Framework Agreement and any other Transaction Agreement, this Framework Agreement will control unless the conflicting provision of the other Transaction Agreement specifically references the provision of this Framework Agreement to be superseded.




9.5    Amendments and Waivers. The Transaction Agreements may only be amended or modified (including any waiver of or exception to any obligation or covenant under a Transaction Agreement) by an instrument in writing signed by the Seller and the Required Buyers and acknowledged by the Agent, or by the Seller and the Agent with the consent of the Required Buyers; provided, that no such amendment, waiver, exception or other modification shall:

(a)    increase the Individual Commitment Amount of any Buyer applicable to any monthly period without the written consent of such Buyer;

(b)    reduce any fees or other amounts payable hereunder or under any other Transaction Agreement, without the written consent of each such Buyer directly and adversely affected thereby;

(c)    change any provision of this Section or the percentage in the definition of “Required Buyers” or any other provision hereof specifying the number or percentage of Buyers required to amend, waive or otherwise modify any rights or duties hereunder or make any determination or grant any consent hereunder, without the written consent of each Buyer;

(d)    reduce or forgive any Repurchase Price, extend any Commitment Reduction Date, the Scheduled Facility Expiration Date, any Repurchase Date or the Facility Expiration Date, adjust any Undivided Commitment Percentages or Undivided Funding Percentages, or reduce any Distribution Amount, in each case, without the written consent of each Buyer;

(e)    amend, modify or waive any provision of Article IV in a manner that would alter the pro rata sharing of payments required thereunder, without the written consent of each Buyer; and

(f)    release (i) all or a material portion of the Security Interests created pursuant to the Transaction Agreements, (ii) Seller from all or a material portion of its obligations under the Transaction Agreements or (iii) any Guarantor from its obligations under the Guaranty, in each case, without the written consent of each Buyer;

provided, further, that no such amendment, waiver or consent shall amend, modify or otherwise affect the rights or duties hereunder or under any other Transaction Agreement of the Agent, unless in writing executed by the Agent, in addition to the Seller and the Buyers required above. For the avoidance of doubt, Agent is not authorized to sign any waiver or amendment on behalf of any Buyer without the consent of such Buyer.

Notwithstanding anything herein to the contrary, no Defaulting Buyer shall have any right to approve or disapprove any amendment, waiver or consent hereunder and any amendment, waiver or consent that by its terms requires the consent of all the Buyers or each affected Buyer may be effected with the consent of the applicable Buyers other than Defaulting Buyers, except that (x)



the Individual Commitment Amount or a Defaulting Buyer may not be increased or extended without the consent of such Defaulting Buyer and (y) any amendment, waiver or consent requiring the consent of all Buyers or each affected Buyer shall require the consent of such Defaulting Buyer.

9.6    Binding Effect. The Transaction Agreements will be binding upon and inure to the benefit of the Parties and their respective heirs, legal representatives, successors, and permitted assigns.

9.7    Assignment. Except as provided in this Framework Agreement or any other Transaction Agreement, neither this Framework Agreement nor any other Transaction Agreement, respectively, may be assigned or otherwise transferred, nor may any right or obligation hereunder or under another Transaction Agreement be assigned or transferred by any Party without the consent of the other Parties. Any permitted assignee shall assume all obligations of its assignor under this Framework Agreement; provided, that in the event of any assignment by a Defaulting Buyer required pursuant to Section 4.5(b), any indemnity obligations owed to or by such Defaulting Buyer under the Transaction Agreements shall survive such assignment. This Framework Agreement is binding upon the permitted successors and assigns of the Parties. Any attempted assignment not in accordance with this Section 9.7 shall be void.

9.8    Notices. All notices, requests, demands, and other communications required or permitted to be given under any of the Transaction Agreements by any Party must be in writing delivered to the applicable Party at the following address:

If to Rabobank or Agent:    

Coöperatieve Rabobank, U.A., New York Branch
245 Park Avenue
New York, New York 10167
Attention:    Vikram Malkani    
E-Mail:    Vikram.Malkani@rabobank.com    

With copy to:

Coöperatieve Rabobank, U.A., New York Branch
245 Park Avenue
New York, New York 10167
Attention:    Chris Kortlandt    
E-Mail:    Chris.Kortlandt@rabobank.com

If to MUFG:    

MUFG Bank, Ltd.
1251 Avenue of the Americas
New York, New York 10020-1104



Attention:    Robert Wenzel    
E-Mail:    RWenzel@us.mufg.jp


With copy to:

The Bank of Tokyo-Mitsubishi UFJ, Ltd.
1251 Avenue of the Americas
New York, NY 10020-1104
Attention:    Thomas Giuntini    
E-Mail:    TGiuntini@us.mufg.jp

If to Standard Chartered:    

Standard Chartered Bank
2700 Post Oak Boulevard
21st Floor
Houston, TX 77056
Attention: Anita Gray
Email: Anita.Gray@sc.com

With copy to:

Standard Chartered Bank
1095 Avenue of the Americas
New York, New York 10003
Attention: Filipe Mossmann
Email: Filipe.Mossmann@sc.com

If to HSBC:    

HSBC Securities (USA) Inc.
452 Fifth Avenue New York, New York 10018
Attention : David Mendell
Email : david.a.mendell@us.hsbc.com

If to Seller:    

PHI Financial Services, Inc.
7100 NW 62nd Avenue
P.O. Box 1050
Johnston, Iowa 50131
Attention:    Secretary
E-Mail:    mike.wineland@pioneer.com
    




With a copy to:    

E. I. du Pont de Nemours and Company
974 Centre Road
Chestnut Run Plaza 730/5218
Wilmington, Delaware 19805
Attention:    Treasury Consultant and Corporate Secretary    
E-Mails:    james.p.donaghey@dupont.com    
                erik.t.hoover@dupont.com

or to such other address as any Party may designate by written notice to the other Party. Each notice, request, demand, or other communication will be deemed given and effective, as follows: (i) if sent by hand delivery, upon delivery; (ii) if sent by first-class U.S. Mail, postage prepaid, upon the earlier to occur of receipt or three (3) days after deposit in the U.S. Mail; (iii) if sent by a recognized prepaid overnight courier service, one (1) Business Day after the date it is given to such service; (iv) if sent by facsimile, upon receipt of confirmation of successful transmission by the facsimile machine; and (v) if sent by email, upon acknowledgement of receipt by the recipient.

9.9    GOVERNING LAW. THIS FRAMEWORK AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT GIVING EFFECT TO THE CONFLICTS OF LAW PROVISIONS THEREOF OTHER THAN SECTIONS 5-1401 AND 5-1402 OF THE NEW YORK GENERAL OBLIGATIONS LAW.

9.10    Jurisdiction. Each Party hereby irrevocably and unconditionally:

(a)    submits for itself and its property in any legal action or proceeding relating to any Transaction Agreement, or for recognition and enforcement of any judgment in respect thereof, to the non-exclusive general jurisdiction of the courts of the State of New York located in the Borough of Manhattan in the City of New York, the courts of the United States of America for the Southern District of New York and appellate courts from any thereof;

(b)    consents that any such action or proceeding may be brought in such courts and waives any objection that it may now or hereafter have to the venue of any such action or proceeding in any such court or that such action or proceeding was brought in an inconvenient court and agrees not to plead or claim the same;

(c)    agrees that service of process in any such action or proceeding may be effected by mailing a copy thereof by registered or certified mail (or any substantially similar form of mail), postage prepaid, to the applicable party at its respective address set forth in Section 9.8 or at such other address which has been designated in accordance therewith; and




(d)    agrees that nothing herein shall affect the right to effect service of process in any other manner permitted by Law or shall limit the right to sue in any other jurisdiction.

9.11    WAIVER OF JURY TRIAL. EACH PARTY HEREBY WAIVES ITS RIGHTS TO A TRIAL BY JURY OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF OR RELATED TO ANY OF THE TRANSACTION AGREEMENTS OR THE TRANSACTIONS CONTEMPLATED BY THE TRANSACTION AGREEMENTS, IN ANY ACTION, PROCEEDING OR OTHER LITIGATION OF ANY TYPE BROUGHT BY ANY PARTY AGAINST ANOTHER PARTY, WHETHER WITH RESPECT TO CONTRACT CLAIMS, TORT CLAIMS, OR OTHERWISE. EACH PARTY HEREBY AGREES THAT ANY SUCH CLAIM OR CAUSE OF ACTION WILL BE TRIED BY A COURT TRIAL WITHOUT A JURY. WITHOUT LIMITING THE PREVIOUS SENTENCE, THE PARTIES FURTHER AGREE THAT THEIR RESPECTIVE RIGHTS TO A TRIAL BY JURY IS WAIVED BY OPERATION OF THIS SECTION AS TO ANY ACTION, COUNTERCLAIM, OR OTHER PROCEEDING THAT SEEKS, IN WHOLE OR IN PART, TO CHALLENGE THE VALIDITY OR ENFORCEABILITY OF ANY PORTION OF ANY TRANSACTION AGREEMENTS. THIS WAIVER WILL APPLY TO ANY SUBSEQUENT AMENDMENT, RENEWAL, SUPPLEMENT, OR MODIFICATION TO ANY OF THE TRANSACTION AGREEMENTS.

9.12    Severability. If any provision of a Transaction Agreement is held by a court of competent jurisdiction to be invalid, unenforceable, or void, that provision will be enforced to the fullest extent permitted by applicable Law, and the remainder of the applicable Transaction Agreement will remain in full force and effect. If the time period or scope of any provision is declared by a court of competent jurisdiction to exceed the maximum time period or scope that that court deems enforceable, then that court will reduce the time period or scope to the maximum time period or scope permitted by Law.

9.13    Survival. The provisions of Section 5.3(c), Article VI, Article VII, Article VIII and this Article IX shall survive any termination or expiration of this Framework Agreement and any of the other Transaction Agreements.

9.14    Counterparts. The Transaction Agreements and any document related to the Transaction Agreements may be executed by the Parties on any number of separate counterparts, by facsimile or email, and all of those counterparts taken together will be deemed to constitute one and the same instrument; signature pages may be detached from multiple separate counterparts and attached to a single counterpart so that all signatures are physically attached to the same document. A facsimile, portable document format (“.pdf”) or other electronic format signature page will constitute an original for the purposes of this Section 9.14 (including with respect to each of the Transaction Agreements and related documents).




9.15    Joint Lead Arrangers. The Joint Lead Arrangers shall not have any duties or responsibilities hereunder or under any of the other Transaction Agreements in their capacities as such.

9.16    Acknowledgment and Consent to Bail-In of EEA Financial Institutions. Notwithstanding anything to the contrary in any Transaction Agreement or in any other agreement, arrangement or understanding among any such parties, each party hereto acknowledges that any liability of any EEA Financial Institution arising under any Transaction Agreement, to the extent such liability is unsecured, may be subject to the Write-Down and Conversion Powers of an EEA Resolution Authority and agrees and consents to, and acknowledges and agrees to be bound by:

(a)    the application of any Write-Down and Conversion Powers by an EEA Resolution Authority to any such liabilities arising hereunder which may be payable to it by any party hereto that is an EEA Financial Institution; and

(b)    the effects of any Bail-In Action on any such liability, including, if applicable:

(i)    a reduction in full or in part or cancellation of any such liability;

(ii)    a conversion of all, or a portion of, such liability into shares or other instruments of ownership in such EEA Financial Institution, its parent undertaking, or a bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect to any such liability under this Framework Agreement or any other Transaction Agreement; or

(iii)    the variation of the terms of such liability in connection with the exercise of the Write-Down and Conversion Powers of any EEA Resolution Authority.

[SIGNATURE PAGES FOLLOW]















IN WITNESS WHEREOF, the Parties have executed this Master Framework Agreement as of the date first written above.
Buyer and Agent:

Coöperatieve Rabobank, U.A., New York Branch



By:    /s/ Vikram Malkani
Name:    Vikram Malkani
Title:    Managing Director


By:    /s/ David Epstein
Name:    David Epstein
Title:    Vice President


[SIGNATURE PAGES CONTINUE ON FOLLOWING PAGE]






















IN WITNESS WHEREOF, the Parties have executed this Master Framework Agreement as of the date first written above.
Buyer:

MUFG Bank, Ltd., New York Branch



By:     
Name:    
Title:    





[SIGNATURE PAGES CONTINUE ON FOLLOWING PAGE]
































IN WITNESS WHEREOF, the Parties have executed this Master Framework Agreement as of the date first written above.
Buyer:

Standard Chartered Bank, acting through its New      York branch



By:    /s/ Anita Gray
Name:    Anita Gray
Title:    Executive Director





[SIGNATURE PAGES CONTINUE ON FOLLOWING PAGE]

















IN WITNESS WHEREOF, the Parties have executed this Master Framework Agreement as of the date first written above.
Buyer:

HSBC Bank USA, N.A.



By:    /s/ Adam Hendley
Name:    Adam Hendley
Title:    Manage Director





[SIGNATURE PAGES CONTINUE ON FOLLOWING PAGE]































    IN WITNESS WHEREOF, the Parties have executed this Master Framework Agreement as of the date first written above.

Seller:

PHI Financial Services, Inc.



By:    /s/ Timothy A. Johnson
Name:    Timothy A. Johnson
Title:    Treasurer ad Director




































SCHEDULE 1

DEFINITIONS
As used in the Transaction Agreements, the following terms have the following meanings unless otherwise defined in any Transaction Agreement:

Action means any suit in equity, action at law or other judicial or administrative proceeding conducted or presided over by any Governmental Authority.

Additional Funding Conditions has the meaning set forth in Section 4.3(a).

Additional Funding Transaction means a Transaction with respect to which any Funded Purchase Price is to be paid, whether pursuant to Section 4.2(b) or Section 4.5(a)(ii).

Affiliate of a Party means any Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, that Party. The term “control” (including the terms “controlled by” and “under common control with”) means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract, or otherwise.

Agent has the meaning set forth in the Preamble.

Aggregate Buyer Balance means, as of any time of determination, the aggregate Purchase Price with respect to the applicable Current Transaction.

Aggregate Commitment Amount means, as of any date of determination with respect to any Transaction or proposed Transaction, the sum of the applicable Individual Commitment Amounts for each of the Buyers as of such date of determination.
“Aggregate Exposure Amount” means the sum of all Individual Exposure Amounts for all Buyers.
Anti-Corruption Laws means all laws, rules, and regulations of any jurisdiction applicable to any Borrower or its Subsidiaries from time to time concerning or relating to bribery, corruption or money laundering.

Asset Representations, Warranties and Covenants means, collectively, the representations, warranties and covenants set forth in Section 5.2, Section 5.3(b), Section 5.3(d), Section 5.3(f), Section 5.3(g) and Section 5.3(h).

Bail-In Action means the exercise of any Write-Down and Conversion Powers by the applicable EEA Resolution Authority in respect of any liability of an EEA Financial Institution.

Bail-In Legislation means, with respect to any EEA Member Country implementing Article 55 of Directive 2014/59/EU of the European Parliament and of the Council of the



European Union, the implementing law for such EEA Member Country from time to time which is described in the EU Bail-In Legislation Schedule.

Beneficial Ownership Rule means 31 C.F.R. § 1010.230.

Book Value means, with respect to any Eligible Farmer Loan as of any date of determination, the outstanding principal amount of such Eligible Farmer Loan as of such date of determination.

Breakage Amount has the meaning set forth in the Master Repurchase Agreement.

Business Day means any day other than (i) a Saturday or Sunday or (ii) a day on which banking institutions located in New York City are permitted or required by applicable Law or regulation to remain closed.

Buyer has the meaning set forth in the Preamble.

CBR Score means, with respect to any Debtor that is a natural person as of any date of determination, the most recent numerical FICO score issued by Equifax, Experian or TransUnion with respect to such Debtor obtained by Seller and maintained in its records in accordance with its underwriting procedures for the 2021 season; provided, that any such Debtor for which Seller does not have a FICO score in its records as of such date of determination (with respect to which the most recent FICO score in Seller’s records was issued more than three (3) years prior to such date of determination) shall be deemed to have a FICO score of zero.

Certification of Beneficial Owner(s)means a certificate in form and substance satisfactory to the Agent regarding beneficial ownership of Seller, as required by the Beneficial Ownership Rule.

Change of Control means with respect to any Person, the acquisition of ownership, directly or indirectly, beneficially or of record, by any Person or group (within the meaning of the Securities Exchange Act of 1934 and the rules of the Securities and Exchange Commission thereunder as in effect on the date hereof), of voting equity securities representing more than 50% of the aggregate ordinary voting power represented by the issued and outstanding voting equity securities of such Person; provided, that the occurrence of any of the following shall also be treated as a Change of Control with respect to Seller:
(i)    Corteva ceases to own, directly or indirectly, 100% of the issued and outstanding equity interests in DuPont (other than, unless redeemed or otherwise extinguished, the Preferred Stock - $4.50 Series and the Preferred Stock - $3.50 Series of DuPont outstanding on November 12, 2018);

(ii)    any Guarantor violates the provisions of Sections 5.09, 6.01, 6.03 or 6.04 of the Corteva Revolver, as amended from time to time;




(iii)    any Guarantor violates the provisions of Section 6.02 of the Corteva Revolver, as amended from time to time, replacing the reference to a “Default” thereunder with an Event of Default under this Framework Agreement; or

(iv)    Seller ceases to be a direct or indirect wholly-owned Subsidiary of DuPont.

Code means the Internal Revenue Code of 1986, as amended.

Commitment Reduction Date means each of the Monthly Dates occurring in October, 2021 and November, 2021.

Confidential Information means any and all information, know-how and data, technical or non-technical, disclosed or provided by one Party to another Party concerning any of the Transaction Agreements, the subject matter thereof or any of the transactions contemplated thereby, whether disclosed or provided in oral, written, graphic, photographic, electronic, or any other form, but excluding any such information to the extent that such information:
(a)    is or becomes generally known or available to the public without breach of this Framework Agreement;
(b)    is known to the Receiving Party or any of its Representatives at the time of disclosure, as evidenced by written records of the Receiving Party;

(c)    is independently developed by the Receiving Party or any of its Representatives, as evidenced by written records of the Receiving Party; or

(d)    is disclosed to the Receiving Party by a third party who, to the knowledge of the Receiving Party, is not bound by any duty of confidentiality to the Disclosing Party.

Confirmation has the meaning set forth in the Master Repurchase Agreement.

Contract means contracts, leases, deeds, mortgages, licenses, instruments, notes, commitments, undertakings, indentures, joint ventures and all other agreements, commitments, and legally binding arrangements, whether written or oral.

Corteva means Corteva, Inc., a Delaware corporation.

Corteva Revolver means the Five-Year Revolving Credit Agreement dated as of November 12, 2018, among DuPont, Corteva, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent, as amended by (i) that certain Amendment No. 1 to Five-Year Revolving Credit Agreement dated as of May 2, 2019, among DuPont, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent, and (ii) that certain Joinder Agreement dated as of June 1, 2019, among DuPont, Corteva, and JPMorgan Chase Bank, N.A., as administrative agent.



Current Transaction means, as of any time of determination, the Transaction, if any, outstanding at such time of determination.

Data Transfer Agreement means that certain Data Transfer Agreement dated as of September 15, 2015, between Agent and DuPont, as set forth on Schedule 4.

Debtor means, with respect to any Eligible Farmer Loan, each of the Persons designated as a “borrower” under the applicable Loan Agreement.

Deemed Roll-Over Conditions has the meaning set forth in Section 4.3(c).

Deemed Roll-Over Transaction” has the meaning set forth in Section 4.1(c).

Defaulting Buyer has the meaning set forth in Section 4.5.

Direct Taxes means sales, use, excise, gross receipts, fuel, value added, export/import, acquisition, transfer and similar Taxes, or any inspection fees, environmental fees and similar amounts imposed on or with respect to any Eligible Farmer Loan or any Contracts related thereto.

Disclosing Party means the Party who provides (by any means, including indirectly through Agent or any third party or third party application or website) any Confidential Information to the Receiving Party.

Distribution Amount means, for any Buyer with respect to any Funded Repurchase Price or Margin Payment paid by Seller in connection with any Transaction, an amount equal to the product of such Funded Repurchase Price or Margin Payment, multiplied by such Buyer’s Undivided Funding Percentage as of the date such Funded Repurchase Price or Margin Payment was paid by Seller to Agent.

DuPont means E. I. du Pont de Nemours and Company, a Delaware corporation.

EEA Financial Institution means (a) any credit institution or investment firm established in any EEA Member Country which is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country which is a parent of an institution described in clause (a) of this definition, or (c) any financial institution established in an EEA Member Country which is a subsidiary of an institution described in clauses (a) or (b) of this definition and is subject to consolidated supervision with its parent.

EEA Member Country means any member state of the European Union, Iceland, Liechtenstein and Norway.

EEA Resolution Authority means any public administrative authority or any person entrusted with public administrative authority of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution.




Effective Date has the meaning set forth in the Preamble.

Eligible Farmer Loan means any outstanding loan made by Seller to a customer of Seller or its Affiliates in connection with Seller’s Pioneer Deferred Payment Plan program with a stated final maturity date of December 1, 2021 (the “Farmer Loan Maturity Date”).

ERISA Event has the meaning ascribed to such term in the Corteva Revolver.

EU Bail-In Legislation Schedule means the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor person), as in effect from time to time.
Event of Default means any of the following:

(a)    Seller or any Guarantor shall have failed to pay any margin payment required to be paid under Paragraph 4(a) of the Master Repurchase Agreement or any Repurchase Price due and payable on the Scheduled Facility Expiration Date or on any Commitment Reduction Date, in each case, when and as the same shall become due and payable;

(b)    Seller or any Guarantor shall have failed to pay any Repurchase Price (other than any Repurchase Price payable on the Scheduled Facility Expiration Date or any Commitment Reduction Date), Price Differential, any fee required to be paid under the Fee Letter or the Side Letter, any amount required to be refunded pursuant to Section 4.5(a)(iii) hereof, or any other amounts owing under any Transaction Agreement (other than amounts specified in clause (a) of this definition), in each case, when and as the same shall become due and payable, and such failure shall continue unremedied for a period of three (3) or more Business Days;

(c)    Seller shall fail to perform any covenant set forth in Section 5.3(f)(i) or Section 5.3(o);

(d)    Seller or any Guarantor shall fail to observe or perform any covenant, condition or agreement contained in this Framework Agreement or any other Transaction Agreement (excluding (i) any covenants, conditions or agreements contained in the Asset Representations, Warranties and Covenants unless the failure to observe such covenants, conditions and agreements would, individually or in the aggregate, have a Material Adverse Effect and (ii) any covenants, conditions or agreements specified in clauses (a), (b) or (c) of this definition) and such failure shall continue unremedied for a period of 30 or more days;

(e)    any representation or warranty made or deemed made by or on behalf of Seller or any Guarantor in or in connection with this Framework Agreement, any other Transaction Agreement or any amendment or modification hereof or thereof, shall prove to have been incorrect in any material respect when made or deemed made (excluding any representations or warranties contained in the Asset Representations, Warranties and Covenants unless the failure of such representations and warranties would, individually or in the aggregate,



have a Material Adverse Effect), and such failure to be correct shall continue unremedied for a period of 30 or more days;

(f)    an involuntary proceeding shall be commenced or an involuntary petition shall be filed seeking (i) liquidation, reorganization or other relief in respect of either of Seller or any Guarantor or its debts, or of a substantial part of the assets thereof, under any Federal, state or foreign bankruptcy, insolvency, receivership or similar law now or hereafter in effect or (ii) the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for either of Seller or any Guarantor or for a substantial part of its assets, and in any such case, such proceeding or petition shall continue undismissed for a period of 60 or more days or an order or decree approving or ordering any of the foregoing shall be entered;

(g)    Seller or any Guarantor shall (i) voluntarily commence any proceeding or file any petition seeking liquidation, reorganization or other relief under any Federal, state or foreign bankruptcy, insolvency, receivership or similar law now or hereafter in effect, (ii) consent to the institution of, or fail to contest in a timely and appropriate manner, any proceeding or petition described in clause (f) of this definition, (iii) apply for or consent to the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for Seller or for a substantial part of its assets, (iv) file an answer admitting the material allegations of a petition filed against it in any such proceeding, (v) make a general assignment for the benefit of creditors or (vi) take any action for the purpose of effecting any of the foregoing;

(h)    Seller or any Guarantor shall become unable, admit in writing its inability or fail generally to pay its debts as they become due;

(i)    one or more judgments for the payment of money in an aggregate amount (to the extent not covered by insurance) in excess of $100,000,000 shall be rendered against Seller, any Guarantor or any Material Subsidiaries of any Guarantor or any combination thereof, and the same shall remain undischarged for a period of thirty (30) or more consecutive days during which execution shall not be effectively stayed, vacated or bonded pending appeal;

(j)    an ERISA Event shall have occurred that, in the reasonable determination of Agent, when taken together with all other ERISA Events that have occurred, could reasonably be expected to result in a Material Adverse Effect; and

(k)    the Guaranty shall cease to be in full force and effect, or its validity or enforceability shall be disputed by Seller or any Guarantor.

Facility Expiration Date means the Scheduled Facility Expiration Date; provided, that on any Business Day following the occurrence of a Change of Control with respect to any Guarantor or Seller, Agent may deliver a written notice to Seller terminating the Facility Term, in which case the Facility Expiration Date shall be the first Monthly Date to occur that is at least five (5) Business Days following the date of such delivery.




Facility Term” means the period beginning on the Effective Date and ending on the Facility Expiration Date.

Farmer Loan Maturity Date has the meaning set forth in the definition of Eligible Farmer Loan.

Fee Letter means that certain Fee Letter Agreement dated as of the Effective Date, by and between Seller, Agent and the Buyers.

Financial Officer means, with respect to any Person, the chief financial officer, principal accounting officer, treasurer or controller of such Person, or any other individual to whom any of the chief financial officer, principal accounting officer, treasurer or controller of such Person shall have delegated in writing his or her authority to execute and deliver certificates and other documents hereunder; provided, that, when such term is used in reference to any document executed by, or a certification of, a Financial Officer, the secretary or assistant secretary of such Person shall have delivered an incumbency certificate to Agent as to the authority of such individual.

Fitch means Fitch Ratings, Inc., or any successor to its rating agency business.

Framework Agreement has the meaning set forth in the Preamble.

Funded Purchase Pricemeans, with respect to any Transaction entered into (or proposed to be entered into) on any Purchase Date, the excess of (x) Purchase Price for such Transaction over (y) the amount of Repurchase Price under the Transaction (if any) whose Repurchase Date coincides with such Purchase Date which is netted against such Purchase Price in accordance with Paragraph 12 of the Master Repurchase Agreement (any such netting being subject to Paragraph 12 of Annex I to the Master Repurchase Agreement).

Funded Repurchase Price” means, with respect to any Transaction expiring on any Repurchase Date, the Repurchase Price for such Transaction minus the amount of any Purchase Price under any other Transaction whose Purchase Date coincides with such Repurchase Date which is netted against such Repurchase Price in accordance with Paragraph 12 of the Master Repurchase Agreement (any such netting being subject to Paragraph 12 of Annex I to the Master Repurchase Agreement).

“Funding Amount means, with respect to any Buyer in connection with any proposed Additional Funding Transaction, an amount equal to the product of (x) the Funded Purchase Price anticipated to be payable with respect to such Additional Funding Transaction (as specified in the relevant Funding Notice and without regard to any subsequent reduction thereof) multiplied by (y) such Buyer’s Undivided Commitment Percentage with respect to such Additional Funding Transaction; provided, that if one or more Buyers are Defaulting Buyers as of the date on which Agent delivers (or is required to deliver) the relevant Funding Notice in connection with such proposed Additional Funding Transaction pursuant to Section 4.2(a), then solely for purposes of calculating the applicable Funding Amounts for each Buyer in connection



with such proposed Additional Funding Transaction, (i) the Undivided Commitment Percentage of each such existing Defaulting Buyer with respect to such Additional Funding Transaction shall be deemed to be zero, and (ii) the Undivided Commitment Percentages of the remaining Buyers shall be deemed to be proportionately increased (as calculated by Agent and indicated in the relevant Funding Notice for such proposed Additional Funding Transaction) such that the sum of the Undivided Commitment Percentages of such remaining Buyers equals 100%.

Funding Notice has the meaning set forth in Section 4.2(a).

GAAP” means generally accepted accounting principles as applied in the United States.

Governmental Authority means any federal, state, local or foreign government or political subdivision thereof, or any agency or instrumentality of such government or political subdivision, or any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government (including any supranational bodies such as the European Union or the European Central Bank).

Governmental Order means any order, writ, judgment, injunction, decree, stipulation, determination or award entered by or with any Governmental Authority.

Guarantors means each of DuPont and Corteva.

Guaranty” means that certain Guaranty, dated as of the Effective Date, executed by the Guarantors in favor of the Buyers.

HSBC has the meaning set forth in the Preamble.

Individual Buyer Balance means, for any Buyer as of any time of determination, the excess, if any, of (x) the aggregate amount of Funded Purchase Price funded by such Buyer and applied to Purchase Price over (y) the aggregate Distribution Amounts allocated to such Buyer with respect to amounts of Funded Repurchase Price or Margin Payments paid by Seller (excluding any such amounts of Funded Repurchase Price attributable to payments of Price Differential), in each case, in connection with the Current Transaction and all prior Transactions as of such time of determination, subject to transfer or adjustment in accordance with the terms hereof.

Individual Commitment Amount means, with respect to each Buyer in connection with any outstanding or proposed Transaction, the amount set forth in Schedule 5 to this Framework Agreement for such Buyer corresponding to the calendar month in which the Purchase Date for such Transaction occurs, subject to transfer, adjustment or reduction in accordance with the terms hereof.




Individual Exposure Amount means, (a) with respect to any Buyer other than a Defaulting Buyer, its highest Individual Commitment Amount for any single month as set forth in Schedule 5 to this Framework Agreement and (b) with respect to any Defaulting Buyer, zero.

Joint Lead Arranger has the meaning set forth in the Preamble.

Law means any statute, law, ordinance, regulation, rule, code, order, constitution, treaty, common law, judgment, decree, other requirement or rule of law of any Governmental Authority.

Loan Agreement means, with respect to each Eligible Farmer Loan, the Contract governing such loan, as amended.

Margin Deficit has the meaning set forth in the Master Repurchase Agreement.

Margin Payment means any cash transferred by Seller to Agent as required pursuant to Paragraph 4(a) of the Master Repurchase Agreement or as permitted under Paragraph 4(f) of Annex I to the Master Repurchase Agreement.

Market Value has the meaning set forth in the Master Repurchase Agreement.

Master Repurchase Agreement means that certain 1996 SIFMA Master Repurchase Agreement dated as of February 9, 2021, between Seller and Buyers, including Annex I thereto (and as amended thereby).

Material Adverse Effect means a material adverse effect on (a) the Eligible Farmer Loans, taken as a whole, (b) the ability of Seller to perform any of its obligations under the Transaction Agreements to which it is a party or (c) the rights of or benefits available to the Buyers under the Transaction Agreements.

Material Subsidiary has the meaning ascribed to such term in the Corteva Revolver.

Moody’s means Moody’s Investors Service, Inc., or any successor to its rating agency business.

Monthly Date” means each of (i) February 16, 2021 and (ii) the eleventh (11th) Business Day of each subsequent calendar month occurring during the Facility Term.

MUFG” has the meaning set forth in the Preamble.

Organizational Documents” means a Party’s articles or certificate of incorporation and its by-laws or similar governing instruments required by the laws of its jurisdiction of formation or organization.

Party” and “Parties” have the meaning set forth in the Preamble.




Permits” means all permits, licenses, franchises, approvals, authorizations, registrations, certificates, variances and similar rights obtained, or required to be obtained, from Governmental Authorities.

Person” means an individual, corporation, partnership, joint venture, limited liability company, Governmental Authority, unincorporated organization, trust, association, or other entity.

Portfolio Schedule” has the meaning set forth in the Master Repurchase Agreement.

Potential Event of Default” means the occurrence of any event that, with the giving of notice or lapse of time, would become an Event of Default.

Price Differential” has the meaning set forth in the Master Repurchase Agreement.

Pricing Rate” has the meaning set forth in the Master Repurchase Agreement.

Purchase Date” has the meaning set forth in the Master Repurchase Agreement.

Purchase Price” has the meaning set forth in the Master Repurchase Agreement.

Purchased Securities” has the meaning set forth in the Master Repurchase Agreement.

Rabobank” has the meaning set forth in the Preamble.

Recalculation Date” means each of November 1, 2021, November 22, 2021, November 29, 2021 and December 6, 2021, as each such date may be adjusted at the request of Seller with the consent of Agent.

Receiving Party” means the Party to whom any Confidential Information is provided (by any means, including indirectly through Agent or any third party or third party application or website) by the Disclosing Party.

Related Parties” means, with respect to any Person, such Person’s Affiliates and the partners, directors, officers, employees, agents, sub-agents, trustees and advisors of such Person and of such Person’s Affiliates.

Representatives” means, with respect to any Person, its Affiliates, and the respective directors, officers, employees, consultants, representatives, attorneys, accountants, auditors, professional advisors and agents of such Person and each such Affiliate.

Repurchase Date” has the meaning set forth in the Master Repurchase Agreement.

Repurchase Price” has the meaning set forth in the Master Repurchase Agreement.




Required Buyers” means, at any time, Buyers having Individual Exposure Amounts equal to more than 75% of the Aggregate Exposure Amount.

Roll-Over Conditions” has the meaning set forth in Section 4.3(b).

Roll-Over Portfolio Schedule” has the meaning set forth in Section 4.1(d)(C).

Roll-Over Transaction” means any Transaction other than an Additional Funding Transaction.

S&P” means S&P Global Ratings, a division of S&P Global Inc., or any successor to its rating agency business.

Sanctioned Country” means, at any time, a country, region or territory that is itself the target of any comprehensive Sanctions.

Sanctioned Person” means, at any time, (a) any Person listed in any Sanctions-related list of designated Persons maintained by the Office of Foreign Assets Control of the U.S. Department of the Treasury, the U.S. Department of State, the United Nations Security Council, the European Union or Her Majesty’s Treasury of the United Kingdom, (b) any Person located, organized or resident in a Sanctioned Country or (c) any Person 50% or more owned or controlled by any other Person or Persons referred to in clause (a) or (b) above.

Sanctions” means economic or financial sanctions or trade embargoes imposed, administered or enforced from time to time by (a) the U.S. government, including those administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury or the U.S. Department of State, or (b) the United Nations Security Council, the European Union or Her Majesty’s Treasury of the United Kingdom.

Scheduled Facility Expiration Date” means December 13, 2021.

Security Interest” means any pledge, charge, lien, assignment by way of security, retention of title and any other encumbrance or security interest whatsoever created or arising under any relevant law, as well as any other agreement or arrangement having the effect of or performing the economic function of the same.

Seller” has the meaning set forth in the Preamble.

Side Letter” means that certain Side Letter Agreement dated as of the Effective Date, by and between Seller and Rabobank.

Standard Chartered” has the meaning set forth in the Preamble.




Subsidiary” of any Person means any corporation, partnership, limited liability company, association, trust, unincorporated association or other legal entity of which such Person (either alone or through or together with any other Subsidiary), (i) owns, directly or indirectly, fifty percent (50%) or more of the shares of capital stock or other equity interests that are generally entitled to vote for the election of the board of directors or other governing body of such corporation or other legal entity; or (ii) has the contractual or other power to designate a majority of the board of directors or other governing body (and, where the context permits, includes any predecessor of such an entity).

Tax” means all taxes, levies, imposts, duties, deductions, withholdings (including backup withholding), assessments, fees or other charges payable to or imposed by any Governmental Authority, including any sales, use, excise or similar taxes and inclusive of any interest, additions to tax, penalties or fines applicable thereto.

Transaction” has the meaning set forth in the Master Repurchase Agreement.

Transaction Agreements” has the meaning set forth in Section 2.1.

Transaction Conditions” means (i) in the case of any Additional Funding Transaction, the Additional Funding Conditions, (ii) in the case of any Roll-Over Transaction, the Roll-Over Conditions and (iii) in the case of any Deemed Roll-Over Transaction, the Deemed Roll-Over Conditions.
Transaction Notice” has the meaning set forth in Section 4.1.

Transaction Period” means, with respect to any Transaction, the period commencing on (and including) the Purchase Date for such Transaction and expiring on (but excluding) the Repurchase Date for such Transaction.

Transaction Portfolio” means, with respect to any Transaction, the portfolio of Eligible Farmer Loans comprising the Purchased Securities acquired by Buyers in connection with such Transaction, as such portfolio may be modified from time to time during the Transaction Period for such Transaction in accordance with the terms of the Master Repurchase Agreement and applicable Confirmation.

Undivided Commitment Percentage” means, with respect to any Buyer as of any date of determination or in connection with any Transaction or proposed Transaction, a fraction (expressed as a percentage) (a) the numerator of which is the Individual Commitment Amount of such Buyer applicable to such Transaction as of such date of determination and (b) the denominator of which is the Aggregate Commitment Amount in connection with such Transaction as of such date of determination.

Undivided Funding Percentage” means, with respect to any Buyer as of any date of determination in connection with any Transaction, a fraction (expressed as a percentage), (a) the numerator of which is the Individual Buyer Balance of such Buyer as of such date of



determination and (b) the denominator of which is the Aggregate Buyer Balance as of such date of determination.

Unsecured Rating” has the meaning ascribed to such term in the Corteva Revolver.

Weighted Average CBR Score” means, with respect to any Transaction Portfolio, the average of the CBR Scores for the applicable Debtors with respect to all Eligible Farmer Loans included in such Transaction Portfolio made to Debtors who are natural persons, weighted in accordance with the respective Book Values of such Eligible Farmer Loans.

Write-Down and Conversion Powers” means, with respect to any EEA Resolution Authority, the write-down and conversion powers of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which writedown and conversion powers are described in the EU Bail-In Legislation Schedule.


































SCHEDULE 2

BANK ACCOUNTS













































SCHEDULE 3

FORMS OF DEFERRED PAYMENT LOAN AGREEMENT














































SCHEDULE 4

DATA TRANSFER AGREEMENT













































SCHEDULE 5

INDIVIDUAL COMMITMENT AMOUNTS

RabobankMUFGStandard CharteredHSBCTotal
February 20210000$0.00
March 2021$12,000,000.00 $12,000,000.00 $3,000,000.00 $3,000,000.00 $30,000,000.00 
April 2021$60,000,000.00 $60,000,000.00 $15,000,000.00 $15,000,000.00 $150,000,000.00 
May 2021$220,000,000.00 $220,000,000.00 $55,000,000.00 $55,000,000.00 $550,000,000.00 
June 2021$320,000,000.00 $320,000,000.00 $80,000,000.00 $80,000,000.00 $800,000,000.00 
July 2021$400,000,000.00 $400,000,000.00 $100,000,000.00 $100,000,000.00 $1,000,000,000.00 
August 2021$400,000,000.00 $400,000,000.00 $100,000,000.00 $100,000,000.00 $1,000,000,000.00 
September 2021$400,000,000.00 $400,000,000.00 $100,000,000.00 $100,000,000.00 $1,000,000,000.00 
October 2021$400,000,000.00 $400,000,000.00 $100,000,000.00 $100,000,000.00 $1,000,000,000.00 
November 2021$320,000,000.00 $320,000,000.00 $80,000,000.00 $80,000,000.00 $800,000,000.00 



























Exhibit A

Form of Transaction Notice

COÖPERATIEVE RABOBANK, U.A., NEW YORK BRANCH, A DUTCH COÖPERATIEVE ACTING THROUGH ITS NEW YORK BRANCH, as Agent

RE:    Transaction under the Framework Agreement and the Master Repurchase Agreement

Ladies and Gentlemen:

This Transaction Notice is delivered to you pursuant to Section 4.1 of the Master Framework Agreement, dated as of February 9, 2021 (the “Framework Agreement”), by and among PHI Financial Services, Inc., an Iowa corporation, as seller (the “Seller”), each of the buyers from time to time party thereto (each, a “Buyer”), and Coöperatieve Rabobank, U.A., New York Branch, a Dutch coöperatieve acting through its New York Branch, as agent for the Buyers (in such capacity, the “Agent”), relating to repurchase transactions to be entered into pursuant to the terms of the 1996 SIFMA Master Repurchase Agreement, dated as of February 9, 2021, including Annex I thereto (the “Master Repurchase Agreement”) by and among Seller and the Buyers. Capitalized terms used but not defined herein have the meanings set forth in the Framework Agreement, or if not defined therein, in the Master Repurchase Agreement.

Seller hereby requests that, in accordance with the terms of the Framework Agreement, a Transaction under the Master Repurchase Agreement with a proposed Purchase Price of $__________________ be entered into on the proposed Purchase Date of _____________________, with a proposed Repurchase Date of ________________________. [Seller further requests that, pursuant to Paragraph 3(c)(ii) of Annex I to the Master Repurchase Agreement, the current Transaction thereunder evidenced by the Confirmation dated as of [ ] and originally scheduled to expire on [ ] be instead terminated as of such proposed Purchase Date.] Attached hereto is a completed proposed Portfolio Schedule setting forth information with respect to the proposed Purchased Securities to be subject to such Transaction








1 To be used in connection with an early termination of a transaction by Seller.




PROPOSED PORTFOLIO SCHEDULE

Date:                 
Reference is hereby made to the 1996 SIFMA Master Repurchase Agreement dated as of February 9, 2021 (including, and as amended by, Annex I thereto, the “Master Repurchase Agreement”), among PHI Financial Services, Inc., Coöperatieve Rabobank, U.A., New York Branch, MUFG Bank, Ltd., New York Branch, Standard Chartered Bank, a bank organized and existing under the laws of England and Wales, acting through its New York branch and HSBC Bank USA, N.A., a national banking association organized under the laws of the United States. Capitalized terms used but not defined herein shall have the meaning set forth in the Master Repurchase Agreement.

[Applicable box to be checked below]

□    Portfolio Schedule for New Transaction. In accordance with and subject to the terms and conditions of the Master Repurchase Agreement, this schedule constitutes the “Portfolio Schedule” for the Transaction evidenced by Confirmation to which this schedule is attached.

□    Amendment and Restatement of Portfolio Schedule. Further reference is made to the Confirmation dated as of __________, entered into in accordance with the Master Repurchase Agreement by Seller and each of the Buyers set forth in such Confirmation. In accordance with and subject to the terms and conditions of the Master Repurchase Agreement, Seller hereby amends and restates the Portfolio Schedule to such Confirmation in its entirety with the information set forth below.


Part I: Balance and Market Value Summary

Aggregate Loan Balance of All Purchased Securities: _______________________
Aggregate Market Value of All Purchased Securities: _______________________

Weighted Average CBR Score of Transaction Portfolio:     _______________________


















Part II: Key Metrics

Loans by Size

Loan Balance# of LoansAggregate Market Value% of Portfolio Market valueAverage Market Value
0 to 10,000
10,001 to 25,000
25,001 to 50,000
50,001 to 100,000
100,001 to 250,000
250,001 to 500,000
500,001 to 1,000,000
1,000,001+

Loans by CBR Score

CBR Score# of Loans% of Loans in PortfolioAggregate Market Value% of Portfolio Market Value
1-550
551-600
601-650
651-700
701-750
751-800
801+
No Score










Loans by Debtor Type

Debtor Type# of Loans% of Loans in PortfolioAggregate Market Value% of Portfolio Market Value
Corporation
Estate (Executor)
General Partnership
Individual
LLC
LLP
LP
Trust
Unknown































Part III: List of Purchased Securities
Loan ID No.Debtor TypeCBR ScoreOrigination DateMaturity DateInterest RateLoan BalanceMarket Value

EX-31.1 4 corteva-3312021xex3111.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATIONS
 
I, James C. Collins, Jr., certify that:
1.I have reviewed this report on Form 10-Q for the period ended March 31, 2021 of Corteva, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
  Date: May 5, 2021
  By: /s/ James C. Collins, Jr.
James C. Collins, Jr.
Chief Executive Officer




I, James C. Collins, Jr., certify that:
1.I have reviewed this report on Form 10-Q for the period ended March 31, 2021 of E. I. du Pont de Nemours and Company;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date:May 5, 2021
By:/s/ James C. Collins, Jr.
James C. Collins, Jr.
Chief Executive Officer




EX-31.2 5 corteva-3312021xex3121.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATIONS
 
I, David J. Anderson, certify that:
1.I have reviewed this report on Form 10-Q for the period ended March 31, 2021 of Corteva, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
  Date: May 5, 2021
  By: 
/s/ David J. Anderson
David J. Anderson
Executive Vice President and
Chief Financial Officer





I, David J. Anderson, certify that:
1.I have reviewed this report on Form 10-Q for the period ended March 31, 2021 of E. I. du Pont de Nemours and Company;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date:May 5, 2021
By:
/s/ David J. Anderson
David J. Anderson
Executive Vice President and
Chief Financial Officer



EX-32.1 6 corteva-3312021xex3211.htm EX-32.1 Document

Exhibit 32.1

Certification of CEO Pursuant to
18 U.S.C. Section 1350,
As Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 
In connection with the Quarterly Report of Corteva, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), James C. Collins, Jr., as Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ James C. Collins, Jr.
 
James C. Collins, Jr.
Chief Executive Officer
May 5, 2021





Certification of CEO Pursuant to
18 U.S.C. Section 1350,
As Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 
In connection with the Quarterly Report of E. I. du Pont de Nemours and Company on Form 10-Q for the period ended March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), James C. Collins, Jr., as Chief Executive Officer of E. I. du Pont de Nemours and Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of E. I. du Pont de Nemours and Company.
/s/ James C. Collins, Jr.
 
James C. Collins, Jr.
Chief Executive Officer
May 5, 2021


EX-32.2 7 corteva-3312021xex3221.htm EX-32.2 Document

Exhibit 32.2

Certification of CFO Pursuant to
18 U.S.C. Section 1350,
As Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 
In connection with the Quarterly Report of Corteva, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), David J. Anderson, as Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ David J. Anderson
 
David J. Anderson
Chief Financial Officer
May 5, 2021




Certification of CFO Pursuant to
18 U.S.C. Section 1350,
As Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 
In connection with the Quarterly Report of E. I. du Pont de Nemours and Company on Form 10-Q for the period ended March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), David J. Anderson, as Chief Financial Officer of E. I. du Pont de Nemours and Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of E. I. du Pont de Nemours and Company.
/s/ David J. Anderson
 
David J. Anderson
Chief Financial Officer
May 5, 2021




EX-101.SCH 8 dd-20210331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 000010001 - Document - DEI Document link:presentationLink link:calculationLink link:definitionLink 100010002 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 100010002 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 100020003 - Statement - Consolidated Statements of Comprehensive (Loss) Income link:presentationLink link:calculationLink link:definitionLink 100030004 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 100040005 - Statement - Consolidated Balance Sheets (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 100050006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 100060007 - Statement - Statement of Stockholders Equity Statement link:presentationLink link:calculationLink link:definitionLink 100070008 - Statement - Statement of Stockholders' Equity Parentheticals (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 210011001 - Disclosure - Summary of Significant Accounting Policies (Notes) link:presentationLink link:calculationLink link:definitionLink 220022001 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 240034001 - Disclosure - Summary of Significant Accounting Policies Summary of Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 210041002 - Disclosure - Recent Accounting Guidance link:presentationLink link:calculationLink link:definitionLink 220052002 - Disclosure - Recent Accounting Guidance Recent Accounting Guidance (Policies) link:presentationLink link:calculationLink link:definitionLink 210061003 - Disclosure - Divestitures and Other Transactions link:presentationLink link:calculationLink link:definitionLink 230073001 - Disclosure - Divestitures and Other Transactions (Tables) link:presentationLink link:calculationLink link:definitionLink 240084002 - Disclosure - Divestitures and Other Transactions Separation Agreements (Details) link:presentationLink link:calculationLink link:definitionLink 240094003 - Disclosure - Divestitures and Other Transactions Other Discontinued Operations (Details) link:presentationLink link:calculationLink link:definitionLink 240104004 - Disclosure - Divestitures and Other Transactions - PChem Results of Operations (Details) link:presentationLink link:calculationLink link:definitionLink 210111004 - Disclosure - Revenue (Notes) link:presentationLink link:calculationLink link:definitionLink 220122003 - Disclosure - Revenue Revenue Recognition (Policies) link:presentationLink link:calculationLink link:definitionLink 230133002 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 240144005 - Disclosure - Revenue Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240154006 - Disclosure - Revenue Contract Balances (Details) link:presentationLink link:calculationLink link:definitionLink 240164007 - Disclosure - Revenue Disaggregation of Revenue - Principal Product Groups (Details) link:presentationLink link:calculationLink link:definitionLink 240174008 - Disclosure - Revenue Disaggregation of Revenue - Geography (Details) link:presentationLink link:calculationLink link:definitionLink 230183003 - Disclosure - Restructuring and Asset Related Charges (Tables) link:presentationLink link:calculationLink link:definitionLink 240194009 - Disclosure - Restructuring and Asset Related Charges - 2021 Restructuring Activities (Details) link:presentationLink link:calculationLink link:definitionLink 240204010 - Disclosure - Restructuring and Asset Related Charges Execute to Win Productivity Program (Details) link:presentationLink link:calculationLink link:definitionLink 240214011 - Disclosure - Restructuring and Asset Related Charges Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 210221005 - Disclosure - Restructuring and Asset Related Charges link:presentationLink link:calculationLink link:definitionLink 210231006 - Disclosure - Related Party Transactions (Notes) link:presentationLink link:calculationLink link:definitionLink 240244012 - Disclosure - Related Party Transactions Dow Intercompany Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 240254013 - Disclosure - Related Party Transactions Transactions with DowDuPont (Details) link:presentationLink link:calculationLink link:definitionLink 210261007 - Disclosure - Supplementary Information link:presentationLink link:calculationLink link:definitionLink 230273004 - Disclosure - Supplementary Information (Tables) link:presentationLink link:calculationLink link:definitionLink 240284014 - Disclosure - Supplementary Information Other Income (Expense) - Net (Details) link:presentationLink link:calculationLink link:definitionLink 240294015 - Disclosure - Supplementary Information Foreign Currency Exchange Gain (Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 240304016 - Disclosure - Supplementary Information Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) link:presentationLink link:calculationLink link:definitionLink 210311008 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 240324017 - Disclosure - Income Taxes Income Tax Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240334018 - Disclosure - Income Taxes Tax benefit (charge) associated with changes in accruals for certain prior year tax positions and reductions in unrecognized tax benefits (Details) link:presentationLink link:calculationLink link:definitionLink 210341009 - Disclosure - Earnings Per Share (Notes) link:presentationLink link:calculationLink link:definitionLink 230353005 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 240364019 - Disclosure - Earnings Per Share Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240374020 - Disclosure - Earnings Per Share Net Income for Earnings Per Share Calculations - Basic and Diluted (Details) link:presentationLink link:calculationLink link:definitionLink 240384021 - Disclosure - Earnings Per Share Earnings Per Share Calculations - Basic (Details) link:presentationLink link:calculationLink link:definitionLink 240394022 - Disclosure - Earnings Per Share Earnings Per Share Calculations - Diluted (Details) link:presentationLink link:calculationLink link:definitionLink 240404023 - Disclosure - Earnings Per Share Share Count Information (Details) link:presentationLink link:calculationLink link:definitionLink 210411010 - Disclosure - Accounts and Notes Receivable (Notes) link:presentationLink link:calculationLink link:definitionLink 230423006 - Disclosure - Accounts and Notes Receivable (Tables) link:presentationLink link:calculationLink link:definitionLink 240434024 - Disclosure - Accounts and Notes Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 240444025 - Disclosure - Accounts and Notes Receivable Allowance Rollforward (Details) link:presentationLink link:calculationLink link:definitionLink 210451011 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 230463007 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 240474026 - Disclosure - Inventories Schedule of Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 210481012 - Disclosure - Property, Plant and Equipment (Notes) link:presentationLink link:calculationLink link:definitionLink 230493008 - Disclosure - Property, Plant and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 240504027 - Disclosure - Property, Plant and Equipment Schedule of Property, Plant and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 240514028 - Disclosure - Property, Plant and Equipment Depreciation (Details) link:presentationLink link:calculationLink link:definitionLink 210521013 - Disclosure - Other Intangible Assets link:presentationLink link:calculationLink link:definitionLink 230533009 - Disclosure - Other Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 240544029 - Disclosure - Other Intangible Assets Other Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 240554030 - Disclosure - Other Intangible Assets Future Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 210561014 - Disclosure - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities link:presentationLink link:calculationLink link:definitionLink 230573010 - Disclosure - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 240584031 - Disclosure - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Short-term borrowings and finance lease obligations (Details) link:presentationLink link:calculationLink link:definitionLink 240594032 - Disclosure - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Long-term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 240604033 - Disclosure - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Repurchase Facility and Revolving Credit Facilities (Details) link:presentationLink link:calculationLink link:definitionLink 210611015 - Disclosure - Commitments and Contingent Liabilities link:presentationLink link:calculationLink link:definitionLink 230623011 - Disclosure - Commitments and Contingent Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 240634034 - Disclosure - Commitments and Contingent Liabilities Guarantee Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240644035 - Disclosure - Commitments and Contingent Liabilities Chemours (Details) link:presentationLink link:calculationLink link:definitionLink 240654036 - Disclosure - Commitments and Contingent Liabilities DuPont (Details) link:presentationLink link:calculationLink link:definitionLink 240664037 - Disclosure - Commitments and Contingent Liabilities PFOA / Leach Settlement (Details) link:presentationLink link:calculationLink link:definitionLink 240674038 - Disclosure - Commitments and Contingent Liabilities Other PFOA Matters / Fayetteville (Details) link:presentationLink link:calculationLink link:definitionLink 240684039 - Disclosure - Commitments and Contingent Liabilities Environmental (Details) link:presentationLink link:calculationLink link:definitionLink 210691016 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 230703012 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 240714040 - Disclosure - Stockholders' Equity Common Stock (Details) link:presentationLink link:calculationLink link:definitionLink 240724041 - Disclosure - Stockholders' Equity Noncontrolling interests (Details) link:presentationLink link:calculationLink link:definitionLink 240734042 - Disclosure - Stockholders' Equity Preferred Stock (Details) link:presentationLink link:calculationLink link:definitionLink 240744043 - Disclosure - Stockholders' Equity Other Comprehensive Income (Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 240754044 - Disclosure - Stockholders' Equity Tax Benefit (Expense) on Net Activity (Details) link:presentationLink link:calculationLink link:definitionLink 240764045 - Disclosure - Stockholders' Equity Reclassifications out of AOCI (Details) link:presentationLink link:calculationLink link:definitionLink 210771017 - Disclosure - Pension Plans and Other Post Employment Benefit Plans link:presentationLink link:calculationLink link:definitionLink 230783013 - Disclosure - Pension Plans and Other Post Employment Benefit Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 240794046 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Components of net periodic benefit cost (credit) (Details) link:presentationLink link:calculationLink link:definitionLink 210801018 - Disclosure - Financial Instruments link:presentationLink link:calculationLink link:definitionLink 230813014 - Disclosure - Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 240824047 - Disclosure - Financial Instruments Financial Instruments (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240834048 - Disclosure - Financial Instruments Notional Amounts (Details) link:presentationLink link:calculationLink link:definitionLink 240844049 - Disclosure - Financial Instruments Cash Flow Hedges Included in AOCI (Details) link:presentationLink link:calculationLink link:definitionLink 240854050 - Disclosure - Financial Instruments Fair Value of Derivatives (Details) link:presentationLink link:calculationLink link:definitionLink 240864051 - Disclosure - Financial Instruments Effect of Derivative Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 240874052 - Disclosure - Financial Instruments Contractual Maturities of Debt Securities (Details) link:presentationLink link:calculationLink link:definitionLink 240884053 - Disclosure - Financial Instruments- AFS Investing Results (Details) link:presentationLink link:calculationLink link:definitionLink 240894054 - Disclosure - Financial Instruments- Debt Securities- Gross Unrealized Losses Aggregated by Investment Category (Details) link:presentationLink link:calculationLink link:definitionLink 210901019 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 230913015 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 240924055 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 210931020 - Disclosure - Segment Reporting (Notes) link:presentationLink link:calculationLink link:definitionLink 230943016 - Disclosure - Segment Reporting (Tables) link:presentationLink link:calculationLink link:definitionLink 240954056 - Disclosure - Segment Reporting Segment Information (Details) link:presentationLink link:calculationLink link:definitionLink 240964057 - Disclosure - Segment Reporting Segment Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 240974058 - Disclosure - Segment Reporting Segment Asset Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 240984059 - Disclosure - Segment Reporting Significant Items (Details) link:presentationLink link:calculationLink link:definitionLink 210991021 - Disclosure - EID - Basis of Presentation (Notes) link:presentationLink link:calculationLink link:definitionLink 241004060 - Disclosure - EID - Basis of Presentation Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 211011022 - Disclosure - EID - Related Party Transactions (Notes) link:presentationLink link:calculationLink link:definitionLink 241024061 - Disclosure - EID - Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 211031023 - Disclosure - EID Segment FN (Notes) link:presentationLink link:calculationLink link:definitionLink 231043017 - Disclosure - EID Segment FN (Tables) link:presentationLink link:calculationLink link:definitionLink 241054062 - Disclosure - EID Segment FN Segment reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 241064063 - Disclosure - EID Segment FN Segment Asset Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 dd-20210331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 10 dd-20210331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 11 dd-20210331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Disclosure [Text Block] Related Party [Axis] Related Party [Axis] Interest Expense Interest and Debt Expense Other oilseeds [Member] Other oilseeds [Member] Other oilseeds [Member] Noncontrolling Interest [Table] Noncontrolling Interest [Table] Cash, Cash Equivalents and Restricted Cash at Beginning of Period Cash, Cash Equivalents and Restricted Cash at End of Period Cash, Cash Equivalents and Restricted Cash, Total Company Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Alabama Water Utility [Member] Alabama Water Utility [Member] Alabama Water Utility [Member] Proceeds from Sale and Maturities of Investments Proceeds from Sale and Maturity of Marketable Securities WEST VIRGINIA AND OHIO [Domain] Post-MDL Settlement PFOA Personal Injury Claims [Domain] Post-MDL Settlement PFOA Personal Injury Claims [Domain] Foreign Exchange Impact on Income (Loss) from Continuing Operations Foreign Exchange Impact on Income (Loss) from Continuing Operations Impact to pre-tax earnings as a result of the deterioration of the Peso to USD exchange rate Statistical Measurement [Domain] Statistical Measurement [Domain] Preferred Stock [Member] Preferred Stock [Member] Security Exchange Name Security Exchange Name Proceeds from debt Proceeds from Issuance of Long-term Debt Accounts and Notes Receivable [Abstract] Accounts and Notes Receivable [Abstract] Accounts and Notes Receivable [Abstract] Total current liabilities Liabilities, Current Restricted Cash and Cash Equivalents Items [Line Items] Restricted Cash and Cash Equivalents Items [Line Items] Variable Rate [Domain] Variable Rate [Domain] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Accounting Policies [Abstract] Accounting Policies [Abstract] Litigation Settlement, Medical Monitoring Program, Escrow Account, Disbursements To Date Litigation Settlement, Medical Monitoring Program, Escrow Account, Disbursements To Date Litigation Settlement, Medical Monitoring Program, Escrow Account, Disbursements To Date Subsidiary Monetary Position Subsidiaries [Member] Payment Timing [Domain] Payment Timing [Domain] [Domain] for Payment Timing [Axis] Restricted cash of discontinued operations Disposal group, Including Discontinued Operation, Restricted Cash Disposal Group, Including Discontinued Operation, Restricted Cash Other discontinued or divested business obligations [Member] Other discontinued or divested business obligations [Member] Other discontinued or divested business obligations [Member] Purchases from Historical Dow and affiliates Related Party Transaction, Purchases from Related Party Fair Value of Assets and Liabilities Measured on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Other Tax Benefit Other Tax Benefit Tax benefit associated with changes in accruals for certain prior year tax positions and reductions in the company's unrecognized tax benefits due to closure of various state statutes of limitations. Long-term Debt Long-term Debt and Lease Obligation Guarantee Obligations Guarantor Obligations, Maximum Exposure, Undiscounted Preferred Stock Preferred Stock, Value, Issued Deferred Revenue Deferred Revenue Diluted earnings per share of common stock from continuing operations Diluted earnings (loss) per share of common stock from continuing operations Income (Loss) from Continuing Operations, Per Diluted Share Crop Protection [Member] Crop Protection [Member] Crop Protection [Member] Share Count Information Share Count Information [Table Text Block] [Table Text Block] for Share Count Information [Table] Diluted loss per share of common stock from discontinued operations Diluted earnings (loss) per share of common stock from discontinued operations Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share Additional annual PFOA liabilities for the next five years paid by Chemours Additional annual PFOA liabilities for the next five years paid by Chemours Additional annual PFOA liabilities for the next five years paid by Chemours, up to $25 million per year. Building [Member] Building [Member] Once $300 million threshold is met [Member] Once $300 million threshold is met [Member] Once $300 million threshold is met [Member] Common Stock, Par Value Common Stock, Par or Stated Value Per Share Other noncurrent obligations Other Liabilities, Noncurrent Deferred Income Taxes Deferred Income Tax Assets, Net Operating Activities [Axis] Operating Activities [Axis] Factoring Agreement [Member] Factoring Agreement [Member] Factoring Agreement [Member] Document Information [Table] Document Information [Table] Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Segment Reconciling Items [Member] Segment Reconciling Items [Member] Inventories Inventory, Net Additional annual PFOA liabilities for the next five years paid by Corteva Additional annual PFOA liabilities for the next five years paid by Corteva Additional amounts EID will pay annually, if Chemours $25 million is exceeded. EID will pay excess up to the next $25 million, with Chemours annually bearing excess liabilities above that amount. Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Measurement Frequency [Domain] Measurement Frequency [Domain] Total Proceeds from Sale of Available-for-sale Securities Income from continuing operations after income taxes Income (loss) from continuing operations after income taxes Income (loss) from continuing operations after income taxes Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Germplasm [Member] Germplasm [Member] Germplasm [Member] Environmental Remediation Stray Liabilities [Axis] Environmental Remediation Stray Liabilities [Axis] Environmental Remediation Stray Liabilities [Axis] Statement [Line Items] Statement [Line Items] Current Portion [Member] Current Portion [Member] Current Portion [Member] Foreign Currency Transaction (Loss) Gain Tax (Expense) Benefit Foreign Currency Transaction Gain (Loss) Tax Foreign Currency Transaction Gain (Loss) Tax Foreign Currency Loans [Member] Foreign Currency Loans [Member] Foreign Currency Loans [Member] Class of Stock [Domain] Class of Stock [Domain] Long-term Debt, Weighted Average Interest Rate, at Point in Time Long-term Debt, Weighted Average Interest Rate, at Point in Time Tax Period [Axis] Tax Period [Axis] Debt Instrument, Term Debt Instrument, Term Loans, Notes, Trade and Other Receivables Disclosure [Text Block] Loans, Notes, Trade and Other Receivables Disclosure [Text Block] Statement [Table] Statement [Table] Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Write-offs charged against allowance Accounts Receivable, Allowance for Credit Loss, Writeoff Interest Cost Defined Benefit Plan, Interest Cost Type of Restructuring [Domain] Type of Restructuring [Domain] Statistical Measurement [Axis] Statistical Measurement [Axis] Performance Chemicals Performance Chemicals [Member] Performance Chemicals Entity Small Business Entity Small Business Latin America Latin America [Member] Ratio of Indebtedness to Net Capital Ratio of Indebtedness to Net Capital Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Debt Disclosure [Text Block] Debt Disclosure [Text Block] Restrictions on Cash and Cash Equivalents [Table] Restrictions on Cash and Cash Equivalents [Table] Amendment Flag Amendment Flag Company [Domain] Company [Domain] [Domain] for Company [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Derivative Liability, Counterparty and Cash Collateral Netting Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset Corporate Corporate, Non-Segment [Member] MDL Settlement [Domain] MDL Settlement [Member] MDL Settlement Indemnification Asset Indemnification Asset Indemnification asset for indemnified liabilities related to environmental remediation. Repayments of Related Party Debt Repayments of Related Party Debt Indemnified Liabilities for Liabilities Indemnified by Corteva Indemnified Liabilities for Liabilities Indemnified by Corteva Indemnified Liabilities for Liabilities Indemnified by Corteva associated with environmental remediation related to PFAS. Restructuring and Related Activities Disclosure [Text Block] Restructuring and Related Activities Disclosure [Text Block] Measurement Frequency [Axis] Measurement Frequency [Axis] Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] Balance Sheet [Member] Balance Sheet [Member] Balance Sheet [Member] Financial Instruments [Domain] Financial Instruments [Domain] Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Amount of gain (loss) recognized in Income - Pre-tax Derivative, Gain (Loss) on Derivative, Net Senior Notes Due 2025 [Member] Senior Notes Due 2025 [Member] Senior Notes Due 2025 [Member] Fair Value, 12 Months or Longer Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer Litigation Settlement, Liability For Medical Monitoring Program, Threshold Litigation Settlement, Liability For Medical Monitoring Program, Threshold Litigation Settlement, Liability For Medical Monitoring Program, Threshold Document and Entity Information [Abstract] Document and Entity Information [Abstract] Document and Entity Information [Abstract] Total Escrow Deposit Amount Total Escrow Deposit Amount From September 30, 2021 through September 30, 2028, Chemours will deposit a total of $500 million in the escrow account and DuPont and Corteva will deposit an additional $500 million pursuant to the terms of the Letter Agreement. Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Impairment of Intangible Assets Indefinite lived Excluding Goodwill After Tax Impairment of Intangible Assets Indefinite lived Excluding Goodwill After Tax Impairment of Intangible Assets Indefinite lived Excluding Goodwill After Tax Accounts Receivable, Allowance for Credit Loss, Current Accounts Receivable, Allowance for Credit Loss, Beginning Balance Accounts Receivable, Allowance for Credit Loss, Ending Balance Accounts Receivable, Allowance for Credit Loss, Current Income Statement Location [Domain] Income Statement Location [Domain] Environmental Remediation Stray Liabilities [Domain] Environmental Remediation Stray Liabilities [Domain] [Domain] for Environmental Remediation Stray Liabilities [Axis] Cash provided by financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Selling, General and Administrative Expenses Selling, General and Administrative Expense Foreign Currency Contract [Member] Foreign Exchange Contract [Member] Compensatory damages [Member] Compensatory damages [Member] Compensatory damages [Member] Customer-Related Intangible Assets [Member] Customer-Related Intangible Assets [Member] Other assets Other Assets, Noncurrent Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Stock Conversion Description [Axis] Stock Conversion Description [Axis] Total Assets Total Assets Assets Related Party Transactions Disclosure [Text Block] Related Party Transactions Disclosure [Text Block] Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges Net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting represents the non-cash net gain (loss) from the changes in fair value of certain undesignated foreign currency derivative contracts. Accelerated Prepaid Royalty Amortization Expense Accelerated Prepaid Royalty Amortization Expense Asset related cost for non-cash accelerated prepaid royalty amortization expense Corporate Segment Corporate Segment [Member] Scheduled for trial [Member] Scheduled for trial [Member] Scheduled for trial [Member] Entity Listing, Description Entity Listing, Description Amortization of Prior Service Benefit Defined Benefit Plan, Amortization of Prior Service Cost (Credit) PFOA Details [Abstract] PFOA Details [Abstract] PFOA Details [Abstract] Tax charge related to U.S. state blended tax rate changes associated with the Internal Reorganizations Tax charge related to U.S. state blended tax rate changes associated with the Business Separations Tax charge related to U.S. state blended tax rate changes associated with the Business Separations. Cost of Goods Sold Cost of Sales [Member] Environmental Remediation Site [Domain] Environmental Remediation Site [Domain] Natural Resources Damages [Member] Natural Resources Damages [Member] Natural Resources Damages [Member] Other Intangible Assets [Member] Other Intangible Assets [Member] Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] Asset Related Charges [Member] Asset Related Charges [Member] Asset Related Charges Retirement Plan Type [Axis] Retirement Plan Type [Axis] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Stock by Class [Table Text Block] Schedule of Stock by Class [Table Text Block] ECP Disposal [Member] ECP Disposal [Member] ECP Disposal [Member] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Fair Value, Inputs, Level 1 Fair Value, Inputs, Level 1 [Member] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Inventories Increase (Decrease) in Inventories Debt, Weighted Average Interest Rate Debt, Weighted Average Interest Rate Notes Maturing 2025 [Domain] Notes Maturing 2025 [Domain] Notes Maturing 2025 [Domain] Other Assets and Liabilities Increase (Decrease) in Other Operating Assets and Liabilities, Net Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Preferred Stock Dividends and Other Adjustments Preferred Stock Dividends and Other Adjustments Total inventories Inventory, Gross Schedule of Other Nonoperating Income (Expense) Schedule of Other Nonoperating Income (Expense) [Table Text Block] Revenue Recognition, Sales of Goods Revenue Recognition, Sales of Goods [Policy Text Block] Basic earnings per share of common stock from continuing operations Basic earnings (loss) per share of common stock from continuing operations Income (Loss) from Continuing Operations, Per Basic Share Machinery and Equipment [Member] Machinery and Equipment [Member] Other Intangible Assets Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block] Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite or indefinite life, by either major class or business segment. Common Stock, Shares, Outstanding Common Stock, Shares, Outstanding Investments in nonconsolidated affiliates Equity Method Investments Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Income from continuing operations before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Short-term Debt [Line Items] Short-term Debt [Line Items] Soybean [Member] Soybean [Member] Soybean [Member] Cash Equivalents [Member] Cash Equivalents [Member] Argentine peso devaluation Argentine peso devaluation Argentine peso devaluation Actuarial (Gains) Losses Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member] Accounting Changes and Error Corrections [Abstract] Accounting Changes and Error Corrections [Abstract] Common Stock, Shares Authorized Common Stock, Shares Authorized Property, Plant and Equipment, Gross Property, Plant and Equipment, Gross Proceeds from Exercise of Stock Options Proceeds from Stock Options Exercised Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of Segment Reporting Information, by Segment [Table Text Block] Indemnified Liabilities for liabilities indemnified by Chemours Indemnified Liabilities for liabilities indemnified by Chemours Indemnified Liabilities for liabilities indemnified by Chemours against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the spin-off of Chemours. Defined Benefit Plan, Funded (Unfunded) Status of Plan Defined Benefit Plan, Funded (Unfunded) Status of Plan Guarantor Obligations, Nature [Axis] Guarantor Obligations, Nature [Axis] Income Statement [Abstract] Income Statement [Abstract] Accumulated Other Comp (Loss) Income Total AOCI Attributable to Parent [Member] Contractual Maturities of Debt Securities Investments Classified by Contractual Maturity Date [Table Text Block] Herbicides [Member] Herbicides [Member] Herbicides [Member] Favorable Supply Contract [Member] Favorable Supply Contract [Member] Favorable Supply Contract [Member] Lawsuits alleging personal injury filed Lawsuits alleging personal injury filed Lawsuits alleging personal injury which were filed. Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Income Tax Authority [Domain] Income Tax Authority [Domain] Defined Benefit Plans and Other Postretirement Benefit Plans [Axis] Defined Benefit Plans and Other Postretirement Benefit Plans [Axis] Information by defined benefits pension or other postretirement plan or groupings of similar plans. Asset write-offs and adjustments Asset write-offs and adjustments Noncash activity affecting the restructuring reserve related to asset write-offs and adjustments. Consolidated Entities [Axis] Consolidated Entities [Axis] Other [Member] Other [Member] Other [Member] Restructuring and Asset related charges, net Restructuring and Asset related charges, net Amount of restructuring charges, remediation cost, asset impairment loss and other asset related charges. Scenario [Domain] Scenario [Domain] Counterparty Name [Domain] Counterparty Name [Domain] Consolidation Items [Domain] Consolidation Items [Domain] Binding Settlement Agreement Class Size Binding Settlement Agreement Class Size Binding settlement agreement, class size Interest Expense, Related Party Interest Expense, Related Party Intangible Assets Disclosure [Text Block] Goodwill and Intangible Assets Disclosure [Text Block] Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Equity in earnings / (losses) of affiliates - net Income (Loss) from Equity Method Investments Hedging Designation [Axis] Hedging Designation [Axis] Schedule of Guarantor Obligations [Table] Schedule of Guarantor Obligations [Table] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Schedule of Inventory, Current [Table Text Block] Schedule of Inventory, Current [Table Text Block] Agreements with lenders to provide financing for select customers [Member] Agreements with lenders to provide financing for select customers [Member] Agreements with lenders to provide financing for select customers [Member] Entity [Domain] Entity [Domain] De minimis threshold De minimis threshold De minimis requirement for which certain stray liabilities will be subject to for sharing arrangement between DuPont and Corteva. Deferred revenue recognized during the period Deferred Revenue, Revenue Recognized Designated as Hedging Instrument [Member] Designated as Hedging Instrument [Member] Rounded Amount [Member] Rounded Amount [Member] Rounded Amount Chemours related obligation subject to indemnification [Member] Chemours related obligation subject to indemnification [Member] Chemours related obligation subject to indemnification [Member] Property, Plant and Equipment, Useful Life Property, Plant and Equipment, Useful Life Loans Payable [Member] Loans Payable [Member] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Pension and OPEB Contributions Payment for Pension Benefits Income Statement [Member] Income Statement [Member] Income Statement [Member] Deferred Revenue Increase (Decrease) in Deferred Revenue Subsegments Consolidation Items [Axis] Subsegments Consolidation Items [Axis] Revolving Credit Facilities due 2024 [Member] Revolving Credit Facilities due 2024 [Member] Revolving Credit Facilities due 2024 [Member] Available - for- sale securities Debt Securities, Available-for-sale Debt Securities, Available-for-sale Settled Litigation Settled Litigation [Member] Cost Sharing Arrangement Term Cost Sharing Arrangement Term Term of cost sharing arrangement under the MOU. Senior Notes Due 2030 [Member] Senior Notes Due 2030 [Member] Senior Notes Due 2030 [Member] Accounts Receivable, Allowance for Credit Loss [Table Text Block] Accounts Receivable, Allowance for Credit Loss [Table Text Block] Consolidated Entities [Domain] Consolidated Entities [Domain] Short-term Debt, Weighted Average Interest Rate, at Point in Time Short-term Debt, Weighted Average Interest Rate, at Point in Time Merger with Dow [Member] Merger with Dow [Member] Merger with Dow [Member] Amount credited to each company's threshold Amount credited to each company's threshold Amount credited to each company's threshold for PFAS costs shared between DuPont and Corteva. Schedule of Short-term Debt [Table] Schedule of Short-term Debt [Table] Effect of Derivatives Derivative Instruments, Gain (Loss) [Table Text Block] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Fair Value Disclosures [Text Block] Fair Value Disclosures [Text Block] Derivative Asset, Gross Derivative Asset Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement Qualified Spend and Escrow Account Contribution Threshold Qualified Spend and Escrow Account Contribution Threshold Qualified Spend and Escrow Account Contribution Threshold Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Land Improvements [Member] Land Improvements [Member] Entity Registrant Name Entity Registrant Name Securities Sold under Agreements to Repurchase [Member] Securities Sold under Agreements to Repurchase [Member] Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] Contract Termination Contract Termination [Member] Total company [Member] Total company [Member] Total company [Member] CTVA Related Party Liability CTVA Related Party Liability Payables to Corteva, Inc. related to Corteva's indemnification liabilities to Dow and DuPont per the Separation Agreements. Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Other Comprehensive Income Location [Axis] Other Comprehensive Income Location [Axis] Restructuring Reserve Restructuring Reserve, Beginning Balance Restructuring Reserve, Ending Balance Restructuring Reserve Entity Address, Postal Zip Code Entity Address, Postal Zip Code Tax (Expense) Benefit of Other Comprehensive (Loss) Income Comprehensive Income (Loss) [Table Text Block] Other Asset Related [Member] Other Asset Related [Member] Other Asset Related Restructuring Type [Axis] Restructuring Type [Axis] Other Tax Expense (Benefit) Other Tax Expense (Benefit) Goodwill Goodwill Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-sale [Line Items] Indemnification Asset for liabilities indemnified by Chemours Indemnification Assets for liabilities indemnified by Chemours Indemnification asset for liabilities indemnified by Chemours against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the spin-off of Chemours. Common Stock, Dividends, Per Share, Declared Common Stock, Dividends, Per Share, Declared Other current assets Other Assets, Current Interest rate in addition to LIBOR Interest rate in addition to LIBOR Interest rate in addition to LIBOR on borrowings under the repurchase facility Assets at Fair Value Assets, Fair Value Disclosure Equity [Abstract] Equity [Abstract] EMEA EMEA [Member] Commodity Contract Asset, Current Commodity Contract Asset, Current Debt Securities, Held-to-maturity [Table] Debt Securities, Held-to-maturity [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Entities [Table] Entities [Table] Derivative Contract [Domain] Derivative Contract [Domain] Weighted Average Common Shares - diluted Weighted Average Number of Shares Outstanding, Diluted Trade receivables sold the remain outstanding with an element of recourse Continuing Involvement with Derecognized Transferred Financial Assets, Amount Outstanding Conversion of Stock, Name [Domain] Conversion of Stock, Name [Domain] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Inventory, Current [Table] Inventory, Current [Table] Foreign Currency Transaction Type [Axis] Foreign Currency Transaction Type [Axis] Foreign Currency Transaction Type [Axis] Restructuring Plan [Axis] Restructuring Plan [Axis] Cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Payments on Debt Repayments of Long-term Debt Repayments of Long-term Debt Short-term Debt, Type [Axis] Short-term Debt, Type [Axis] Revenue, Remaining Performance Obligation, Amount Revenue, Remaining Performance Obligation, Amount Counterparty Name [Axis] Counterparty Name [Axis] Common stock Common Stock, Value, Issued Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block] Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block] Revenue Recognition, Licenses of Intellectual Property Revenue Recognition, Services, Licensing Fees [Policy Text Block] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Document Fiscal Year Focus Document Fiscal Year Focus Pre-tax amortization expense, 2023 Finite-Lived Intangible Asset, Expected Amortization, Year Two Long-term Debt Payable within one year Long-term Debt, Current Maturities Entity Current Reporting Status Entity Current Reporting Status Available-for-sale Securities Available-for-sale Securities [Member] Short-term borrowings and finance lease obligations Debt, Current Restructuring and Related Cost, Expected Cost Restructuring and Related Cost, Expected Cost Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Type of Disclosure [Domain] Type of Disclosure [Domain] [Domain] for Type of Disclosure [Axis] Impact of Internal Reorganizations Stockholders' Equity Note, Spinoff Transaction Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Corteva [Member] Corteva [Member] Corteva [Member] Document [Domain] Document [Domain] Common Stock, Shares, Issued Common Stock, Shares, Issued Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Seed [Member] Seed [Member] Seed [Member] Deferred Tax Liabilities, Net Deferred Tax Liabilities, Net Segment Reporting [Abstract] Segment Reporting [Abstract] Accounts Receivable, after Allowance for Credit Loss Accounts Receivable, after Allowance for Credit Loss Geography [Domain] Location [Domain] Debt Instrument [Line Items] Debt Instrument [Line Items] Other loans - various currencies [Member] Other loans - various currencies [Member] Other loans - various currencies [Member] Total stockholders' equity attributable to the company Stockholders' Equity Attributable to Parent Derivative Asset, Counterparty and Cash Collateral Netting Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset Entity Address, City or Town Entity Address, City or Town Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Indemnification Assets Indemnification Assets Indemnification asset for liabilities indemnified against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the spin-off of Corteva. Other Assets [Member] Other Assets [Member] Financial Instrument [Axis] Financial Instrument [Axis] Noncontrolling Interest in Joint Ventures Noncontrolling Interest in Joint Ventures Provision for Deferred Income Tax Deferred Income Tax Expense (Benefit), Continuing Operations and Discontinued Operations Deferred Income Tax Expense (Benefit), Continuing Operations and Discontinued Operations Stray liability threshold Stray liability threshold Amount over and above specified amounts of liability, for which Corteva and DuPont are responsible for strays. Revolving Credit Facilities due 2022 [Member] Revolving Credit Facilities due 2022 [Member] Revolving Credit Facilities due 2022 [Member] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested After-Tax Effect of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Dividends paid to stockholders Payments of Dividends Loss Contingency, Claims Settled, Number Loss Contingency, Claims Settled, Number Tax benefit related to the enactment of the Swiss Tax Reform Tax benefit related to the enactment of the Swiss Tax Reform Tax benefit related to the enactment of the Swiss Tax Reform Total assets of discontinued operations Disposal Group, Including Discontinued Operation, Assets Pre-tax amortization expense, 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Three Construction in Progress [Member] Construction in Progress [Member] Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Potential shares of common stock excluded from EPS calculations Stock options and restricted stock units excluded from EPS Outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units that were excluded from the calculation of diluted EPS because the effect of including them would have been anti-dilutive. Total other comprehensive loss Other comprehensive (loss) income Other Comprehensive Income (Loss), Net of Tax Semi-finished Products Inventory, Work in Process, Gross Tax benefit (charge) related to application of the Act's foreign tax provisions Tax benefit (charge) related to application of the Act's foreign tax provisions Tax benefit (charge) related to application of the Act's foreign tax provisions Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Total current assets Assets, Current Comprehensive Income Attributable to Noncontrolling Interest - Net of Tax Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Earnings Per Share [Abstract] Earnings Per Share [Abstract] Income Tax Authority, Name [Axis] Income Tax Authority, Name [Axis] La Porte [Member] La Porte [Member] La Porte [Member] Amortization of Prior Service Benefit Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Indemnified Liabilities Indemnified Liabilities Indemnified Liabilities for liabilities indemnified by Corteva against certain litigation, environmental, workers compensation and other liabilities that arose prior to the spin-off of Corteva. Percentage deterioration of the official Peso to USD exchange rate Percentage deterioration of the official Peso to USD exchange rate Increase of deterioration in the official Peso to USD exchange rate which would cause a reduction in net monetary assets and negatively impact pre-tax earnings. Accumulated Defined Benefit Plans Adjustment Attributable to Parent Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Disposal Group Name [Domain] Disposal Group Name [Domain] Derivative, Remaining Maturity Derivative, Remaining Maturity Schedule of Noncontrolling Interests Represented by Preferred Stock [Table Text Block] Schedule of Noncontrolling Interests Represented by Preferred Stock [Table Text Block] Schedule of Noncontrolling Interests Represented by Preferred Stock [Table Text Block] Pre-tax amortization expense, 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Five Document Fiscal Period Focus Document Fiscal Period Focus Schedule of Additional Segment Details [Table Text Block] Schedule of Additional Segment Details [Table Text Block] Schedule of Additional Segment Details [Table Text Block] Exchange Ratio Exchange Ratio Exchange Ratio Stray liability sharing percentage Stray liability sharing percentage Stray liability sharing percentage Diluted earnings (loss) per share of common stock Net Income (Loss) Available to Common Stockholders, Diluted Method of Disaggregation [Axis] Method of Disaggregation [Axis] Method of Disaggregation [Axis] Entity Filer Category Entity Filer Category Common Stock [Member] Common Stock [Member] Cumulative Translation Adjustment Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Product and Service [Domain] Product and Service [Domain] Reclassification out of Accumulated Other Comprehensive (Loss) Income [Table Text Block] Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Other Commitments [Axis] Other Commitments [Axis] Other Income - net Other Nonoperating Income (Expense) [Member] Unusual or Infrequent Item, or Both [Domain] Unusual or Infrequent Item, or Both [Domain] Debt Instrument, Interest Rate, Stated Percentage Debt Instrument, Interest Rate, Stated Percentage Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Other income - net Nonoperating Income (Expense) Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Dividends, Preferred Stock Dividends, Preferred Stock Public Utility [Axis] Public Utility [Axis] Subsegments Consolidation Items [Domain] Subsegments Consolidation Items [Domain] Derivative Liability, Gross Derivative Liability Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement Cumulative Translation Adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Severance and Related Benefit Costs Employee Severance [Member] Ownership [Domain] Ownership [Domain] Internal Reorganization [Member] Internal Reorganization [Member] Internal Reorganization [Member] Tax Period [Domain] Tax Period [Domain] Corporate Assets Corporate Assets Corporate Assets Total Equity Beginning Balance Ending Balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Additional Paid in Capital Additional Paid in Capital Pre-tax amortization expense, 2022 Finite-Lived Intangible Asset, Expected Amortization, Year One Net Sales Revenues Class of Stock [Axis] Class of Stock [Axis] EID - Basis of Presentation [Abstract] EID - Basis of Presentation [Abstract] EID - Basis of Presentation [Abstract] Liabilities at Fair Value Financial and Nonfinancial Liabilities, Fair Value Disclosure Percentage of outstanding amounts borrowed utilized as collateral Percentage of outstanding amounts borrowed utilized as collateral Percentage of outstanding amounts borrowed utilized as collateral Accrued and other current liabilities Accrued Liabilities, Current Schedule of Environmental Loss Contingencies by Site [Table Text Block] Schedule of Environmental Loss Contingencies [Table Text Block] Tabluar disclosure of environmental loss contingencies. Does not include loss contingencies that are not environmental in nature. Diluted earnings per share of common stock Earnings Per Share, Diluted Proceeds from sales of available-for-sale securities Proceeds from Sale of Debt Securities, Available-for-sale Schedule of Short-term Debt [Table Text Block] Schedule of Short-term Debt [Table Text Block] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Noncontrolling Interest [Line Items] Noncontrolling Interest [Line Items] Fungicides [Member] Fungicides [Member] Fungicides [Member] Net Periodic Pension and OPEB benefit, net Pension Expense (Reversal of Expense), Noncash Schedule of Long-term Debt Instruments [Table Text Block] Schedule of Long-term Debt Instruments [Table Text Block] Depreciation expense Depreciation Entity Address, Address Line One Entity Address, Address Line One Investments, All Other Investments [Abstract] Investments, All Other Investments [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Indefinite-lived Intangible Assets (Excluding Goodwill) Indefinite-lived Intangible Assets (Excluding Goodwill) Proceeds from Dividends Received Proceeds from Dividends Received Utility Plant [Domain] Utility Plant [Domain] Due from Affiliates Due from Affiliates Firefighting Foam [Member] Firefighting Foam [Member] Firefighting Foam [Member] Property, Plant and Equipment - Depreciation Expense [Table Text Block] Property, Plant and Equipment - Depreciation Expense [Table Text Block] Property, Plant and Equipment - Depreciation Expense [Table Text Block] Net income (loss) Attributable to Noncontrolling Interest, Continuing Operations Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest Finite-Lived Intangible Assets, Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Maximum [Member] Maximum [Member] Preferred Stock, Shares Authorized Preferred Stock, Shares Authorized Noncontrolling Interest [Member] Noncontrolling Interest [Member] Foreign Exchange Foreign Exchange [Member] Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block] Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block] Distributions to DowDuPont Payments of Distributions to Affiliates Specialty Products Disposal [Member] Specialty Products Disposal [Member] Specialty Products Disposal [Member] Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Foreign Currency Transaction (Loss) Gain After Tax Foreign Currency Transaction Gain (Loss) After Tax Foreign Currency Transaction Gain (Loss) After Tax Investments [Domain] Investments [Domain] Other Benefit Plans Other Benefit Plans Other Postretirement Benefits Plan [Member] Trading Symbol Trading Symbol Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Annual Escrow Deposit Annual Escrow Deposit No later than each of September 30, 2021 and September 30, 2022, Chemours shall deposit $100 million into an escrow account and DuPont and Corteva shall together deposit $100 million in the aggregate into an escrow account. Disposal Group Classification [Domain] Disposal Group Classification [Domain] Restructuring and Asset Related Charges - Net Restructuring, Settlement and Impairment Provisions Cash Flow [Member] Cash Flow [Member] Cash Flow [Member] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Entity Shell Company Entity Shell Company Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Fair Value, Recurring [Member] Fair Value, Recurring [Member] Accounts and notes receivable - trade Accounts and notes receivable - trade Accounts and notes receivable - trade (does not include Other AR), net of allowance for doubtful accounts Document Type Document Type Treasury Stock [Member] Treasury Stock [Member] Segments [Axis] Segments [Axis] Pension and Other Postretirement Benefits Disclosure [Text Block] Retirement Benefits [Text Block] Derivatives Instruments Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] In Process Research and Development [Member] In Process Research and Development [Member] Additions and revaluations of derivatives designated as cash flow hedges Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Guarantor Obligations, Nature [Domain] Guarantor Obligations, Nature [Domain] Other Current Assets [Member] Other Current Assets [Member] Derivative Asset, Net Derivative Asset Debt Securities, Available-for-Sale with contractual maturities within one to five years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Deferred income tax liabilities Deferred Income Tax Liabilities, Net Other intangible assets Total other intangible assets Intangible Assets, Net (Excluding Goodwill) DowDuPont [Member] DowDuPont [Member] DowDuPont [Member] 2021 Restructuring Actions [Domain] 2021 Restructuring Actions [Domain] 2021 Restructuring Actions Trademarks and Trade Names [Member] Trademarks and Trade Names [Member] Deferred Revenue, Current Deferred Revenue, Current DuPont de Nemours [Member] DuPont de Nemours [Member] DuPont de Nemours [Member] Corteva [Domain] Corteva [Domain] Corteva [Domain] Contract Balances Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Variable Rate [Axis] Variable Rate [Axis] Repurchase of Common Stock Repurchase of Common Stock Payments for Repurchase of Common Stock Accounts and Notes Receivable [Member] Accounts and Notes Receivable [Member] Accounts and Notes Receivable [Member] Entity Address, State or Province Entity Address, State or Province Accounts payable Accounts Payable, Current Corn [Member] Corn [Member] Corn [Member] Retained earnings / (accumulated deficit) Retained Earnings (Accumulated Deficit) Loss on Extinguishment of Debt Gain (Loss) on Extinguishment of Debt Payments for Legal Settlements Payments for Legal Settlements DuPont de Nemours and Corteva Contribution to MDL Settlement DuPont de Nemours and Corteva Contribution to MDL Settlement [Member] DuPont de Nemours and Corteva Contribution to MDL Settlement Amount of gain (loss) recognized in income - pre-tax Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Hedging Designation [Domain] Hedging Designation [Domain] Business Combination, Fair Value Step Up Of Acquired Inventory Business Combination, Fair Value Step Up Of Acquired Inventory Business Combination, Fair Value Step Up Of Acquired Inventory Other investing activities - net Payments for (Proceeds from) Other Investing Activities Acquired Finite-Lived Intangible Assets [Line Items] Acquired Finite-Lived Intangible Assets [Line Items] Pro forma adjustments Pro forma adjustments Pro forma adjustments Share-based compensation APIC, Share-based Payment Arrangement, Increase for Cost Recognition Asset Retirement Obligation Asset Retirement Obligation North America North America [Member] Inventory [Line Items] Inventory [Line Items] Lender Name [Axis] Lender Name [Axis] Business Acquisition [Axis] Business Acquisition [Axis] Geographical [Domain] Geographical [Domain] Settlement/Curtailment Loss (Gain) Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement $4.50 Series Preferred Stock [Member] $4.50 Series Preferred Stock [Member] $4.50 preferred stock [Member] Beginning Balance Ending Balance Cash Flow Hedges Derivative Instruments at Fair Value, Net Forecast [Member] Forecast [Member] Unrealized Gain (Loss) on Investments Unrealized Gain (Loss) on Investments Credit Facility [Axis] Credit Facility [Axis] Preferred Stock, Shares Issued Preferred Stock, Shares Issued Fair Value of Derivatives Instruments Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block] Net (Loss) Income from Discontinued Operations Available to Common Shareholders Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic DowDuPont Cost Synergy Program [Member] DowDuPont Cost Synergy Program [Member] DowDuPont Cost Synergy Program [Member] Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Major Product Line [Member] Major Product Line [Member] Major Product Line [Member] Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] PFOA Matters: Drinking Water Actions [Member] PFOA Matters: Drinking Water Actions [Member] PFOA Matters: Drinking Water Actions [Member] Net income (loss) from Continuing Operations Available to Common Shareholders Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic and Diluted Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders. Long-term Line of Credit Long-term Line of Credit Cash used for operating activities Net Cash Provided by (Used in) Operating Activities Entity Central Index Key Entity Central Index Key Related Party [Domain] Related Party [Domain] Computer Software, Intangible Asset [Member] Computer Software, Intangible Asset [Member] Escrow Account Deposit Percentage Escrow Account Deposit Percentage Percentage of deposits to be made to the escrow account as part of the cost sharing agreement under the MOU. Related Party Transaction [Line Items] Related Party Transaction [Line Items] Derivative Instrument [Axis] Derivative Instrument [Axis] Ownership interest in an entity Ownership interest in an entity Ownership interest in an entity Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Foreign Currency Exchange Gain (Loss) [Line Items] Foreign Currency Exchange Gain (Loss) [Line Items] [Line Items] for Foreign Currency Exchange Gain (Loss) [Table] Other noncurrent obligations Other Noncurrent Liabilities [Member] Loss Contingency, Number of Additional Plaintiffs Loss Contingency, Number of Additional Plaintiffs Loss Contingency, Number of Additional Plaintiffs Escrow Balance Escrow Deposit Geographical [Axis] Geographical [Axis] Reclassification from Accumulated Other Comprehensive Loss, Current Period, Tax Reclassification from AOCI, Current Period, Tax Segments [Domain] Segments [Domain] Pledged Financial Instruments, Not Separately Reported, Loans Receivable Pledged as Collateral Pledged Financial Instruments, Not Separately Reported, Loans Receivable Pledged as Collateral Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Costs Associated with Exit and Disposal Activities Costs Related To Contract Termination [Member] Costs Related To Contract Termination [Member] Income Statement Location [Axis] Income Statement Location [Axis] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Hedging Program Gain (Loss) Type [Axis] Hedging Program Gain (Loss) Type [Axis] Hedging Program Gain (Loss) Type Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax Derivative, Notional Amount Derivative, Notional Amount Amortization of Intangibles Amortization expense Amortization of Intangible Assets Segment operating EBITDA Segment operating EBITDA Segment operating EBITDA Line of Credit Facility [Table] Line of Credit Facility [Table] Marketable Securities Short Term Investments, Fair Value Disclosure Short Term Investments, Fair Value Disclosure Segment Reporting Disclosure [Text Block] Segment Reporting Disclosure [Text Block] Accounts and notes receivable - net Receivables, Net, Current Scenario [Axis] Scenario [Axis] Title of 12(b) Security Title of 12(b) Security Disposal Group Classification [Axis] Disposal Group Classification [Axis] Income (loss) from discontinued operations before income taxes Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax Tax benefit related to an elective change in accounting method for the impact of the Act's foreign tax provisions Tax benefit related to an elective change in accounting method for the impact of the Act's foreign tax provisions Tax benefit related to return to accrual adjustment associated with elective change in accounting method for 2019 tax year impact of The Act's foreign tax provisions. Finite-Lived Intangible Assets, Net Finite-Lived Intangible Assets, Net Income Taxes Payable Accrued Income Taxes, Current Accounts Payable, Related Parties Accounts Payable, Related Parties Disease Categories for MDL Disease Categories for MDL Disease Categories for MDL Non-operating benefits - net Non-operating (benefits) costs - net Non-operating (benefits) costs - net Other-net Stockholders' Equity, Other Depreciation and Amortization Depreciation, Depletion and Amortization Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners Discontinued Operations [Member] Discontinued Operations [Member] Environmental Remediation Site [Axis] Environmental Remediation Site [Axis] Product and Service [Axis] Product and Service [Axis] Investment Type [Axis] Investment Type [Axis] Cash and cash equivalents of discontinued operations Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents Asset Retirement Obligation Costs [Member] Asset Retirement Obligation Costs [Member] Other Comprehensive Income Location [Domain] Other Comprehensive Income Location [Domain] Basic earnings (loss) per share of common stock Net Income (Loss) Available to Common Stockholders, Basic Land and Land Improvements [Member] Land and Land Improvements [Member] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Long Term Debt - Related Party Notes Payable, Related Parties, Noncurrent Accounts Payable Increase (Decrease) in Accounts Payable Basic loss per share of common stock from discontinued operations Basic earnings (loss) per share of common stock from discontinued operations Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share Debt Instrument [Axis] Debt Instrument [Axis] Amortization of inventory step up included in COGS Business Combination, Fair Value Step-Up Of Acquired Inventory, Amount recognized in Cost of Goods sold Business Combination, Fair Value Step-Up Of Acquired Inventory, Amount recognized in Cost of Goods sold Defined Benefit Plan Remeasurement Impact Underfunded Status Defined Benefit Plan Remeasurement Impact Underfunded Status Defined Benefit Plan Remeasurement Impact Underfunded Status Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Class of Stock [Line Items] Class of Stock [Line Items] Repurchase of common stock Treasury Stock, Value, Acquired, Cost Method PFOA Matters [Member] PFOA Matters [Member] PFOA Matters [Member] Derivative Liability, Net Derivative Liability Litigation Case [Axis] Litigation Case [Axis] Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Entity Information [Line Items] Entity Information [Line Items] Repurchase Agreements [Member] Repurchase Agreements [Member] Operating Activities [Domain] Operating Activities [Domain] Other deductions against allowance Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) Tax benefit related to the impact of recent tax law enactment in foreign jurisdictions Tax benefit related to the impact of recent tax law enactment in foreign jurisdictions Tax benefit related to accrual adjustment to reflect change in estimate on impact of tax law enactment in a foreign jurisdiction. Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Research and Development Expense Research and Development Expense OHIO OHIO Schedule of Realized Gains (Losses) Schedule of Realized Gain (Loss) [Table Text Block] Restructuring Plan [Domain] Restructuring Plan [Domain] NEW YORK NEW YORK Notes Maturing 2030 [Domain] Notes Maturing 2030 [Domain] Notes Maturing 2030 [Domain] Interest income Interest Income, Operating Gain (Loss) on Disposition of Assets Loss on Divestiture Gain (Loss) on Disposition of Assets Pre-tax amortization expense, 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Four NORTH CAROLINA NORTH CAROLINA Loss Contingency, Number Of Water Districts Receiving Water Treatment Loss Contingency, Number Of Water Districts Receiving Water Treatment Loss Contingency, Number Of Water Districts Receiving Water Treatment Adjustments to benefit plans Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Amount of (loss) gain recognized in OCI- Pre Tax Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax NEW JERSEY NEW JERSEY Corteva and DuPont stray liability threshold for PFAS Corteva and DuPont stray liability threshold for PFAS Amount by which DuPont and Corteva will share PFAS costs. After threshold is exceeded, companies will share proportionally on basis of 29% (Corteva) and 71% (DuPont). Net loss (gain) on sales of property, businesses, consolidated companies, and investments Net gain on sales of property, businesses, consolidated companies, and investments Gain (loss) from sale or disposal of an organization or integrated set of activities (for example, but not limited to, a partnership or corporation) engaged in providing a product or service in a commercial, industrial, or professional environment. Also includes amount of gain (loss) on sale or disposal of assets, including but not limited to property, plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee. Subsegments [Domain] Subsegments [Domain] Comprehensive Income (Loss) Attributable to Corteva Comprehensive Income (Loss), Net of Tax, Attributable to Parent EID - Related Party Transactions [Abstract] EID - Related Party Transactions [Abstract] EID - Related Party Transactions [Abstract] Asia Pacific Asia Pacific [Member] City Area Code City Area Code Legal Entity [Axis] Legal Entity [Axis] Income Tax Authority [Axis] Income Tax Authority [Axis] Document Period End Date Document Period End Date Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Shares of DowDuPont Common Stock Held [Member] Shares of DowDuPont Common Stock Held [Member] Shares of DowDuPont Common Stock Held [Member] Net Investment Hedging [Member] Net Investment Hedging [Member] Superfund Sites [Member] Superfund Sites [Member] Superfund Sites [Member] Preferred Stock, Par Value Preferred Stock, No Par Value Gain (Loss) on Derivative Instruments, Net, Pretax Gain (Loss) on Derivative Instruments, Net, Pretax Stock Repurchase Program, Authorized Amount Stock Repurchase Program, Authorized Amount Net income Net income Net income (loss) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Amounts Reclassified from Accumulated Other Comprehensive Loss Amounts Reclassified from Accumulated Other Comprehensive Loss Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Schedule of Held-to-maturity Securities [Line Items] Schedule of Held-to-maturity Securities [Line Items] Gross realized losses Available-for-sale Securities, Gross Realized Losses Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Net change in borrowings (less than 90 days) Proceeds from (Repayments of) Short-term Debt Capital expenditures Payments to Acquire Productive Assets Other financing activities Proceeds from (Payments for) Other Financing Activities Chemours Contribution to MDL Settlement Chemours Contribution to MDL Settlement [Member] Chemours Contribution to MDL Settlement PFOA Matters: Multi-District Litigation [Member] PFOA Matters: Multi-District Litigation [Member] PFOA Matters: Multi-District Litigation [Member] Integration and Separation Costs Business Combination, Integration And Separation Related Costs Integration and separation costs includes costs incurred to prepare for and close the Merger, post-Merger integration expenses and costs incurred to prepare for the Intended Business Separations. These costs primarily consist of financial advisory, information technology, legal, accounting, consulting and other professional advisory fees associated with preparation and execution of these activities. Stock Repurchased and Retired During Period, Shares Stock Repurchased and Retired During Period, Shares Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Loss on Sale of Accounts Receivable Gain (Loss) on Sale of Accounts Receivable Miscellaneous expenses - net Miscellaneous income and expenses, net Miscellaneous income and expenses, net Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont [Member] Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont [Member] Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont [Member] Service Cost Defined Benefit Plan, Service Cost Other discontinued operations [Member] Other discontinued operations [Member] Other discontinued operations [Member] Medium-term Notes [Member] Medium-term Notes [Member] Cost of Goods Sold Cost of Goods and Services Sold Equity Components [Axis] Equity Components [Axis] Loss Contingency, Pending Claims, Number Loss Contingency, Pending Claims, Number Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Receivables [Abstract] Receivables [Abstract] Minimum [Member] Minimum [Member] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Type of Disclosure [Axis] Type of Disclosure [Axis] Type of Disclosure [Axis] Income Tax Authority, Name [Domain] Income Tax Authority, Name [Domain] Net income attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Amortization of unrecognized loss (gain) Defined Benefit Plan, Amortization of Gain (Loss) Contract assets - noncurrent Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent Income from Continuing Operations After Taxes Income from Continuing Operations After Taxes Income from Continuing Operations After Taxes Income from Continuing Operations After Taxes Entity Interactive Data Current Entity Interactive Data Current Defined Benefit Plan, Net Periodic Benefit (Credit) Cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Restrictions on Cash and Cash Equivalents Restrictions on Cash and Cash Equivalents [Table Text Block] Cash used for operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Stockholders' Equity Note Disclosure [Text Block] Stockholders' Equity Note Disclosure [Text Block] Recoveries collected Financing Receivable, Allowance for Credit Loss, Recovery Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table Text Block] Commodity Contract [Member] Commodity Contract [Member] Pre-tax amortization expense, remainder of 2021 Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Unusual or Infrequent Item, or Both [Axis] Unusual or Infrequent Item, or Both [Axis] Litigation Settlement, Amount Awarded to Other Party Litigation Settlement, Amount Awarded to Other Party Derivative [Table] Derivative [Table] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Intangible Assets, Gross (Excluding Goodwill) Intangible Assets, Gross (Excluding Goodwill) Loss Contingency, Limited Sharing of Potential Future Liabilities, Period Loss Contingency, Limited Sharing of Potential Future Liabilities, Period Loss Contingency, Limited Sharing of Potential Future Liabilities, Period Retirement Plan Type [Domain] Retirement Plan Type [Domain] PFAS [Member] PFAS [Member] PFAS [Member] Borrowing rate term Borrowing rate term Period of time elected for interest rate on borrowing under Revolving Credit Facility Hedging Program Gain (Loss) Type [Domain] Hedging Program Gain (Loss) Type [Domain] Hedging Program Gain (Loss) Type After-tax net gain (loss) to be reclassified from AOCL into earnings over the next twelve months Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months Debt Instrument, Interest Rate, Effective Percentage Debt Instrument, Interest Rate, Effective Percentage Consolidation Items [Axis] Consolidation Items [Axis] Not Designated as Hedging Instrument [Member] Not Designated as Hedging Instrument [Member] Settlement Loss Accumulated Defined Benefit Plans Adjustment, Settlement Gain (Loss) [Member] Accumulated Defined Benefit Plans Adjustment, Settlement Gain (Loss) [Member] Accounts Receivable - trade Accounts Receivable, after Allowance for Credit Loss, Current Finished Products Inventory, Finished Goods, Gross Hedging Program [Member] Hedging Program [Member] Hedging Program [Member] Noncontrolling Interest [Abstract] Noncontrolling Interest [Abstract] Reclassification of Divisional Equity to APIC Adjustments to Additional Paid in Capital, Other Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] $3.50 Series Preferred Stock [Member] $3.50 Series Preferred Stock [Member] $3.50 Series Preferred Stock [Member] Escrow Account Balance Escrow Account Balance Amount by which if escrow is below, on December 31, 2028, then Chemours will make 50% of the deposits and DuPont and Corteva together will make 50% of the deposits necessary to restore the balance of the escrow account to $700MM. Insecticides [Member] Insecticides [Member] Insecticides [Member] Payments for Restructuring Payments for Restructuring Payments for Restructuring Clearance of hedge results to earnings Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Document Transition Report Document Transition Report Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Gross Unrealized Losses, 12 Months or Longer Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss Personal injury cases [Member] Personal injury cases [Member] Personal injury cases [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 2 [Member] Document Quarterly Report Document Quarterly Report Chemours [Member] Chemours [Member] Chemours [Member] Sale of JV [Member] Sale of JV [Member] Sale of JV [Member] Notes receivable - trade Financing Receivable, after Allowance for Credit Loss, Current Additional Financial Information Disclosure [Text Block] Additional Financial Information Disclosure [Text Block] Credit Facility [Domain] Credit Facility [Domain] Recent Accounting Guidance Accounting Standards Update and Change in Accounting Principle [Text Block] Net gain (loss) on sales of businesses and other assets Net gain on sales of businesses and other assets Net gain on sales of businesses and other assets Litigation Case [Domain] Litigation Case [Domain] Basic earnings per share of common stock Earnings Per Share, Basic Loss of consortium [Member] Loss of consortium [Member] Loss of consortium [Member] Entity File Number Entity File Number Pension and other post employment benefits - noncurrent Liability, Defined Benefit Plan, Noncurrent Annual Escrow Deposit, remainder of period Annual Escrow Deposit, remainder of period No later than September 30 of each subsequent year through and including 2028, Chemours shall deposit $50 million into an escrow account and DuPont and Corteva shall together deposit $50 million in the aggregate into an escrow account Preferred Stock, Redemption Amount Preferred Stock, Redemption Amount Indemnification Agreement [Member] Indemnification Agreement [Member] Income (loss) from discontinued operations after income taxes Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Discontinued Operations [Table Text Block] Disposal Groups, Including Discontinued Operations [Table Text Block] Common Dividends ($.13 per share) Dividends, Common Stock Execute to Win Productivity Program [Domain] Execute to Win Productivity Program [Domain] Execute to Win Productivity Program [Domain] Unrealized Gain (loss) on Investments Unrealized loss on investments AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member] Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual Balance Sheet Location [Axis] Balance Sheet Location [Axis] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Disposal Group Name [Axis] Disposal Group Name [Axis] Commercial Paper [Member] Commercial Paper [Member] Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Retirement Benefits [Abstract] Retirement Benefits [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Noncontrolling Interests Stockholders' Equity Attributable to Noncontrolling Interest Short-term borrowings Short-term Debt Document Information, Document [Axis] Document Information, Document [Axis] Cash provided by (used for) investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] EID [Member] EID [Member] EID [Member] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Litigation Status [Axis] Litigation Status [Axis] Loss Contingency, Threatened Claims, Number Loss Contingency, Threatened Claims, Number Loss Contingency, Threatened Claims, Number Accounts and notes receivable Increase (Decrease) in Accounts Receivable Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Liabilities and Equity Liabilities and Equity Loss Contingencies [Line Items] Loss Contingencies [Line Items] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated Other Comprehensive Income (Loss), Net of Tax Income Tax Disclosure [Text Block] Income Tax Disclosure [Text Block] Total noncurrent liabilities Liabilities, Noncurrent Hedging Relationship [Axis] Hedging Relationship [Axis] Future Cash Payments Future Cash Payments Future cash payments related to restructuring program Shares in which vesting conditions were met Shares in which vesting conditions were met Shares in which vesting conditions were met Method of Disaggregation [Domain] Method of Disaggregation [Domain] [Domain] for Method of Disaggregation [Axis] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Other net loss Other Noncash Income (Expense) Tax benefit related to an internal legal entity restructuring associated with the Internal Reorganizations Tax benefit related to an internal legal entity restructuring associated with the Business Separations Tax benefit related to an internal legal entity restructuring associated with the Business Separations Finite-Lived Intangible Asset, Useful Life Finite-Lived Intangible Asset, Useful Life Equity Component [Domain] Equity Component [Domain] Property, plant and equipment - net of accumulated depreciation (March 31, 2021 - $3,874; December 31, 2020 - $3,857; March 31, 2020 - $3,406) Property, plant and equipment - net of accumulated depreciation (March 31, 2020 - $3,406; December 31, 2019 - $3,326; March 31, 2019 - $2,970) Property, Plant and Equipment, Net Entity Tax Identification Number Entity Tax Identification Number Argentine Peso Devaluation [Member] Argentine Peso Devaluation [Member] Argentine Peso Devaluation Net income attributable to Corteva Net Income (Loss) Attributable to Parent Payments for acquisition of subsidiary's interest from the non-controlling Interests Payments to Noncontrolling Interests Inventory Disclosure [Text Block] Inventory Disclosure [Text Block] Trade Names [Member] Trade Names [Member] Segment Assets Segment Assets Segment Assets Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase of Interest by Parent Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase of Interest by Parent Foreign Currency Exchange Gain (Loss) Foreign Currency Exchange Gain (Loss) [Table Text Block] Foreign Currency Exchange Gain (Loss) [Table Text Block] Marketable Securities [Member] Marketable Securities [Member] Marketable Securities [Member] Current Fiscal Year End Date Current Fiscal Year End Date Defined Benefit Plans and Other Postretirement Benefit Plans [Domain] Defined Benefit Plans and Other Postretirement Benefit Plans [Domain] [Domain] for Information by defined benefits pension or other postretirement plan or groupings of similar plans. Guarantee Payment Timing [Axis] Guarantee Payment Timing [Axis] Guarantee Payment Timing [Axis] Held-to-maturity securities Debt Securities, Held-to-maturity Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Developed Technology Rights [Member] Developed Technology Rights [Member] Cash and Cash Equivalents [Abstract] Cash and Cash Equivalents [Abstract] Non-operating pension and other post employment benefit credit Defined Benefit Plan, Other Net Periodic Benefit Cost (Credit) Amount of other net periodic benefit cost (credit) for defined benefit plan. Includes non-operating cost components for defined benefit pension and other post employment benefit plans (interest cost, expected return on plan assets, amortization of unrecognized loss, amortization of prior service benefit) Other Other Receivables, Net, Current Reallocation of goodwill [Member] Reallocation of goodwill [Member] Reallocation of goodwill [Member] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Income from Discontinued Operations, Attributable to Noncontrolling Interest Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Noncontrolling Interest Loss Contingency, Number of Property Owners Loss Contingency, Number of Property Owners Loss Contingency, Number of Property Owners Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Property, Plant and Equipment [Table Text Block] Property, Plant and Equipment [Table Text Block] Other Commitments [Domain] Other Commitments [Domain] US Treasury Securities US Treasury Securities [Member] Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Other Comprehensive Income (Loss), Tax Benefit (Expense) Other Comprehensive Income (Loss), Tax Line of Credit Facility, Remaining Borrowing Capacity Line of Credit Facility, Remaining Borrowing Capacity Net income (loss) Available to Common Stockholders Net Income (Loss) Available to Common Stockholders, Basic and Diluted Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Finite-Lived Intangible Assets, Gross Finite-Lived Intangible Assets, Gross Ceased Operations Required time to remove assets Amount of time, from operations being ceased, that lease agreement requires assets to be removed. Trade Receivables Sold Trade Receivables Sold Trade Receivables Sold Net provision for credit losses Accounts Receivable, Credit Loss Expense (Reversal) Foreign Currency Exchange Gain (Loss) Foreign Currency Exchange Gain (Loss) [Table] Foreign Currency Exchange Gain (Loss) [Table] Accumulated Depreciation Accumulated Depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Contract assets - current Contract with Customer, Asset, after Allowance for Credit Loss, Current Related Party Transactions [Abstract] Related Party Transactions [Abstract] Hedging Relationship [Domain] Hedging Relationship [Domain] Corporate Expenses Segment Reporting Reconciling Item Corporate Expenses Segment Reporting Reconciling Item Corporate Expenses Basis of Accounting, Policy [Policy Text Block] Basis of Accounting, Policy [Policy Text Block] Weighted Average Common Shares - basic Weighted Average Number of Shares Outstanding, Basic Ownership [Axis] Ownership [Axis] Document Information [Line Items] Document Information [Line Items] Cash Flow Hedging [Member] Cash Flow Hedging [Member] Loss Contingencies [Table] Loss Contingencies [Table] Revenue from Contract with Customer Revenue from Contract with Customer [Text Block] Accrued and Other Current Liabilities [Member] Accrued and Other Current Liabilities [Member] Accrued and Other Current Liabilities [Member] Preferred Stock, Dividends Per Share, Declared Preferred Stock, Dividends Per Share, Declared Long-term Debt, Fair Value Long-term Debt, Fair Value Net exchange gains (losses) Pre-tax exchange (losses) gains - net Exchange (gains) losses - net Foreign Currency Transaction Gain (Loss), before Tax Provision for income taxes on continuing operations Income Tax Expense (Benefit) Foreign Currency Transaction Type [Domain] Foreign Currency Transaction Type [Domain] [Domain] for Foreign Currency Transaction Type [Axis] Cash, Cash Equivalents, and Restricted Cash, Continuing Operations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-sale [Table] Purchases of investments Payments to Acquire Marketable Securities Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Stray liability sharing percentage for PFAS Corteva and DuPont stray liability sharing percentage for PFAS Corteva and DuPont stray liability sharing percentage for PFAS Finance Lease, Liability, Current Finance Lease, Liability, Current Local Phone Number Local Phone Number Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Dow [Member] Dow [Member] Dow [Member] Reconciliation of Assets from Segment to Consolidated [Table Text Block] Reconciliation of Assets from Segment to Consolidated [Table Text Block] Derivative [Line Items] Derivative [Line Items] Accrual for Environmental Loss Contingencies Accrual for Environmental Loss Contingencies Derivative Instruments Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Long-term Debt, Gross Long-term Debt, Gross Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Line of Credit Facility, Maximum Borrowing Capacity Line of Credit Facility, Maximum Borrowing Capacity Raw Materials and Supplies Inventory, Raw Materials and Supplies, Gross Restricted Cash Restricted Cash Retained Earnings [Member] Retained Earnings [Member] Short-term Debt, Type [Domain] Short-term Debt, Type [Domain] Schedule of Net Benefit Costs [Table Text Block] Schedule of Net Benefit Costs [Table Text Block] Significant Accounting Policies [Text Block] Significant Accounting Policies [Text Block] Cash provided by (used for) investing activities Net Cash Provided by (Used in) Investing Activities Company [Axis] Company [Axis] Company [Axis] Significant Items Segment Reporting Information Other Benefit (Charge) Segment Reporting Information Other Benefit (Charge) Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Discontinued Operations and Disposal Groups [Abstract] Discontinued Operations and Disposal Groups [Abstract] Property, Plant and Equipment Disclosure [Text Block] Property, Plant and Equipment Disclosure [Text Block] Litigation Status [Domain] Litigation Status [Domain] Not subject to indemnification [Member] Not subject to indemnification [Member] Not subject to indemnification [Member] Continuing Operations [Member] Continuing Operations [Member] Earnings Per Share [Text Block] Earnings Per Share [Text Block] Pension Plan Pension Plan [Member] Discount Rate Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Financial Instruments Disclosure [Text Block] Financial Instruments Disclosure [Text Block] Dilutive effect of equity compensation plans Dilutive effect of equity compensation plans Dilutive effect of equity compensation plans Guarantor Obligations [Line Items] Guarantor Obligations [Line Items] Issuance of Corteva Stock Stock Issued During Period, Value, Other Income Tax Contingency [Table] Income Tax Contingency [Table] Recent Accounting Guidance New Accounting Pronouncements, Policy [Policy Text Block] Shares of Corteva Stock [Member] Shares of Corteva Stock [Member] Shares of Corteva Stock [Member] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Subsegments [Axis] Subsegments [Axis] Marketable Securities Short-term Investments EX-101.PRE 12 dd-20210331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 13 requireddislcosure1.gif begin 644 requireddislcosure1.gif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

GQ#2BU?A(/RK]U$N M(D).PTROH"-6Z3.)F9*IRRJCRYK#?&XT6SBJ&*(L#6FTM]PAI_2IRC/-O%*1 M4\,K5!J/>X)*&#*^U$W=6O*,]R+@?YU!9FI'U4?D>QVQ*QR=.^*H;DX@+=.Q M,<*;^6$LM&HA6[?GHYTIW?G2'04-]ZFOF,Z^UF'[NAU28/$&NE2*G]R&CQR[ MGB0J30>3J1J700X4S,AK$*,^-:#FB'Q%?-CBZ2?D,PH:$6A)VYQBKWFZXNMDCR( X<[C&2)2W%R7L=+B/*MEKK>E(8[@S[GW@2LA!\,Z.D M@=MC%.,=M?W4*]$[OI!=W^5"#"5TH+$ZM;I6.[Y(W84M,CF2M]$>M3&?.:#> ML]9]$$][G!M;PWE[%/D-L\/_5MY(:R4!FK:?^=U!C^[18NGT?#/N,?26.?"=&?8H_7>#\4K ._4;LM?_ B

H#B5*$;+/OZ[W27AB/ M RJ+_X/^#NRJ1IWVHW_$[]M1 )%IWT""R@!, M)+AR(,F?14VJ))B)V$"#(&_B9"ERGQBGDVX4%3K0:4P !2,^!1L69]BN8LT^ MO0I39<-)+ G:'%J6X<:ERB;MRYI7(("T%%T.S$31X+Z[ ZT.;4MT'QJ0,5Y" MW.HPTZ1Z );B5=9TZ%2GT#X.I(AYGV>G!I;&X+G/HD!HD9&V+ M7Z$8 : K' M4&:S\$ #=V/T#2W&KD^[>)VN<(N8H$R!KV, Z$C89\_"5_\5WQ2.,K1AEEUE M&DXY'235GBO%I(4->O+4JP:K*TLK)OG+3&@J.[V:'>:D[8ZU9HYL,:A>0FP M(]7$42LU@1)P48?FU/,B-OGBPHW_)2FJT/,( MV1L&1;1*:(.&1Z!R.( MX:=,*ZACD5=^RB"569;WX;$ROO4KF&_&.>=E/;57R)=UUMG9K,SBM5B@CT9: M1[*29KIIIY^&.FJIISY:9KRHQCIKK;?FNFNO,;;:ZJ_')KMLL\]&6^.PTV:[ M;;??AIOM_[7CIKMNN^_&.^2Y\WVMW:$]XC1ONBUJB/!ZKY,7Q+#Z#AGQ@J=3 M^^>;#;_I;WWS9'IOEGFFU_*HW8S5[$:G DM(:*8,/-T%3<;WS)57AYKSMV]- M%">$<]9\XQFALI=(J(E!6*I7,8_::+"F6[-EX@" L%UE\&,=7\8E@I0@XP^/ MGBF&GS?K>A_1"%%RH+G%5\3*8E]Z9>1PJE[>&TQZ^H9,1Z13:KC$NG^QL"R" MT"*0FY?CGA+ :,TO*0@\"_+:ES3^ &PZ)'-:[NRUD4#9 MAG@X@0A%5J(F2]&)1:6[RPHBTZ@\G>=131)1JO#2)V1Q93N88O]3DT"R)0ZY MA4D+0A5?: ,2E5QE=.QYX4(<)<(EP; LYSD3,9[$$.A($2:>>=@1X0<_KD2D M*34TUDQV0IN3="E,*V .Y1RU$L*MJ$SHN95 M'43E8B!BD)9%%5(V!/3T!!( M2)F5G,;SD3BJ*GDE.](;9[A'& K$(K!+"B%/4J3+W*I)'JK-5&(@)REVQ5D3 MNHP9N<(]L<"H2.2K6OJD5T,_[:,WE>M.H7*3)_A(YUTRZI%/.$@;B-G2-K:3 M4Z$LXYF&Q$!#KO*?*Q$63)ZUJ%PMV4Y)2A0#7MX$+C>XRG/2@J(9TB8_K2K+ M#>KA,CJ&#B739!-&^!>2PLT$,FAQRG/_/'07#)'34LL3%9C(J1*_",: BPG- M84)B-(6L98;J&65,%").Q:DHG-#3"D\F$9UZ_DV@""I*DY;BDQ5@1"5G4EE! M?2*7KJ A4:=)385,=?^D%H4BI3.J6 MPY0+^H28 +TGF9YSRH,V=26\.@C\CDK-IZP/A"TES(ON0C"AE=1XF3C18U0F M%6<>YC4*A,E2Y;A&HUP$JE1,'7D$J!4O.0;%\N8A]1J_>W MK*Q/KI5)4V3D^AJYRI4Q607AEY9U&<6)J+"9@"IF_]E4V#A*&<:\R2MC) M1!*KGMFH7:='_Y;+Y"]SJL17!24#FIYVISM+>0VA$ :ZK>SU+YP!3*5XMRS; ML@^#@'N0,I\B/.H 5T ')-U4,B77RKTT-7\EDARK LZ!3 F"OV*@1_K'O+Q> M<;.*44!Y*O+T2PS74LY.GPE,=6]B5:HZ,SW.#:J!EP,HLM04?]OGK4(;L%/6Z)3()\>IJY/?D1=EG6<=4V+3X?17 MVB,JPWUG,1.**XZ)H1@P+0A"H&;O6YX8N/B6A4)J0=6"H,MCP[AAMMGE0E\\ MA&J*[,1@C 7?\THRI'##-SG6;DFBE,$330L$HU.9T/\<I5I/\K<;*4FFC6P%=!R.TG;JX:#.EO3(QW84S,N#+*(+,580:XI\,J-YT5OMLI_[;$E*QN.YS4T@HT^ M+,>=O.ME_[32?XVM7_/9R)8X^[ (#?.\!S[2:A]\XA??^,<'VZ21OWSF-]_Y MZ1K^__.E/WWJSS[ZU<=^]K7?MNMOW_O?!S_5NC]["\O+P=B9Z<7.?Q;^8FRU MY6<:GXDO?R0'["L^M1-RVW\6^)!L:GQ MB0PCFHB?(8XXR\RS&J,1"BBR%*!.5F41> M4HF:L);"6) "*9/& !]FN18@*1)0[#M$'#2% XUXLHP .8@%Z8@F.I0UF15- MB:+R:+VA>Q_+D!,@HZ0I8I0=(:=%<9(D60KF,*1Y6Q#R <2.H9)?G#,RN4;I M "=I,8E/XC-1FL2=Z8HC<9V\")]R@K'V(Z/%"!T#<3H.J46J0>_6!=G@IW'PA#/< N#')6? M8AY5&0^),IZ\P*7D )^0 $G Z C_@U@VS ()-)#%N-BJY0'(CA2*SY((XCHI\# OA? ,?JL?"^)'>?DMZ;B+9$*L@R.BJ=0IJ80SS@J*8N*I%P-# M.Y0((',YN]H/!T&S$'DIRRRP$@NR&V"XA> Y)HNP=>*,^:*<]5DGPQ25V5@C M@;NP;M.R"UNNV\!-)SJDO2JKJ^ "D\DP+C(@L\HB0EN3RRJ* <',]=H_]$-' M+NF8TR/._S!SKLI2+9Q\H+B D/P:KC,K"^<0-X) N?RH"HK*P^FP"A9:KWJ) M0OSA.7';(@DB&"X,+K!8'X&RJ!="#413QC0KF?@(*)=[M,',K7G#J@A;+:%@ M,EOC$"Q93/F:#HM<%"[:S_A$M9'2B":$,;@@&;E2D_81K1"]B\VR1;>DB+B[ M"=3JB1"!E"-;K>,RJ*Q(.])2LV/KP3JIG$'DE"4LF8"22&WKS)5;RL )IH-T M2I=P X/I3CKT"!A;$KA3Q',.+X1K@6!AG4:P_-PBKY1B@5% MQ*"X#)48T3BY#>VRDWN+C^WBK,A84$T4$6&["MF:K(-[)K.#K/\F2Z;14J)9 MJK]D\E*:U @'& W:G"M$ ID5,#>'B%1(C5//H C>A-.@X!8+K=$\F4YK MZI%8"4QW(0;-9!*$!)3D*;4[Y;GN0J6L"" "H2I M0J[ MB(_DL(J'ZTU5D9%/VQ&X,)ZRVDG"F+7)T(R0X+P:<0[H4!SYP@]B(*:[>*5[ M/:HE^2QV!<;]Z8I!:TRB6 ^'X!01I2UQ;8G)*)&V0->88+?*(09^8U&281&E M"-AC\XJ7V,_L"I1HLC?Z6XZ(+9F(C9'_A>4BD)B$Q^"+^TFF;\T$%3W9F*J1 MF[ *GE#)^G.JCF%4L0PHXL#+4#L>UJ#)$L%2'CG"-2HU0V*QH0 *J@,>''W. M@S"4)S&Y@_ 3@\ -E3LV Q Y;UH\R*LA5Y% D@@71*&[:(D(+/JGK)-126FQ MBMBZARB3%/()DLLG+RH2"(' 2PH[1!D2M4,222' UK[_A9GU MBR#,FTRS2-#M_;PG E^T\1S/\9MC/<-Z26#[6PH#CAD&OIG5&845KS91DA6;K8 M8E\2UE_;P[SSZ4,F/;;QZKS%Q,-WL& V9T+7ISMI35^82YZ"4U4S9G* MD,T->F# 9%ZWD6#S\N$)4^*WF!0'ZM,GUEBTN3A[\6)^69_*H& DV=XRO!<^ M=I<@JPPAS!DKSBDC_^Q==I%B3YFC-HH(4%D);5)(&",)C=3-O6 )45(XR"&2 M03/"@6)PA+FA 0R*$#()ARI17FD0V*Q5 P0H2N/C8!: MKL!87+*C"P44VI##/2QC.L8MA;@HW&B3/$$*,D&=H'(=,Q)+GJB,XDI+9UTZ MDMFB3GJ16!I2F\5';FH_1=,.K>@-I/L\?]/%D0147KNCKI@>D8(&FUR,A?^* MR0F921T*%*% L[LEVLDXC9*6CF(:,:3TJ!I2JX/:J\D4"BRJLJ7\R_J#Y)9@ MR--PI 3SN<\@"OS,%*E8#7=]Z9Y O2O^4[;*PL6T6?2PWA*4B>V\L(L;FIIQ)U#%B*"R+\'& M"M62F3Y9;-$B*SAZ;(2R*LL1"C7DDZG\M0C.#0**.<*KV45S^HIP?8S M7IAX51-,I^1ZYZ%SDC_-S.46"[!ZKM'H2-9NB2;_Y2S1'L-^SI@27HAB.>WR M"LAUPC^;?B(N8[Q;FZ2]V-'"T,,+(0RD* S9PK\MSM&3)LV6DL.Q7"X(]&^= M"JJ'0XW,N##7PJ\]U6[J]"_(0>_%_B>VBY:MD+K(G%.Q"I0,Q8D@KDG+DB($ M0D(]X58]OC#',M"0\%;TZ+&E@K-$)6 M(&ZWR*O]1#@F(P_,GH36R!YG.T.!^A:)(K$R\[]!V8Y)^ 0#8G+RVI<-*3/ M[FJNB!926PI+HZ>MT/(%_XLL421*Y F/I!BLV[*4$24&,./R"X/RNK-9!\'F M4>)":LH>*V2U0FT>,+5QIL#8(/Y,Z:@>F4B)9.DO8E52-@$*]UA0N(+5S3'R M4JKOUH"O99-Q5]]9WJ$S^9[!^IM9C-6(OOT(O4*VLL#F$64)0S,HR'J\UFB) MEVB1=OVF=ZE9HBJ-2BIJ,&)4ZR&X?W4F*=I76*3*'**B;+&WMI@97>NL:6-( M\T"/.\MPB!4+Y'#TP(K6'F+VW\:,FBN/3AKLQV)W_YLWJI61%3#PQQ,+/*TC MZW9KHTJ>?Q..!.8T_'CU);_M8E^>"H&?EQ@4XS X9WL.0\;K?[9@7/E%(WHY MI?%ME"=QEF$A%/E@*T/9NB%RL3Z'L521EISC&:58*D2MDRI1N5KA6N06W"R! M'.',9EC\H*!OL>9)DOAXW50V%*=GD""7'?S")Y)PVR JND=V$J&95C'Y)#+A M7;4M)*M%9V2)M5."C)D''4X1$@0Y%Z(C-:^(#*5-'KRUF-PM]%NF$V1IO Y4 M$TC&^2Z,6S6)CD:A&)"[ZR.L=:B!EX<3X-F1F#S.&7\19+.@WG;Y?!J>?*>! MO10->/0T?I_./Q3W[Y7O"3_=H7 M_N$?O> G_N-'_K@Q_N1G_N8O_YOE=_[HEWZL@?[IM_[K3YKJ9\00R\'!SIH- MT6!W\6/0-_F[62T/)ILS[CWL)7( ,IH0%LSO['Y)0_E[D8G=]Q$8-N,Z]AOU M!XA] @<2%#@)P(V""A>* >#PX:2%$B<25 9@!<6,&C=R[.CQ(\B0!Q-2'!F2 MH$-E$S,YO*$LHD)B#O?)!+!1)LF3.A?:Y+F3(#&8,=!HS$DQ4XR?2C=FRO01 M +&E F,X!4E2C%&)30M:5+F/I1BI ]V(#1FT+-JT&<4DS8CT))JH%J,N[$H3 M -&%+ 7NY0A3[5.)/97>R!OCKT293#$"%KNB:D< 7I=2!3FIK9BP&1\7K#=X MWXVV4O\/-]Y8N#1JM&@TE\P:V:MDK:+W(2;8MZ]& )!39_R,T:)T )IK/JSX4+/NZ@^CWM ]\&$,BPU=?C\/ MXOC?$*(<=?/<^ ]HY*]>M/&%- Q4G&5;*R=5>< 1!$]L^GD6T'&COC1>A M4\6%I1Y"!8$UR61WW9 )71/N4UQ2#CEE(FC%*;/7"MWA-B%.(!:$GD#SI00= M@RBA.&)W=T'WX'L"&3!)==7M,]<^;JP 757'M31B6SAZ==QE!*E87%0.U3,? MCNE)YM!L'L;4XVV#/>243 VQQI=V'/*FD&_GC0:3?E$9<*+_2C,?B25EPF.=T$S*&V^B1$12\K$@&)T-\"4W(PG:B?0HU_%%MM!RD#' MXZ;SC4B41?A%QY)32T)YUT!Y"7C5IF(019^G*IGG77"3#3654Y8*A"FNJ3JT MYD 814J0 3Y*9Y!-MA[Y:554&#E3,IYNL^DYE&JZ8I@TO9M3S=PP6E"DG*:%!HD94A0NVSR12Y>#3(X MDT6+(GSL0,H8FE294RW*4DWX":1LCF\*%.?(HQD&D[ #3?(OGP5].&Q/T4F7 M)61!VK5@/78)VAFUP(X[(IQ.[2R0_V=?B;9JOYJM!AK*B GL\T#$G&OJ2P5A M!;!!1GE6CW3X>>853D(V_3-XP8GQ-4\>T_M7?RF%W/7'P;*V[E0P^>EIKZ11 M5*EF3J;47)@R=Z5S;';I??AUT57YE;+G2HVUWY+%0%?"WJEKGF:F+GA@B'3- M.-V ,RD&*WVB*3_"QP5>VJ=W9[KLZHT3\S*O/:SMHE[%L*&;FKS,(B M"S?: J8D[<@JR:>9M+V'7'"RD.G'&':32"P@\WWG5-RBN N$77/1(5YC1.!U MN+E>% /UY-T5Q[FK >3-S6U5:&#,6-1/*G1)[;A76U$)'G+0?"40_=-AE7TRDO*C#@R MR(CA=-YACF?H,QA$>2^'G'F@PO(#$[KA!E$37!-+B!(=/-+-(&7$W\C^ A7" MJ<0NVM*CV*85GYYH\3BBN9J28G7#Q2'L!L00U2*?Z)G.C",,6-0PQRYM<: JF4+(]3MSKA]QI6DX-P#2G$V!@R57:#>F2B MBPESID78^1C$%&]4*9H6%:=IO')FHG@%8N.,%(4&*H)BA%R^ M"TL<.UH>(:70?0D N&,NLTT, /JYSQ2+N-18:6="QSDK MWAJ2G(=(=37'BAQ76G)%,!%33@JQ2 R*_V.IEAQGBOM 0\,X%9P>X3.PLLK$ M4J5JU>FXC+&*G8G#?BC5MBB'+>VDF"4;]2B'-,LS?T,L9L/'UREN]"&Q=!^$ M2)44[O2G;)^'(][OU)%A'V MWOFZMZGO10,BU1)%3IW$-:49'7]% L[V^I>^!CZPD""#7@0SN#3V;7!:%FN9 MU(HL=."=2&SG>QP(+N,0F/C&*4ZSB%:M.,"Q^,8QC+.,9 MTQC!)*XQCG.LXU8=\WC'-^XQD(,LY"$3F:DN+C*2DZSD)3/YR-WE\ U-J)1T M@J0_&@GL&M?8W(&D['-4_,F9L*>A_-9(O2>ALAO3XLHHG[A]*M-N>+L%F#!C M^22NK/(M:__IY"0O=R>]Z\BDOKJKW3U*:K6I3%DP]R&->DJ5?%*36/KLW04! MX+4J9HEV64+FC!Q'#)CJ4U^Q->5XM7+ M-8@6RZY(I#++EKDLKM8),=;*3(V0%,+!UHB;'^J1T9EQ(84L9$>VDINL&K74 ME89QJAO,R9U$\9%VAO-&@%>5)-)5(2C%M>L<@K\!?1"/4O%V2+K,P(VD>;[R MEDU!MJT1"2ZX3XQ)]D;.O;<3UGLB!4?UGG?2D()*USVZV;"\P/*>KK#[12@R MM=KJ99/W& F&[_F/#VW#&*E:[$8S^;7,!!>;H7!H!;6)'\Q^E!W_H71'JA6B MXB ]R6B6J!+:99:J\6K*ID%!W1%* M/#H.=.8VZG4-HF$;?)TX+D M;EDA<[_SQFYL&C(BVJ<39)^GEU/TLZAW49IKGAQ7^[0%;\L#D%[Y[0JE'4C\ M_H#RDV&)O-5V"*(=O>P@V9$,VA[9>7D*_RF_!XE(J$K(Q0Q//H+G*F2WBNY1 M1C7[/%[I,_BTD70LE5U<33P-WSXL"(@83"8]6=V\$*+=&ZY98$@41["(5YC(W>/@AAU^T73YAFG! MVHAHAM[8BC_!#/]M?-"?,4J[M%%5J)^L"402401*'2#XW)G,32+0H$XALL:7 M#%AGQ6!E/))B=,4E"MQQB9SMC-'/V$7(W%#P,5[M\)]O !T.,.(7<,0X,,HTY'F.$ M$>))P(=##5^8="#(N _7=)$(>D6_'0QV@4=56(H.'@D"N1TB94802 Y\>!G3&<\GX=Y*0I*@Y$L1N=_1>,5A#(_7Y<\]\9?<\='_'.7+ M&YI?]9V'-*&);TQ*)Q6$ ;$11U7&[F6+4-!)AJTC"\%7YD"3T @23* !._7$ MI,3/8!0;D6117Q35B&Q)(X&8K7S2(Y'&3!T6V/2@%@V+M@#6!>7%ZTF21I1B M!ZD$255.+M6(;U2D1G21\,2&M'T,7Q#%KS!4G7'&[AA'OGB%"3'*J7EV @@:F3;1X2= M^H06/E%1O:P+=W0G*.D&V6%.O8B);2#$%+4+_X2LYPII2.#T(W$NQYE,R PB MGP^1IXF,QT.T2!$A2QT!6H9)5F5=! IY%G'MRIVY9Z,XQ*(\U1EJGO[DSW[^ M#8&BX9F 5;Z-8(\4QUEA*') Z/GUX[%04W#-B+/57DX45H,.A;Y(R=M929#4 MWA'1!6[!$+F07%Z9#AHF5WY."E6U*$0LG6U58%;RF)EYQ/\H(YA1FT+<6DCX M$0UU6 FM&#U=F HEZ8&)8X,1():>&3O*&'/N1'G!IU3<9X!Z!#4AIH>MFHA5 MJ9:*3)F&6)HB&)P:Z9,U66\D%JA)G;51%D5\YT?(R]9]J7?QFHI9&'WIUHF% M68EBJJIJJJ M7BJH<@2;&ISW. D9CJ4_@3 ?:JA+L70W%E9N)*Q M=H2.9N?J ..P[D^>I<:K;M>N]J&>':E.E(>PY88X5DE7>$F'5"FT@-A$' 2Y MI@9;C NX=HU5/2NH@5ND?5EI0,=KF=JR=@0NTEN RIU7.>5G7$6<*@0XBH23:D04+>S<"5V42N)2_%IJ> 92'>!KC(QZ M(6NT/NG$WD2SUNF)'9L4"92VG1J>HNA23-]&+.2^H!":/1UFN*E$6-"9P:S= M1*2K=%4%WP'KN2H%S0+&/X83T+J/EV\J,V6TH=,1DRG7'A!Q*4B%=T*T)Q&%62J!,;/W(M>6/ MR(Q33UP7X00%Q;"$[%"NXG71=<5( M5G'?&G45MCR!6Q(+_*;;J MQ*2H1 PD1/#]%BC5P^8\31X]DT;F)H^$Q=($6L=47U_MFNY%RS9MB8$FX"") MD[LDA/'9ZD)"Z??X)AH<1T)<3?0A$LBM1Q^&79:ES*<-5$\8P/]N'\)'YQ1_^8+!N>E;!Q9Q0H$KY(73H+Q M+NU=Q-(#%9)ZU4O4=0?)0L,AIYGBQ.&_5"OR --B00/:\)17"!J-W%HC+Y:D MT%*7;20160GO$<4CH90_IN R!=!EC4>8%!OX().I% \ -A8 M.HO'&RN6NLQJH@4Y<4H/1$XQJ*M@H3,N9/V@@V<]29? MX ]#O=#P_,HS!FPA&=!,7"(8]I"O(L\B7=CU@J,7A\PH&F MRF#%\!"#RP[**G'0U/WC2UAR5!BE3;L;*\(*M''()S,(,/4:?WE;0D=7>7$4 ME\7A@WRB*0EM"!&A0!T&67M=YH):.VV/N$8ASHP1U?CT]P$UF[@KAI&T#U(B M+'U%_"P+]GT*VVAL. '.5[@3_0#G7 *IC *0'V>1MTF&"DX+R@Q;_PJU7QA* M1(DVCPP3;;(>'V?TS%3+IM695#YG>A+704<%-$SC",V5,=4JDB@CQM:T"+[_ M]@T.$U]DB9/&QH(09U14:TNB%EXG!+GIG77*Q&[F#M9\MQ19U/HX1='8T7GA MG/-%E+F,S5SNU.EX\/#-4D?5&8CHH(KH<%8D2DR\O MEM1@UDLO!(#)A $(EO]^!V.!5584C+JA4+W<*(40Z-MMEIAQ)&C.18C^';-T/@VAE^C_T:UBAA8)NJJ!CK7VKD* MZ9N$EZQ.3*]:]'F(\6R#);"@1WJ=5Z^&(:I&UJI8]&II.'F);1B*B9VDA_I( M4[JHE[JIGWJ#93&JKSJKM_JG$KJKQ[JLSWINP#JMWSJNR[JJYSJO][JI[SJ$ M9>VFA['(O.-Z&7LBX1B>P^K6[F)(-/D M^3JWGAJ]8MCQ .QX(A5,.SJO#-BWKSJV2_BV H9U1BK3>>YCTY>AT'%JJ#N1 ML9E@#!C6@ACA6%I)6!O!$P2R1_!&$#N'L2Q6!G.VXBI:S+):&"^]L(88+(I: MK]?B)/QZ,:F>6JUWH/LV!O^80ESSM#.D9%OA/JKPOO$[A GBI$-\2#A=?HA' MC\Q'?>RMFPQY!FI'T>Z*K,**^F"1F9707((&P!C(97&0=AY-B,9NJ/5(A:=6 M6-D*_S2]"!&=>!JF=M3$>.J*>$041.20U74NLOB\CD>'B,"6S 1IKO"H>70% M%::041ZTIT\A5"31V6/N@!D>G$R'#KXQHPXOLAQ$-H>9L0A5]I29%_;5YVX[ MB1=$U3\B9KU?"/:(%^;H=(C(D&_DD]B\F>_$NRN$MI0'9SF]U9F*\2F#;T9$ M%RKORKGMU'R)Z&04[+LIS/&P8%)TK=R*2G&?+T++,'Y%:$\%5JROE1A*D A/ M\"?_5:.9R\#D3L0H4Z45BF$Z,TU52/!'U,4#Q>LK7LE<,3WVH3P7;E*8Z\U* M\NU#@ZA%X.EW(]D$/]HTQ,&+HF7)&9(<8'KH)D )!I7T&#RF[LFP3 8,$5 MRO:)B;&/&("$%3.) 2"FX V.&CDJ P!1I$&.#<4DC'C28L,8 ";N0]@Q!K2) M"_=E+!B#8PR"F0#46\BP(%&38AI//CG7_^#0Q24;ZKU+V>Z^ M%4O]DIZ\$>G?MDQC2E[\N*#.AI6!]B4:VZ_(QV^/.U88<_/EI74=$L3[>+88 MWV\-9]6X,>=L97@A5E3V=O(DU5;!?RTNERG'LY=/WD 3MY[G?=#$FDSX%EI! M\0V;VVZQ]#K*3"W>GNJLN\F(2:L]JY0CRS2!LOOK*[BTLE!#M>Q:RR#)S/IL M/LE&$TFIBJP2J3\.62PHJO]4'(O"KTKZR("(3#HI,;4J/&^D3%;@;,2"N&@M M.LY.BF&^!RN[BD2%5/(/KO_>@LR@S6([D$>K#)@Q18&6 JVW(+$2TR 4"P*/ MN.&(>DHUU="(";JQ"$(CH1A5:T?2N30!6/$KC3(AYL;4W Q*I/K.U-,@-,#$ MJLN)_HMHOO?,/.L\%,VS2LR*$#UO)['$6'+11F]#:3[4% 3RRR,+&@JBS>S< M4/]6#(N2]:_FE"Q()(Z@,]-!F902::*VL&LHTK5X,J@NU?!"-")%(=1)I$E: M2W4B#R,R#K(L P56(?L*ZDE4_<(]*2UL1SM(*3?(9,I38.O+LS4LMUH+78,P M(W38^5+=2K#2H@36+KW6E!+8QZ9;[;'8S!<\J$VEH!#I?:FN^.25ZG6MQ,I3I8G2^^2I?)DB)L845;).W;D? NHQU-Y[+U?) M;S:R5=>K%CW:S\5RO7BJUU+F:B2U4BFARRT6ZT>? A6Z(Z>7SHIIIQ>2J%$3 M89JL*8%26FPU@598J\O.1[*8L?$O+@*I")B"MI2%\,8J6:H9HRPR%,7A#R\4 M.DT%>;:MDA_+_$64WP)E(MMW2E6NDI6M=.4K3YDEF]FJ8K $9=)> MN;5P_:58K5K;*9GV/EL.DYC%-.8Q&]G$7R*3F (9URO[=QH+3:B4J@PF,[&9 M36UNDYO=].8W67E-<(Z3G.4TYSG1F$R*3%4:HVK:3$6J M\J!/PXI5-07458I!K!H"V89Z6<5AJ@9-ZJHH(P_%2+ VR*R&X4[(C )6K^#T M*Y,XZM)$JM>KT-619+60VBR$FO4=AI$D1:9+*TG5P6*H:UZI)2LONZ',>J59 M)OGK*Y7S+LG"%5JR4BR^^$HHE&2%='_9+&LYRA7I5=9"I2+_;5FMQ$O@D$FE M2C,3-B'K-$"1E4(_?Y:-)*?R0CX@Q :R>@$*%1>N>&,5-3-BA^6G;A"T&4&YAD$ MI=I'^$@)C3Q>V$9:S,G@TI(P#(FK7O 2I+<4YB.!(_R/)31Q+),P\8 MI9F,!=)&&=28)?-+1T=5M6.)[@>!,I6VP?H,$2=9#(L)E M-G_0L&VSJV%PN1IDQP2K#YK$EQM29N58:G>*@>),;TC/K5JT21Q;#33.DQAO M^XPT<6I5;H+T'P_NL"%S F0 _:0P*_'9/I%: 8UU:!%.JPLBH;I23VB,GLI, MFC1THC-', BFX34Z)B3#T9N>,FX^(;NZWOE05V*#(DZ5B[%-#& #,82EHU:E MI"B>3>D48-A%1E+:C[?RD7EP_NG_0"Q%W?ZDE MM/UX_A6\D37 M><)4Q?%-6MYSG/9@=CQ(Y]4)N%U-<@P5OX0H_)5N6UJ*ZW5<63@QUC]+6Z%C_='_:"3>C?.< MOW-M].@-W0![&TAR#*.,26Q\\<^>?,1.%YZSGB=4;;4N2OH$35#D/%+F(Z*$ MN$#N*J CUGJ#J0BK*)2A9F ,+:2N-QI$L,*EZ;0B2/QM]^QFQ&C.:@E M;2HD/=Q++>JC8::J,BIH)T;DAE; :C(F)"6_!04=:B6*JPT<3P M/^2N4& &6++'U2P0>O %#3(!+W;'2,YC_ST*$4UBHP][S@\=(CM,ICTJK0$+ M;@\E:@D+A"T4D1%WPDC(QX7T3PB]QPMGBB)4HDGP8I/2*D@R FZ^4"9$20RN ML'6<(GM0 RDB0Y@DZ0+R%_PA]YR8ER^\9 (Q3 B MAXB."/ "J?@R*"?JBXP\BG[(I8X:C"7T)'Y8K*(B(VC(B&F\1OE)RATXZA:<56*3XRDJQJ= M#B*C2#<<8I!.#@&8_Y OIG@2Y_1)^'@2D0@/FSYIM/2)&(,2GZ3*GL3@K9)R MI;0)"Z_BM>P)*9\2GH9"GY#K*IU&,K(),P1K9W KGJR2*\WR+-$R+<-I)]6R M+=WR+>'2DJTSGA4C:MD4P&(BM9[(:48Q(>XC/'*(-6J"@F8;T\B"!2S$KHLS33 MT2;:BE4\Q";5 @H74\%NH(T@C,6J2:AXHRX(R#32AXXL!6?N!H>H2"/&I^R, MR"XZC+C"T0TPJ"+?:]V@2,($3"JW@V)V@U&LS,F0S"1--#^]!HRHZ__4$R_9 M4C++""!GS]_PHC4&HDM<9'P:;H">)31&(F'P!2)0;!M_#L8B(\Z\A8:D@F<\I/U6 MHB-*C(&*C5\(XK@:A_@F[V'BXX.0XUE.A2HT(R[_TK-'_XD]HXY5;J-4;"NA MEN:MGB+7;@-.G 53-40X>U-&DF@LLD>4E! P>"_G0LFBMJ(+4M M)?7BV+ CEB(3\?,Q?Z-"AN(Q&F;0/N(WN/4KFH-*2XEFQB7U2J=6KT2!6J\K M9\]4&TT#*^NW MVHTTPS-E9J27(%(^Y# M5K$50F*B2%;58D:Q3":S1M"2,N #,403*I%2_M\P0L!OZCLAP-*NI! M198B6"5294$$-)3!&-$B.PQK*IYE=A81=++6B3(H6+$P0^/#-7I#.:T6H"P6 M@M9MB=8E)Y76*WA&-]9-*?XQ60O.5L9Q';,S2-;Q'QO,/]DME.XJO'"VA M,X=YN(<-EAAK?3B(A9@K@7B(C?B(2?='D7B)F?AJE;B)H3B* ZJ(I;B*K9B; MJ/B*M7B+M6J'N?B+P9BYB1'3F201B2 M);F2?_B.+3F3HYB2-;F3G9.3/3F4^_\2E$6YE.V2E$TYE=^RB/6D5,WIM"K) M76G)8+7#Q"$9\&.97T3,Y/.\1"3Z^RHRNINM@GHS?$I^/X M-R!)2:R#HX[_&0#7[*?B,W^"42/QM%0/*%VTD2E\6:?7B\56-C2\"&S/Z [7 M*-J$!HYXQ*1>@OP*B"4 )92D*MG&\T&DTB7T[S%+8D-[8G:NL"L^:3[LN6X. M5E?&J&7UK*=,I'C>X!*]6BTT8ES28E=>!G@AC",8S%!EI".3XK$_4T8A$&(\ MN[%]XB72 (.S3;(3FC;?S[G^B">XP\[8C=YJDU$\3)P#X'??&C$?PD1X5SFZ M9GIGTYMGA3-*R?$>)DB$^HK\$6%W1$G=8'0L>R*J9'6%6I>'3%UX<4LD3UI& M @OM!8J*QHNL2KGSVFW0@%\4R%"N3 DC6H,TQ7?_XL$$$Z'3<"="_X(@])1I M]PS)%6H<@B $.?\)S?O5N9!=\Z\6+PD027,1-J3%_7D:MQ :9,FYTT6Y M]7M08N.H'-PY,*,- 4 2HH$A@J:0PGM+0L5QAB%FPFK38J8>TL)D_I9'/-1% MY,)XWEJH:T-Q+AP Z $YN@143J?[&*=5G&*G[+BB)TD,?'-E:;333CKU$.M7 M,&-T6/S&1,F>C[D>_BH3O7%G-O1!TN-NA&HC]#MBC8=A^\UOE/%'RD.PH^UE MK-M:^XH+D?9QA0DU3.8D@,TWEJ$KR&:UQF)AHH27X=PWSK.X[*>?7:,C:PBQ M0JD-G;+*HVU$:'$T$,NP %PT!MW(]UOM4O_G%8M5<3185>AN97E#F5JR-UX1 MBMS(BX:!3Z_+N>0YVD %OE9D*[+&U42%(8,B$\]8R25)N2%$#$Z=S+RL(*"!HRC7%4_=2;AP*RJB,!S0%DVE3N7B7(YMQD,3*R)V M*#_'2(RS()X;I?_Y]XC"&^E'X:9PC""]6#;CS^N#I=U[3>%BH_=A&&!Z MNC\,&HB]%(TE*<#52.$7!^S";<^J* )&# R^G]DC21/7 -I%J \"]!@)D9M: M;YBV2IA'@=8&.E[_(C'&9G0RZ7%PT26\+B=$*1.%.E:+#J-2+2040\BG;7OG M8R$4HS_$)%F6"NJ].RLV;RD7J%6D)Z>_RAYK"C5D%]*%^@9B_4PFMKI9LGB> M\T-T)%WVF3) A2G$0@5>Y3/&XI?2PK":6L?-"^V69S1N3S]W"=+3@C\:_4&V M!.MQY 9*/4A@V?'3IS]HATQ&1-A(W(VB82SR_N[]/BE0 A/$W3":1^PZ5(HB M5QGH.^B%&Y%>%WKYIWY@8NLFQ'H[XX""',OS[,-NPOA*0\+T3&(9@DE+3-FS MDPO&*+$90HGLW2(*Q6UBSW>A]RYJ2C>6I"*8]*\D@G[>3&@\2L!H^$J&__G9 MHR0& L9M-U][[<+< 6*?,@ Q(@A"&"?0F698A#,M! AM$D/;Q!1X8$*1+DZ//@S(P$ ME0GU>8/HI(\C 93S[)TZ]JM:C?AW;U\^_9E^7%IWTSU OL]C#BQXL6,&SM^G#B3X+IB M/$*^_'@R5,R<.WO^#/JN7KJC0SL>S=!O1X70 )M^#3NV[,8W(-+-1'6VZ8$W M;>O^#3SXX=(FB0NWZY+@T\$(5QQ_#CUZXN4?)7E+Q^S3Z?7MW#T;Q]L]O/CQ MY,N;/X]>]_>,Z=N[?P\_OOSYG->OIX\_O_[]_/M_MN]?@ (.2&"!^ %H8((* M+LA@@Z8AZ&"$$DY(H8,05HAAAAINV-Z%P*%T6 R^/<;;8R*&YE-(EEU6(EUB MN*;0B8FAD5N((W*(8XX?_WGX6UI['72C8IEDY6-B;\$$&C$V39*4;!1IEA@Q M0=9(UR0KZH@EECSJUB)?-V3EF $>=8D8C5*!Z1ENP8GA!FTW9M)D7:ME26>. M6S:V%6 &:5=<07J%!(!@9&EEVTY0"5460A"%59!<,EF&D$)[+I?=/F( *IBB M G5TEDE"49E=)B5RBB112"J)TFB1;BH507I"N9H8DQR4FT52R]^=BZ$AK&0 V%36EY8F1,Q3:_%6HK2R[M,0H"Z.N9J8 M^T #0%+22LLD1=":- E@#G&;E)IP$E62M#L M8C%8IN:V)I7(6W:E4O34B2I%JG%Q@2UE,:O[<,'22PFA >4^9F[,K7.2 L"% MST#?5J3"^\@5X\5Q'E22,M9F @UU)ZVKKJ0P[A.LI4N-&F=MDB[5D-@^YU0U M>R#Q;/7)=NN7Y]W"PY^(QSKB<8]\5*,>^PC(0 KO MCX(LI"&UE)=#*G*1@TPD(Q\)_TE$RLD[5SJ:0E)5JO>X[#697 R3Z.B;EV1O M6N6"V$]G*B$2WP3G)9)2DK-'T6E(2^U@F535"%"T]1B:^R$@Q MO)S39=HFIRMU3&]7XDLP!T1(NAQ,#$J*'4/L5YQF7N>7@5D);(#4F(% <"\V M],WERK*")J%D;+(M[E4J2 F-1EMBNE#'0 M5=WV/NZ1:J(RZM-1'C:E$-'50T9EL*S<$IM&7>!JU":Y+OTM9,_S%+XZ4LV, MJ-:HGP180MC7$?C>:+HOPM3[M)B4\)+*+F6#[8U6H+Q$KI4 W4[1VWX9RPID8QDDA6C.HXCG1J7CZL#H[[55&8C$M<#N56J57:$ M"[:QZXZ$## !HK=)G^0R>J'JY@,VL[#D!-EMS%4TFN2&:*(Z29,Z.^0=_7)B M8[&-OFAJML1YV2Z^(O-JBXQFA$RB="8IV[LJV^6C3E=MR\2:0)0&DZZ5I<;\ MRDU#8!!JLDXIM0NHQ!%+%4@7>2UZ$79J]:+E3[2N :VY&SGU6Z9]QVHD%'SBZ(2P^E" MK4688,_+];@JOW3M!H\F ;+)TQ2.KB=*"1&8]L\%8)- M_/GT=N"MK3*M!3*JH'UE)7H?FZN2%8<,R9Y6W;L E0;N^+S\,#C1-%24XZ= M16HK0TG)B5#8$48-Y5,"YO^97P5/D(T"BK&O+U?3FO*4J*"EAS<2(C6[F!"D MN/13LP1^)L7@X"=C-$9?4NO?5[FTA$!Y@TUQ+:6VCTDPH808.+G)^8W_$9YV MNBAJ39U&8NF^@8*1]!P-%U02 MQ8(-4H*OH6U^,50P&(.O$5!)E8,+,H.O07N^5A8WTTD]^!LZ41(BJFHBJO(BJWHBJ\(B[$HB[-(B[5HB[>(B[FHB[O(B[WHBZ\8BL$HC,-( 2C,5HC,>(C,FHC,O(C/L1$ [ end XML 14 dd-20210331_htm.xml IDEA: XBRL DOCUMENT 0001755672 2021-01-01 2021-03-31 0001755672 dd:EIDMember 2021-01-01 2021-03-31 0001755672 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001755672 dd:A3.50SeriesPreferredStockMember dd:EIDMember 2021-01-01 2021-03-31 0001755672 dd:A4.50SeriesPreferredStockMember dd:EIDMember 2021-01-01 2021-03-31 0001755672 2021-04-30 0001755672 dd:EIDMember 2021-04-30 0001755672 2020-01-01 2020-03-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-03-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-03-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-03-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-03-31 0001755672 2021-03-31 0001755672 2020-12-31 0001755672 2020-03-31 0001755672 dd:TotalcompanyMember 2021-01-01 2021-03-31 0001755672 dd:TotalcompanyMember 2020-01-01 2020-03-31 0001755672 2019-12-31 0001755672 us-gaap:CommonStockMember 2019-12-31 0001755672 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001755672 us-gaap:RetainedEarningsMember 2019-12-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001755672 us-gaap:NoncontrollingInterestMember 2019-12-31 0001755672 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001755672 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-03-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001755672 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001755672 us-gaap:CommonStockMember 2020-03-31 0001755672 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001755672 us-gaap:RetainedEarningsMember 2020-03-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001755672 us-gaap:NoncontrollingInterestMember 2020-03-31 0001755672 us-gaap:CommonStockMember 2020-12-31 0001755672 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001755672 us-gaap:RetainedEarningsMember 2020-12-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001755672 us-gaap:NoncontrollingInterestMember 2020-12-31 0001755672 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001755672 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001755672 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001755672 us-gaap:CommonStockMember 2021-03-31 0001755672 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001755672 us-gaap:RetainedEarningsMember 2021-03-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001755672 us-gaap:NoncontrollingInterestMember 2021-03-31 0001755672 dd:InternalReorganizationMember 2020-01-01 2020-03-31 0001755672 dd:DuPontdeNemoursMember dd:AccountsandNotesReceivableMember 2021-03-31 0001755672 dd:DuPontdeNemoursMember us-gaap:OtherAssetsMember 2021-03-31 0001755672 dd:DuPontdeNemoursMember us-gaap:OtherNoncurrentLiabilitiesMember 2021-03-31 0001755672 dd:DowMember dd:AccruedandOtherCurrentLiabilitiesMember 2021-03-31 0001755672 dd:DowMember us-gaap:OtherNoncurrentLiabilitiesMember 2021-03-31 0001755672 dd:PerformanceChemicalsMember dd:AccountsandNotesReceivableMember 2021-03-31 0001755672 dd:PerformanceChemicalsMember us-gaap:OtherAssetsMember 2021-03-31 0001755672 dd:PerformanceChemicalsMember dd:AccruedandOtherCurrentLiabilitiesMember 2021-03-31 0001755672 dd:PerformanceChemicalsMember us-gaap:OtherNoncurrentLiabilitiesMember 2021-03-31 0001755672 dd:PerformanceChemicalsMember 2021-01-01 2021-03-31 0001755672 srt:MinimumMember 2021-03-31 0001755672 srt:MaximumMember 2021-03-31 0001755672 dd:AccruedandOtherCurrentLiabilitiesMember 2021-03-31 0001755672 dd:AccruedandOtherCurrentLiabilitiesMember 2020-12-31 0001755672 dd:AccruedandOtherCurrentLiabilitiesMember 2020-03-31 0001755672 us-gaap:OtherNoncurrentLiabilitiesMember 2021-03-31 0001755672 us-gaap:OtherNoncurrentLiabilitiesMember 2020-12-31 0001755672 us-gaap:OtherNoncurrentLiabilitiesMember 2020-03-31 0001755672 dd:MajorProductLineMember 2021-01-01 2021-03-31 0001755672 dd:CornMember dd:SeedMember 2021-01-01 2021-03-31 0001755672 dd:CornMember dd:SeedMember 2020-01-01 2020-03-31 0001755672 dd:SoybeanMember dd:SeedMember 2021-01-01 2021-03-31 0001755672 dd:SoybeanMember dd:SeedMember 2020-01-01 2020-03-31 0001755672 dd:OtheroilseedsMember dd:SeedMember 2021-01-01 2021-03-31 0001755672 dd:OtheroilseedsMember dd:SeedMember 2020-01-01 2020-03-31 0001755672 dd:OtherMember dd:SeedMember 2021-01-01 2021-03-31 0001755672 dd:OtherMember dd:SeedMember 2020-01-01 2020-03-31 0001755672 dd:SeedMember 2021-01-01 2021-03-31 0001755672 dd:SeedMember 2020-01-01 2020-03-31 0001755672 dd:HerbicidesMember dd:CropProtectionMember 2021-01-01 2021-03-31 0001755672 dd:HerbicidesMember dd:CropProtectionMember 2020-01-01 2020-03-31 0001755672 dd:InsecticidesMember dd:CropProtectionMember 2021-01-01 2021-03-31 0001755672 dd:InsecticidesMember dd:CropProtectionMember 2020-01-01 2020-03-31 0001755672 dd:FungicidesMember dd:CropProtectionMember 2021-01-01 2021-03-31 0001755672 dd:FungicidesMember dd:CropProtectionMember 2020-01-01 2020-03-31 0001755672 dd:OtherMember dd:CropProtectionMember 2021-01-01 2021-03-31 0001755672 dd:OtherMember dd:CropProtectionMember 2020-01-01 2020-03-31 0001755672 dd:CropProtectionMember 2021-01-01 2021-03-31 0001755672 dd:CropProtectionMember 2020-01-01 2020-03-31 0001755672 dei:LocationDomain 2021-01-01 2021-03-31 0001755672 srt:NorthAmericaMember dd:SeedMember 2021-01-01 2021-03-31 0001755672 srt:NorthAmericaMember dd:SeedMember 2020-01-01 2020-03-31 0001755672 us-gaap:EMEAMember dd:SeedMember 2021-01-01 2021-03-31 0001755672 us-gaap:EMEAMember dd:SeedMember 2020-01-01 2020-03-31 0001755672 srt:LatinAmericaMember dd:SeedMember 2021-01-01 2021-03-31 0001755672 srt:LatinAmericaMember dd:SeedMember 2020-01-01 2020-03-31 0001755672 srt:AsiaPacificMember dd:SeedMember 2021-01-01 2021-03-31 0001755672 srt:AsiaPacificMember dd:SeedMember 2020-01-01 2020-03-31 0001755672 srt:NorthAmericaMember dd:CropProtectionMember 2021-01-01 2021-03-31 0001755672 srt:NorthAmericaMember dd:CropProtectionMember 2020-01-01 2020-03-31 0001755672 us-gaap:EMEAMember dd:CropProtectionMember 2021-01-01 2021-03-31 0001755672 us-gaap:EMEAMember dd:CropProtectionMember 2020-01-01 2020-03-31 0001755672 srt:LatinAmericaMember dd:CropProtectionMember 2021-01-01 2021-03-31 0001755672 srt:LatinAmericaMember dd:CropProtectionMember 2020-01-01 2020-03-31 0001755672 srt:AsiaPacificMember dd:CropProtectionMember 2021-01-01 2021-03-31 0001755672 srt:AsiaPacificMember dd:CropProtectionMember 2020-01-01 2020-03-31 0001755672 srt:MinimumMember dd:A2021RestructuringActionsDomain 2021-03-31 0001755672 srt:MaximumMember dd:A2021RestructuringActionsDomain 2021-03-31 0001755672 srt:MinimumMember us-gaap:EmployeeSeveranceMember dd:A2021RestructuringActionsDomain 2021-03-31 0001755672 srt:MaximumMember us-gaap:EmployeeSeveranceMember dd:A2021RestructuringActionsDomain 2021-03-31 0001755672 srt:MinimumMember dd:AssetRelatedChargesMember dd:A2021RestructuringActionsDomain 2021-03-31 0001755672 srt:MaximumMember dd:AssetRelatedChargesMember dd:A2021RestructuringActionsDomain 2021-03-31 0001755672 srt:MinimumMember us-gaap:AssetRetirementObligationCostsMember dd:A2021RestructuringActionsDomain 2021-03-31 0001755672 srt:MaximumMember us-gaap:AssetRetirementObligationCostsMember dd:A2021RestructuringActionsDomain 2021-03-31 0001755672 srt:MinimumMember us-gaap:ContractTerminationMember dd:A2021RestructuringActionsDomain 2021-03-31 0001755672 srt:MaximumMember us-gaap:ContractTerminationMember dd:A2021RestructuringActionsDomain 2021-03-31 0001755672 dd:A2021RestructuringActionsDomain dd:SeedMember 2021-01-01 2021-03-31 0001755672 dd:A2021RestructuringActionsDomain dd:CropProtectionMember 2021-01-01 2021-03-31 0001755672 dd:A2021RestructuringActionsDomain us-gaap:CorporateMember 2021-01-01 2021-03-31 0001755672 dd:A2021RestructuringActionsDomain 2021-01-01 2021-03-31 0001755672 us-gaap:EmployeeSeveranceMember dd:A2021RestructuringActionsDomain 2020-12-31 0001755672 dd:AssetRelatedChargesMember dd:A2021RestructuringActionsDomain 2020-12-31 0001755672 dd:CostsRelatedToContractTerminationMember dd:A2021RestructuringActionsDomain 2020-12-31 0001755672 dd:A2021RestructuringActionsDomain 2020-12-31 0001755672 us-gaap:EmployeeSeveranceMember dd:A2021RestructuringActionsDomain 2021-01-01 2021-03-31 0001755672 dd:AssetRelatedChargesMember dd:A2021RestructuringActionsDomain 2021-01-01 2021-03-31 0001755672 dd:CostsRelatedToContractTerminationMember dd:A2021RestructuringActionsDomain 2021-01-01 2021-03-31 0001755672 us-gaap:EmployeeSeveranceMember dd:A2021RestructuringActionsDomain 2021-03-31 0001755672 dd:AssetRelatedChargesMember dd:A2021RestructuringActionsDomain 2021-03-31 0001755672 dd:CostsRelatedToContractTerminationMember dd:A2021RestructuringActionsDomain 2021-03-31 0001755672 dd:A2021RestructuringActionsDomain 2021-03-31 0001755672 dd:ExecutetoWinProductivityProgramDomain 2020-01-01 2021-03-31 0001755672 dd:AssetRelatedChargesMember dd:ExecutetoWinProductivityProgramDomain 2020-01-01 2021-03-31 0001755672 us-gaap:EmployeeSeveranceMember dd:ExecutetoWinProductivityProgramDomain 2020-01-01 2021-03-31 0001755672 dd:ExecutetoWinProductivityProgramDomain 2021-01-01 2021-03-31 0001755672 dd:ExecutetoWinProductivityProgramDomain dd:SeedMember 2021-01-01 2021-03-31 0001755672 dd:ExecutetoWinProductivityProgramDomain dd:SeedMember 2020-01-01 2020-03-31 0001755672 dd:ExecutetoWinProductivityProgramDomain dd:CropProtectionMember 2021-01-01 2021-03-31 0001755672 dd:ExecutetoWinProductivityProgramDomain dd:CropProtectionMember 2020-01-01 2020-03-31 0001755672 dd:ExecutetoWinProductivityProgramDomain us-gaap:CorporateNonSegmentMember 2021-01-01 2021-03-31 0001755672 dd:ExecutetoWinProductivityProgramDomain us-gaap:CorporateNonSegmentMember 2020-01-01 2020-03-31 0001755672 dd:ExecutetoWinProductivityProgramDomain 2020-01-01 2020-03-31 0001755672 us-gaap:EmployeeSeveranceMember dd:ExecutetoWinProductivityProgramDomain 2021-01-01 2021-03-31 0001755672 us-gaap:EmployeeSeveranceMember dd:ExecutetoWinProductivityProgramDomain 2020-01-01 2020-03-31 0001755672 dd:AssetRelatedChargesMember dd:ExecutetoWinProductivityProgramDomain 2021-01-01 2021-03-31 0001755672 dd:AssetRelatedChargesMember dd:ExecutetoWinProductivityProgramDomain 2020-01-01 2020-03-31 0001755672 us-gaap:EmployeeSeveranceMember dd:ExecutetoWinProductivityProgramDomain 2020-12-31 0001755672 dd:AssetRelatedChargesMember dd:ExecutetoWinProductivityProgramDomain 2020-12-31 0001755672 dd:ExecutetoWinProductivityProgramDomain 2020-12-31 0001755672 us-gaap:EmployeeSeveranceMember dd:ExecutetoWinProductivityProgramDomain 2021-03-31 0001755672 dd:AssetRelatedChargesMember dd:ExecutetoWinProductivityProgramDomain 2021-03-31 0001755672 dd:ExecutetoWinProductivityProgramDomain 2021-03-31 0001755672 srt:MinimumMember dd:ExecutetoWinProductivityProgramDomain 2021-01-01 2021-03-31 0001755672 srt:MaximumMember dd:ExecutetoWinProductivityProgramDomain 2021-01-01 2021-03-31 0001755672 dd:OtherAssetRelatedMember 2021-01-01 2021-03-31 0001755672 dd:OtherAssetRelatedMember 2020-01-01 2020-03-31 0001755672 us-gaap:MaterialReconcilingItemsMember dd:CropProtectionMember 2021-01-01 2021-03-31 0001755672 dd:HedgingProgramMember dd:ArgentinePesoDevaluationMember 2021-01-01 2021-03-31 0001755672 dd:HedgingProgramMember dd:ArgentinePesoDevaluationMember 2020-01-01 2020-03-31 0001755672 srt:SubsidiariesMember 2021-01-01 2021-03-31 0001755672 srt:SubsidiariesMember 2020-01-01 2020-03-31 0001755672 dd:HedgingProgramMember 2021-01-01 2021-03-31 0001755672 dd:HedgingProgramMember 2020-01-01 2020-03-31 0001755672 us-gaap:OtherCurrentAssetsMember 2021-03-31 0001755672 us-gaap:OtherCurrentAssetsMember 2020-12-31 0001755672 us-gaap:OtherCurrentAssetsMember 2020-03-31 0001755672 dd:FactoringAgreementMember 2021-01-01 2021-03-31 0001755672 dd:FactoringAgreementMember 2020-01-01 2020-03-31 0001755672 dd:FactoringAgreementMember 2021-03-31 0001755672 dd:FactoringAgreementMember 2020-12-31 0001755672 dd:FactoringAgreementMember 2020-03-31 0001755672 dd:GermplasmMember 2021-03-31 0001755672 dd:GermplasmMember 2020-12-31 0001755672 dd:GermplasmMember 2020-03-31 0001755672 us-gaap:CustomerRelatedIntangibleAssetsMember 2021-03-31 0001755672 us-gaap:CustomerRelatedIntangibleAssetsMember 2020-12-31 0001755672 us-gaap:CustomerRelatedIntangibleAssetsMember 2020-03-31 0001755672 us-gaap:DevelopedTechnologyRightsMember 2021-03-31 0001755672 us-gaap:DevelopedTechnologyRightsMember 2020-12-31 0001755672 us-gaap:DevelopedTechnologyRightsMember 2020-03-31 0001755672 us-gaap:TrademarksAndTradeNamesMember 2021-03-31 0001755672 us-gaap:TrademarksAndTradeNamesMember 2020-12-31 0001755672 us-gaap:TrademarksAndTradeNamesMember 2020-03-31 0001755672 dd:FavorableSupplyContractMember 2021-03-31 0001755672 dd:FavorableSupplyContractMember 2020-12-31 0001755672 dd:FavorableSupplyContractMember 2020-03-31 0001755672 us-gaap:OtherIntangibleAssetsMember 2021-03-31 0001755672 us-gaap:OtherIntangibleAssetsMember 2020-12-31 0001755672 us-gaap:OtherIntangibleAssetsMember 2020-03-31 0001755672 us-gaap:InProcessResearchAndDevelopmentMember 2021-03-31 0001755672 us-gaap:InProcessResearchAndDevelopmentMember 2020-12-31 0001755672 us-gaap:InProcessResearchAndDevelopmentMember 2020-03-31 0001755672 us-gaap:TradeNamesMember 2020-03-31 0001755672 us-gaap:SegmentContinuingOperationsMember 2021-03-31 0001755672 us-gaap:CommercialPaperMember 2021-03-31 0001755672 us-gaap:CommercialPaperMember 2020-12-31 0001755672 us-gaap:CommercialPaperMember 2020-03-31 0001755672 us-gaap:RepurchaseAgreementsMember us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember 2021-03-31 0001755672 us-gaap:RepurchaseAgreementsMember us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember 2020-12-31 0001755672 us-gaap:RepurchaseAgreementsMember us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember 2020-03-31 0001755672 dd:OtherloansvariouscurrenciesMember 2021-03-31 0001755672 dd:OtherloansvariouscurrenciesMember 2020-12-31 0001755672 dd:OtherloansvariouscurrenciesMember 2020-03-31 0001755672 us-gaap:FairValueInputsLevel2Member 2021-03-31 0001755672 us-gaap:FairValueInputsLevel2Member 2020-12-31 0001755672 us-gaap:FairValueInputsLevel2Member 2020-03-31 0001755672 us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember 2021-02-09 0001755672 dd:AccountsandNotesReceivableMember us-gaap:RepurchaseAgreementsMember us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember 2021-03-31 0001755672 dd:RevolvingCreditFacilitiesdue2024Member 2018-11-13 0001755672 srt:ScenarioForecastMember dd:RevolvingCreditFacilitiesdue2024Member 2018-11-13 2023-11-13 0001755672 dd:RevolvingCreditFacilitiesdue2022Member 2018-11-13 0001755672 srt:ScenarioForecastMember dd:RevolvingCreditFacilitiesdue2022Member 2018-11-13 2021-11-13 0001755672 dd:RevolvingCreditFacilitiesdue2022Member 2018-11-13 0001755672 dd:RevolvingCreditFacilitiesdue2022Member 2020-03-31 0001755672 dd:RevolvingCreditFacilitiesdue2022Member 2021-03-31 0001755672 dd:NotesMaturing2030Domain us-gaap:LoansPayableMember 2021-03-31 0001755672 dd:FactoringAgreementMember 2021-03-31 0001755672 dd:FactoringAgreementMember 2020-12-31 0001755672 dd:AgreementswithlenderstoprovidefinancingforselectcustomersMember 2021-03-31 0001755672 dd:AgreementswithlenderstoprovidefinancingforselectcustomersMember 2020-12-31 0001755672 dd:AgreementswithlenderstoprovidefinancingforselectcustomersMember 2020-03-31 0001755672 dd:DuPontdeNemoursMember dd:PFOAMattersMultiDistrictLitigationMember dd:CortevaMember 2017-04-01 2017-06-30 0001755672 dd:PFOAMattersMultiDistrictLitigationMember 2017-12-31 0001755672 dd:PostMDLSettlementPFOAPersonalInjuryClaimsDomain dd:ScheduledfortrialMember dd:PFOAMattersDrinkingWaterActionsMember 2021-03-31 0001755672 dd:PFASMember srt:MaximumMember 2021-01-01 2021-03-31 0001755672 dd:PFASMember srt:MaximumMember 2021-03-31 0001755672 dd:DuPontdeNemoursMember dd:PFASMember dd:CortevaMember 2021-03-31 0001755672 dd:DuPontdeNemoursMember dd:PFASMember srt:MaximumMember dd:CortevaMember 2021-03-31 0001755672 dd:DuPontdeNemoursMember 2021-03-31 0001755672 dd:DuPontdeNemoursMember 2021-03-31 0001755672 dd:CortevaMember 2021-03-31 0001755672 dd:PFASMember dd:ChemoursMember 2022-09-30 0001755672 dd:DuPontdeNemoursMember dd:PFASMember dd:CortevaMember 2022-09-30 0001755672 dd:PFASMember dd:ChemoursMember 2028-09-30 0001755672 dd:DuPontdeNemoursMember dd:PFASMember dd:CortevaMember 2028-09-30 0001755672 dd:PFASMember srt:MaximumMember dd:ChemoursMember 2028-09-30 0001755672 dd:DuPontdeNemoursMember dd:PFASMember srt:MaximumMember dd:CortevaMember 2028-09-30 0001755672 dd:PFASMember 2028-12-31 0001755672 dd:PFASMember dd:ChemoursMember 2021-03-31 0001755672 dd:DuPontdeNemoursMember dd:DuPontdeNemoursMember 2021-03-31 0001755672 dd:DuPontdeNemoursMember dd:CortevaMember 2021-03-31 0001755672 dd:PFASMember dd:CortevaMember 2021-03-31 0001755672 dd:PFASMember dd:DuPontdeNemoursMember 2021-03-31 0001755672 dd:PFASMember srt:MinimumMember 2021-03-31 0001755672 dd:PFASMember srt:MinimumMember dd:Once300millionthresholdismetMember 2021-03-31 0001755672 dd:ChemoursMember dd:PFOAMattersMember 2021-03-31 0001755672 dd:PFOAMattersDrinkingWaterActionsMember 2004-01-01 2004-12-31 0001755672 dd:PFOAMattersDrinkingWaterActionsMember 2012-01-01 0001755672 dd:PFOAMattersDrinkingWaterActionsMember 2004-12-31 0001755672 dd:PFOAMattersDrinkingWaterActionsMember 2012-01-01 2020-09-30 0001755672 dd:PFOAMattersDrinkingWaterActionsMember 2021-03-31 0001755672 dd:PFOAMattersMultiDistrictLitigationMember 2021-03-31 0001755672 dd:PFOAMattersMultiDistrictLitigationMember 2017-10-01 2017-12-31 0001755672 dd:CompensatorydamagesMember dd:PostMDLSettlementPFOAPersonalInjuryClaimsDomain dd:PFOAMattersDrinkingWaterActionsMember 2021-01-01 2021-03-31 0001755672 dd:LossofconsortiumMember dd:PostMDLSettlementPFOAPersonalInjuryClaimsDomain dd:PFOAMattersDrinkingWaterActionsMember 2021-01-01 2021-03-31 0001755672 dd:PostMDLSettlementPFOAPersonalInjuryClaimsDomain us-gaap:SettledLitigationMember dd:PFOAMattersDrinkingWaterActionsMember 2021-01-01 2021-03-31 0001755672 dd:MDLSettlementMember 2021-01-01 2021-03-31 0001755672 dd:ChemoursContributionToMDLSettlementMember 2021-01-01 2021-03-31 0001755672 dd:DuPontDeNemoursAndCortevaContributionToMDLSettlementMember 2021-01-01 2021-03-31 0001755672 stpr:NY dd:PFOAMattersDrinkingWaterActionsMember 2021-03-31 0001755672 stpr:NJ dd:PFOAMattersDrinkingWaterActionsMember 2021-03-31 0001755672 stpr:NJ dd:NaturalResourcesDamagesMember 2021-03-31 0001755672 stpr:OH dd:PFOAMattersDrinkingWaterActionsMember 2021-03-31 0001755672 dd:FirefightingFoamMember 2021-03-31 0001755672 dd:PersonalinjurycasesMember dd:FirefightingFoamMember 2021-03-31 0001755672 stpr:NC dd:PFOAMattersDrinkingWaterActionsMember 2021-01-01 2021-03-31 0001755672 dd:SuperfundSitesMember 2021-03-31 0001755672 dd:ChemoursrelatedobligationsubjecttoindemnificationMember 2021-03-31 0001755672 us-gaap:SegmentDiscontinuedOperationsMember 2021-03-31 0001755672 dd:OtherdiscontinuedordivestedbusinessobligationsMember 2021-03-31 0001755672 dd:EnvironmentalremediationliabilitiesprimarilyrelatedtoDuPontsubjecttoindemnityfromDuPontMember 2021-03-31 0001755672 dd:NotsubjecttoindemnificationMember 2021-03-31 0001755672 dd:ChemoursMember dd:SuperfundSitesMember us-gaap:IndemnificationGuaranteeMember 2021-03-31 0001755672 dd:PerformanceChemicalsMember 2021-03-31 0001755672 dd:NaturalResourcesDamagesMember dd:AlabamaWaterUtilityMember 2021-03-31 0001755672 dd:FactoringAgreementMember 2020-03-31 0001755672 2019-06-26 0001755672 dd:CortevaMember 2019-06-26 0001755672 dd:CortevaMember 2021-01-01 2021-03-31 0001755672 dd:CortevaMember 2020-01-01 2020-03-31 0001755672 dd:CortevaMember dd:EIDMember 2021-01-01 2021-03-31 0001755672 dd:A4.50SeriesPreferredStockMember dd:EIDMember 2021-03-31 0001755672 dd:A3.50SeriesPreferredStockMember dd:EIDMember 2021-03-31 0001755672 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0001755672 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-12-31 0001755672 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-12-31 0001755672 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-03-31 0001755672 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-01-01 2020-03-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-03-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-03-31 0001755672 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-03-31 0001755672 us-gaap:AccumulatedTranslationAdjustmentMember 2020-03-31 0001755672 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-03-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember 2020-03-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-03-31 0001755672 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-03-31 0001755672 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0001755672 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-12-31 0001755672 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-03-31 0001755672 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-01-01 2021-03-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-03-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-03-31 0001755672 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-01-01 2021-03-31 0001755672 us-gaap:AccumulatedTranslationAdjustmentMember 2021-03-31 0001755672 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-03-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember 2021-03-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-03-31 0001755672 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-03-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-03-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-03-31 0001755672 dd:AccumulatedDefinedBenefitPlansAdjustmentSettlementGainLossMember us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-03-31 0001755672 dd:AccumulatedDefinedBenefitPlansAdjustmentSettlementGainLossMember us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-03-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-03-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-03-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-03-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-03-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-03-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-03-31 0001755672 dd:A4.50SeriesPreferredStockMember dd:EIDMember 2020-12-31 0001755672 dd:A4.50SeriesPreferredStockMember dd:EIDMember 2020-03-31 0001755672 dd:A3.50SeriesPreferredStockMember dd:EIDMember 2020-12-31 0001755672 dd:A3.50SeriesPreferredStockMember dd:EIDMember 2020-03-31 0001755672 us-gaap:CashEquivalentsMember 2021-03-31 0001755672 us-gaap:CashEquivalentsMember 2020-12-31 0001755672 us-gaap:CashEquivalentsMember 2020-03-31 0001755672 dd:MarketableSecuritiesMember 2021-03-31 0001755672 dd:MarketableSecuritiesMember 2020-12-31 0001755672 dd:MarketableSecuritiesMember 2020-03-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-03-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0001755672 us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-03-31 0001755672 us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001755672 us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2021-03-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-03-31 0001755672 us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2021-03-31 0001755672 us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2020-12-31 0001755672 us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2020-03-31 0001755672 us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-03-31 0001755672 us-gaap:CommodityContractMember 2021-01-01 2021-03-31 0001755672 us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001755672 us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-03-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-03-31 0001755672 us-gaap:ForeignExchangeContractMember 2021-01-01 2021-03-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-03-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2021-03-31 0001755672 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-03-31 0001755672 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2021-03-31 0001755672 dd:AccruedandOtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-03-31 0001755672 dd:AccruedandOtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2021-03-31 0001755672 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001755672 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-12-31 0001755672 dd:AccruedandOtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001755672 dd:AccruedandOtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-12-31 0001755672 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0001755672 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-03-31 0001755672 dd:AccruedandOtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-03-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-03-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-03-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-03-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-03-31 0001755672 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-03-31 0001755672 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-03-31 0001755672 us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-03-31 0001755672 us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-03-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2021-01-01 2021-03-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2020-01-01 2020-03-31 0001755672 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2021-01-01 2021-03-31 0001755672 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2020-01-01 2020-03-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2021-01-01 2021-03-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2020-01-01 2020-03-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2021-01-01 2021-03-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2020-01-01 2020-03-31 0001755672 us-gaap:CommodityContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2021-01-01 2021-03-31 0001755672 us-gaap:CommodityContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2020-01-01 2020-03-31 0001755672 us-gaap:NondesignatedMember 2021-01-01 2021-03-31 0001755672 us-gaap:NondesignatedMember 2020-01-01 2020-03-31 0001755672 us-gaap:AvailableforsaleSecuritiesMember 2021-01-01 2021-03-31 0001755672 us-gaap:USTreasurySecuritiesMember 2021-03-31 0001755672 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001755672 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2021-03-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001755672 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001755672 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001755672 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2020-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001755672 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001755672 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001755672 dd:SeedMember 2021-03-31 0001755672 dd:CropProtectionMember 2021-03-31 0001755672 dd:SeedMember 2020-03-31 0001755672 dd:CropProtectionMember 2020-03-31 0001755672 dd:SeedMember 2020-12-31 0001755672 dd:CropProtectionMember 2020-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember 2021-01-01 2021-03-31 0001755672 us-gaap:MaterialReconcilingItemsMember 2020-01-01 2020-03-31 0001755672 us-gaap:MaterialReconcilingItemsMember dd:SeedMember 2021-01-01 2021-03-31 0001755672 us-gaap:MaterialReconcilingItemsMember us-gaap:CorporateNonSegmentMember 2021-01-01 2021-03-31 0001755672 us-gaap:MaterialReconcilingItemsMember dd:SeedMember 2020-01-01 2020-03-31 0001755672 us-gaap:MaterialReconcilingItemsMember dd:CropProtectionMember 2020-01-01 2020-03-31 0001755672 us-gaap:MaterialReconcilingItemsMember us-gaap:CorporateNonSegmentMember 2020-01-01 2020-03-31 0001755672 us-gaap:MaterialReconcilingItemsMember dd:CropProtectionMember dd:LaPorteMember 2020-01-01 2020-03-31 0001755672 us-gaap:MaterialReconcilingItemsMember dd:LaPorteMember 2020-01-01 2020-03-31 0001755672 dd:EIDMember 2020-01-01 2020-03-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember dd:EIDMember 2021-01-01 2021-03-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember dd:EIDMember 2020-01-01 2020-03-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember dd:EIDMember 2021-01-01 2021-03-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember dd:EIDMember 2020-01-01 2020-03-31 0001755672 dd:EIDMember 2021-03-31 0001755672 dd:EIDMember 2020-12-31 0001755672 dd:EIDMember 2020-03-31 0001755672 dd:TotalcompanyMember dd:EIDMember 2021-01-01 2021-03-31 0001755672 dd:TotalcompanyMember dd:EIDMember 2020-01-01 2020-03-31 0001755672 dd:EIDMember 2019-12-31 0001755672 us-gaap:PreferredStockMember dd:EIDMember 2019-12-31 0001755672 us-gaap:CommonStockMember dd:EIDMember 2019-12-31 0001755672 us-gaap:AdditionalPaidInCapitalMember dd:EIDMember 2019-12-31 0001755672 us-gaap:RetainedEarningsMember dd:EIDMember 2019-12-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember dd:EIDMember 2019-12-31 0001755672 us-gaap:NoncontrollingInterestMember dd:EIDMember 2019-12-31 0001755672 us-gaap:RetainedEarningsMember dd:EIDMember 2020-01-01 2020-03-31 0001755672 us-gaap:NoncontrollingInterestMember dd:EIDMember 2020-01-01 2020-03-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember dd:EIDMember 2020-01-01 2020-03-31 0001755672 us-gaap:AdditionalPaidInCapitalMember dd:EIDMember 2020-01-01 2020-03-31 0001755672 us-gaap:PreferredStockMember dd:EIDMember 2020-03-31 0001755672 us-gaap:CommonStockMember dd:EIDMember 2020-03-31 0001755672 us-gaap:AdditionalPaidInCapitalMember dd:EIDMember 2020-03-31 0001755672 us-gaap:RetainedEarningsMember dd:EIDMember 2020-03-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember dd:EIDMember 2020-03-31 0001755672 us-gaap:NoncontrollingInterestMember dd:EIDMember 2020-03-31 0001755672 us-gaap:PreferredStockMember dd:EIDMember 2020-12-31 0001755672 us-gaap:CommonStockMember dd:EIDMember 2020-12-31 0001755672 us-gaap:AdditionalPaidInCapitalMember dd:EIDMember 2020-12-31 0001755672 us-gaap:RetainedEarningsMember dd:EIDMember 2020-12-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember dd:EIDMember 2020-12-31 0001755672 us-gaap:NoncontrollingInterestMember dd:EIDMember 2020-12-31 0001755672 us-gaap:RetainedEarningsMember dd:EIDMember 2021-01-01 2021-03-31 0001755672 us-gaap:NoncontrollingInterestMember dd:EIDMember 2021-01-01 2021-03-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember dd:EIDMember 2021-01-01 2021-03-31 0001755672 us-gaap:AdditionalPaidInCapitalMember dd:EIDMember 2021-01-01 2021-03-31 0001755672 us-gaap:PreferredStockMember dd:EIDMember 2021-03-31 0001755672 us-gaap:CommonStockMember dd:EIDMember 2021-03-31 0001755672 us-gaap:AdditionalPaidInCapitalMember dd:EIDMember 2021-03-31 0001755672 us-gaap:RetainedEarningsMember dd:EIDMember 2021-03-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember dd:EIDMember 2021-03-31 0001755672 us-gaap:NoncontrollingInterestMember dd:EIDMember 2021-03-31 0001755672 dd:A4.50SeriesPreferredStockMember dd:EIDMember 2020-01-01 2020-03-31 0001755672 dd:A3.50SeriesPreferredStockMember dd:EIDMember 2020-01-01 2020-03-31 0001755672 dd:CortevaMember 2021-03-31 0001755672 dd:CortevaMember dd:EIDMember 2021-03-31 0001755672 dd:CortevaMember dd:EIDMember 2020-03-31 0001755672 dd:CortevaMember dd:EIDMember 2021-01-01 2021-03-31 0001755672 dd:CortevaMember dd:EIDMember 2020-01-01 2020-03-31 0001755672 dd:AccruedandOtherCurrentLiabilitiesMember dd:CortevaMember dd:EIDMember 2021-03-31 0001755672 us-gaap:OtherNoncurrentLiabilitiesMember dd:CortevaMember dd:EIDMember 2021-03-31 0001755672 dd:AccruedandOtherCurrentLiabilitiesMember dd:CortevaMember dd:EIDMember 2020-12-31 0001755672 dd:AccruedandOtherCurrentLiabilitiesMember dd:CortevaMember dd:EIDMember 2020-03-31 0001755672 us-gaap:OtherNoncurrentLiabilitiesMember dd:CortevaMember dd:EIDMember 2020-03-31 0001755672 dd:CortevaMember dd:EIDMember 2020-12-31 0001755672 us-gaap:OtherNoncurrentLiabilitiesMember dd:CortevaMember dd:EIDMember 2020-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember dd:EIDMember 2021-01-01 2021-03-31 0001755672 us-gaap:MaterialReconcilingItemsMember dd:EIDMember 2020-01-01 2020-03-31 shares iso4217:USD shares iso4217:USD pure dd:lawsuits iso4217:EUR 2021-03-31 2021-03-31 10-Q 10-Q false false 2021-03-31 2021-03-31 0001755672 0000030554 --12-31 --12-31 2021 2021 Q1 Q1 Large Accelerated Filer Non-accelerated Filer false false false false false true 0.01 0.01 0.01 1666667000 1666667000 1666667000 738321000 743458000 748369000 3874000000 3857000000 3406000000 0.13 0.13 -83000000 38000000 54000000 41000000 500000000 0.0230 1 17000000 120 120 120 102 102 102 23000000 23000000 1673000 1673000 700000 700000 23000000 23000000 23000000 0.30 0.30 0.30 1800000000 1800000000 1800000000 200 200 200 0 0 0 23000000 23000000 23000000 1673000 1673000 1673000 120 120 120 0 0 0 23000000 23000000 23000000 700000 700000 700000 102 102 102 3874000000 3857000000 3406000000 1.125 1.125 0.875 0.875 0.0162 92000000 10-Q true false 001-38710 Corteva, Inc. DE 82-4979096 974 Centre Road, Wilmington, DE 19805 (302) 485-3000 1-815 E. I. du Pont de Nemours and Company DE 51-0014090 974 Centre Road, Wilmington, DE 19805 (302) 485-3000 Common Stock, par value $0.01 per share CTVA NYSE $3.50 Series Preferred Stock CTAPrA NYSE $4.50 Series Preferred Stock CTAPrB NYSE Yes Yes Yes Yes Large Accelerated Filer Non-accelerated Filer false false 737101000 0.01 200 0.30 4178000000 3956000000 2420000000 2269000000 281000000 280000000 733000000 757000000 183000000 163000000 100000000 70000000 337000000 1000000 7000000 10000000 791000000 408000000 178000000 127000000 613000000 281000000 -10000000 1000000 603000000 282000000 3000000 10000000 600000000 272000000 0.82 0.36 -0.01 0 0.81 0.36 0.81 0.36 -0.01 0 0.80 0.36 603000000 282000000 -403000000 -672000000 -8000000 0 157000000 -3000000 10000000 0 65000000 6000000 -477000000 -663000000 126000000 -381000000 3000000 10000000 123000000 -391000000 2404000000 3526000000 1963000000 114000000 269000000 10000000 6792000000 4926000000 6775000000 4321000000 4882000000 4401000000 1405000000 1165000000 1530000000 15036000000 14768000000 14679000000 64000000 66000000 64000000 4299000000 4396000000 4358000000 10146000000 10269000000 10027000000 10584000000 10747000000 11241000000 433000000 464000000 273000000 1987000000 1939000000 2336000000 42549000000 42649000000 42978000000 1250000000 3000000 1996000000 3098000000 3615000000 3021000000 165000000 123000000 143000000 2247000000 2662000000 1996000000 2239000000 2145000000 2043000000 8999000000 8548000000 9199000000 1102000000 1102000000 614000000 902000000 893000000 911000000 4954000000 5176000000 6186000000 1814000000 1867000000 1989000000 8772000000 9038000000 9700000000 7000000 7000000 7000000 27630000000 27707000000 27906000000 268000000 0 -155000000 -3367000000 -2890000000 -3933000000 24538000000 24824000000 23825000000 240000000 239000000 254000000 24778000000 25063000000 24079000000 42549000000 42649000000 42978000000 603000000 282000000 304000000 283000000 47000000 26000000 -318000000 -85000000 -84000000 -95000000 0 46000000 100000000 70000000 54000000 138000000 -2012000000 -1685000000 467000000 398000000 -448000000 -557000000 -401000000 -575000000 -262000000 -176000000 -1950000000 -1930000000 137000000 128000000 20000000 11000000 40000000 67000000 194000000 58000000 1000000 4000000 36000000 -130000000 828000000 1619000000 419000000 875000000 0 1000000 350000000 50000000 38000000 14000000 97000000 97000000 -17000000 -16000000 821000000 2344000000 -50000000 -117000000 -1143000000 167000000 3873000000 2173000000 2730000000 2340000000 7000000 27997000000 -425000000 -3270000000 246000000 24555000000 272000000 10000000 282000000 -663000000 -663000000 -97000000 -97000000 14000000 14000000 2000000 2000000 -50000000 -50000000 40000000 -2000000 -2000000 36000000 7000000 27906000000 -155000000 -3933000000 254000000 24079000000 7000000 27707000000 0 -2890000000 239000000 25063000000 600000000 3000000 603000000 -477000000 -477000000 -97000000 -97000000 38000000 38000000 -18000000 -332000000 -350000000 -2000000 -2000000 7000000 27630000000 268000000 -3367000000 240000000 24778000000 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited interim Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included.  Results for interim periods should not be considered indicative of results for a full year.  These interim Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2020, collectively referred to as the “2020 Annual Report.”  The interim Consolidated Financial Statements include the accounts of the company and all of its subsidiaries in which a controlling interest is maintained.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications of prior year's data have been made to conform to current year's presentation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter 2020, the company recorded an increase of $40 million to APIC relating to net assets recorded as transferred as part of the 2019 Internal Reorganizations that were retained. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since 2018, Argentina has been considered a hyper-inflationary economy under U.S. GAAP and therefore the U.S. Dollar (“USD”) is the functional currency for our related subsidiaries. We remeasure the net monetary assets utilizing the official Argentine Peso (“Peso”) to USD exchange rate. The devaluation of the Peso relative to the USD over the last several years has resulted in the recognition of exchange losses (refer to Note 6 of these financial statements and Note 9 of the 2020 financial statements included in the Company's Annual Report on Form 10-K). As of March 31, 2021, a further 10% deterioration in the official Peso to USD exchange rate would reduce the USD value of our net monetary assets and negatively impact pre-tax earnings by approximately $20 million.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited interim Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included.  Results for interim periods should not be considered indicative of results for a full year.  These interim Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2020, collectively referred to as the “2020 Annual Report.”  The interim Consolidated Financial Statements include the accounts of the company and all of its subsidiaries in which a controlling interest is maintained.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications of prior year's data have been made to conform to current year's presentation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter 2020, the company recorded an increase of $40 million to APIC relating to net assets recorded as transferred as part of the 2019 Internal Reorganizations that were retained. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since 2018, Argentina has been considered a hyper-inflationary economy under U.S. GAAP and therefore the U.S. Dollar (“USD”) is the functional currency for our related subsidiaries. We remeasure the net monetary assets utilizing the official Argentine Peso (“Peso”) to USD exchange rate. The devaluation of the Peso relative to the USD over the last several years has resulted in the recognition of exchange losses (refer to Note 6 of these financial statements and Note 9 of the 2020 financial statements included in the Company's Annual Report on Form 10-K). As of March 31, 2021, a further 10% deterioration in the official Peso to USD exchange rate would reduce the USD value of our net monetary assets and negatively impact pre-tax earnings by approximately $20 million.</span></div> 40000000 0.10 20000000 RECENT ACCOUNTING GUIDANCE <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Guidance</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which was part of the FASB’s Simplification Initiative to identify, evaluate, and improve areas of U.S. GAAP for which cost and complexity can be reduced, while maintaining or improving the usefulness of the information provided to users of financial statements. This ASU amends ASC 740, Income Taxes, by removing certain exceptions to the general principles, and clarifying and amending current guidance. The new standard is effective for fiscal years, and periods within those fiscal years, beginning after December 15, 2020. The company adopted this guidance on January 1, 2021 and it did not have a material impact on the company’s financial position, results of operation or cash flows.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Guidance</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which was part of the FASB’s Simplification Initiative to identify, evaluate, and improve areas of U.S. GAAP for which cost and complexity can be reduced, while maintaining or improving the usefulness of the information provided to users of financial statements. This ASU amends ASC 740, Income Taxes, by removing certain exceptions to the general principles, and clarifying and amending current guidance. The new standard is effective for fiscal years, and periods within those fiscal years, beginning after December 15, 2020. The company adopted this guidance on January 1, 2021 and it did not have a material impact on the company’s financial position, results of operation or cash flows.</span></div> DIVESTITURES AND OTHER TRANSACTIONS <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Separation Agreements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Distributions, DuPont, Corteva, and Dow (together, the “Parties” and each a “Party”) have entered into certain agreements to effect the Separation, provide for the allocation of DowDuPont’s assets, employees, liabilities and obligations (including its investments, property and employee benefits and tax-related assets and liabilities) among the Parties, and provide a framework for Corteva's relationship with Dow and DuPont following the separations and Distributions (collectively, the "Separation Agreements"). For additional information see Note 13 - Commitments and Contingent Liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DuPont</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Separation Agreements, DuPont and Corteva indemnifies the other against certain litigation, environmental, tax, workers' compensation and other liabilities that arose prior to the Corteva Distribution. The term of this indemnification is generally indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. At March 31, 2021, the indemnification assets are $28 million within accounts and notes receivable - net and $51 million within other assets in the interim Condensed Consolidated Balance Sheet. At March 31, 2021, the indemnification liabilities are $77 million within other noncurrent obligations in the interim Condensed Consolidated Balance Sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dow</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Separation Agreements, Dow and Corteva indemnifies the other against certain litigation, environmental, tax and other liabilities that arose prior to the Corteva Distribution. The term of this indemnification is generally indefinite and </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. At March 31, 2021, the indemnification liabilities are $52 million within accrued and other current liabilities and $14 million within other noncurrent obligations in the interim Condensed Consolidated Balance Sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Chemicals</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2015, Historical DuPont completed the separation of its Performance Chemicals segment through the spin-off of all of the issued and outstanding stock of The Chemours Company (the "Chemours Separation"). In connection with the Chemours Separation, Historical DuPont and The Chemours Company ("Chemours") entered into a Separation Agreement (as amended, the "Chemours Separation Agreement"), discussed below, a Tax Matters Agreement and certain ancillary agreements, including an employee matters agreement, agreements related to transition and site services, and intellectual property cross licensing arrangements. In addition, the companies entered into certain supply agreements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Separation Agreement</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Chemours Separation Agreement sets forth, among other things, the agreements between the company and Chemours regarding the principal transactions necessary to effect the Chemours Separation and also sets forth ancillary agreements that govern certain aspects of the company’s relationship with Chemours after the separation. Among other matters, the Chemours Separation Agreement and the ancillary agreements provide for the allocation between Historical DuPont and Chemours of assets, employees, liabilities and obligations (including investments, property and employee benefits and tax-related assets and liabilities) attributable to periods prior to, at and after the completion of the Chemours Separation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Chemours Separation Agreement, Chemours indemnifies the company against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the distribution. The term of this indemnification is generally indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In 2017, EID and Chemours amended the Chemours Separation Agreement ("2017 Amendment") to provide for a limited sharing of potential future perfluorooctanoic acid (“PFOA”) liabilities for a period of five years beginning July 6, 2017. In January 2021, Chemours, DuPont and Corteva entered into a binding memorandum of understanding ("MOU") amending the Chemours Separation Agreement, and thereby replacing the 2017 Amendment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. At March 31, 2021, the indemnification assets are $63 million within accounts and notes receivable - net and $259 million within other assets (along with the corresponding liabilities within accrued and other current liabilities and other noncurrent obligations in the interim Condensed Consolidated Balance Sheet.) Additionally, at March 31, 2021 indemnification liabilities related to the MOU, primarily associated with environmental remediation related to PFAS, were $10 million within accrued and other current liabilities and $44 million within other noncurrent obligations in the interim Condensed Consolidated Balance Sheet. During the three months ended March 31, 2021, the company recorded a charge of $3 million to (loss) income from discontinued operations after income taxes, related to the MOU.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 13 - Commitments and Contingent Liabilities, to the interim Consolidated Financial Statements, for further discussion of the amendment to the Chemours Separation Agreement, MOU, and environmental matters indemnified by Chemours.</span></div> 28000000 51000000 77000000 52000000 14000000 63000000 259000000 -10000000 -44000000 3000000 REVENUE<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Products</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of Corteva's revenue is derived from product sales. Product sales consist of sales of Corteva's products to farmers, distributors, and manufacturers. Corteva considers purchase orders, which in some cases are governed by master supply agreements, to be a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year. However, the company has some long-term contracts which can span multiple years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from product sales is recognized when the customer obtains control of the company's product, which occurs at a point in time according to shipping terms. Payment terms are generally less than one year from invoicing. The company elected the practical expedient and does not adjust the promised amount of consideration for the effects of a significant financing component when the company expects it will be one year or less between when a customer obtains control of the company's product and when payment is due. The company has elected to recognize shipping and handling activities when control has transferred to the customer as an expense in cost of goods sold. Taxes collected from customers relating to product sales and </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">remitted to governmental authorities are excluded from revenues. In addition, the company elected the practical expedient to expense any costs to obtain contracts as incurred, as the amortization period for these costs would have been one year or less.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price includes estimates of variable consideration, such as rights of return, rebates, and discounts, that are reductions in revenue. All estimates are based on the company's historical experience, anticipated performance, and the company's best judgment at the time the estimate is made. Estimates of variable consideration included in the transaction price utilize either the expected value method or most likely amount depending on the nature of the variable consideration. These estimates are reassessed each reporting period and are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur upon resolution of uncertainty associated with the variable consideration. The majority of contracts have a single performance obligation satisfied at a point in time and the transaction price is stated in the contract, usually as quantity times price per unit. For contracts with multiple performance obligations, the company allocates the transaction price to each performance obligation based on the relative standalone selling price. The standalone selling price is the observable price which depicts the price as if sold to a similar customer in similar circumstances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Licenses of Intellectual Property</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corteva enters into licensing arrangements with customers under which it licenses its intellectual property. Revenue from the majority of intellectual property licenses is derived from sales-based royalties. Revenue for licensing agreements that contain sales-based royalties is recognized at the later of (i) when the subsequent sale occurs or (ii) when the performance obligation to which some or all of the royalty has been allocated is satisfied. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Remaining Performance Obligations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. The company applies the practical expedient to disclose the transaction price allocated to the remaining performance obligations for only those contracts with an original duration of one year or more. The transaction price allocated to remaining performance obligations with an original duration of more than one year related to material rights granted to customers for contract renewal options were $113 million at March 31, 2021 ($115 million and $106 million at December 31, 2020 and March 31, 2020, respectively). The company expects revenue to be recognized for the remaining performance obligations over the next 1 year to 6 years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Balances</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily reflect deferred revenue from prepayments under contracts with customers where the company receives advance payments for products to be delivered in future periods. Corteva classifies deferred revenue as current or noncurrent based on the timing of when the company expects to recognize revenue. Contract assets primarily include amounts related to contractual rights to consideration for completed performance not yet invoiced. Accounts receivable are recorded when the right to consideration becomes unconditional.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.030%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Balances</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts and notes receivable - trade</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,764 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,917 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,779 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets - current</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets - noncurrent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue - current</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,247 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,662 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,996 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue - noncurrent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Included in accounts and notes receivable - net in the interim Condensed Consolidated Balance Sheets.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Included in other current assets in the interim Condensed Consolidated Balance Sheets. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Included in other assets in the interim Condensed Consolidated Balance Sheets.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Included in other noncurrent obligations in the interim Condensed Consolidated Balance Sheets. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized during the three months ended March 31, 2021 from amounts included in deferred revenue at the beginning of the period was $924 million ($822 million in the three months ended March 31, 2020).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corteva's operations are classified into two reportable segments: Seed and Crop Protection. The company disaggregates its revenue by major product line and geographic region, as the company believes it best depicts the nature, amount and timing of its revenue and cash flows. Net sales by major product line are included below:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.036%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Corn</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,888 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,864 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Soybean</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Other oilseeds</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Other</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seed</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,492 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Herbicides</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">986 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Insecticides</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Fungicides</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Other</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Crop Protection</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,686 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,501 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,178 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,956 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales are attributed to geographic regions based on customer location. Net sales by geographic region and segment are included below:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.338%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.182%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Seed</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,492 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.338%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.182%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Crop Protection</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,686 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,501 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Represents U.S. &amp; Canada.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Europe, Middle East, and Africa ("EMEA").</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Products</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of Corteva's revenue is derived from product sales. Product sales consist of sales of Corteva's products to farmers, distributors, and manufacturers. Corteva considers purchase orders, which in some cases are governed by master supply agreements, to be a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year. However, the company has some long-term contracts which can span multiple years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from product sales is recognized when the customer obtains control of the company's product, which occurs at a point in time according to shipping terms. Payment terms are generally less than one year from invoicing. The company elected the practical expedient and does not adjust the promised amount of consideration for the effects of a significant financing component when the company expects it will be one year or less between when a customer obtains control of the company's product and when payment is due. The company has elected to recognize shipping and handling activities when control has transferred to the customer as an expense in cost of goods sold. Taxes collected from customers relating to product sales and </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">remitted to governmental authorities are excluded from revenues. In addition, the company elected the practical expedient to expense any costs to obtain contracts as incurred, as the amortization period for these costs would have been one year or less.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price includes estimates of variable consideration, such as rights of return, rebates, and discounts, that are reductions in revenue. All estimates are based on the company's historical experience, anticipated performance, and the company's best judgment at the time the estimate is made. Estimates of variable consideration included in the transaction price utilize either the expected value method or most likely amount depending on the nature of the variable consideration. These estimates are reassessed each reporting period and are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur upon resolution of uncertainty associated with the variable consideration. The majority of contracts have a single performance obligation satisfied at a point in time and the transaction price is stated in the contract, usually as quantity times price per unit. For contracts with multiple performance obligations, the company allocates the transaction price to each performance obligation based on the relative standalone selling price. The standalone selling price is the observable price which depicts the price as if sold to a similar customer in similar circumstances.</span></div> Licenses of Intellectual PropertyCorteva enters into licensing arrangements with customers under which it licenses its intellectual property. Revenue from the majority of intellectual property licenses is derived from sales-based royalties. Revenue for licensing agreements that contain sales-based royalties is recognized at the later of (i) when the subsequent sale occurs or (ii) when the performance obligation to which some or all of the royalty has been allocated is satisfied. 113000000 115000000 106000000 P1Y P6Y <div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.030%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Balances</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts and notes receivable - trade</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,764 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,917 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,779 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets - current</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets - noncurrent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue - current</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,247 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,662 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,996 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue - noncurrent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Included in accounts and notes receivable - net in the interim Condensed Consolidated Balance Sheets.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Included in other current assets in the interim Condensed Consolidated Balance Sheets. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Included in other assets in the interim Condensed Consolidated Balance Sheets.</span></div>4.Included in other noncurrent obligations in the interim Condensed Consolidated Balance Sheets. 5764000000 3917000000 5779000000 22000000 22000000 20000000 53000000 54000000 49000000 2247000000 2662000000 1996000000 111000000 116000000 104000000 924000000 822000000 <div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.036%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Corn</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,888 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,864 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Soybean</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Other oilseeds</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Other</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seed</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,492 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Herbicides</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">986 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Insecticides</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Fungicides</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Other</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Crop Protection</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,686 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,501 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,178 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,956 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div> 1888000000 1864000000 177000000 181000000 296000000 248000000 131000000 162000000 2492000000 2455000000 986000000 823000000 385000000 378000000 261000000 229000000 54000000 71000000 1686000000 1501000000 4178000000 3956000000 <div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.338%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.182%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Seed</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,492 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.338%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.182%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Crop Protection</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,686 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,501 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Represents U.S. &amp; Canada.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Europe, Middle East, and Africa ("EMEA").</span></div> 1210000000 1290000000 947000000 881000000 274000000 216000000 61000000 68000000 2492000000 2455000000 533000000 475000000 655000000 586000000 244000000 218000000 254000000 222000000 1686000000 1501000000 130000000 170000000 40000000 50000000 40000000 60000000 10000000 15000000 40000000 45000000 80000000 100000000 14000000 28000000 47000000 89000000 0 0 0 0 39000000 13000000 37000000 89000000 -1000000 0 -6000000 -7000000 0 -13000000 0 -13000000 38000000 0 31000000 69000000 6000000 180000000 117000000 63000000 <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.952%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.375%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seed</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Crop Protection</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.952%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.375%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and related benefit costs</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset related charges</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring and asset related charges - net</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:37.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.458%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.458%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:19.459%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Severance and Related Benefit Costs</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Asset Related</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges to income from continuing operations for the three months ended March 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset write-offs</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 0 3000000 4000000 18000000 0 42000000 4000000 63000000 0 42000000 4000000 21000000 4000000 63000000 53000000 3000000 56000000 0 4000000 4000000 11000000 3000000 14000000 0 -4000000 -4000000 42000000 0 42000000 20000000 P12M P24M 7000000 10000000 SUPPLEMENTARY INFORMATION<div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.427%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Income - Net</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings / (losses) of affiliates - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss on sales of businesses and other assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net exchange losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating pension and other post employment benefit credit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Miscellaneous income - net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income - net</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The three months ended March 31, 2020 includes a loss of $(53) million relating to the sale of the La Porte site, for which the company signed an agreement in 2020, and closed during the first quarter of 2021.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Includes net pre-tax exchange losses of $(23) million and $(9) million associated with the devaluation of the Argentine peso for the three months ended March 31, 2021 and 2020, respectively.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement loss).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Miscellaneous income - net, includes a gain from a remeasurement of an equity investment, losses on sale of available-for-sale securities, tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont, losses on sale of receivables, and other items.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the impacts of the company's foreign currency hedging program on the company's results of operations. The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The hedging program gains (losses) are largely taxable (tax deductible) in the U.S., whereas the offsetting exchange gains (losses) on the remeasurement of the net monetary asset positions are often not taxable (tax deductible) in their local jurisdictions. The net pre-tax exchange gains (losses) are recorded in other income - net and the related tax impact is recorded in provision for (benefit from) income taxes on continuing operations in the interim Consolidated Statement of Operations. </span></div><div style="margin-bottom:8pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.989%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Subsidiary Monetary Position (Losses) Gains</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-tax exchange losses</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Local tax (expenses) / benefits</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net after-tax impact from subsidiary exchange losses</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(203)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Hedging Program Gains</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-tax exchange gains</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax expenses</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net after-tax impact from hedging program exchange gains</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Exchange Losses</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-tax exchange losses</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax expenses</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net after-tax exchange losses</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash, cash equivalents and restricted cash</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash and cash equivalents and restricted cash (included in other current assets) presented in the interim Condensed Consolidated Balance Sheets to the total cash, cash equivalents and restricted cash presented in the interim Consolidated Statements of Cash Flows.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:42.448%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.816%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,404 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,526 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,963 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,730 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,873 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,340 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EID entered into a trust agreement in 2013 (as amended and restated in 2017), establishing and requiring EID to fund a trust (the "Trust") for cash obligations under certain non-qualified benefit and deferred compensation plans upon a change in control event as defined in the Trust agreement. Under the Trust agreement, the consummation of the Merger was a change in control event. Restricted cash at March 31, 2021, December 31, 2020, and March 31, 2020 is related to the Trust.</span></div> <div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.427%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Income - Net</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings / (losses) of affiliates - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss on sales of businesses and other assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net exchange losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating pension and other post employment benefit credit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Miscellaneous income - net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income - net</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The three months ended March 31, 2020 includes a loss of $(53) million relating to the sale of the La Porte site, for which the company signed an agreement in 2020, and closed during the first quarter of 2021.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Includes net pre-tax exchange losses of $(23) million and $(9) million associated with the devaluation of the Argentine peso for the three months ended March 31, 2021 and 2020, respectively.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement loss).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Miscellaneous income - net, includes a gain from a remeasurement of an equity investment, losses on sale of available-for-sale securities, tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont, losses on sale of receivables, and other items.</span></div> 21000000 18000000 3000000 -1000000 0 -46000000 -35000000 -61000000 325000000 91000000 23000000 0 337000000 1000000 -53000000 -23000000 -9000000 <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.989%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Subsidiary Monetary Position (Losses) Gains</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-tax exchange losses</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Local tax (expenses) / benefits</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net after-tax impact from subsidiary exchange losses</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(203)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Hedging Program Gains</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-tax exchange gains</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax expenses</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net after-tax impact from hedging program exchange gains</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Exchange Losses</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-tax exchange losses</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax expenses</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net after-tax exchange losses</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> -51000000 -226000000 -1000000 23000000 -52000000 -203000000 16000000 165000000 -4000000 -40000000 12000000 125000000 -35000000 -61000000 -5000000 -17000000 -40000000 -78000000 <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:42.448%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.816%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,404 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,526 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,963 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,730 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,873 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,340 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 2404000000 3526000000 1963000000 326000000 347000000 377000000 2730000000 3873000000 2340000000 INCOME TAXES <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For periods between the Merger Effectiveness Time and the Corteva Distribution, Corteva and its subsidiaries were included in DowDuPont's consolidated federal income tax group and consolidated tax return.  Generally, the consolidated tax liability of the DowDuPont U.S. tax group for each year was apportioned among the members of the consolidated group based on each member’s separate taxable income.  Corteva, DuPont and Dow intend that to the extent Federal and/or State corporate income tax liabilities are reduced through the utilization of tax attributes of the other, settlement of any receivable and payable generated from the use of the other party’s sub-group attributes will be in accordance with a tax matters agreement. See Note 3 - Divestitures and Other Transactions, for further information related to indemnifications between Corteva, Dow and DuPont.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each year the company files hundreds of tax returns in the various national, state and local income taxing jurisdictions in which it operates. These tax returns are subject to examination and possible challenge by the tax authorities. Positions challenged by the tax authorities may be settled or appealed by the company. As a result, there is an uncertainty in income taxes recognized in the company's financial statements in accordance with accounting for income taxes and accounting for uncertainty in income taxes. The ultimate resolution of such uncertainties is not expected to have a material impact on the company's results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of the program, which resides in the U.S., is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions, which can drive material impacts on the company's effective tax rate. For further discussion of pre-tax and after-tax impacts of the company's foreign currency hedging program and net monetary asset programs, refer to Note 6 - Supplementary Information.</span></div> EARNINGS PER SHARE OF COMMON STOCK<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide earnings per share calculations for the periods indicated below: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.696%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Income for Earnings Per Share Calculations - Basic and Diluted</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations after income taxes</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to continuing operations noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations available to Corteva common stockholders</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from discontinued operations available to Corteva common stockholders</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income available to common stockholders</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.696%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings Per Share Calculations - Basic</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars per share)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per share of common stock from continuing operations</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.82 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss per share of common stock from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share of common stock</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.81 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.696%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings Per Share Calculations - Diluted</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars per share)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share of common stock from continuing operations</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.81 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss per share of common stock from discontinued operations </span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share of common stock</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.80 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.696%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share Count Information</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Shares in millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares - basic</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749.9 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus dilutive effect of equity compensation plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares - diluted</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752.5 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential shares of common stock excluded from EPS calculations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1 </span></td><td style="border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">Diluted earnings per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been anti-dilutive.</span></div> <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.696%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Income for Earnings Per Share Calculations - Basic and Diluted</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations after income taxes</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to continuing operations noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations available to Corteva common stockholders</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from discontinued operations available to Corteva common stockholders</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income available to common stockholders</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> 613000000 281000000 3000000 10000000 610000000 271000000 -10000000 1000000 600000000 272000000 <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.696%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings Per Share Calculations - Basic</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars per share)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per share of common stock from continuing operations</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.82 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss per share of common stock from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share of common stock</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.81 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> 0.82 0.36 -0.01 0 0.81 0.36 <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.696%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings Per Share Calculations - Diluted</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars per share)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share of common stock from continuing operations</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.81 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss per share of common stock from discontinued operations </span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share of common stock</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.80 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> 0.81 0.36 -0.01 0 0.80 0.36 <div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.696%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share Count Information</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Shares in millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares - basic</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749.9 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus dilutive effect of equity compensation plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares - diluted</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752.5 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential shares of common stock excluded from EPS calculations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1 </span></td><td style="border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">Diluted earnings per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been anti-dilutive.</span></div> 743400000 749900000 6200000 2600000 749600000 752500000 2900000 9100000 ACCOUNTS AND NOTES RECEIVABLE - NET<div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:39.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.813%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable – trade</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,231 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,754 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,367 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes receivable – trade</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1,2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts and notes receivable - net</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,792 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,926 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,775 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Accounts receivable – trade and notes receivable - trade are net of allowances of $203 million at March 31, 2021, $208 million at December 31, 2020, and $203 million at March 31, 2020. Allowances are equal to the estimated uncollectible amounts and are based on the expected credit losses and were developed using a loss-rate method.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid pre-approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of March 31, 2021, December 31, 2020, and March 31, 2020 there were no significant impairments related to current loan agreements.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Other includes receivables in relation to indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than 10 percent of total receivables. In addition, Other includes amounts due from nonconsolidated affiliates of $115 million, $106 million, and $140 million as of March 31, 2021, December 31, 2020, and March 31, 2020, respectively.</span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts and notes receivable are carried at the expected amount to be collected, which approximates fair value. The company establishes the allowance for doubtful receivables using a loss-rate method where the loss rate is developed using past events, historical experience, current conditions and forecasts that affect the collectability of the financial assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in the allowance for doubtful receivables for the three months ended March 31, 2021 and 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:64.346%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.454%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net provision for credit losses</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs charged against allowance</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoveries collected</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2020</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net benefit for credit losses</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company enters into various factoring agreements with third-party financial institutions to sell its trade receivables under both recourse and non-recourse agreements in exchange for cash proceeds. These financing arrangements result in a transfer of the company's receivables and risks to the third-party. As these transfers qualify as true sales under the applicable accounting guidance, the receivables are derecognized from the interim Condensed Consolidated Balance Sheets upon transfer, and the company receives a payment for the receivables from the third-party within a mutually agreed upon time period. For arrangements involving an element of recourse, which is typically provided through a guarantee of accounts in the event of customer default, the guarantee obligation is measured using market data from similar transactions and reported as a current liability in the interim Condensed Consolidated Balance Sheets. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade receivables sold under these agreements were $11 million and $15 million for the three months ended March 31, 2021 and March 31, 2020, respectively. The trade receivables sold that remained outstanding under these agreements which include an element of recourse as of March 31, 2021, December 31, 2020, and March 31, 2020 were $128 million, $157 million, and $43 million, respectively. The net proceeds received are included in cash provided by operating activities in the interim Consolidated Statements of Cash Flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of receivables in other income - net in the Consolidated Statements of Operations. Loss on sale of receivables for the three months ended March 31, 2021 and 2020 were not material. The guarantee obligations recorded as of March 31, 2021, December 31, 2020, and March 31, 2020 in the interim Condensed Consolidated Balance Sheets were not material. See Note 13 - Commitments and Contingent Liabilities for additional information on the company’s guarantees.</span></div> <div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:39.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.813%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable – trade</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,231 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,754 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,367 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes receivable – trade</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1,2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts and notes receivable - net</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,792 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,926 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,775 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Accounts receivable – trade and notes receivable - trade are net of allowances of $203 million at March 31, 2021, $208 million at December 31, 2020, and $203 million at March 31, 2020. Allowances are equal to the estimated uncollectible amounts and are based on the expected credit losses and were developed using a loss-rate method.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid pre-approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of March 31, 2021, December 31, 2020, and March 31, 2020 there were no significant impairments related to current loan agreements.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Other includes receivables in relation to indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than 10 percent of total receivables. In addition, Other includes amounts due from nonconsolidated affiliates of $115 million, $106 million, and $140 million as of March 31, 2021, December 31, 2020, and March 31, 2020, respectively.</span></div> 5231000000 3754000000 5367000000 533000000 163000000 412000000 1028000000 1009000000 996000000 6792000000 4926000000 6775000000 203000000 208000000 203000000 115000000 106000000 140000000 <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:64.346%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.454%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net provision for credit losses</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs charged against allowance</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoveries collected</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2020</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net benefit for credit losses</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 174000000 60000000 -1000000 -30000000 203000000 208000000 -5000000 203000000 11000000 15000000 128000000 157000000 43000000 INVENTORIES<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:39.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.667%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,508 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,584 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,721 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Semi-finished products</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,386 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,260 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and supplies</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,321 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,882 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,401 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:39.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.667%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,508 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,584 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,721 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Semi-finished products</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,386 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,260 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and supplies</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,321 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,882 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,401 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 2508000000 2584000000 2721000000 1386000000 1813000000 1260000000 427000000 485000000 420000000 4321000000 4882000000 4401000000 OTHER INTANGIBLE ASSETS <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.046%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.507%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets subject to amortization (Definite-lived):</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germplasm</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(380)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,885 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,265 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,948 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,265 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,139 </span></td><td style="border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,956 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(404)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,552 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,984 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(380)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,956 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,485 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(565)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,451 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(525)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(409)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,054 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/trade names</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,013 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,019 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Favorable supply contracts</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(326)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(238)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangible assets with finite lives</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,599 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,025)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,574 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,599 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,862)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,737 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,725 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,365)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,360 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets not subject to amortization (Indefinite-lived):</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,871 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,871 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,881 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,881 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,609 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,025)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,584 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,609 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,862)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,747 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,606 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,365)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,241 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Beginning on October 1, 2020, the company changed its indefinite life assertion of its trade name asset to definite lived with a useful life of 25 years. This change is the result of the launch of Brevant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> seed in the retail channel in the U.S. Prior to changing the useful life of the trade name asset, the company tested the asset for the impairment under ASC 350- Intangibles, Goodwill and Other, concluding the asset was not impaired. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate pre-tax amortization expense from continuing operations for definite-lived intangible assets was $183 million and $163 million for the three months ended March 31, 2021 and 2020, respectively. The current estimated aggregate pre-tax amortization expense from continuing operations for the remainder of 2021 and each of the next five years is approximately $537 million, $700 million, $620 million, $606 million, $569 million and $555 million, respectively.</span></div> <div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.046%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.507%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets subject to amortization (Definite-lived):</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germplasm</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(380)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,885 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,265 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,948 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,265 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,139 </span></td><td style="border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,956 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(404)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,552 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,984 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(380)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,956 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,485 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(565)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,451 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(525)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(409)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,054 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/trade names</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,013 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,019 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Favorable supply contracts</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(326)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(238)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangible assets with finite lives</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,599 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,025)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,574 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,599 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,862)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,737 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,725 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,365)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,360 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets not subject to amortization (Indefinite-lived):</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,871 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,871 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,881 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,881 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,609 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,025)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,584 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,609 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,862)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,747 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,606 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,365)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,241 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Beginning on October 1, 2020, the company changed its indefinite life assertion of its trade name asset to definite lived with a useful life of 25 years. This change is the result of the launch of Brevant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> seed in the retail channel in the U.S. Prior to changing the useful life of the trade name asset, the company tested the asset for the impairment under ASC 350- Intangibles, Goodwill and Other, concluding the asset was not impaired. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.</span></div> 6265000000 -380000000 5885000000 6265000000 -317000000 5948000000 6265000000 -126000000 6139000000 1956000000 -404000000 1552000000 1984000000 -380000000 1604000000 1956000000 -293000000 1663000000 1485000000 -565000000 920000000 1451000000 -525000000 926000000 1463000000 -409000000 1054000000 2013000000 -112000000 1901000000 2019000000 -99000000 1920000000 166000000 -88000000 78000000 475000000 -326000000 149000000 475000000 -302000000 173000000 475000000 -231000000 244000000 405000000 -238000000 167000000 405000000 -239000000 166000000 400000000 -218000000 182000000 12599000000 -2025000000 10574000000 12599000000 -1862000000 10737000000 10725000000 -1365000000 9360000000 10000000 10000000 10000000 10000000 10000000 10000000 1871000000 1871000000 10000000 10000000 10000000 10000000 1881000000 1881000000 12609000000 -2025000000 10584000000 12609000000 -1862000000 10747000000 12606000000 -1365000000 11241000000 183000000 163000000 537000000 700000000 620000000 606000000 569000000 555000000 SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize Corteva's short-term borrowings and finance lease obligations:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:45.674%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.644%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term borrowings and finance lease obligations</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,218 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,918 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase facility</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other loans - various currencies</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt payable within one year</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations payable within one year</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term borrowings and finance lease obligations</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,996 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the company's short-term borrowings, including interest rate financial instruments, was determined using Level 2 inputs within the fair value hierarchy. Based on quoted market prices for the same or similar issues, or on current rates offered to the company for debt of the same remaining maturities, the fair value of the company's short-term borrowings and finance lease obligations was approximately carrying value.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the company’s long-term borrowings, including debt due within one year, was $1,121 million, $1,168 million, and $612 million as of March 31, 2021, December 31, 2020, and March 31, 2020, respectively, and was determined using quoted market prices for the same or similar issues, or current rates offered to the company for debt of the same remaining maturities (Level 2 inputs).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Repurchase Facility</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the company entered into a new committed receivable repurchase facility of up to $1 billion (the "2021 Repurchase Facility") which expires in December 2021. Under the 2021 Repurchase Facility, Corteva may sell a portfolio of available and eligible outstanding customer notes receivables to participating institutions and simultaneously agree to repurchase at a future date. The 2021 Repurchase Facility is considered a secured borrowing with the customer notes receivables inclusive of those that are sold and repurchased, equal to 105 percent of the outstanding amounts borrowed utilized as collateral. Borrowings under the 2021 Repurchase Facility have an interest rate of LIBOR+0.85 percent.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021, $32 million of notes receivable, recorded in accounts and notes receivable - net, were pledged as collateral against outstanding borrowings under the 2021 Repurchase Facility of $30 million, recorded in short-term borrowings and finance lease obligations on the interim Condensed Consolidated Balance Sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facilities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, EID entered into a $3.0 billion 5-year revolving credit facility and a $3.0 billion 3-year revolving credit facility (the “Revolving Credit Facilities”). The Revolving Credit Facilities became effective May 2019. Corteva, Inc. became a party at the time of the Corteva Distribution. The Revolving Credit Facilities may serve as a substitute to the company's commercial paper program, and can be used, from time to time, for general corporate purposes including, but not limited to, the funding of seasonal working capital needs. The Revolving Credit Facilities contain customary representations and warranties, affirmative and negative covenants and events of default that are typical for companies with similar credit ratings. Additionally, the Revolving Credit Facilities contain a financial covenant requiring that the ratio of total indebtedness to total capitalization for Corteva and its consolidated subsidiaries not exceed 0.60.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In March 2020, the company drew down $500 million under the $3.0 billion 3-year revolving credit facility as a result of the volatility and increased borrowing costs of commercial paper resulting from the unstable market conditions caused by the COVID-19 pandemic and repaid that borrowing in full in June 2020. There were no additional borrowings and the unused commitments under the 3-year revolving credit facility were $3.0 billion as of March 31, 2021.</span></div> <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:45.674%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.644%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term borrowings and finance lease obligations</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,218 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,918 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase facility</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other loans - various currencies</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt payable within one year</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations payable within one year</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term borrowings and finance lease obligations</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,996 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 1218000000 0 1918000000 30000000 0 30000000 0 1000000 45000000 1000000 1000000 1000000 1000000 1000000 2000000 1250000000 3000000 1996000000 1121000000 1168000000 612000000 1000000000 1.05 0.0085 32000000 30000000 3000000000.0 P5Y 3000000000.0 P3Y 0.60 500000000 3000000000.0 P3Y P3Y 3000000000.0 COMMITMENTS AND CONTINGENT LIABILITIES <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indemnifications</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with acquisitions and divestitures as of March 31, 2021, the company has indemnified respective parties against certain liabilities that may arise in connection with these transactions and business activities prior to the completion of the transactions. The term of these indemnifications, which typically pertain to environmental, tax and product liabilities, is generally indefinite. In addition, the company indemnifies its duly elected or appointed directors and officers to the fullest extent permitted by Delaware law, against liabilities incurred as a result of their activities for the company, such as adverse judgments relating to litigation matters. If the indemnified party were to incur a liability or have a liability increase as a result of a successful claim, pursuant to the terms of the indemnification, the company would be required to reimburse the indemnified party. The maximum amount of potential future payments is generally unlimited. See pages 9 and 22 for additional information relating to the indemnification obligations under the Chemours Separation Agreement and the Corteva Separation Agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Obligations for Customers and Other Third Parties</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company has directly guaranteed various debt obligations under agreements with third parties related to customers and other third parties. At March 31, 2021, December 31, 2020 and March 31, 2020, the company had directly guaranteed $108 million, $94 million, and $90 million, respectively, of such obligations. These amounts represent the maximum potential amount of future (undiscounted) payments that the company could be required to make under the guarantees in the event of default by the guaranteed party. All of the maximum future payments at March 31, 2021 had terms less than one year. The maximum future payments include $23 million at March 31, 2021 and $17 million at December 31, 2020 and March 31, 2020, respectively, of guarantees related to the various factoring agreements that the company enters into with third-party financial institutions to sell its trade receivables. See Note 9 - Accounts and Notes Receivable, Net, for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maximum future payments also include agreements with lenders to establish programs that provide financing for select customers. The terms of the guarantees are equivalent to the terms of the customer loans that are primarily made to finance customer invoices. The total amounts owed from customers to the lenders relating to these agreements was $178 million, $16 million and $125 million at March 31, 2021, December 31, 2020 and March 31, 2020, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company assesses the payment/performance risk by assigning default rates based on the duration of the guarantees. These default rates are assigned based on the external credit rating of the counterparty or through internal credit analysis and historical default history for counterparties that do not have published credit ratings. For counterparties without an external rating or available credit history, a cumulative average default rate is used.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company is subject to various legal proceedings, including, but not limited to, product liability, intellectual property, antitrust, commercial, property damage, personal injury, environmental and regulatory matters arising out of the normal course of its current businesses or legacy EID businesses unrelated to Corteva’s current businesses but allocated to Corteva as part of the separation of Corteva from DuPont. It is not possible to predict the outcome of these various proceedings, as considerable uncertainty exists.  However, the ultimate liabilities could be material to results of operations and the cash flows in the period recognized.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indemnifications under Separation Agreements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company has entered into various agreements where the company is indemnified for certain liabilities. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. See Note 3 - Divestitures and Other Transactions, to the interim Consolidated Financial Statements for additional information related to indemnifications.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Chemours/Performance Chemicals</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 3 - Divestitures and Other Transactions, to the interim Consolidated Financial Statements for additional discussion of the Chemours Separation Agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2017, EID and Chemours amended the Chemours Separation Agreement to provide for a limited sharing of potential future liabilities related to alleged historical releases of perfluorooctanoic acids and its ammonium salts (“PFOA”) for a five-year period that began on July 6, 2017. In addition, in 2017, Chemours and EID each paid $335 million to settle multi-district litigation in the U.S. District Court for the Southern District of Ohio (“Ohio MDL”), thereby resolving claims of about 3,550 plaintiffs alleging injury from exposure to PFOA in drinking water as a result of the historical manufacture or use of PFOA at the Washington Works plant outside Parkersburg, West Virginia. This plant was previously owned and/or operated by the performance chemicals segment of EID and is now owned and/or operated by Chemours. The 2017 settlement did not resolve </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">claims of certain class members who did not have claims in the Ohio MDL or whose claims are based on diseases first diagnosed after February 11, 2017. About 96 claims alleging personal injury were filed in the Ohio MDL since the 2017 settlement and a number of additional pre-suit claims for personal injury were asserted.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 13, 2019, Chemours filed suit in the Delaware Court of Chancery against DuPont, EID, and Corteva, seeking, among other things, to limit its responsibility for the litigation and environmental liabilities allocated to and assumed by Chemours under the Chemours Separation Agreement (the “Delaware Litigation”). On March 30, 2020, the Court of Chancery granted a motion to dismiss. On December 15, 2020, the Delaware Supreme Court affirmed the judgment of the Court of Chancery. Meanwhile, a confidential arbitration process regarding the same and other claims had proceeded (the “Pending Arbitration”).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding environmental indemnification, see discussion on page 25.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 22, 2021, Chemours, DuPont, Corteva and EID entered into a binding memorandum of understanding containing a settlement to resolve legal disputes originating from the Delaware Litigation and Pending Arbitration, and to establish a cost sharing arrangement and escrow account to be used to support and manage potential future legacy per- and polyfluoroalkyl substances (“PFAS”) liabilities arising out of pre-July 1, 2015 conduct (the “MOU”). The MOU replaces the 2017 amendment to the Chemours Separation Agreement. According to the terms of the cost sharing arrangement within the MOU, Corteva and DuPont together, on one hand, and Chemours, on the other hand, agreed to a 50-50 split of certain qualified expenses related to PFAS liabilities incurred over a term not to exceed twenty years or $4 billion of qualified spend and escrow account contributions (see below for discussion of escrow account) in the aggregate. DuPont’s and Corteva’s 50% share under the MOU will be limited to $2 billion, including qualified expenses and escrow contributions. These expenses and escrow account contributions will be subject to the existing Letter Agreement, under which DuPont and Corteva will each bear 50% of the first $300 million (up to $150 million each), and thereafter DuPont bears 71% and Corteva bears the remaining 29%. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In order to support and manage any potential future PFAS liabilities, the parties have also agreed to establish an escrow account. The MOU provides that (1) no later than each of September 30, 2021 and September 30, 2022, Chemours shall deposit $100 million into an escrow account and DuPont and Corteva shall together deposit $100 million in the aggregate into an escrow account and (2) no later than September 30 of each subsequent year through and including 2028, Chemours shall deposit $50 million into an escrow account and DuPont and Corteva shall together deposit $50 million in the aggregate into an escrow account. Subject to the terms and conditions set forth in the MOU, each party may be permitted to defer funding in any year (excluding 2021). Over this period, Chemours will deposit a total of $500 million in the account and DuPont and Corteva will deposit an additional $500 million pursuant to the terms of the Letter Agreement. Additionally, if on December 31, 2028, the balance of the escrow account (including interest) is less than $700 million, Chemours will make 50% of the deposits and DuPont and Corteva together will make 50% of the deposits necessary to restore the balance of the escrow account to $700 million. Such payments will be made in a series of consecutive annual equal installments commencing on September 30, 2029 pursuant to the escrow account replenishment terms as set forth in the MOU. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the term of this arrangement, Chemours’ indemnification obligations under the original 2015 Chemours Separation Agreement, would continue unchanged, subject in each case to certain exceptions set out in the MOU. Under the MOU, Chemours waived specified claims regarding the construct of its 2015 spin-off transaction, and the parties will dismiss the pending arbitration regarding those claims (as discussed below). Additionally, the parties have agreed to resolve the Ohio MDL PFOA personal injury litigation (as discussed below). The parties are expected to cooperate in good faith to enter into additional agreements reflecting the terms set forth in the MOU.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Corteva Separation Agreement</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2019, in connection with the Dow Distribution, Corteva, DuPont and Dow entered into the Corteva Separation Agreement, the Tax Matters Agreement, the Employee Matters Agreement, and certain other agreements (collectively, the “Corteva Separation Agreements”). The Corteva Separation Agreements allocate among Corteva, DuPont and Dow certain liabilities and obligations among the parties and provides for indemnification obligation among the parties. Under the Corteva Separation Agreements, DuPont will indemnify Corteva against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the Corteva Distribution and (ii) Dow indemnifies Corteva against certain litigation and other liabilities that relate to the Historical Dow business, but were transferred over as part of the common control combination with DAS, and Corteva indemnifies DuPont and Dow for certain liabilities. The term of this indemnification is generally indefinite with exceptions, and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. See Note 3 - Divestitures and Other Transactions, to the interim Consolidated Financial Statements for additional information relating to the Separation.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DuPont</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Corteva Separation Agreement, certain legacy EID liabilities from discontinued and/or divested operations and businesses of EID (including Performance Chemicals) (a “stray liability”) were allocated to Corteva or DuPont. For those stray liabilities allocated to Corteva (which may include a specified amount of liability associated with that liability), Corteva is responsible for liabilities in an amount up to that specified amount plus an additional $200 million and, for those stray liabilities allocated to DuPont (which may include a specified amount of liability associated with that liability), DuPont is responsible for liabilities up to a specified amount plus an additional $200 million. Once each company has met the $200 million threshold, Corteva and DuPont will share future liabilities proportionally on the basis of 29% and 71%, respectively; provided, however, that for PFAS, DuPont will manage such liabilities with Corteva and DuPont sharing the costs on a 50% - 50% basis starting from $1 and up to $300 million (with such amount, up to $150 million, to be credited to each company’s $200 million threshold) and once the $300 million threshold is met, then the companies will share proportionally on the basis of 29% and 71% respectively, subject to a $1 million de minimis requirement. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation related to legacy EID businesses unrelated to Corteva’s current businesses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PFAS, PFOA, PFOS and Other Related Liabilities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For purposes of this report, the term PFOA means collectively perfluorooctanoic acid and its salts, including the ammonium salt and does not distinguish between the two forms, and PFAS, which means per- and polyfluoroalkyl substances, including PFOA, PFOS (perfluorooctanesulfonic acid), GenX and other perfluorinated chemicals and compounds ("PFCs").</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">EID is a party to various legal proceedings relating to the use of PFOA by its former Performance Chemicals segment for which potential liabilities would be subject to the cost sharing arrangement under the MOU as long as it remains effective. Management believes that it is reasonably possible that EID could incur liabilities related to PFOA in excess of amounts accrued. However, any such losses are not estimable at this time due to various reasons, including, among others, that the underlying matters are in their early stages and have significant factual issues to be resolved. The company has recorded a liability of $21 million and an indemnification asset of $16 million at March 31, 2021, related to testing drinking water in and around certain former EID sites and offering treatment or an alternative supply of drinking water if tests indicate the presence of PFOA in drinking water at or greater than the national health advisory level established from time to time by the EPA. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Leach Settlement and Ohio MDL Settlement</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EID has residual liabilities under its 2004 settlement of a West Virginia state court class action, Leach v. EID, which alleged that PFOA from EID’s former Washington Works facility had contaminated area drinking water supplies and affected the health of area residents. The settlement class has about 80,000 members. In addition to relief that was provided to class members years ago, the settlement requires EID to continue providing PFOA water treatment to six area water districts and private well users and to fund, through an escrow account, up to $235 million for a medical monitoring program for eligible class members. As of March 31, 2021, approximately $2 million had been disbursed from the account since its establishment in 2012 and the remaining balance is approximately $1 million. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Leach settlement permits class members to pursue personal injury claims for six health conditions (and no others) that an expert panel appointed under the settlement reported in 2012 had a “probable link” (as defined in the settlement) with PFOA: pregnancy-induced hypertension, including preeclampsia; kidney cancer; testicular cancer; thyroid disease; ulcerative colitis; and diagnosed high cholesterol. After the panel reported its findings, approximately 3,550 personal injury lawsuits were filed in federal and state courts in Ohio and West Virginia and consolidated in multi-district litigation in the U.S. District Court for the Southern District of Ohio (“Ohio MDL”). The Ohio MDL was settled in early 2017 for $670.7 million in cash, with Chemours and EID (without indemnification from Chemours) each paying half. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Post-MDL Settlement PFOA Personal Injury Claims</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2017 Ohio MDL settlement did not resolve claims of plaintiffs who did not have claims in the Ohio MDL or whose claims are based on diseases first diagnosed after February 11, 2017. The first trial for these claims, a kidney cancer case, resulted in a hung jury, while the second, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Travis and Julie Abbot v. E.I du Pont de Nemours and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (the “Abbot Case”), a testicular cancer case, resulted in a jury verdict of $40 million in compensatory damages and $10 million for loss of consortium. Following entry of the judgment by the court, EID filed post-trial motions to reduce the verdict, and to appeal the verdict on the basis of procedural and substantive legal errors made by the trial court. The trial court recently granted EID’s motion to reduce the loss of consortium award to conform with state tort reform laws limiting these damages to $250,000. The company is continuing its other appeals to reduce the jury verdict or eliminate its liability, in whole or part. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In January 2021, Chemours, DuPont and Corteva agreed to settle the remaining approximately 95 matters, as well as unfiled matters, remaining in the Ohio MDL, with the exception of the Abbot case, for $83 million, with Chemours contributing $29 million to the settlement, and DuPont and Corteva contributing $27 million each. The company recorded a liability for its share </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">of the settlement, with a charge to (loss) income from discontinued operations after income taxes, during the year ended December 31, 2020, and paid $16 million during the three months ended March 31, 2021. Following this settlement, the parties have agreed to petition the court for the dissolution of the MDL.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other PFOA Matters</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EID is a party to other PFOA lawsuits that do not involve claims for personal injury. Defense costs and any future liabilities that may arise out of these lawsuits are subject to the MOU and the cost sharing arrangement disclosed above. Under the MOU, fraudulent conveyance claims associated with these matters are not qualified expenses, unless Corteva, Inc. and EID would prevail on the merits of these claims.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">New York</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. EID is a defendant in about 50 lawsuits, including a putative class action, brought by persons who live in and around Hoosick Falls, New York. These lawsuits assert claims for medical monitoring and property damage based on alleged PFOA releases from manufacturing facilities owned and operated by co-defendants in Hoosick Falls and allege that EID and 3M supplied some of the materials used at these facilities. EID is also one of more than ten defendants in a lawsuit brought by the Town of East Hampton, New York alleging PFOA and PFOS contamination of the town’s well water. Additionally, EID, along with 3M, Chemours and Dyneon, have been named defendants in complaints filed by eight water districts in Nassau County, New York alleging that the drinking water they provide to customers is contaminated with PFAS and seeking reimbursement for clean-up costs. The water district complaints also include allegations of fraudulent transfer.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">New Jersey</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At March 31, 2021, two lawsuits were pending, one brought by a local water utility and the second a putative class action, against EID alleging that PFOA from EID’s former Chambers Works facility contaminated drinking water sources. The putative class action was voluntarily dismissed without prejudice by the plaintiff.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In late March of 2019, the New Jersey State Attorney General filed four lawsuits against EID, Chemours, 3M and others alleging that operations at and discharges from former EID sites in New Jersey (Chambers Works, Pompton Lakes, Parlin and Repauno) damaged the State’s natural resources. Two of these lawsuits (those involving the Chambers Works and Parlin sites) allege contamination from PFAS. The Ridgewood Water District in New Jersey filed suit in the first quarter 2019 against EID, 3M, Chemours, and Dyneon alleging losses related to the investigation, remediation and monitoring of polyfluorinated surfactants, including PFOA, in water supplies. DuPont and Corteva were subsequently added as defendants to these lawsuits. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Alabama / Others</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. EID is one of more than thirty defendants in a lawsuit by the Alabama water utility alleging contamination from PFCs, including PFOA, used by co-defendant carpet manufacturers to make their products more stain and grease resistant. In addition, the states of Alaska, Michigan, Mississippi, New Hampshire, South Dakota, and Vermont recently filed lawsuits against EID, Chemours, 3M and others, claiming, among other things, PFC (including PFOA) contamination of groundwater and drinking water. The complaints seek reimbursement for past and future costs to investigate and remediate the alleged contamination and compensation for the loss of value and use of the state’s natural resources. Motions to dismiss the Michigan, Vermont and New Hampshire cases have been denied. Additionally, the State of Delaware has indicated it may file a similar natural resource claim related to alleged PFAS contamination and other contaminants.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Ohio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. EID is a defendant in three lawsuits: an action by the State of Ohio based on alleged damage to natural resources, a putative nationwide class action brought on behalf of anyone who has detectable levels of PFAS in their blood serum, and an action by the City of Dayton claiming losses related to the investigation, remediation and monitoring of PFAS in water supplies.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Aqueous Firefighting Foam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s. Approximately 985 cases have been filed against 3M and other defendants, including EID and Chemours, and more recently also including Corteva and DuPont, alleging PFOS or PFOA contamination of soil and groundwater from the use of aqueous firefighting foams. Most of those cases claim some form of property damage and seek to recover the costs of responding to this contamination and damages for the loss of use and enjoyment of property and diminution in value. Most of these cases have been transferred to a multidistrict litigation proceeding in federal district court in South Carolina. Approximately 910 of these cases were filed on behalf of firefighters who allege personal injuries (primarily kidney and testicular cancer) as a result of aqueous firefighting foams. Most of these recent cases assert claims that the EID and Chemours separation constituted a fraudulent conveyance. A schedule of initial trials is expected to be established in the second quarter of 2021.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EID did not make firefighting foams, PFOS, or PFOS products. While EID made surfactants and intermediaries that some manufacturers used in making foams, which may have contained PFOA as an unintended byproduct or an impurity, EID’s </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products were not formulated with PFOA, nor was PFOA an ingredient of these products. EID has never made or sold PFOA as a commercial product. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fayetteville Works Facility, North Carolina</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the separation of Chemours, EID introduced GenX as a polymerization processing aid and a replacement for PFOA at the Fayetteville Works facility in Bladen County, North Carolina. The facility is now owned and operated by Chemours, which continues to manufacture and use GenX.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2021, several actions are pending in federal court against Chemours and EID relating to PFC discharges from the Fayetteville Works facility. One of these is a consolidated putative class action that asserts claims for medical monitoring and property damage on behalf of putative classes of property owners and residents in areas near or who draw drinking water from the Cape Fear River. Another action is a consolidated action brought by various North Carolina water authorities, including the Cape Fear Public Utility Authority and Brunswick County, that seek actual and punitive damages as well as injunctive relief. In another action over approximately 100 property owners near the Fayetteville Works facility filed a complaint against Chemours and EID in May 2020. The plaintiffs seek compensatory and punitive damages for their claims of private nuisance, trespass, and negligence allegedly caused by release of PFAS.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the federal court actions, there is an action on behalf of about 100 plaintiffs who own wells and property near the Fayetteville Works facility. The plaintiffs seek damages for nuisance allegedly caused by releases of certain PFCs from the site. The plaintiffs’ claims for medical monitoring, punitive damages, public nuisance, trespass, unjust enrichment, failure to warn, and negligent manufacture were dismissed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Generally, site-related expenses related GenX claims are subject to the cost sharing arrangements as defined in the MOU. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on current law and existing technologies. At March 31, 2021, the company had accrued obligations of $333 million for probable environmental remediation and restoration costs, including $56 million for the remediation of Superfund sites. These obligations are included in accrued and other current liabilities and other noncurrent obligations in the interim Condensed Consolidated Balance Sheet. This is management’s best estimate of the costs for remediation and restoration with respect to environmental matters for which the company has accrued liabilities, although it is reasonably possible that the ultimate cost with respect to these particular matters could range up to $577 million above the amount accrued at March 31, 2021. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the company’s results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of the allocation of environmental liabilities under the Chemours Separation Agreement and the Corteva Separation Agreement, see the previous discussion on page 22.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above noted $333 million accrued obligations includes the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.219%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.687%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.667%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indemnification Asset</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrual balance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3,4</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Potential exposure above amount accrued</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Environmental Remediation Stray Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chemours related obligations - subject to indemnity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1,2</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other discontinued or divested businesses obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Environmental remediation liabilities not subject to indemnity</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Represents liabilities that are subject to the $200 million thresholds and sharing arrangements as discussed on page 22, under Corteva Separation Agreement.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">The company has recorded an indemnification asset related to these accruals, including $30 million related to the Superfund sites.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Accrual balance excludes indemnification liabilities of $54 million to Chemours, related to the cost sharing arrangement under the MOU (see page 10).</span></div> 108000000 94000000 90000000 23000000 17000000 178000000 16000000 125000000 335000000 3550 96 P20Y 4000000000 0.50 2000000000 0.50 300000000 150000000 0.71 0.29 100000000 100000000 50000000 50000000 500000000 500000000 700000000 0.50 0.50 700000000 200000000 200000000 200000000 0.29 0.71 0.50 0.50 1 300000000 150000000 200000000 300000000 0.29 0.71 1000000 21000000 16000000 80000 6 235000000 2000000 1000000 6 3550 670700000 40000000 10000000 95000000 83000000 29000000 27000000 16000000 50 2 4 3 985 910 100 100 333000000 56000000 577000000 333000000 <div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.219%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.687%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.667%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indemnification Asset</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrual balance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3,4</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Potential exposure above amount accrued</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Environmental Remediation Stray Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chemours related obligations - subject to indemnity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1,2</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other discontinued or divested businesses obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Environmental remediation liabilities not subject to indemnity</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Represents liabilities that are subject to the $200 million thresholds and sharing arrangements as discussed on page 22, under Corteva Separation Agreement.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">The company has recorded an indemnification asset related to these accruals, including $30 million related to the Superfund sites.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Accrual balance excludes indemnification liabilities of $54 million to Chemours, related to the cost sharing arrangement under the MOU (see page 10).</span></div> 152000000 152000000 280000000 0 78000000 177000000 34000000 34000000 65000000 0 69000000 55000000 186000000 333000000 577000000 200000000 30000000 54000000 STOCKHOLDERS' EQUITY<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Buyback Plan</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 26, 2019, Corteva, Inc. announced that the Board of Directors of Corteva, Inc. authorized a $1 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date. The timing, price and volume of purchases will be based on market conditions, relevant securities laws and other factors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2021, the company purchased and retired 7,646,000 shares in the open market for a total cost of $350 million. During the three months ended March 31, 2020, the company purchased and retired 1,865,000 shares in the open market for a total cost of $50 million. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares repurchased pursuant to Corteva's share buyback plan are immediately retired upon purchase. Repurchased common stock is reflected as a reduction of stockholders' equity. The company's accounting policy related to its share repurchases is to reduce its common stock based on the par value of the shares and to reduce its retained earnings for the excess of the repurchase price over the par value. When Corteva has an accumulated deficit balance, the excess over the par value is applied to additional paid-in capital. When Corteva has retained earnings, the excess is charged entirely to retained earnings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Noncontrolling Interest</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corteva, Inc. owns 100% of the outstanding common shares of EID. However, EID has preferred stock outstanding to third parties which is accounted for as a non-controlling interest in Corteva's interim Condensed Consolidated Balance Sheets. Each share of EID Preferred Stock - $4.50 Series and EID Preferred Stock - $3.50 Series issued and outstanding at the effective date of the Corteva Distribution remains issued and outstanding as to EID and was unaffected by the Corteva Distribution.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the EID Preferred Stock at March 31, 2021, December 31, 2020, and March 31, 2020, which is classified as noncontrolling interests in Corteva's interim Condensed Consolidated Balance Sheets.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:75.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.508%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares in thousands</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.50 Series, callable at $120</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,673</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.50 Series, callable at $102</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Comprehensive (Loss) Income</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes and after-tax balances of components comprising accumulated other comprehensive loss are summarized below:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.428%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cumulative Translation Adjustment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">1 </span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative Instruments</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pension Benefit Plans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Benefit Plans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Investments</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total </span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance January 1, 2020</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,944)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,247)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,270)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(672)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(670)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive (loss) income </span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(672)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(663)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance March 31, 2020</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,616)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,247)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,933)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance January 1, 2021</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,970)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,433)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,890)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(403)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive (loss) income</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(403)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(477)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance March 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,373)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,425)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,367)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">The cumulative translation adjustment loss for the three months ended March 31, 2020 was primarily driven by the strengthening of the USD against the Brazilian Real (“BRL”) and the South African Rand ("ZAR"). The cumulative translation adjustment loss for the three months ended March 31, 2021 was primarily driven by strengthening of the USD against the Swiss Franc ("CHF"), Brazilian Real ("BRL") and European Euro.</span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax benefit (expense) on the net activity related to each component of other comprehensive (loss) income was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.174%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.176%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="6" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefit plans - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other benefit plans - net</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit from income taxes related to other comprehensive (loss) income items</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the reclassifications out of accumulated other comprehensive loss is provided as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.299%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">:</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization of pension benefit plans:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Actuarial losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3,4</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Settlement loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3,4</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization of other benefit plans:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Prior service benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3,4</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(230)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Actuarial gains</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3,4</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Loss on Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total reclassifications for the period, after-tax</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Reflected in cost of goods sold.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Reflected in provision for (benefit from) income taxes from continuing operations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">These accumulated other comprehensive (loss) income components are included in the computation of net periodic benefit credit of the company's pension and other benefit plans. See Note 15 - Pension Plans and Other Post Employment Benefits, for additional information. </span></div>4.Reflected in other income - net. 1000000000 0.01 7646000 350000000 1865000 50000000 1 <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:75.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.508%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares in thousands</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.50 Series, callable at $120</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,673</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.50 Series, callable at $102</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700</span></td></tr></table> 23000000 1673000 700000 <div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.428%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cumulative Translation Adjustment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">1 </span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative Instruments</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pension Benefit Plans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Benefit Plans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Investments</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total </span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance January 1, 2020</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,944)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,247)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,270)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(672)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(670)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive (loss) income </span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(672)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(663)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance March 31, 2020</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,616)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,247)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,933)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance January 1, 2021</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,970)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,433)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,890)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(403)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive (loss) income</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(403)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(477)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance March 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,373)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,425)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,367)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">The cumulative translation adjustment loss for the three months ended March 31, 2020 was primarily driven by the strengthening of the USD against the Brazilian Real (“BRL”) and the South African Rand ("ZAR"). The cumulative translation adjustment loss for the three months ended March 31, 2021 was primarily driven by strengthening of the USD against the Swiss Franc ("CHF"), Brazilian Real ("BRL") and European Euro.</span></div> -1944000000 2000000 -1247000000 -81000000 0 -3270000000 -672000000 1000000 -2000000 3000000 0 -670000000 0 5000000 2000000 0 0 7000000 -672000000 6000000 0 3000000 0 -663000000 -2616000000 8000000 -1247000000 -78000000 0 -3933000000 -1970000000 -67000000 -1433000000 590000000 -10000000 -2890000000 -403000000 71000000 -4000000 1000000 4000000 -331000000 0 -6000000 12000000 -158000000 6000000 -146000000 -403000000 65000000 8000000 -157000000 10000000 -477000000 -2373000000 -2000000 -1425000000 433000000 0 -3367000000 <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.174%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.176%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="6" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefit plans - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other benefit plans - net</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit from income taxes related to other comprehensive (loss) income items</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> -18000000 5000000 -2000000 -4000000 49000000 0 29000000 1000000 <div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.299%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">:</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization of pension benefit plans:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Actuarial losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3,4</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Settlement loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3,4</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization of other benefit plans:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Prior service benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3,4</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(230)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Actuarial gains</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3,4</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Loss on Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total reclassifications for the period, after-tax</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Reflected in cost of goods sold.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Reflected in provision for (benefit from) income taxes from continuing operations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">These accumulated other comprehensive (loss) income components are included in the computation of net periodic benefit credit of the company's pension and other benefit plans. See Note 15 - Pension Plans and Other Post Employment Benefits, for additional information. </span></div>4.Reflected in other income - net. -5000000 7000000 -1000000 -2000000 -6000000 5000000 14000000 1000000 1000000 2000000 15000000 3000000 -3000000 -1000000 12000000 2000000 -230000000 0 23000000 0 -207000000 0 49000000 0 -158000000 0 6000000 0 0 0 6000000 0 -146000000 7000000 PENSION PLANS AND OTHER POST EMPLOYMENT BENEFITS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth the components of the company's net periodic benefit (credit) cost for defined benefit pension plans and other post employment benefits:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Defined Benefit Pension Plans:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(230)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(251)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized loss</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit credit</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other Post Employment Benefits:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized loss</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service benefit</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(230)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit (credit) cost</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Defined Benefit Pension Plans:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(230)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(251)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized loss</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit credit</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other Post Employment Benefits:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized loss</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service benefit</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(230)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit (credit) cost</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> 7000000 5000000 91000000 141000000 -230000000 -251000000 14000000 1000000 1000000 2000000 -117000000 -102000000 0 1000000 6000000 16000000 23000000 0 -230000000 0 -201000000 17000000 FINANCIAL INSTRUMENTS <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2021, the company had $1,602 million ($2,511 million and $1,536 million at December 31, 2020 and March 31, 2020, respectively) of held-to-maturity securities (primarily time deposits and money market funds) classified as cash equivalents, as these securities had maturities of three months or less at the time of purchase; and $49 million ($43 million and $10 million at December 31, 2020 and March 31, 2020, respectively) of held-to-maturity securities (primarily time deposits) classified as marketable securities as these securities had maturities of more than three months to less than one year at the time of purchase. The company’s investments in held-to-maturity securities are held at amortized cost, which approximates fair value. Additionally, at March 31, 2021, the company had $65 million ($226 million at December 31, 2020) of available-for-sale securities. The above noted securities are included in cash and cash equivalents, marketable securities, and other current assets in the interim Condensed Consolidated Balance Sheets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Instruments</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Objectives and Strategies for Holding Derivative Instruments</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, the company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency and commodity price risks. The company has established a variety of derivative programs to be utilized for financial risk management. These programs reflect varying levels of exposure coverage and time horizons based on an assessment of risk.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative programs have procedures and controls and are approved by the Corporate Financial Risk Management Committee, consistent with the company's financial risk management policies and guidelines. Derivative instruments used are forwards, options, futures and swaps. The company has not designated any non-derivatives as hedging instruments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's financial risk management procedures also address counterparty credit approval, limits and routine exposure monitoring and reporting. The counterparties to these contractual arrangements are major financial institutions and major commodity exchanges, and multinational grain exporters. The company is exposed to credit loss in the event of nonperformance by these counterparties. The company utilizes collateral support annex agreements with certain counterparties to limit its exposure to credit losses. The company anticipates performance by counterparties to these contracts and therefore no material loss is expected. Market and counterparty credit risks associated with these instruments are regularly reported to management.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of the company's derivative instruments were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:42.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.640%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.640%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.643%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional Amounts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,030 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,164 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Risk</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's objective in managing exposure to foreign currency fluctuations is to reduce earnings and cash flow volatility associated with foreign currency rate changes and to mitigate the exposure of certain investments in foreign subsidiaries against changes in the Euro/USD exchange rate. Accordingly, the company enters into various contracts that change in value as foreign exchange rates change to protect the value of its existing foreign currency-denominated assets, liabilities, commitments, investments and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company uses foreign exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The primary business objective of this hedging program is to maintain an approximately balanced position in foreign currencies so that exchange gains and losses resulting from exchange rate changes, after related tax effects, are minimized. The company also uses foreign currency exchange contracts to offset a portion of the company’s exposure to certain forecasted transactions as well as the translation of foreign currency-denominated earnings. The company also uses commodity contracts to offset risks associated with foreign currency devaluation in certain countries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commodity Price Risk</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commodity price risk management programs serve to reduce exposure to price fluctuations on purchases of inventory such as corn and soybeans. The company enters into over-the-counter and exchange-traded derivative commodity instruments to hedge the commodity price risk associated with agricultural commodity exposures.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives Designated as Cash Flow Hedges</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commodity Contracts</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company enters into over-the-counter and exchange-traded derivative commodity instruments, including options, futures and swaps, to hedge the commodity price risk associated with agriculture commodity exposures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two years. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is not probable of occurring.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the after-tax effect of commodity contract cash flow hedges on accumulated other comprehensive loss:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.153%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.274%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions and revaluations of derivatives designated as cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clearance of hedge results to earnings</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2021, an after-tax net loss of $8 million is expected to be reclassified from accumulated other comprehensive loss into earnings over the next twelve months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Contracts</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company enters into forward contracts to hedge the foreign currency risk associated with forecasted transactions within certain foreign subsidiaries.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two years. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is not probable of occurring.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the after-tax effect of foreign currency cash flow hedges on accumulated other comprehensive loss:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions and revaluations of derivatives designated as cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clearance of hedge results to earnings</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2021, an after-tax net gain of $6 million is expected to be reclassified from accumulated other comprehensive loss into earnings over the next twelve months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives Designated as Net Investment Hedges</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Contracts</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company has designated €450 million of forward contracts to exchange EUR as net investment hedges. The purpose of these forward contracts is to mitigate FX exposure related to a portion of the company’s Euro net investments in certain foreign subsidiaries against changes in Euro/USD exchange rates. These hedges will expire and be settled in 2023, unless terminated early at the discretion of the company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company elected to apply the spot method in testing for effectiveness of the hedging relationship.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives not Designated in Hedging Relationships</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Contracts</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company uses foreign exchange contracts to reduce its net exposure, by currency, related to foreign currency-denominated monetary assets and liabilities of its operations so that exchange gains and losses resulting from exchange rate changes are minimized. The netting of such exposures precludes the use of hedge accounting; however, the required revaluation of the forward contracts and the associated foreign currency-denominated monetary assets and liabilities intends to achieve a minimal earnings impact, after taxes. The company also uses foreign currency exchange contracts to offset a portion of the company’s exposure to the translation of certain foreign currency-denominated earnings so that gains and losses on the contracts offset changes in the USD value of the related foreign currency-denominated earnings over the relevant aggregate period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commodity Contracts</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The company utilizes options, futures and swaps that are not designated as hedging instruments to reduce exposure to commodity price fluctuations on purchases of inventory such as corn and soybeans. The company uses forward agreements, with durations less than one year, to buy and sell USD priced commodities in order to reduce its exposure to currency devaluation for a portion of its local currency cash balances. Counterparties to the forward sales agreements are multinational grain exporters and subject to the company’s financial risk management procedures. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Derivative Instruments</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asset and liability derivatives subject to an enforceable master netting arrangement with the same counterparty are presented on a net basis in the interim Condensed Consolidated Balance Sheets. The presentation of the company's derivative assets and liabilities is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.817%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Counterparty and Cash Collateral Netting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts Included in the interim Condensed Consolidated Balance Sheet</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset derivatives:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total asset derivatives</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability derivatives:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liability derivatives</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.817%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Counterparty and Cash Collateral Netting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts Included in the Condensed Consolidated Balance Sheet</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset derivatives:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total asset derivatives</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability derivatives:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liability derivatives</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:28.036%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.621%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.416%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.790%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Counterparty and Cash Collateral Netting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts Included in the interim Condensed Consolidated Balance Sheet</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset derivatives:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total asset derivatives</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability derivatives:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liability derivatives</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">    Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Effect of Derivative Instruments</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:54.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.008%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.009%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount of (Loss) Gain Recognized in OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> - Pre-Tax</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Commodity contracts</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">OCI is defined as other comprehensive income (loss).</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:54.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.008%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.009%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in Income - Pre-Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Commodity contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives not designated as hedging instruments</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Recorded in cost of goods sold.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Gain recognized in other income (expense) - net was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 6 - Supplementary Information, for additional information. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Securities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's investment in debt securities are classified as available-for-sale. At March 31, 2021, the fair value and amortized cost of the company's investments in debt securities with contractual maturities within one to five years was $65 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the available-for-sale securities as of March 31, 2021 and December 31, 2020 was determined using Level 1 inputs within the fair value hierarchy. Level 1 measurements were based on quoted market prices in active markets for identical assets and liabilities. The available-for-sale securities as of March 31, 2021 and December 31, 2020 are held by certain foreign subsidiaries in which the USD is not the functional currency. The fluctuations in foreign exchange are recorded in accumulated other comprehensive loss within the interim Consolidated Statements of Equity. These fluctuations are subsequently reclassified from accumulated other comprehensive loss to earnings in the period in which the marketable securities are sold and the gains and losses on these securities offset a portion of the foreign exchange fluctuations in earnings for the company.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the investing results from available-for-sale securities for the three months ended March 31, 2021:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:17.055%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.055%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.055%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.055%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.280%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing Results</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/> March 31,</span></td></tr><tr><td colspan="12" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales of available-for-sale securities</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized losses</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the fair value and gross unrealized losses of the company's investments in debt securities at March 31, 2021, aggregated by investment category:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.228%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="6" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12 months or more</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasuries</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1602000000 2511000000 1536000000 49000000 43000000 10000000 65000000 226000000 <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:42.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.640%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.640%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.643%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional Amounts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,030 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,164 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 1030000000 1164000000 751000000 239000000 383000000 418000000 715000000 647000000 644000000 154000000 0 59000000 P2Y <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.153%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.274%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions and revaluations of derivatives designated as cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clearance of hedge results to earnings</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> -16000000 2000000 30000000 -22000000 -4000000 5000000 10000000 -15000000 -8000000 P2Y <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions and revaluations of derivatives designated as cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clearance of hedge results to earnings</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table> -17000000 0 25000000 16000000 -2000000 0 6000000 16000000 6000000 450000000 <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.817%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Counterparty and Cash Collateral Netting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts Included in the interim Condensed Consolidated Balance Sheet</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset derivatives:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total asset derivatives</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability derivatives:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liability derivatives</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.817%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Counterparty and Cash Collateral Netting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts Included in the Condensed Consolidated Balance Sheet</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset derivatives:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total asset derivatives</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability derivatives:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liability derivatives</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:28.036%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.621%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.416%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.790%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Counterparty and Cash Collateral Netting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts Included in the interim Condensed Consolidated Balance Sheet</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset derivatives:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total asset derivatives</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability derivatives:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liability derivatives</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>1.    Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty. 38000000 0 38000000 52000000 -32000000 20000000 90000000 -32000000 58000000 16000000 0 16000000 46000000 -30000000 16000000 62000000 -30000000 32000000 15000000 0 15000000 40000000 -40000000 0 55000000 -40000000 15000000 38000000 0 38000000 97000000 -40000000 57000000 135000000 -40000000 95000000 36000000 0 36000000 230000000 -110000000 120000000 266000000 -110000000 156000000 108000000 -103000000 5000000 108000000 -103000000 5000000 <div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:54.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.008%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.009%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount of (Loss) Gain Recognized in OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> - Pre-Tax</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Commodity contracts</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">OCI is defined as other comprehensive income (loss).</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:54.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.008%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.009%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in Income - Pre-Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Commodity contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives not designated as hedging instruments</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Recorded in cost of goods sold.</span></div>3.Gain recognized in other income (expense) - net was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 6 - Supplementary Information, for additional information. 21000000 9000000 31000000 19000000 36000000 -34000000 88000000 -6000000 1000000 0 4000000 -7000000 5000000 -7000000 16000000 165000000 2000000 0 -12000000 9000000 6000000 174000000 11000000 167000000 65000000 <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:17.055%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.055%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.055%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.055%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.280%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing Results</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/> March 31,</span></td></tr><tr><td colspan="12" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales of available-for-sale securities</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized losses</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 161000000 -6000000 155000000 <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.228%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="6" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12 months or more</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasuries</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 65000000 0 FAIR VALUE MEASUREMENTS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the basis used to measure certain assets and liabilities at fair value on a recurring basis:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.706%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.731%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.263%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="6" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Significant Other Observable Inputs</span></td><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets at fair value:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></div></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasuries</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives relating to:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities at fair value:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives relating to:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities at fair value</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.245%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.228%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="6" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Significant Other Observable Inputs</span></td><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets at fair value:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></div></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasuries</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives relating to:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities at fair value:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives relating to:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities at fair value</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.349%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:27.451%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Significant Other Observable Inputs (Level 2)</span></td><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets at fair value:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></div></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives relating to:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities at fair value:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives relating to:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities at fair value</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.    The company's investments in debt securities, which are available-for-sale, are included in "marketable securities" in the interim Condensed Consolidated Balance Sheets. </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2. See Note 16 - Financial Instruments for the classification of derivatives in the interim Condensed Consolidated Balance Sheets.</span></div> <div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.706%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.731%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.263%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="6" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Significant Other Observable Inputs</span></td><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets at fair value:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></div></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasuries</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives relating to:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities at fair value:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives relating to:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities at fair value</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.245%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.228%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="6" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Significant Other Observable Inputs</span></td><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets at fair value:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></div></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasuries</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives relating to:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities at fair value:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives relating to:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities at fair value</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.349%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:27.451%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Significant Other Observable Inputs (Level 2)</span></td><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets at fair value:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></div></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives relating to:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities at fair value:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives relating to:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities at fair value</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.    The company's investments in debt securities, which are available-for-sale, are included in "marketable securities" in the interim Condensed Consolidated Balance Sheets. </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2. See Note 16 - Financial Instruments for the classification of derivatives in the interim Condensed Consolidated Balance Sheets.</span></div> 49000000 65000000 90000000 65000000 139000000 62000000 62000000 43000000 226000000 55000000 226000000 98000000 135000000 135000000 10000000 266000000 276000000 108000000 108000000 SEGMENT INFORMATION<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Corteva’s reportable segments reflects the manner in which its chief operating decision maker ("CODM") allocates resources and assesses performance, which is at the operating segment level (seed and crop protection). For purposes of allocating resources to the segments and assessing segment performance, segment operating EBITDA is the primary measure used by Corteva’s CODM. The company defines segment operating EBITDA as earnings (i.e., income (loss) from continuing operations before income taxes) before interest, depreciation, amortization, corporate expenses, non-operating (benefits) costs - net, foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items. Effective January 1, 2021, on a prospective basis, the company excludes from segment operating EBITDA net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. Non-operating (benefits) costs - net consists of non-operating pension and other post-employment benefit (OPEB) costs, tax indemnification adjustments and environmental remediation and legal costs associated with legacy EID businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.952%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of and for the Three Months Ended March 31,</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Seed</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Crop Protection</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,492 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,686 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,178 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating EBITDA</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,799 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,349 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,148 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,501 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,956 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating EBITDA</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,857 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,251 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,108 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.    Segment assets at December 31, 2020 were $23,751 million and $13,099 million for Seed and Crop Protection, respectively.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span><br/></span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation to interim Consolidated Financial Statements</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.866%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from continuing operations after income taxes to segment operating EBITDA </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></div></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr style="height:18pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations after income taxes</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes on continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">791 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange losses - net</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating benefits - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark-to-market gains on certain foreign currency contracts not designated as hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#929292;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Significant items</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating EBITDA</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There was no activity in the three months ended March 31, 2020. Refer to page 48 for further discussion of the company’s Non-GAAP financial measures.</span></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.468%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment assets to total assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,148 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,850 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,108 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate assets</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,401 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,799 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,870 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,549 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,649 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,978 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-15.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Pre-tax (Charges) Benefits Not Included in Segment Operating EBITDA</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The three months ended March 31, 2021 and 2020, respectively, included the following significant pre-tax (charges) benefits which are excluded from segment operating EBITDA:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:37.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.130%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Seed</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Crop Protection</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and Asset Related Charges - Net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:37.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.130%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Seed</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Crop Protection</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and Asset Related Charges - Net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on Divestiture</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements for additional information. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Includes a loss recorded in other income - net related to the sale of the La Porte site.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div> <div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.952%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of and for the Three Months Ended March 31,</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Seed</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Crop Protection</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,492 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,686 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,178 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating EBITDA</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,799 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,349 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,148 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,501 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,956 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating EBITDA</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,857 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,251 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,108 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.    Segment assets at December 31, 2020 were $23,751 million and $13,099 million for Seed and Crop Protection, respectively.</span></div> 2492000000 1686000000 4178000000 617000000 321000000 938000000 24799000000 13349000000 38148000000 2455000000 1501000000 3956000000 581000000 238000000 819000000 25857000000 13251000000 39108000000 23751000000 13099000000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation to interim Consolidated Financial Statements</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.866%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from continuing operations after income taxes to segment operating EBITDA </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></div></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr style="height:18pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations after income taxes</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes on continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">791 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange losses - net</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating benefits - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark-to-market gains on certain foreign currency contracts not designated as hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#929292;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Significant items</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating EBITDA</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There was no activity in the three months ended March 31, 2020. Refer to page 48 for further discussion of the company’s Non-GAAP financial measures.</span></div> 613000000 281000000 178000000 127000000 791000000 408000000 304000000 283000000 -21000000 -18000000 7000000 10000000 35000000 61000000 -311000000 -73000000 -1000000 100000000 123000000 34000000 25000000 938000000 819000000 <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.468%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment assets to total assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,148 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,850 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,108 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate assets</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,401 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,799 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,870 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,549 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,649 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,978 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 38148000000 36850000000 39108000000 4401000000 5799000000 3870000000 42549000000 42649000000 42978000000 <div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:37.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.130%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Seed</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Crop Protection</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and Asset Related Charges - Net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:37.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.130%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Seed</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Crop Protection</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and Asset Related Charges - Net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on Divestiture</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements for additional information. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Includes a loss recorded in other income - net related to the sale of the La Porte site.</span></div> -21000000 -32000000 -47000000 -100000000 -21000000 -32000000 -47000000 -100000000 -10000000 -18000000 -42000000 -70000000 -53000000 -53000000 -10000000 -71000000 -42000000 -123000000 4178000000 3956000000 2420000000 2269000000 281000000 280000000 733000000 757000000 183000000 163000000 100000000 70000000 337000000 1000000 22000000 42000000 776000000 376000000 174000000 119000000 602000000 257000000 -10000000 1000000 592000000 258000000 1000000 8000000 591000000 250000000 592000000 258000000 -403000000 -672000000 -8000000 0 157000000 -3000000 10000000 0 65000000 6000000 -477000000 -663000000 115000000 -405000000 1000000 8000000 114000000 -413000000 2404000000 3526000000 1963000000 114000000 269000000 10000000 6792000000 4926000000 6775000000 4321000000 4882000000 4401000000 1405000000 1165000000 1530000000 15036000000 14768000000 14679000000 64000000 66000000 64000000 4299000000 4396000000 4358000000 10146000000 10269000000 10027000000 10584000000 10747000000 11241000000 433000000 464000000 273000000 1987000000 1939000000 2336000000 42549000000 42649000000 42978000000 1250000000 3000000 1996000000 3098000000 3615000000 3021000000 165000000 123000000 143000000 2247000000 2662000000 1996000000 2257000000 2148000000 2083000000 9017000000 8551000000 9239000000 1102000000 1102000000 614000000 3012000000 3459000000 3872000000 902000000 893000000 911000000 4954000000 5176000000 6186000000 1814000000 1867000000 1989000000 11784000000 12497000000 13572000000 169000000 169000000 169000000 70000000 70000000 70000000 0 0 0 24083000000 24049000000 24004000000 792000000 203000000 -158000000 -3367000000 -2890000000 -3933000000 21747000000 21601000000 20152000000 1000000 0 15000000 21748000000 21601000000 20167000000 42549000000 42649000000 42978000000 592000000 258000000 304000000 283000000 47000000 26000000 -318000000 -85000000 -84000000 -95000000 0 46000000 100000000 70000000 54000000 138000000 -2012000000 -1685000000 467000000 398000000 -448000000 -557000000 -401000000 -575000000 -247000000 -144000000 -1946000000 -1922000000 137000000 128000000 20000000 11000000 40000000 67000000 194000000 58000000 1000000 4000000 36000000 -130000000 828000000 1619000000 447000000 148000000 419000000 875000000 0 1000000 38000000 14000000 -21000000 -23000000 817000000 2336000000 -50000000 -117000000 -1143000000 167000000 3873000000 2173000000 2730000000 2340000000 239000000 0 23958000000 -406000000 -3270000000 7000000 20528000000 250000000 8000000 258000000 -663000000 -663000000 -2000000 -2000000 14000000 14000000 2000000 2000000 32000000 -2000000 30000000 239000000 0 24004000000 -158000000 -3933000000 15000000 20167000000 239000000 0 24049000000 203000000 -2890000000 0 21601000000 591000000 1000000 592000000 -477000000 -477000000 -2000000 -2000000 38000000 38000000 -4000000 -4000000 239000000 0 24083000000 792000000 -3367000000 1000000 21748000000 BASIS OF PRESENTATION<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Business Realignment and the Internal Reorganization, Corteva, Inc. owns 100% of the outstanding common stock of EID. EID is a subsidiary of Corteva, Inc. and continues to be a reporting company, subject to the requirements of the Exchange Act. The primary differences between Corteva, Inc. and EID are outlined below: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Preferred Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - EID has preferred stock outstanding to third parties which is accounted for as a non-controlling interest at the Corteva, Inc. level. Each share of EID Preferred Stock - $4.50 Series and EID Preferred Stock - $3.50 Series issued and outstanding at the effective date of the Corteva Distribution remains issued and outstanding as to EID and was unaffected by the Corteva Distribution.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Related Party Loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - EID engaged in a series of debt redemptions during the second quarter of 2019 that were partially funded through an intercompany loan from Corteva, Inc. This was eliminated in consolidation at the Corteva, Inc. level but remains on EID's financial statements at the standalone level (including the associated interest).</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Capital Structure</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - At March 31, 2021, Corteva, Inc.'s capital structure consists of 738,321,000 issued shares of common stock, par value $0.01 per share. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying footnotes relate to EID only, and not to Corteva, Inc., and are presented to show differences between EID and Corteva, Inc. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the footnotes listed below, refer to the following Corteva, Inc. footnotes:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 1 - Summary of Significant Accounting Policies - refer to page 9 of the Corteva, Inc. interim Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 2 - Recent Accounting Guidance - refer to page 9 of the Corteva, Inc. interim Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 3 - Divestitures and Other Transactions - refer to page 9 of the Corteva, Inc. interim Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 4 - Revenue - refer to page 10 of the Corteva, Inc. interim Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 5 - Restructuring and Asset Related Charges - Net - refer to page 13 of the Corteva, Inc. interim Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 6 - Supplementary Information - refer to page 14 of the Corteva, Inc. interim Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 7 - Income Taxes - refer to page 16 of the Corteva, Inc. interim Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 8 - Earnings Per Share of Common Stock - Not applicable for EID</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 9 - Accounts and Notes Receivable - Net - refer to page 18 of the Corteva, Inc. interim Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 10 - Inventories - refer to page 19 of the Corteva, Inc. interim Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 11 - Other Intangible Assets - refer to page 19 of the Corteva, Inc. interim Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 12 - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities - refer to page 20 of the Corteva, Inc. interim Consolidated Financial Statements. In addition, EID has a related party loan payable to Corteva, Inc.; refer to EID Note 2 - Related Party Transactions, below</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 13 - Commitments and Contingent Liabilities - refer to page 21 of the Corteva, Inc. interim Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 14 - Stockholders' Equity - refer to page 26 of the Corteva, Inc. interim Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 15 - Pension Plans and Other Post Employment Benefits - refer to page 29 of the Corteva, Inc. interim Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 16 - Financial Instruments - refer to page 29 of the Corteva, Inc. interim Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 17 - Fair Value Measurements - refer to page 35 of the Corteva, Inc. interim Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 18 - Segment Information - Differences exist between Corteva, Inc. and EID; refer to EID Note 3 - Segment Information, below</span></div> 1 738321000 0.01 RELATED PARTY TRANSACTIONS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transactions with Corteva</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2019, EID entered into a related party revolving loan from Corteva, Inc., with a maturity date in 2024. As of March 31, 2021, December 31, 2020, and March 31, 2020, the outstanding related party loan balance was $3,012 million, $3,459 million, and $3,872 million respectively (which approximates fair value), with interest rates of 1.62% at March 31, 2021 and December 31, 2020, respectively, and 3.27% at March 31, 2020, and is reflected as long-term debt - related party in EID's interim Condensed Consolidated Balance Sheets. Additionally, EID has incurred tax deductible interest expense of $15 million and $32 million for the three months ended March 31, 2021 and 2020, respectively, associated with the related party loan from Corteva, Inc. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021, EID had payables to Corteva, Inc., of $55 million and $91 million included in accrued and other current liabilities and other noncurrent obligations, respectively, $92 million at December 31, 2020 included in both accrued and other current liabilities and other noncurrent obligations, respectively, and $166 million and $82 million at March 31, 2020, included in accrued and other current liabilities and other noncurrent obligations, respectively, in the interim Condensed Consolidated Balance Sheets related to Corteva's indemnification liabilities to Dow and DuPont per the Separation Agreements (refer to page 9 of the Corteva, Inc. interim Consolidated Financial Statements for further details of the Separation Agreements).</span></div> 3012000000 3459000000 3872000000 0.0162 0.0327 15000000 15000000 32000000 55000000 91000000 92000000 166000000 82000000 SEGMENT INFORMATION <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no differences in reporting structure or segments between Corteva, Inc. and EID. In addition, there are no differences between Corteva, Inc. and EID segment net sales, segment operating EBITDA, segment assets, or significant items by segment; refer to page 36 of the Corteva, Inc. interim Consolidated Financial Statements for background information on the segments as well as further details regarding segment metrics. The tables below reconcile income from continuing operations after income taxes to segment operating EBITDA, as differences exist between Corteva, Inc. and EID.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation to interim Consolidated Financial Statements</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from continuing operations after income taxes to segment operating EBITDA </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></div></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations after income taxes</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes on continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange losses - net</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating benefits - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark-to-market gains on certain foreign currency contracts not designated as hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#929292;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Significant items</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating EBITDA</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>1.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There was no activity in the three months ended March 31, 2020. <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from continuing operations after income taxes to segment operating EBITDA </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></div></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations after income taxes</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes on continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange losses - net</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating benefits - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark-to-market gains on certain foreign currency contracts not designated as hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#929292;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Significant items</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating EBITDA</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table>1.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There was no activity in the three months ended March 31, 2020. 602000000 257000000 174000000 119000000 776000000 376000000 304000000 283000000 -21000000 -18000000 22000000 42000000 35000000 61000000 -311000000 -73000000 -1000000 100000000 123000000 34000000 25000000 938000000 819000000 Gain recognized in other income (expense) - net was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 6 - Supplementary Information, for additional information. For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period. Recorded in cost of goods sold. These accumulated other comprehensive (loss) income components are included in the computation of net periodic benefit credit of the company's pension and other benefit plans. See Note 15 - Pension Plans and Other Post Employment Benefits, for additional information. Reflected in other income - net. Accrual balance excludes indemnification liabilities of $54 million to Chemours, related to the cost sharing arrangement under the MOU (see page 10). Represents liabilities that are subject to the $200 million thresholds and sharing arrangements as discussed on page 22, under Corteva Separation Agreement. Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates The company has recorded an indemnification asset related to these accruals, including $30 million related to the Superfund sites. Accounts receivable – trade and notes receivable - trade are net of allowances of $203 million at March 31, 2021, $208 million at December 31, 2020, and $203 million at March 31, 2020. Allowances are equal to the estimated uncollectible amounts and are based on the expected credit losses and were developed using a loss-rate method. Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid pre-approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of March 31, 2021, December 31, 2020, and March 31, 2020 there were no significant impairments related to current loan agreements. Europe, Middle East, and Africa ("EMEA"). The three months ended March 31, 2020 includes a loss of $(53) million relating to the sale of the La Porte site, for which the company signed an agreement in 2020, and closed during the first quarter of 2021.2.Includes net pre-tax exchange losses of $(23) million and $(9) million associated with the devaluation of the Argentine peso for the three months ended March 31, 2021 and 2020, respectively. Includes a loss recorded in other income - net related to the sale of the La Porte site. See page 15 for reconciliation of cash and cash equivalents and restricted cash presented in interim Condensed Consolidated Balance Sheets to total cash, cash equivalents and restricted cash presented in the interim Consolidated Statements of Cash Flows. Miscellaneous income - net, includes a gain from a remeasurement of an equity investment, losses on sale of available-for-sale securities, tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont, losses on sale of receivables, and other items. Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements for additional information. Included in other assets in the interim Condensed Consolidated Balance Sheets. Other includes receivables in relation to indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than 10 percent of total receivables. In addition, Other includes amounts due from nonconsolidated affiliates of $115 million, $106 million, and $140 million as of March 31, 2021, December 31, 2020, and March 31, 2020, respectively. These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been anti-dilutive. The cumulative translation adjustment loss for the three months ended March 31, 2020 was primarily driven by the strengthening of the USD against the Brazilian Real (“BRL”) and the South African Rand ("ZAR"). The cumulative translation adjustment loss for the three months ended March 31, 2021 was primarily driven by strengthening of the USD against the Swiss Franc ("CHF"), Brazilian Real ("BRL") and European Euro. Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements. Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There was no activity in the three months ended March 31, 2020. Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement loss). Diluted earnings per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect. See Note 16 - Financial Instruments for the classification of derivatives in the interim Condensed Consolidated Balance Sheets. Included in accounts and notes receivable - net in the interim Condensed Consolidated Balance Sheets. Reflected in provision for (benefit from) income taxes from continuing operations. Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There was no activity in the three months ended March 31, 2020. Refer to page 48 for further discussion of the company’s Non-GAAP financial measures. Included in other noncurrent obligations in the interim Condensed Consolidated Balance Sheets. Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty. Beginning on October 1, 2020, the company changed its indefinite life assertion of its trade name asset to definite lived with a useful life of 25 years. This change is the result of the launch of BrevantTM seed in the retail channel in the U.S. Prior to changing the useful life of the trade name asset, the company tested the asset for the impairment under ASC 350- Intangibles, Goodwill and Other, concluding the asset was not impaired. Represents U.S. & Canada. Reflected in cost of goods sold. OCI is defined as other comprehensive income (loss). Segment assets at December 31, 2020 were $23,751 million and $13,099 million for Seed and Crop Protection, respectively. Includes net pre-tax exchange losses of $(23) million and $(9) million associated with the devaluation of the Argentine peso for the three months ended March 31, 2021 and 2020, respectively. Included in other current assets in the interim Condensed Consolidated Balance Sheets. The company's investments in debt securities, which are available-for-sale, are included in "marketable securities" in the interim Condensed Consolidated Balance Sheets XML 15 R1.htm IDEA: XBRL DOCUMENT v3.21.1
DEI Document - $ / shares
3 Months Ended
Mar. 31, 2021
Apr. 30, 2021
Dec. 31, 2020
Mar. 31, 2020
Document Information [Line Items]        
Document Type 10-Q      
Document Quarterly Report true      
Document Period End Date Mar. 31, 2021      
Amendment Flag false      
Document Transition Report false      
Entity File Number 001-38710      
Entity Registrant Name Corteva, Inc.      
Entity Incorporation, State or Country Code DE      
Entity Tax Identification Number 82-4979096      
Entity Address, Address Line One 974 Centre Road,      
Entity Address, City or Town Wilmington,      
Entity Address, State or Province DE      
Entity Address, Postal Zip Code 19805      
City Area Code (302)      
Local Phone Number 485-3000      
Entity Current Reporting Status Yes      
Entity Interactive Data Current Yes      
Entity Filer Category Large Accelerated Filer      
Entity Emerging Growth Company false      
Entity Shell Company false      
Entity Common Stock, Shares Outstanding   737,101,000    
Common Stock, Par Value $ 0.01 $ 0.01 $ 0.01 $ 0.01
Entity Central Index Key 0001755672      
Current Fiscal Year End Date --12-31      
Document Fiscal Year Focus 2021      
Document Fiscal Period Focus Q1      
Entity Small Business false      
Common Stock [Member]        
Document Information [Line Items]        
Title of 12(b) Security Common Stock, par value $0.01 per share      
Trading Symbol CTVA      
Security Exchange Name NYSE      
EID [Member]        
Document Information [Line Items]        
Document Type 10-Q      
Document Quarterly Report true      
Document Period End Date Mar. 31, 2021      
Amendment Flag false      
Document Transition Report false      
Entity File Number 1-815      
Entity Registrant Name E. I. du Pont de Nemours and Company      
Entity Incorporation, State or Country Code DE      
Entity Tax Identification Number 51-0014090      
Entity Address, Address Line One 974 Centre Road,      
Entity Address, City or Town Wilmington,      
Entity Address, State or Province DE      
Entity Address, Postal Zip Code 19805      
City Area Code (302)      
Local Phone Number 485-3000      
Entity Current Reporting Status Yes      
Entity Interactive Data Current Yes      
Entity Filer Category Non-accelerated Filer      
Entity Emerging Growth Company false      
Entity Shell Company false      
Entity Common Stock, Shares Outstanding   200    
Common Stock, Par Value $ 0.30 $ 0.30 $ 0.30 $ 0.30
Entity Central Index Key 0000030554      
Current Fiscal Year End Date --12-31      
Document Fiscal Year Focus 2021      
Document Fiscal Period Focus Q1      
Entity Small Business false      
EID [Member] | $3.50 Series Preferred Stock [Member]        
Document Information [Line Items]        
Title of 12(b) Security $3.50 Series Preferred Stock      
Trading Symbol CTAPrA      
Security Exchange Name NYSE      
EID [Member] | $4.50 Series Preferred Stock [Member]        
Document Information [Line Items]        
Title of 12(b) Security $4.50 Series Preferred Stock      
Trading Symbol CTAPrB      
Security Exchange Name NYSE      

XML 16 R2.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Operations - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Net Sales $ 4,178 $ 3,956
Cost of Goods Sold 2,420 2,269
Research and Development Expense 281 280
Selling, General and Administrative Expenses 733 757
Amortization of Intangibles 183 163
Restructuring and Asset related charges, net 100 70
Other income - net 337 1
Interest Expense 7 10
Income from continuing operations before income taxes 791 408
Provision for income taxes on continuing operations 178 127
Income from continuing operations after income taxes 613 281
Income (loss) from discontinued operations after income taxes (10) 1
Net income 603 282
Net income attributable to noncontrolling interests 3 10
Net income attributable to Corteva $ 600 $ 272
Basic earnings per share of common stock from continuing operations $ 0.82 $ 0.36
Basic loss per share of common stock from discontinued operations (0.01) 0
Basic earnings per share of common stock 0.81 0.36
Diluted earnings per share of common stock from continuing operations 0.81 0.36
Diluted loss per share of common stock from discontinued operations (0.01) 0
Diluted earnings per share of common stock $ 0.80 $ 0.36
EID [Member]    
Net Sales $ 4,178 $ 3,956
Cost of Goods Sold 2,420 2,269
Research and Development Expense 281 280
Selling, General and Administrative Expenses 733 757
Amortization of Intangibles 183 163
Restructuring and Asset related charges, net 100 70
Other income - net 337 1
Interest Expense 22 42
Income from continuing operations before income taxes 776 376
Provision for income taxes on continuing operations 174 119
Income from Continuing Operations After Taxes 602 257
Income (loss) from discontinued operations after income taxes (10) 1
Net income 592 258
Net income attributable to noncontrolling interests 1 8
Net income attributable to Corteva $ 591 $ 250
XML 17 R3.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Comprehensive (Loss) Income - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Net income $ 603 $ 282
Cumulative Translation Adjustments (403) (672)
Unrealized Gain (Loss) on Investments 10 0
Derivatives Instruments 65 6
Total other comprehensive loss (477) (663)
Comprehensive income (loss) 126 (381)
Comprehensive Income Attributable to Noncontrolling Interest - Net of Tax 3 10
Comprehensive Income (Loss) Attributable to Corteva 123 (391)
Pension Plan    
Adjustments to benefit plans 8 0
Other Benefit Plans    
Adjustments to benefit plans (157) 3
EID [Member]    
Net income 592 258
Cumulative Translation Adjustments (403) (672)
Unrealized Gain (Loss) on Investments 10 0
Derivatives Instruments 65 6
Total other comprehensive loss (477) (663)
Comprehensive income (loss) 115 (405)
Comprehensive Income Attributable to Noncontrolling Interest - Net of Tax 1 8
Comprehensive Income (Loss) Attributable to Corteva 114 (413)
EID [Member] | Pension Plan    
Adjustments to benefit plans 8 0
EID [Member] | Other Benefit Plans    
Adjustments to benefit plans $ (157) $ 3
XML 18 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Mar. 31, 2020
Cash and cash equivalents $ 2,404 $ 3,526 $ 1,963
Marketable Securities 114 269 10
Accounts and notes receivable - net 6,792 4,926 6,775
Inventories 4,321 4,882 4,401
Other current assets 1,405 1,165 1,530
Total current assets 15,036 14,768 14,679
Investments in nonconsolidated affiliates 64 66 64
Property, plant and equipment - net of accumulated depreciation (March 31, 2021 - $3,874; December 31, 2020 - $3,857; March 31, 2020 - $3,406) 4,299 4,396 4,358
Goodwill 10,146 10,269 10,027
Other intangible assets 10,584 10,747 11,241
Deferred Income Taxes 433 464 273
Other assets 1,987 1,939 2,336
Total Assets 42,549 42,649 42,978
Short-term borrowings and finance lease obligations 1,250 3 1,996
Accounts payable 3,098 3,615 3,021
Income Taxes Payable 165 123 143
Deferred Revenue 2,247 2,662 1,996
Accrued and other current liabilities 2,239 2,145 2,043
Total current liabilities 8,999 8,548 9,199
Long-term Debt 1,102 1,102 614
Deferred income tax liabilities 902 893 911
Pension and other post employment benefits - noncurrent 4,954 5,176 6,186
Other noncurrent obligations 1,814 1,867 1,989
Total noncurrent liabilities 8,772 9,038 9,700
Common stock 7 7 7
Additional Paid in Capital 27,630 27,707 27,906
Retained earnings / (accumulated deficit) 268 0 (155)
Accumulated other comprehensive loss (3,367) (2,890) (3,933)
Total stockholders' equity attributable to the company 24,538 24,824 23,825
Noncontrolling Interests 240 239 254
Total Equity 24,778 25,063 24,079
Liabilities and Equity 42,549 42,649 42,978
EID [Member]      
Cash and cash equivalents 2,404 3,526 1,963
Marketable Securities 114 269 10
Accounts and notes receivable - net 6,792 4,926 6,775
Inventories 4,321 4,882 4,401
Other current assets 1,405 1,165 1,530
Total current assets 15,036 14,768 14,679
Investments in nonconsolidated affiliates 64 66 64
Property, plant and equipment - net of accumulated depreciation (March 31, 2021 - $3,874; December 31, 2020 - $3,857; March 31, 2020 - $3,406) 4,299 4,396 4,358
Goodwill 10,146 10,269 10,027
Other intangible assets 10,584 10,747 11,241
Deferred Income Taxes 433 464 273
Other assets 1,987 1,939 2,336
Total Assets 42,549 42,649 42,978
Short-term borrowings and finance lease obligations 1,250 3 1,996
Accounts payable 3,098 3,615 3,021
Income Taxes Payable 165 123 143
Deferred Revenue 2,247 2,662 1,996
Accrued and other current liabilities 2,257 2,148 2,083
Total current liabilities 9,017 8,551 9,239
Long-term Debt 1,102 1,102 614
Long Term Debt - Related Party 3,012 3,459 3,872
Deferred income tax liabilities 902 893 911
Pension and other post employment benefits - noncurrent 4,954 5,176 6,186
Other noncurrent obligations 1,814 1,867 1,989
Total noncurrent liabilities 11,784 12,497 13,572
Common stock 0 0 0
Additional Paid in Capital 24,083 24,049 24,004
Retained earnings / (accumulated deficit) 792 203 (158)
Accumulated other comprehensive loss (3,367) (2,890) (3,933)
Total stockholders' equity attributable to the company 21,747 21,601 20,152
Noncontrolling Interests 1 0 15
Total Equity 21,748 21,601 20,167
Liabilities and Equity 42,549 42,649 42,978
EID [Member] | $4.50 Series Preferred Stock [Member]      
Preferred Stock 169 169 169
EID [Member] | $3.50 Series Preferred Stock [Member]      
Preferred Stock $ 70 $ 70 $ 70
XML 19 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Balance Sheets (Parentheticals) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Mar. 31, 2020
Common Stock, Par Value $ 0.01 $ 0.01 $ 0.01
Common Stock, Shares Authorized 1,666,667,000 1,666,667,000 1,666,667,000
Common Stock, Shares, Outstanding 738,321,000 743,458,000 748,369,000
Accumulated Depreciation $ (3,874,000,000) $ (3,857,000,000) $ (3,406,000,000)
EID [Member]      
Common Stock, Par Value $ 0.30 $ 0.30 $ 0.30
Common Stock, Shares Authorized 1,800,000,000 1,800,000,000 1,800,000,000
Common Stock, Shares, Outstanding 200 200 200
Accumulated Depreciation $ (3,874,000,000) $ (3,857,000,000) $ (3,406,000,000)
EID [Member] | $4.50 Series Preferred Stock [Member]      
Preferred Stock, Par Value $ 0 $ 0 $ 0
Preferred Stock, Shares Authorized 23,000,000 23,000,000 23,000,000
Preferred Stock, Shares Issued 1,673,000 1,673,000 1,673,000
Preferred Stock, Redemption Amount $ 120 $ 120 $ 120
EID [Member] | $3.50 Series Preferred Stock [Member]      
Preferred Stock, Par Value $ 0 $ 0 $ 0
Preferred Stock, Shares Authorized 23,000,000 23,000,000 23,000,000
Preferred Stock, Shares Issued 700,000 700,000 700,000
Preferred Stock, Redemption Amount $ 102 $ 102 $ 102
XML 20 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash used for operating activities    
Net income $ 603 $ 282
Provision for Deferred Income Tax 47 26
Net Periodic Pension and OPEB benefit, net (318) (85)
Pension and OPEB Contributions (84) (95)
Net loss (gain) on sales of property, businesses, consolidated companies, and investments 0 46
Restructuring and Asset related charges, net 100 70
Other net loss 54 138
Accounts and notes receivable (2,012) (1,685)
Inventories 467 398
Accounts Payable (448) (557)
Deferred Revenue (401) (575)
Other Assets and Liabilities (262) (176)
Cash used for operating activities (1,950) (1,930)
Cash provided by (used for) investing activities    
Capital expenditures (137) (128)
Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested 20 11
Purchases of investments (40) (67)
Proceeds from Sale and Maturities of Investments 194 58
Other investing activities - net (1) (4)
Cash provided by (used for) investing activities 36 (130)
Cash provided by financing activities    
Net change in borrowings (less than 90 days) 828 1,619
Proceeds from debt 419 875
Payments on Debt 0 (1)
Repurchase of Common Stock (350) (50)
Proceeds from Exercise of Stock Options 38 14
Dividends paid to stockholders (97) (97)
Other financing activities (17) (16)
Cash provided by financing activities 821 2,344
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash (50) (117)
Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash (1,143) 167
Cash, Cash Equivalents and Restricted Cash at Beginning of Period 3,873 2,173
Cash, Cash Equivalents and Restricted Cash at End of Period [1] 2,730 2,340
EID [Member]    
Cash used for operating activities    
Net income 592 258
Depreciation and Amortization 304 283
Provision for Deferred Income Tax 47 26
Net Periodic Pension and OPEB benefit, net (318) (85)
Pension and OPEB Contributions (84) (95)
Net loss (gain) on sales of property, businesses, consolidated companies, and investments 0 46
Restructuring and Asset related charges, net 100 70
Other net loss 54 138
Accounts and notes receivable (2,012) (1,685)
Inventories 467 398
Accounts Payable (448) (557)
Deferred Revenue (401) (575)
Other Assets and Liabilities (247) (144)
Cash used for operating activities (1,946) (1,922)
Cash provided by (used for) investing activities    
Capital expenditures (137) (128)
Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested 20 11
Purchases of investments (40) (67)
Proceeds from Sale and Maturities of Investments 194 58
Other investing activities - net (1) (4)
Cash provided by (used for) investing activities 36 (130)
Cash provided by financing activities    
Net change in borrowings (less than 90 days) 828 1,619
Repayments of Related Party Debt (447) (148)
Proceeds from debt 419 875
Payments on Debt 0 (1)
Proceeds from Exercise of Stock Options 38 14
Other financing activities (21) (23)
Cash provided by financing activities 817 2,336
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash (50) (117)
Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash (1,143) 167
Cash, Cash Equivalents and Restricted Cash at Beginning of Period 3,873 2,173
Cash, Cash Equivalents and Restricted Cash at End of Period 2,730 2,340
Total company [Member]    
Cash used for operating activities    
Depreciation and Amortization 304 283
Restructuring and Asset related charges, net 100 70
Total company [Member] | EID [Member]    
Cash used for operating activities    
Depreciation and Amortization 304 283
Restructuring and Asset related charges, net $ 100 $ 70
[1] See page 15 for reconciliation of cash and cash equivalents and restricted cash presented in interim Condensed Consolidated Balance Sheets to total cash, cash equivalents and restricted cash presented in the interim Consolidated Statements of Cash Flows.
XML 21 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Statement of Stockholders Equity Statement - USD ($)
$ in Millions
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Accumulated Other Comp (Loss) Income
Noncontrolling Interest [Member]
EID [Member]
EID [Member]
Preferred Stock [Member]
EID [Member]
Common Stock [Member]
EID [Member]
Additional Paid-in Capital [Member]
EID [Member]
Retained Earnings [Member]
EID [Member]
Accumulated Other Comp (Loss) Income
EID [Member]
Noncontrolling Interest [Member]
Beginning Balance at Dec. 31, 2019 $ 24,555 $ 7 $ 27,997 $ (425) $ (3,270) $ 246 $ 20,528 $ 239 $ 0 $ 23,958 $ (406) $ (3,270) $ 7
Net income (loss) 282     272   10 258       250   8
Other comprehensive (loss) income (663)       (663)   (663)         (663)  
Common Dividends ($.13 per share) (97)   (97)                    
Issuance of Corteva Stock 14   14       14     14      
Dividends, Preferred Stock             (2)     (2)      
Share-based compensation 2   2       2     2      
Repurchase of common stock (50)   (50)                    
Other-net 36   40 (2)   (2) 30     32 (2)    
Ending Balance at Mar. 31, 2020 24,079 7 27,906 (155) (3,933) 254 20,167 239 0 24,004 (158) (3,933) 15
Beginning Balance at Dec. 31, 2020 25,063 7 27,707 0 (2,890) 239 21,601 239 0 24,049 203 (2,890) 0
Net income (loss) 603     600   3 592       591   1
Other comprehensive (loss) income (477)       (477)   (477)         (477)  
Common Dividends ($.13 per share) (97)   (97)                    
Issuance of Corteva Stock 38   38       38     38      
Dividends, Preferred Stock             (2)       (2)    
Repurchase of common stock (350)   (18) (332)                  
Other-net (2)         (2) (4)     (4)      
Ending Balance at Mar. 31, 2021 $ 24,778 $ 7 $ 27,630 $ 268 $ (3,367) $ 240 $ 21,748 $ 239 $ 0 $ 24,083 $ 792 $ (3,367) $ 1
XML 22 R8.htm IDEA: XBRL DOCUMENT v3.21.1
Statement of Stockholders' Equity Parentheticals (Parentheticals) - $ / shares
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Common Stock, Dividends, Per Share, Declared $ 0.13 $ 0.13
EID [Member] | $4.50 Series Preferred Stock [Member]    
Preferred Stock, Dividends Per Share, Declared 1.125 1.125
EID [Member] | $3.50 Series Preferred Stock [Member]    
Preferred Stock, Dividends Per Share, Declared $ 0.875 $ 0.875
XML 23 R9.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Significant Accounting Policies (Notes)
3 Months Ended
Mar. 31, 2021
Accounting Policies [Abstract]  
Significant Accounting Policies [Text Block] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited interim Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included.  Results for interim periods should not be considered indicative of results for a full year.  These interim Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2020, collectively referred to as the “2020 Annual Report.”  The interim Consolidated Financial Statements include the accounts of the company and all of its subsidiaries in which a controlling interest is maintained.

Certain reclassifications of prior year's data have been made to conform to current year's presentation.

During the first quarter 2020, the company recorded an increase of $40 million to APIC relating to net assets recorded as transferred as part of the 2019 Internal Reorganizations that were retained. 

Since 2018, Argentina has been considered a hyper-inflationary economy under U.S. GAAP and therefore the U.S. Dollar (“USD”) is the functional currency for our related subsidiaries. We remeasure the net monetary assets utilizing the official Argentine Peso (“Peso”) to USD exchange rate. The devaluation of the Peso relative to the USD over the last several years has resulted in the recognition of exchange losses (refer to Note 6 of these financial statements and Note 9 of the 2020 financial statements included in the Company's Annual Report on Form 10-K). As of March 31, 2021, a further 10% deterioration in the official Peso to USD exchange rate would reduce the USD value of our net monetary assets and negatively impact pre-tax earnings by approximately $20 million.
XML 24 R10.htm IDEA: XBRL DOCUMENT v3.21.1
Recent Accounting Guidance
3 Months Ended
Mar. 31, 2021
Accounting Changes and Error Corrections [Abstract]  
Recent Accounting Guidance RECENT ACCOUNTING GUIDANCE
Recently Adopted Accounting Guidance
In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which was part of the FASB’s Simplification Initiative to identify, evaluate, and improve areas of U.S. GAAP for which cost and complexity can be reduced, while maintaining or improving the usefulness of the information provided to users of financial statements. This ASU amends ASC 740, Income Taxes, by removing certain exceptions to the general principles, and clarifying and amending current guidance. The new standard is effective for fiscal years, and periods within those fiscal years, beginning after December 15, 2020. The company adopted this guidance on January 1, 2021 and it did not have a material impact on the company’s financial position, results of operation or cash flows.
XML 25 R11.htm IDEA: XBRL DOCUMENT v3.21.1
Divestitures and Other Transactions
3 Months Ended
Mar. 31, 2021
Discontinued Operations and Disposal Groups [Abstract]  
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] DIVESTITURES AND OTHER TRANSACTIONS
Separation Agreements
In connection with the Distributions, DuPont, Corteva, and Dow (together, the “Parties” and each a “Party”) have entered into certain agreements to effect the Separation, provide for the allocation of DowDuPont’s assets, employees, liabilities and obligations (including its investments, property and employee benefits and tax-related assets and liabilities) among the Parties, and provide a framework for Corteva's relationship with Dow and DuPont following the separations and Distributions (collectively, the "Separation Agreements"). For additional information see Note 13 - Commitments and Contingent Liabilities.

DuPont
Pursuant to the Separation Agreements, DuPont and Corteva indemnifies the other against certain litigation, environmental, tax, workers' compensation and other liabilities that arose prior to the Corteva Distribution. The term of this indemnification is generally indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. At March 31, 2021, the indemnification assets are $28 million within accounts and notes receivable - net and $51 million within other assets in the interim Condensed Consolidated Balance Sheet. At March 31, 2021, the indemnification liabilities are $77 million within other noncurrent obligations in the interim Condensed Consolidated Balance Sheet.

Dow
Pursuant to the Separation Agreements, Dow and Corteva indemnifies the other against certain litigation, environmental, tax and other liabilities that arose prior to the Corteva Distribution. The term of this indemnification is generally indefinite and
includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. At March 31, 2021, the indemnification liabilities are $52 million within accrued and other current liabilities and $14 million within other noncurrent obligations in the interim Condensed Consolidated Balance Sheet.

Performance Chemicals
On July 1, 2015, Historical DuPont completed the separation of its Performance Chemicals segment through the spin-off of all of the issued and outstanding stock of The Chemours Company (the "Chemours Separation"). In connection with the Chemours Separation, Historical DuPont and The Chemours Company ("Chemours") entered into a Separation Agreement (as amended, the "Chemours Separation Agreement"), discussed below, a Tax Matters Agreement and certain ancillary agreements, including an employee matters agreement, agreements related to transition and site services, and intellectual property cross licensing arrangements. In addition, the companies entered into certain supply agreements.

Separation Agreement
The Chemours Separation Agreement sets forth, among other things, the agreements between the company and Chemours regarding the principal transactions necessary to effect the Chemours Separation and also sets forth ancillary agreements that govern certain aspects of the company’s relationship with Chemours after the separation. Among other matters, the Chemours Separation Agreement and the ancillary agreements provide for the allocation between Historical DuPont and Chemours of assets, employees, liabilities and obligations (including investments, property and employee benefits and tax-related assets and liabilities) attributable to periods prior to, at and after the completion of the Chemours Separation.

Pursuant to the Chemours Separation Agreement, Chemours indemnifies the company against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the distribution. The term of this indemnification is generally indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In 2017, EID and Chemours amended the Chemours Separation Agreement ("2017 Amendment") to provide for a limited sharing of potential future perfluorooctanoic acid (“PFOA”) liabilities for a period of five years beginning July 6, 2017. In January 2021, Chemours, DuPont and Corteva entered into a binding memorandum of understanding ("MOU") amending the Chemours Separation Agreement, and thereby replacing the 2017 Amendment.

In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. At March 31, 2021, the indemnification assets are $63 million within accounts and notes receivable - net and $259 million within other assets (along with the corresponding liabilities within accrued and other current liabilities and other noncurrent obligations in the interim Condensed Consolidated Balance Sheet.) Additionally, at March 31, 2021 indemnification liabilities related to the MOU, primarily associated with environmental remediation related to PFAS, were $10 million within accrued and other current liabilities and $44 million within other noncurrent obligations in the interim Condensed Consolidated Balance Sheet. During the three months ended March 31, 2021, the company recorded a charge of $3 million to (loss) income from discontinued operations after income taxes, related to the MOU.

See Note 13 - Commitments and Contingent Liabilities, to the interim Consolidated Financial Statements, for further discussion of the amendment to the Chemours Separation Agreement, MOU, and environmental matters indemnified by Chemours.
XML 26 R12.htm IDEA: XBRL DOCUMENT v3.21.1
Revenue (Notes)
3 Months Ended
Mar. 31, 2021
Revenue from Contract with Customer [Abstract]  
Revenue from Contract with Customer REVENUE
Revenue Recognition
Products
Substantially all of Corteva's revenue is derived from product sales. Product sales consist of sales of Corteva's products to farmers, distributors, and manufacturers. Corteva considers purchase orders, which in some cases are governed by master supply agreements, to be a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year. However, the company has some long-term contracts which can span multiple years.

Revenue from product sales is recognized when the customer obtains control of the company's product, which occurs at a point in time according to shipping terms. Payment terms are generally less than one year from invoicing. The company elected the practical expedient and does not adjust the promised amount of consideration for the effects of a significant financing component when the company expects it will be one year or less between when a customer obtains control of the company's product and when payment is due. The company has elected to recognize shipping and handling activities when control has transferred to the customer as an expense in cost of goods sold. Taxes collected from customers relating to product sales and
remitted to governmental authorities are excluded from revenues. In addition, the company elected the practical expedient to expense any costs to obtain contracts as incurred, as the amortization period for these costs would have been one year or less.

The transaction price includes estimates of variable consideration, such as rights of return, rebates, and discounts, that are reductions in revenue. All estimates are based on the company's historical experience, anticipated performance, and the company's best judgment at the time the estimate is made. Estimates of variable consideration included in the transaction price utilize either the expected value method or most likely amount depending on the nature of the variable consideration. These estimates are reassessed each reporting period and are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur upon resolution of uncertainty associated with the variable consideration. The majority of contracts have a single performance obligation satisfied at a point in time and the transaction price is stated in the contract, usually as quantity times price per unit. For contracts with multiple performance obligations, the company allocates the transaction price to each performance obligation based on the relative standalone selling price. The standalone selling price is the observable price which depicts the price as if sold to a similar customer in similar circumstances.

Licenses of Intellectual Property
Corteva enters into licensing arrangements with customers under which it licenses its intellectual property. Revenue from the majority of intellectual property licenses is derived from sales-based royalties. Revenue for licensing agreements that contain sales-based royalties is recognized at the later of (i) when the subsequent sale occurs or (ii) when the performance obligation to which some or all of the royalty has been allocated is satisfied.

Remaining Performance Obligations
Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. The company applies the practical expedient to disclose the transaction price allocated to the remaining performance obligations for only those contracts with an original duration of one year or more. The transaction price allocated to remaining performance obligations with an original duration of more than one year related to material rights granted to customers for contract renewal options were $113 million at March 31, 2021 ($115 million and $106 million at December 31, 2020 and March 31, 2020, respectively). The company expects revenue to be recognized for the remaining performance obligations over the next 1 year to 6 years.

Contract Balances
Contract liabilities primarily reflect deferred revenue from prepayments under contracts with customers where the company receives advance payments for products to be delivered in future periods. Corteva classifies deferred revenue as current or noncurrent based on the timing of when the company expects to recognize revenue. Contract assets primarily include amounts related to contractual rights to consideration for completed performance not yet invoiced. Accounts receivable are recorded when the right to consideration becomes unconditional.
Contract BalancesMarch 31, 2021December 31, 2020March 31, 2020
(In millions)
Accounts and notes receivable - trade1
$5,764 $3,917 $5,779 
Contract assets - current2
$22 $22 $20 
Contract assets - noncurrent3
$53 $54 $49 
Deferred revenue - current$2,247 $2,662 $1,996 
Deferred revenue - noncurrent4
$111 $116 $104 
1.Included in accounts and notes receivable - net in the interim Condensed Consolidated Balance Sheets.
2.Included in other current assets in the interim Condensed Consolidated Balance Sheets.
3.Included in other assets in the interim Condensed Consolidated Balance Sheets.
4.Included in other noncurrent obligations in the interim Condensed Consolidated Balance Sheets.

Revenue recognized during the three months ended March 31, 2021 from amounts included in deferred revenue at the beginning of the period was $924 million ($822 million in the three months ended March 31, 2020).
Disaggregation of Revenue
Corteva's operations are classified into two reportable segments: Seed and Crop Protection. The company disaggregates its revenue by major product line and geographic region, as the company believes it best depicts the nature, amount and timing of its revenue and cash flows. Net sales by major product line are included below:
Three Months Ended
March 31,
(In millions)20212020
    Corn$1,888 $1,864 
    Soybean177 181 
    Other oilseeds296 248 
    Other131 162 
Seed2,492 2,455 
    Herbicides986 823 
    Insecticides385 378 
    Fungicides261 229 
    Other54 71 
Crop Protection1,686 1,501 
Total$4,178 $3,956 
.

Sales are attributed to geographic regions based on customer location. Net sales by geographic region and segment are included below:
SeedThree Months Ended
March 31,
(In millions)20212020
North America1
$1,210 $1,290 
EMEA2
947 881 
Latin America274 216 
Asia Pacific61 68 
Total$2,492 $2,455 
Crop ProtectionThree Months Ended
March 31,
(In millions)20212020
North America1
$533 $475 
EMEA2
655 586 
Latin America244 218 
Asia Pacific254 222 
Total$1,686 $1,501 
1.Represents U.S. & Canada.
2.Europe, Middle East, and Africa ("EMEA").
XML 27 R13.htm IDEA: XBRL DOCUMENT v3.21.1
Supplementary Information
3 Months Ended
Mar. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Additional Financial Information Disclosure [Text Block] SUPPLEMENTARY INFORMATION
Other Income - NetThree Months Ended
March 31,
(In millions)20212020
Interest income$21 $18 
Equity in earnings / (losses) of affiliates - net(1)
Net loss on sales of businesses and other assets1
— (46)
Net exchange losses2
(35)(61)
Non-operating pension and other post employment benefit credit3
325 91 
Miscellaneous income - net4
23 — 
Other income - net$337 $
 
1.The three months ended March 31, 2020 includes a loss of $(53) million relating to the sale of the La Porte site, for which the company signed an agreement in 2020, and closed during the first quarter of 2021.
2.Includes net pre-tax exchange losses of $(23) million and $(9) million associated with the devaluation of the Argentine peso for the three months ended March 31, 2021 and 2020, respectively.
3.Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement loss).
4.Miscellaneous income - net, includes a gain from a remeasurement of an equity investment, losses on sale of available-for-sale securities, tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont, losses on sale of receivables, and other items.
The following table summarizes the impacts of the company's foreign currency hedging program on the company's results of operations. The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The hedging program gains (losses) are largely taxable (tax deductible) in the U.S., whereas the offsetting exchange gains (losses) on the remeasurement of the net monetary asset positions are often not taxable (tax deductible) in their local jurisdictions. The net pre-tax exchange gains (losses) are recorded in other income - net and the related tax impact is recorded in provision for (benefit from) income taxes on continuing operations in the interim Consolidated Statement of Operations.
(In millions)Three Months Ended
March 31,
20212020
Subsidiary Monetary Position (Losses) Gains
Pre-tax exchange losses$(51)$(226)
Local tax (expenses) / benefits(1)23 
Net after-tax impact from subsidiary exchange losses$(52)$(203)
Hedging Program Gains
Pre-tax exchange gains$16 $165 
Tax expenses(4)(40)
Net after-tax impact from hedging program exchange gains$12 $125 
Total Exchange Losses
Pre-tax exchange losses$(35)$(61)
Tax expenses(5)(17)
Net after-tax exchange losses$(40)$(78)
Cash, cash equivalents and restricted cash
The following table provides a reconciliation of cash and cash equivalents and restricted cash (included in other current assets) presented in the interim Condensed Consolidated Balance Sheets to the total cash, cash equivalents and restricted cash presented in the interim Consolidated Statements of Cash Flows.
(In millions)March 31, 2021December 31, 2020March 31, 2020
Cash and cash equivalents$2,404 $3,526 $1,963 
Restricted cash326 347 377 
Total cash, cash equivalents and restricted cash$2,730 $3,873 $2,340 

EID entered into a trust agreement in 2013 (as amended and restated in 2017), establishing and requiring EID to fund a trust (the "Trust") for cash obligations under certain non-qualified benefit and deferred compensation plans upon a change in control event as defined in the Trust agreement. Under the Trust agreement, the consummation of the Merger was a change in control event. Restricted cash at March 31, 2021, December 31, 2020, and March 31, 2020 is related to the Trust.
XML 28 R14.htm IDEA: XBRL DOCUMENT v3.21.1
Income Taxes
3 Months Ended
Mar. 31, 2021
Income Tax Disclosure [Abstract]  
Income Tax Disclosure [Text Block] INCOME TAXES
For periods between the Merger Effectiveness Time and the Corteva Distribution, Corteva and its subsidiaries were included in DowDuPont's consolidated federal income tax group and consolidated tax return.  Generally, the consolidated tax liability of the DowDuPont U.S. tax group for each year was apportioned among the members of the consolidated group based on each member’s separate taxable income.  Corteva, DuPont and Dow intend that to the extent Federal and/or State corporate income tax liabilities are reduced through the utilization of tax attributes of the other, settlement of any receivable and payable generated from the use of the other party’s sub-group attributes will be in accordance with a tax matters agreement. See Note 3 - Divestitures and Other Transactions, for further information related to indemnifications between Corteva, Dow and DuPont.

Each year the company files hundreds of tax returns in the various national, state and local income taxing jurisdictions in which it operates. These tax returns are subject to examination and possible challenge by the tax authorities. Positions challenged by the tax authorities may be settled or appealed by the company. As a result, there is an uncertainty in income taxes recognized in the company's financial statements in accordance with accounting for income taxes and accounting for uncertainty in income taxes. The ultimate resolution of such uncertainties is not expected to have a material impact on the company's results of operations.

The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of the program, which resides in the U.S., is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions, which can drive material impacts on the company's effective tax rate. For further discussion of pre-tax and after-tax impacts of the company's foreign currency hedging program and net monetary asset programs, refer to Note 6 - Supplementary Information.
XML 29 R15.htm IDEA: XBRL DOCUMENT v3.21.1
Earnings Per Share (Notes)
3 Months Ended
Mar. 31, 2021
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block] EARNINGS PER SHARE OF COMMON STOCK
The following tables provide earnings per share calculations for the periods indicated below:
Net Income for Earnings Per Share Calculations - Basic and DilutedThree Months Ended
March 31,
(In millions)20212020
Income from continuing operations after income taxes$613 $281 
Net income attributable to continuing operations noncontrolling interests10 
Income from continuing operations available to Corteva common stockholders610 271 
(Loss) income from discontinued operations available to Corteva common stockholders(10)
Net income available to common stockholders$600 $272 
Earnings Per Share Calculations - BasicThree Months Ended
March 31,
(Dollars per share)20212020
Earnings per share of common stock from continuing operations
$0.82 $0.36 
Loss per share of common stock from discontinued operations(0.01)— 
Earnings per share of common stock$0.81 $0.36 
Earnings Per Share Calculations - DilutedThree Months Ended
March 31,
(Dollars per share)20212020
Earnings per share of common stock from continuing operations$0.81 $0.36 
Loss per share of common stock from discontinued operations (0.01)— 
Earnings per share of common stock$0.80 $0.36 
Share Count InformationThree Months Ended
March 31,
(Shares in millions)20212020
Weighted-average common shares - basic743.4 749.9 
Plus dilutive effect of equity compensation plans1
6.2 2.6 
Weighted-average common shares - diluted749.6 752.5 
Potential shares of common stock excluded from EPS calculations2
2.9 9.1 
1.Diluted earnings per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.
2.These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been anti-dilutive.
XML 30 R16.htm IDEA: XBRL DOCUMENT v3.21.1
Accounts and Notes Receivable (Notes)
3 Months Ended
Mar. 31, 2021
Accounts and Notes Receivable [Abstract]  
Loans, Notes, Trade and Other Receivables Disclosure [Text Block] ACCOUNTS AND NOTES RECEIVABLE - NET
(In millions)March 31, 2021December 31, 2020March 31, 2020
Accounts receivable – trade1
$5,231 $3,754 $5,367 
Notes receivable – trade1,2
533 163 412 
Other3
1,028 1,009 996 
Total accounts and notes receivable - net$6,792 $4,926 $6,775 
1.Accounts receivable – trade and notes receivable - trade are net of allowances of $203 million at March 31, 2021, $208 million at December 31, 2020, and $203 million at March 31, 2020. Allowances are equal to the estimated uncollectible amounts and are based on the expected credit losses and were developed using a loss-rate method.
2.Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid pre-approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of March 31, 2021, December 31, 2020, and March 31, 2020 there were no significant impairments related to current loan agreements.
3.Other includes receivables in relation to indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than 10 percent of total receivables. In addition, Other includes amounts due from nonconsolidated affiliates of $115 million, $106 million, and $140 million as of March 31, 2021, December 31, 2020, and March 31, 2020, respectively.

Accounts and notes receivable are carried at the expected amount to be collected, which approximates fair value. The company establishes the allowance for doubtful receivables using a loss-rate method where the loss rate is developed using past events, historical experience, current conditions and forecasts that affect the collectability of the financial assets.

The following table summarizes changes in the allowance for doubtful receivables for the three months ended March 31, 2021 and 2020:
(In millions)
2020
Balance at December 31, 2019$174 
Net provision for credit losses60 
Write-offs charged against allowance(1)
Recoveries collected(30)
Balance at March 31, 2020
$203 
2021
Balance at December 31, 2020$208 
Net benefit for credit losses(5)
Balance at March 31, 2021
$203 

The company enters into various factoring agreements with third-party financial institutions to sell its trade receivables under both recourse and non-recourse agreements in exchange for cash proceeds. These financing arrangements result in a transfer of the company's receivables and risks to the third-party. As these transfers qualify as true sales under the applicable accounting guidance, the receivables are derecognized from the interim Condensed Consolidated Balance Sheets upon transfer, and the company receives a payment for the receivables from the third-party within a mutually agreed upon time period. For arrangements involving an element of recourse, which is typically provided through a guarantee of accounts in the event of customer default, the guarantee obligation is measured using market data from similar transactions and reported as a current liability in the interim Condensed Consolidated Balance Sheets.

Trade receivables sold under these agreements were $11 million and $15 million for the three months ended March 31, 2021 and March 31, 2020, respectively. The trade receivables sold that remained outstanding under these agreements which include an element of recourse as of March 31, 2021, December 31, 2020, and March 31, 2020 were $128 million, $157 million, and $43 million, respectively. The net proceeds received are included in cash provided by operating activities in the interim Consolidated Statements of Cash Flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of receivables in other income - net in the Consolidated Statements of Operations. Loss on sale of receivables for the three months ended March 31, 2021 and 2020 were not material. The guarantee obligations recorded as of March 31, 2021, December 31, 2020, and March 31, 2020 in the interim Condensed Consolidated Balance Sheets were not material. See Note 13 - Commitments and Contingent Liabilities for additional information on the company’s guarantees.
XML 31 R17.htm IDEA: XBRL DOCUMENT v3.21.1
Inventories
3 Months Ended
Mar. 31, 2021
Inventory Disclosure [Abstract]  
Inventory Disclosure [Text Block] INVENTORIES
(In millions)March 31, 2021December 31, 2020March 31, 2020
Finished products$2,508 $2,584 $2,721 
Semi-finished products1,386 1,813 1,260 
Raw materials and supplies427 485 420 
Total inventories$4,321 $4,882 $4,401 
XML 32 R18.htm IDEA: XBRL DOCUMENT v3.21.1
Other Intangible Assets
3 Months Ended
Mar. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets Disclosure [Text Block] OTHER INTANGIBLE ASSETS
The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows: 
(In millions)March 31, 2021December 31, 2020March 31, 2020
 GrossAccumulated
Amortization
NetGrossAccumulated
Amortization
NetGrossAccumulated
Amortization
Net
Intangible assets subject to amortization (Definite-lived):
      
Germplasm$6,265 $(380)$5,885 $6,265 $(317)$5,948 $6,265 $(126)$6,139 
Customer-related
1,956 (404)1,552 1,984 (380)1,604 1,956 (293)1,663 
Developed technology
1,485 (565)920 1,451 (525)926 1,463 (409)1,054 
Trademarks/trade names1
2,013 (112)1,901 2,019 (99)1,920 166 (88)78 
Favorable supply contracts
475 (326)149 475 (302)173 475 (231)244 
Other2
405 (238)167 405 (239)166 400 (218)182 
Total other intangible assets with finite lives
12,599 (2,025)10,574 12,599 (1,862)10,737 10,725 (1,365)9,360 
Intangible assets not subject to amortization (Indefinite-lived):
      
IPR&D10 — 10 10 — 10 10 — 10 
Trade name1
1,871 — 1,871 
Total other intangible assets10 — 10 10 — 10 1,881 — 1,881 
Total$12,609 $(2,025)$10,584 $12,609 $(1,862)$10,747 $12,606 $(1,365)$11,241 
1.Beginning on October 1, 2020, the company changed its indefinite life assertion of its trade name asset to definite lived with a useful life of 25 years. This change is the result of the launch of BrevantTM seed in the retail channel in the U.S. Prior to changing the useful life of the trade name asset, the company tested the asset for the impairment under ASC 350- Intangibles, Goodwill and Other, concluding the asset was not impaired.
2.Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.

The aggregate pre-tax amortization expense from continuing operations for definite-lived intangible assets was $183 million and $163 million for the three months ended March 31, 2021 and 2020, respectively. The current estimated aggregate pre-tax amortization expense from continuing operations for the remainder of 2021 and each of the next five years is approximately $537 million, $700 million, $620 million, $606 million, $569 million and $555 million, respectively.
XML 33 R19.htm IDEA: XBRL DOCUMENT v3.21.1
Short-Term Borrowings, Long-Term Debt and Available Credit Facilities
3 Months Ended
Mar. 31, 2021
Debt Disclosure [Abstract]  
Debt Disclosure [Text Block] SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES
The following tables summarize Corteva's short-term borrowings and finance lease obligations:
Short-term borrowings and finance lease obligations
(In millions)March 31, 2021December 31, 2020March 31, 2020
Commercial paper$1,218 $— $1,918 
Repurchase facility30 — 30 
Other loans - various currencies— 45 
Long-term debt payable within one year
Finance lease obligations payable within one year
Total short-term borrowings and finance lease obligations$1,250 $$1,996 

The estimated fair value of the company's short-term borrowings, including interest rate financial instruments, was determined using Level 2 inputs within the fair value hierarchy. Based on quoted market prices for the same or similar issues, or on current rates offered to the company for debt of the same remaining maturities, the fair value of the company's short-term borrowings and finance lease obligations was approximately carrying value.

The fair value of the company’s long-term borrowings, including debt due within one year, was $1,121 million, $1,168 million, and $612 million as of March 31, 2021, December 31, 2020, and March 31, 2020, respectively, and was determined using quoted market prices for the same or similar issues, or current rates offered to the company for debt of the same remaining maturities (Level 2 inputs).

Repurchase Facility
In February 2021, the company entered into a new committed receivable repurchase facility of up to $1 billion (the "2021 Repurchase Facility") which expires in December 2021. Under the 2021 Repurchase Facility, Corteva may sell a portfolio of available and eligible outstanding customer notes receivables to participating institutions and simultaneously agree to repurchase at a future date. The 2021 Repurchase Facility is considered a secured borrowing with the customer notes receivables inclusive of those that are sold and repurchased, equal to 105 percent of the outstanding amounts borrowed utilized as collateral. Borrowings under the 2021 Repurchase Facility have an interest rate of LIBOR+0.85 percent.

As of March 31, 2021, $32 million of notes receivable, recorded in accounts and notes receivable - net, were pledged as collateral against outstanding borrowings under the 2021 Repurchase Facility of $30 million, recorded in short-term borrowings and finance lease obligations on the interim Condensed Consolidated Balance Sheet.

Revolving Credit Facilities
In November 2018, EID entered into a $3.0 billion 5-year revolving credit facility and a $3.0 billion 3-year revolving credit facility (the “Revolving Credit Facilities”). The Revolving Credit Facilities became effective May 2019. Corteva, Inc. became a party at the time of the Corteva Distribution. The Revolving Credit Facilities may serve as a substitute to the company's commercial paper program, and can be used, from time to time, for general corporate purposes including, but not limited to, the funding of seasonal working capital needs. The Revolving Credit Facilities contain customary representations and warranties, affirmative and negative covenants and events of default that are typical for companies with similar credit ratings. Additionally, the Revolving Credit Facilities contain a financial covenant requiring that the ratio of total indebtedness to total capitalization for Corteva and its consolidated subsidiaries not exceed 0.60.

In March 2020, the company drew down $500 million under the $3.0 billion 3-year revolving credit facility as a result of the volatility and increased borrowing costs of commercial paper resulting from the unstable market conditions caused by the COVID-19 pandemic and repaid that borrowing in full in June 2020. There were no additional borrowings and the unused commitments under the 3-year revolving credit facility were $3.0 billion as of March 31, 2021.
XML 34 R20.htm IDEA: XBRL DOCUMENT v3.21.1
Commitments and Contingent Liabilities
3 Months Ended
Mar. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Disclosure [Text Block] COMMITMENTS AND CONTINGENT LIABILITIES
Guarantees
Indemnifications
In connection with acquisitions and divestitures as of March 31, 2021, the company has indemnified respective parties against certain liabilities that may arise in connection with these transactions and business activities prior to the completion of the transactions. The term of these indemnifications, which typically pertain to environmental, tax and product liabilities, is generally indefinite. In addition, the company indemnifies its duly elected or appointed directors and officers to the fullest extent permitted by Delaware law, against liabilities incurred as a result of their activities for the company, such as adverse judgments relating to litigation matters. If the indemnified party were to incur a liability or have a liability increase as a result of a successful claim, pursuant to the terms of the indemnification, the company would be required to reimburse the indemnified party. The maximum amount of potential future payments is generally unlimited. See pages 9 and 22 for additional information relating to the indemnification obligations under the Chemours Separation Agreement and the Corteva Separation Agreement.

Obligations for Customers and Other Third Parties
The company has directly guaranteed various debt obligations under agreements with third parties related to customers and other third parties. At March 31, 2021, December 31, 2020 and March 31, 2020, the company had directly guaranteed $108 million, $94 million, and $90 million, respectively, of such obligations. These amounts represent the maximum potential amount of future (undiscounted) payments that the company could be required to make under the guarantees in the event of default by the guaranteed party. All of the maximum future payments at March 31, 2021 had terms less than one year. The maximum future payments include $23 million at March 31, 2021 and $17 million at December 31, 2020 and March 31, 2020, respectively, of guarantees related to the various factoring agreements that the company enters into with third-party financial institutions to sell its trade receivables. See Note 9 - Accounts and Notes Receivable, Net, for additional information.

The maximum future payments also include agreements with lenders to establish programs that provide financing for select customers. The terms of the guarantees are equivalent to the terms of the customer loans that are primarily made to finance customer invoices. The total amounts owed from customers to the lenders relating to these agreements was $178 million, $16 million and $125 million at March 31, 2021, December 31, 2020 and March 31, 2020, respectively.

The company assesses the payment/performance risk by assigning default rates based on the duration of the guarantees. These default rates are assigned based on the external credit rating of the counterparty or through internal credit analysis and historical default history for counterparties that do not have published credit ratings. For counterparties without an external rating or available credit history, a cumulative average default rate is used.

Litigation
The company is subject to various legal proceedings, including, but not limited to, product liability, intellectual property, antitrust, commercial, property damage, personal injury, environmental and regulatory matters arising out of the normal course of its current businesses or legacy EID businesses unrelated to Corteva’s current businesses but allocated to Corteva as part of the separation of Corteva from DuPont. It is not possible to predict the outcome of these various proceedings, as considerable uncertainty exists.  However, the ultimate liabilities could be material to results of operations and the cash flows in the period recognized.

Indemnifications under Separation Agreements
The company has entered into various agreements where the company is indemnified for certain liabilities. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. See Note 3 - Divestitures and Other Transactions, to the interim Consolidated Financial Statements for additional information related to indemnifications.

Chemours/Performance Chemicals
Refer to Note 3 - Divestitures and Other Transactions, to the interim Consolidated Financial Statements for additional discussion of the Chemours Separation Agreement.

In 2017, EID and Chemours amended the Chemours Separation Agreement to provide for a limited sharing of potential future liabilities related to alleged historical releases of perfluorooctanoic acids and its ammonium salts (“PFOA”) for a five-year period that began on July 6, 2017. In addition, in 2017, Chemours and EID each paid $335 million to settle multi-district litigation in the U.S. District Court for the Southern District of Ohio (“Ohio MDL”), thereby resolving claims of about 3,550 plaintiffs alleging injury from exposure to PFOA in drinking water as a result of the historical manufacture or use of PFOA at the Washington Works plant outside Parkersburg, West Virginia. This plant was previously owned and/or operated by the performance chemicals segment of EID and is now owned and/or operated by Chemours. The 2017 settlement did not resolve
claims of certain class members who did not have claims in the Ohio MDL or whose claims are based on diseases first diagnosed after February 11, 2017. About 96 claims alleging personal injury were filed in the Ohio MDL since the 2017 settlement and a number of additional pre-suit claims for personal injury were asserted.

On May 13, 2019, Chemours filed suit in the Delaware Court of Chancery against DuPont, EID, and Corteva, seeking, among other things, to limit its responsibility for the litigation and environmental liabilities allocated to and assumed by Chemours under the Chemours Separation Agreement (the “Delaware Litigation”). On March 30, 2020, the Court of Chancery granted a motion to dismiss. On December 15, 2020, the Delaware Supreme Court affirmed the judgment of the Court of Chancery. Meanwhile, a confidential arbitration process regarding the same and other claims had proceeded (the “Pending Arbitration”).

For additional information regarding environmental indemnification, see discussion on page 25.

On January 22, 2021, Chemours, DuPont, Corteva and EID entered into a binding memorandum of understanding containing a settlement to resolve legal disputes originating from the Delaware Litigation and Pending Arbitration, and to establish a cost sharing arrangement and escrow account to be used to support and manage potential future legacy per- and polyfluoroalkyl substances (“PFAS”) liabilities arising out of pre-July 1, 2015 conduct (the “MOU”). The MOU replaces the 2017 amendment to the Chemours Separation Agreement. According to the terms of the cost sharing arrangement within the MOU, Corteva and DuPont together, on one hand, and Chemours, on the other hand, agreed to a 50-50 split of certain qualified expenses related to PFAS liabilities incurred over a term not to exceed twenty years or $4 billion of qualified spend and escrow account contributions (see below for discussion of escrow account) in the aggregate. DuPont’s and Corteva’s 50% share under the MOU will be limited to $2 billion, including qualified expenses and escrow contributions. These expenses and escrow account contributions will be subject to the existing Letter Agreement, under which DuPont and Corteva will each bear 50% of the first $300 million (up to $150 million each), and thereafter DuPont bears 71% and Corteva bears the remaining 29%.

In order to support and manage any potential future PFAS liabilities, the parties have also agreed to establish an escrow account. The MOU provides that (1) no later than each of September 30, 2021 and September 30, 2022, Chemours shall deposit $100 million into an escrow account and DuPont and Corteva shall together deposit $100 million in the aggregate into an escrow account and (2) no later than September 30 of each subsequent year through and including 2028, Chemours shall deposit $50 million into an escrow account and DuPont and Corteva shall together deposit $50 million in the aggregate into an escrow account. Subject to the terms and conditions set forth in the MOU, each party may be permitted to defer funding in any year (excluding 2021). Over this period, Chemours will deposit a total of $500 million in the account and DuPont and Corteva will deposit an additional $500 million pursuant to the terms of the Letter Agreement. Additionally, if on December 31, 2028, the balance of the escrow account (including interest) is less than $700 million, Chemours will make 50% of the deposits and DuPont and Corteva together will make 50% of the deposits necessary to restore the balance of the escrow account to $700 million. Such payments will be made in a series of consecutive annual equal installments commencing on September 30, 2029 pursuant to the escrow account replenishment terms as set forth in the MOU.

After the term of this arrangement, Chemours’ indemnification obligations under the original 2015 Chemours Separation Agreement, would continue unchanged, subject in each case to certain exceptions set out in the MOU. Under the MOU, Chemours waived specified claims regarding the construct of its 2015 spin-off transaction, and the parties will dismiss the pending arbitration regarding those claims (as discussed below). Additionally, the parties have agreed to resolve the Ohio MDL PFOA personal injury litigation (as discussed below). The parties are expected to cooperate in good faith to enter into additional agreements reflecting the terms set forth in the MOU.

Corteva Separation Agreement
On April 1, 2019, in connection with the Dow Distribution, Corteva, DuPont and Dow entered into the Corteva Separation Agreement, the Tax Matters Agreement, the Employee Matters Agreement, and certain other agreements (collectively, the “Corteva Separation Agreements”). The Corteva Separation Agreements allocate among Corteva, DuPont and Dow certain liabilities and obligations among the parties and provides for indemnification obligation among the parties. Under the Corteva Separation Agreements, DuPont will indemnify Corteva against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the Corteva Distribution and (ii) Dow indemnifies Corteva against certain litigation and other liabilities that relate to the Historical Dow business, but were transferred over as part of the common control combination with DAS, and Corteva indemnifies DuPont and Dow for certain liabilities. The term of this indemnification is generally indefinite with exceptions, and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. See Note 3 - Divestitures and Other Transactions, to the interim Consolidated Financial Statements for additional information relating to the Separation.
DuPont
Under the Corteva Separation Agreement, certain legacy EID liabilities from discontinued and/or divested operations and businesses of EID (including Performance Chemicals) (a “stray liability”) were allocated to Corteva or DuPont. For those stray liabilities allocated to Corteva (which may include a specified amount of liability associated with that liability), Corteva is responsible for liabilities in an amount up to that specified amount plus an additional $200 million and, for those stray liabilities allocated to DuPont (which may include a specified amount of liability associated with that liability), DuPont is responsible for liabilities up to a specified amount plus an additional $200 million. Once each company has met the $200 million threshold, Corteva and DuPont will share future liabilities proportionally on the basis of 29% and 71%, respectively; provided, however, that for PFAS, DuPont will manage such liabilities with Corteva and DuPont sharing the costs on a 50% - 50% basis starting from $1 and up to $300 million (with such amount, up to $150 million, to be credited to each company’s $200 million threshold) and once the $300 million threshold is met, then the companies will share proportionally on the basis of 29% and 71% respectively, subject to a $1 million de minimis requirement.

Litigation related to legacy EID businesses unrelated to Corteva’s current businesses

PFAS, PFOA, PFOS and Other Related Liabilities
For purposes of this report, the term PFOA means collectively perfluorooctanoic acid and its salts, including the ammonium salt and does not distinguish between the two forms, and PFAS, which means per- and polyfluoroalkyl substances, including PFOA, PFOS (perfluorooctanesulfonic acid), GenX and other perfluorinated chemicals and compounds ("PFCs").

EID is a party to various legal proceedings relating to the use of PFOA by its former Performance Chemicals segment for which potential liabilities would be subject to the cost sharing arrangement under the MOU as long as it remains effective. Management believes that it is reasonably possible that EID could incur liabilities related to PFOA in excess of amounts accrued. However, any such losses are not estimable at this time due to various reasons, including, among others, that the underlying matters are in their early stages and have significant factual issues to be resolved. The company has recorded a liability of $21 million and an indemnification asset of $16 million at March 31, 2021, related to testing drinking water in and around certain former EID sites and offering treatment or an alternative supply of drinking water if tests indicate the presence of PFOA in drinking water at or greater than the national health advisory level established from time to time by the EPA.

Leach Settlement and Ohio MDL Settlement
EID has residual liabilities under its 2004 settlement of a West Virginia state court class action, Leach v. EID, which alleged that PFOA from EID’s former Washington Works facility had contaminated area drinking water supplies and affected the health of area residents. The settlement class has about 80,000 members. In addition to relief that was provided to class members years ago, the settlement requires EID to continue providing PFOA water treatment to six area water districts and private well users and to fund, through an escrow account, up to $235 million for a medical monitoring program for eligible class members. As of March 31, 2021, approximately $2 million had been disbursed from the account since its establishment in 2012 and the remaining balance is approximately $1 million.

The Leach settlement permits class members to pursue personal injury claims for six health conditions (and no others) that an expert panel appointed under the settlement reported in 2012 had a “probable link” (as defined in the settlement) with PFOA: pregnancy-induced hypertension, including preeclampsia; kidney cancer; testicular cancer; thyroid disease; ulcerative colitis; and diagnosed high cholesterol. After the panel reported its findings, approximately 3,550 personal injury lawsuits were filed in federal and state courts in Ohio and West Virginia and consolidated in multi-district litigation in the U.S. District Court for the Southern District of Ohio (“Ohio MDL”). The Ohio MDL was settled in early 2017 for $670.7 million in cash, with Chemours and EID (without indemnification from Chemours) each paying half.

Post-MDL Settlement PFOA Personal Injury Claims
The 2017 Ohio MDL settlement did not resolve claims of plaintiffs who did not have claims in the Ohio MDL or whose claims are based on diseases first diagnosed after February 11, 2017. The first trial for these claims, a kidney cancer case, resulted in a hung jury, while the second, Travis and Julie Abbot v. E.I du Pont de Nemours and Company (the “Abbot Case”), a testicular cancer case, resulted in a jury verdict of $40 million in compensatory damages and $10 million for loss of consortium. Following entry of the judgment by the court, EID filed post-trial motions to reduce the verdict, and to appeal the verdict on the basis of procedural and substantive legal errors made by the trial court. The trial court recently granted EID’s motion to reduce the loss of consortium award to conform with state tort reform laws limiting these damages to $250,000. The company is continuing its other appeals to reduce the jury verdict or eliminate its liability, in whole or part.

In January 2021, Chemours, DuPont and Corteva agreed to settle the remaining approximately 95 matters, as well as unfiled matters, remaining in the Ohio MDL, with the exception of the Abbot case, for $83 million, with Chemours contributing $29 million to the settlement, and DuPont and Corteva contributing $27 million each. The company recorded a liability for its share
of the settlement, with a charge to (loss) income from discontinued operations after income taxes, during the year ended December 31, 2020, and paid $16 million during the three months ended March 31, 2021. Following this settlement, the parties have agreed to petition the court for the dissolution of the MDL.

Other PFOA Matters
EID is a party to other PFOA lawsuits that do not involve claims for personal injury. Defense costs and any future liabilities that may arise out of these lawsuits are subject to the MOU and the cost sharing arrangement disclosed above. Under the MOU, fraudulent conveyance claims associated with these matters are not qualified expenses, unless Corteva, Inc. and EID would prevail on the merits of these claims.

New York. EID is a defendant in about 50 lawsuits, including a putative class action, brought by persons who live in and around Hoosick Falls, New York. These lawsuits assert claims for medical monitoring and property damage based on alleged PFOA releases from manufacturing facilities owned and operated by co-defendants in Hoosick Falls and allege that EID and 3M supplied some of the materials used at these facilities. EID is also one of more than ten defendants in a lawsuit brought by the Town of East Hampton, New York alleging PFOA and PFOS contamination of the town’s well water. Additionally, EID, along with 3M, Chemours and Dyneon, have been named defendants in complaints filed by eight water districts in Nassau County, New York alleging that the drinking water they provide to customers is contaminated with PFAS and seeking reimbursement for clean-up costs. The water district complaints also include allegations of fraudulent transfer.

New Jersey. At March 31, 2021, two lawsuits were pending, one brought by a local water utility and the second a putative class action, against EID alleging that PFOA from EID’s former Chambers Works facility contaminated drinking water sources. The putative class action was voluntarily dismissed without prejudice by the plaintiff.

In late March of 2019, the New Jersey State Attorney General filed four lawsuits against EID, Chemours, 3M and others alleging that operations at and discharges from former EID sites in New Jersey (Chambers Works, Pompton Lakes, Parlin and Repauno) damaged the State’s natural resources. Two of these lawsuits (those involving the Chambers Works and Parlin sites) allege contamination from PFAS. The Ridgewood Water District in New Jersey filed suit in the first quarter 2019 against EID, 3M, Chemours, and Dyneon alleging losses related to the investigation, remediation and monitoring of polyfluorinated surfactants, including PFOA, in water supplies. DuPont and Corteva were subsequently added as defendants to these lawsuits.

Alabama / Others. EID is one of more than thirty defendants in a lawsuit by the Alabama water utility alleging contamination from PFCs, including PFOA, used by co-defendant carpet manufacturers to make their products more stain and grease resistant. In addition, the states of Alaska, Michigan, Mississippi, New Hampshire, South Dakota, and Vermont recently filed lawsuits against EID, Chemours, 3M and others, claiming, among other things, PFC (including PFOA) contamination of groundwater and drinking water. The complaints seek reimbursement for past and future costs to investigate and remediate the alleged contamination and compensation for the loss of value and use of the state’s natural resources. Motions to dismiss the Michigan, Vermont and New Hampshire cases have been denied. Additionally, the State of Delaware has indicated it may file a similar natural resource claim related to alleged PFAS contamination and other contaminants.

Ohio. EID is a defendant in three lawsuits: an action by the State of Ohio based on alleged damage to natural resources, a putative nationwide class action brought on behalf of anyone who has detectable levels of PFAS in their blood serum, and an action by the City of Dayton claiming losses related to the investigation, remediation and monitoring of PFAS in water supplies.

Aqueous Firefighting Foams. Approximately 985 cases have been filed against 3M and other defendants, including EID and Chemours, and more recently also including Corteva and DuPont, alleging PFOS or PFOA contamination of soil and groundwater from the use of aqueous firefighting foams. Most of those cases claim some form of property damage and seek to recover the costs of responding to this contamination and damages for the loss of use and enjoyment of property and diminution in value. Most of these cases have been transferred to a multidistrict litigation proceeding in federal district court in South Carolina. Approximately 910 of these cases were filed on behalf of firefighters who allege personal injuries (primarily kidney and testicular cancer) as a result of aqueous firefighting foams. Most of these recent cases assert claims that the EID and Chemours separation constituted a fraudulent conveyance. A schedule of initial trials is expected to be established in the second quarter of 2021.

EID did not make firefighting foams, PFOS, or PFOS products. While EID made surfactants and intermediaries that some manufacturers used in making foams, which may have contained PFOA as an unintended byproduct or an impurity, EID’s
products were not formulated with PFOA, nor was PFOA an ingredient of these products. EID has never made or sold PFOA as a commercial product.

Fayetteville Works Facility, North Carolina
Prior to the separation of Chemours, EID introduced GenX as a polymerization processing aid and a replacement for PFOA at the Fayetteville Works facility in Bladen County, North Carolina. The facility is now owned and operated by Chemours, which continues to manufacture and use GenX.

At March 31, 2021, several actions are pending in federal court against Chemours and EID relating to PFC discharges from the Fayetteville Works facility. One of these is a consolidated putative class action that asserts claims for medical monitoring and property damage on behalf of putative classes of property owners and residents in areas near or who draw drinking water from the Cape Fear River. Another action is a consolidated action brought by various North Carolina water authorities, including the Cape Fear Public Utility Authority and Brunswick County, that seek actual and punitive damages as well as injunctive relief. In another action over approximately 100 property owners near the Fayetteville Works facility filed a complaint against Chemours and EID in May 2020. The plaintiffs seek compensatory and punitive damages for their claims of private nuisance, trespass, and negligence allegedly caused by release of PFAS.

In addition to the federal court actions, there is an action on behalf of about 100 plaintiffs who own wells and property near the Fayetteville Works facility. The plaintiffs seek damages for nuisance allegedly caused by releases of certain PFCs from the site. The plaintiffs’ claims for medical monitoring, punitive damages, public nuisance, trespass, unjust enrichment, failure to warn, and negligent manufacture were dismissed.

Generally, site-related expenses related GenX claims are subject to the cost sharing arrangements as defined in the MOU.

Environmental
Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on current law and existing technologies. At March 31, 2021, the company had accrued obligations of $333 million for probable environmental remediation and restoration costs, including $56 million for the remediation of Superfund sites. These obligations are included in accrued and other current liabilities and other noncurrent obligations in the interim Condensed Consolidated Balance Sheet. This is management’s best estimate of the costs for remediation and restoration with respect to environmental matters for which the company has accrued liabilities, although it is reasonably possible that the ultimate cost with respect to these particular matters could range up to $577 million above the amount accrued at March 31, 2021. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the company’s results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration.

For a discussion of the allocation of environmental liabilities under the Chemours Separation Agreement and the Corteva Separation Agreement, see the previous discussion on page 22.
The above noted $333 million accrued obligations includes the following:
As of March 31, 2021
(In millions)Indemnification Asset
Accrual balance3,4
Potential exposure above amount accrued3
Environmental Remediation Stray Liabilities
Chemours related obligations - subject to indemnity1,2
$152 $152 $280 
Other discontinued or divested businesses obligations1
— 78 177 
Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont2
34 34 65 
Environmental remediation liabilities not subject to indemnity— 69 55 
Total$186 $333 $577 
1.Represents liabilities that are subject to the $200 million thresholds and sharing arrangements as discussed on page 22, under Corteva Separation Agreement.
2.The company has recorded an indemnification asset related to these accruals, including $30 million related to the Superfund sites.
3.Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates
4.Accrual balance excludes indemnification liabilities of $54 million to Chemours, related to the cost sharing arrangement under the MOU (see page 10).
XML 35 R21.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders' Equity
3 Months Ended
Mar. 31, 2021
Equity [Abstract]  
Stockholders' Equity Note Disclosure [Text Block] STOCKHOLDERS' EQUITY
Share Buyback Plan
On June 26, 2019, Corteva, Inc. announced that the Board of Directors of Corteva, Inc. authorized a $1 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date. The timing, price and volume of purchases will be based on market conditions, relevant securities laws and other factors.

During the three months ended March 31, 2021, the company purchased and retired 7,646,000 shares in the open market for a total cost of $350 million. During the three months ended March 31, 2020, the company purchased and retired 1,865,000 shares in the open market for a total cost of $50 million.

Shares repurchased pursuant to Corteva's share buyback plan are immediately retired upon purchase. Repurchased common stock is reflected as a reduction of stockholders' equity. The company's accounting policy related to its share repurchases is to reduce its common stock based on the par value of the shares and to reduce its retained earnings for the excess of the repurchase price over the par value. When Corteva has an accumulated deficit balance, the excess over the par value is applied to additional paid-in capital. When Corteva has retained earnings, the excess is charged entirely to retained earnings.

Noncontrolling Interest
Corteva, Inc. owns 100% of the outstanding common shares of EID. However, EID has preferred stock outstanding to third parties which is accounted for as a non-controlling interest in Corteva's interim Condensed Consolidated Balance Sheets. Each share of EID Preferred Stock - $4.50 Series and EID Preferred Stock - $3.50 Series issued and outstanding at the effective date of the Corteva Distribution remains issued and outstanding as to EID and was unaffected by the Corteva Distribution.

Below is a summary of the EID Preferred Stock at March 31, 2021, December 31, 2020, and March 31, 2020, which is classified as noncontrolling interests in Corteva's interim Condensed Consolidated Balance Sheets.
Shares in thousandsNumber of Shares
Authorized23,000
$4.50 Series, callable at $1201,673
$3.50 Series, callable at $102700
Other Comprehensive (Loss) Income
The changes and after-tax balances of components comprising accumulated other comprehensive loss are summarized below:
(In millions)
Cumulative Translation Adjustment1
Derivative InstrumentsPension Benefit PlansOther Benefit PlansUnrealized Gain (Loss) on InvestmentsTotal
2020
Balance January 1, 2020$(1,944)$$(1,247)$(81)$— $(3,270)
Other comprehensive (loss) income before reclassifications
(672)(2)— (670)
Amounts reclassified from accumulated other comprehensive loss
— — — 
Net other comprehensive (loss) income
(672)— — (663)
Balance March 31, 2020$(2,616)$$(1,247)$(78)$— $(3,933)
2021     
Balance January 1, 2021$(1,970)$(67)$(1,433)$590 $(10)$(2,890)
Other comprehensive (loss) income before reclassifications
(403)71 (4)(331)
Amounts reclassified from accumulated other comprehensive loss
— (6)12 (158)(146)
Net other comprehensive (loss) income
(403)65 (157)10 (477)
Balance March 31, 2021$(2,373)$(2)$(1,425)$433 $— $(3,367)
1.The cumulative translation adjustment loss for the three months ended March 31, 2020 was primarily driven by the strengthening of the USD against the Brazilian Real (“BRL”) and the South African Rand ("ZAR"). The cumulative translation adjustment loss for the three months ended March 31, 2021 was primarily driven by strengthening of the USD against the Swiss Franc ("CHF"), Brazilian Real ("BRL") and European Euro.

The tax benefit (expense) on the net activity related to each component of other comprehensive (loss) income was as follows:
(In millions)Three Months Ended
March 31,
20212020
Derivative instruments$(18)$
Pension benefit plans - net(2)(4)
Other benefit plans - net49 — 
Benefit from income taxes related to other comprehensive (loss) income items$29 $
A summary of the reclassifications out of accumulated other comprehensive loss is provided as follows:
(In millions)Three Months Ended
March 31,
20212020
Derivative Instruments1:
$(5)$
Tax benefit2
(1)(2)
After-tax$(6)$
Amortization of pension benefit plans:
  Actuarial losses3,4
$14 $
  Settlement loss3,4
Total before tax$15 $
Tax benefit2
(3)(1)
After-tax$12 $
Amortization of other benefit plans:
  Prior service benefit3,4
$(230)$— 
  Actuarial gains3,4
23 — 
Total before tax$(207)$— 
Tax benefit2
49 — 
After-tax$(158)$— 
Unrealized Loss on Investments4
$$— 
Tax benefit2
— — 
After-tax$$— 
Total reclassifications for the period, after-tax$(146)$
1.Reflected in cost of goods sold.
2.Reflected in provision for (benefit from) income taxes from continuing operations.
3.These accumulated other comprehensive (loss) income components are included in the computation of net periodic benefit credit of the company's pension and other benefit plans. See Note 15 - Pension Plans and Other Post Employment Benefits, for additional information.
4.Reflected in other income - net.
XML 36 R22.htm IDEA: XBRL DOCUMENT v3.21.1
Pension Plans and Other Post Employment Benefit Plans
3 Months Ended
Mar. 31, 2021
Retirement Benefits [Abstract]  
Pension and Other Postretirement Benefits Disclosure [Text Block] PENSION PLANS AND OTHER POST EMPLOYMENT BENEFITS
The following sets forth the components of the company's net periodic benefit (credit) cost for defined benefit pension plans and other post employment benefits:
Three Months Ended
March 31,
(In millions)20212020
Defined Benefit Pension Plans:
Service cost$$
Interest cost91 141 
Expected return on plan assets(230)(251)
Amortization of unrecognized loss14 
Settlement loss
Net periodic benefit credit$(117)$(102)
Other Post Employment Benefits:
Service cost$— $
Interest cost16 
Amortization of unrecognized loss23 — 
Amortization of prior service benefit(230)— 
Net periodic benefit (credit) cost$(201)$17 
XML 37 R23.htm IDEA: XBRL DOCUMENT v3.21.1
Financial Instruments
3 Months Ended
Mar. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Financial Instruments Disclosure [Text Block] FINANCIAL INSTRUMENTS
At March 31, 2021, the company had $1,602 million ($2,511 million and $1,536 million at December 31, 2020 and March 31, 2020, respectively) of held-to-maturity securities (primarily time deposits and money market funds) classified as cash equivalents, as these securities had maturities of three months or less at the time of purchase; and $49 million ($43 million and $10 million at December 31, 2020 and March 31, 2020, respectively) of held-to-maturity securities (primarily time deposits) classified as marketable securities as these securities had maturities of more than three months to less than one year at the time of purchase. The company’s investments in held-to-maturity securities are held at amortized cost, which approximates fair value. Additionally, at March 31, 2021, the company had $65 million ($226 million at December 31, 2020) of available-for-sale securities. The above noted securities are included in cash and cash equivalents, marketable securities, and other current assets in the interim Condensed Consolidated Balance Sheets.

Derivative Instruments
Objectives and Strategies for Holding Derivative Instruments
In the ordinary course of business, the company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency and commodity price risks. The company has established a variety of derivative programs to be utilized for financial risk management. These programs reflect varying levels of exposure coverage and time horizons based on an assessment of risk.

Derivative programs have procedures and controls and are approved by the Corporate Financial Risk Management Committee, consistent with the company's financial risk management policies and guidelines. Derivative instruments used are forwards, options, futures and swaps. The company has not designated any non-derivatives as hedging instruments.

The company's financial risk management procedures also address counterparty credit approval, limits and routine exposure monitoring and reporting. The counterparties to these contractual arrangements are major financial institutions and major commodity exchanges, and multinational grain exporters. The company is exposed to credit loss in the event of nonperformance by these counterparties. The company utilizes collateral support annex agreements with certain counterparties to limit its exposure to credit losses. The company anticipates performance by counterparties to these contracts and therefore no material loss is expected. Market and counterparty credit risks associated with these instruments are regularly reported to management.
The notional amounts of the company's derivative instruments were as follows:
Notional Amounts
(In millions)
March 31, 2021December 31, 2020March 31, 2020
Derivatives designated as hedging instruments:
Foreign currency contracts
$1,030 $1,164 $751 
Commodity contracts
$239 $383 $418 
Derivatives not designated as hedging instruments:
Foreign currency contracts$715 $647 $644 
Commodity contracts$154 $— $59 

Foreign Currency Risk
The company's objective in managing exposure to foreign currency fluctuations is to reduce earnings and cash flow volatility associated with foreign currency rate changes and to mitigate the exposure of certain investments in foreign subsidiaries against changes in the Euro/USD exchange rate. Accordingly, the company enters into various contracts that change in value as foreign exchange rates change to protect the value of its existing foreign currency-denominated assets, liabilities, commitments, investments and cash flows.

The company uses foreign exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The primary business objective of this hedging program is to maintain an approximately balanced position in foreign currencies so that exchange gains and losses resulting from exchange rate changes, after related tax effects, are minimized. The company also uses foreign currency exchange contracts to offset a portion of the company’s exposure to certain forecasted transactions as well as the translation of foreign currency-denominated earnings. The company also uses commodity contracts to offset risks associated with foreign currency devaluation in certain countries.

Commodity Price Risk
Commodity price risk management programs serve to reduce exposure to price fluctuations on purchases of inventory such as corn and soybeans. The company enters into over-the-counter and exchange-traded derivative commodity instruments to hedge the commodity price risk associated with agricultural commodity exposures.

Derivatives Designated as Cash Flow Hedges
Commodity Contracts
The company enters into over-the-counter and exchange-traded derivative commodity instruments, including options, futures and swaps, to hedge the commodity price risk associated with agriculture commodity exposures.

While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two years. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is not probable of occurring.

The following table summarizes the after-tax effect of commodity contract cash flow hedges on accumulated other comprehensive loss:
Three Months Ended
March 31,
(In millions)20212020
Beginning balance$(16)$
Additions and revaluations of derivatives designated as cash flow hedges30 (22)
Clearance of hedge results to earnings(4)
Ending balance$10 $(15)

At March 31, 2021, an after-tax net loss of $8 million is expected to be reclassified from accumulated other comprehensive loss into earnings over the next twelve months.

Foreign Currency Contracts
The company enters into forward contracts to hedge the foreign currency risk associated with forecasted transactions within certain foreign subsidiaries.
While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two years. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is not probable of occurring.

The following table summarizes the after-tax effect of foreign currency cash flow hedges on accumulated other comprehensive loss:
Three Months Ended
March 31,
(In millions)20212020
Beginning balance$(17)$— 
Additions and revaluations of derivatives designated as cash flow hedges25 16 
Clearance of hedge results to earnings(2)— 
Ending balance$$16 

At March 31, 2021, an after-tax net gain of $6 million is expected to be reclassified from accumulated other comprehensive loss into earnings over the next twelve months.

Derivatives Designated as Net Investment Hedges
Foreign Currency Contracts
The company has designated €450 million of forward contracts to exchange EUR as net investment hedges. The purpose of these forward contracts is to mitigate FX exposure related to a portion of the company’s Euro net investments in certain foreign subsidiaries against changes in Euro/USD exchange rates. These hedges will expire and be settled in 2023, unless terminated early at the discretion of the company.

The company elected to apply the spot method in testing for effectiveness of the hedging relationship.

Derivatives not Designated in Hedging Relationships
Foreign Currency Contracts
The company uses foreign exchange contracts to reduce its net exposure, by currency, related to foreign currency-denominated monetary assets and liabilities of its operations so that exchange gains and losses resulting from exchange rate changes are minimized. The netting of such exposures precludes the use of hedge accounting; however, the required revaluation of the forward contracts and the associated foreign currency-denominated monetary assets and liabilities intends to achieve a minimal earnings impact, after taxes. The company also uses foreign currency exchange contracts to offset a portion of the company’s exposure to the translation of certain foreign currency-denominated earnings so that gains and losses on the contracts offset changes in the USD value of the related foreign currency-denominated earnings over the relevant aggregate period.

Commodity Contracts
The company utilizes options, futures and swaps that are not designated as hedging instruments to reduce exposure to commodity price fluctuations on purchases of inventory such as corn and soybeans. The company uses forward agreements, with durations less than one year, to buy and sell USD priced commodities in order to reduce its exposure to currency devaluation for a portion of its local currency cash balances. Counterparties to the forward sales agreements are multinational grain exporters and subject to the company’s financial risk management procedures.
Fair Value of Derivative Instruments
Asset and liability derivatives subject to an enforceable master netting arrangement with the same counterparty are presented on a net basis in the interim Condensed Consolidated Balance Sheets. The presentation of the company's derivative assets and liabilities is as follows:
March 31, 2021
(In millions)Balance Sheet LocationGross
Counterparty and Cash Collateral Netting1
Net Amounts Included in the interim Condensed Consolidated Balance Sheet
Asset derivatives:   
Derivatives designated as hedging instruments:
Foreign currency contracts
Other current assets$38 $— $38 
Derivatives not designated as hedging instruments:
  
Foreign currency contractsOther current assets52(32)20 
Total asset derivatives
 $90 $(32)$58 
Liability derivatives:  
Derivatives designated as hedging instruments:
Foreign currency contractsAccrued and other current liabilities$16 $— $16 
Derivatives not designated as hedging instruments:
  
Foreign currency contractsAccrued and other current liabilities46(30)16 
Total liability derivatives
 $62 $(30)$32 
December 31, 2020
(In millions)Balance Sheet LocationGross
Counterparty and Cash Collateral Netting1
Net Amounts Included in the Condensed Consolidated Balance Sheet
Asset derivatives:   
Derivatives designated as hedging instruments:
Foreign currency contractsOther current assets$15 $— $15 
Derivatives not designated as hedging instruments:
  
Foreign currency contracts
Other current assets40 (40)— 
Total asset derivatives
 $55 $(40)$15 
Liability derivatives:  
Derivatives designated as hedging instruments:
Foreign currency contractsAccrued and other current liabilities$38 $— $38 
Derivatives not designated as hedging instruments:
  
Foreign currency contracts
Accrued and other current liabilities97 (40)57 
Total liability derivatives
 $135 $(40)$95 
March 31, 2020
(In millions)Balance Sheet LocationGross
Counterparty and Cash Collateral Netting1
Net Amounts Included in the interim Condensed Consolidated Balance Sheet
Asset derivatives:   
Derivatives designated as hedging instruments:
Foreign currency contracts
Other current assets$36 $— $36 
Derivatives not designated as hedging instruments:
  
Foreign currency contracts
Other current assets230 (110)120 
Total asset derivatives
 $266 $(110)$156 
Liability derivatives:  
Derivatives not designated as hedging instruments:
  
Foreign currency contracts
Accrued and other current liabilities$108 $(103)$
Total liability derivatives
 $108 $(103)$
1.    Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.
Effect of Derivative Instruments
Amount of (Loss) Gain Recognized in OCI1 - Pre-Tax
Three Months Ended
March 31,
(In millions)20212020
Derivatives designated as hedging instruments:
Net investment hedges:
Foreign currency contracts
$21 $
Cash flow hedges:
Foreign currency contracts
31 19 
 Commodity contracts36 (34)
Total derivatives designated as hedging instruments$88 $(6)
1.OCI is defined as other comprehensive income (loss).
Amount of Gain (Loss) Recognized in Income - Pre-Tax1
Three Months Ended
March 31,
(In millions)20212020
Derivatives designated as hedging instruments:
Cash flow hedges:
Foreign currency contracts2
$$— 
 Commodity contracts2
(7)
Total derivatives designated as hedging instruments
$$(7)
Derivatives not designated as hedging instruments:
Foreign currency contracts3
$16 $165 
Foreign currency contracts2
— 
Commodity contracts2
(12)
Total derivatives not designated as hedging instruments
174 
Total derivatives$11 $167 
1.For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period.
2.Recorded in cost of goods sold.
3.Gain recognized in other income (expense) - net was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 6 - Supplementary Information, for additional information.

Debt Securities
The company's investment in debt securities are classified as available-for-sale. At March 31, 2021, the fair value and amortized cost of the company's investments in debt securities with contractual maturities within one to five years was $65 million.

The estimated fair value of the available-for-sale securities as of March 31, 2021 and December 31, 2020 was determined using Level 1 inputs within the fair value hierarchy. Level 1 measurements were based on quoted market prices in active markets for identical assets and liabilities. The available-for-sale securities as of March 31, 2021 and December 31, 2020 are held by certain foreign subsidiaries in which the USD is not the functional currency. The fluctuations in foreign exchange are recorded in accumulated other comprehensive loss within the interim Consolidated Statements of Equity. These fluctuations are subsequently reclassified from accumulated other comprehensive loss to earnings in the period in which the marketable securities are sold and the gains and losses on these securities offset a portion of the foreign exchange fluctuations in earnings for the company.
The following table provides the investing results from available-for-sale securities for the three months ended March 31, 2021:
Investing ResultsThree Months Ended
 March 31,
(In millions)2021
Proceeds from sales of available-for-sale securities$161 
Gross realized losses(6)
Total$155 

The following table provides the fair value and gross unrealized losses of the company's investments in debt securities at March 31, 2021, aggregated by investment category:
March 31, 202112 months or more
(In millions)Fair valueGross unrealized losses
U.S. Treasuries$65 $— 
XML 38 R24.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements
3 Months Ended
Mar. 31, 2021
Fair Value Disclosures [Abstract]  
Fair Value Disclosures [Text Block] FAIR VALUE MEASUREMENTS
The following tables summarize the basis used to measure certain assets and liabilities at fair value on a recurring basis:
March 31, 2021Significant Other Observable Inputs
(In millions)Level 1Level 2
Assets at fair value:
Marketable securities
$— $49 
Debt securities:
U.S. treasuries1
65— 
Derivatives relating to:2
Foreign currency
— 90 
Total assets at fair value$65 $139 
Liabilities at fair value:
Derivatives relating to:2
Foreign currency
— 62 
Total liabilities at fair value$— $62 
December 31, 2020Significant Other Observable Inputs
(In millions)Level 1Level 2
Assets at fair value:
Marketable securities
$— $43 
Debt securities:
U.S. treasuries1
226— 
Derivatives relating to:2
Foreign currency
— 55 
Total assets at fair value$226 $98 
Liabilities at fair value:
Derivatives relating to:2
Foreign currency
— 135 
Total liabilities at fair value$— $135 
March 31, 2020Significant Other Observable Inputs (Level 2)
(In millions)
Assets at fair value:
Marketable securities
$10 
Derivatives relating to:2
Foreign currency
266 
Total assets at fair value$276 
Liabilities at fair value:
Derivatives relating to:2
Foreign currency
108 
Total liabilities at fair value$108 
1.    The company's investments in debt securities, which are available-for-sale, are included in "marketable securities" in the interim Condensed Consolidated Balance Sheets.
2. See Note 16 - Financial Instruments for the classification of derivatives in the interim Condensed Consolidated Balance Sheets.
XML 39 R25.htm IDEA: XBRL DOCUMENT v3.21.1
Segment Reporting (Notes)
3 Months Ended
Mar. 31, 2021
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block] SEGMENT INFORMATION
Corteva’s reportable segments reflects the manner in which its chief operating decision maker ("CODM") allocates resources and assesses performance, which is at the operating segment level (seed and crop protection). For purposes of allocating resources to the segments and assessing segment performance, segment operating EBITDA is the primary measure used by Corteva’s CODM. The company defines segment operating EBITDA as earnings (i.e., income (loss) from continuing operations before income taxes) before interest, depreciation, amortization, corporate expenses, non-operating (benefits) costs - net, foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items. Effective January 1, 2021, on a prospective basis, the company excludes from segment operating EBITDA net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. Non-operating (benefits) costs - net consists of non-operating pension and other post-employment benefit (OPEB) costs, tax indemnification adjustments and environmental remediation and legal costs associated with legacy EID businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense.

As of and for the Three Months Ended March 31,
(In millions)
SeedCrop ProtectionTotal
2021   
Net sales$2,492 $1,686 $4,178 
Segment operating EBITDA$617 $321 $938 
Segment assets1
$24,799 $13,349 $38,148 
2020   
Net sales$2,455 $1,501 $3,956 
Segment operating EBITDA$581 $238 $819 
Segment assets1
$25,857 $13,251 $39,108 
1.    Segment assets at December 31, 2020 were $23,751 million and $13,099 million for Seed and Crop Protection, respectively.

 
Reconciliation to interim Consolidated Financial Statements
Income from continuing operations after income taxes to segment operating EBITDA


(In millions)
Three Months Ended
March 31,
20212020
Income from continuing operations after income taxes$613 $281 
Provision for income taxes on continuing operations178 127 
Income from continuing operations before income taxes791 408 
Depreciation and amortization304 283 
Interest income(21)(18)
Interest expense10 
Exchange losses - net35 61 
Non-operating benefits - net(311)(73)
Mark-to-market gains on certain foreign currency contracts not designated as hedges1
(1)
Significant items100 123 
Corporate expenses34 25 
Segment operating EBITDA$938 $819 
1.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There was no activity in the three months ended March 31, 2020. Refer to page 48 for further discussion of the company’s Non-GAAP financial measures.

Segment assets to total assets (in millions)
March 31, 2021December 31, 2020March 31, 2020
Total segment assets$38,148 $36,850 $39,108 
Corporate assets4,401 5,799 3,870 
Total assets$42,549 $42,649 $42,978 

Significant Pre-tax (Charges) Benefits Not Included in Segment Operating EBITDA
The three months ended March 31, 2021 and 2020, respectively, included the following significant pre-tax (charges) benefits which are excluded from segment operating EBITDA:
(In millions)SeedCrop ProtectionCorporateTotal
For the Three Months Ended March 31, 2021
Restructuring and Asset Related Charges - Net 1
$(21)$(32)$(47)$(100)
Total$(21)$(32)$(47)$(100)
(In millions)SeedCrop ProtectionCorporateTotal
For the Three Months Ended March 31, 2020
Restructuring and Asset Related Charges - Net 1
$(10)$(18)$(42)$(70)
Loss on Divestiture2
— (53)— (53)
Total$(10)$(71)$(42)$(123)
1.Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements for additional information.
2.Includes a loss recorded in other income - net related to the sale of the La Porte site.
.
XML 40 R26.htm IDEA: XBRL DOCUMENT v3.21.1
EID - Basis of Presentation (Notes)
3 Months Ended
Mar. 31, 2021
EID [Member]  
Entity Information [Line Items]  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] BASIS OF PRESENTATION
As a result of the Business Realignment and the Internal Reorganization, Corteva, Inc. owns 100% of the outstanding common stock of EID. EID is a subsidiary of Corteva, Inc. and continues to be a reporting company, subject to the requirements of the Exchange Act. The primary differences between Corteva, Inc. and EID are outlined below:

Preferred Stock - EID has preferred stock outstanding to third parties which is accounted for as a non-controlling interest at the Corteva, Inc. level. Each share of EID Preferred Stock - $4.50 Series and EID Preferred Stock - $3.50 Series issued and outstanding at the effective date of the Corteva Distribution remains issued and outstanding as to EID and was unaffected by the Corteva Distribution.
Related Party Loan - EID engaged in a series of debt redemptions during the second quarter of 2019 that were partially funded through an intercompany loan from Corteva, Inc. This was eliminated in consolidation at the Corteva, Inc. level but remains on EID's financial statements at the standalone level (including the associated interest).
Capital Structure - At March 31, 2021, Corteva, Inc.'s capital structure consists of 738,321,000 issued shares of common stock, par value $0.01 per share.

The accompanying footnotes relate to EID only, and not to Corteva, Inc., and are presented to show differences between EID and Corteva, Inc.

For the footnotes listed below, refer to the following Corteva, Inc. footnotes:
Note 1 - Summary of Significant Accounting Policies - refer to page 9 of the Corteva, Inc. interim Consolidated Financial Statements
Note 2 - Recent Accounting Guidance - refer to page 9 of the Corteva, Inc. interim Consolidated Financial Statements
Note 3 - Divestitures and Other Transactions - refer to page 9 of the Corteva, Inc. interim Consolidated Financial Statements
Note 4 - Revenue - refer to page 10 of the Corteva, Inc. interim Consolidated Financial Statements
Note 5 - Restructuring and Asset Related Charges - Net - refer to page 13 of the Corteva, Inc. interim Consolidated Financial Statements
Note 6 - Supplementary Information - refer to page 14 of the Corteva, Inc. interim Consolidated Financial Statements
Note 7 - Income Taxes - refer to page 16 of the Corteva, Inc. interim Consolidated Financial Statements
Note 8 - Earnings Per Share of Common Stock - Not applicable for EID
Note 9 - Accounts and Notes Receivable - Net - refer to page 18 of the Corteva, Inc. interim Consolidated Financial Statements
Note 10 - Inventories - refer to page 19 of the Corteva, Inc. interim Consolidated Financial Statements
Note 11 - Other Intangible Assets - refer to page 19 of the Corteva, Inc. interim Consolidated Financial Statements
Note 12 - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities - refer to page 20 of the Corteva, Inc. interim Consolidated Financial Statements. In addition, EID has a related party loan payable to Corteva, Inc.; refer to EID Note 2 - Related Party Transactions, below
Note 13 - Commitments and Contingent Liabilities - refer to page 21 of the Corteva, Inc. interim Consolidated Financial Statements
Note 14 - Stockholders' Equity - refer to page 26 of the Corteva, Inc. interim Consolidated Financial Statements
Note 15 - Pension Plans and Other Post Employment Benefits - refer to page 29 of the Corteva, Inc. interim Consolidated Financial Statements
Note 16 - Financial Instruments - refer to page 29 of the Corteva, Inc. interim Consolidated Financial Statements
Note 17 - Fair Value Measurements - refer to page 35 of the Corteva, Inc. interim Consolidated Financial Statements
Note 18 - Segment Information - Differences exist between Corteva, Inc. and EID; refer to EID Note 3 - Segment Information, below
XML 41 R27.htm IDEA: XBRL DOCUMENT v3.21.1
EID - Related Party Transactions (Notes)
3 Months Ended
Mar. 31, 2021
EID [Member]  
Related Party Transaction [Line Items]  
Related Party Transactions Disclosure [Text Block] RELATED PARTY TRANSACTIONS
Transactions with Corteva
In the second quarter of 2019, EID entered into a related party revolving loan from Corteva, Inc., with a maturity date in 2024. As of March 31, 2021, December 31, 2020, and March 31, 2020, the outstanding related party loan balance was $3,012 million, $3,459 million, and $3,872 million respectively (which approximates fair value), with interest rates of 1.62% at March 31, 2021 and December 31, 2020, respectively, and 3.27% at March 31, 2020, and is reflected as long-term debt - related party in EID's interim Condensed Consolidated Balance Sheets. Additionally, EID has incurred tax deductible interest expense of $15 million and $32 million for the three months ended March 31, 2021 and 2020, respectively, associated with the related party loan from Corteva, Inc.

As of March 31, 2021, EID had payables to Corteva, Inc., of $55 million and $91 million included in accrued and other current liabilities and other noncurrent obligations, respectively, $92 million at December 31, 2020 included in both accrued and other current liabilities and other noncurrent obligations, respectively, and $166 million and $82 million at March 31, 2020, included in accrued and other current liabilities and other noncurrent obligations, respectively, in the interim Condensed Consolidated Balance Sheets related to Corteva's indemnification liabilities to Dow and DuPont per the Separation Agreements (refer to page 9 of the Corteva, Inc. interim Consolidated Financial Statements for further details of the Separation Agreements).
XML 42 R28.htm IDEA: XBRL DOCUMENT v3.21.1
EID Segment FN (Notes)
3 Months Ended
Mar. 31, 2021
Segment Reporting Information [Line Items]  
Segment Reporting Disclosure [Text Block] SEGMENT INFORMATION
Corteva’s reportable segments reflects the manner in which its chief operating decision maker ("CODM") allocates resources and assesses performance, which is at the operating segment level (seed and crop protection). For purposes of allocating resources to the segments and assessing segment performance, segment operating EBITDA is the primary measure used by Corteva’s CODM. The company defines segment operating EBITDA as earnings (i.e., income (loss) from continuing operations before income taxes) before interest, depreciation, amortization, corporate expenses, non-operating (benefits) costs - net, foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items. Effective January 1, 2021, on a prospective basis, the company excludes from segment operating EBITDA net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. Non-operating (benefits) costs - net consists of non-operating pension and other post-employment benefit (OPEB) costs, tax indemnification adjustments and environmental remediation and legal costs associated with legacy EID businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense.

As of and for the Three Months Ended March 31,
(In millions)
SeedCrop ProtectionTotal
2021   
Net sales$2,492 $1,686 $4,178 
Segment operating EBITDA$617 $321 $938 
Segment assets1
$24,799 $13,349 $38,148 
2020   
Net sales$2,455 $1,501 $3,956 
Segment operating EBITDA$581 $238 $819 
Segment assets1
$25,857 $13,251 $39,108 
1.    Segment assets at December 31, 2020 were $23,751 million and $13,099 million for Seed and Crop Protection, respectively.

 
Reconciliation to interim Consolidated Financial Statements
Income from continuing operations after income taxes to segment operating EBITDA


(In millions)
Three Months Ended
March 31,
20212020
Income from continuing operations after income taxes$613 $281 
Provision for income taxes on continuing operations178 127 
Income from continuing operations before income taxes791 408 
Depreciation and amortization304 283 
Interest income(21)(18)
Interest expense10 
Exchange losses - net35 61 
Non-operating benefits - net(311)(73)
Mark-to-market gains on certain foreign currency contracts not designated as hedges1
(1)
Significant items100 123 
Corporate expenses34 25 
Segment operating EBITDA$938 $819 
1.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There was no activity in the three months ended March 31, 2020. Refer to page 48 for further discussion of the company’s Non-GAAP financial measures.

Segment assets to total assets (in millions)
March 31, 2021December 31, 2020March 31, 2020
Total segment assets$38,148 $36,850 $39,108 
Corporate assets4,401 5,799 3,870 
Total assets$42,549 $42,649 $42,978 

Significant Pre-tax (Charges) Benefits Not Included in Segment Operating EBITDA
The three months ended March 31, 2021 and 2020, respectively, included the following significant pre-tax (charges) benefits which are excluded from segment operating EBITDA:
(In millions)SeedCrop ProtectionCorporateTotal
For the Three Months Ended March 31, 2021
Restructuring and Asset Related Charges - Net 1
$(21)$(32)$(47)$(100)
Total$(21)$(32)$(47)$(100)
(In millions)SeedCrop ProtectionCorporateTotal
For the Three Months Ended March 31, 2020
Restructuring and Asset Related Charges - Net 1
$(10)$(18)$(42)$(70)
Loss on Divestiture2
— (53)— (53)
Total$(10)$(71)$(42)$(123)
1.Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements for additional information.
2.Includes a loss recorded in other income - net related to the sale of the La Porte site.
.
EID [Member]  
Segment Reporting Information [Line Items]  
Segment Reporting Disclosure [Text Block] SEGMENT INFORMATION
There are no differences in reporting structure or segments between Corteva, Inc. and EID. In addition, there are no differences between Corteva, Inc. and EID segment net sales, segment operating EBITDA, segment assets, or significant items by segment; refer to page 36 of the Corteva, Inc. interim Consolidated Financial Statements for background information on the segments as well as further details regarding segment metrics. The tables below reconcile income from continuing operations after income taxes to segment operating EBITDA, as differences exist between Corteva, Inc. and EID.

Reconciliation to interim Consolidated Financial Statements
Income from continuing operations after income taxes to segment operating EBITDA


(In millions)
Three Months Ended
March 31,
20212020
Income from continuing operations after income taxes$602 $257 
Provision for income taxes on continuing operations174 119 
Income from continuing operations before income taxes776 376 
Depreciation and amortization304 283 
Interest income(21)(18)
Interest expense22 42 
Exchange losses - net35 61 
Non-operating benefits - net(311)(73)
Mark-to-market gains on certain foreign currency contracts not designated as hedges1
(1)
Significant items100 123 
Corporate expenses34 25 
Segment operating EBITDA$938 $819 
1.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There was no activity in the three months ended March 31, 2020.
XML 43 R29.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2021
Accounting Policies [Abstract]  
Basis of Accounting, Policy [Policy Text Block]
Basis of Presentation
The accompanying unaudited interim Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included.  Results for interim periods should not be considered indicative of results for a full year.  These interim Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2020, collectively referred to as the “2020 Annual Report.”  The interim Consolidated Financial Statements include the accounts of the company and all of its subsidiaries in which a controlling interest is maintained.

Certain reclassifications of prior year's data have been made to conform to current year's presentation.

During the first quarter 2020, the company recorded an increase of $40 million to APIC relating to net assets recorded as transferred as part of the 2019 Internal Reorganizations that were retained. 

Since 2018, Argentina has been considered a hyper-inflationary economy under U.S. GAAP and therefore the U.S. Dollar (“USD”) is the functional currency for our related subsidiaries. We remeasure the net monetary assets utilizing the official Argentine Peso (“Peso”) to USD exchange rate. The devaluation of the Peso relative to the USD over the last several years has resulted in the recognition of exchange losses (refer to Note 6 of these financial statements and Note 9 of the 2020 financial statements included in the Company's Annual Report on Form 10-K). As of March 31, 2021, a further 10% deterioration in the official Peso to USD exchange rate would reduce the USD value of our net monetary assets and negatively impact pre-tax earnings by approximately $20 million.
XML 44 R30.htm IDEA: XBRL DOCUMENT v3.21.1
Recent Accounting Guidance Recent Accounting Guidance (Policies)
3 Months Ended
Mar. 31, 2021
Accounting Policies [Abstract]  
Recent Accounting Guidance
Recently Adopted Accounting Guidance
In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which was part of the FASB’s Simplification Initiative to identify, evaluate, and improve areas of U.S. GAAP for which cost and complexity can be reduced, while maintaining or improving the usefulness of the information provided to users of financial statements. This ASU amends ASC 740, Income Taxes, by removing certain exceptions to the general principles, and clarifying and amending current guidance. The new standard is effective for fiscal years, and periods within those fiscal years, beginning after December 15, 2020. The company adopted this guidance on January 1, 2021 and it did not have a material impact on the company’s financial position, results of operation or cash flows.
XML 45 R31.htm IDEA: XBRL DOCUMENT v3.21.1
Revenue Revenue Recognition (Policies)
3 Months Ended
Mar. 31, 2021
Revenue from Contract with Customer [Abstract]  
Revenue Recognition, Sales of Goods
Products
Substantially all of Corteva's revenue is derived from product sales. Product sales consist of sales of Corteva's products to farmers, distributors, and manufacturers. Corteva considers purchase orders, which in some cases are governed by master supply agreements, to be a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year. However, the company has some long-term contracts which can span multiple years.

Revenue from product sales is recognized when the customer obtains control of the company's product, which occurs at a point in time according to shipping terms. Payment terms are generally less than one year from invoicing. The company elected the practical expedient and does not adjust the promised amount of consideration for the effects of a significant financing component when the company expects it will be one year or less between when a customer obtains control of the company's product and when payment is due. The company has elected to recognize shipping and handling activities when control has transferred to the customer as an expense in cost of goods sold. Taxes collected from customers relating to product sales and
remitted to governmental authorities are excluded from revenues. In addition, the company elected the practical expedient to expense any costs to obtain contracts as incurred, as the amortization period for these costs would have been one year or less.

The transaction price includes estimates of variable consideration, such as rights of return, rebates, and discounts, that are reductions in revenue. All estimates are based on the company's historical experience, anticipated performance, and the company's best judgment at the time the estimate is made. Estimates of variable consideration included in the transaction price utilize either the expected value method or most likely amount depending on the nature of the variable consideration. These estimates are reassessed each reporting period and are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur upon resolution of uncertainty associated with the variable consideration. The majority of contracts have a single performance obligation satisfied at a point in time and the transaction price is stated in the contract, usually as quantity times price per unit. For contracts with multiple performance obligations, the company allocates the transaction price to each performance obligation based on the relative standalone selling price. The standalone selling price is the observable price which depicts the price as if sold to a similar customer in similar circumstances.
Revenue Recognition, Licenses of Intellectual Property Licenses of Intellectual PropertyCorteva enters into licensing arrangements with customers under which it licenses its intellectual property. Revenue from the majority of intellectual property licenses is derived from sales-based royalties. Revenue for licensing agreements that contain sales-based royalties is recognized at the later of (i) when the subsequent sale occurs or (ii) when the performance obligation to which some or all of the royalty has been allocated is satisfied.
XML 46 R32.htm IDEA: XBRL DOCUMENT v3.21.1
Revenue (Tables)
3 Months Ended
Mar. 31, 2021
Disaggregation of Revenue [Line Items]  
Contract Balances
Contract BalancesMarch 31, 2021December 31, 2020March 31, 2020
(In millions)
Accounts and notes receivable - trade1
$5,764 $3,917 $5,779 
Contract assets - current2
$22 $22 $20 
Contract assets - noncurrent3
$53 $54 $49 
Deferred revenue - current$2,247 $2,662 $1,996 
Deferred revenue - noncurrent4
$111 $116 $104 
1.Included in accounts and notes receivable - net in the interim Condensed Consolidated Balance Sheets.
2.Included in other current assets in the interim Condensed Consolidated Balance Sheets.
3.Included in other assets in the interim Condensed Consolidated Balance Sheets.
4.Included in other noncurrent obligations in the interim Condensed Consolidated Balance Sheets.
Major Product Line [Member]  
Disaggregation of Revenue [Line Items]  
Disaggregation of Revenue
Three Months Ended
March 31,
(In millions)20212020
    Corn$1,888 $1,864 
    Soybean177 181 
    Other oilseeds296 248 
    Other131 162 
Seed2,492 2,455 
    Herbicides986 823 
    Insecticides385 378 
    Fungicides261 229 
    Other54 71 
Crop Protection1,686 1,501 
Total$4,178 $3,956 
.
Geography [Domain]  
Disaggregation of Revenue [Line Items]  
Disaggregation of Revenue
SeedThree Months Ended
March 31,
(In millions)20212020
North America1
$1,210 $1,290 
EMEA2
947 881 
Latin America274 216 
Asia Pacific61 68 
Total$2,492 $2,455 
Crop ProtectionThree Months Ended
March 31,
(In millions)20212020
North America1
$533 $475 
EMEA2
655 586 
Latin America244 218 
Asia Pacific254 222 
Total$1,686 $1,501 
1.Represents U.S. & Canada.
2.Europe, Middle East, and Africa ("EMEA").
XML 47 R33.htm IDEA: XBRL DOCUMENT v3.21.1
Restructuring and Asset Related Charges (Tables)
3 Months Ended
Mar. 31, 2021
Execute to Win Productivity Program [Domain]  
Restructuring Cost and Reserve [Line Items]  
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]
Three Months Ended March 31,
(In millions)20212020
Seed$— $
Crop Protection18 
Corporate expenses— 42 
Total$$63 
Three Months Ended March 31,
(In millions)20212020
Severance and related benefit costs$— $42 
Asset related charges21 
Total restructuring and asset related charges - net$$63 
(In millions)Severance and Related Benefit CostsAsset RelatedTotal
Balance at December 31, 2020$53 $$56 
Charges to income from continuing operations for the three months ended March 31, 2021— 
Payments(11)(3)(14)
Asset write-offs— (4)(4)
Balance at March 31, 2021$42 $— $42 
XML 48 R34.htm IDEA: XBRL DOCUMENT v3.21.1
Supplementary Information (Tables)
3 Months Ended
Mar. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Other Nonoperating Income (Expense)
Other Income - NetThree Months Ended
March 31,
(In millions)20212020
Interest income$21 $18 
Equity in earnings / (losses) of affiliates - net(1)
Net loss on sales of businesses and other assets1
— (46)
Net exchange losses2
(35)(61)
Non-operating pension and other post employment benefit credit3
325 91 
Miscellaneous income - net4
23 — 
Other income - net$337 $
 
1.The three months ended March 31, 2020 includes a loss of $(53) million relating to the sale of the La Porte site, for which the company signed an agreement in 2020, and closed during the first quarter of 2021.
2.Includes net pre-tax exchange losses of $(23) million and $(9) million associated with the devaluation of the Argentine peso for the three months ended March 31, 2021 and 2020, respectively.
3.Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement loss).
4.Miscellaneous income - net, includes a gain from a remeasurement of an equity investment, losses on sale of available-for-sale securities, tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont, losses on sale of receivables, and other items.
Foreign Currency Exchange Gain (Loss)
(In millions)Three Months Ended
March 31,
20212020
Subsidiary Monetary Position (Losses) Gains
Pre-tax exchange losses$(51)$(226)
Local tax (expenses) / benefits(1)23 
Net after-tax impact from subsidiary exchange losses$(52)$(203)
Hedging Program Gains
Pre-tax exchange gains$16 $165 
Tax expenses(4)(40)
Net after-tax impact from hedging program exchange gains$12 $125 
Total Exchange Losses
Pre-tax exchange losses$(35)$(61)
Tax expenses(5)(17)
Net after-tax exchange losses$(40)$(78)
Restrictions on Cash and Cash Equivalents
(In millions)March 31, 2021December 31, 2020March 31, 2020
Cash and cash equivalents$2,404 $3,526 $1,963 
Restricted cash326 347 377 
Total cash, cash equivalents and restricted cash$2,730 $3,873 $2,340 
XML 49 R35.htm IDEA: XBRL DOCUMENT v3.21.1
Earnings Per Share (Tables)
3 Months Ended
Mar. 31, 2021
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Net Income for Earnings Per Share Calculations - Basic and DilutedThree Months Ended
March 31,
(In millions)20212020
Income from continuing operations after income taxes$613 $281 
Net income attributable to continuing operations noncontrolling interests10 
Income from continuing operations available to Corteva common stockholders610 271 
(Loss) income from discontinued operations available to Corteva common stockholders(10)
Net income available to common stockholders$600 $272 
Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block]
Earnings Per Share Calculations - BasicThree Months Ended
March 31,
(Dollars per share)20212020
Earnings per share of common stock from continuing operations
$0.82 $0.36 
Loss per share of common stock from discontinued operations(0.01)— 
Earnings per share of common stock$0.81 $0.36 
Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block]
Earnings Per Share Calculations - DilutedThree Months Ended
March 31,
(Dollars per share)20212020
Earnings per share of common stock from continuing operations$0.81 $0.36 
Loss per share of common stock from discontinued operations (0.01)— 
Earnings per share of common stock$0.80 $0.36 
Share Count Information
Share Count InformationThree Months Ended
March 31,
(Shares in millions)20212020
Weighted-average common shares - basic743.4 749.9 
Plus dilutive effect of equity compensation plans1
6.2 2.6 
Weighted-average common shares - diluted749.6 752.5 
Potential shares of common stock excluded from EPS calculations2
2.9 9.1 
1.Diluted earnings per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.
2.These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been anti-dilutive.
XML 50 R36.htm IDEA: XBRL DOCUMENT v3.21.1
Accounts and Notes Receivable (Tables)
3 Months Ended
Mar. 31, 2021
Accounts and Notes Receivable [Abstract]  
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]
(In millions)March 31, 2021December 31, 2020March 31, 2020
Accounts receivable – trade1
$5,231 $3,754 $5,367 
Notes receivable – trade1,2
533 163 412 
Other3
1,028 1,009 996 
Total accounts and notes receivable - net$6,792 $4,926 $6,775 
1.Accounts receivable – trade and notes receivable - trade are net of allowances of $203 million at March 31, 2021, $208 million at December 31, 2020, and $203 million at March 31, 2020. Allowances are equal to the estimated uncollectible amounts and are based on the expected credit losses and were developed using a loss-rate method.
2.Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid pre-approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of March 31, 2021, December 31, 2020, and March 31, 2020 there were no significant impairments related to current loan agreements.
3.Other includes receivables in relation to indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than 10 percent of total receivables. In addition, Other includes amounts due from nonconsolidated affiliates of $115 million, $106 million, and $140 million as of March 31, 2021, December 31, 2020, and March 31, 2020, respectively.
Accounts Receivable, Allowance for Credit Loss [Table Text Block]
(In millions)
2020
Balance at December 31, 2019$174 
Net provision for credit losses60 
Write-offs charged against allowance(1)
Recoveries collected(30)
Balance at March 31, 2020
$203 
2021
Balance at December 31, 2020$208 
Net benefit for credit losses(5)
Balance at March 31, 2021
$203 
XML 51 R37.htm IDEA: XBRL DOCUMENT v3.21.1
Inventories (Tables)
3 Months Ended
Mar. 31, 2021
Inventory Disclosure [Abstract]  
Schedule of Inventory, Current [Table Text Block]
(In millions)March 31, 2021December 31, 2020March 31, 2020
Finished products$2,508 $2,584 $2,721 
Semi-finished products1,386 1,813 1,260 
Raw materials and supplies427 485 420 
Total inventories$4,321 $4,882 $4,401 
XML 52 R38.htm IDEA: XBRL DOCUMENT v3.21.1
Other Intangible Assets (Tables)
3 Months Ended
Mar. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Other Intangible Assets
(In millions)March 31, 2021December 31, 2020March 31, 2020
 GrossAccumulated
Amortization
NetGrossAccumulated
Amortization
NetGrossAccumulated
Amortization
Net
Intangible assets subject to amortization (Definite-lived):
      
Germplasm$6,265 $(380)$5,885 $6,265 $(317)$5,948 $6,265 $(126)$6,139 
Customer-related
1,956 (404)1,552 1,984 (380)1,604 1,956 (293)1,663 
Developed technology
1,485 (565)920 1,451 (525)926 1,463 (409)1,054 
Trademarks/trade names1
2,013 (112)1,901 2,019 (99)1,920 166 (88)78 
Favorable supply contracts
475 (326)149 475 (302)173 475 (231)244 
Other2
405 (238)167 405 (239)166 400 (218)182 
Total other intangible assets with finite lives
12,599 (2,025)10,574 12,599 (1,862)10,737 10,725 (1,365)9,360 
Intangible assets not subject to amortization (Indefinite-lived):
      
IPR&D10 — 10 10 — 10 10 — 10 
Trade name1
1,871 — 1,871 
Total other intangible assets10 — 10 10 — 10 1,881 — 1,881 
Total$12,609 $(2,025)$10,584 $12,609 $(1,862)$10,747 $12,606 $(1,365)$11,241 
1.Beginning on October 1, 2020, the company changed its indefinite life assertion of its trade name asset to definite lived with a useful life of 25 years. This change is the result of the launch of BrevantTM seed in the retail channel in the U.S. Prior to changing the useful life of the trade name asset, the company tested the asset for the impairment under ASC 350- Intangibles, Goodwill and Other, concluding the asset was not impaired.
2.Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.
XML 53 R39.htm IDEA: XBRL DOCUMENT v3.21.1
Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Debt (Tables)
3 Months Ended
Mar. 31, 2021
Debt Instrument [Line Items]  
Schedule of Short-term Debt [Table Text Block]
Short-term borrowings and finance lease obligations
(In millions)March 31, 2021December 31, 2020March 31, 2020
Commercial paper$1,218 $— $1,918 
Repurchase facility30 — 30 
Other loans - various currencies— 45 
Long-term debt payable within one year
Finance lease obligations payable within one year
Total short-term borrowings and finance lease obligations$1,250 $$1,996 
XML 54 R40.htm IDEA: XBRL DOCUMENT v3.21.1
Commitments and Contingent Liabilities (Tables)
3 Months Ended
Mar. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Environmental Loss Contingencies by Site [Table Text Block]
As of March 31, 2021
(In millions)Indemnification Asset
Accrual balance3,4
Potential exposure above amount accrued3
Environmental Remediation Stray Liabilities
Chemours related obligations - subject to indemnity1,2
$152 $152 $280 
Other discontinued or divested businesses obligations1
— 78 177 
Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont2
34 34 65 
Environmental remediation liabilities not subject to indemnity— 69 55 
Total$186 $333 $577 
1.Represents liabilities that are subject to the $200 million thresholds and sharing arrangements as discussed on page 22, under Corteva Separation Agreement.
2.The company has recorded an indemnification asset related to these accruals, including $30 million related to the Superfund sites.
3.Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates
4.Accrual balance excludes indemnification liabilities of $54 million to Chemours, related to the cost sharing arrangement under the MOU (see page 10).
XML 55 R41.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2021
Equity [Abstract]  
Schedule of Noncontrolling Interests Represented by Preferred Stock [Table Text Block]
Shares in thousandsNumber of Shares
Authorized23,000
$4.50 Series, callable at $1201,673
$3.50 Series, callable at $102700
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]
(In millions)
Cumulative Translation Adjustment1
Derivative InstrumentsPension Benefit PlansOther Benefit PlansUnrealized Gain (Loss) on InvestmentsTotal
2020
Balance January 1, 2020$(1,944)$$(1,247)$(81)$— $(3,270)
Other comprehensive (loss) income before reclassifications
(672)(2)— (670)
Amounts reclassified from accumulated other comprehensive loss
— — — 
Net other comprehensive (loss) income
(672)— — (663)
Balance March 31, 2020$(2,616)$$(1,247)$(78)$— $(3,933)
2021     
Balance January 1, 2021$(1,970)$(67)$(1,433)$590 $(10)$(2,890)
Other comprehensive (loss) income before reclassifications
(403)71 (4)(331)
Amounts reclassified from accumulated other comprehensive loss
— (6)12 (158)(146)
Net other comprehensive (loss) income
(403)65 (157)10 (477)
Balance March 31, 2021$(2,373)$(2)$(1,425)$433 $— $(3,367)
1.The cumulative translation adjustment loss for the three months ended March 31, 2020 was primarily driven by the strengthening of the USD against the Brazilian Real (“BRL”) and the South African Rand ("ZAR"). The cumulative translation adjustment loss for the three months ended March 31, 2021 was primarily driven by strengthening of the USD against the Swiss Franc ("CHF"), Brazilian Real ("BRL") and European Euro.
Tax (Expense) Benefit of Other Comprehensive (Loss) Income
(In millions)Three Months Ended
March 31,
20212020
Derivative instruments$(18)$
Pension benefit plans - net(2)(4)
Other benefit plans - net49 — 
Benefit from income taxes related to other comprehensive (loss) income items$29 $
Reclassification out of Accumulated Other Comprehensive (Loss) Income [Table Text Block]
(In millions)Three Months Ended
March 31,
20212020
Derivative Instruments1:
$(5)$
Tax benefit2
(1)(2)
After-tax$(6)$
Amortization of pension benefit plans:
  Actuarial losses3,4
$14 $
  Settlement loss3,4
Total before tax$15 $
Tax benefit2
(3)(1)
After-tax$12 $
Amortization of other benefit plans:
  Prior service benefit3,4
$(230)$— 
  Actuarial gains3,4
23 — 
Total before tax$(207)$— 
Tax benefit2
49 — 
After-tax$(158)$— 
Unrealized Loss on Investments4
$$— 
Tax benefit2
— — 
After-tax$$— 
Total reclassifications for the period, after-tax$(146)$
1.Reflected in cost of goods sold.
2.Reflected in provision for (benefit from) income taxes from continuing operations.
3.These accumulated other comprehensive (loss) income components are included in the computation of net periodic benefit credit of the company's pension and other benefit plans. See Note 15 - Pension Plans and Other Post Employment Benefits, for additional information.
4.Reflected in other income - net.
XML 56 R42.htm IDEA: XBRL DOCUMENT v3.21.1
Pension Plans and Other Post Employment Benefit Plans (Tables)
3 Months Ended
Mar. 31, 2021
Retirement Benefits [Abstract]  
Schedule of Net Benefit Costs [Table Text Block]
Three Months Ended
March 31,
(In millions)20212020
Defined Benefit Pension Plans:
Service cost$$
Interest cost91 141 
Expected return on plan assets(230)(251)
Amortization of unrecognized loss14 
Settlement loss
Net periodic benefit credit$(117)$(102)
Other Post Employment Benefits:
Service cost$— $
Interest cost16 
Amortization of unrecognized loss23 — 
Amortization of prior service benefit(230)— 
Net periodic benefit (credit) cost$(201)$17 
XML 57 R43.htm IDEA: XBRL DOCUMENT v3.21.1
Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2021
Derivative [Line Items]  
Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]
Notional Amounts
(In millions)
March 31, 2021December 31, 2020March 31, 2020
Derivatives designated as hedging instruments:
Foreign currency contracts
$1,030 $1,164 $751 
Commodity contracts
$239 $383 $418 
Derivatives not designated as hedging instruments:
Foreign currency contracts$715 $647 $644 
Commodity contracts$154 $— $59 
Fair Value of Derivatives Instruments
March 31, 2021
(In millions)Balance Sheet LocationGross
Counterparty and Cash Collateral Netting1
Net Amounts Included in the interim Condensed Consolidated Balance Sheet
Asset derivatives:   
Derivatives designated as hedging instruments:
Foreign currency contracts
Other current assets$38 $— $38 
Derivatives not designated as hedging instruments:
  
Foreign currency contractsOther current assets52(32)20 
Total asset derivatives
 $90 $(32)$58 
Liability derivatives:  
Derivatives designated as hedging instruments:
Foreign currency contractsAccrued and other current liabilities$16 $— $16 
Derivatives not designated as hedging instruments:
  
Foreign currency contractsAccrued and other current liabilities46(30)16 
Total liability derivatives
 $62 $(30)$32 
December 31, 2020
(In millions)Balance Sheet LocationGross
Counterparty and Cash Collateral Netting1
Net Amounts Included in the Condensed Consolidated Balance Sheet
Asset derivatives:   
Derivatives designated as hedging instruments:
Foreign currency contractsOther current assets$15 $— $15 
Derivatives not designated as hedging instruments:
  
Foreign currency contracts
Other current assets40 (40)— 
Total asset derivatives
 $55 $(40)$15 
Liability derivatives:  
Derivatives designated as hedging instruments:
Foreign currency contractsAccrued and other current liabilities$38 $— $38 
Derivatives not designated as hedging instruments:
  
Foreign currency contracts
Accrued and other current liabilities97 (40)57 
Total liability derivatives
 $135 $(40)$95 
March 31, 2020
(In millions)Balance Sheet LocationGross
Counterparty and Cash Collateral Netting1
Net Amounts Included in the interim Condensed Consolidated Balance Sheet
Asset derivatives:   
Derivatives designated as hedging instruments:
Foreign currency contracts
Other current assets$36 $— $36 
Derivatives not designated as hedging instruments:
  
Foreign currency contracts
Other current assets230 (110)120 
Total asset derivatives
 $266 $(110)$156 
Liability derivatives:  
Derivatives not designated as hedging instruments:
  
Foreign currency contracts
Accrued and other current liabilities$108 $(103)$
Total liability derivatives
 $108 $(103)$
1.    Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.
Effect of Derivatives
Amount of (Loss) Gain Recognized in OCI1 - Pre-Tax
Three Months Ended
March 31,
(In millions)20212020
Derivatives designated as hedging instruments:
Net investment hedges:
Foreign currency contracts
$21 $
Cash flow hedges:
Foreign currency contracts
31 19 
 Commodity contracts36 (34)
Total derivatives designated as hedging instruments$88 $(6)
1.OCI is defined as other comprehensive income (loss).
Amount of Gain (Loss) Recognized in Income - Pre-Tax1
Three Months Ended
March 31,
(In millions)20212020
Derivatives designated as hedging instruments:
Cash flow hedges:
Foreign currency contracts2
$$— 
 Commodity contracts2
(7)
Total derivatives designated as hedging instruments
$$(7)
Derivatives not designated as hedging instruments:
Foreign currency contracts3
$16 $165 
Foreign currency contracts2
— 
Commodity contracts2
(12)
Total derivatives not designated as hedging instruments
174 
Total derivatives$11 $167 
1.For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period.
2.Recorded in cost of goods sold.
3.Gain recognized in other income (expense) - net was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 6 - Supplementary Information, for additional information.
Schedule of Realized Gains (Losses)
Investing ResultsThree Months Ended
 March 31,
(In millions)2021
Proceeds from sales of available-for-sale securities$161 
Gross realized losses(6)
Total$155 
Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value
March 31, 202112 months or more
(In millions)Fair valueGross unrealized losses
U.S. Treasuries$65 $— 
Commodity Contract [Member]  
Derivative [Line Items]  
After-Tax Effect of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)
Three Months Ended
March 31,
(In millions)20212020
Beginning balance$(16)$
Additions and revaluations of derivatives designated as cash flow hedges30 (22)
Clearance of hedge results to earnings(4)
Ending balance$10 $(15)
Foreign Currency Contract [Member]  
Derivative [Line Items]  
After-Tax Effect of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)
Three Months Ended
March 31,
(In millions)20212020
Beginning balance$(17)$— 
Additions and revaluations of derivatives designated as cash flow hedges25 16 
Clearance of hedge results to earnings(2)— 
Ending balance$$16 
XML 58 R44.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2021
Fair Value Disclosures [Abstract]  
Fair Value of Assets and Liabilities Measured on Recurring Basis
March 31, 2021Significant Other Observable Inputs
(In millions)Level 1Level 2
Assets at fair value:
Marketable securities
$— $49 
Debt securities:
U.S. treasuries1
65— 
Derivatives relating to:2
Foreign currency
— 90 
Total assets at fair value$65 $139 
Liabilities at fair value:
Derivatives relating to:2
Foreign currency
— 62 
Total liabilities at fair value$— $62 
December 31, 2020Significant Other Observable Inputs
(In millions)Level 1Level 2
Assets at fair value:
Marketable securities
$— $43 
Debt securities:
U.S. treasuries1
226— 
Derivatives relating to:2
Foreign currency
— 55 
Total assets at fair value$226 $98 
Liabilities at fair value:
Derivatives relating to:2
Foreign currency
— 135 
Total liabilities at fair value$— $135 
March 31, 2020Significant Other Observable Inputs (Level 2)
(In millions)
Assets at fair value:
Marketable securities
$10 
Derivatives relating to:2
Foreign currency
266 
Total assets at fair value$276 
Liabilities at fair value:
Derivatives relating to:2
Foreign currency
108 
Total liabilities at fair value$108 
1.    The company's investments in debt securities, which are available-for-sale, are included in "marketable securities" in the interim Condensed Consolidated Balance Sheets.
2. See Note 16 - Financial Instruments for the classification of derivatives in the interim Condensed Consolidated Balance Sheets.
XML 59 R45.htm IDEA: XBRL DOCUMENT v3.21.1
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2021
Segment Reporting Information [Line Items]  
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Reconciliation to interim Consolidated Financial Statements
Income from continuing operations after income taxes to segment operating EBITDA


(In millions)
Three Months Ended
March 31,
20212020
Income from continuing operations after income taxes$613 $281 
Provision for income taxes on continuing operations178 127 
Income from continuing operations before income taxes791 408 
Depreciation and amortization304 283 
Interest income(21)(18)
Interest expense10 
Exchange losses - net35 61 
Non-operating benefits - net(311)(73)
Mark-to-market gains on certain foreign currency contracts not designated as hedges1
(1)
Significant items100 123 
Corporate expenses34 25 
Segment operating EBITDA$938 $819 
1.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There was no activity in the three months ended March 31, 2020. Refer to page 48 for further discussion of the company’s Non-GAAP financial measures.
Schedule of Segment Reporting Information, by Segment [Table Text Block]
As of and for the Three Months Ended March 31,
(In millions)
SeedCrop ProtectionTotal
2021   
Net sales$2,492 $1,686 $4,178 
Segment operating EBITDA$617 $321 $938 
Segment assets1
$24,799 $13,349 $38,148 
2020   
Net sales$2,455 $1,501 $3,956 
Segment operating EBITDA$581 $238 $819 
Segment assets1
$25,857 $13,251 $39,108 
1.    Segment assets at December 31, 2020 were $23,751 million and $13,099 million for Seed and Crop Protection, respectively.
Reconciliation of Assets from Segment to Consolidated [Table Text Block]
Segment assets to total assets (in millions)
March 31, 2021December 31, 2020March 31, 2020
Total segment assets$38,148 $36,850 $39,108 
Corporate assets4,401 5,799 3,870 
Total assets$42,549 $42,649 $42,978 
Schedule of Additional Segment Details [Table Text Block]
(In millions)SeedCrop ProtectionCorporateTotal
For the Three Months Ended March 31, 2021
Restructuring and Asset Related Charges - Net 1
$(21)$(32)$(47)$(100)
Total$(21)$(32)$(47)$(100)
(In millions)SeedCrop ProtectionCorporateTotal
For the Three Months Ended March 31, 2020
Restructuring and Asset Related Charges - Net 1
$(10)$(18)$(42)$(70)
Loss on Divestiture2
— (53)— (53)
Total$(10)$(71)$(42)$(123)
1.Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements for additional information.
2.Includes a loss recorded in other income - net related to the sale of the La Porte site.
XML 60 R46.htm IDEA: XBRL DOCUMENT v3.21.1
EID Segment FN (Tables)
3 Months Ended
Mar. 31, 2021
Segment Reporting Information [Line Items]  
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Reconciliation to interim Consolidated Financial Statements
Income from continuing operations after income taxes to segment operating EBITDA


(In millions)
Three Months Ended
March 31,
20212020
Income from continuing operations after income taxes$613 $281 
Provision for income taxes on continuing operations178 127 
Income from continuing operations before income taxes791 408 
Depreciation and amortization304 283 
Interest income(21)(18)
Interest expense10 
Exchange losses - net35 61 
Non-operating benefits - net(311)(73)
Mark-to-market gains on certain foreign currency contracts not designated as hedges1
(1)
Significant items100 123 
Corporate expenses34 25 
Segment operating EBITDA$938 $819 
1.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There was no activity in the three months ended March 31, 2020. Refer to page 48 for further discussion of the company’s Non-GAAP financial measures.
Reconciliation of Assets from Segment to Consolidated [Table Text Block]
Segment assets to total assets (in millions)
March 31, 2021December 31, 2020March 31, 2020
Total segment assets$38,148 $36,850 $39,108 
Corporate assets4,401 5,799 3,870 
Total assets$42,549 $42,649 $42,978 
EID [Member]  
Segment Reporting Information [Line Items]  
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Income from continuing operations after income taxes to segment operating EBITDA


(In millions)
Three Months Ended
March 31,
20212020
Income from continuing operations after income taxes$602 $257 
Provision for income taxes on continuing operations174 119 
Income from continuing operations before income taxes776 376 
Depreciation and amortization304 283 
Interest income(21)(18)
Interest expense22 42 
Exchange losses - net35 61 
Non-operating benefits - net(311)(73)
Mark-to-market gains on certain foreign currency contracts not designated as hedges1
(1)
Significant items100 123 
Corporate expenses34 25 
Segment operating EBITDA$938 $819 
1.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There was no activity in the three months ended March 31, 2020.
XML 61 R47.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Significant Accounting Policies Summary of Accounting Policies (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Foreign Exchange Impact on Income (Loss) from Continuing Operations $ 20  
Percentage deterioration of the official Peso to USD exchange rate 10.00%  
Internal Reorganization [Member]    
Reclassification of Divisional Equity to APIC   $ 40
XML 62 R48.htm IDEA: XBRL DOCUMENT v3.21.1
Divestitures and Other Transactions Separation Agreements (Details)
$ in Millions
Mar. 31, 2021
USD ($)
Accounts and Notes Receivable [Member] | DuPont de Nemours [Member]  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Indemnification Assets $ 28
Other Assets [Member] | DuPont de Nemours [Member]  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Indemnification Assets 51
Accrued and Other Current Liabilities [Member] | Dow [Member]  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Indemnified Liabilities 52
Other noncurrent obligations | DuPont de Nemours [Member]  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Indemnified Liabilities 77
Other noncurrent obligations | Dow [Member]  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Indemnified Liabilities $ 14
XML 63 R49.htm IDEA: XBRL DOCUMENT v3.21.1
Divestitures and Other Transactions Other Discontinued Operations (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Income (loss) from discontinued operations after income taxes $ (10) $ 1
XML 64 R50.htm IDEA: XBRL DOCUMENT v3.21.1
Divestitures and Other Transactions - PChem Results of Operations (Details)
$ in Millions
3 Months Ended
Mar. 31, 2021
USD ($)
Performance Chemicals | Accounts and Notes Receivable [Member]  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Indemnification Asset for liabilities indemnified by Chemours $ 63
Performance Chemicals | Other Assets [Member]  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Indemnification Asset for liabilities indemnified by Chemours 259
Performance Chemicals | Accrued and Other Current Liabilities [Member]  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Indemnified Liabilities for liabilities indemnified by Chemours (10)
Performance Chemicals | Other noncurrent obligations  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Indemnified Liabilities for liabilities indemnified by Chemours (44)
Performance Chemicals  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Income (loss) from discontinued operations before income taxes $ 3
XML 65 R51.htm IDEA: XBRL DOCUMENT v3.21.1
Revenue Narrative (Details) - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Mar. 31, 2020
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]      
Revenue, Remaining Performance Obligation, Amount $ 113 $ 115 $ 106
Minimum [Member]      
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]      
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period 1 year    
Maximum [Member]      
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]      
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period 6 years    
XML 66 R52.htm IDEA: XBRL DOCUMENT v3.21.1
Revenue Contract Balances (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Disaggregation of Revenue [Line Items]      
Accounts and notes receivable - trade [1] $ 5,764 $ 5,779 $ 3,917
Contract assets - current [2] 22 20 22
Contract assets - noncurrent [3] 53 49 54
Deferred Revenue 2,247 1,996 2,662
Deferred revenue recognized during the period 924 822  
Accrued and Other Current Liabilities [Member]      
Disaggregation of Revenue [Line Items]      
Deferred Revenue 2,247 1,996 2,662
Other noncurrent obligations      
Disaggregation of Revenue [Line Items]      
Deferred Revenue [4] $ 111 $ 104 $ 116
[1] Included in accounts and notes receivable - net in the interim Condensed Consolidated Balance Sheets.
[2] Included in other current assets in the interim Condensed Consolidated Balance Sheets.
[3] Included in other assets in the interim Condensed Consolidated Balance Sheets.
[4] Included in other noncurrent obligations in the interim Condensed Consolidated Balance Sheets.
XML 67 R53.htm IDEA: XBRL DOCUMENT v3.21.1
Revenue Disaggregation of Revenue - Principal Product Groups (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Disaggregation of Revenue [Line Items]    
Net Sales $ 4,178 $ 3,956
Seed [Member]    
Disaggregation of Revenue [Line Items]    
Net Sales 2,492 2,455
Seed [Member] | Corn [Member]    
Disaggregation of Revenue [Line Items]    
Net Sales 1,888 1,864
Seed [Member] | Soybean [Member]    
Disaggregation of Revenue [Line Items]    
Net Sales 177 181
Seed [Member] | Other oilseeds [Member]    
Disaggregation of Revenue [Line Items]    
Net Sales 296 248
Seed [Member] | Other [Member]    
Disaggregation of Revenue [Line Items]    
Net Sales 131 162
Crop Protection [Member]    
Disaggregation of Revenue [Line Items]    
Net Sales 1,686 1,501
Crop Protection [Member] | Other [Member]    
Disaggregation of Revenue [Line Items]    
Net Sales 54 71
Crop Protection [Member] | Herbicides [Member]    
Disaggregation of Revenue [Line Items]    
Net Sales 986 823
Crop Protection [Member] | Insecticides [Member]    
Disaggregation of Revenue [Line Items]    
Net Sales 385 378
Crop Protection [Member] | Fungicides [Member]    
Disaggregation of Revenue [Line Items]    
Net Sales $ 261 $ 229
XML 68 R54.htm IDEA: XBRL DOCUMENT v3.21.1
Revenue Disaggregation of Revenue - Geography (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Disaggregation of Revenue [Line Items]    
Net Sales $ 4,178 $ 3,956
Seed [Member]    
Disaggregation of Revenue [Line Items]    
Net Sales 2,492 2,455
Seed [Member] | North America    
Disaggregation of Revenue [Line Items]    
Net Sales [1] 1,210 1,290
Seed [Member] | EMEA    
Disaggregation of Revenue [Line Items]    
Net Sales [2] 947 881
Seed [Member] | Latin America    
Disaggregation of Revenue [Line Items]    
Net Sales 274 216
Seed [Member] | Asia Pacific    
Disaggregation of Revenue [Line Items]    
Net Sales 61 68
Crop Protection [Member]    
Disaggregation of Revenue [Line Items]    
Net Sales 1,686 1,501
Crop Protection [Member] | North America    
Disaggregation of Revenue [Line Items]    
Net Sales [1] 533 475
Crop Protection [Member] | EMEA    
Disaggregation of Revenue [Line Items]    
Net Sales [2] 655 586
Crop Protection [Member] | Latin America    
Disaggregation of Revenue [Line Items]    
Net Sales 244 218
Crop Protection [Member] | Asia Pacific    
Disaggregation of Revenue [Line Items]    
Net Sales $ 254 $ 222
[1] Represents U.S. & Canada.
[2] Europe, Middle East, and Africa ("EMEA").
XML 69 R55.htm IDEA: XBRL DOCUMENT v3.21.1
Restructuring and Asset Related Charges - 2021 Restructuring Activities (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Restructuring Cost and Reserve [Line Items]      
Restructuring and Asset related charges, net $ 100 $ 70  
2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Asset Retirement Obligation 6    
Payments for Restructuring (7)    
Asset write-offs and adjustments (13)    
Restructuring Reserve 69   $ 0
Restructuring and Asset related charges, net 89    
Minimum [Member] | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Expected Cost 130    
Future Cash Payments 80    
Maximum [Member] | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Expected Cost 170    
Future Cash Payments 100    
Severance and Related Benefit Costs | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Payments for Restructuring (1)    
Asset write-offs and adjustments 0    
Restructuring Reserve 38   0
Restructuring and Asset related charges, net 39    
Severance and Related Benefit Costs | Minimum [Member] | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Expected Cost 40    
Severance and Related Benefit Costs | Maximum [Member] | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Expected Cost 50    
Asset Related Charges [Member] | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Payments for Restructuring 0    
Asset write-offs and adjustments (13)    
Restructuring Reserve 0   0
Restructuring and Asset related charges, net 13    
Asset Related Charges [Member] | Minimum [Member] | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Expected Cost 40    
Asset Related Charges [Member] | Maximum [Member] | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Expected Cost 60    
Asset Retirement Obligation Costs [Member] | Minimum [Member] | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Expected Cost 10    
Asset Retirement Obligation Costs [Member] | Maximum [Member] | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Expected Cost 15    
Contract Termination | Minimum [Member] | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Expected Cost 40    
Contract Termination | Maximum [Member] | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Expected Cost 45    
Costs Associated with Exit and Disposal Activities | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Payments for Restructuring (6)    
Asset write-offs and adjustments 0    
Restructuring Reserve 31   $ 0
Restructuring and Asset related charges, net 37    
Seed [Member] | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Asset related charges, net 14    
Crop Protection [Member] | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Asset related charges, net 28    
Corporate Segment | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Asset related charges, net $ 47    
XML 70 R56.htm IDEA: XBRL DOCUMENT v3.21.1
Restructuring and Asset Related Charges Execute to Win Productivity Program (Details) - USD ($)
$ in Millions
3 Months Ended 15 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Mar. 31, 2021
Restructuring Cost and Reserve [Line Items]      
Restructuring and Asset related charges, net $ 100 $ 70  
Execute to Win Productivity Program [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring Reserve, Beginning Balance 56    
Payments for Restructuring (14)    
Asset write-offs and adjustments (4)    
Asset Retirement Obligation 20   $ 20
Restructuring Reserve, Ending Balance 42   42
Restructuring and Asset related charges, net 4 63  
Restructuring and Asset Related Charges - Net     180
2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring Reserve, Beginning Balance 0    
Payments for Restructuring 7    
Asset write-offs and adjustments (13)    
Asset Retirement Obligation 6   6
Restructuring Reserve, Ending Balance 69   69
Restructuring and Asset related charges, net 89    
Severance and Related Benefit Costs | Execute to Win Productivity Program [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring Reserve, Beginning Balance 53    
Payments for Restructuring (11)    
Asset write-offs and adjustments 0    
Restructuring Reserve, Ending Balance 42   42
Restructuring and Asset related charges, net 0 42  
Restructuring and Asset Related Charges - Net     63
Severance and Related Benefit Costs | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring Reserve, Beginning Balance 0    
Payments for Restructuring 1    
Asset write-offs and adjustments 0    
Restructuring Reserve, Ending Balance 38   38
Restructuring and Asset related charges, net 39    
Costs Associated with Exit and Disposal Activities | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring Reserve, Beginning Balance 0    
Payments for Restructuring 6    
Asset write-offs and adjustments 0    
Restructuring Reserve, Ending Balance 31   31
Restructuring and Asset related charges, net 37    
Asset Related Charges [Member] | Execute to Win Productivity Program [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring Reserve, Beginning Balance 3    
Payments for Restructuring (3)    
Asset write-offs and adjustments (4)    
Restructuring Reserve, Ending Balance 0   0
Restructuring and Asset related charges, net 4 21  
Restructuring and Asset Related Charges - Net     117
Asset Related Charges [Member] | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring Reserve, Beginning Balance 0    
Payments for Restructuring 0    
Asset write-offs and adjustments (13)    
Restructuring Reserve, Ending Balance 0   0
Restructuring and Asset related charges, net 13    
Seed [Member] | Execute to Win Productivity Program [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Asset related charges, net 0 3  
Seed [Member] | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Asset related charges, net 14    
Crop Protection [Member] | Execute to Win Productivity Program [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Asset related charges, net 4 18  
Crop Protection [Member] | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Asset related charges, net 28    
Corporate | Execute to Win Productivity Program [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Asset related charges, net $ 0 $ 42  
Minimum [Member] | Execute to Win Productivity Program [Domain]      
Restructuring Cost and Reserve [Line Items]      
Ceased Operations 12 months    
Minimum [Member] | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Expected Cost $ 130   130
Minimum [Member] | Severance and Related Benefit Costs | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Expected Cost 40   40
Minimum [Member] | Asset Related Charges [Member] | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Expected Cost 40   40
Minimum [Member] | Asset Retirement Obligation Costs [Member] | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Expected Cost $ 10   10
Maximum [Member] | Execute to Win Productivity Program [Domain]      
Restructuring Cost and Reserve [Line Items]      
Ceased Operations 24 months    
Maximum [Member] | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Expected Cost $ 170   170
Maximum [Member] | Severance and Related Benefit Costs | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Expected Cost 50   50
Maximum [Member] | Asset Related Charges [Member] | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Expected Cost 60   60
Maximum [Member] | Asset Retirement Obligation Costs [Member] | 2021 Restructuring Actions [Domain]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Expected Cost $ 15   $ 15
XML 71 R57.htm IDEA: XBRL DOCUMENT v3.21.1
Restructuring and Asset Related Charges Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Other Asset Related [Member]    
Restructuring Cost and Reserve [Line Items]    
Accelerated Prepaid Royalty Amortization Expense $ 7 $ 10
XML 72 R58.htm IDEA: XBRL DOCUMENT v3.21.1
Related Party Transactions Dow Intercompany Transactions (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Corteva [Member] | EID [Member]    
Related Party Transaction [Line Items]    
Interest Expense, Related Party $ 15 $ 32
XML 73 R59.htm IDEA: XBRL DOCUMENT v3.21.1
Supplementary Information Other Income (Expense) - Net (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Equity in earnings / (losses) of affiliates - net $ 3 $ (1)
Net gain (loss) on sales of businesses and other assets [1] 0 (46)
Net exchange gains (losses) [2] (35) (61)
Non-operating pension and other post employment benefit credit [3] 325 91
Miscellaneous expenses - net [4] 23 0
Other income - net 337 1
Interest income 21 18
Hedging Program [Member]    
Net exchange gains (losses) 16 165
Hedging Program [Member] | Argentine Peso Devaluation [Member]    
Net exchange gains (losses) (23) (9)
Subsidiary Monetary Position    
Net exchange gains (losses) (51) (226)
Segment Reconciling Items [Member]    
Net exchange gains (losses) 35 61
Non-operating pension and other post employment benefit credit (311) (73)
Interest income (21) $ (18)
Segment Reconciling Items [Member] | Crop Protection [Member]    
Gain (Loss) on Disposition of Assets $ (53)  
[1] The three months ended March 31, 2020 includes a loss of $(53) million relating to the sale of the La Porte site, for which the company signed an agreement in 2020, and closed during the first quarter of 2021.2.Includes net pre-tax exchange losses of $(23) million and $(9) million associated with the devaluation of the Argentine peso for the three months ended March 31, 2021 and 2020, respectively.
[2] Includes net pre-tax exchange losses of $(23) million and $(9) million associated with the devaluation of the Argentine peso for the three months ended March 31, 2021 and 2020, respectively.
[3] Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement loss).
[4] Miscellaneous income - net, includes a gain from a remeasurement of an equity investment, losses on sale of available-for-sale securities, tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont, losses on sale of receivables, and other items.
XML 74 R60.htm IDEA: XBRL DOCUMENT v3.21.1
Supplementary Information Foreign Currency Exchange Gain (Loss) (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Foreign Currency Exchange Gain (Loss) [Line Items]    
Pre-tax exchange (losses) gains - net [1] $ (35) $ (61)
Foreign Currency Transaction (Loss) Gain Tax (Expense) Benefit (5) (17)
Foreign Currency Transaction (Loss) Gain After Tax (40) (78)
Subsidiary Monetary Position    
Foreign Currency Exchange Gain (Loss) [Line Items]    
Pre-tax exchange (losses) gains - net (51) (226)
Foreign Currency Transaction (Loss) Gain Tax (Expense) Benefit (1) 23
Foreign Currency Transaction (Loss) Gain After Tax (52) (203)
Hedging Program [Member]    
Foreign Currency Exchange Gain (Loss) [Line Items]    
Pre-tax exchange (losses) gains - net 16 165
Foreign Currency Transaction (Loss) Gain Tax (Expense) Benefit (4) (40)
Foreign Currency Transaction (Loss) Gain After Tax $ 12 $ 125
[1] Includes net pre-tax exchange losses of $(23) million and $(9) million associated with the devaluation of the Argentine peso for the three months ended March 31, 2021 and 2020, respectively.
XML 75 R61.htm IDEA: XBRL DOCUMENT v3.21.1
Supplementary Information Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Mar. 31, 2020
Dec. 31, 2019
Restricted Cash and Cash Equivalents Items [Line Items]        
Cash and cash equivalents $ 2,404 $ 3,526 $ 1,963  
Cash, Cash Equivalents and Restricted Cash, Total Company 2,730 [1] 3,873 2,340 [1] $ 2,173
Other Current Assets [Member]        
Restricted Cash and Cash Equivalents Items [Line Items]        
Restricted Cash $ 326 $ 347 $ 377  
[1] See page 15 for reconciliation of cash and cash equivalents and restricted cash presented in interim Condensed Consolidated Balance Sheets to total cash, cash equivalents and restricted cash presented in the interim Consolidated Statements of Cash Flows.
XML 76 R62.htm IDEA: XBRL DOCUMENT v3.21.1
Income Taxes Income Tax Narrative (Details)
$ in Millions
3 Months Ended
Mar. 31, 2020
USD ($)
Income Tax Disclosure [Abstract]  
Tax benefit related to the enactment of the Swiss Tax Reform $ 38
Tax benefit (charge) related to application of the Act's foreign tax provisions $ (83)
XML 77 R63.htm IDEA: XBRL DOCUMENT v3.21.1
Earnings Per Share Net Income for Earnings Per Share Calculations - Basic and Diluted (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Earnings Per Share [Abstract]    
Income (loss) from continuing operations after income taxes $ 613 $ 281
Net income (loss) Attributable to Noncontrolling Interest, Continuing Operations 3 10
Net income (loss) from Continuing Operations Available to Common Shareholders 610 271
Income (loss) from discontinued operations after income taxes (10) 1
Net income (loss) Available to Common Stockholders $ 600 $ 272
XML 78 R64.htm IDEA: XBRL DOCUMENT v3.21.1
Earnings Per Share Earnings Per Share Calculations - Basic (Details) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Earnings Per Share [Abstract]    
Basic earnings (loss) per share of common stock from continuing operations $ 0.82 $ 0.36
Basic earnings (loss) per share of common stock from discontinued operations $ (0.01) $ 0
Basic earnings (loss) per share of common stock $ 0.81 $ 0.36
XML 79 R65.htm IDEA: XBRL DOCUMENT v3.21.1
Earnings Per Share Earnings Per Share Calculations - Diluted (Details) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Earnings Per Share [Abstract]    
Diluted earnings (loss) per share of common stock from continuing operations $ 0.81 $ 0.36
Diluted earnings (loss) per share of common stock from discontinued operations $ (0.01) $ 0
Diluted earnings (loss) per share of common stock $ 0.80 $ 0.36
XML 80 R66.htm IDEA: XBRL DOCUMENT v3.21.1
Earnings Per Share Share Count Information (Details) - shares
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Earnings Per Share [Line Items]      
Weighted Average Common Shares - basic 743,400,000 749,900,000  
Dilutive effect of equity compensation plans [1] 6,200,000 2,600,000  
Weighted Average Common Shares - diluted 749,600,000 752,500,000  
Potential shares of common stock excluded from EPS calculations [2] 2,900,000 9,100,000  
Common Stock, Shares Authorized 1,666,667,000 1,666,667,000 1,666,667,000
[1] Diluted earnings per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.
[2] These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been anti-dilutive.
XML 81 R67.htm IDEA: XBRL DOCUMENT v3.21.1
Accounts and Notes Receivable (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Accounts Receivable - trade [1] $ 5,231 $ 5,367 $ 3,754  
Notes receivable - trade [1],[2] 533 412 163  
Other [3] 1,028 996 1,009  
Accounts and notes receivable - net 6,792 6,775 4,926  
Accounts Receivable, Allowance for Credit Loss, Current 203 203 208 $ 174
Due from Affiliates 115 140 106  
Factoring Agreement [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Trade Receivables Sold 11 15    
Trade receivables sold the remain outstanding with an element of recourse $ 128 $ 43 $ 157  
[1] Accounts receivable – trade and notes receivable - trade are net of allowances of $203 million at March 31, 2021, $208 million at December 31, 2020, and $203 million at March 31, 2020. Allowances are equal to the estimated uncollectible amounts and are based on the expected credit losses and were developed using a loss-rate method.
[2] Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid pre-approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of March 31, 2021, December 31, 2020, and March 31, 2020 there were no significant impairments related to current loan agreements.
[3] Other includes receivables in relation to indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than 10 percent of total receivables. In addition, Other includes amounts due from nonconsolidated affiliates of $115 million, $106 million, and $140 million as of March 31, 2021, December 31, 2020, and March 31, 2020, respectively.
XML 82 R68.htm IDEA: XBRL DOCUMENT v3.21.1
Accounts and Notes Receivable Allowance Rollforward (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Receivables [Abstract]    
Accounts Receivable, Allowance for Credit Loss, Beginning Balance $ 208 $ 174
Net provision for credit losses (5) 60
Write-offs charged against allowance   (1)
Recoveries collected   (30)
Accounts Receivable, Allowance for Credit Loss, Ending Balance $ 203 $ 203
XML 83 R69.htm IDEA: XBRL DOCUMENT v3.21.1
Inventories Schedule of Inventory (Details) - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Mar. 31, 2020
Inventory [Line Items]      
Finished Products $ 2,508 $ 2,584 $ 2,721
Semi-finished Products 1,386 1,813 1,260
Raw Materials and Supplies 427 485 420
Total inventories $ 4,321 $ 4,882 $ 4,401
XML 84 R70.htm IDEA: XBRL DOCUMENT v3.21.1
Property, Plant and Equipment Schedule of Property, Plant and Equipment (Details) - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Mar. 31, 2020
Property, Plant and Equipment [Line Items]      
Accumulated Depreciation $ (3,874) $ (3,857) $ (3,406)
XML 85 R71.htm IDEA: XBRL DOCUMENT v3.21.1
Other Intangible Assets Other Intangible Assets (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2020
Mar. 31, 2021
Dec. 31, 2020
Acquired Finite-Lived Intangible Assets [Line Items]      
Finite-Lived Intangible Assets, Gross $ 10,725 $ 12,599 $ 12,599
Finite-Lived Intangible Assets, Accumulated Amortization (1,365) (2,025) (1,862)
Finite-Lived Intangible Assets, Net 9,360 10,574 10,737
Indefinite-lived Intangible Assets (Excluding Goodwill) 1,881 10 10
Intangible Assets, Gross (Excluding Goodwill) 12,606 12,609 12,609
Total other intangible assets 11,241 10,584 10,747
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 54    
Impairment of Intangible Assets Indefinite lived Excluding Goodwill After Tax 41    
Trade Names [Member]      
Acquired Finite-Lived Intangible Assets [Line Items]      
Indefinite-lived Intangible Assets (Excluding Goodwill) [1] 1,871    
In Process Research and Development [Member]      
Acquired Finite-Lived Intangible Assets [Line Items]      
Indefinite-lived Intangible Assets (Excluding Goodwill) 10 10 10
Germplasm [Member]      
Acquired Finite-Lived Intangible Assets [Line Items]      
Finite-Lived Intangible Assets, Gross 6,265 6,265 6,265
Finite-Lived Intangible Assets, Accumulated Amortization (126) (380) (317)
Finite-Lived Intangible Assets, Net 6,139 5,885 5,948
Customer-Related Intangible Assets [Member]      
Acquired Finite-Lived Intangible Assets [Line Items]      
Finite-Lived Intangible Assets, Gross 1,956 1,956 1,984
Finite-Lived Intangible Assets, Accumulated Amortization (293) (404) (380)
Finite-Lived Intangible Assets, Net 1,663 1,552 1,604
Developed Technology Rights [Member]      
Acquired Finite-Lived Intangible Assets [Line Items]      
Finite-Lived Intangible Assets, Gross 1,463 1,485 1,451
Finite-Lived Intangible Assets, Accumulated Amortization (409) (565) (525)
Finite-Lived Intangible Assets, Net 1,054 920 926
Trademarks and Trade Names [Member]      
Acquired Finite-Lived Intangible Assets [Line Items]      
Finite-Lived Intangible Assets, Gross [1] 166 2,013 2,019
Finite-Lived Intangible Assets, Accumulated Amortization [1] (88) (112) (99)
Finite-Lived Intangible Assets, Net [1] 78 1,901 1,920
Favorable Supply Contract [Member]      
Acquired Finite-Lived Intangible Assets [Line Items]      
Finite-Lived Intangible Assets, Gross 475 475 475
Finite-Lived Intangible Assets, Accumulated Amortization (231) (326) (302)
Finite-Lived Intangible Assets, Net 244 149 173
Other Intangible Assets [Member]      
Acquired Finite-Lived Intangible Assets [Line Items]      
Finite-Lived Intangible Assets, Gross [2] 400 405 405
Finite-Lived Intangible Assets, Accumulated Amortization [2] (218) (238) (239)
Finite-Lived Intangible Assets, Net [2] $ 182 $ 167 $ 166
[1] Beginning on October 1, 2020, the company changed its indefinite life assertion of its trade name asset to definite lived with a useful life of 25 years. This change is the result of the launch of BrevantTM seed in the retail channel in the U.S. Prior to changing the useful life of the trade name asset, the company tested the asset for the impairment under ASC 350- Intangibles, Goodwill and Other, concluding the asset was not impaired.
[2] Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.
XML 86 R72.htm IDEA: XBRL DOCUMENT v3.21.1
Other Intangible Assets Future Amortization Expense (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Finite-Lived Intangible Assets [Line Items]    
Amortization expense $ 183 $ 163
Continuing Operations [Member]    
Finite-Lived Intangible Assets [Line Items]    
Pre-tax amortization expense, remainder of 2021 537  
Pre-tax amortization expense, 2022 700  
Pre-tax amortization expense, 2023 620  
Pre-tax amortization expense, 2024 606  
Pre-tax amortization expense, 2025 569  
Pre-tax amortization expense, 2026 $ 555  
XML 87 R73.htm IDEA: XBRL DOCUMENT v3.21.1
Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Short-term borrowings and finance lease obligations (Details) - USD ($)
$ in Millions
Mar. 31, 2021
Feb. 09, 2021
Dec. 31, 2020
Mar. 31, 2020
Short-term Debt [Line Items]        
Long-term Debt Payable within one year $ 1   $ 1 $ 1
Finance Lease, Liability, Current 1   1 2
Short-term borrowings and finance lease obligations 1,250   3 1,996
Commercial Paper [Member]        
Short-term Debt [Line Items]        
Short-term borrowings 1,218   0 1,918
Securities Sold under Agreements to Repurchase [Member]        
Short-term Debt [Line Items]        
Short-term borrowings   $ 1,000    
Other loans - various currencies [Member]        
Short-term Debt [Line Items]        
Short-term borrowings 0   1 45
Repurchase Agreements [Member] | Securities Sold under Agreements to Repurchase [Member]        
Short-term Debt [Line Items]        
Short-term borrowings $ 30   $ 0 $ 30
XML 88 R74.htm IDEA: XBRL DOCUMENT v3.21.1
Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Long-term Debt (Details) - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Mar. 31, 2020
Debt Instrument [Line Items]      
Long-term Debt Payable within one year $ 1 $ 1 $ 1
Notes Maturing 2030 [Domain] | Loans Payable [Member]      
Debt Instrument [Line Items]      
Long-term Debt, Weighted Average Interest Rate, at Point in Time 2.30%    
Long-term Debt, Gross $ 500    
Fair Value, Inputs, Level 2 [Member]      
Debt Instrument [Line Items]      
Long-term Debt, Fair Value $ 1,121 $ 1,168 $ 612
XML 89 R75.htm IDEA: XBRL DOCUMENT v3.21.1
Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Repurchase Facility and Revolving Credit Facilities (Details)
$ in Millions
3 Months Ended 36 Months Ended 60 Months Ended
Mar. 31, 2021
USD ($)
Mar. 31, 2020
USD ($)
Nov. 13, 2021
Nov. 13, 2023
Feb. 09, 2021
USD ($)
Dec. 31, 2020
USD ($)
Nov. 13, 2018
USD ($)
Line of Credit Facility [Line Items]              
Proceeds from debt $ 419 $ 875          
Repayments of Long-term Debt 0 1          
Revolving Credit Facilities due 2024 [Member]              
Line of Credit Facility [Line Items]              
Line of Credit Facility, Maximum Borrowing Capacity             $ 3,000
Revolving Credit Facilities due 2022 [Member]              
Line of Credit Facility [Line Items]              
Line of Credit Facility, Maximum Borrowing Capacity             $ 3,000
Long-term Line of Credit   500          
Line of Credit Facility, Remaining Borrowing Capacity 3,000            
Securities Sold under Agreements to Repurchase [Member]              
Line of Credit Facility [Line Items]              
Short-term borrowings         $ 1,000    
Percentage of outstanding amounts borrowed utilized as collateral         105.00%    
Interest rate in addition to LIBOR         0.85%    
Securities Sold under Agreements to Repurchase [Member] | Repurchase Agreements [Member]              
Line of Credit Facility [Line Items]              
Short-term borrowings 30 $ 30       $ 0  
Revolving Credit Facilities due 2022 [Member]              
Line of Credit Facility [Line Items]              
Ratio of Indebtedness to Net Capital             0.60
Accounts and Notes Receivable [Member] | Securities Sold under Agreements to Repurchase [Member] | Repurchase Agreements [Member]              
Line of Credit Facility [Line Items]              
Pledged Financial Instruments, Not Separately Reported, Loans Receivable Pledged as Collateral $ 32            
Forecast [Member] | Revolving Credit Facilities due 2024 [Member]              
Line of Credit Facility [Line Items]              
Debt Instrument, Term       5 years      
Forecast [Member] | Revolving Credit Facilities due 2022 [Member]              
Line of Credit Facility [Line Items]              
Debt Instrument, Term     3 years        
XML 90 R76.htm IDEA: XBRL DOCUMENT v3.21.1
Commitments and Contingent Liabilities Guarantee Narrative (Details) - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Mar. 31, 2020
Guarantor Obligations [Line Items]      
Guarantee Obligations $ 108 $ 94 $ 90
Factoring Agreement [Member]      
Guarantor Obligations [Line Items]      
Guarantee Obligations 23 17 17
Agreements with lenders to provide financing for select customers [Member]      
Guarantor Obligations [Line Items]      
Accounts Receivable, after Allowance for Credit Loss $ 178 $ 16 $ 125
XML 91 R77.htm IDEA: XBRL DOCUMENT v3.21.1
Commitments and Contingent Liabilities Chemours (Details)
$ in Millions
3 Months Ended
Mar. 31, 2021
USD ($)
lawsuits
Dec. 31, 2017
USD ($)
lawsuits
Jun. 30, 2017
USD ($)
Dec. 31, 2028
USD ($)
Sep. 30, 2028
USD ($)
Sep. 30, 2022
USD ($)
PFAS [Member]            
Loss Contingencies [Line Items]            
Escrow Account Balance       $ 700.0    
PFAS [Member] | Maximum [Member]            
Loss Contingencies [Line Items]            
Cost Sharing Arrangement Term 20 years          
Qualified Spend and Escrow Account Contribution Threshold $ 4,000.0          
Corteva and DuPont stray liability threshold for PFAS $ 300.0          
PFOA Matters: Multi-District Litigation [Member]            
Loss Contingencies [Line Items]            
Litigation Settlement, Amount Awarded to Other Party   $ 670.7        
Lawsuits alleging personal injury filed | lawsuits   3,550        
PFOA Matters: Drinking Water Actions [Member] | WEST VIRGINIA AND OHIO [Domain] | Scheduled for trial [Member]            
Loss Contingencies [Line Items]            
Loss Contingency, Pending Claims, Number | lawsuits 96          
DuPont de Nemours [Member]            
Loss Contingencies [Line Items]            
Amount credited to each company's threshold $ 150.0          
Chemours [Member] | PFAS [Member]            
Loss Contingencies [Line Items]            
Annual Escrow Deposit           $ 100.0
Annual Escrow Deposit, remainder of period         $ 50.0  
Escrow Account Deposit Percentage 50.00%          
Chemours [Member] | PFAS [Member] | Maximum [Member]            
Loss Contingencies [Line Items]            
Total Escrow Deposit Amount         500.0  
Corteva [Member]            
Loss Contingencies [Line Items]            
Stray liability sharing percentage 29.00%          
Corteva [Member] | PFAS [Member]            
Loss Contingencies [Line Items]            
Stray liability sharing percentage for PFAS 50.00%          
Corteva [Member] | DuPont de Nemours [Member] | PFAS [Member]            
Loss Contingencies [Line Items]            
Stray liability sharing percentage for PFAS 50.00%          
Annual Escrow Deposit           $ 100.0
Annual Escrow Deposit, remainder of period         50.0  
Escrow Account Deposit Percentage 50.00%          
Corteva [Member] | DuPont de Nemours [Member] | PFAS [Member] | Maximum [Member]            
Loss Contingencies [Line Items]            
Qualified Spend and Escrow Account Contribution Threshold $ 2,000.0          
Total Escrow Deposit Amount         $ 500.0  
Corteva [Member] | DuPont de Nemours [Member] | PFOA Matters: Multi-District Litigation [Member]            
Loss Contingencies [Line Items]            
Litigation Settlement, Amount Awarded to Other Party     $ 335.0      
DuPont de Nemours [Member]            
Loss Contingencies [Line Items]            
Stray liability sharing percentage 71.00%          
DuPont de Nemours [Member] | PFAS [Member]            
Loss Contingencies [Line Items]            
Stray liability sharing percentage for PFAS 50.00%          
DuPont de Nemours [Member] | DuPont de Nemours [Member]            
Loss Contingencies [Line Items]            
Corteva and DuPont stray liability threshold for PFAS $ 200.0          
XML 92 R78.htm IDEA: XBRL DOCUMENT v3.21.1
Commitments and Contingent Liabilities DuPont (Details)
Mar. 31, 2021
USD ($)
PFAS [Member] | Minimum [Member]  
Loss Contingencies [Line Items]  
Corteva and DuPont stray liability threshold for PFAS $ 1
PFAS [Member] | Minimum [Member] | Once $300 million threshold is met [Member]  
Loss Contingencies [Line Items]  
De minimis threshold 1,000,000
PFAS [Member] | Maximum [Member]  
Loss Contingencies [Line Items]  
Corteva and DuPont stray liability threshold for PFAS 300,000,000
DuPont de Nemours [Member]  
Loss Contingencies [Line Items]  
Amount credited to each company's threshold $ 150,000,000
Corteva [Member]  
Loss Contingencies [Line Items]  
Stray liability sharing percentage 29.00%
Corteva [Member] | PFAS [Member]  
Loss Contingencies [Line Items]  
Stray liability sharing percentage for PFAS 50.00%
Corteva [Member] | DuPont de Nemours [Member]  
Loss Contingencies [Line Items]  
Stray liability threshold $ 200,000,000
Corteva [Member] | DuPont de Nemours [Member] | PFAS [Member]  
Loss Contingencies [Line Items]  
Stray liability sharing percentage for PFAS 50.00%
DuPont de Nemours [Member]  
Loss Contingencies [Line Items]  
Stray liability sharing percentage 71.00%
DuPont de Nemours [Member] | PFAS [Member]  
Loss Contingencies [Line Items]  
Stray liability sharing percentage for PFAS 50.00%
DuPont de Nemours [Member] | DuPont de Nemours [Member]  
Loss Contingencies [Line Items]  
Stray liability threshold $ 200,000,000
Corteva and DuPont stray liability threshold for PFAS $ 200,000,000
XML 93 R79.htm IDEA: XBRL DOCUMENT v3.21.1
Commitments and Contingent Liabilities PFOA / Leach Settlement (Details)
3 Months Ended 12 Months Ended 105 Months Ended
Mar. 31, 2021
USD ($)
lawsuits
Dec. 31, 2017
USD ($)
lawsuits
Dec. 31, 2004
USD ($)
Sep. 30, 2020
USD ($)
Jan. 01, 2012
MDL Settlement [Domain]          
Loss Contingencies [Line Items]          
Litigation Settlement, Amount Awarded to Other Party $ 83,000,000        
Chemours Contribution to MDL Settlement          
Loss Contingencies [Line Items]          
Litigation Settlement, Amount Awarded to Other Party 29,000,000        
DuPont de Nemours and Corteva Contribution to MDL Settlement          
Loss Contingencies [Line Items]          
Litigation Settlement, Amount Awarded to Other Party 27,000,000        
Payments for Legal Settlements 16,000,000        
PFOA Matters: Drinking Water Actions [Member]          
Loss Contingencies [Line Items]          
Binding Settlement Agreement Class Size     80,000    
Loss Contingency, Number Of Water Districts Receiving Water Treatment         6
Litigation Settlement, Liability For Medical Monitoring Program, Threshold     $ 235,000,000    
Litigation Settlement, Medical Monitoring Program, Escrow Account, Disbursements To Date       $ 2,000,000  
Escrow Balance $ 1,000,000        
PFOA Matters: Drinking Water Actions [Member] | WEST VIRGINIA AND OHIO [Domain] | Scheduled for trial [Member]          
Loss Contingencies [Line Items]          
Loss Contingency, Pending Claims, Number | lawsuits 96        
PFOA Matters: Drinking Water Actions [Member] | WEST VIRGINIA AND OHIO [Domain] | Settled Litigation          
Loss Contingencies [Line Items]          
Loss Contingency, Claims Settled, Number | lawsuits 95,000,000        
PFOA Matters: Drinking Water Actions [Member] | WEST VIRGINIA AND OHIO [Domain] | Compensatory damages [Member]          
Loss Contingencies [Line Items]          
Litigation Settlement, Amount Awarded to Other Party $ 40,000,000        
PFOA Matters: Drinking Water Actions [Member] | WEST VIRGINIA AND OHIO [Domain] | Loss of consortium [Member]          
Loss Contingencies [Line Items]          
Litigation Settlement, Amount Awarded to Other Party $ 10,000,000        
PFOA Matters: Multi-District Litigation [Member]          
Loss Contingencies [Line Items]          
Disease Categories for MDL 6        
Lawsuits alleging personal injury filed | lawsuits   3,550      
Litigation Settlement, Amount Awarded to Other Party   $ 670,700,000      
Chemours [Member] | PFOA Matters [Member]          
Loss Contingencies [Line Items]          
Indemnification Asset for liabilities indemnified by Chemours $ 16,000,000        
Indemnified Liabilities for liabilities indemnified by Chemours $ 21,000,000        
XML 94 R80.htm IDEA: XBRL DOCUMENT v3.21.1
Commitments and Contingent Liabilities Other PFOA Matters / Fayetteville (Details)
$ in Millions
3 Months Ended
Mar. 31, 2021
USD ($)
lawsuits
Dec. 31, 2020
USD ($)
Mar. 31, 2020
USD ($)
Loss Contingencies [Line Items]      
Guarantee Obligations | $ $ 108 $ 94 $ 90
Factoring Agreement [Member]      
Loss Contingencies [Line Items]      
Guarantee Obligations | $ $ 23 $ 17 $ 17
Firefighting Foam [Member]      
Loss Contingencies [Line Items]      
Loss Contingency, Pending Claims, Number 985    
Personal injury cases [Member] | Firefighting Foam [Member]      
Loss Contingencies [Line Items]      
Loss Contingency, Pending Claims, Number 910    
NEW YORK | PFOA Matters: Drinking Water Actions [Member]      
Loss Contingencies [Line Items]      
Loss Contingency, Pending Claims, Number 50    
NEW JERSEY | PFOA Matters: Drinking Water Actions [Member]      
Loss Contingencies [Line Items]      
Loss Contingency, Pending Claims, Number 2    
NEW JERSEY | Natural Resources Damages [Member]      
Loss Contingencies [Line Items]      
Loss Contingency, Pending Claims, Number 4    
OHIO | PFOA Matters: Drinking Water Actions [Member]      
Loss Contingencies [Line Items]      
Loss Contingency, Pending Claims, Number 3    
NORTH CAROLINA | PFOA Matters: Drinking Water Actions [Member]      
Loss Contingencies [Line Items]      
Loss Contingency, Number of Property Owners 100    
Loss Contingency, Number of Additional Plaintiffs 100    
Alabama Water Utility [Member] | Natural Resources Damages [Member]      
Loss Contingencies [Line Items]      
Loss Contingency, Pending Claims, Number 1    
XML 95 R81.htm IDEA: XBRL DOCUMENT v3.21.1
Commitments and Contingent Liabilities Environmental (Details)
$ in Millions
Mar. 31, 2021
USD ($)
Loss Contingencies [Line Items]  
Indemnification Asset $ 186
Accrual for Environmental Loss Contingencies 333 [1],[2]
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual 577 [2]
Performance Chemicals  
Loss Contingencies [Line Items]  
Indemnified Liabilities for Liabilities Indemnified by Corteva 54
Chemours related obligation subject to indemnification [Member]  
Loss Contingencies [Line Items]  
Indemnification Asset 152 [3],[4]
Accrual for Environmental Loss Contingencies 152 [1],[2],[3],[4]
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual 280 [2],[3],[4]
Discontinued Operations [Member]  
Loss Contingencies [Line Items]  
Indemnification Asset 0 [3]
Other discontinued or divested business obligations [Member]  
Loss Contingencies [Line Items]  
Accrual for Environmental Loss Contingencies 78 [1],[2],[3]
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual 177 [2],[3]
Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont [Member]  
Loss Contingencies [Line Items]  
Indemnification Asset 34 [4]
Accrual for Environmental Loss Contingencies 34 [1],[2],[4]
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual 65 [2],[4]
Not subject to indemnification [Member]  
Loss Contingencies [Line Items]  
Indemnification Asset 0
Accrual for Environmental Loss Contingencies 69 [1],[2]
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual 55 [2]
DuPont de Nemours [Member] | DuPont de Nemours [Member]  
Loss Contingencies [Line Items]  
Stray liability threshold 200
Superfund Sites [Member]  
Loss Contingencies [Line Items]  
Accrual for Environmental Loss Contingencies 56
Superfund Sites [Member] | Chemours [Member] | Indemnification Agreement [Member]  
Loss Contingencies [Line Items]  
Indemnification Asset $ 30
[1] Accrual balance excludes indemnification liabilities of $54 million to Chemours, related to the cost sharing arrangement under the MOU (see page 10).
[2] Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates
[3] Represents liabilities that are subject to the $200 million thresholds and sharing arrangements as discussed on page 22, under Corteva Separation Agreement.
[4] The company has recorded an indemnification asset related to these accruals, including $30 million related to the Superfund sites.
XML 96 R82.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders' Equity Common Stock (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Apr. 30, 2021
Dec. 31, 2020
Jun. 26, 2019
Class of Stock [Line Items]          
Common Stock, Par Value $ 0.01 $ 0.01 $ 0.01 $ 0.01  
Stock Repurchase Program, Authorized Amount         $ 1,000
Repurchase of Common Stock $ 350 $ 50      
Corteva [Member]          
Class of Stock [Line Items]          
Common Stock, Par Value $ 0.01       $ 0.01
Stock Repurchased and Retired During Period, Shares 7,646 1,865      
XML 97 R83.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders' Equity Preferred Stock (Details) - EID [Member] - USD ($)
3 Months Ended
Mar. 31, 2021
Dec. 31, 2020
Mar. 31, 2020
$4.50 Series Preferred Stock [Member]      
Class of Stock [Line Items]      
Preferred Stock, Shares Authorized 23,000,000 23,000,000 23,000,000
Preferred Stock, Shares Issued 1,673,000 1,673,000 1,673,000
Preferred Stock, Redemption Amount $ 120 $ 120 $ 120
$3.50 Series Preferred Stock [Member]      
Class of Stock [Line Items]      
Preferred Stock, Shares Authorized 23,000,000 23,000,000 23,000,000
Preferred Stock, Shares Issued 700,000 700,000 700,000
Preferred Stock, Redemption Amount $ 102 $ 102 $ 102
Corteva [Member]      
Class of Stock [Line Items]      
Ownership interest in an entity 100.00%    
XML 98 R84.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders' Equity Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Beginning Balance $ 25,063 $ 24,555    
Amounts Reclassified from Accumulated Other Comprehensive Loss (146) 7    
Other comprehensive (loss) income (477) (663)    
Ending Balance 24,778 24,079    
Accumulated Other Comprehensive Income (Loss), Net of Tax (3,367) (3,933) $ (2,890)  
Pension Plan        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax (4) (2)    
Amounts Reclassified from Accumulated Other Comprehensive Loss 12 2    
Other comprehensive (loss) income 8 0    
Accumulated Other Comprehensive Income (Loss), Net of Tax (1,425) (1,247) (1,433) $ (1,247)
Other Benefit Plans        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax 1 3    
Amounts Reclassified from Accumulated Other Comprehensive Loss (158) 0    
Other comprehensive (loss) income (157) 3    
Accumulated Other Comprehensive Income (Loss), Net of Tax 433 (78) 590 (81)
Cumulative Translation Adjustment        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax [1] (403) (672)    
Amounts Reclassified from Accumulated Other Comprehensive Loss 0 0    
Other comprehensive (loss) income (403) (672)    
Accumulated Other Comprehensive Income (Loss), Net of Tax (2,373) (2,616) (1,970) (1,944)
Derivative Instruments        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax 71 1    
Amounts Reclassified from Accumulated Other Comprehensive Loss (6) 5    
Other comprehensive (loss) income 65 6    
Accumulated Other Comprehensive Income (Loss), Net of Tax (2) 8 (67) 2
Unrealized Gain (loss) on Investments        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Beginning Balance (10) 0    
Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax 4 0    
Amounts Reclassified from Accumulated Other Comprehensive Loss [2] 6 0    
Other comprehensive (loss) income 10 0    
Ending Balance 0 0    
Total        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Beginning Balance (2,890) (3,270)    
Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax (331) (670)    
Amounts Reclassified from Accumulated Other Comprehensive Loss (146) 7    
Other comprehensive (loss) income (477) (663)    
Ending Balance (3,367) (3,933)    
Accumulated Other Comprehensive Income (Loss), Net of Tax $ (3,367) $ (3,933) $ (2,890) $ (3,270)
[1] The cumulative translation adjustment loss for the three months ended March 31, 2020 was primarily driven by the strengthening of the USD against the Brazilian Real (“BRL”) and the South African Rand ("ZAR"). The cumulative translation adjustment loss for the three months ended March 31, 2021 was primarily driven by strengthening of the USD against the Swiss Franc ("CHF"), Brazilian Real ("BRL") and European Euro.
[2] Reflected in other income - net.
XML 99 R85.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders' Equity Tax Benefit (Expense) on Net Activity (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Other Comprehensive Income (Loss), Tax Benefit (Expense) $ 29 $ 1
Pension Plan    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Other Comprehensive Income (Loss), Tax Benefit (Expense) (2) (4)
Other Benefit Plans    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Other Comprehensive Income (Loss), Tax Benefit (Expense) 49 0
Derivative Instruments    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Other Comprehensive Income (Loss), Tax Benefit (Expense) $ (18) $ 5
XML 100 R86.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders' Equity Reclassifications out of AOCI (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
Amounts Reclassified from Accumulated Other Comprehensive Loss $ (146) $ 7
Other Benefit Plans    
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
Amortization of Prior Service Benefit [1],[2] (230) 0
Pension Plan    
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
Amounts Reclassified from Accumulated Other Comprehensive Loss 12 2
Other Benefit Plans    
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
Amounts Reclassified from Accumulated Other Comprehensive Loss (158) 0
Derivative Instruments    
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax [3] (5) 7
Reclassification from Accumulated Other Comprehensive Loss, Current Period, Tax [4] (1) (2)
Amounts Reclassified from Accumulated Other Comprehensive Loss (6) 5
Actuarial (Gains) Losses | Pension Plan    
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax [1],[2] 14 1
Actuarial (Gains) Losses | Other Benefit Plans    
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax [1],[2] 23 0
Settlement Loss | Pension Plan    
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax [1],[2] 1 2
Accumulated Defined Benefit Plans Adjustment Attributable to Parent | Pension Plan    
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax 15 3
Reclassification from Accumulated Other Comprehensive Loss, Current Period, Tax [4] (3) (1)
Amounts Reclassified from Accumulated Other Comprehensive Loss 12 2
Accumulated Defined Benefit Plans Adjustment Attributable to Parent | Other Benefit Plans    
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax (207) 0
Reclassification from Accumulated Other Comprehensive Loss, Current Period, Tax [4] 49 0
Amounts Reclassified from Accumulated Other Comprehensive Loss (158) 0
Unrealized loss on investments    
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
Reclassification from Accumulated Other Comprehensive Loss, Current Period, Tax [4] 0 0
Amounts Reclassified from Accumulated Other Comprehensive Loss [1] $ 6 $ 0
[1] Reflected in other income - net.
[2] These accumulated other comprehensive (loss) income components are included in the computation of net periodic benefit credit of the company's pension and other benefit plans. See Note 15 - Pension Plans and Other Post Employment Benefits, for additional information.
[3] Reflected in cost of goods sold.
[4] Reflected in provision for (benefit from) income taxes from continuing operations.
XML 101 R87.htm IDEA: XBRL DOCUMENT v3.21.1
Pension Plans and Other Post Employment Benefit Plans Components of net periodic benefit cost (credit) (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Pension Plan    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Service Cost $ 7 $ 5
Interest Cost 91 141
Expected return on plan assets (230) (251)
Amortization of unrecognized loss (gain) 14 1
Settlement/Curtailment Loss (Gain) 1 2
Defined Benefit Plan, Net Periodic Benefit (Credit) Cost (117) (102)
Other Benefit Plans    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Service Cost 0 1
Interest Cost 6 16
Amortization of unrecognized loss (gain) 23 0
Amortization of Prior Service Benefit (230) 0
Defined Benefit Plan, Net Periodic Benefit (Credit) Cost $ (201) $ 17
XML 102 R88.htm IDEA: XBRL DOCUMENT v3.21.1
Financial Instruments Financial Instruments (Narrative) (Details) - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Mar. 31, 2020
Cash Equivalents [Member]      
Schedule of Held-to-maturity Securities [Line Items]      
Held-to-maturity securities $ 1,602 $ 2,511 $ 1,536
Available - for- sale securities 65 226  
Marketable Securities [Member]      
Schedule of Held-to-maturity Securities [Line Items]      
Held-to-maturity securities $ 49 $ 43 $ 10
XML 103 R89.htm IDEA: XBRL DOCUMENT v3.21.1
Financial Instruments Notional Amounts (Details) - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Mar. 31, 2020
Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member]      
Derivative Instruments, Gain (Loss) [Line Items]      
Derivative, Notional Amount $ 1,030 $ 1,164 $ 751
Designated as Hedging Instrument [Member] | Commodity Contract [Member]      
Derivative Instruments, Gain (Loss) [Line Items]      
Derivative, Notional Amount 239 383 418
Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member]      
Derivative Instruments, Gain (Loss) [Line Items]      
Derivative, Notional Amount 715 647 644
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member]      
Derivative Instruments, Gain (Loss) [Line Items]      
Derivative, Notional Amount $ 154 $ 0 $ 59
XML 104 R90.htm IDEA: XBRL DOCUMENT v3.21.1
Financial Instruments Cash Flow Hedges Included in AOCI (Details)
€ in Millions, $ in Millions
3 Months Ended
Mar. 31, 2021
USD ($)
Mar. 31, 2020
USD ($)
Mar. 31, 2021
EUR (€)
Dec. 31, 2020
USD ($)
Designated as Hedging Instrument [Member] | Commodity Contract [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Derivative, Remaining Maturity 2 years      
Beginning Balance $ (16) $ 2    
Additions and revaluations of derivatives designated as cash flow hedges 30 (22)    
Clearance of hedge results to earnings (4) 5    
Ending Balance 10 (15)    
After-tax net gain (loss) to be reclassified from AOCL into earnings over the next twelve months (8)      
Derivative, Notional Amount $ 239 418   $ 383
Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Derivative, Remaining Maturity 2 years      
Beginning Balance $ (17) 0    
Additions and revaluations of derivatives designated as cash flow hedges 25 16    
Clearance of hedge results to earnings (2) 0    
Ending Balance 6 16    
After-tax net gain (loss) to be reclassified from AOCL into earnings over the next twelve months 6      
Derivative, Notional Amount $ 1,030 $ 751   $ 1,164
Net Investment Hedging [Member] | Foreign Currency Contract [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Derivative, Notional Amount | €     € 450  
XML 105 R91.htm IDEA: XBRL DOCUMENT v3.21.1
Financial Instruments Fair Value of Derivatives (Details) - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Mar. 31, 2020
Derivative Instruments, Gain (Loss) [Line Items]      
Derivative Asset, Gross $ 90 $ 55 $ 266
Derivative Asset, Counterparty and Cash Collateral Netting [1] (32) (40) (110)
Derivative Asset, Net 58 15 156
Derivative Liability, Gross 62 135 108
Derivative Liability, Counterparty and Cash Collateral Netting [1] (30) (40) (103)
Derivative Liability, Net 32 95 5
Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Other Current Assets [Member]      
Derivative Instruments, Gain (Loss) [Line Items]      
Derivative Asset, Gross 38 15 36
Derivative Asset, Counterparty and Cash Collateral Netting [1] 0 0 0
Derivative Asset, Net 38 15 36
Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Accrued and Other Current Liabilities [Member]      
Derivative Instruments, Gain (Loss) [Line Items]      
Derivative Liability, Gross 16 38  
Derivative Liability, Counterparty and Cash Collateral Netting [1] 0 0  
Derivative Liability, Net 16 38  
Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Other Current Assets [Member]      
Derivative Instruments, Gain (Loss) [Line Items]      
Derivative Asset, Gross 52 40 230
Derivative Asset, Counterparty and Cash Collateral Netting [1] (32) (40) (110)
Derivative Asset, Net 20 0 120
Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Accrued and Other Current Liabilities [Member]      
Derivative Instruments, Gain (Loss) [Line Items]      
Derivative Liability, Gross 46 97 108
Derivative Liability, Counterparty and Cash Collateral Netting [1] (30) (40) (103)
Derivative Liability, Net $ 16 $ 57 $ 5
[1] Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.
XML 106 R92.htm IDEA: XBRL DOCUMENT v3.21.1
Financial Instruments Effect of Derivative Instruments (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (Loss) on Derivative Instruments, Net, Pretax [1] $ 11 $ 167
Designated as Hedging Instrument [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of (loss) gain recognized in OCI- Pre Tax [2] 88 (6)
Amount of gain (loss) recognized in Income - Pre-tax [1] 5 (7)
Designated as Hedging Instrument [Member] | Net Investment Hedging [Member] | Foreign Currency Contract [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of (loss) gain recognized in OCI- Pre Tax [2] 21 9
Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Foreign Currency Contract [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of (loss) gain recognized in OCI- Pre Tax [2] 31 19
Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Foreign Currency Contract [Member] | Cost of Goods Sold    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of gain (loss) recognized in Income - Pre-tax [1],[3] 1 0
Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Commodity Contract [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of (loss) gain recognized in OCI- Pre Tax [2] 36 (34)
Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Commodity Contract [Member] | Cost of Goods Sold    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of gain (loss) recognized in Income - Pre-tax [1],[3] 4 (7)
Not Designated as Hedging Instrument [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of gain (loss) recognized in income - pre-tax [1] 6 174
Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Cost of Goods Sold    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of gain (loss) recognized in income - pre-tax [1],[3] 2 0
Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Other Income - net    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of gain (loss) recognized in income - pre-tax [1],[4] 16 165
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Cost of Goods Sold    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of gain (loss) recognized in income - pre-tax [1],[3] $ (12) $ 9
[1] For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period.
[2] OCI is defined as other comprehensive income (loss).
[3] Recorded in cost of goods sold.
[4] Gain recognized in other income (expense) - net was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 6 - Supplementary Information, for additional information.
XML 107 R93.htm IDEA: XBRL DOCUMENT v3.21.1
Financial Instruments Contractual Maturities of Debt Securities (Details)
$ in Millions
Mar. 31, 2021
USD ($)
Debt Securities, Available-for-sale [Line Items]  
Debt Securities, Available-for-Sale with contractual maturities within one to five years $ 65
XML 108 R94.htm IDEA: XBRL DOCUMENT v3.21.1
Financial Instruments- AFS Investing Results (Details) - Available-for-sale Securities
$ in Millions
3 Months Ended
Mar. 31, 2021
USD ($)
Debt Securities, Available-for-sale [Line Items]  
Proceeds from sales of available-for-sale securities $ 161
Gross realized losses (6)
Total $ 155
XML 109 R95.htm IDEA: XBRL DOCUMENT v3.21.1
Financial Instruments- Debt Securities- Gross Unrealized Losses Aggregated by Investment Category (Details) - US Treasury Securities
$ in Millions
Mar. 31, 2021
USD ($)
Debt Securities, Available-for-sale [Line Items]  
Fair Value, 12 Months or Longer $ 65
Gross Unrealized Losses, 12 Months or Longer $ 0
XML 110 R96.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements (Details) - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Mar. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]      
Derivative Asset $ 90 $ 55 $ 266
Derivative Liability 62 135 108
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1      
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]      
Assets at Fair Value 65 226  
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 | US Treasury Securities      
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]      
Debt Securities, Available-for-sale [1] 65 226  
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]      
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]      
Assets at Fair Value 139 98 276
Liabilities at Fair Value 62 135 108
Marketable Securities 49 43 10
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Foreign Currency Contract [Member]      
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]      
Derivative Asset [2] 90 55 266
Derivative Liability [2] $ 62 $ 135 $ 108
[1] The company's investments in debt securities, which are available-for-sale, are included in "marketable securities" in the interim Condensed Consolidated Balance Sheets
[2] See Note 16 - Financial Instruments for the classification of derivatives in the interim Condensed Consolidated Balance Sheets.
XML 111 R97.htm IDEA: XBRL DOCUMENT v3.21.1
Segment Reporting Segment Information (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Segment Reporting Information [Line Items]      
Net Sales $ 4,178 $ 3,956  
Segment operating EBITDA 938 819  
Segment Assets 38,148 39,108 $ 36,850
Seed [Member]      
Segment Reporting Information [Line Items]      
Net Sales 2,492 2,455  
Segment operating EBITDA 617 581  
Segment Assets 24,799 [1] 25,857 [1] 23,751
Crop Protection [Member]      
Segment Reporting Information [Line Items]      
Net Sales 1,686 1,501  
Segment operating EBITDA 321 238  
Segment Assets $ 13,349 [1] $ 13,251 [1] $ 13,099
[1] Segment assets at December 31, 2020 were $23,751 million and $13,099 million for Seed and Crop Protection, respectively.
XML 112 R98.htm IDEA: XBRL DOCUMENT v3.21.1
Segment Reporting Segment Reconciliation (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Segment Reporting Information [Line Items]    
Income (loss) from continuing operations after income taxes $ 613 $ 281
Provision for income taxes on continuing operations 178 127
Income from continuing operations before income taxes 791 408
Interest income 21 18
Interest Expense 7 10
Exchange (gains) losses - net [1] (35) (61)
Significant Items 100 123
Corporate Expenses 34 25
Segment operating EBITDA 938 819
Non-operating pension and other post employment benefit credit [2] 325 91
Segment Reconciling Items [Member]    
Segment Reporting Information [Line Items]    
Depreciation and Amortization 304 283
Interest income (21) (18)
Exchange (gains) losses - net 35 61
Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges [3] (1)  
Significant Items (100) (123)
Non-operating pension and other post employment benefit credit $ (311) $ (73)
[1] Includes net pre-tax exchange losses of $(23) million and $(9) million associated with the devaluation of the Argentine peso for the three months ended March 31, 2021 and 2020, respectively.
[2] Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement loss).
[3] Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There was no activity in the three months ended March 31, 2020. Refer to page 48 for further discussion of the company’s Non-GAAP financial measures.
XML 113 R99.htm IDEA: XBRL DOCUMENT v3.21.1
Segment Reporting Segment Asset Reconciliation (Details) - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Mar. 31, 2020
Segment Reporting [Abstract]      
Segment Assets $ 38,148 $ 36,850 $ 39,108
Corporate Assets 4,401 5,799 3,870
Total Assets $ 42,549 $ 42,649 $ 42,978
XML 114 R100.htm IDEA: XBRL DOCUMENT v3.21.1
Segment Reporting Significant Items (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Segment Reporting Information [Line Items]    
Restructuring and Asset related charges, net $ 100 $ 70
Significant Items 100 123
Net exchange gains (losses) [1] (35) (61)
Hedging Program [Member]    
Segment Reporting Information [Line Items]    
Net exchange gains (losses) 16 165
Argentine Peso Devaluation [Member] | Hedging Program [Member]    
Segment Reporting Information [Line Items]    
Net exchange gains (losses) (23) (9)
Segment Reconciling Items [Member]    
Segment Reporting Information [Line Items]    
Restructuring and Asset related charges, net [2] (100) (70)
Significant Items (100) (123)
Net exchange gains (losses) 35 61
Segment Reconciling Items [Member] | La Porte [Member]    
Segment Reporting Information [Line Items]    
Loss on Divestiture [3]   (53)
Segment Reconciling Items [Member] | Seed [Member]    
Segment Reporting Information [Line Items]    
Restructuring and Asset related charges, net [2] (21) (10)
Significant Items (21) (10)
Segment Reconciling Items [Member] | Crop Protection [Member]    
Segment Reporting Information [Line Items]    
Restructuring and Asset related charges, net [2] (32) (18)
Loss on Divestiture (53)  
Significant Items (32) (71)
Segment Reconciling Items [Member] | Crop Protection [Member] | La Porte [Member]    
Segment Reporting Information [Line Items]    
Loss on Divestiture [3]   (53)
Segment Reconciling Items [Member] | Corporate    
Segment Reporting Information [Line Items]    
Restructuring and Asset related charges, net [2] (47) (42)
Significant Items $ (47) $ (42)
[1] Includes net pre-tax exchange losses of $(23) million and $(9) million associated with the devaluation of the Argentine peso for the three months ended March 31, 2021 and 2020, respectively.
[2] Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements for additional information.
[3] Includes a loss recorded in other income - net related to the sale of the La Porte site.
XML 115 R101.htm IDEA: XBRL DOCUMENT v3.21.1
EID - Basis of Presentation Narrative (Details) - $ / shares
3 Months Ended
Mar. 31, 2021
Apr. 30, 2021
Dec. 31, 2020
Mar. 31, 2020
Jun. 26, 2019
EID [Member]          
Common Stock, Shares, Outstanding 200   200 200  
Common Stock, Par Value $ 0.30 $ 0.30 $ 0.30 $ 0.30  
Common Stock, Shares, Outstanding 738,321,000   743,458,000 748,369,000  
Common Stock, Par Value $ 0.01 $ 0.01 $ 0.01 $ 0.01  
Corteva [Member] | EID [Member]          
Ownership interest in an entity 100.00%        
Corteva [Member]          
Common Stock, Par Value $ 0.01       $ 0.01
XML 116 R102.htm IDEA: XBRL DOCUMENT v3.21.1
EID - Related Party Transactions (Details) - EID [Member] - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Related Party Transaction [Line Items]      
Long Term Debt - Related Party $ 3,012 $ 3,872 $ 3,459
Corteva [Member]      
Related Party Transaction [Line Items]      
Debt, Weighted Average Interest Rate 1.62% 3.27% 1.62%
Interest Expense, Related Party $ 15 $ 32  
Corteva [Member] | Accrued and Other Current Liabilities [Member]      
Related Party Transaction [Line Items]      
CTVA Related Party Liability 55 166 $ 92
Corteva [Member] | Other noncurrent obligations      
Related Party Transaction [Line Items]      
CTVA Related Party Liability $ 91 $ 82 $ 92
XML 117 R103.htm IDEA: XBRL DOCUMENT v3.21.1
EID Segment FN Segment reconciliation (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Segment Reporting Information [Line Items]    
Provision for income taxes on continuing operations $ 178 $ 127
Income from continuing operations before income taxes 791 408
Interest income 21 18
Interest Expense 7 10
Exchange (gains) losses - net [1] (35) (61)
Significant Items 100 123
Corporate Expenses 34 25
Segment operating EBITDA 938 819
EID [Member]    
Segment Reporting Information [Line Items]    
Income from Continuing Operations After Taxes 602 257
Provision for income taxes on continuing operations 174 119
Income from continuing operations before income taxes 776 376
Depreciation and Amortization 304 283
Interest Expense 22 42
Non-operating benefits - net (311) (73)
Significant Items 100 123
Corporate Expenses 34 25
Segment operating EBITDA 938 819
Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges [2] (1)  
Segment Reconciling Items [Member]    
Segment Reporting Information [Line Items]    
Depreciation and Amortization 304 283
Interest income (21) (18)
Exchange (gains) losses - net 35 61
Significant Items (100) (123)
Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges [3] (1)  
Segment Reconciling Items [Member] | EID [Member]    
Segment Reporting Information [Line Items]    
Interest income (21) (18)
Exchange (gains) losses - net 35 61
Hedging Program [Member]    
Segment Reporting Information [Line Items]    
Exchange (gains) losses - net 16 165
Hedging Program [Member] | Argentine Peso Devaluation [Member]    
Segment Reporting Information [Line Items]    
Exchange (gains) losses - net (23) (9)
Corporate | Segment Reconciling Items [Member]    
Segment Reporting Information [Line Items]    
Significant Items (47) (42)
Crop Protection [Member]    
Segment Reporting Information [Line Items]    
Segment operating EBITDA 321 238
Crop Protection [Member] | Segment Reconciling Items [Member]    
Segment Reporting Information [Line Items]    
Significant Items $ (32) $ (71)
[1] Includes net pre-tax exchange losses of $(23) million and $(9) million associated with the devaluation of the Argentine peso for the three months ended March 31, 2021 and 2020, respectively.
[2] Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There was no activity in the three months ended March 31, 2020.
[3] Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There was no activity in the three months ended March 31, 2020. Refer to page 48 for further discussion of the company’s Non-GAAP financial measures.
XML 118 R104.htm IDEA: XBRL DOCUMENT v3.21.1
EID Segment FN Segment Asset Reconciliation (Details) - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Mar. 31, 2020
EID [Member]      
Segment Reporting Information [Line Items]      
Total Assets $ 42,549 $ 42,649 $ 42,978
Segment Assets 38,148 36,850 39,108
Corporate Assets 4,401 5,799 3,870
Total Assets $ 42,549 $ 42,649 $ 42,978
EXCEL 119 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 121 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 122 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 468 431 1 true 136 0 false 6 false false R1.htm 000010001 - Document - DEI Document Sheet http://www.dupont.com/role/DEIDocument DEI Document Cover 1 false false R2.htm 100010002 - Statement - Consolidated Statements of Operations Sheet http://www.dupont.com/role/ConsolidatedStatementsofOperations Consolidated Statements of Operations Statements 2 false false R3.htm 100020003 - Statement - Consolidated Statements of Comprehensive (Loss) Income Sheet http://www.dupont.com/role/ConsolidatedStatementsofComprehensiveLossIncome Consolidated Statements of Comprehensive (Loss) Income Statements 3 false false R4.htm 100030004 - Statement - Consolidated Balance Sheets Sheet http://www.dupont.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 4 false false R5.htm 100040005 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.dupont.com/role/ConsolidatedBalanceSheetsParentheticals Consolidated Balance Sheets (Parentheticals) Statements 5 false false R6.htm 100050006 - Statement - Consolidated Statements of Cash Flows Sheet http://www.dupont.com/role/ConsolidatedStatementsofCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 100060007 - Statement - Statement of Stockholders Equity Statement Sheet http://www.dupont.com/role/StatementofStockholdersEquityStatement Statement of Stockholders Equity Statement Statements 7 false false R8.htm 100070008 - Statement - Statement of Stockholders' Equity Parentheticals (Parentheticals) Sheet http://www.dupont.com/role/StatementofStockholdersEquityParentheticalsParentheticals Statement of Stockholders' Equity Parentheticals (Parentheticals) Statements 8 false false R9.htm 210011001 - Disclosure - Summary of Significant Accounting Policies (Notes) Notes http://www.dupont.com/role/SummaryofSignificantAccountingPoliciesNotes Summary of Significant Accounting Policies (Notes) Notes 9 false false R10.htm 210041002 - Disclosure - Recent Accounting Guidance Sheet http://www.dupont.com/role/RecentAccountingGuidance Recent Accounting Guidance Notes 10 false false R11.htm 210061003 - Disclosure - Divestitures and Other Transactions Sheet http://www.dupont.com/role/DivestituresandOtherTransactions Divestitures and Other Transactions Notes 11 false false R12.htm 210111004 - Disclosure - Revenue (Notes) Notes http://www.dupont.com/role/RevenueNotes Revenue (Notes) Notes 12 false false R13.htm 210261007 - Disclosure - Supplementary Information Sheet http://www.dupont.com/role/SupplementaryInformation Supplementary Information Notes 13 false false R14.htm 210311008 - Disclosure - Income Taxes Sheet http://www.dupont.com/role/IncomeTaxes Income Taxes Notes 14 false false R15.htm 210341009 - Disclosure - Earnings Per Share (Notes) Notes http://www.dupont.com/role/EarningsPerShareNotes Earnings Per Share (Notes) Notes 15 false false R16.htm 210411010 - Disclosure - Accounts and Notes Receivable (Notes) Notes http://www.dupont.com/role/AccountsandNotesReceivableNotes Accounts and Notes Receivable (Notes) Notes 16 false false R17.htm 210451011 - Disclosure - Inventories Sheet http://www.dupont.com/role/Inventories Inventories Notes 17 false false R18.htm 210521013 - Disclosure - Other Intangible Assets Sheet http://www.dupont.com/role/OtherIntangibleAssets Other Intangible Assets Notes 18 false false R19.htm 210561014 - Disclosure - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Sheet http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilities Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Notes 19 false false R20.htm 210611015 - Disclosure - Commitments and Contingent Liabilities Sheet http://www.dupont.com/role/CommitmentsandContingentLiabilities Commitments and Contingent Liabilities Notes 20 false false R21.htm 210691016 - Disclosure - Stockholders' Equity Sheet http://www.dupont.com/role/StockholdersEquity Stockholders' Equity Notes 21 false false R22.htm 210771017 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Sheet http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlans Pension Plans and Other Post Employment Benefit Plans Notes 22 false false R23.htm 210801018 - Disclosure - Financial Instruments Sheet http://www.dupont.com/role/FinancialInstruments Financial Instruments Notes 23 false false R24.htm 210901019 - Disclosure - Fair Value Measurements Sheet http://www.dupont.com/role/FairValueMeasurements Fair Value Measurements Notes 24 false false R25.htm 210931020 - Disclosure - Segment Reporting (Notes) Notes http://www.dupont.com/role/SegmentReportingNotes Segment Reporting (Notes) Notes 25 false false R26.htm 210991021 - Disclosure - EID - Basis of Presentation (Notes) Notes http://www.dupont.com/role/EIDBasisofPresentationNotes EID - Basis of Presentation (Notes) Notes 26 false false R27.htm 211011022 - Disclosure - EID - Related Party Transactions (Notes) Notes http://www.dupont.com/role/EIDRelatedPartyTransactionsNotes EID - Related Party Transactions (Notes) Notes 27 false false R28.htm 211031023 - Disclosure - EID Segment FN (Notes) Notes http://www.dupont.com/role/EIDSegmentFNNotes EID Segment FN (Notes) Notes 28 false false R29.htm 220022001 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.dupont.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.dupont.com/role/SummaryofSignificantAccountingPoliciesNotes 29 false false R30.htm 220052002 - Disclosure - Recent Accounting Guidance Recent Accounting Guidance (Policies) Sheet http://www.dupont.com/role/RecentAccountingGuidanceRecentAccountingGuidancePolicies Recent Accounting Guidance Recent Accounting Guidance (Policies) Policies http://www.dupont.com/role/SummaryofSignificantAccountingPoliciesNotes 30 false false R31.htm 220122003 - Disclosure - Revenue Revenue Recognition (Policies) Sheet http://www.dupont.com/role/RevenueRevenueRecognitionPolicies Revenue Revenue Recognition (Policies) Policies http://www.dupont.com/role/SummaryofSignificantAccountingPoliciesNotes 31 false false R32.htm 230133002 - Disclosure - Revenue (Tables) Sheet http://www.dupont.com/role/RevenueTables Revenue (Tables) Tables http://www.dupont.com/role/RevenueNotes 32 false false R33.htm 230183003 - Disclosure - Restructuring and Asset Related Charges (Tables) Sheet http://www.dupont.com/role/RestructuringandAssetRelatedChargesTables Restructuring and Asset Related Charges (Tables) Tables 33 false false R34.htm 230273004 - Disclosure - Supplementary Information (Tables) Sheet http://www.dupont.com/role/SupplementaryInformationTables Supplementary Information (Tables) Tables http://www.dupont.com/role/SupplementaryInformation 34 false false R35.htm 230353005 - Disclosure - Earnings Per Share (Tables) Sheet http://www.dupont.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.dupont.com/role/EarningsPerShareNotes 35 false false R36.htm 230423006 - Disclosure - Accounts and Notes Receivable (Tables) Notes http://www.dupont.com/role/AccountsandNotesReceivableTables Accounts and Notes Receivable (Tables) Tables http://www.dupont.com/role/AccountsandNotesReceivableNotes 36 false false R37.htm 230463007 - Disclosure - Inventories (Tables) Sheet http://www.dupont.com/role/InventoriesTables Inventories (Tables) Tables http://www.dupont.com/role/Inventories 37 false false R38.htm 230533009 - Disclosure - Other Intangible Assets (Tables) Sheet http://www.dupont.com/role/OtherIntangibleAssetsTables Other Intangible Assets (Tables) Tables http://www.dupont.com/role/OtherIntangibleAssets 38 false false R39.htm 230573010 - Disclosure - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Debt (Tables) Sheet http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesDebtTables Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Debt (Tables) Tables http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilities 39 false false R40.htm 230623011 - Disclosure - Commitments and Contingent Liabilities (Tables) Sheet http://www.dupont.com/role/CommitmentsandContingentLiabilitiesTables Commitments and Contingent Liabilities (Tables) Tables http://www.dupont.com/role/CommitmentsandContingentLiabilities 40 false false R41.htm 230703012 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.dupont.com/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.dupont.com/role/StockholdersEquity 41 false false R42.htm 230783013 - Disclosure - Pension Plans and Other Post Employment Benefit Plans (Tables) Sheet http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTables Pension Plans and Other Post Employment Benefit Plans (Tables) Tables http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlans 42 false false R43.htm 230813014 - Disclosure - Financial Instruments (Tables) Sheet http://www.dupont.com/role/FinancialInstrumentsTables Financial Instruments (Tables) Tables http://www.dupont.com/role/FinancialInstruments 43 false false R44.htm 230913015 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.dupont.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.dupont.com/role/FairValueMeasurements 44 false false R45.htm 230943016 - Disclosure - Segment Reporting (Tables) Sheet http://www.dupont.com/role/SegmentReportingTables Segment Reporting (Tables) Tables http://www.dupont.com/role/SegmentReportingNotes 45 false false R46.htm 231043017 - Disclosure - EID Segment FN (Tables) Sheet http://www.dupont.com/role/EIDSegmentFNTables EID Segment FN (Tables) Tables http://www.dupont.com/role/EIDSegmentFNNotes 46 false false R47.htm 240034001 - Disclosure - Summary of Significant Accounting Policies Summary of Accounting Policies (Details) Sheet http://www.dupont.com/role/SummaryofSignificantAccountingPoliciesSummaryofAccountingPoliciesDetails Summary of Significant Accounting Policies Summary of Accounting Policies (Details) Details 47 false false R48.htm 240084002 - Disclosure - Divestitures and Other Transactions Separation Agreements (Details) Sheet http://www.dupont.com/role/DivestituresandOtherTransactionsSeparationAgreementsDetails Divestitures and Other Transactions Separation Agreements (Details) Details 48 false false R49.htm 240094003 - Disclosure - Divestitures and Other Transactions Other Discontinued Operations (Details) Sheet http://www.dupont.com/role/DivestituresandOtherTransactionsOtherDiscontinuedOperationsDetails Divestitures and Other Transactions Other Discontinued Operations (Details) Details 49 false false R50.htm 240104004 - Disclosure - Divestitures and Other Transactions - PChem Results of Operations (Details) Sheet http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails Divestitures and Other Transactions - PChem Results of Operations (Details) Details 50 false false R51.htm 240144005 - Disclosure - Revenue Narrative (Details) Sheet http://www.dupont.com/role/RevenueNarrativeDetails Revenue Narrative (Details) Details 51 false false R52.htm 240154006 - Disclosure - Revenue Contract Balances (Details) Sheet http://www.dupont.com/role/RevenueContractBalancesDetails Revenue Contract Balances (Details) Details 52 false false R53.htm 240164007 - Disclosure - Revenue Disaggregation of Revenue - Principal Product Groups (Details) Sheet http://www.dupont.com/role/RevenueDisaggregationofRevenuePrincipalProductGroupsDetails Revenue Disaggregation of Revenue - Principal Product Groups (Details) Details 53 false false R54.htm 240174008 - Disclosure - Revenue Disaggregation of Revenue - Geography (Details) Sheet http://www.dupont.com/role/RevenueDisaggregationofRevenueGeographyDetails Revenue Disaggregation of Revenue - Geography (Details) Details 54 false false R55.htm 240194009 - Disclosure - Restructuring and Asset Related Charges - 2021 Restructuring Activities (Details) Sheet http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails Restructuring and Asset Related Charges - 2021 Restructuring Activities (Details) Details 55 false false R56.htm 240204010 - Disclosure - Restructuring and Asset Related Charges Execute to Win Productivity Program (Details) Sheet http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails Restructuring and Asset Related Charges Execute to Win Productivity Program (Details) Details 56 false false R57.htm 240214011 - Disclosure - Restructuring and Asset Related Charges Narrative (Details) Sheet http://www.dupont.com/role/RestructuringandAssetRelatedChargesNarrativeDetails Restructuring and Asset Related Charges Narrative (Details) Details 57 false false R58.htm 240244012 - Disclosure - Related Party Transactions Dow Intercompany Transactions (Details) Sheet http://www.dupont.com/role/RelatedPartyTransactionsDowIntercompanyTransactionsDetails Related Party Transactions Dow Intercompany Transactions (Details) Details 58 false false R59.htm 240284014 - Disclosure - Supplementary Information Other Income (Expense) - Net (Details) Sheet http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails Supplementary Information Other Income (Expense) - Net (Details) Details 59 false false R60.htm 240294015 - Disclosure - Supplementary Information Foreign Currency Exchange Gain (Loss) (Details) Sheet http://www.dupont.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails Supplementary Information Foreign Currency Exchange Gain (Loss) (Details) Details 60 false false R61.htm 240304016 - Disclosure - Supplementary Information Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) Sheet http://www.dupont.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails Supplementary Information Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) Details 61 false false R62.htm 240324017 - Disclosure - Income Taxes Income Tax Narrative (Details) Sheet http://www.dupont.com/role/IncomeTaxesIncomeTaxNarrativeDetails Income Taxes Income Tax Narrative (Details) Details 62 false false R63.htm 240374020 - Disclosure - Earnings Per Share Net Income for Earnings Per Share Calculations - Basic and Diluted (Details) Sheet http://www.dupont.com/role/EarningsPerShareNetIncomeforEarningsPerShareCalculationsBasicandDilutedDetails Earnings Per Share Net Income for Earnings Per Share Calculations - Basic and Diluted (Details) Details 63 false false R64.htm 240384021 - Disclosure - Earnings Per Share Earnings Per Share Calculations - Basic (Details) Sheet http://www.dupont.com/role/EarningsPerShareEarningsPerShareCalculationsBasicDetails Earnings Per Share Earnings Per Share Calculations - Basic (Details) Details 64 false false R65.htm 240394022 - Disclosure - Earnings Per Share Earnings Per Share Calculations - Diluted (Details) Sheet http://www.dupont.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails Earnings Per Share Earnings Per Share Calculations - Diluted (Details) Details 65 false false R66.htm 240404023 - Disclosure - Earnings Per Share Share Count Information (Details) Sheet http://www.dupont.com/role/EarningsPerShareShareCountInformationDetails Earnings Per Share Share Count Information (Details) Details 66 false false R67.htm 240434024 - Disclosure - Accounts and Notes Receivable (Details) Notes http://www.dupont.com/role/AccountsandNotesReceivableDetails Accounts and Notes Receivable (Details) Details http://www.dupont.com/role/AccountsandNotesReceivableTables 67 false false R68.htm 240444025 - Disclosure - Accounts and Notes Receivable Allowance Rollforward (Details) Notes http://www.dupont.com/role/AccountsandNotesReceivableAllowanceRollforwardDetails Accounts and Notes Receivable Allowance Rollforward (Details) Details 68 false false R69.htm 240474026 - Disclosure - Inventories Schedule of Inventory (Details) Sheet http://www.dupont.com/role/InventoriesScheduleofInventoryDetails Inventories Schedule of Inventory (Details) Details 69 false false R70.htm 240504027 - Disclosure - Property, Plant and Equipment Schedule of Property, Plant and Equipment (Details) Sheet http://www.dupont.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails Property, Plant and Equipment Schedule of Property, Plant and Equipment (Details) Details 70 false false R71.htm 240544029 - Disclosure - Other Intangible Assets Other Intangible Assets (Details) Sheet http://www.dupont.com/role/OtherIntangibleAssetsOtherIntangibleAssetsDetails Other Intangible Assets Other Intangible Assets (Details) Details 71 false false R72.htm 240554030 - Disclosure - Other Intangible Assets Future Amortization Expense (Details) Sheet http://www.dupont.com/role/OtherIntangibleAssetsFutureAmortizationExpenseDetails Other Intangible Assets Future Amortization Expense (Details) Details 72 false false R73.htm 240584031 - Disclosure - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Short-term borrowings and finance lease obligations (Details) Sheet http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Short-term borrowings and finance lease obligations (Details) Details 73 false false R74.htm 240594032 - Disclosure - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Long-term Debt (Details) Sheet http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Long-term Debt (Details) Details http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesDebtTables 74 false false R75.htm 240604033 - Disclosure - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Repurchase Facility and Revolving Credit Facilities (Details) Sheet http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Repurchase Facility and Revolving Credit Facilities (Details) Details 75 false false R76.htm 240634034 - Disclosure - Commitments and Contingent Liabilities Guarantee Narrative (Details) Sheet http://www.dupont.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails Commitments and Contingent Liabilities Guarantee Narrative (Details) Details 76 false false R77.htm 240644035 - Disclosure - Commitments and Contingent Liabilities Chemours (Details) Sheet http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails Commitments and Contingent Liabilities Chemours (Details) Details http://www.dupont.com/role/CommitmentsandContingentLiabilitiesTables 77 false false R78.htm 240654036 - Disclosure - Commitments and Contingent Liabilities DuPont (Details) Sheet http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails Commitments and Contingent Liabilities DuPont (Details) Details http://www.dupont.com/role/CommitmentsandContingentLiabilitiesTables 78 false false R79.htm 240664037 - Disclosure - Commitments and Contingent Liabilities PFOA / Leach Settlement (Details) Sheet http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails Commitments and Contingent Liabilities PFOA / Leach Settlement (Details) Details 79 false false R80.htm 240674038 - Disclosure - Commitments and Contingent Liabilities Other PFOA Matters / Fayetteville (Details) Sheet http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails Commitments and Contingent Liabilities Other PFOA Matters / Fayetteville (Details) Details 80 false false R81.htm 240684039 - Disclosure - Commitments and Contingent Liabilities Environmental (Details) Sheet http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails Commitments and Contingent Liabilities Environmental (Details) Details 81 false false R82.htm 240714040 - Disclosure - Stockholders' Equity Common Stock (Details) Sheet http://www.dupont.com/role/StockholdersEquityCommonStockDetails Stockholders' Equity Common Stock (Details) Details 82 false false R83.htm 240734042 - Disclosure - Stockholders' Equity Preferred Stock (Details) Sheet http://www.dupont.com/role/StockholdersEquityPreferredStockDetails Stockholders' Equity Preferred Stock (Details) Details 83 false false R84.htm 240744043 - Disclosure - Stockholders' Equity Other Comprehensive Income (Loss) (Details) Sheet http://www.dupont.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails Stockholders' Equity Other Comprehensive Income (Loss) (Details) Details 84 false false R85.htm 240754044 - Disclosure - Stockholders' Equity Tax Benefit (Expense) on Net Activity (Details) Sheet http://www.dupont.com/role/StockholdersEquityTaxBenefitExpenseonNetActivityDetails Stockholders' Equity Tax Benefit (Expense) on Net Activity (Details) Details 85 false false R86.htm 240764045 - Disclosure - Stockholders' Equity Reclassifications out of AOCI (Details) Sheet http://www.dupont.com/role/StockholdersEquityReclassificationsoutofAOCIDetails Stockholders' Equity Reclassifications out of AOCI (Details) Details 86 false false R87.htm 240794046 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Components of net periodic benefit cost (credit) (Details) Sheet http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditDetails Pension Plans and Other Post Employment Benefit Plans Components of net periodic benefit cost (credit) (Details) Details 87 false false R88.htm 240824047 - Disclosure - Financial Instruments Financial Instruments (Narrative) (Details) Sheet http://www.dupont.com/role/FinancialInstrumentsFinancialInstrumentsNarrativeDetails Financial Instruments Financial Instruments (Narrative) (Details) Details 88 false false R89.htm 240834048 - Disclosure - Financial Instruments Notional Amounts (Details) Sheet http://www.dupont.com/role/FinancialInstrumentsNotionalAmountsDetails Financial Instruments Notional Amounts (Details) Details 89 false false R90.htm 240844049 - Disclosure - Financial Instruments Cash Flow Hedges Included in AOCI (Details) Sheet http://www.dupont.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails Financial Instruments Cash Flow Hedges Included in AOCI (Details) Details 90 false false R91.htm 240854050 - Disclosure - Financial Instruments Fair Value of Derivatives (Details) Sheet http://www.dupont.com/role/FinancialInstrumentsFairValueofDerivativesDetails Financial Instruments Fair Value of Derivatives (Details) Details 91 false false R92.htm 240864051 - Disclosure - Financial Instruments Effect of Derivative Instruments (Details) Sheet http://www.dupont.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails Financial Instruments Effect of Derivative Instruments (Details) Details 92 false false R93.htm 240874052 - Disclosure - Financial Instruments Contractual Maturities of Debt Securities (Details) Sheet http://www.dupont.com/role/FinancialInstrumentsContractualMaturitiesofDebtSecuritiesDetails Financial Instruments Contractual Maturities of Debt Securities (Details) Details 93 false false R94.htm 240884053 - Disclosure - Financial Instruments- AFS Investing Results (Details) Sheet http://www.dupont.com/role/FinancialInstrumentsAFSInvestingResultsDetails Financial Instruments- AFS Investing Results (Details) Details 94 false false R95.htm 240894054 - Disclosure - Financial Instruments- Debt Securities- Gross Unrealized Losses Aggregated by Investment Category (Details) Sheet http://www.dupont.com/role/FinancialInstrumentsDebtSecuritiesGrossUnrealizedLossesAggregatedbyInvestmentCategoryDetails Financial Instruments- Debt Securities- Gross Unrealized Losses Aggregated by Investment Category (Details) Details 95 false false R96.htm 240924055 - Disclosure - Fair Value Measurements (Details) Sheet http://www.dupont.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.dupont.com/role/FairValueMeasurementsTables 96 false false R97.htm 240954056 - Disclosure - Segment Reporting Segment Information (Details) Sheet http://www.dupont.com/role/SegmentReportingSegmentInformationDetails Segment Reporting Segment Information (Details) Details 97 false false R98.htm 240964057 - Disclosure - Segment Reporting Segment Reconciliation (Details) Sheet http://www.dupont.com/role/SegmentReportingSegmentReconciliationDetails Segment Reporting Segment Reconciliation (Details) Details 98 false false R99.htm 240974058 - Disclosure - Segment Reporting Segment Asset Reconciliation (Details) Sheet http://www.dupont.com/role/SegmentReportingSegmentAssetReconciliationDetails Segment Reporting Segment Asset Reconciliation (Details) Details 99 false false R100.htm 240984059 - Disclosure - Segment Reporting Significant Items (Details) Sheet http://www.dupont.com/role/SegmentReportingSignificantItemsDetails Segment Reporting Significant Items (Details) Details 100 false false R101.htm 241004060 - Disclosure - EID - Basis of Presentation Narrative (Details) Sheet http://www.dupont.com/role/EIDBasisofPresentationNarrativeDetails EID - Basis of Presentation Narrative (Details) Details 101 false false R102.htm 241024061 - Disclosure - EID - Related Party Transactions (Details) Sheet http://www.dupont.com/role/EIDRelatedPartyTransactionsDetails EID - Related Party Transactions (Details) Details http://www.dupont.com/role/EIDRelatedPartyTransactionsNotes 102 false false R103.htm 241054062 - Disclosure - EID Segment FN Segment reconciliation (Details) Sheet http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails EID Segment FN Segment reconciliation (Details) Details 103 false false R104.htm 241064063 - Disclosure - EID Segment FN Segment Asset Reconciliation (Details) Sheet http://www.dupont.com/role/EIDSegmentFNSegmentAssetReconciliationDetails EID Segment FN Segment Asset Reconciliation (Details) Details 104 false false All Reports Book All Reports dd-20210331.htm a101.htm a102.htm corteva-3312021xex3111.htm corteva-3312021xex3121.htm corteva-3312021xex3211.htm corteva-3312021xex3221.htm dd-20210331.xsd dd-20210331_cal.xml dd-20210331_def.xml dd-20210331_lab.xml dd-20210331_pre.xml http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/stpr/2018-01-31 true true JSON 125 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "dd-20210331.htm": { "axisCustom": 6, "axisStandard": 37, "contextCount": 468, "dts": { "calculationLink": { "local": [ "dd-20210331_cal.xml" ] }, "definitionLink": { "local": [ "dd-20210331_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "dd-20210331.htm" ] }, "labelLink": { "local": [ "dd-20210331_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "dd-20210331_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml" ] }, "schema": { "local": [ "dd-20210331.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 807, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2020-01-31": 75, "http://www.dupont.com/20210331": 4, "http://xbrl.sec.gov/dei/2020-01-31": 24, "total": 103 }, "keyCustom": 71, "keyStandard": 360, "memberCustom": 61, "memberStandard": 63, "nsprefix": "dd", "nsuri": "http://www.dupont.com/20210331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentQuarterlyReport", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000010001 - Document - DEI Document", "role": "http://www.dupont.com/role/DEIDocument", "shortName": "DEI Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentQuarterlyReport", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210041002 - Disclosure - Recent Accounting Guidance", "role": "http://www.dupont.com/role/RecentAccountingGuidance", "shortName": "Recent Accounting Guidance", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R100": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "dd:RestructuringAndAssetRelatedChargesNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240984059 - Disclosure - Segment Reporting Significant Items (Details)", "role": "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails", "shortName": "Segment Reporting Significant Items (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "dd:ScheduleofAdditionalSegmentDetailsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i975d434a331e448197368ae38be0034b_D20210101-20210331", "decimals": "-6", "lang": "en-US", "name": "dd:RestructuringAndAssetRelatedChargesNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R101": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i2e085e66954d49d59a5aadd1c2b31385_I20210430", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241004060 - Disclosure - EID - Basis of Presentation Narrative (Details)", "role": "http://www.dupont.com/role/EIDBasisofPresentationNarrativeDetails", "shortName": "EID - Basis of Presentation Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R102": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ie698c768a4a74ef0ba977c1636f66946_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:NotesPayableRelatedPartiesNoncurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241024061 - Disclosure - EID - Related Party Transactions (Details)", "role": "http://www.dupont.com/role/EIDRelatedPartyTransactionsDetails", "shortName": "EID - Related Party Transactions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i013a92afba5d441eac4df88e5231212e_I20210331", "decimals": "INF", "lang": "en-US", "name": "us-gaap:DebtWeightedAverageInterestRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R103": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxExpenseBenefit", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241054062 - Disclosure - EID Segment FN Segment reconciliation (Details)", "role": "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "shortName": "EID Segment FN Segment reconciliation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "iff67eb825fd14a5f9610d7173c36cb54_D20210101-20210331", "decimals": "-6", "lang": "en-US", "name": "dd:Nonoperatingbenefitscostsnet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R104": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ie698c768a4a74ef0ba977c1636f66946_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Assets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241064063 - Disclosure - EID Segment FN Segment Asset Reconciliation (Details)", "role": "http://www.dupont.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "shortName": "EID Segment FN Segment Asset Reconciliation (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210061003 - Disclosure - Divestitures and Other Transactions", "role": "http://www.dupont.com/role/DivestituresandOtherTransactions", "shortName": "Divestitures and Other Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210111004 - Disclosure - Revenue (Notes)", "role": "http://www.dupont.com/role/RevenueNotes", "shortName": "Revenue (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210261007 - Disclosure - Supplementary Information", "role": "http://www.dupont.com/role/SupplementaryInformation", "shortName": "Supplementary Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210311008 - Disclosure - Income Taxes", "role": "http://www.dupont.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210341009 - Disclosure - Earnings Per Share (Notes)", "role": "http://www.dupont.com/role/EarningsPerShareNotes", "shortName": "Earnings Per Share (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210411010 - Disclosure - Accounts and Notes Receivable (Notes)", "role": "http://www.dupont.com/role/AccountsandNotesReceivableNotes", "shortName": "Accounts and Notes Receivable (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210451011 - Disclosure - Inventories", "role": "http://www.dupont.com/role/Inventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210521013 - Disclosure - Other Intangible Assets", "role": "http://www.dupont.com/role/OtherIntangibleAssets", "shortName": "Other Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210561014 - Disclosure - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities", "role": "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilities", "shortName": "Short-Term Borrowings, Long-Term Debt and Available Credit Facilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100010002 - Statement - Consolidated Statements of Operations", "role": "http://www.dupont.com/role/ConsolidatedStatementsofOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210611015 - Disclosure - Commitments and Contingent Liabilities", "role": "http://www.dupont.com/role/CommitmentsandContingentLiabilities", "shortName": "Commitments and Contingent Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210691016 - Disclosure - Stockholders' Equity", "role": "http://www.dupont.com/role/StockholdersEquity", "shortName": "Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210771017 - Disclosure - Pension Plans and Other Post Employment Benefit Plans", "role": "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlans", "shortName": "Pension Plans and Other Post Employment Benefit Plans", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210801018 - Disclosure - Financial Instruments", "role": "http://www.dupont.com/role/FinancialInstruments", "shortName": "Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210901019 - Disclosure - Fair Value Measurements", "role": "http://www.dupont.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210931020 - Disclosure - Segment Reporting (Notes)", "role": "http://www.dupont.com/role/SegmentReportingNotes", "shortName": "Segment Reporting (Notes)", "subGroupType": "", "uniqueAnchor": null }, "R26": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "iff67eb825fd14a5f9610d7173c36cb54_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210991021 - Disclosure - EID - Basis of Presentation (Notes)", "role": "http://www.dupont.com/role/EIDBasisofPresentationNotes", "shortName": "EID - Basis of Presentation (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "iff67eb825fd14a5f9610d7173c36cb54_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "iff67eb825fd14a5f9610d7173c36cb54_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "211011022 - Disclosure - EID - Related Party Transactions (Notes)", "role": "http://www.dupont.com/role/EIDRelatedPartyTransactionsNotes", "shortName": "EID - Related Party Transactions (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "iff67eb825fd14a5f9610d7173c36cb54_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "211031023 - Disclosure - EID Segment FN (Notes)", "role": "http://www.dupont.com/role/EIDSegmentFNNotes", "shortName": "EID Segment FN (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "iff67eb825fd14a5f9610d7173c36cb54_D20210101-20210331", "decimals": null, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "220022001 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://www.dupont.com/role/SummaryofSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100020003 - Statement - Consolidated Statements of Comprehensive (Loss) Income", "role": "http://www.dupont.com/role/ConsolidatedStatementsofComprehensiveLossIncome", "shortName": "Consolidated Statements of Comprehensive (Loss) Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "220052002 - Disclosure - Recent Accounting Guidance Recent Accounting Guidance (Policies)", "role": "http://www.dupont.com/role/RecentAccountingGuidanceRecentAccountingGuidancePolicies", "shortName": "Recent Accounting Guidance Recent Accounting Guidance (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRecognitionSalesOfGoods", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "220122003 - Disclosure - Revenue Revenue Recognition (Policies)", "role": "http://www.dupont.com/role/RevenueRevenueRecognitionPolicies", "shortName": "Revenue Revenue Recognition (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRecognitionSalesOfGoods", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230133002 - Disclosure - Revenue (Tables)", "role": "http://www.dupont.com/role/RevenueTables", "shortName": "Revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i0eaa4b9915d04b90a4f03f2f9754b741_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230183003 - Disclosure - Restructuring and Asset Related Charges (Tables)", "role": "http://www.dupont.com/role/RestructuringandAssetRelatedChargesTables", "shortName": "Restructuring and Asset Related Charges (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i0eaa4b9915d04b90a4f03f2f9754b741_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230273004 - Disclosure - Supplementary Information (Tables)", "role": "http://www.dupont.com/role/SupplementaryInformationTables", "shortName": "Supplementary Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230353005 - Disclosure - Earnings Per Share (Tables)", "role": "http://www.dupont.com/role/EarningsPerShareTables", "shortName": "Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230423006 - Disclosure - Accounts and Notes Receivable (Tables)", "role": "http://www.dupont.com/role/AccountsandNotesReceivableTables", "shortName": "Accounts and Notes Receivable (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230463007 - Disclosure - Inventories (Tables)", "role": "http://www.dupont.com/role/InventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "dd:ScheduleofFiniteandIndefiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230533009 - Disclosure - Other Intangible Assets (Tables)", "role": "http://www.dupont.com/role/OtherIntangibleAssetsTables", "shortName": "Other Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "dd:ScheduleofFiniteandIndefiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230573010 - Disclosure - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Debt (Tables)", "role": "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesDebtTables", "shortName": "Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib12efc2752034a71962bab61b8376f76_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100030004 - Statement - Consolidated Balance Sheets", "role": "http://www.dupont.com/role/ConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib12efc2752034a71962bab61b8376f76_I20210331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:ShortTermInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "dd:ScheduleofEnvironmentalLossContingenciesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230623011 - Disclosure - Commitments and Contingent Liabilities (Tables)", "role": "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesTables", "shortName": "Commitments and Contingent Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "dd:ScheduleofEnvironmentalLossContingenciesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "dd:ScheduleofNoncontrollingInterestsRepresentedbyPreferredStockTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230703012 - Disclosure - Stockholders' Equity (Tables)", "role": "http://www.dupont.com/role/StockholdersEquityTables", "shortName": "Stockholders' Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "dd:ScheduleofNoncontrollingInterestsRepresentedbyPreferredStockTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230783013 - Disclosure - Pension Plans and Other Post Employment Benefit Plans (Tables)", "role": "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTables", "shortName": "Pension Plans and Other Post Employment Benefit Plans (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230813014 - Disclosure - Financial Instruments (Tables)", "role": "http://www.dupont.com/role/FinancialInstrumentsTables", "shortName": "Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230913015 - Disclosure - Fair Value Measurements (Tables)", "role": "http://www.dupont.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230943016 - Disclosure - Segment Reporting (Tables)", "role": "http://www.dupont.com/role/SegmentReportingTables", "shortName": "Segment Reporting (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "231043017 - Disclosure - EID Segment FN (Tables)", "role": "http://www.dupont.com/role/EIDSegmentFNTables", "shortName": "EID Segment FN (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "iff67eb825fd14a5f9610d7173c36cb54_D20210101-20210331", "decimals": null, "lang": "en-US", "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "dd:ForeignExchangeImpactOnIncomeLossFromContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240034001 - Disclosure - Summary of Significant Accounting Policies Summary of Accounting Policies (Details)", "role": "http://www.dupont.com/role/SummaryofSignificantAccountingPoliciesSummaryofAccountingPoliciesDetails", "shortName": "Summary of Significant Accounting Policies Summary of Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "dd:ForeignExchangeImpactOnIncomeLossFromContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i65ed0aa7ad02400a8a6db6d7d626f11b_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "dd:IndemnificationAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240084002 - Disclosure - Divestitures and Other Transactions Separation Agreements (Details)", "role": "http://www.dupont.com/role/DivestituresandOtherTransactionsSeparationAgreementsDetails", "shortName": "Divestitures and Other Transactions Separation Agreements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i65ed0aa7ad02400a8a6db6d7d626f11b_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "dd:IndemnificationAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240094003 - Disclosure - Divestitures and Other Transactions Other Discontinued Operations (Details)", "role": "http://www.dupont.com/role/DivestituresandOtherTransactionsOtherDiscontinuedOperationsDetails", "shortName": "Divestitures and Other Transactions Other Discontinued Operations (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "dd:ScheduleofNoncontrollingInterestsRepresentedbyPreferredStockTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib4797820cd244a71b9f69fa66039909b_I20210331", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100040005 - Statement - Consolidated Balance Sheets (Parentheticals)", "role": "http://www.dupont.com/role/ConsolidatedBalanceSheetsParentheticals", "shortName": "Consolidated Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R50": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ife8f2e96c1fe432290962e332c137d65_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "dd:IndemnificationAssetsForLiabilitiesIndemnifiedByChemours", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240104004 - Disclosure - Divestitures and Other Transactions - PChem Results of Operations (Details)", "role": "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails", "shortName": "Divestitures and Other Transactions - PChem Results of Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ife8f2e96c1fe432290962e332c137d65_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "dd:IndemnificationAssetsForLiabilitiesIndemnifiedByChemours", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib12efc2752034a71962bab61b8376f76_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240144005 - Disclosure - Revenue Narrative (Details)", "role": "http://www.dupont.com/role/RevenueNarrativeDetails", "shortName": "Revenue Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib12efc2752034a71962bab61b8376f76_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib12efc2752034a71962bab61b8376f76_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "dd:Accountsandnotesreceivabletrade", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240154006 - Disclosure - Revenue Contract Balances (Details)", "role": "http://www.dupont.com/role/RevenueContractBalancesDetails", "shortName": "Revenue Contract Balances (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib12efc2752034a71962bab61b8376f76_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "dd:Accountsandnotesreceivabletrade", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240164007 - Disclosure - Revenue Disaggregation of Revenue - Principal Product Groups (Details)", "role": "http://www.dupont.com/role/RevenueDisaggregationofRevenuePrincipalProductGroupsDetails", "shortName": "Revenue Disaggregation of Revenue - Principal Product Groups (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ie91831be463c46bc8223e20436bfc161_D20210101-20210331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240174008 - Disclosure - Revenue Disaggregation of Revenue - Geography (Details)", "role": "http://www.dupont.com/role/RevenueDisaggregationofRevenueGeographyDetails", "shortName": "Revenue Disaggregation of Revenue - Geography (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i2f983c34cf524238aff4dac75b3ca9af_D20210101-20210331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "dd:RestructuringAndAssetRelatedChargesNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240194009 - Disclosure - Restructuring and Asset Related Charges - 2021 Restructuring Activities (Details)", "role": "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "shortName": "Restructuring and Asset Related Charges - 2021 Restructuring Activities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i87de8e9ad01b40aabb42cabc5bbb70d0_I20210331", "decimals": "-6", "lang": "en-US", "name": "dd:FutureCashPayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "dd:RestructuringAndAssetRelatedChargesNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240204010 - Disclosure - Restructuring and Asset Related Charges Execute to Win Productivity Program (Details)", "role": "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "shortName": "Restructuring and Asset Related Charges Execute to Win Productivity Program (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i71f34a3e8779471d80bc3ced2ead72dc_I20201231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "if8dd4afb39c84f13bd95e35069bd8a4e_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "dd:AcceleratedPrepaidRoyaltyAmortizationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240214011 - Disclosure - Restructuring and Asset Related Charges Narrative (Details)", "role": "http://www.dupont.com/role/RestructuringandAssetRelatedChargesNarrativeDetails", "shortName": "Restructuring and Asset Related Charges Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "if8dd4afb39c84f13bd95e35069bd8a4e_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "dd:AcceleratedPrepaidRoyaltyAmortizationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "us-gaap:InterestExpenseRelatedParty", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "if596d1f35e93429fbe5fe0aa5aec70f0_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseRelatedParty", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240244012 - Disclosure - Related Party Transactions Dow Intercompany Transactions (Details)", "role": "http://www.dupont.com/role/RelatedPartyTransactionsDowIntercompanyTransactionsDetails", "shortName": "Related Party Transactions Dow Intercompany Transactions (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R59": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromEquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240284014 - Disclosure - Supplementary Information Other Income (Expense) - Net (Details)", "role": "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails", "shortName": "Supplementary Information Other Income (Expense) - Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromEquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100050006 - Statement - Consolidated Statements of Cash Flows", "role": "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "lang": "en-US", "name": "dd:DeferredIncomeTaxExpenseBenefitContinuingOperationsandDiscontinuedOperations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "dd:ForeignCurrencyExchangeGainLossTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240294015 - Disclosure - Supplementary Information Foreign Currency Exchange Gain (Loss) (Details)", "role": "http://www.dupont.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails", "shortName": "Supplementary Information Foreign Currency Exchange Gain (Loss) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "dd:ForeignCurrencyExchangeGainLossTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "lang": "en-US", "name": "dd:ForeignCurrencyTransactionGainLossTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib12efc2752034a71962bab61b8376f76_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240304016 - Disclosure - Supplementary Information Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details)", "role": "http://www.dupont.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails", "shortName": "Supplementary Information Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ia27a04b200554e2cb59c56c46feac1ca_I20210331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:RestrictedCash", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": null, "groupType": "disclosure", "isDefault": "false", "longName": "240324017 - Disclosure - Income Taxes Income Tax Narrative (Details)", "role": "http://www.dupont.com/role/IncomeTaxesIncomeTaxNarrativeDetails", "shortName": "Income Taxes Income Tax Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R63": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240374020 - Disclosure - Earnings Per Share Net Income for Earnings Per Share Calculations - Basic and Diluted (Details)", "role": "http://www.dupont.com/role/EarningsPerShareNetIncomeforEarningsPerShareCalculationsBasicandDilutedDetails", "shortName": "Earnings Per Share Net Income for Earnings Per Share Calculations - Basic and Diluted (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsPerBasicShare", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240384021 - Disclosure - Earnings Per Share Earnings Per Share Calculations - Basic (Details)", "role": "http://www.dupont.com/role/EarningsPerShareEarningsPerShareCalculationsBasicDetails", "shortName": "Earnings Per Share Earnings Per Share Calculations - Basic (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "2", "lang": "en-US", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240394022 - Disclosure - Earnings Per Share Earnings Per Share Calculations - Diluted (Details)", "role": "http://www.dupont.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails", "shortName": "Earnings Per Share Earnings Per Share Calculations - Diluted (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "2", "lang": "en-US", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "dd:ShareCountInformationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240404023 - Disclosure - Earnings Per Share Share Count Information (Details)", "role": "http://www.dupont.com/role/EarningsPerShareShareCountInformationDetails", "shortName": "Earnings Per Share Share Count Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "dd:ShareCountInformationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib12efc2752034a71962bab61b8376f76_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240434024 - Disclosure - Accounts and Notes Receivable (Details)", "role": "http://www.dupont.com/role/AccountsandNotesReceivableDetails", "shortName": "Accounts and Notes Receivable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib12efc2752034a71962bab61b8376f76_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i8c15a87db39f415097c9aa28b30e8d0b_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240444025 - Disclosure - Accounts and Notes Receivable Allowance Rollforward (Details)", "role": "http://www.dupont.com/role/AccountsandNotesReceivableAllowanceRollforwardDetails", "shortName": "Accounts and Notes Receivable Allowance Rollforward (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:ProvisionForDoubtfulAccounts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib12efc2752034a71962bab61b8376f76_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240474026 - Disclosure - Inventories Schedule of Inventory (Details)", "role": "http://www.dupont.com/role/InventoriesScheduleofInventoryDetails", "shortName": "Inventories Schedule of Inventory (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib12efc2752034a71962bab61b8376f76_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ie144382bb72849fd9a65b431b5d3b684_I20191231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100060007 - Statement - Statement of Stockholders Equity Statement", "role": "http://www.dupont.com/role/StatementofStockholdersEquityStatement", "shortName": "Statement of Stockholders Equity Statement", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i37bb02939d0d4a68961aba10712e6f41_I20191231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R70": { "firstAnchor": null, "groupType": "disclosure", "isDefault": "false", "longName": "240504027 - Disclosure - Property, Plant and Equipment Schedule of Property, Plant and Equipment (Details)", "role": "http://www.dupont.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails", "shortName": "Property, Plant and Equipment Schedule of Property, Plant and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R71": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "dd:ScheduleofFiniteandIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "id001f4c2e5154a63bed0c7af80c775b6_I20200331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240544029 - Disclosure - Other Intangible Assets Other Intangible Assets (Details)", "role": "http://www.dupont.com/role/OtherIntangibleAssetsOtherIntangibleAssetsDetails", "shortName": "Other Intangible Assets Other Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "dd:ScheduleofFiniteandIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "id001f4c2e5154a63bed0c7af80c775b6_I20200331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240554030 - Disclosure - Other Intangible Assets Future Amortization Expense (Details)", "role": "http://www.dupont.com/role/OtherIntangibleAssetsFutureAmortizationExpenseDetails", "shortName": "Other Intangible Assets Future Amortization Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i4e5b50336b0943a3af7f65891cb4b15e_I20210331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShortTermDebtTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib12efc2752034a71962bab61b8376f76_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240584031 - Disclosure - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Short-term borrowings and finance lease obligations (Details)", "role": "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails", "shortName": "Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Short-term borrowings and finance lease obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShortTermDebtTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib12efc2752034a71962bab61b8376f76_I20210331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:FinanceLeaseLiabilityCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShortTermDebtTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib12efc2752034a71962bab61b8376f76_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240594032 - Disclosure - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Long-term Debt (Details)", "role": "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails", "shortName": "Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Long-term Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i73d1b0989ce744ce8ac9b68954733a0a_I20210331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:LongTermDebtFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ProceedsFromIssuanceOfLongTermDebt", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240604033 - Disclosure - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Repurchase Facility and Revolving Credit Facilities (Details)", "role": "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails", "shortName": "Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Repurchase Facility and Revolving Credit Facilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i68393d78ecee499d9061c18c2cdfe575_I20181113", "decimals": "-8", "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib12efc2752034a71962bab61b8376f76_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:GuaranteeObligationsMaximumExposure", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240634034 - Disclosure - Commitments and Contingent Liabilities Guarantee Narrative (Details)", "role": "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails", "shortName": "Commitments and Contingent Liabilities Guarantee Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i63180f3fa5304389a984c3909ca26feb_I20210331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:AccountsReceivableNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib0098abb50624f5ca5b34a2fa506c5bd_I20281231", "decimals": "-6", "first": true, "lang": "en-US", "name": "dd:EscrowAccountBalance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240644035 - Disclosure - Commitments and Contingent Liabilities Chemours (Details)", "role": "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "shortName": "Commitments and Contingent Liabilities Chemours (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib0098abb50624f5ca5b34a2fa506c5bd_I20281231", "decimals": "-6", "first": true, "lang": "en-US", "name": "dd:EscrowAccountBalance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i443634d686c445d3b0a3e7f7fca3bd74_I20210331", "decimals": "0", "first": true, "lang": "en-US", "name": "dd:CortevaAndDuPontStrayLiabilityThresholdForPFAS", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240654036 - Disclosure - Commitments and Contingent Liabilities DuPont (Details)", "role": "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails", "shortName": "Commitments and Contingent Liabilities DuPont (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i443634d686c445d3b0a3e7f7fca3bd74_I20210331", "decimals": "0", "first": true, "lang": "en-US", "name": "dd:CortevaAndDuPontStrayLiabilityThresholdForPFAS", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i08c309ad6cad412b9e91500b39249bb9_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LitigationSettlementAmountAwardedToOtherParty", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240664037 - Disclosure - Commitments and Contingent Liabilities PFOA / Leach Settlement (Details)", "role": "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails", "shortName": "Commitments and Contingent Liabilities PFOA / Leach Settlement (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i08c309ad6cad412b9e91500b39249bb9_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LitigationSettlementAmountAwardedToOtherParty", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": null, "groupType": "statement", "isDefault": "false", "longName": "100070008 - Statement - Statement of Stockholders' Equity Parentheticals (Parentheticals)", "role": "http://www.dupont.com/role/StatementofStockholdersEquityParentheticalsParentheticals", "shortName": "Statement of Stockholders' Equity Parentheticals (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R80": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib12efc2752034a71962bab61b8376f76_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:GuaranteeObligationsMaximumExposure", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240674038 - Disclosure - Commitments and Contingent Liabilities Other PFOA Matters / Fayetteville (Details)", "role": "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails", "shortName": "Commitments and Contingent Liabilities Other PFOA Matters / Fayetteville (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "idb17112af4954a39943378ec57a0c9ce_I20210331", "decimals": "INF", "lang": "en-US", "name": "us-gaap:LossContingencyPendingClaimsNumber", "reportCount": 1, "unique": true, "unitRef": "lawsuits", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "dd:ScheduleofEnvironmentalLossContingenciesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib12efc2752034a71962bab61b8376f76_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "dd:IndemnificationAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240684039 - Disclosure - Commitments and Contingent Liabilities Environmental (Details)", "role": "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "shortName": "Commitments and Contingent Liabilities Environmental (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "dd:ScheduleofEnvironmentalLossContingenciesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib12efc2752034a71962bab61b8376f76_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "dd:IndemnificationAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ibbc777e30ecb471b963aac0577acded4_I20210430", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240714040 - Disclosure - Stockholders' Equity Common Stock (Details)", "role": "http://www.dupont.com/role/StockholdersEquityCommonStockDetails", "shortName": "Stockholders' Equity Common Stock (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i1173fde8410c422db51a00928bb744c0_I20190626", "decimals": "-9", "lang": "en-US", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "dd:ScheduleofNoncontrollingInterestsRepresentedbyPreferredStockTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib4797820cd244a71b9f69fa66039909b_I20210331", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240734042 - Disclosure - Stockholders' Equity Preferred Stock (Details)", "role": "http://www.dupont.com/role/StockholdersEquityPreferredStockDetails", "shortName": "Stockholders' Equity Preferred Stock (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R84": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i8c15a87db39f415097c9aa28b30e8d0b_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240744043 - Disclosure - Stockholders' Equity Other Comprehensive Income (Loss) (Details)", "role": "http://www.dupont.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "shortName": "Stockholders' Equity Other Comprehensive Income (Loss) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ic8d2c726847c4ff8b94e88dec3cdf9d5_D20210101-20210331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240754044 - Disclosure - Stockholders' Equity Tax Benefit (Expense) on Net Activity (Details)", "role": "http://www.dupont.com/role/StockholdersEquityTaxBenefitExpenseonNetActivityDetails", "shortName": "Stockholders' Equity Tax Benefit (Expense) on Net Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240764045 - Disclosure - Stockholders' Equity Reclassifications out of AOCI (Details)", "role": "http://www.dupont.com/role/StockholdersEquityReclassificationsoutofAOCIDetails", "shortName": "Stockholders' Equity Reclassifications out of AOCI (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i8adbf46463bd498abec20ab4aa32e0f4_D20210101-20210331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib2aba4e13104457bb7d942ed37f5635a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240794046 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Components of net periodic benefit cost (credit) (Details)", "role": "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditDetails", "shortName": "Pension Plans and Other Post Employment Benefit Plans Components of net periodic benefit cost (credit) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib2aba4e13104457bb7d942ed37f5635a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i573a636cc7194127844f6fc750148be9_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:HeldToMaturitySecurities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240824047 - Disclosure - Financial Instruments Financial Instruments (Narrative) (Details)", "role": "http://www.dupont.com/role/FinancialInstrumentsFinancialInstrumentsNarrativeDetails", "shortName": "Financial Instruments Financial Instruments (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i573a636cc7194127844f6fc750148be9_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:HeldToMaturitySecurities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i9242749e99bf457d8f01e5bf25cc039f_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240834048 - Disclosure - Financial Instruments Notional Amounts (Details)", "role": "http://www.dupont.com/role/FinancialInstrumentsNotionalAmountsDetails", "shortName": "Financial Instruments Notional Amounts (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i03d2efa18ee1494ea6192fd04605bda8_I20210331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210011001 - Disclosure - Summary of Significant Accounting Policies (Notes)", "role": "http://www.dupont.com/role/SummaryofSignificantAccountingPoliciesNotes", "shortName": "Summary of Significant Accounting Policies (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i740ab7bdba1c452983e571c29dbb933b_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeRemainingMaturity1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240844049 - Disclosure - Financial Instruments Cash Flow Hedges Included in AOCI (Details)", "role": "http://www.dupont.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "shortName": "Financial Instruments Cash Flow Hedges Included in AOCI (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i740ab7bdba1c452983e571c29dbb933b_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeRemainingMaturity1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib12efc2752034a71962bab61b8376f76_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240854050 - Disclosure - Financial Instruments Fair Value of Derivatives (Details)", "role": "http://www.dupont.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "shortName": "Financial Instruments Fair Value of Derivatives (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib12efc2752034a71962bab61b8376f76_I20210331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:DerivativeAssetFairValueGrossLiabilityAndObligationToReturnCashOffset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:GainLossOnDerivativeInstrumentsNetPretax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240864051 - Disclosure - Financial Instruments Effect of Derivative Instruments (Details)", "role": "http://www.dupont.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "shortName": "Financial Instruments Effect of Derivative Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:GainLossOnDerivativeInstrumentsNetPretax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib12efc2752034a71962bab61b8376f76_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240874052 - Disclosure - Financial Instruments Contractual Maturities of Debt Securities (Details)", "role": "http://www.dupont.com/role/FinancialInstrumentsContractualMaturitiesofDebtSecuritiesDetails", "shortName": "Financial Instruments Contractual Maturities of Debt Securities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib12efc2752034a71962bab61b8376f76_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRealizedGainLossTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "iba3fc03b5d9643e49d82e61515ecdc75_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240884053 - Disclosure - Financial Instruments- AFS Investing Results (Details)", "role": "http://www.dupont.com/role/FinancialInstrumentsAFSInvestingResultsDetails", "shortName": "Financial Instruments- AFS Investing Results (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRealizedGainLossTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "iba3fc03b5d9643e49d82e61515ecdc75_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i10baebba960e4fdb91f2dde4eb293f86_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240894054 - Disclosure - Financial Instruments- Debt Securities- Gross Unrealized Losses Aggregated by Investment Category (Details)", "role": "http://www.dupont.com/role/FinancialInstrumentsDebtSecuritiesGrossUnrealizedLossesAggregatedbyInvestmentCategoryDetails", "shortName": "Financial Instruments- Debt Securities- Gross Unrealized Losses Aggregated by Investment Category (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i10baebba960e4fdb91f2dde4eb293f86_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib12efc2752034a71962bab61b8376f76_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240924055 - Disclosure - Fair Value Measurements (Details)", "role": "http://www.dupont.com/role/FairValueMeasurementsDetails", "shortName": "Fair Value Measurements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "if9d77cac45804e2d80d6ecd10af5dedc_I20210331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240954056 - Disclosure - Segment Reporting Segment Information (Details)", "role": "http://www.dupont.com/role/SegmentReportingSegmentInformationDetails", "shortName": "Segment Reporting Segment Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ia314b022247d49f8840fd4156dddb28d_D20210101-20210331", "decimals": "-6", "lang": "en-US", "name": "dd:SegmentoperatingEBITDA", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "i66ac36110f284b65aa9172d85fd1904a_D20210101-20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240964057 - Disclosure - Segment Reporting Segment Reconciliation (Details)", "role": "http://www.dupont.com/role/SegmentReportingSegmentReconciliationDetails", "shortName": "Segment Reporting Segment Reconciliation (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R99": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dd-20210331.htm", "contextRef": "ib12efc2752034a71962bab61b8376f76_I20210331", "decimals": "-6", "first": true, "lang": "en-US", "name": "dd:SegmentAssets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240974058 - Disclosure - Segment Reporting Segment Asset Reconciliation (Details)", "role": "http://www.dupont.com/role/SegmentReportingSegmentAssetReconciliationDetails", "shortName": "Segment Reporting Segment Asset Reconciliation (Details)", "subGroupType": "details", "uniqueAnchor": null } }, "segmentCount": 136, "tag": { "dd_A2021RestructuringActionsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2021 Restructuring Actions", "label": "2021 Restructuring Actions [Domain]", "terseLabel": "2021 Restructuring Actions [Domain]" } } }, "localname": "A2021RestructuringActionsDomain", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails" ], "xbrltype": "domainItemType" }, "dd_A3.50SeriesPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "$3.50 Series Preferred Stock [Member]", "label": "$3.50 Series Preferred Stock [Member]", "terseLabel": "$3.50 Series Preferred Stock [Member]" } } }, "localname": "A3.50SeriesPreferredStockMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets", "http://www.dupont.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.dupont.com/role/DEIDocument", "http://www.dupont.com/role/StatementofStockholdersEquityParentheticalsParentheticals", "http://www.dupont.com/role/StockholdersEquityPreferredStockDetails" ], "xbrltype": "domainItemType" }, "dd_A4.50SeriesPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "$4.50 preferred stock [Member]", "label": "$4.50 Series Preferred Stock [Member]", "terseLabel": "$4.50 Series Preferred Stock [Member]" } } }, "localname": "A4.50SeriesPreferredStockMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets", "http://www.dupont.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.dupont.com/role/DEIDocument", "http://www.dupont.com/role/StatementofStockholdersEquityParentheticalsParentheticals", "http://www.dupont.com/role/StockholdersEquityPreferredStockDetails" ], "xbrltype": "domainItemType" }, "dd_AcceleratedPrepaidRoyaltyAmortizationExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Asset related cost for non-cash accelerated prepaid royalty amortization expense", "label": "Accelerated Prepaid Royalty Amortization Expense", "terseLabel": "Accelerated Prepaid Royalty Amortization Expense" } } }, "localname": "AcceleratedPrepaidRoyaltyAmortizationExpense", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedChargesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "dd_AccountsandNotesReceivableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounts and Notes Receivable [Abstract]", "label": "Accounts and Notes Receivable [Abstract]", "terseLabel": "Accounts and Notes Receivable [Abstract]" } } }, "localname": "AccountsandNotesReceivableAbstract", "nsuri": "http://www.dupont.com/20210331", "xbrltype": "stringItemType" }, "dd_AccountsandNotesReceivableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounts and Notes Receivable [Member]", "label": "Accounts and Notes Receivable [Member]", "terseLabel": "Accounts and Notes Receivable [Member]" } } }, "localname": "AccountsandNotesReceivableMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsSeparationAgreementsDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails" ], "xbrltype": "domainItemType" }, "dd_Accountsandnotesreceivabletrade": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accounts and notes receivable - trade (does not include Other AR), net of allowance for doubtful accounts", "label": "Accounts and notes receivable - trade", "terseLabel": "Accounts and notes receivable - trade" } } }, "localname": "Accountsandnotesreceivabletrade", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/RevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "dd_AccrualforEnvironmentalLossContingenciesPotentialExposureinExcessofAccrual": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual", "label": "Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual", "terseLabel": "Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual" } } }, "localname": "AccrualforEnvironmentalLossContingenciesPotentialExposureinExcessofAccrual", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "monetaryItemType" }, "dd_AccruedandOtherCurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accrued and Other Current Liabilities [Member]", "label": "Accrued and Other Current Liabilities [Member]", "terseLabel": "Accrued and Other Current Liabilities [Member]" } } }, "localname": "AccruedandOtherCurrentLiabilitiesMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsSeparationAgreementsDetails", "http://www.dupont.com/role/EIDRelatedPartyTransactionsDetails", "http://www.dupont.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.dupont.com/role/RevenueContractBalancesDetails" ], "xbrltype": "domainItemType" }, "dd_AccumulatedDefinedBenefitPlansAdjustmentSettlementGainLossMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accumulated Defined Benefit Plans Adjustment, Settlement Gain (Loss) [Member]", "label": "Accumulated Defined Benefit Plans Adjustment, Settlement Gain (Loss) [Member]", "terseLabel": "Settlement Loss" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentSettlementGainLossMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "domainItemType" }, "dd_AdditionalannualPFOAliabilitiesforthenextfiveyearspaidbyChemours": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Additional annual PFOA liabilities for the next five years paid by Chemours, up to $25 million per year.", "label": "Additional annual PFOA liabilities for the next five years paid by Chemours", "terseLabel": "Additional annual PFOA liabilities for the next five years paid by Chemours" } } }, "localname": "AdditionalannualPFOAliabilitiesforthenextfiveyearspaidbyChemours", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails" ], "xbrltype": "monetaryItemType" }, "dd_AdditionalannualPFOAliabilitiesforthenextfiveyearspaidbyCorteva": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Additional amounts EID will pay annually, if Chemours $25 million is exceeded. EID will pay excess up to the next $25 million, with Chemours annually bearing excess liabilities above that amount.", "label": "Additional annual PFOA liabilities for the next five years paid by Corteva", "terseLabel": "Additional annual PFOA liabilities for the next five years paid by Corteva" } } }, "localname": "AdditionalannualPFOAliabilitiesforthenextfiveyearspaidbyCorteva", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails" ], "xbrltype": "monetaryItemType" }, "dd_AgreementswithlenderstoprovidefinancingforselectcustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreements with lenders to provide financing for select customers [Member]", "label": "Agreements with lenders to provide financing for select customers [Member]", "terseLabel": "Agreements with lenders to provide financing for select customers [Member]" } } }, "localname": "AgreementswithlenderstoprovidefinancingforselectcustomersMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails" ], "xbrltype": "domainItemType" }, "dd_AlabamaWaterUtilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Alabama Water Utility [Member]", "label": "Alabama Water Utility [Member]", "terseLabel": "Alabama Water Utility [Member]" } } }, "localname": "AlabamaWaterUtilityMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails" ], "xbrltype": "domainItemType" }, "dd_Amountcreditedtoeachcompanysthreshold": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount credited to each company's threshold for PFAS costs shared between DuPont and Corteva.", "label": "Amount credited to each company's threshold", "terseLabel": "Amount credited to each company's threshold" } } }, "localname": "Amountcreditedtoeachcompanysthreshold", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails" ], "xbrltype": "monetaryItemType" }, "dd_AnnualEscrowDeposit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "No later than each of September 30, 2021 and September 30, 2022, Chemours shall deposit $100 million into an escrow account and DuPont and Corteva shall together deposit $100 million in the aggregate into an escrow account.", "label": "Annual Escrow Deposit", "terseLabel": "Annual Escrow Deposit" } } }, "localname": "AnnualEscrowDeposit", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails" ], "xbrltype": "monetaryItemType" }, "dd_AnnualEscrowDepositRemainderOfPeriod": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "No later than September 30 of each subsequent year through and including 2028, Chemours shall deposit $50 million into an escrow account and DuPont and Corteva shall together deposit $50 million in the aggregate into an escrow account", "label": "Annual Escrow Deposit, remainder of period", "terseLabel": "Annual Escrow Deposit, remainder of period" } } }, "localname": "AnnualEscrowDepositRemainderOfPeriod", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails" ], "xbrltype": "monetaryItemType" }, "dd_ArgentinePesoDevaluation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Argentine peso devaluation", "label": "Argentine peso devaluation", "terseLabel": "Argentine peso devaluation" } } }, "localname": "ArgentinePesoDevaluation", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails" ], "xbrltype": "monetaryItemType" }, "dd_ArgentinePesoDevaluationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Argentine Peso Devaluation", "label": "Argentine Peso Devaluation [Member]", "terseLabel": "Argentine Peso Devaluation [Member]" } } }, "localname": "ArgentinePesoDevaluationMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails", "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "dd_AssetRelatedChargesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset Related Charges", "label": "Asset Related Charges [Member]", "terseLabel": "Asset Related Charges [Member]" } } }, "localname": "AssetRelatedChargesMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails" ], "xbrltype": "domainItemType" }, "dd_Assetwriteoffsandadjustments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Noncash activity affecting the restructuring reserve related to asset write-offs and adjustments.", "label": "Asset write-offs and adjustments", "terseLabel": "Asset write-offs and adjustments" } } }, "localname": "Assetwriteoffsandadjustments", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails" ], "xbrltype": "monetaryItemType" }, "dd_BalanceSheetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Balance Sheet [Member]", "label": "Balance Sheet [Member]", "terseLabel": "Balance Sheet [Member]" } } }, "localname": "BalanceSheetMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/DivestituresandOtherTransactionsTables" ], "xbrltype": "domainItemType" }, "dd_BindingSettlementAgreementClassSize": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Binding settlement agreement, class size", "label": "Binding Settlement Agreement Class Size", "terseLabel": "Binding Settlement Agreement Class Size" } } }, "localname": "BindingSettlementAgreementClassSize", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails" ], "xbrltype": "integerItemType" }, "dd_Borrowingrateterm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time elected for interest rate on borrowing under Revolving Credit Facility", "label": "Borrowing rate term", "terseLabel": "Borrowing rate term" } } }, "localname": "Borrowingrateterm", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails" ], "xbrltype": "durationItemType" }, "dd_BusinessCombinationFairValueStepUpOfAcquiredInventory": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Fair Value Step Up Of Acquired Inventory", "label": "Business Combination, Fair Value Step Up Of Acquired Inventory", "terseLabel": "Business Combination, Fair Value Step Up Of Acquired Inventory" } } }, "localname": "BusinessCombinationFairValueStepUpOfAcquiredInventory", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/InventoriesScheduleofInventoryDetails" ], "xbrltype": "monetaryItemType" }, "dd_BusinessCombinationFairValueStepUpOfAcquiredInventoryAmountrecognizedinCostofGoodssold": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Fair Value Step-Up Of Acquired Inventory, Amount recognized in Cost of Goods sold", "label": "Business Combination, Fair Value Step-Up Of Acquired Inventory, Amount recognized in Cost of Goods sold", "terseLabel": "Amortization of inventory step up included in COGS" } } }, "localname": "BusinessCombinationFairValueStepUpOfAcquiredInventoryAmountrecognizedinCostofGoodssold", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/InventoriesScheduleofInventoryDetails", "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails" ], "xbrltype": "monetaryItemType" }, "dd_BusinessCombinationIntegrationAndSeparationRelatedCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Integration and separation costs includes costs incurred to prepare for and close the Merger, post-Merger integration expenses and costs incurred to prepare for the Intended Business Separations. These costs primarily consist of financial advisory, information technology, legal, accounting, consulting and other professional advisory fees associated with preparation and execution of these activities.", "label": "Business Combination, Integration And Separation Related Costs", "terseLabel": "Integration and Separation Costs" } } }, "localname": "BusinessCombinationIntegrationAndSeparationRelatedCosts", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails" ], "xbrltype": "monetaryItemType" }, "dd_CTVARelatedPartyLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payables to Corteva, Inc. related to Corteva's indemnification liabilities to Dow and DuPont per the Separation Agreements.", "label": "CTVA Related Party Liability", "terseLabel": "CTVA Related Party Liability" } } }, "localname": "CTVARelatedPartyLiability", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EIDRelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "dd_CashFlowMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash Flow [Member]", "label": "Cash Flow [Member]", "terseLabel": "Cash Flow [Member]" } } }, "localname": "CashFlowMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/DivestituresandOtherTransactionsTables" ], "xbrltype": "domainItemType" }, "dd_ChemoursContributionToMDLSettlementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chemours Contribution to MDL Settlement", "label": "Chemours Contribution to MDL Settlement [Member]", "terseLabel": "Chemours Contribution to MDL Settlement" } } }, "localname": "ChemoursContributionToMDLSettlementMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "domainItemType" }, "dd_ChemoursMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chemours [Member]", "label": "Chemours [Member]", "terseLabel": "Chemours [Member]" } } }, "localname": "ChemoursMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails" ], "xbrltype": "domainItemType" }, "dd_ChemoursrelatedobligationsubjecttoindemnificationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chemours related obligation subject to indemnification [Member]", "label": "Chemours related obligation subject to indemnification [Member]", "terseLabel": "Chemours related obligation subject to indemnification [Member]" } } }, "localname": "ChemoursrelatedobligationsubjecttoindemnificationMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "domainItemType" }, "dd_CompanyAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Company [Axis]", "label": "Company [Axis]", "terseLabel": "Company [Axis]" } } }, "localname": "CompanyAxis", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EIDBasisofPresentationNarrativeDetails", "http://www.dupont.com/role/EarningsPerShareNarrativeDetails", "http://www.dupont.com/role/EarningsPerShareShareCountInformationDetails", "http://www.dupont.com/role/StockholdersEquityCommonStockDetails", "http://www.dupont.com/role/StockholdersEquityPreferredStockDetails" ], "xbrltype": "stringItemType" }, "dd_CompanyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Company [Axis]", "label": "Company [Domain]", "terseLabel": "Company [Domain]" } } }, "localname": "CompanyDomain", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EIDBasisofPresentationNarrativeDetails", "http://www.dupont.com/role/EarningsPerShareNarrativeDetails", "http://www.dupont.com/role/EarningsPerShareShareCountInformationDetails", "http://www.dupont.com/role/StockholdersEquityCommonStockDetails", "http://www.dupont.com/role/StockholdersEquityPreferredStockDetails" ], "xbrltype": "domainItemType" }, "dd_CompensatorydamagesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Compensatory damages [Member]", "label": "Compensatory damages [Member]", "terseLabel": "Compensatory damages [Member]" } } }, "localname": "CompensatorydamagesMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails" ], "xbrltype": "domainItemType" }, "dd_CornMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corn [Member]", "label": "Corn [Member]", "terseLabel": "Corn [Member]" } } }, "localname": "CornMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/RevenueDisaggregationofRevenuePrincipalProductGroupsDetails" ], "xbrltype": "domainItemType" }, "dd_CorporateAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Corporate Assets", "label": "Corporate Assets", "terseLabel": "Corporate Assets" } } }, "localname": "CorporateAssets", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.dupont.com/role/SegmentReportingSegmentAssetReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "dd_CortevaAndDuPontStrayLiabilitySharingPercentageForPFAS": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corteva and DuPont stray liability sharing percentage for PFAS", "label": "Corteva and DuPont stray liability sharing percentage for PFAS", "terseLabel": "Stray liability sharing percentage for PFAS" } } }, "localname": "CortevaAndDuPontStrayLiabilitySharingPercentageForPFAS", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails" ], "xbrltype": "percentItemType" }, "dd_CortevaAndDuPontStrayLiabilityThresholdForPFAS": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount by which DuPont and Corteva will share PFAS costs. After threshold is exceeded, companies will share proportionally on basis of 29% (Corteva) and 71% (DuPont).", "label": "Corteva and DuPont stray liability threshold for PFAS", "terseLabel": "Corteva and DuPont stray liability threshold for PFAS" } } }, "localname": "CortevaAndDuPontStrayLiabilityThresholdForPFAS", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails" ], "xbrltype": "monetaryItemType" }, "dd_CortevaDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corteva [Domain]", "label": "Corteva [Domain]", "terseLabel": "Corteva [Domain]" } } }, "localname": "CortevaDomain", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EIDBasisofPresentationNarrativeDetails", "http://www.dupont.com/role/EIDSegmentFNSegmentAssetReconciliationDetails" ], "xbrltype": "domainItemType" }, "dd_CortevaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corteva [Member]", "label": "Corteva [Member]", "terseLabel": "Corteva [Member]" } } }, "localname": "CortevaMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails", "http://www.dupont.com/role/ConsolidatedBalanceSheets", "http://www.dupont.com/role/EIDBasisofPresentationNarrativeDetails", "http://www.dupont.com/role/EIDRelatedPartyTransactionsDetails", "http://www.dupont.com/role/EarningsPerShareNarrativeDetails", "http://www.dupont.com/role/EarningsPerShareShareCountInformationDetails", "http://www.dupont.com/role/RelatedPartyTransactionsDowIntercompanyTransactionsDetails", "http://www.dupont.com/role/StockholdersEquityCommonStockDetails", "http://www.dupont.com/role/StockholdersEquityPreferredStockDetails" ], "xbrltype": "domainItemType" }, "dd_CostSharingArrangementTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term of cost sharing arrangement under the MOU.", "label": "Cost Sharing Arrangement Term", "terseLabel": "Cost Sharing Arrangement Term" } } }, "localname": "CostSharingArrangementTerm", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails" ], "xbrltype": "durationItemType" }, "dd_CostsRelatedToContractTerminationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Costs Related To Contract Termination [Member]", "label": "Costs Related To Contract Termination [Member]", "terseLabel": "Costs Associated with Exit and Disposal Activities" } } }, "localname": "CostsRelatedToContractTerminationMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails" ], "xbrltype": "domainItemType" }, "dd_CropProtectionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Crop Protection [Member]", "label": "Crop Protection [Member]", "terseLabel": "Crop Protection [Member]" } } }, "localname": "CropProtectionMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.dupont.com/role/RevenueDisaggregationofRevenueGeographyDetails", "http://www.dupont.com/role/RevenueDisaggregationofRevenuePrincipalProductGroupsDetails", "http://www.dupont.com/role/SegmentReportingSegmentInformationDetails", "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails", "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "dd_CurrentPortionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Current Portion [Member]", "label": "Current Portion [Member]", "terseLabel": "Current Portion [Member]" } } }, "localname": "CurrentPortionMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails" ], "xbrltype": "domainItemType" }, "dd_DeferredIncomeTaxExpenseBenefitContinuingOperationsandDiscontinuedOperations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Income Tax Expense (Benefit), Continuing Operations and Discontinued Operations", "label": "Deferred Income Tax Expense (Benefit), Continuing Operations and Discontinued Operations", "terseLabel": "Provision for Deferred Income Tax" } } }, "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsandDiscontinuedOperations", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "dd_DefinedBenefitPlanOtherNetPeriodicBenefitCostCredit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other net periodic benefit cost (credit) for defined benefit plan. Includes non-operating cost components for defined benefit pension and other post employment benefit plans (interest cost, expected return on plan assets, amortization of unrecognized loss, amortization of prior service benefit)", "label": "Defined Benefit Plan, Other Net Periodic Benefit Cost (Credit)", "terseLabel": "Non-operating pension and other post employment benefit credit" } } }, "localname": "DefinedBenefitPlanOtherNetPeriodicBenefitCostCredit", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "dd_DefinedBenefitPlanRemeasurementImpactUnderfundedStatus": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan Remeasurement Impact Underfunded Status", "label": "Defined Benefit Plan Remeasurement Impact Underfunded Status", "terseLabel": "Defined Benefit Plan Remeasurement Impact Underfunded Status" } } }, "localname": "DefinedBenefitPlanRemeasurementImpactUnderfundedStatus", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditDetails" ], "xbrltype": "monetaryItemType" }, "dd_DefinedBenefitPlansandOtherPostretirementBenefitPlansAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by defined benefits pension or other postretirement plan or groupings of similar plans.", "label": "Defined Benefit Plans and Other Postretirement Benefit Plans [Axis]", "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans [Axis]" } } }, "localname": "DefinedBenefitPlansandOtherPostretirementBenefitPlansAxis", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.dupont.com/role/StockholdersEquityReclassificationsoutofAOCIDetails", "http://www.dupont.com/role/StockholdersEquityTaxBenefitExpenseonNetActivityDetails" ], "xbrltype": "stringItemType" }, "dd_DefinedBenefitPlansandOtherPostretirementBenefitPlansDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Information by defined benefits pension or other postretirement plan or groupings of similar plans.", "label": "Defined Benefit Plans and Other Postretirement Benefit Plans [Domain]", "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans [Domain]" } } }, "localname": "DefinedBenefitPlansandOtherPostretirementBenefitPlansDomain", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.dupont.com/role/StockholdersEquityReclassificationsoutofAOCIDetails", "http://www.dupont.com/role/StockholdersEquityTaxBenefitExpenseonNetActivityDetails" ], "xbrltype": "domainItemType" }, "dd_Deminimisthreshold": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "De minimis requirement for which certain stray liabilities will be subject to for sharing arrangement between DuPont and Corteva.", "label": "De minimis threshold", "terseLabel": "De minimis threshold" } } }, "localname": "Deminimisthreshold", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails" ], "xbrltype": "monetaryItemType" }, "dd_Dilutiveeffectofequitycompensationplans": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dilutive effect of equity compensation plans", "label": "Dilutive effect of equity compensation plans", "terseLabel": "Dilutive effect of equity compensation plans" } } }, "localname": "Dilutiveeffectofequitycompensationplans", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EarningsPerShareShareCountInformationDetails" ], "xbrltype": "sharesItemType" }, "dd_DiseaseCategoriesforMDL": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disease Categories for MDL", "label": "Disease Categories for MDL", "terseLabel": "Disease Categories for MDL" } } }, "localname": "DiseaseCategoriesforMDL", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails" ], "xbrltype": "integerItemType" }, "dd_DisposalgroupIncludingDiscontinuedOperationRestrictedCash": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Restricted Cash", "label": "Disposal group, Including Discontinued Operation, Restricted Cash", "terseLabel": "Restricted cash of discontinued operations" } } }, "localname": "DisposalgroupIncludingDiscontinuedOperationRestrictedCash", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "dd_DocumentandEntityInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Document and Entity Information [Abstract]", "label": "Document and Entity Information [Abstract]", "terseLabel": "Document and Entity Information [Abstract]" } } }, "localname": "DocumentandEntityInformationAbstract", "nsuri": "http://www.dupont.com/20210331", "xbrltype": "stringItemType" }, "dd_DowDuPontCostSynergyProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DowDuPont Cost Synergy Program [Member]", "label": "DowDuPont Cost Synergy Program [Member]", "terseLabel": "DowDuPont Cost Synergy Program [Member]" } } }, "localname": "DowDuPontCostSynergyProgramMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedChargesTables" ], "xbrltype": "domainItemType" }, "dd_DowDuPontMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DowDuPont [Member]", "label": "DowDuPont [Member]", "terseLabel": "DowDuPont [Member]" } } }, "localname": "DowDuPontMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/RelatedPartyTransactionsTransactionswithDowDuPontDetails" ], "xbrltype": "domainItemType" }, "dd_DowMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dow [Member]", "label": "Dow [Member]", "terseLabel": "Dow [Member]" } } }, "localname": "DowMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/DivestituresandOtherTransactionsSeparationAgreementsDetails", "http://www.dupont.com/role/RelatedPartyTransactionsDowIntercompanyTransactionsDetails" ], "xbrltype": "domainItemType" }, "dd_DuPontDeNemoursAndCortevaContributionToMDLSettlementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DuPont de Nemours and Corteva Contribution to MDL Settlement", "label": "DuPont de Nemours and Corteva Contribution to MDL Settlement [Member]", "terseLabel": "DuPont de Nemours and Corteva Contribution to MDL Settlement" } } }, "localname": "DuPontDeNemoursAndCortevaContributionToMDLSettlementMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "domainItemType" }, "dd_DuPontdeNemoursMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DuPont de Nemours [Member]", "label": "DuPont de Nemours [Member]", "terseLabel": "DuPont de Nemours [Member]" } } }, "localname": "DuPontdeNemoursMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsSeparationAgreementsDetails" ], "xbrltype": "domainItemType" }, "dd_ECPDisposalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ECP Disposal [Member]", "label": "ECP Disposal [Member]", "terseLabel": "ECP Disposal [Member]" } } }, "localname": "ECPDisposalMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/DivestituresandOtherTransactionsTables" ], "xbrltype": "domainItemType" }, "dd_EIDBasisofPresentationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "EID - Basis of Presentation [Abstract]", "label": "EID - Basis of Presentation [Abstract]", "terseLabel": "EID - Basis of Presentation [Abstract]" } } }, "localname": "EIDBasisofPresentationAbstract", "nsuri": "http://www.dupont.com/20210331", "xbrltype": "stringItemType" }, "dd_EIDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "EID [Member]", "label": "EID [Member]", "terseLabel": "EID [Member]" } } }, "localname": "EIDMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets", "http://www.dupont.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows", "http://www.dupont.com/role/ConsolidatedStatementsofComprehensiveLossIncome", "http://www.dupont.com/role/ConsolidatedStatementsofOperations", "http://www.dupont.com/role/DEIDocument", "http://www.dupont.com/role/EIDBasisofPresentationNarrativeDetails", "http://www.dupont.com/role/EIDBasisofPresentationNotes", "http://www.dupont.com/role/EIDRelatedPartyTransactionsDetails", "http://www.dupont.com/role/EIDRelatedPartyTransactionsNotes", "http://www.dupont.com/role/EIDSegmentFNNotes", "http://www.dupont.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/EIDSegmentFNTables", "http://www.dupont.com/role/RelatedPartyTransactionsDowIntercompanyTransactionsDetails", "http://www.dupont.com/role/StatementofStockholdersEquityParentheticalsParentheticals", "http://www.dupont.com/role/StatementofStockholdersEquityStatement", "http://www.dupont.com/role/StockholdersEquityPreferredStockDetails" ], "xbrltype": "domainItemType" }, "dd_EIDRelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "EID - Related Party Transactions [Abstract]", "label": "EID - Related Party Transactions [Abstract]", "terseLabel": "EID - Related Party Transactions [Abstract]" } } }, "localname": "EIDRelatedPartyTransactionsAbstract", "nsuri": "http://www.dupont.com/20210331", "xbrltype": "stringItemType" }, "dd_EnvironmentalRemediationStrayLiabilitiesAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Environmental Remediation Stray Liabilities [Axis]", "label": "Environmental Remediation Stray Liabilities [Axis]", "terseLabel": "Environmental Remediation Stray Liabilities [Axis]" } } }, "localname": "EnvironmentalRemediationStrayLiabilitiesAxis", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "stringItemType" }, "dd_EnvironmentalRemediationStrayLiabilitiesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Environmental Remediation Stray Liabilities [Axis]", "label": "Environmental Remediation Stray Liabilities [Domain]", "terseLabel": "Environmental Remediation Stray Liabilities [Domain]" } } }, "localname": "EnvironmentalRemediationStrayLiabilitiesDomain", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "domainItemType" }, "dd_EnvironmentalremediationliabilitiesprimarilyrelatedtoDuPontsubjecttoindemnityfromDuPontMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont [Member]", "label": "Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont [Member]", "terseLabel": "Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont [Member]" } } }, "localname": "EnvironmentalremediationliabilitiesprimarilyrelatedtoDuPontsubjecttoindemnityfromDuPontMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "domainItemType" }, "dd_EscrowAccountBalance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount by which if escrow is below, on December 31, 2028, then Chemours will make 50% of the deposits and DuPont and Corteva together will make 50% of the deposits necessary to restore the balance of the escrow account to $700MM.", "label": "Escrow Account Balance", "terseLabel": "Escrow Account Balance" } } }, "localname": "EscrowAccountBalance", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails" ], "xbrltype": "monetaryItemType" }, "dd_EscrowAccountDepositPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of deposits to be made to the escrow account as part of the cost sharing agreement under the MOU.", "label": "Escrow Account Deposit Percentage", "terseLabel": "Escrow Account Deposit Percentage" } } }, "localname": "EscrowAccountDepositPercentage", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails" ], "xbrltype": "percentItemType" }, "dd_ExchangeRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exchange Ratio", "label": "Exchange Ratio", "terseLabel": "Exchange Ratio" } } }, "localname": "ExchangeRatio", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "integerItemType" }, "dd_ExecutetoWinProductivityProgramDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Execute to Win Productivity Program [Domain]", "label": "Execute to Win Productivity Program [Domain]", "terseLabel": "Execute to Win Productivity Program [Domain]" } } }, "localname": "ExecutetoWinProductivityProgramDomain", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesTables" ], "xbrltype": "domainItemType" }, "dd_FactoringAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Factoring Agreement [Member]", "label": "Factoring Agreement [Member]", "terseLabel": "Factoring Agreement [Member]" } } }, "localname": "FactoringAgreementMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/AccountsandNotesReceivableDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails" ], "xbrltype": "domainItemType" }, "dd_FavorableSupplyContractMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Favorable Supply Contract [Member]", "label": "Favorable Supply Contract [Member]", "terseLabel": "Favorable Supply Contract [Member]" } } }, "localname": "FavorableSupplyContractMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "dd_FirefightingFoamMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Firefighting Foam [Member]", "label": "Firefighting Foam [Member]", "terseLabel": "Firefighting Foam [Member]" } } }, "localname": "FirefightingFoamMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails" ], "xbrltype": "domainItemType" }, "dd_ForeignCurrencyExchangeGainLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Line Items] for Foreign Currency Exchange Gain (Loss) [Table]", "label": "Foreign Currency Exchange Gain (Loss) [Line Items]", "terseLabel": "Foreign Currency Exchange Gain (Loss) [Line Items]" } } }, "localname": "ForeignCurrencyExchangeGainLossLineItems", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails" ], "xbrltype": "stringItemType" }, "dd_ForeignCurrencyExchangeGainLossTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Currency Exchange Gain (Loss) [Table]", "label": "Foreign Currency Exchange Gain (Loss) [Table]", "terseLabel": "Foreign Currency Exchange Gain (Loss)" } } }, "localname": "ForeignCurrencyExchangeGainLossTable", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails" ], "xbrltype": "stringItemType" }, "dd_ForeignCurrencyExchangeGainLossTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Currency Exchange Gain (Loss) [Table Text Block]", "label": "Foreign Currency Exchange Gain (Loss) [Table Text Block]", "terseLabel": "Foreign Currency Exchange Gain (Loss)" } } }, "localname": "ForeignCurrencyExchangeGainLossTableTextBlock", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/SupplementaryInformationTables" ], "xbrltype": "textBlockItemType" }, "dd_ForeignCurrencyLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Currency Loans [Member]", "label": "Foreign Currency Loans [Member]", "terseLabel": "Foreign Currency Loans [Member]" } } }, "localname": "ForeignCurrencyLoansMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "dd_ForeignCurrencyTransactionGainLossAfterTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Foreign Currency Transaction Gain (Loss) After Tax", "label": "Foreign Currency Transaction Gain (Loss) After Tax", "terseLabel": "Foreign Currency Transaction (Loss) Gain After Tax" } } }, "localname": "ForeignCurrencyTransactionGainLossAfterTax", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails" ], "xbrltype": "monetaryItemType" }, "dd_ForeignCurrencyTransactionGainLossTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Foreign Currency Transaction Gain (Loss) Tax", "label": "Foreign Currency Transaction Gain (Loss) Tax", "terseLabel": "Foreign Currency Transaction (Loss) Gain Tax (Expense) Benefit" } } }, "localname": "ForeignCurrencyTransactionGainLossTax", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails" ], "xbrltype": "monetaryItemType" }, "dd_ForeignCurrencyTransactionTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Currency Transaction Type [Axis]", "label": "Foreign Currency Transaction Type [Axis]", "terseLabel": "Foreign Currency Transaction Type [Axis]" } } }, "localname": "ForeignCurrencyTransactionTypeAxis", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails", "http://www.dupont.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails", "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "stringItemType" }, "dd_ForeignCurrencyTransactionTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Foreign Currency Transaction Type [Axis]", "label": "Foreign Currency Transaction Type [Domain]", "terseLabel": "Foreign Currency Transaction Type [Domain]" } } }, "localname": "ForeignCurrencyTransactionTypeDomain", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails", "http://www.dupont.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails", "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "dd_ForeignExchangeImpactOnIncomeLossFromContinuingOperations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Impact to pre-tax earnings as a result of the deterioration of the Peso to USD exchange rate", "label": "Foreign Exchange Impact on Income (Loss) from Continuing Operations", "terseLabel": "Foreign Exchange Impact on Income (Loss) from Continuing Operations" } } }, "localname": "ForeignExchangeImpactOnIncomeLossFromContinuingOperations", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/SummaryofSignificantAccountingPoliciesSummaryofAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "dd_FungicidesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fungicides [Member]", "label": "Fungicides [Member]", "terseLabel": "Fungicides [Member]" } } }, "localname": "FungicidesMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/RevenueDisaggregationofRevenuePrincipalProductGroupsDetails" ], "xbrltype": "domainItemType" }, "dd_FutureCashPayments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Future cash payments related to restructuring program", "label": "Future Cash Payments", "terseLabel": "Future Cash Payments" } } }, "localname": "FutureCashPayments", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails" ], "xbrltype": "monetaryItemType" }, "dd_GermplasmMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Germplasm [Member]", "label": "Germplasm [Member]", "terseLabel": "Germplasm [Member]" } } }, "localname": "GermplasmMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "dd_GuaranteePaymentTimingAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Guarantee Payment Timing [Axis]", "label": "Guarantee Payment Timing [Axis]", "terseLabel": "Guarantee Payment Timing [Axis]" } } }, "localname": "GuaranteePaymentTimingAxis", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails" ], "xbrltype": "stringItemType" }, "dd_HedgingProgramGainLossTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hedging Program Gain (Loss) Type", "label": "Hedging Program Gain (Loss) Type [Axis]", "terseLabel": "Hedging Program Gain (Loss) Type [Axis]" } } }, "localname": "HedgingProgramGainLossTypeAxis", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails", "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "stringItemType" }, "dd_HedgingProgramGainLossTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hedging Program Gain (Loss) Type", "label": "Hedging Program Gain (Loss) Type [Domain]", "terseLabel": "Hedging Program Gain (Loss) Type [Domain]" } } }, "localname": "HedgingProgramGainLossTypeDomain", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails", "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "dd_HedgingProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hedging Program [Member]", "label": "Hedging Program [Member]", "terseLabel": "Hedging Program [Member]" } } }, "localname": "HedgingProgramMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails", "http://www.dupont.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails", "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "dd_HerbicidesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Herbicides [Member]", "label": "Herbicides [Member]", "terseLabel": "Herbicides [Member]" } } }, "localname": "HerbicidesMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/RevenueDisaggregationofRevenuePrincipalProductGroupsDetails" ], "xbrltype": "domainItemType" }, "dd_ImpairmentOfIntangibleAssetsIndefiniteLivedExcludingGoodwillAfterTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Impairment of Intangible Assets Indefinite lived Excluding Goodwill After Tax", "label": "Impairment of Intangible Assets Indefinite lived Excluding Goodwill After Tax", "terseLabel": "Impairment of Intangible Assets Indefinite lived Excluding Goodwill After Tax" } } }, "localname": "ImpairmentOfIntangibleAssetsIndefiniteLivedExcludingGoodwillAfterTax", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "dd_IncomeStatementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Income Statement [Member]", "label": "Income Statement [Member]", "terseLabel": "Income Statement [Member]" } } }, "localname": "IncomeStatementMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/DivestituresandOtherTransactionsTables" ], "xbrltype": "domainItemType" }, "dd_IncomefromContinuingOperationsAfterTaxes": { "auth_ref": [], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Income from Continuing Operations After Taxes", "label": "Income from Continuing Operations After Taxes", "terseLabel": "Income from Continuing Operations After Taxes", "totalLabel": "Income from Continuing Operations After Taxes" } } }, "localname": "IncomefromContinuingOperationsAfterTaxes", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofOperations", "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails" ], "xbrltype": "monetaryItemType" }, "dd_IndemnificationAsset": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Indemnification asset for indemnified liabilities related to environmental remediation.", "label": "Indemnification Asset", "terseLabel": "Indemnification Asset" } } }, "localname": "IndemnificationAsset", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "monetaryItemType" }, "dd_IndemnificationAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Indemnification asset for liabilities indemnified against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the spin-off of Corteva.", "label": "Indemnification Assets", "terseLabel": "Indemnification Assets" } } }, "localname": "IndemnificationAssets", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsSeparationAgreementsDetails" ], "xbrltype": "monetaryItemType" }, "dd_IndemnificationAssetsForLiabilitiesIndemnifiedByChemours": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Indemnification asset for liabilities indemnified by Chemours against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the spin-off of Chemours.", "label": "Indemnification Assets for liabilities indemnified by Chemours", "terseLabel": "Indemnification Asset for liabilities indemnified by Chemours" } } }, "localname": "IndemnificationAssetsForLiabilitiesIndemnifiedByChemours", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "monetaryItemType" }, "dd_IndemnifiedLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Indemnified Liabilities for liabilities indemnified by Corteva against certain litigation, environmental, workers compensation and other liabilities that arose prior to the spin-off of Corteva.", "label": "Indemnified Liabilities", "terseLabel": "Indemnified Liabilities" } } }, "localname": "IndemnifiedLiabilities", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/DivestituresandOtherTransactionsSeparationAgreementsDetails" ], "xbrltype": "monetaryItemType" }, "dd_IndemnifiedLiabilitiesForLiabilitiesIndemnifiedByChemours": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Indemnified Liabilities for liabilities indemnified by Chemours against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the spin-off of Chemours.", "label": "Indemnified Liabilities for liabilities indemnified by Chemours", "terseLabel": "Indemnified Liabilities for liabilities indemnified by Chemours" } } }, "localname": "IndemnifiedLiabilitiesForLiabilitiesIndemnifiedByChemours", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "monetaryItemType" }, "dd_IndemnifiedLiabilitiesForLiabilitiesIndemnifiedByCorteva": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Indemnified Liabilities for Liabilities Indemnified by Corteva associated with environmental remediation related to PFAS.", "label": "Indemnified Liabilities for Liabilities Indemnified by Corteva", "terseLabel": "Indemnified Liabilities for Liabilities Indemnified by Corteva" } } }, "localname": "IndemnifiedLiabilitiesForLiabilitiesIndemnifiedByCorteva", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "monetaryItemType" }, "dd_InsecticidesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Insecticides [Member]", "label": "Insecticides [Member]", "terseLabel": "Insecticides [Member]" } } }, "localname": "InsecticidesMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/RevenueDisaggregationofRevenuePrincipalProductGroupsDetails" ], "xbrltype": "domainItemType" }, "dd_InterestrateinadditiontoLIBOR": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate in addition to LIBOR on borrowings under the repurchase facility", "label": "Interest rate in addition to LIBOR", "terseLabel": "Interest rate in addition to LIBOR" } } }, "localname": "InterestrateinadditiontoLIBOR", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails" ], "xbrltype": "percentItemType" }, "dd_InternalReorganizationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Internal Reorganization [Member]", "label": "Internal Reorganization [Member]", "terseLabel": "Internal Reorganization [Member]" } } }, "localname": "InternalReorganizationMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.dupont.com/role/SummaryofSignificantAccountingPoliciesSummaryofAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "dd_LaPorteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "La Porte [Member]", "label": "La Porte [Member]", "terseLabel": "La Porte [Member]" } } }, "localname": "LaPorteMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails" ], "xbrltype": "domainItemType" }, "dd_Lawsuitsallegingpersonalinjuryfiled": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lawsuits alleging personal injury which were filed.", "label": "Lawsuits alleging personal injury filed", "terseLabel": "Lawsuits alleging personal injury filed" } } }, "localname": "Lawsuitsallegingpersonalinjuryfiled", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails" ], "xbrltype": "integerItemType" }, "dd_LitigationSettlementLiabilityForMedicalMonitoringProgramThreshold": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Litigation Settlement, Liability For Medical Monitoring Program, Threshold", "label": "Litigation Settlement, Liability For Medical Monitoring Program, Threshold", "terseLabel": "Litigation Settlement, Liability For Medical Monitoring Program, Threshold" } } }, "localname": "LitigationSettlementLiabilityForMedicalMonitoringProgramThreshold", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails" ], "xbrltype": "monetaryItemType" }, "dd_LitigationSettlementMedicalMonitoringProgramEscrowAccountDisbursementsToDate": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Litigation Settlement, Medical Monitoring Program, Escrow Account, Disbursements To Date", "label": "Litigation Settlement, Medical Monitoring Program, Escrow Account, Disbursements To Date", "terseLabel": "Litigation Settlement, Medical Monitoring Program, Escrow Account, Disbursements To Date" } } }, "localname": "LitigationSettlementMedicalMonitoringProgramEscrowAccountDisbursementsToDate", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails" ], "xbrltype": "monetaryItemType" }, "dd_LossContingencyLimitedSharingofPotentialFutureLiabilitiesPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss Contingency, Limited Sharing of Potential Future Liabilities, Period", "label": "Loss Contingency, Limited Sharing of Potential Future Liabilities, Period", "terseLabel": "Loss Contingency, Limited Sharing of Potential Future Liabilities, Period" } } }, "localname": "LossContingencyLimitedSharingofPotentialFutureLiabilitiesPeriod", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails" ], "xbrltype": "durationItemType" }, "dd_LossContingencyNumberOfWaterDistrictsReceivingWaterTreatment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss Contingency, Number Of Water Districts Receiving Water Treatment", "label": "Loss Contingency, Number Of Water Districts Receiving Water Treatment", "terseLabel": "Loss Contingency, Number Of Water Districts Receiving Water Treatment" } } }, "localname": "LossContingencyNumberOfWaterDistrictsReceivingWaterTreatment", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails" ], "xbrltype": "integerItemType" }, "dd_LossContingencyNumberofAdditionalPlaintiffs": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss Contingency, Number of Additional Plaintiffs", "label": "Loss Contingency, Number of Additional Plaintiffs", "terseLabel": "Loss Contingency, Number of Additional Plaintiffs" } } }, "localname": "LossContingencyNumberofAdditionalPlaintiffs", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails" ], "xbrltype": "integerItemType" }, "dd_LossContingencyNumberofPropertyOwners": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss Contingency, Number of Property Owners", "label": "Loss Contingency, Number of Property Owners", "terseLabel": "Loss Contingency, Number of Property Owners" } } }, "localname": "LossContingencyNumberofPropertyOwners", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails" ], "xbrltype": "integerItemType" }, "dd_LossContingencyThreatenedClaimsNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss Contingency, Threatened Claims, Number", "label": "Loss Contingency, Threatened Claims, Number", "terseLabel": "Loss Contingency, Threatened Claims, Number" } } }, "localname": "LossContingencyThreatenedClaimsNumber", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails" ], "xbrltype": "integerItemType" }, "dd_LossofconsortiumMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss of consortium [Member]", "label": "Loss of consortium [Member]", "terseLabel": "Loss of consortium [Member]" } } }, "localname": "LossofconsortiumMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails" ], "xbrltype": "domainItemType" }, "dd_MDLSettlementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "MDL Settlement", "label": "MDL Settlement [Member]", "terseLabel": "MDL Settlement [Domain]" } } }, "localname": "MDLSettlementMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "domainItemType" }, "dd_MajorProductLineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Major Product Line [Member]", "label": "Major Product Line [Member]", "terseLabel": "Major Product Line [Member]" } } }, "localname": "MajorProductLineMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/RevenueTables" ], "xbrltype": "domainItemType" }, "dd_MarkToMarketGainLossOnCertainForeignCurrencyContractsNotDesignatedAsHedges": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting represents the non-cash net gain (loss) from the changes in fair value of certain undesignated foreign currency derivative contracts.", "label": "Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges", "terseLabel": "Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges" } } }, "localname": "MarkToMarketGainLossOnCertainForeignCurrencyContractsNotDesignatedAsHedges", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/SegmentReportingSegmentReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "dd_MarketableSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Marketable Securities [Member]", "label": "Marketable Securities [Member]", "terseLabel": "Marketable Securities [Member]" } } }, "localname": "MarketableSecuritiesMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "dd_MergerwithDowMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Merger with Dow [Member]", "label": "Merger with Dow [Member]", "terseLabel": "Merger with Dow [Member]" } } }, "localname": "MergerwithDowMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/InventoriesScheduleofInventoryDetails" ], "xbrltype": "domainItemType" }, "dd_MethodofDisaggregationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Method of Disaggregation [Axis]", "label": "Method of Disaggregation [Axis]", "terseLabel": "Method of Disaggregation [Axis]" } } }, "localname": "MethodofDisaggregationAxis", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/RevenueTables" ], "xbrltype": "stringItemType" }, "dd_MethodofDisaggregationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Method of Disaggregation [Axis]", "label": "Method of Disaggregation [Domain]", "terseLabel": "Method of Disaggregation [Domain]" } } }, "localname": "MethodofDisaggregationDomain", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/RevenueTables" ], "xbrltype": "domainItemType" }, "dd_Miscellaneousincomeandexpensesnet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Miscellaneous income and expenses, net", "label": "Miscellaneous income and expenses, net", "terseLabel": "Miscellaneous expenses - net" } } }, "localname": "Miscellaneousincomeandexpensesnet", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "dd_NaturalResourcesDamagesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Natural Resources Damages [Member]", "label": "Natural Resources Damages [Member]", "terseLabel": "Natural Resources Damages [Member]" } } }, "localname": "NaturalResourcesDamagesMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails" ], "xbrltype": "domainItemType" }, "dd_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic and Diluted", "terseLabel": "Net income (loss) Available to Common Stockholders" } } }, "localname": "NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EarningsPerShareNetIncomeforEarningsPerShareCalculationsBasicandDilutedDetails" ], "xbrltype": "monetaryItemType" }, "dd_NetIncomeLossfromContinuingOperationsAvailabletoCommonShareholdersBasicandDiluted": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders.", "label": "Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic and Diluted", "terseLabel": "Net income (loss) from Continuing Operations Available to Common Shareholders" } } }, "localname": "NetIncomeLossfromContinuingOperationsAvailabletoCommonShareholdersBasicandDiluted", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EarningsPerShareNetIncomeforEarningsPerShareCalculationsBasicandDilutedDetails" ], "xbrltype": "monetaryItemType" }, "dd_Netgainonsalesofbusinessesandotherassets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net gain on sales of businesses and other assets", "label": "Net gain on sales of businesses and other assets", "terseLabel": "Net gain (loss) on sales of businesses and other assets" } } }, "localname": "Netgainonsalesofbusinessesandotherassets", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "dd_Netgainonsalesofpropertybusinessesconsolidatedcompaniesandinvestments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain (loss) from sale or disposal of an organization or integrated set of activities (for example, but not limited to, a partnership or corporation) engaged in providing a product or service in a commercial, industrial, or professional environment. Also includes amount of gain (loss) on sale or disposal of assets, including but not limited to property, plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.", "label": "Net gain on sales of property, businesses, consolidated companies, and investments", "terseLabel": "Net loss (gain) on sales of property, businesses, consolidated companies, and investments" } } }, "localname": "Netgainonsalesofpropertybusinessesconsolidatedcompaniesandinvestments", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "dd_Nonoperatingbenefitscostsnet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Non-operating (benefits) costs - net", "label": "Non-operating (benefits) costs - net", "terseLabel": "Non-operating benefits - net" } } }, "localname": "Nonoperatingbenefitscostsnet", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails" ], "xbrltype": "monetaryItemType" }, "dd_NotesMaturing2025Domain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notes Maturing 2025 [Domain]", "label": "Notes Maturing 2025 [Domain]", "terseLabel": "Notes Maturing 2025 [Domain]" } } }, "localname": "NotesMaturing2025Domain", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "dd_NotesMaturing2030Domain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notes Maturing 2030 [Domain]", "label": "Notes Maturing 2030 [Domain]", "terseLabel": "Notes Maturing 2030 [Domain]" } } }, "localname": "NotesMaturing2030Domain", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "dd_NotsubjecttoindemnificationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Not subject to indemnification [Member]", "label": "Not subject to indemnification [Member]", "terseLabel": "Not subject to indemnification [Member]" } } }, "localname": "NotsubjecttoindemnificationMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "domainItemType" }, "dd_Once300millionthresholdismetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Once $300 million threshold is met [Member]", "label": "Once $300 million threshold is met [Member]", "terseLabel": "Once $300 million threshold is met [Member]" } } }, "localname": "Once300millionthresholdismetMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails" ], "xbrltype": "domainItemType" }, "dd_OtherAssetRelatedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Asset Related", "label": "Other Asset Related [Member]", "terseLabel": "Other Asset Related [Member]" } } }, "localname": "OtherAssetRelatedMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedChargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "dd_OtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other [Member]", "label": "Other [Member]", "terseLabel": "Other [Member]" } } }, "localname": "OtherMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/RevenueDisaggregationofRevenuePrincipalProductGroupsDetails" ], "xbrltype": "domainItemType" }, "dd_OtherTaxBenefit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Tax benefit associated with changes in accruals for certain prior year tax positions and reductions in the company's unrecognized tax benefits due to closure of various state statutes of limitations.", "label": "Other Tax Benefit", "terseLabel": "Other Tax Benefit" } } }, "localname": "OtherTaxBenefit", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/IncomeTaxesIncomeTaxNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "dd_OtherdiscontinuedoperationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other discontinued operations [Member]", "label": "Other discontinued operations [Member]", "terseLabel": "Other discontinued operations [Member]" } } }, "localname": "OtherdiscontinuedoperationsMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/DivestituresandOtherTransactionsOtherDiscontinuedOperationsDetails" ], "xbrltype": "domainItemType" }, "dd_OtherdiscontinuedordivestedbusinessobligationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other discontinued or divested business obligations [Member]", "label": "Other discontinued or divested business obligations [Member]", "terseLabel": "Other discontinued or divested business obligations [Member]" } } }, "localname": "OtherdiscontinuedordivestedbusinessobligationsMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "domainItemType" }, "dd_OtherloansvariouscurrenciesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other loans - various currencies [Member]", "label": "Other loans - various currencies [Member]", "terseLabel": "Other loans - various currencies [Member]" } } }, "localname": "OtherloansvariouscurrenciesMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails" ], "xbrltype": "domainItemType" }, "dd_OtheroilseedsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other oilseeds [Member]", "label": "Other oilseeds [Member]", "terseLabel": "Other oilseeds [Member]" } } }, "localname": "OtheroilseedsMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/RevenueDisaggregationofRevenuePrincipalProductGroupsDetails" ], "xbrltype": "domainItemType" }, "dd_Ownershipinterestinanentity": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ownership interest in an entity", "label": "Ownership interest in an entity", "terseLabel": "Ownership interest in an entity" } } }, "localname": "Ownershipinterestinanentity", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EIDBasisofPresentationNarrativeDetails", "http://www.dupont.com/role/StockholdersEquityPreferredStockDetails" ], "xbrltype": "percentItemType" }, "dd_PFASMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PFAS [Member]", "label": "PFAS [Member]", "terseLabel": "PFAS [Member]" } } }, "localname": "PFASMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails" ], "xbrltype": "domainItemType" }, "dd_PFOADetailsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PFOA Details [Abstract]", "label": "PFOA Details [Abstract]", "terseLabel": "PFOA Details [Abstract]" } } }, "localname": "PFOADetailsAbstract", "nsuri": "http://www.dupont.com/20210331", "xbrltype": "stringItemType" }, "dd_PFOAMattersDrinkingWaterActionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PFOA Matters: Drinking Water Actions [Member]", "label": "PFOA Matters: Drinking Water Actions [Member]", "terseLabel": "PFOA Matters: Drinking Water Actions [Member]" } } }, "localname": "PFOAMattersDrinkingWaterActionsMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "domainItemType" }, "dd_PFOAMattersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PFOA Matters [Member]", "label": "PFOA Matters [Member]", "terseLabel": "PFOA Matters [Member]" } } }, "localname": "PFOAMattersMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails" ], "xbrltype": "domainItemType" }, "dd_PFOAMattersMultiDistrictLitigationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PFOA Matters: Multi-District Litigation [Member]", "label": "PFOA Matters: Multi-District Litigation [Member]", "terseLabel": "PFOA Matters: Multi-District Litigation [Member]" } } }, "localname": "PFOAMattersMultiDistrictLitigationMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails" ], "xbrltype": "domainItemType" }, "dd_PaymentTimingDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Payment Timing [Axis]", "label": "Payment Timing [Domain]", "terseLabel": "Payment Timing [Domain]" } } }, "localname": "PaymentTimingDomain", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails" ], "xbrltype": "domainItemType" }, "dd_PercentageDeteriorationOfTheOfficialPesoToUSDExchangeRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Increase of deterioration in the official Peso to USD exchange rate which would cause a reduction in net monetary assets and negatively impact pre-tax earnings.", "label": "Percentage deterioration of the official Peso to USD exchange rate", "terseLabel": "Percentage deterioration of the official Peso to USD exchange rate" } } }, "localname": "PercentageDeteriorationOfTheOfficialPesoToUSDExchangeRate", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/SummaryofSignificantAccountingPoliciesSummaryofAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "dd_Percentageofoutstandingamountsborrowedutilizedascollateral": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of outstanding amounts borrowed utilized as collateral", "label": "Percentage of outstanding amounts borrowed utilized as collateral", "terseLabel": "Percentage of outstanding amounts borrowed utilized as collateral" } } }, "localname": "Percentageofoutstandingamountsborrowedutilizedascollateral", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails" ], "xbrltype": "percentItemType" }, "dd_PerformanceChemicalsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance Chemicals", "label": "Performance Chemicals [Member]", "terseLabel": "Performance Chemicals" } } }, "localname": "PerformanceChemicalsMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "domainItemType" }, "dd_PersonalinjurycasesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Personal injury cases [Member]", "label": "Personal injury cases [Member]", "terseLabel": "Personal injury cases [Member]" } } }, "localname": "PersonalinjurycasesMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails" ], "xbrltype": "domainItemType" }, "dd_PostMDLSettlementPFOAPersonalInjuryClaimsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Post-MDL Settlement PFOA Personal Injury Claims [Domain]", "label": "Post-MDL Settlement PFOA Personal Injury Claims [Domain]", "terseLabel": "WEST VIRGINIA AND OHIO [Domain]" } } }, "localname": "PostMDLSettlementPFOAPersonalInjuryClaimsDomain", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "domainItemType" }, "dd_Proceedsfromthesaleofpropertybusinessesandconsolidatedcompaniesnetofcashdivested": { "auth_ref": [], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested", "label": "Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested", "terseLabel": "Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested" } } }, "localname": "Proceedsfromthesaleofpropertybusinessesandconsolidatedcompaniesnetofcashdivested", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "dd_Proformaadjustments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Pro forma adjustments", "label": "Pro forma adjustments", "terseLabel": "Pro forma adjustments" } } }, "localname": "Proformaadjustments", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/SegmentReportingSegmentReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "dd_PropertyPlantandEquipmentDepreciationExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Property, Plant and Equipment - Depreciation Expense [Table Text Block]", "label": "Property, Plant and Equipment - Depreciation Expense [Table Text Block]", "terseLabel": "Property, Plant and Equipment - Depreciation Expense [Table Text Block]" } } }, "localname": "PropertyPlantandEquipmentDepreciationExpenseTableTextBlock", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/PropertyPlantandEquipmentTables" ], "xbrltype": "textBlockItemType" }, "dd_QualifiedSpendAndEscrowAccountContributionThreshold": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Qualified Spend and Escrow Account Contribution Threshold", "label": "Qualified Spend and Escrow Account Contribution Threshold", "terseLabel": "Qualified Spend and Escrow Account Contribution Threshold" } } }, "localname": "QualifiedSpendAndEscrowAccountContributionThreshold", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails" ], "xbrltype": "monetaryItemType" }, "dd_ReallocationofgoodwillMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reallocation of goodwill [Member]", "label": "Reallocation of goodwill [Member]", "terseLabel": "Reallocation of goodwill [Member]" } } }, "localname": "ReallocationofgoodwillMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/SegmentReportingSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "dd_Requiredtimetoremoveassets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of time, from operations being ceased, that lease agreement requires assets to be removed.", "label": "Required time to remove assets", "terseLabel": "Ceased Operations" } } }, "localname": "Requiredtimetoremoveassets", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails" ], "xbrltype": "durationItemType" }, "dd_RestructuringAndAssetRelatedChargesNet": { "auth_ref": [], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of restructuring charges, remediation cost, asset impairment loss and other asset related charges.", "label": "Restructuring and Asset related charges, net", "terseLabel": "Restructuring and Asset related charges, net" } } }, "localname": "RestructuringAndAssetRelatedChargesNet", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows", "http://www.dupont.com/role/ConsolidatedStatementsofOperations", "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails" ], "xbrltype": "monetaryItemType" }, "dd_RevolvingCreditFacilitiesdue2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revolving Credit Facilities due 2022 [Member]", "label": "Revolving Credit Facilities due 2022 [Member]", "terseLabel": "Revolving Credit Facilities due 2022 [Member]" } } }, "localname": "RevolvingCreditFacilitiesdue2022Member", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails" ], "xbrltype": "domainItemType" }, "dd_RevolvingCreditFacilitiesdue2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revolving Credit Facilities due 2024 [Member]", "label": "Revolving Credit Facilities due 2024 [Member]", "terseLabel": "Revolving Credit Facilities due 2024 [Member]" } } }, "localname": "RevolvingCreditFacilitiesdue2024Member", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails" ], "xbrltype": "domainItemType" }, "dd_RoundedAmountMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rounded Amount", "label": "Rounded Amount [Member]", "terseLabel": "Rounded Amount [Member]" } } }, "localname": "RoundedAmountMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EarningsPerShareShareCountInformationDetails" ], "xbrltype": "domainItemType" }, "dd_SaleofJVMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of JV [Member]", "label": "Sale of JV [Member]", "terseLabel": "Sale of JV [Member]" } } }, "localname": "SaleofJVMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails", "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "dd_ScheduledfortrialMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Scheduled for trial [Member]", "label": "Scheduled for trial [Member]", "terseLabel": "Scheduled for trial [Member]" } } }, "localname": "ScheduledfortrialMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails" ], "xbrltype": "domainItemType" }, "dd_ScheduleofAdditionalSegmentDetailsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Additional Segment Details [Table Text Block]", "label": "Schedule of Additional Segment Details [Table Text Block]", "terseLabel": "Schedule of Additional Segment Details [Table Text Block]" } } }, "localname": "ScheduleofAdditionalSegmentDetailsTableTextBlock", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/SegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "dd_ScheduleofEnvironmentalLossContingenciesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabluar disclosure of environmental loss contingencies. Does not include loss contingencies that are not environmental in nature.", "label": "Schedule of Environmental Loss Contingencies [Table Text Block]", "terseLabel": "Schedule of Environmental Loss Contingencies by Site [Table Text Block]" } } }, "localname": "ScheduleofEnvironmentalLossContingenciesTableTextBlock", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "dd_ScheduleofFiniteandIndefiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite or indefinite life, by either major class or business segment.", "label": "Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Other Intangible Assets" } } }, "localname": "ScheduleofFiniteandIndefiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "dd_ScheduleofNoncontrollingInterestsRepresentedbyPreferredStockTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Noncontrolling Interests Represented by Preferred Stock [Table Text Block]", "label": "Schedule of Noncontrolling Interests Represented by Preferred Stock [Table Text Block]", "terseLabel": "Schedule of Noncontrolling Interests Represented by Preferred Stock [Table Text Block]" } } }, "localname": "ScheduleofNoncontrollingInterestsRepresentedbyPreferredStockTableTextBlock", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "dd_SeedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Seed [Member]", "label": "Seed [Member]", "terseLabel": "Seed [Member]" } } }, "localname": "SeedMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.dupont.com/role/RevenueDisaggregationofRevenueGeographyDetails", "http://www.dupont.com/role/RevenueDisaggregationofRevenuePrincipalProductGroupsDetails", "http://www.dupont.com/role/SegmentReportingSegmentInformationDetails", "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails", "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "dd_SegmentAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Segment Assets", "label": "Segment Assets", "terseLabel": "Segment Assets" } } }, "localname": "SegmentAssets", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.dupont.com/role/SegmentReportingSegmentAssetReconciliationDetails", "http://www.dupont.com/role/SegmentReportingSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "dd_SegmentReportingInformationOtherBenefitCharge": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Segment Reporting Information Other Benefit (Charge)", "label": "Segment Reporting Information Other Benefit (Charge)", "terseLabel": "Significant Items" } } }, "localname": "SegmentReportingInformationOtherBenefitCharge", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails" ], "xbrltype": "monetaryItemType" }, "dd_SegmentReportingReconcilingItemCorporateExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Segment Reporting Reconciling Item Corporate Expenses", "label": "Segment Reporting Reconciling Item Corporate Expenses", "terseLabel": "Corporate Expenses" } } }, "localname": "SegmentReportingReconcilingItemCorporateExpenses", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/SegmentReportingSegmentReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "dd_SegmentoperatingEBITDA": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Segment operating EBITDA", "label": "Segment operating EBITDA", "terseLabel": "Segment operating EBITDA" } } }, "localname": "SegmentoperatingEBITDA", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/SegmentReportingSegmentInformationDetails", "http://www.dupont.com/role/SegmentReportingSegmentReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "dd_SeniorNotesDue2025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Notes Due 2025 [Member]", "label": "Senior Notes Due 2025 [Member]", "terseLabel": "Senior Notes Due 2025 [Member]" } } }, "localname": "SeniorNotesDue2025Member", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "dd_SeniorNotesDue2030Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Notes Due 2030 [Member]", "label": "Senior Notes Due 2030 [Member]", "terseLabel": "Senior Notes Due 2030 [Member]" } } }, "localname": "SeniorNotesDue2030Member", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "dd_ShareCountInformationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Table Text Block] for Share Count Information [Table]", "label": "Share Count Information [Table Text Block]", "terseLabel": "Share Count Information" } } }, "localname": "ShareCountInformationTableTextBlock", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "dd_Sharesinwhichvestingconditionsweremet": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares in which vesting conditions were met", "label": "Shares in which vesting conditions were met", "terseLabel": "Shares in which vesting conditions were met" } } }, "localname": "Sharesinwhichvestingconditionsweremet", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EarningsPerShareShareCountInformationDetails" ], "xbrltype": "sharesItemType" }, "dd_SharesofCortevaStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares of Corteva Stock [Member]", "label": "Shares of Corteva Stock [Member]", "terseLabel": "Shares of Corteva Stock [Member]" } } }, "localname": "SharesofCortevaStockMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "domainItemType" }, "dd_SharesofDowDuPontCommonStockHeldMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares of DowDuPont Common Stock Held [Member]", "label": "Shares of DowDuPont Common Stock Held [Member]", "terseLabel": "Shares of DowDuPont Common Stock Held [Member]" } } }, "localname": "SharesofDowDuPontCommonStockHeldMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "domainItemType" }, "dd_ShortTermInvestmentsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Short Term Investments, Fair Value Disclosure", "label": "Short Term Investments, Fair Value Disclosure", "terseLabel": "Marketable Securities" } } }, "localname": "ShortTermInvestmentsFairValueDisclosure", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "dd_SoybeanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Soybean [Member]", "label": "Soybean [Member]", "terseLabel": "Soybean [Member]" } } }, "localname": "SoybeanMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/RevenueDisaggregationofRevenuePrincipalProductGroupsDetails" ], "xbrltype": "domainItemType" }, "dd_SpecialtyProductsDisposalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Specialty Products Disposal [Member]", "label": "Specialty Products Disposal [Member]", "terseLabel": "Specialty Products Disposal [Member]" } } }, "localname": "SpecialtyProductsDisposalMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/DivestituresandOtherTransactionsTables" ], "xbrltype": "domainItemType" }, "dd_StockoptionsandrestrictedstockunitsexcludedfromEPS": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units that were excluded from the calculation of diluted EPS because the effect of including them would have been anti-dilutive.", "label": "Stock options and restricted stock units excluded from EPS", "terseLabel": "Potential shares of common stock excluded from EPS calculations" } } }, "localname": "StockoptionsandrestrictedstockunitsexcludedfromEPS", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/EarningsPerShareShareCountInformationDetails" ], "xbrltype": "sharesItemType" }, "dd_Strayliabilitysharingpercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stray liability sharing percentage", "label": "Stray liability sharing percentage", "terseLabel": "Stray liability sharing percentage" } } }, "localname": "Strayliabilitysharingpercentage", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails" ], "xbrltype": "percentItemType" }, "dd_Strayliabilitythreshold": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount over and above specified amounts of liability, for which Corteva and DuPont are responsible for strays.", "label": "Stray liability threshold", "terseLabel": "Stray liability threshold" } } }, "localname": "Strayliabilitythreshold", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "monetaryItemType" }, "dd_SuperfundSitesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Superfund Sites [Member]", "label": "Superfund Sites [Member]", "terseLabel": "Superfund Sites [Member]" } } }, "localname": "SuperfundSitesMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "domainItemType" }, "dd_TaxBenefitChargeRelatedToApplicationOfTheActsForeignTaxProvisions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Tax benefit (charge) related to application of the Act's foreign tax provisions", "label": "Tax benefit (charge) related to application of the Act's foreign tax provisions", "terseLabel": "Tax benefit (charge) related to application of the Act's foreign tax provisions" } } }, "localname": "TaxBenefitChargeRelatedToApplicationOfTheActsForeignTaxProvisions", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/IncomeTaxesIncomeTaxNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "dd_TaxBenefitRelatedToTheEnactmentOfTheSwissTaxReform": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Tax benefit related to the enactment of the Swiss Tax Reform", "label": "Tax benefit related to the enactment of the Swiss Tax Reform", "terseLabel": "Tax benefit related to the enactment of the Swiss Tax Reform" } } }, "localname": "TaxBenefitRelatedToTheEnactmentOfTheSwissTaxReform", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/IncomeTaxesIncomeTaxNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "dd_TaxbenefitrelatedtoanelectivechangeinaccountingmethodfortheimpactoftheActsforeigntaxprovisions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Tax benefit related to return to accrual adjustment associated with elective change in accounting method for 2019 tax year impact of The Act's foreign tax provisions.", "label": "Tax benefit related to an elective change in accounting method for the impact of the Act's foreign tax provisions", "terseLabel": "Tax benefit related to an elective change in accounting method for the impact of the Act's foreign tax provisions" } } }, "localname": "TaxbenefitrelatedtoanelectivechangeinaccountingmethodfortheimpactoftheActsforeigntaxprovisions", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/IncomeTaxesIncomeTaxNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "dd_TaxbenefitrelatedtoaninternallegalentityrestructuringassociatedwiththeBusinessSeparations": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Tax benefit related to an internal legal entity restructuring associated with the Business Separations", "label": "Tax benefit related to an internal legal entity restructuring associated with the Business Separations", "terseLabel": "Tax benefit related to an internal legal entity restructuring associated with the Internal Reorganizations" } } }, "localname": "TaxbenefitrelatedtoaninternallegalentityrestructuringassociatedwiththeBusinessSeparations", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/IncomeTaxesIncomeTaxNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "dd_Taxbenefitrelatedtotheimpactofrecenttaxlawenactmentinforeignjurisdictions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Tax benefit related to accrual adjustment to reflect change in estimate on impact of tax law enactment in a foreign jurisdiction.", "label": "Tax benefit related to the impact of recent tax law enactment in foreign jurisdictions", "terseLabel": "Tax benefit related to the impact of recent tax law enactment in foreign jurisdictions" } } }, "localname": "Taxbenefitrelatedtotheimpactofrecenttaxlawenactmentinforeignjurisdictions", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/IncomeTaxesIncomeTaxNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "dd_TaxchargerelatedtoU.S.stateblendedtaxratechangesassociatedwiththeBusinessSeparations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Tax charge related to U.S. state blended tax rate changes associated with the Business Separations.", "label": "Tax charge related to U.S. state blended tax rate changes associated with the Business Separations", "terseLabel": "Tax charge related to U.S. state blended tax rate changes associated with the Internal Reorganizations" } } }, "localname": "TaxchargerelatedtoU.S.stateblendedtaxratechangesassociatedwiththeBusinessSeparations", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/IncomeTaxesIncomeTaxNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "dd_TotalEscrowDepositAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "From September 30, 2021 through September 30, 2028, Chemours will deposit a total of $500 million in the escrow account and DuPont and Corteva will deposit an additional $500 million pursuant to the terms of the Letter Agreement.", "label": "Total Escrow Deposit Amount", "terseLabel": "Total Escrow Deposit Amount" } } }, "localname": "TotalEscrowDepositAmount", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails" ], "xbrltype": "monetaryItemType" }, "dd_TotalcompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total company [Member]", "label": "Total company [Member]", "terseLabel": "Total company [Member]" } } }, "localname": "TotalcompanyMember", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "domainItemType" }, "dd_TradeReceivablesSold": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Trade Receivables Sold", "label": "Trade Receivables Sold", "terseLabel": "Trade Receivables Sold" } } }, "localname": "TradeReceivablesSold", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/AccountsandNotesReceivableDetails" ], "xbrltype": "monetaryItemType" }, "dd_TypeofDisclosureAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of Disclosure [Axis]", "label": "Type of Disclosure [Axis]", "terseLabel": "Type of Disclosure [Axis]" } } }, "localname": "TypeofDisclosureAxis", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/DivestituresandOtherTransactionsTables" ], "xbrltype": "stringItemType" }, "dd_TypeofDisclosureDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Type of Disclosure [Axis]", "label": "Type of Disclosure [Domain]", "terseLabel": "Type of Disclosure [Domain]" } } }, "localname": "TypeofDisclosureDomain", "nsuri": "http://www.dupont.com/20210331", "presentation": [ "http://www.dupont.com/role/DivestituresandOtherTransactionsTables" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards.", "label": "Document [Domain]", "terseLabel": "Document [Domain]" } } }, "localname": "DocumentDomain", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "domainItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationDocumentAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Document Information, Document [Axis]", "terseLabel": "Document Information, Document [Axis]" } } }, "localname": "DocumentInformationDocumentAxis", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r806" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r807" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "submissionTypeItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/EIDBasisofPresentationNotes" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r808" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.dupont.com/role/ConsolidatedBalanceSheets", "http://www.dupont.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows", "http://www.dupont.com/role/ConsolidatedStatementsofComprehensiveLossIncome", "http://www.dupont.com/role/ConsolidatedStatementsofOperations", "http://www.dupont.com/role/DEIDocument", "http://www.dupont.com/role/EIDBasisofPresentationNarrativeDetails", "http://www.dupont.com/role/EIDBasisofPresentationNotes", "http://www.dupont.com/role/EIDRelatedPartyTransactionsDetails", "http://www.dupont.com/role/EIDRelatedPartyTransactionsNotes", "http://www.dupont.com/role/EIDSegmentFNNotes", "http://www.dupont.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/EIDSegmentFNTables", "http://www.dupont.com/role/RelatedPartyTransactionsDowIntercompanyTransactionsDetails", "http://www.dupont.com/role/StatementofStockholdersEquityParentheticalsParentheticals", "http://www.dupont.com/role/StatementofStockholdersEquityStatement", "http://www.dupont.com/role/StockholdersEquityPreferredStockDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r808" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r808" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/EIDBasisofPresentationNotes" ], "xbrltype": "stringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r809" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "yesNoItemType" }, "dei_EntityListingDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security.", "label": "Entity Listing, Description", "terseLabel": "Entity Listing, Description" } } }, "localname": "EntityListingDescription", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "stringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r808" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r808" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r808" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r808" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.dupont.com/role/ConsolidatedBalanceSheets", "http://www.dupont.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows", "http://www.dupont.com/role/ConsolidatedStatementsofComprehensiveLossIncome", "http://www.dupont.com/role/ConsolidatedStatementsofOperations", "http://www.dupont.com/role/DEIDocument", "http://www.dupont.com/role/EIDBasisofPresentationNarrativeDetails", "http://www.dupont.com/role/EIDBasisofPresentationNotes", "http://www.dupont.com/role/EIDRelatedPartyTransactionsDetails", "http://www.dupont.com/role/EIDRelatedPartyTransactionsNotes", "http://www.dupont.com/role/EIDSegmentFNNotes", "http://www.dupont.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/EIDSegmentFNTables", "http://www.dupont.com/role/RelatedPartyTransactionsDowIntercompanyTransactionsDetails", "http://www.dupont.com/role/StatementofStockholdersEquityParentheticalsParentheticals", "http://www.dupont.com/role/StatementofStockholdersEquityStatement", "http://www.dupont.com/role/StockholdersEquityPreferredStockDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_LocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A domain representing all geographic locations. Depending on the axis, it may contain members that are specific geographies, or synthetic entity-specific geographical groups.", "label": "Location [Domain]", "terseLabel": "Geography [Domain]" } } }, "localname": "LocationDomain", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/RevenueTables" ], "xbrltype": "domainItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r804" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r805" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument" ], "xbrltype": "tradingSymbolItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asia Pacific [Member]", "terseLabel": "Asia Pacific" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.dupont.com/role/RevenueDisaggregationofRevenueGeographyDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r564", "r565", "r573", "r574", "r800" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]", "terseLabel": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityNoncontrollinginterestsDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r564", "r565", "r573", "r574" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]", "terseLabel": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityNoncontrollinginterestsDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r231", "r244", "r245", "r246", "r247", "r249", "r251", "r255" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesNarrativeDetails", "http://www.dupont.com/role/SegmentReportingTables", "http://www.dupont.com/role/StockholdersEquityNoncontrollinginterestsDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r231", "r244", "r245", "r246", "r247", "r249", "r251", "r255" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesNarrativeDetails", "http://www.dupont.com/role/SegmentReportingTables", "http://www.dupont.com/role/StockholdersEquityNoncontrollinginterestsDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r100", "r180" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsSeparationAgreementsDetails" ], "xbrltype": "stringItemType" }, "srt_LatinAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Latin America [Member]", "terseLabel": "Latin America" } } }, "localname": "LatinAmericaMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.dupont.com/role/RevenueDisaggregationofRevenueGeographyDetails" ], "xbrltype": "domainItemType" }, "srt_LitigationCaseAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Litigation Case [Axis]", "terseLabel": "Litigation Case [Axis]" } } }, "localname": "LitigationCaseAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "stringItemType" }, "srt_LitigationCaseTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Litigation Case [Domain]", "terseLabel": "Litigation Case [Domain]" } } }, "localname": "LitigationCaseTypeDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r505", "r511", "r655", "r656", "r657", "r659", "r660", "r661", "r682", "r759", "r762" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails", "http://www.dupont.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.dupont.com/role/RevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r505", "r511", "r655", "r656", "r657", "r659", "r660", "r661", "r682", "r759", "r762" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails", "http://www.dupont.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.dupont.com/role/RevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "North America [Member]", "terseLabel": "North America" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.dupont.com/role/RevenueDisaggregationofRevenueGeographyDetails" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Axis]", "terseLabel": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityNoncontrollinginterestsDetails" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Domain]", "terseLabel": "Ownership [Domain]" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityNoncontrollinginterestsDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r258", "r407", "r410", "r683", "r758", "r760" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.dupont.com/role/RevenueDisaggregationofRevenuePrincipalProductGroupsDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r258", "r407", "r410", "r683", "r758", "r760" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.dupont.com/role/RevenueDisaggregationofRevenuePrincipalProductGroupsDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r449", "r505", "r511", "r655", "r656", "r657", "r659", "r660", "r661", "r682", "r759", "r762" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails", "http://www.dupont.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.dupont.com/role/RevenueNarrativeDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesDebtTables", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r449", "r505", "r511", "r655", "r656", "r657", "r659", "r660", "r661", "r682", "r759", "r762" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails", "http://www.dupont.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.dupont.com/role/RevenueNarrativeDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesDebtTables", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsSeparationAgreementsDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r506" ], "lang": { "en-us": { "role": { "label": "Forecast [Member]", "terseLabel": "Forecast [Member]" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r506" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails", "http://www.dupont.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/EarningsPerShareShareCountInformationDetails", "http://www.dupont.com/role/SegmentReportingSegmentInformationDetails", "http://www.dupont.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails", "http://www.dupont.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r259", "r260", "r407", "r411", "r761", "r791", "r792", "r793", "r794", "r795", "r796", "r797", "r798" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.dupont.com/role/RevenueDisaggregationofRevenueGeographyDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r259", "r260", "r407", "r411", "r761", "r787", "r791", "r792", "r793", "r794", "r795", "r796", "r797", "r798", "r799" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.dupont.com/role/RevenueDisaggregationofRevenueGeographyDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r354", "r506", "r648" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails", "http://www.dupont.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/EarningsPerShareShareCountInformationDetails", "http://www.dupont.com/role/SegmentReportingSegmentInformationDetails", "http://www.dupont.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails", "http://www.dupont.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "stringItemType" }, "srt_SubsidiariesMember": { "auth_ref": [ "r475", "r641", "r642", "r645" ], "lang": { "en-us": { "role": { "label": "Subsidiaries [Member]", "terseLabel": "Subsidiary Monetary Position" } } }, "localname": "SubsidiariesMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.dupont.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails", "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "stpr_NC": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NORTH CAROLINA", "terseLabel": "NORTH CAROLINA" } } }, "localname": "NC", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails" ], "xbrltype": "domainItemType" }, "stpr_NJ": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NEW JERSEY", "terseLabel": "NEW JERSEY" } } }, "localname": "NJ", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails" ], "xbrltype": "domainItemType" }, "stpr_NY": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NEW YORK", "terseLabel": "NEW YORK" } } }, "localname": "NY", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails" ], "xbrltype": "domainItemType" }, "stpr_OH": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OHIO", "terseLabel": "OHIO" } } }, "localname": "OH", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Changes and Error Corrections [Abstract]", "terseLabel": "Accounting Changes and Error Corrections [Abstract]" } } }, "localname": "AccountingChangesAndErrorCorrectionsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesAndLoansReceivableLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]", "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]" } } }, "localname": "AccountsNotesAndLoansReceivableLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/AccountsandNotesReceivableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r72" ], "calculation": { "http://www.dupont.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r182", "r642", "r715", "r745" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount for accounts payable to related parties.", "label": "Accounts Payable, Related Parties", "terseLabel": "Accounts Payable, Related Parties" } } }, "localname": "AccountsPayableRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RelatedPartyTransactionsTransactionswithDowDuPontDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]", "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]" } } }, "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/AccountsandNotesReceivableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsReceivableNet": { "auth_ref": [ "r53", "r733" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Accounts Receivable, after Allowance for Credit Loss", "terseLabel": "Accounts Receivable, after Allowance for Credit Loss" } } }, "localname": "AccountsReceivableNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r30", "r53", "r264", "r265" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts Receivable - trade" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/AccountsandNotesReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccrualForEnvironmentalLossContingencies": { "auth_ref": [ "r337", "r352", "r353" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total costs accrued as of the balance sheet date for environmental loss contingencies.", "label": "Accrual for Environmental Loss Contingencies", "terseLabel": "Accrual for Environmental Loss Contingencies" } } }, "localname": "AccrualForEnvironmentalLossContingencies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r45", "r706", "r736" ], "calculation": { "http://www.dupont.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "terseLabel": "Income Taxes Payable" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r78" ], "calculation": { "http://www.dupont.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued and other current liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r110", "r116", "r119", "r570" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "terseLabel": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember": { "auth_ref": [ "r109", "r116", "r119", "r570" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]", "terseLabel": "Actuarial (Gains) Losses" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r70", "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Accumulated Depreciation", "negatedTerseLabel": "Accumulated Depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.dupont.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": { "auth_ref": [ "r105", "r116", "r119", "r569" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.", "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]", "terseLabel": "Derivative Instruments" } } }, "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.dupont.com/role/StockholdersEquityReclassificationsoutofAOCIDetails", "http://www.dupont.com/role/StockholdersEquityTaxBenefitExpenseonNetActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": { "auth_ref": [ "r106", "r107", "r108", "r116", "r119" ], "lang": { "en-us": { "role": { "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.", "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]", "terseLabel": "Unrealized Gain (loss) on Investments", "verboseLabel": "Unrealized loss on investments" } } }, "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.dupont.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.dupont.com/role/StockholdersEquityTaxBenefitExpenseonNetActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r56", "r113", "r115", "r116", "r739", "r767", "r770" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "totalLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets", "http://www.dupont.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r627", "r628", "r629", "r630", "r631", "r633" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.dupont.com/role/StockholdersEquityTaxBenefitExpenseonNetActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r112", "r116", "r119", "r185", "r186", "r187", "r570", "r763", "r764" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comp (Loss) Income", "verboseLabel": "Total" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StatementofStockholdersEquityStatement", "http://www.dupont.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r104", "r116", "r119", "r570", "r628", "r629", "r630", "r631", "r633" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Cumulative Translation Adjustment" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Acquired Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.", "label": "Additional Financial Information Disclosure [Text Block]", "terseLabel": "Additional Financial Information Disclosure [Text Block]" } } }, "localname": "AdditionalFinancialInformationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/SupplementaryInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r54", "r520" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional Paid in Capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r185", "r186", "r187", "r516", "r517", "r518" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/SegmentReportingSegmentInformationDetails", "http://www.dupont.com/role/StatementofStockholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).", "label": "Adjustments to Additional Paid in Capital, Other", "terseLabel": "Reclassification of Divisional Equity to APIC" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/SummaryofSignificantAccountingPoliciesSummaryofAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r513", "r514", "r521", "r522" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Share-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StatementofStockholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r60", "r267", "r289" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "periodEndLabel": "Accounts Receivable, Allowance for Credit Loss, Ending Balance", "periodStartLabel": "Accounts Receivable, Allowance for Credit Loss, Beginning Balance", "terseLabel": "Accounts Receivable, Allowance for Credit Loss, Current" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/AccountsandNotesReceivableAllowanceRollforwardDetails", "http://www.dupont.com/role/AccountsandNotesReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)", "terseLabel": "Other deductions against allowance" } } }, "localname": "AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/AccountsandNotesReceivableAllowanceRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "auth_ref": [ "r292" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.", "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff", "terseLabel": "Write-offs charged against allowance" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/AccountsandNotesReceivableAllowanceRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r166", "r310", "r317" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of Intangibles", "verboseLabel": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofOperations", "http://www.dupont.com/role/OtherIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EarningsPerShareNarrativeDetails", "http://www.dupont.com/role/EarningsPerShareShareCountInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetRetirementObligation": { "auth_ref": [ "r333" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.", "label": "Asset Retirement Obligation", "terseLabel": "Asset Retirement Obligation" } } }, "localname": "AssetRetirementObligation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetRetirementObligationCostsMember": { "auth_ref": [ "r801", "r802" ], "lang": { "en-us": { "role": { "documentation": "Rate action of a regulator resulting in capitalization or accrual of costs for the retirement of long-lived assets.", "label": "Asset Retirement Obligation Costs [Member]", "terseLabel": "Asset Retirement Obligation Costs [Member]" } } }, "localname": "AssetRetirementObligationCostsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r176", "r239", "r246", "r253", "r285", "r564", "r573", "r621", "r704", "r735" ], "calculation": { "http://www.dupont.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "terseLabel": "Total Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets", "http://www.dupont.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.dupont.com/role/SegmentReportingSegmentAssetReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r32", "r33", "r95", "r176", "r285", "r564", "r573", "r621" ], "calculation": { "http://www.dupont.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r612" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "terseLabel": "Assets at Fair Value" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": { "auth_ref": [ "r0", "r1", "r19", "r21", "r25", "r328" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Assets", "terseLabel": "Total assets of discontinued operations" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/SegmentReportingSegmentAssetReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": { "auth_ref": [ "r273", "r274", "r728" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five", "terseLabel": "Debt Securities, Available-for-Sale with contractual maturities within one to five years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsContractualMaturitiesofDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "auth_ref": [ "r270", "r272", "r299", "r712" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale", "terseLabel": "Available - for- sale securities", "verboseLabel": "Debt Securities, Available-for-sale" } } }, "localname": "AvailableForSaleSecuritiesDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FairValueMeasurementsDetails", "http://www.dupont.com/role/FinancialInstrumentsFinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the gross loss realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities.", "label": "Available-for-sale Securities, Gross Realized Losses", "terseLabel": "Gross realized losses" } } }, "localname": "AvailableForSaleSecuritiesGrossRealizedLosses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsAFSInvestingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableforsaleSecuritiesMember": { "auth_ref": [ "r281" ], "lang": { "en-us": { "role": { "documentation": "Investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Available-for-sale Securities [Member]", "terseLabel": "Available-for-sale Securities" } } }, "localname": "AvailableforsaleSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsAFSInvestingResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsSeparationAgreementsDetails", "http://www.dupont.com/role/EIDRelatedPartyTransactionsDetails", "http://www.dupont.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.dupont.com/role/FinancialInstrumentsFinancialInstrumentsNarrativeDetails", "http://www.dupont.com/role/RevenueContractBalancesDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails", "http://www.dupont.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r589", "r594" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsSeparationAgreementsDetails", "http://www.dupont.com/role/EIDRelatedPartyTransactionsDetails", "http://www.dupont.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.dupont.com/role/FinancialInstrumentsFinancialInstrumentsNarrativeDetails", "http://www.dupont.com/role/RevenueContractBalancesDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails", "http://www.dupont.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Accounting, Policy [Policy Text Block]" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r324" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]", "terseLabel": "Building [Member]" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r501", "r507" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/InventoriesScheduleofInventoryDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r501", "r507", "r552", "r553" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/InventoriesScheduleofInventoryDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Abstract]", "terseLabel": "Cash and Cash Equivalents [Abstract]" } } }, "localname": "CashAndCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r28", "r66", "r168" ], "calculation": { "http://www.dupont.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets", "http://www.dupont.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r162", "r168", "r172" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "terseLabel": "Cash, Cash Equivalents, and Restricted Cash, Continuing Operations" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r162", "r168", "r172" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash, Cash Equivalents and Restricted Cash at End of Period", "periodStartLabel": "Cash, Cash Equivalents and Restricted Cash at Beginning of Period", "terseLabel": "Cash, Cash Equivalents and Restricted Cash, Total Company" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows", "http://www.dupont.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r162", "r626" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "terseLabel": "Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsMember": { "auth_ref": [ "r39" ], "lang": { "en-us": { "role": { "documentation": "Short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Equivalents [Member]", "terseLabel": "Cash Equivalents [Member]" } } }, "localname": "CashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": { "auth_ref": [ "r611" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.", "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months", "terseLabel": "After-tax net gain (loss) to be reclassified from AOCL into earnings over the next twelve months" } } }, "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgesDerivativeInstrumentsAtFairValueNet": { "auth_ref": [ "r580" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net fair value of all derivative instruments designated as cash flow hedging instruments, which is ordinarily reflected within other comprehensive income.", "label": "Cash Flow Hedges Derivative Instruments at Fair Value, Net", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance" } } }, "localname": "CashFlowHedgesDerivativeInstrumentsAtFairValueNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r585" ], "lang": { "en-us": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash Flow Hedging [Member]" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r174", "r176", "r208", "r209", "r210", "r213", "r215", "r224", "r225", "r226", "r285", "r621" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets", "http://www.dupont.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.dupont.com/role/DEIDocument", "http://www.dupont.com/role/StatementofStockholdersEquityParentheticalsParentheticals", "http://www.dupont.com/role/StockholdersEquityPreferredStockDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "terseLabel": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityCommonStockDetails", "http://www.dupont.com/role/StockholdersEquityPreferredStockDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommercialPaperMember": { "auth_ref": [ "r370" ], "lang": { "en-us": { "role": { "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.", "label": "Commercial Paper [Member]", "terseLabel": "Commercial Paper [Member]" } } }, "localname": "CommercialPaperMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r349", "r350", "r351", "r362" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies Disclosure [Text Block]" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommodityContractAssetCurrent": { "auth_ref": [ "r77" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the asset arising from commodity contracts such as futures contracts tied to the movement of a particular commodity, which are expected to be converted into cash or otherwise disposed of within a year or the normal operating cycle, if longer.", "label": "Commodity Contract Asset, Current", "terseLabel": "Commodity Contract Asset, Current" } } }, "localname": "CommodityContractAssetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommodityContractMember": { "auth_ref": [ "r450", "r601" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to commodity prices.", "label": "Commodity Contract [Member]", "terseLabel": "Commodity Contract [Member]" } } }, "localname": "CommodityContractMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.dupont.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "http://www.dupont.com/role/FinancialInstrumentsNotionalAmountsDetails", "http://www.dupont.com/role/FinancialInstrumentsTables" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r390" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Common Stock, Dividends, Per Share, Declared" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StatementofStockholdersEquityParentheticalsParentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r185", "r186" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/DEIDocument", "http://www.dupont.com/role/StatementofStockholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common Stock, Par Value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.dupont.com/role/DEIDocument", "http://www.dupont.com/role/EIDBasisofPresentationNarrativeDetails", "http://www.dupont.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.dupont.com/role/EarningsPerShareShareCountInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EarningsPerShareNarrativeDetails", "http://www.dupont.com/role/EarningsPerShareShareCountInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r51", "r383" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common Stock, Shares, Outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.dupont.com/role/EIDBasisofPresentationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r51" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]", "terseLabel": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r122", "r124", "r125", "r136", "r724", "r754" ], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofComprehensiveLossIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive Income (Loss) Attributable to Corteva" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r122", "r124", "r135", "r562", "r563", "r577", "r723", "r753" ], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofComprehensiveLossIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "terseLabel": "Comprehensive Income Attributable to Noncontrolling Interest - Net of Tax" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r122", "r124", "r134", "r561", "r577", "r722", "r752" ], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofComprehensiveLossIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Comprehensive income (loss)" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComputerSoftwareIntangibleAssetMember": { "auth_ref": [ "r311", "r315", "r556" ], "lang": { "en-us": { "role": { "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.", "label": "Computer Software, Intangible Asset [Member]", "terseLabel": "Computer Software, Intangible Asset [Member]" } } }, "localname": "ComputerSoftwareIntangibleAssetMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent": { "auth_ref": [ "r391", "r571", "r578" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the purchase by the parent of an additional equity interest in a subsidiary during the period, thereby effecting a change in total (consolidated) equity attributable to the parent. The purchase of the additional equity interest represented by this element increases the parent's controlling interest in the subsidiary.", "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase of Interest by Parent", "terseLabel": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase of Interest by Parent" } } }, "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityNoncontrollinginterestsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConstructionInProgressMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress [Member]", "terseLabel": "Construction in Progress [Member]" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractTerminationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Termination of a contract associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Contract Termination [Member]", "terseLabel": "Contract Termination" } } }, "localname": "ContractTerminationMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r397" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.", "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]", "terseLabel": "Contract Balances" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetNetCurrent": { "auth_ref": [ "r395", "r396", "r408" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.", "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current", "terseLabel": "Contract assets - current" } } }, "localname": "ContractWithCustomerAssetNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerAssetNetNoncurrent": { "auth_ref": [ "r395", "r396", "r408" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as noncurrent.", "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent", "terseLabel": "Contract assets - noncurrent" } } }, "localname": "ContractWithCustomerAssetNetNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockByUniqueDescriptionAxis": { "auth_ref": [ "r169", "r170", "r171" ], "lang": { "en-us": { "role": { "documentation": "Information by description of stock conversions.", "label": "Stock Conversion Description [Axis]", "terseLabel": "Stock Conversion Description [Axis]" } } }, "localname": "ConversionOfStockByUniqueDescriptionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConversionOfStockNameDomain": { "auth_ref": [ "r169", "r170", "r171" ], "lang": { "en-us": { "role": { "documentation": "The unique name of a noncash or part noncash stock conversion.", "label": "Conversion of Stock, Name [Domain]", "terseLabel": "Conversion of Stock, Name [Domain]" } } }, "localname": "ConversionOfStockNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateMember": { "auth_ref": [ "r227" ], "lang": { "en-us": { "role": { "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.", "label": "Corporate Segment [Member]", "terseLabel": "Corporate Segment" } } }, "localname": "CorporateMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r244", "r245", "r246", "r247", "r249", "r255", "r257" ], "lang": { "en-us": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate, Non-Segment [Member]", "terseLabel": "Corporate" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails", "http://www.dupont.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails", "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r142", "r683" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of Goods Sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of Goods Sold" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelatedIntangibleAssetsMember": { "auth_ref": [ "r554" ], "lang": { "en-us": { "role": { "documentation": "Customer-related asset, including, but not limited to, customer lists, and noncontractual customer relationships.", "label": "Customer-Related Intangible Assets [Member]", "terseLabel": "Customer-Related Intangible Assets [Member]" } } }, "localname": "CustomerRelatedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtCurrent": { "auth_ref": [ "r76" ], "calculation": { "http://www.dupont.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.", "label": "Debt, Current", "terseLabel": "Short-term borrowings and finance lease obligations" } } }, "localname": "DebtCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r376" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt Disclosure [Text Block]" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r43", "r45", "r46", "r705", "r707", "r732" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesDebtTables", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r46", "r372", "r707", "r732" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "terseLabel": "Long-term Debt, Gross" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r80", "r373", "r636" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Debt Instrument, Interest Rate, Effective Percentage" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r80" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesDebtTables", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r81" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesDebtTables", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodAxis": { "auth_ref": [ "r730" ], "lang": { "en-us": { "role": { "documentation": "Information about timing of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period [Axis]", "terseLabel": "Debt Instrument, Redemption, Period [Axis]" } } }, "localname": "DebtInstrumentRedemptionPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesDebtTables", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodDomain": { "auth_ref": [ "r730" ], "lang": { "en-us": { "role": { "documentation": "Period as defined under terms of the debt agreement for debt redemption features.", "label": "Debt Instrument, Redemption, Period [Domain]", "terseLabel": "Debt Instrument, Redemption, Period [Domain]" } } }, "localname": "DebtInstrumentRedemptionPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesDebtTables", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r81", "r181", "r384", "r387", "r388", "r389", "r635", "r636", "r637", "r731" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesDebtTables", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Debt Instrument, Term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": { "auth_ref": [ "r280", "r301", "r304" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer", "terseLabel": "Fair Value, 12 Months or Longer" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsDebtSecuritiesGrossUnrealizedLossesAggregatedbyInvestmentCategoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": { "auth_ref": [ "r280", "r301" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss", "terseLabel": "Gross Unrealized Losses, 12 Months or Longer" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsDebtSecuritiesGrossUnrealizedLossesAggregatedbyInvestmentCategoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleTable": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale [Table]", "terseLabel": "Debt Securities, Available-for-sale [Table]" } } }, "localname": "DebtSecuritiesAvailableForSaleTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsAFSInvestingResultsDetails", "http://www.dupont.com/role/FinancialInstrumentsContractualMaturitiesofDebtSecuritiesDetails", "http://www.dupont.com/role/FinancialInstrumentsDebtSecuritiesGrossUnrealizedLossesAggregatedbyInvestmentCategoryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": { "auth_ref": [ "r279", "r300", "r304" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table Text Block]", "terseLabel": "Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value" } } }, "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of debt outstanding.", "label": "Debt, Weighted Average Interest Rate", "terseLabel": "Debt, Weighted Average Interest Rate" } } }, "localname": "DebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EIDRelatedPartyTransactionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r524", "r525" ], "calculation": { "http://www.dupont.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "terseLabel": "Deferred Income Taxes" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r524", "r525" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred income tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenue": { "auth_ref": [ "r62" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred Revenue", "terseLabel": "Deferred Revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets", "http://www.dupont.com/role/RevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r62" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue, Current", "terseLabel": "Deferred Revenue, Current" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueRevenueRecognized1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously reported as deferred or unearned revenue.", "label": "Deferred Revenue, Revenue Recognized", "terseLabel": "Deferred revenue recognized during the period" } } }, "localname": "DeferredRevenueRevenueRecognized1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r525", "r533" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities, Net", "terseLabel": "Deferred Tax Liabilities, Net" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityNoncontrollinginterestsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "auth_ref": [ "r426", "r465", "r489", "r495", "r496" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Gain (Loss)", "terseLabel": "Amortization of unrecognized loss (gain)" } } }, "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": { "auth_ref": [ "r426", "r466", "r490", "r495", "r496" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)", "terseLabel": "Amortization of Prior Service Benefit" } } }, "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": { "auth_ref": [ "r471" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate", "terseLabel": "Discount Rate" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "auth_ref": [ "r426", "r464", "r488", "r495", "r496" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "terseLabel": "Expected return on plan assets" } } }, "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": { "auth_ref": [ "r424", "r448", "r495" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.", "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan", "terseLabel": "Defined Benefit Plan, Funded (Unfunded) Status of Plan" } } }, "localname": "DefinedBenefitPlanFundedStatusOfPlan", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanInterestCost": { "auth_ref": [ "r426", "r431", "r463", "r487", "r495", "r496" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.", "label": "Defined Benefit Plan, Interest Cost", "terseLabel": "Interest Cost" } } }, "localname": "DefinedBenefitPlanInterestCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r461", "r485", "r495", "r496" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "terseLabel": "Defined Benefit Plan, Net Periodic Benefit (Credit) Cost" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": { "auth_ref": [ "r427", "r468", "r492" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement", "terseLabel": "Settlement/Curtailment Loss (Gain)" } } }, "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanServiceCost": { "auth_ref": [ "r429", "r462", "r486", "r495", "r496" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Service Cost", "terseLabel": "Service Cost" } } }, "localname": "DefinedBenefitPlanServiceCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": { "auth_ref": [ "r481", "r482", "r483", "r484", "r495" ], "lang": { "en-us": { "role": { "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans.", "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]", "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]" } } }, "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]", "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]" } } }, "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditDetails" ], "xbrltype": "stringItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r166", "r323" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PropertyPlantandEquipmentDepreciationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r166", "r234" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and Amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows", "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/SegmentReportingSegmentReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerecognizedAssetsSecuritizedOrAssetbackedFinancingArrangementAssetsAndAnyOtherFinancialAssetsManagedTogetherPrincipalAmountOutstanding": { "auth_ref": [ "r658" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transferred financial assets in which the transferor has continuing involvement with the assets underlying the transaction that have been derecognized. Continuing involvement includes, but is not limited to, servicing, recourse, and restrictions on transferor's interests in transferred financial assets.", "label": "Continuing Involvement with Derecognized Transferred Financial Assets, Amount Outstanding", "terseLabel": "Trade receivables sold the remain outstanding with an element of recourse" } } }, "localname": "DerecognizedAssetsSecuritizedOrAssetbackedFinancingArrangementAssetsAndAnyOtherFinancialAssetsManagedTogetherPrincipalAmountOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/AccountsandNotesReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement": { "auth_ref": [ "r96" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and elected not to be offset.", "label": "Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement", "terseLabel": "Derivative Asset", "verboseLabel": "Derivative Asset, Gross" } } }, "localname": "DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FairValueMeasurementsDetails", "http://www.dupont.com/role/FinancialInstrumentsFairValueofDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetFairValueGrossLiabilityAndObligationToReturnCashOffset": { "auth_ref": [ "r97", "r101", "r580" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, and obligation to return cash collateral under master netting arrangements.", "label": "Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset", "terseLabel": "Derivative Asset, Counterparty and Cash Collateral Netting" } } }, "localname": "DerivativeAssetFairValueGrossLiabilityAndObligationToReturnCashOffset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsFairValueofDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r98", "r99", "r620" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Derivative Asset, Net" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsFairValueofDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FairValueMeasurementsDetails", "http://www.dupont.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.dupont.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "http://www.dupont.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.dupont.com/role/FinancialInstrumentsNotionalAmountsDetails", "http://www.dupont.com/role/FinancialInstrumentsTables" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r591" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "terseLabel": "Amount of gain (loss) recognized in Income - Pre-tax" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r590", "r593", "r598", "r603" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FairValueMeasurementsDetails", "http://www.dupont.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.dupont.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "http://www.dupont.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.dupont.com/role/FinancialInstrumentsNotionalAmountsDetails", "http://www.dupont.com/role/FinancialInstrumentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r587", "r590", "r598" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r587", "r590", "r598", "r603", "r604", "r608", "r609" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments, Gain (Loss) [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.dupont.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "http://www.dupont.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.dupont.com/role/FinancialInstrumentsNotionalAmountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.dupont.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "http://www.dupont.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.dupont.com/role/FinancialInstrumentsNotionalAmountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": { "auth_ref": [ "r596", "r602" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net", "terseLabel": "Clearance of hedge results to earnings" } } }, "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": { "auth_ref": [ "r597", "r599" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.", "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net", "terseLabel": "Amount of gain (loss) recognized in income - pre-tax" } } }, "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r98", "r99", "r620" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Derivative Liability, Net" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsFairValueofDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityFairValueGrossAssetAndRightToReclaimCashOffset": { "auth_ref": [ "r97", "r101", "r580" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of asset associated with financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, and right to receive cash collateral under master netting arrangements.", "label": "Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset", "terseLabel": "Derivative Liability, Counterparty and Cash Collateral Netting" } } }, "localname": "DerivativeLiabilityFairValueGrossAssetAndRightToReclaimCashOffset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsFairValueofDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement": { "auth_ref": [ "r96" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and elected not to be offset.", "label": "Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement", "terseLabel": "Derivative Liability", "verboseLabel": "Derivative Liability, Gross" } } }, "localname": "DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FairValueMeasurementsDetails", "http://www.dupont.com/role/FinancialInstrumentsFairValueofDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r582", "r584" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Derivative, Notional Amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.dupont.com/role/FinancialInstrumentsNotionalAmountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeRemainingMaturity1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period remaining until the derivative contract matures, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Derivative, Remaining Maturity", "terseLabel": "Derivative, Remaining Maturity" } } }, "localname": "DerivativeRemainingMaturity1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r581", "r583", "r584", "r587", "r588", "r595", "r598", "r606", "r607", "r609" ], "lang": { "en-us": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r587" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Designated as Hedging Instrument [Member]" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.dupont.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "http://www.dupont.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.dupont.com/role/FinancialInstrumentsNotionalAmountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DevelopedTechnologyRightsMember": { "auth_ref": [ "r557" ], "lang": { "en-us": { "role": { "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.", "label": "Developed Technology Rights [Member]", "terseLabel": "Developed Technology Rights [Member]" } } }, "localname": "DevelopedTechnologyRightsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RevenueContractBalancesDetails", "http://www.dupont.com/role/RevenueDisaggregationofRevenueGeographyDetails", "http://www.dupont.com/role/RevenueDisaggregationofRevenuePrincipalProductGroupsDetails", "http://www.dupont.com/role/RevenueTables" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r407", "r410", "r411", "r412", "r413", "r414", "r415", "r416" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RevenueContractBalancesDetails", "http://www.dupont.com/role/RevenueDisaggregationofRevenueGeographyDetails", "http://www.dupont.com/role/RevenueDisaggregationofRevenuePrincipalProductGroupsDetails", "http://www.dupont.com/role/RevenueTables" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r407" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Disaggregation of Revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax": { "auth_ref": [ "r6", "r8", "r10", "r22" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.", "label": "Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax", "terseLabel": "Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax" } } }, "localname": "DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": { "auth_ref": [ "r6", "r7", "r8", "r9", "r10", "r18", "r131", "r749" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax", "terseLabel": "Income (loss) from discontinued operations before income taxes" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share", "terseLabel": "Basic loss per share of common stock from discontinued operations", "verboseLabel": "Basic earnings (loss) per share of common stock from discontinued operations" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofOperations", "http://www.dupont.com/role/EarningsPerShareEarningsPerShareCalculationsBasicDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share", "terseLabel": "Diluted loss per share of common stock from discontinued operations", "verboseLabel": "Diluted earnings (loss) per share of common stock from discontinued operations" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofOperations", "http://www.dupont.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Discontinued Operations and Disposal Groups [Abstract]", "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]" } } }, "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationAxis": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Information by disposal group classification.", "label": "Disposal Group Classification [Axis]", "terseLabel": "Disposal Group Classification [Axis]" } } }, "localname": "DisposalGroupClassificationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/DivestituresandOtherTransactionsOtherDiscontinuedOperationsDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.", "label": "Disposal Group Classification [Domain]", "terseLabel": "Disposal Group Classification [Domain]" } } }, "localname": "DisposalGroupClassificationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/DivestituresandOtherTransactionsOtherDiscontinuedOperationsDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": { "auth_ref": [ "r0", "r1", "r19", "r328" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents", "verboseLabel": "Cash and cash equivalents of discontinued operations" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": { "auth_ref": [ "r26", "r332" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]", "terseLabel": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/DivestituresandOtherTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "auth_ref": [ "r501", "r507" ], "lang": { "en-us": { "role": { "documentation": "Name of disposal group.", "label": "Disposal Group Name [Domain]", "terseLabel": "Disposal Group Name [Domain]" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/DivestituresandOtherTransactionsOtherDiscontinuedOperationsDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsTables" ], "xbrltype": "domainItemType" }, "us-gaap_DividendsCommonStock": { "auth_ref": [ "r390", "r729" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Common Stock", "terseLabel": "Common Dividends ($.13 per share)" } } }, "localname": "DividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StatementofStockholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPreferredStock": { "auth_ref": [ "r390", "r729" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Preferred Stock", "terseLabel": "Dividends, Preferred Stock" } } }, "localname": "DividendsPreferredStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StatementofStockholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueFromAffiliates": { "auth_ref": [ "r182", "r642", "r644", "r746" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For an unclassified balance sheet, amount of receivables due from an entity that is affiliated with the reporting entity by means of direct or indirect ownership.", "label": "Due from Affiliates", "terseLabel": "Due from Affiliates" } } }, "localname": "DueFromAffiliates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/AccountsandNotesReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EMEAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Regions of Europe, Middle East and Africa.", "label": "EMEA [Member]", "terseLabel": "EMEA" } } }, "localname": "EMEAMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RevenueDisaggregationofRevenueGeographyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r137", "r194", "r195", "r196", "r197", "r198", "r205", "r208", "r213", "r214", "r215", "r220", "r221", "r725", "r755" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic earnings per share of common stock" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r137", "r194", "r195", "r196", "r197", "r198", "r208", "r213", "r214", "r215", "r220", "r221", "r725", "r755" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted earnings per share of common stock" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r217", "r218", "r219", "r222" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Share [Text Block]" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EarningsPerShareNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r626" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "terseLabel": "Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeSeveranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Employee Severance [Member]", "terseLabel": "Severance and Related Benefit Costs" } } }, "localname": "EmployeeSeveranceMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EnvironmentalRemediationSiteAxis": { "auth_ref": [ "r334", "r335", "r336", "r337", "r361" ], "lang": { "en-us": { "role": { "documentation": "Information by location or named area designated for environmental remediation.", "label": "Environmental Remediation Site [Axis]", "terseLabel": "Environmental Remediation Site [Axis]" } } }, "localname": "EnvironmentalRemediationSiteAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EnvironmentalRemediationSiteDomain": { "auth_ref": [ "r334" ], "lang": { "en-us": { "role": { "documentation": "Location or named area designated for environmental remediation.", "label": "Environmental Remediation Site [Domain]", "terseLabel": "Environmental Remediation Site [Domain]" } } }, "localname": "EnvironmentalRemediationSiteDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r185", "r186", "r187", "r191", "r199", "r201", "r223", "r286", "r383", "r390", "r516", "r517", "r518", "r537", "r538", "r627", "r628", "r629", "r630", "r631", "r633", "r763", "r764", "r765" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/SegmentReportingSegmentInformationDetails", "http://www.dupont.com/role/StatementofStockholdersEquityStatement", "http://www.dupont.com/role/StockholdersEquityNoncontrollinginterestsDetails", "http://www.dupont.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.dupont.com/role/StockholdersEquityReclassificationsoutofAOCIDetails", "http://www.dupont.com/role/StockholdersEquityTaxBenefitExpenseonNetActivityDetails", "http://www.dupont.com/role/SummaryofSignificantAccountingPoliciesSummaryofAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r67", "r240", "r284" ], "calculation": { "http://www.dupont.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Investments in nonconsolidated affiliates" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EscrowDeposit": { "auth_ref": [ "r714" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.", "label": "Escrow Deposit", "terseLabel": "Escrow Balance" } } }, "localname": "EscrowDeposit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r612", "r613", "r614", "r618" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r450", "r452", "r453", "r454", "r455", "r456", "r457", "r495", "r613", "r652", "r653", "r654" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FairValueMeasurementsDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r612", "r613", "r615", "r616", "r619" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r617" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Disclosures [Text Block]" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r450", "r452", "r457", "r495", "r613", "r652" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Fair Value, Inputs, Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r450", "r452", "r457", "r495", "r613", "r653" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FairValueMeasurementsDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r450", "r452", "r453", "r454", "r455", "r456", "r457", "r495", "r652", "r653", "r654" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FairValueMeasurementsDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r617", "r619" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Recurring [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinanceLeaseLiabilityCurrent": { "auth_ref": [ "r638" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.", "label": "Finance Lease, Liability, Current", "terseLabel": "Finance Lease, Liability, Current" } } }, "localname": "FinanceLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r276", "r277", "r290", "r294", "r295", "r296", "r297", "r300", "r302", "r303", "r304", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r659", "r660", "r661", "r662", "r664", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]", "terseLabel": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.", "label": "Financial Instruments Disclosure [Text Block]", "terseLabel": "Financial Instruments Disclosure [Text Block]" } } }, "localname": "FinancialInstrumentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLossesRecovery": { "auth_ref": [ "r266", "r293", "r298" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in allowance for credit loss on financing receivable from recovery.", "label": "Financing Receivable, Allowance for Credit Loss, Recovery", "terseLabel": "Recoveries collected" } } }, "localname": "FinancingReceivableAllowanceForCreditLossesRecovery", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/AccountsandNotesReceivableAllowanceRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Finite-Lived Intangible Asset, Useful Life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r316" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "terseLabel": "Finite-Lived Intangible Assets, Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r318" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "Pre-tax amortization expense, 2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.", "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year", "terseLabel": "Pre-tax amortization expense, remainder of 2021" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r318" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "Pre-tax amortization expense, 2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r318" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "Pre-tax amortization expense, 2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r318" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "Pre-tax amortization expense, 2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r318" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "Pre-tax amortization expense, 2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r311", "r313", "r316", "r320", "r684", "r688" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r316", "r688" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "verboseLabel": "Finite-Lived Intangible Assets, Gross" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r311", "r315" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r316", "r684" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "verboseLabel": "Finite-Lived Intangible Assets, Net" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r622", "r623", "r624", "r625" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), before Tax", "netLabel": "Pre-tax exchange (losses) gains - net", "terseLabel": "Net exchange gains (losses)", "verboseLabel": "Exchange (gains) losses - net" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails", "http://www.dupont.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails", "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r450", "r600" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]", "terseLabel": "Foreign Currency Contract [Member]" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FairValueMeasurementsDetails", "http://www.dupont.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.dupont.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "http://www.dupont.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.dupont.com/role/FinancialInstrumentsNotionalAmountsDetails", "http://www.dupont.com/role/FinancialInstrumentsTables" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignExchangeMember": { "auth_ref": [ "r605" ], "lang": { "en-us": { "role": { "documentation": "Trading of derivative or nonderivative instruments whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange [Member]", "terseLabel": "Foreign Exchange" } } }, "localname": "ForeignExchangeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsNotionalAmountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": { "auth_ref": [ "r590" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.", "label": "Gain (Loss) on Derivative Instruments, Net, Pretax", "terseLabel": "Gain (Loss) on Derivative Instruments, Net, Pretax" } } }, "localname": "GainLossOnDerivativeInstrumentsNetPretax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnDispositionOfAssets1": { "auth_ref": [ "r166" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.", "label": "Gain (Loss) on Disposition of Assets", "terseLabel": "Gain (Loss) on Disposition of Assets", "verboseLabel": "Loss on Divestiture" } } }, "localname": "GainLossOnDispositionOfAssets1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails", "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfAccountsReceivable": { "auth_ref": [ "r663" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale of accounts receivable.", "label": "Gain (Loss) on Sale of Accounts Receivable", "terseLabel": "Loss on Sale of Accounts Receivable" } } }, "localname": "GainLossOnSaleOfAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/AccountsandNotesReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r166", "r374", "r375" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "terseLabel": "Loss on Extinguishment of Debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r306", "r307", "r703" ], "calculation": { "http://www.dupont.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "Intangible Assets Disclosure [Text Block]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GuaranteeObligationsByNatureAxis": { "auth_ref": [ "r368" ], "lang": { "en-us": { "role": { "documentation": "Information by nature of guarantee.", "label": "Guarantor Obligations, Nature [Axis]", "terseLabel": "Guarantor Obligations, Nature [Axis]" } } }, "localname": "GuaranteeObligationsByNatureAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GuaranteeObligationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Guarantor Obligations [Line Items]", "terseLabel": "Guarantor Obligations [Line Items]" } } }, "localname": "GuaranteeObligationsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GuaranteeObligationsMaximumExposure": { "auth_ref": [ "r367" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.", "label": "Guarantor Obligations, Maximum Exposure, Undiscounted", "terseLabel": "Guarantee Obligations" } } }, "localname": "GuaranteeObligationsMaximumExposure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GuaranteeObligationsNatureDomain": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "documentation": "Represents a description of the nature of the guarantee or each group of similar guarantees.", "label": "Guarantor Obligations, Nature [Domain]", "terseLabel": "Guarantor Obligations, Nature [Domain]" } } }, "localname": "GuaranteeObligationsNatureDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r587", "r604" ], "lang": { "en-us": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.dupont.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "http://www.dupont.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.dupont.com/role/FinancialInstrumentsNotionalAmountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r587" ], "lang": { "en-us": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.dupont.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "http://www.dupont.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.dupont.com/role/FinancialInstrumentsNotionalAmountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r587" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HeldToMaturitySecurities": { "auth_ref": [ "r270", "r275", "r712" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-maturity", "terseLabel": "Held-to-maturity securities" } } }, "localname": "HeldToMaturitySecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsFinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": { "auth_ref": [ "r166", "r321" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.", "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)", "terseLabel": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)" } } }, "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InProcessResearchAndDevelopmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.", "label": "In Process Research and Development [Member]", "terseLabel": "In Process Research and Development [Member]" } } }, "localname": "InProcessResearchAndDevelopmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperations": { "auth_ref": [ "r140", "r167", "r194", "r195", "r196", "r197", "r211", "r215", "r560" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "terseLabel": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent" } } }, "localname": "IncomeLossFromContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/SummaryofSignificantAccountingPoliciesSummaryofAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r129", "r239", "r245", "r249", "r252", "r255", "r701", "r718", "r726", "r756" ], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "dd_IncomefromContinuingOperationsAfterTaxes", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "terseLabel": "Income from continuing operations before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofOperations", "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/SegmentReportingSegmentReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r176", "r190", "r239", "r245", "r249", "r252", "r255", "r285", "r561", "r621" ], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Income (loss) from continuing operations after income taxes", "totalLabel": "Income from continuing operations after income taxes", "verboseLabel": "Income (loss) from continuing operations after income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofOperations", "http://www.dupont.com/role/EarningsPerShareNetIncomeforEarningsPerShareCalculationsBasicandDilutedDetails", "http://www.dupont.com/role/SegmentReportingSegmentReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "auth_ref": [ "r127", "r137", "r190", "r194", "r195", "r196", "r197", "r208", "r213", "r214", "r716", "r719", "r725", "r748" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.", "label": "Income (Loss) from Continuing Operations, Per Basic Share", "terseLabel": "Basic earnings per share of common stock from continuing operations", "verboseLabel": "Basic earnings (loss) per share of common stock from continuing operations" } } }, "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofOperations", "http://www.dupont.com/role/EarningsPerShareEarningsPerShareCalculationsBasicDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": { "auth_ref": [ "r127", "r137", "r190", "r194", "r195", "r196", "r197", "r208", "r213", "r214", "r215", "r725", "r748", "r751", "r755" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Income (Loss) from Continuing Operations, Per Diluted Share", "terseLabel": "Diluted earnings per share of common stock from continuing operations", "verboseLabel": "Diluted earnings (loss) per share of common stock from continuing operations" } } }, "localname": "IncomeLossFromContinuingOperationsPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofOperations", "http://www.dupont.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": { "auth_ref": [ "r6", "r7", "r8", "r9", "r10", "r22", "r25", "r548", "r749" ], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Income (loss) from discontinued operations after income taxes" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofOperations", "http://www.dupont.com/role/DivestituresandOtherTransactionsOtherDiscontinuedOperationsDetails", "http://www.dupont.com/role/EarningsPerShareNetIncomeforEarningsPerShareCalculationsBasicandDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r6", "r7", "r8", "r9", "r10", "r18", "r22", "r558", "r561" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Noncontrolling Interest", "terseLabel": "Income from Discontinued Operations, Attributable to Noncontrolling Interest" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EarningsPerShareNetIncomeforEarningsPerShareCalculationsBasicandDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r130", "r166", "r236", "r284", "r717", "r747" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "terseLabel": "Equity in earnings / (losses) of affiliates - net" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "auth_ref": [ "r501", "r507" ], "lang": { "en-us": { "role": { "documentation": "Information by name of disposal group.", "label": "Disposal Group Name [Axis]", "terseLabel": "Disposal Group Name [Axis]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/DivestituresandOtherTransactionsOtherDiscontinuedOperationsDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsTables" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/DivestituresandOtherTransactionsOtherDiscontinuedOperationsDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsSeparationAgreementsDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsTables" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "auth_ref": [ "r1", "r12", "r13", "r14", "r15", "r16", "r17", "r20", "r23", "r24", "r25", "r330", "r331" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table]", "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/DivestituresandOtherTransactionsOtherDiscontinuedOperationsDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsSeparationAgreementsDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsTables" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r327" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/DivestituresandOtherTransactionsOtherDiscontinuedOperationsDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.dupont.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesNarrativeDetails", "http://www.dupont.com/role/StockholdersEquityNoncontrollinginterestsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/DivestituresandOtherTransactionsOtherDiscontinuedOperationsDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.dupont.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesNarrativeDetails", "http://www.dupont.com/role/StockholdersEquityNoncontrollinginterestsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/IncomeTaxesTaxbenefitchargeassociatedwithchangesinaccrualsforcertainprioryeartaxpositionsandreductionsinunrecognizedtaxbenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/IncomeTaxesTaxbenefitchargeassociatedwithchangesinaccrualsforcertainprioryeartaxpositionsandreductionsinunrecognizedtaxbenefitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityNameAxis": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "documentation": "Information by name of taxing authority.", "label": "Income Tax Authority, Name [Axis]", "terseLabel": "Income Tax Authority, Name [Axis]" } } }, "localname": "IncomeTaxAuthorityNameAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/IncomeTaxesTaxbenefitchargeassociatedwithchangesinaccrualsforcertainprioryeartaxpositionsandreductionsinunrecognizedtaxbenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority, Name [Domain]", "terseLabel": "Income Tax Authority, Name [Domain]" } } }, "localname": "IncomeTaxAuthorityNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/IncomeTaxesTaxbenefitchargeassociatedwithchangesinaccrualsforcertainprioryeartaxpositionsandreductionsinunrecognizedtaxbenefitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxContingencyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Tax Contingency [Line Items]", "terseLabel": "Income Tax Contingency [Line Items]" } } }, "localname": "IncomeTaxContingencyLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/IncomeTaxesTaxbenefitchargeassociatedwithchangesinaccrualsforcertainprioryeartaxpositionsandreductionsinunrecognizedtaxbenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxContingencyTable": { "auth_ref": [ "r529", "r530", "r532", "r536" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.", "label": "Income Tax Contingency [Table]", "terseLabel": "Income Tax Contingency [Table]" } } }, "localname": "IncomeTaxContingencyTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/IncomeTaxesTaxbenefitchargeassociatedwithchangesinaccrualsforcertainprioryeartaxpositionsandreductionsinunrecognizedtaxbenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r527", "r531", "r534", "r542", "r544", "r549", "r550", "r551" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Tax Disclosure [Text Block]" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r178", "r200", "r201", "r237", "r526", "r543", "r546", "r757" ], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Provision for income taxes on continuing operations" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofOperations", "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/SegmentReportingSegmentReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r165" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts Payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r165" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "terseLabel": "Accounts and notes receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r165" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Deferred Revenue", "terseLabel": "Deferred Revenue" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r165" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "terseLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "auth_ref": [ "r165" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "terseLabel": "Other Assets and Liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r312", "r319" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets [Axis]", "terseLabel": "Indefinite-lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r319" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)", "terseLabel": "Indefinite-lived Intangible Assets (Excluding Goodwill)" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r312", "r319" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IndemnificationGuaranteeMember": { "auth_ref": [ "r363", "r369" ], "lang": { "en-us": { "role": { "documentation": "An agreement (contract) that contingently requires the guarantor to make payments to the guaranteed party in compensation for that party's or parties' loss or injury attributable to specified events or actions, such as a patent infringement action against an entity that relied on certain representations as to ownership rights made by a software vendor.", "label": "Indemnification Agreement [Member]", "terseLabel": "Indemnification Agreement [Member]" } } }, "localname": "IndemnificationGuaranteeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "terseLabel": "Intangible Assets, Gross (Excluding Goodwill)" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r309", "r314" ], "calculation": { "http://www.dupont.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Other intangible assets", "verboseLabel": "Total other intangible assets" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets", "http://www.dupont.com/role/OtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestAndDebtExpense": { "auth_ref": [ "r634" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity.", "label": "Interest and Debt Expense", "terseLabel": "Interest Expense" } } }, "localname": "InterestAndDebtExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofOperations", "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/SegmentReportingSegmentReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense incurred on a debt or other obligation to related party.", "label": "Interest Expense, Related Party", "terseLabel": "Interest Expense, Related Party" } } }, "localname": "InterestExpenseRelatedParty", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EIDRelatedPartyTransactionsDetails", "http://www.dupont.com/role/RelatedPartyTransactionsDowIntercompanyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeOperating": { "auth_ref": [ "r139" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.", "label": "Interest Income, Operating", "terseLabel": "Interest income" } } }, "localname": "InterestIncomeOperating", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryCurrentTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.", "label": "Inventory, Current [Table]", "terseLabel": "Inventory, Current [Table]" } } }, "localname": "InventoryCurrentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/InventoriesScheduleofInventoryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]", "terseLabel": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r305" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventory Disclosure [Text Block]" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r90" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Inventory, Finished Goods, Gross", "terseLabel": "Finished Products" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/InventoriesScheduleofInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryGross": { "auth_ref": [ "r93" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Inventory, Gross", "terseLabel": "Total inventories" } } }, "localname": "InventoryGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/InventoriesScheduleofInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Inventory [Line Items]", "terseLabel": "Inventory [Line Items]" } } }, "localname": "InventoryLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/InventoriesScheduleofInventoryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r29", "r93" ], "calculation": { "http://www.dupont.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterialsAndSupplies": { "auth_ref": [ "r92" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.", "label": "Inventory, Raw Materials and Supplies, Gross", "terseLabel": "Raw Materials and Supplies" } } }, "localname": "InventoryRawMaterialsAndSupplies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/InventoriesScheduleofInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r91" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Inventory, Work in Process, Gross", "terseLabel": "Semi-finished Products" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/InventoriesScheduleofInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r772", "r773", "r774", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r784", "r785", "r786" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]", "terseLabel": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsAFSInvestingResultsDetails", "http://www.dupont.com/role/FinancialInstrumentsDebtSecuritiesGrossUnrealizedLossesAggregatedbyInvestmentCategoryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r772", "r773", "r774", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r784", "r785", "r786" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]", "terseLabel": "Investments [Domain]" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsAFSInvestingResultsDetails", "http://www.dupont.com/role/FinancialInstrumentsDebtSecuritiesGrossUnrealizedLossesAggregatedbyInvestmentCategoryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsAllOtherInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, All Other Investments [Abstract]", "terseLabel": "Investments, All Other Investments [Abstract]" } } }, "localname": "InvestmentsAllOtherInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.", "label": "Investments Classified by Contractual Maturity Date [Table Text Block]", "terseLabel": "Contractual Maturities of Debt Securities" } } }, "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LandAndLandImprovementsMember": { "auth_ref": [ "r34" ], "lang": { "en-us": { "role": { "documentation": "Real estate held and assets that are an addition or improvement to real estate held.", "label": "Land and Land Improvements [Member]", "terseLabel": "Land and Land Improvements [Member]" } } }, "localname": "LandAndLandImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LandImprovementsMember": { "auth_ref": [ "r34" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to real estate held.", "label": "Land Improvements [Member]", "terseLabel": "Land Improvements [Member]" } } }, "localname": "LandImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r59", "r176", "r285", "r621", "r709", "r742" ], "calculation": { "http://www.dupont.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Liabilities and Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r79", "r176", "r285", "r565", "r573", "r574", "r621" ], "calculation": { "http://www.dupont.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r612" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure", "terseLabel": "Liabilities at Fair Value" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r36", "r37", "r38", "r46", "r47", "r176", "r285", "r565", "r573", "r574", "r621" ], "calculation": { "http://www.dupont.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total noncurrent liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r46", "r707", "r732" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term Line of Credit", "terseLabel": "Long-term Line of Credit" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAxis": { "auth_ref": [ "r74", "r181" ], "lang": { "en-us": { "role": { "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.", "label": "Lender Name [Axis]", "terseLabel": "Lender Name [Axis]" } } }, "localname": "LineOfCreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityLenderDomain": { "auth_ref": [ "r74" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.", "label": "Line of Credit Facility, Lender [Domain]", "terseLabel": "Line of Credit Facility, Lender [Domain]" } } }, "localname": "LineOfCreditFacilityLenderDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Line of Credit Facility [Line Items]", "terseLabel": "Line of Credit Facility [Line Items]" } } }, "localname": "LineOfCreditFacilityLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r74" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r74" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "terseLabel": "Line of Credit Facility, Remaining Borrowing Capacity" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r74", "r181" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]", "terseLabel": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LitigationSettlementAmountAwardedToOtherParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount awarded to other party in judgment or settlement of litigation.", "label": "Litigation Settlement, Amount Awarded to Other Party", "terseLabel": "Litigation Settlement, Amount Awarded to Other Party" } } }, "localname": "LitigationSettlementAmountAwardedToOtherParty", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationStatusAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by status of pending, threatened, or settled litigation.", "label": "Litigation Status [Axis]", "terseLabel": "Litigation Status [Axis]" } } }, "localname": "LitigationStatusAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LitigationStatusDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Status of pending, threatened, or settled litigation.", "label": "Litigation Status [Domain]", "terseLabel": "Litigation Status [Domain]" } } }, "localname": "LitigationStatusDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.", "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]", "terseLabel": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]" } } }, "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/AccountsandNotesReceivableNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_LoansPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Borrowing supported by a written promise to pay an obligation.", "label": "Loans Payable [Member]", "terseLabel": "Loans Payable [Member]" } } }, "localname": "LoansPayableMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligations": { "auth_ref": [ "r46" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.", "label": "Long-term Debt and Lease Obligation", "verboseLabel": "Long-term Debt" } } }, "localname": "LongTermDebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r76" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Current Maturities", "terseLabel": "Long-term Debt Payable within one year" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Long-term Debt, Fair Value", "terseLabel": "Long-term Debt, Fair Value" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r81" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesDebtTables", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r81", "r371" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesDebtTables", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongtermDebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.", "label": "Long-term Debt, Weighted Average Interest Rate, at Point in Time", "terseLabel": "Long-term Debt, Weighted Average Interest Rate, at Point in Time" } } }, "localname": "LongtermDebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "auth_ref": [ "r353", "r354", "r355", "r357", "r358", "r359", "r360", "r364", "r365" ], "lang": { "en-us": { "role": { "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.", "label": "Loss Contingency Nature [Axis]", "terseLabel": "Loss Contingency Nature [Axis]" } } }, "localname": "LossContingenciesByNatureOfContingencyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r353", "r354", "r355", "r357", "r358", "r359", "r360", "r364", "r365" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesDuPontDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyClaimsSettledNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of claims settled.", "label": "Loss Contingency, Claims Settled, Number", "terseLabel": "Loss Contingency, Claims Settled, Number" } } }, "localname": "LossContingencyClaimsSettledNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails" ], "xbrltype": "integerItemType" }, "us-gaap_LossContingencyNatureDomain": { "auth_ref": [ "r353", "r354", "r355", "r357", "r358", "r359", "r360", "r364", "r365" ], "lang": { "en-us": { "role": { "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.", "label": "Loss Contingency, Nature [Domain]", "terseLabel": "Loss Contingency, Nature [Domain]" } } }, "localname": "LossContingencyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingencyPendingClaimsNumber": { "auth_ref": [ "r356" ], "lang": { "en-us": { "role": { "documentation": "Number of pending claims pertaining to a loss contingency.", "label": "Loss Contingency, Pending Claims, Number", "terseLabel": "Loss Contingency, Pending Claims, Number" } } }, "localname": "LossContingencyPendingClaimsNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails", "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails" ], "xbrltype": "integerItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery and Equipment [Member]" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MaterialReconcilingItemsMember": { "auth_ref": [ "r249" ], "lang": { "en-us": { "role": { "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.", "label": "Segment Reconciling Items [Member]", "terseLabel": "Segment Reconciling Items [Member]" } } }, "localname": "MaterialReconcilingItemsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails", "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MediumTermNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instruments with maturities ranging from five to ten years.", "label": "Medium-term Notes [Member]", "terseLabel": "Medium-term Notes [Member]" } } }, "localname": "MediumTermNotesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r89", "r176", "r285", "r621", "r708", "r741" ], "calculation": { "http://www.dupont.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling Interests" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestInJointVentures": { "auth_ref": [ "r559" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of the equity interests owned by noncontrolling shareholders, partners, or other equity holders in joint ventures included in the entity's consolidated financial statements.", "label": "Noncontrolling Interest in Joint Ventures", "terseLabel": "Noncontrolling Interest in Joint Ventures" } } }, "localname": "MinorityInterestInJointVentures", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityNoncontrollinginterestsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Noncontrolling Interest [Line Items]", "terseLabel": "Noncontrolling Interest [Line Items]" } } }, "localname": "MinorityInterestLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityNoncontrollinginterestsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.", "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners", "terseLabel": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners" } } }, "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityNoncontrollinginterestsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_MinorityInterestTable": { "auth_ref": [ "r89", "r141", "r559", "r572" ], "lang": { "en-us": { "role": { "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.", "label": "Noncontrolling Interest [Table]", "terseLabel": "Noncontrolling Interest [Table]" } } }, "localname": "MinorityInterestTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityNoncontrollinginterestsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r162" ], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r162" ], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Cash provided by (used for) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash provided by (used for) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r162", "r164", "r167" ], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Cash used for operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash used for operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r25", "r120", "r123", "r132", "r167", "r176", "r190", "r194", "r195", "r196", "r197", "r200", "r201", "r211", "r239", "r245", "r249", "r252", "r255", "r285", "r621", "r720", "r750" ], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofOperations": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.dupont.com/role/ConsolidatedStatementsofOperations_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net income attributable to Corteva" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r120", "r123", "r200", "r201", "r567", "r576" ], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 }, "http://www.dupont.com/role/ConsolidatedStatementsofOperations_1": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "terseLabel": "Net income attributable to noncontrolling interests" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r194", "r195", "r196", "r197", "r205", "r206", "r212", "r215", "r239", "r245", "r249", "r252", "r255" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "terseLabel": "Basic earnings (loss) per share of common stock" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EarningsPerShareEarningsPerShareCalculationsBasicDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r207", "r212", "r215" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "terseLabel": "Diluted earnings (loss) per share of common stock" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from discontinued operations available to common shareholders.", "label": "Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic", "terseLabel": "Net (Loss) Income from Discontinued Operations Available to Common Shareholders" } } }, "localname": "NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EarningsPerShareNetIncomeforEarningsPerShareCalculationsBasicandDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": { "auth_ref": [ "r379", "r567", "r568" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.", "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest", "verboseLabel": "Net income (loss) Attributable to Noncontrolling Interest, Continuing Operations" } } }, "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EarningsPerShareNetIncomeforEarningsPerShareCalculationsBasicandDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentHedgingMember": { "auth_ref": [ "r586" ], "lang": { "en-us": { "role": { "documentation": "Hedges of a net investment in a foreign operation.", "label": "Net Investment Hedging [Member]", "terseLabel": "Net Investment Hedging [Member]" } } }, "localname": "NetInvestmentHedgingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.dupont.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r188", "r189", "r192", "r193", "r202", "r203", "r204", "r287", "r288", "r417", "r418", "r419", "r420", "r519", "r539", "r540", "r541", "r685", "r686", "r687", "r766", "r767", "r768", "r769", "r770" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.", "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]", "terseLabel": "Recent Accounting Guidance" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RecentAccountingGuidance" ], "xbrltype": "textBlockItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Guidance" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RecentAccountingGuidanceRecentAccountingGuidancePolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest [Abstract]", "terseLabel": "Noncontrolling Interest [Abstract]" } } }, "localname": "NoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r185", "r186", "r187", "r390", "r558" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Noncontrolling Interest [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StatementofStockholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_NondesignatedMember": { "auth_ref": [ "r587" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Not Designated as Hedging Instrument [Member]", "terseLabel": "Not Designated as Hedging Instrument [Member]" } } }, "localname": "NondesignatedMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "http://www.dupont.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.dupont.com/role/FinancialInstrumentsNotionalAmountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r145" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "terseLabel": "Other income - net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofOperations", "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesAndLoansReceivableNetCurrent": { "auth_ref": [ "r30", "r31", "r52", "r264", "r265", "r713" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as current. Includes, but is not limited to, notes and loan receivable.", "label": "Financing Receivable, after Allowance for Credit Loss, Current", "verboseLabel": "Notes receivable - trade" } } }, "localname": "NotesAndLoansReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/AccountsandNotesReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesNoncurrent": { "auth_ref": [ "r82", "r182", "r642" ], "calculation": { "http://www.dupont.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).", "label": "Notes Payable, Related Parties, Noncurrent", "terseLabel": "Long Term Debt - Related Party" } } }, "localname": "NotesPayableRelatedPartiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets", "http://www.dupont.com/role/EIDRelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r27", "r579" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EIDBasisofPresentationNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r94" ], "calculation": { "http://www.dupont.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r589", "r608" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other Assets [Member]", "terseLabel": "Other Assets [Member]" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsSeparationAgreementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r71" ], "calculation": { "http://www.dupont.com/role/ConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of other commitment.", "label": "Other Commitments [Axis]", "terseLabel": "Other Commitments [Axis]" } } }, "localname": "OtherCommitmentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/AccountsandNotesReceivableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other future obligation.", "label": "Other Commitments [Domain]", "terseLabel": "Other Commitments [Domain]" } } }, "localname": "OtherCommitmentsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/AccountsandNotesReceivableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherComprehensiveIncomeLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location in other comprehensive income.", "label": "Other Comprehensive Income Location [Axis]", "terseLabel": "Other Comprehensive Income Location [Axis]" } } }, "localname": "OtherComprehensiveIncomeLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Location in other comprehensive income.", "label": "Other Comprehensive Income Location [Domain]", "terseLabel": "Other Comprehensive Income Location [Domain]" } } }, "localname": "OtherComprehensiveIncomeLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": { "auth_ref": [ "r113", "r117", "r118", "r469" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax", "terseLabel": "Amortization of Prior Service Benefit" } } }, "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r116", "r126", "r627", "r629", "r633" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "terseLabel": "Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax": { "auth_ref": [ "r105" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax", "terseLabel": "Derivatives Instruments" } } }, "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r103" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Cumulative Translation Adjustments" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r121", "r124", "r126", "r133", "r383", "r627", "r632", "r633", "r721", "r751" ], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofComprehensiveLossIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Total other comprehensive loss", "verboseLabel": "Other comprehensive (loss) income" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofComprehensiveLossIncome", "http://www.dupont.com/role/StatementofStockholdersEquityStatement", "http://www.dupont.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r111", "r113" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "negatedLabel": "Adjustments to benefit plans" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTax": { "auth_ref": [ "r114", "r133", "r526", "r545", "r547", "r627", "r630", "r633", "r721", "r751" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Tax", "terseLabel": "Other Comprehensive Income (Loss), Tax Benefit (Expense)" } } }, "localname": "OtherComprehensiveIncomeLossTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityTaxBenefitExpenseonNetActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax": { "auth_ref": [ "r105", "r113", "r610" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax", "terseLabel": "Amount of (loss) gain recognized in OCI- Pre Tax" } } }, "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r105", "r113", "r610" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax", "verboseLabel": "Additions and revaluations of derivatives designated as cash flow hedges" } } }, "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentAssetsMember": { "auth_ref": [ "r589", "r608" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current assets.", "label": "Other Current Assets [Member]", "terseLabel": "Other Current Assets [Member]" } } }, "localname": "OtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.dupont.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets [Member]", "terseLabel": "Other Intangible Assets [Member]" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r83" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other noncurrent obligations" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r167" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "terseLabel": "Other net loss" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Member]", "terseLabel": "Other noncurrent obligations" } } }, "localname": "OtherNoncurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsSeparationAgreementsDetails", "http://www.dupont.com/role/EIDRelatedPartyTransactionsDetails", "http://www.dupont.com/role/RevenueContractBalancesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).", "label": "Other Nonoperating Income (Expense) [Member]", "terseLabel": "Other Income - net" } } }, "localname": "OtherNonoperatingIncomeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "auth_ref": [ "r423", "r424", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r452", "r453", "r454", "r455", "r456", "r457", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r475", "r478", "r482", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r499", "r500", "r501", "r502", "r503", "r504" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.", "label": "Other Postretirement Benefits Plan [Member]", "terseLabel": "Other Benefit Plans", "verboseLabel": "Other Benefit Plans" } } }, "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofComprehensiveLossIncome", "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditDetails", "http://www.dupont.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.dupont.com/role/StockholdersEquityReclassificationsoutofAOCIDetails", "http://www.dupont.com/role/StockholdersEquityTaxBenefitExpenseonNetActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherReceivablesNetCurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.", "label": "Other Receivables, Net, Current", "terseLabel": "Other" } } }, "localname": "OtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/AccountsandNotesReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherTaxExpenseBenefit": { "auth_ref": [ "r177", "r526", "r535" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other income tax expense (benefit).", "label": "Other Tax Expense (Benefit)", "terseLabel": "Other Tax Expense (Benefit)" } } }, "localname": "OtherTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/IncomeTaxesIncomeTaxNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForLegalSettlements": { "auth_ref": [ "r163" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.", "label": "Payments for Legal Settlements", "terseLabel": "Payments for Legal Settlements" } } }, "localname": "PaymentsForLegalSettlements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r150", "r152", "r183" ], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "negatedTerseLabel": "Other investing activities - net" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r156" ], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedTerseLabel": "Repurchase of Common Stock", "terseLabel": "Repurchase of Common Stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows", "http://www.dupont.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRestructuring": { "auth_ref": [ "r160", "r339" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.", "label": "Payments for Restructuring", "negatedTerseLabel": "Payments for Restructuring", "terseLabel": "Payments for Restructuring" } } }, "localname": "PaymentsForRestructuring", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDistributionsToAffiliates": { "auth_ref": [ "r156" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The distributions of earnings to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.", "label": "Payments of Distributions to Affiliates", "terseLabel": "Distributions to DowDuPont" } } }, "localname": "PaymentsOfDistributionsToAffiliates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RelatedPartyTransactionsTransactionswithDowDuPontDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividends": { "auth_ref": [ "r156" ], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.", "label": "Payments of Dividends", "negatedTerseLabel": "Dividends paid to stockholders" } } }, "localname": "PaymentsOfDividends", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "auth_ref": [ "r271" ], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for purchase of marketable security.", "label": "Payments to Acquire Marketable Securities", "negatedTerseLabel": "Purchases of investments" } } }, "localname": "PaymentsToAcquireMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireProductiveAssets": { "auth_ref": [ "r151" ], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Payments to Acquire Productive Assets", "negatedTerseLabel": "Capital expenditures" } } }, "localname": "PaymentsToAcquireProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToMinorityShareholders": { "auth_ref": [ "r158" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.", "label": "Payments to Noncontrolling Interests", "terseLabel": "Payments for acquisition of subsidiary's interest from the non-controlling Interests" } } }, "localname": "PaymentsToMinorityShareholders", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityNoncontrollinginterestsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r449", "r451", "r457", "r474", "r476", "r477", "r478", "r479", "r480", "r495", "r497", "r498", "r499", "r512" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for retirement benefits.", "label": "Retirement Benefits [Text Block]", "terseLabel": "Pension and Other Postretirement Benefits Disclosure [Text Block]" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": { "auth_ref": [ "r48", "r424", "r425", "r448", "r495" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.", "label": "Liability, Defined Benefit Plan, Noncurrent", "terseLabel": "Pension and other post employment benefits - noncurrent" } } }, "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionContributions": { "auth_ref": [ "r163" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for pension benefit. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree. Excludes other postretirement benefit.", "label": "Payment for Pension Benefits", "terseLabel": "Pension and OPEB Contributions" } } }, "localname": "PensionContributions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionExpenseReversalOfExpenseNoncash": { "auth_ref": [ "r166" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense (reversal of expense) for pension benefits. Excludes other postretirement benefits.", "label": "Pension Expense (Reversal of Expense), Noncash", "terseLabel": "Net Periodic Pension and OPEB benefit, net" } } }, "localname": "PensionExpenseReversalOfExpenseNoncash", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionPlansDefinedBenefitMember": { "auth_ref": [ "r422", "r424", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r475", "r478", "r482", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r499", "r500", "r507", "r508", "r509", "r510" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.", "label": "Pension Plan [Member]", "terseLabel": "Pension Plan" } } }, "localname": "PensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofComprehensiveLossIncome", "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditDetails", "http://www.dupont.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.dupont.com/role/StockholdersEquityReclassificationsoutofAOCIDetails", "http://www.dupont.com/role/StockholdersEquityTaxBenefitExpenseonNetActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PledgedFinancialInstrumentsNotSeparatelyReportedLoansReceivablePledgedAsCollateral": { "auth_ref": [ "r665" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The sum of the carrying amounts, as of the date of the latest financial statement presented, of loans receivable which are owned but transferred to serve as collateral for the payment of related debt obligations, primarily secured borrowings and repurchase agreements, and for which the transferees are not permitted to sell or re-pledge them to an unrelated party.", "label": "Pledged Financial Instruments, Not Separately Reported, Loans Receivable Pledged as Collateral", "terseLabel": "Pledged Financial Instruments, Not Separately Reported, Loans Receivable Pledged as Collateral" } } }, "localname": "PledgedFinancialInstrumentsNotSeparatelyReportedLoansReceivablePledgedAsCollateral", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockDividendsAndOtherAdjustments": { "auth_ref": [ "r206", "r216" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders.", "label": "Preferred Stock Dividends and Other Adjustments", "terseLabel": "Preferred Stock Dividends and Other Adjustments" } } }, "localname": "PreferredStockDividendsAndOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EarningsPerShareNetIncomeforEarningsPerShareCalculationsBasicandDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockDividendsPerShareDeclared": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of preferred stock outstanding.", "label": "Preferred Stock, Dividends Per Share, Declared", "terseLabel": "Preferred Stock, Dividends Per Share, Declared" } } }, "localname": "PreferredStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StatementofStockholdersEquityParentheticalsParentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StatementofStockholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockNoParValue": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, No Par Value", "terseLabel": "Preferred Stock, Par Value" } } }, "localname": "PreferredStockNoParValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockRedemptionAmount": { "auth_ref": [ "r84", "r382" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The redemption (or callable) amount of currently redeemable preferred stock. Includes amounts representing dividends not currently declared or paid but which will be payable under the redemption features or for which ultimate payment is solely within the control of the issuer.", "label": "Preferred Stock, Redemption Amount", "terseLabel": "Preferred Stock, Redemption Amount" } } }, "localname": "PreferredStockRedemptionAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.dupont.com/role/StockholdersEquityPreferredStockDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred Stock, Shares Authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.dupont.com/role/StockholdersEquityPreferredStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred Stock, Shares Issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.dupont.com/role/StockholdersEquityPreferredStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r50" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred Stock" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDividendsReceived": { "auth_ref": [ "r159" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Dividends received on equity and other investments during the current period.", "label": "Proceeds from Dividends Received", "terseLabel": "Proceeds from Dividends Received" } } }, "localname": "ProceedsFromDividendsReceived", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesChemoursDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r154" ], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-term Debt", "terseLabel": "Proceeds from debt" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r155", "r158", "r183" ], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "Other financing activities" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": { "auth_ref": [ "r183" ], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Proceeds from (Repayments of) Short-term Debt", "terseLabel": "Net change in borrowings (less than 90 days)" } } }, "localname": "ProceedsFromRepaymentsOfShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": { "auth_ref": [], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.", "label": "Proceeds from Sale and Maturity of Marketable Securities", "terseLabel": "Proceeds from Sale and Maturities of Investments" } } }, "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities": { "auth_ref": [ "r149", "r271" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities.", "label": "Proceeds from Sale of Available-for-sale Securities", "verboseLabel": "Total" } } }, "localname": "ProceedsFromSaleOfAvailableForSaleSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsAFSInvestingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": { "auth_ref": [ "r147", "r148", "r271" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Proceeds from Sale of Debt Securities, Available-for-sale", "terseLabel": "Proceeds from sales of available-for-sale securities" } } }, "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsAFSInvestingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r153", "r515" ], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from Exercise of Stock Options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r25", "r120", "r123", "r161", "r176", "r190", "r200", "r201", "r239", "r245", "r249", "r252", "r255", "r285", "r561", "r566", "r568", "r576", "r577", "r621", "r726" ], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofComprehensiveLossIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.dupont.com/role/ConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 }, "http://www.dupont.com/role/ConsolidatedStatementsofOperations_1": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income", "totalLabel": "Net income", "verboseLabel": "Net income (loss)" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows", "http://www.dupont.com/role/ConsolidatedStatementsofComprehensiveLossIncome", "http://www.dupont.com/role/ConsolidatedStatementsofOperations", "http://www.dupont.com/role/StatementofStockholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]", "terseLabel": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r70", "r326" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r332", "r788", "r789", "r790" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property, Plant and Equipment Disclosure [Text Block]" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PropertyPlantandEquipmentNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r69", "r324" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property, Plant and Equipment, Gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r40", "r41", "r326", "r744" ], "calculation": { "http://www.dupont.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "periodStartLabel": "Property, plant and equipment - net of accumulated depreciation (March 31, 2020 - $3,406; December 31, 2019 - $3,326; March 31, 2019 - $2,970)", "terseLabel": "Property, plant and equipment - net of accumulated depreciation (March 31, 2021 - $3,874; December 31, 2020 - $3,857; March 31, 2020 - $3,406)" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets", "http://www.dupont.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r40", "r326" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Property, Plant and Equipment [Table Text Block]" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PropertyPlantandEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r40", "r324" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Property, Plant and Equipment, Useful Life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r138", "r291" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "terseLabel": "Net provision for credit losses" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/AccountsandNotesReceivableAllowanceRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PublicUtilityAxis": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "Information by type of utility plant.", "label": "Public Utility [Axis]", "terseLabel": "Public Utility [Axis]" } } }, "localname": "PublicUtilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RatioOfIndebtednessToNetCapital1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indebtedness divided by net capital.", "label": "Ratio of Indebtedness to Net Capital", "terseLabel": "Ratio of Indebtedness to Net Capital" } } }, "localname": "RatioOfIndebtednessToNetCapital1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails" ], "xbrltype": "pureItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Receivables [Abstract]", "terseLabel": "Receivables [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_ReceivablesNetCurrent": { "auth_ref": [ "r53", "r61", "r743", "r771" ], "calculation": { "http://www.dupont.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.", "label": "Receivables, Net, Current", "terseLabel": "Accounts and notes receivable - net" } } }, "localname": "ReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/AccountsandNotesReceivableDetails", "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]", "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]" } } }, "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "auth_ref": [ "r116", "r119", "r627", "r631", "r633" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "terseLabel": "Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "auth_ref": [ "r116", "r119", "r126", "r627", "r631", "r633" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "terseLabel": "Amounts Reclassified from Accumulated Other Comprehensive Loss", "verboseLabel": "Amounts Reclassified from Accumulated Other Comprehensive Loss" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.dupont.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodTax": { "auth_ref": [ "r114", "r118" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).", "label": "Reclassification from AOCI, Current Period, Tax", "terseLabel": "Reclassification from Accumulated Other Comprehensive Loss, Current Period, Tax" } } }, "localname": "ReclassificationFromAociCurrentPeriodTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive (Loss) Income [Table Text Block]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": { "auth_ref": [ "r246", "r249" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.", "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]", "terseLabel": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]" } } }, "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNTables", "http://www.dupont.com/role/SegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": { "auth_ref": [ "r245", "r249" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.", "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]", "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]" } } }, "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNTables", "http://www.dupont.com/role/SegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r475", "r641", "r642" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets", "http://www.dupont.com/role/EIDRelatedPartyTransactionsDetails", "http://www.dupont.com/role/RelatedPartyTransactionsDowIntercompanyTransactionsDetails", "http://www.dupont.com/role/RelatedPartyTransactionsTransactionswithDowDuPontDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EIDRelatedPartyTransactionsDetails", "http://www.dupont.com/role/EIDRelatedPartyTransactionsNotes", "http://www.dupont.com/role/RelatedPartyTransactionsDowIntercompanyTransactionsDetails", "http://www.dupont.com/role/RelatedPartyTransactionsTransactionswithDowDuPontDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Purchases from Related Party", "terseLabel": "Purchases from Historical Dow and affiliates" } } }, "localname": "RelatedPartyTransactionPurchasesFromRelatedParty", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RelatedPartyTransactionsDowIntercompanyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]", "terseLabel": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r475", "r641", "r645", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets", "http://www.dupont.com/role/EIDRelatedPartyTransactionsDetails", "http://www.dupont.com/role/RelatedPartyTransactionsDowIntercompanyTransactionsDetails", "http://www.dupont.com/role/RelatedPartyTransactionsTransactionswithDowDuPontDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r639", "r640", "r642", "r646", "r647" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions Disclosure [Text Block]" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EIDRelatedPartyTransactionsNotes", "http://www.dupont.com/role/RelatedPartyTransactionsNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r157" ], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-term Debt", "negatedTerseLabel": "Payments on Debt", "terseLabel": "Repayments of Long-term Debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r157" ], "calculation": { "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Repayments of Related Party Debt", "negatedTerseLabel": "Repayments of Related Party Debt" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepurchaseAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments represented by an agreement between the entity and another party for the sale and repurchase of identical or substantially the same securities at a date certain for a specified price. Such agreements are generally short-term in nature.", "label": "Repurchase Agreements [Member]", "terseLabel": "Repurchase Agreements [Member]" } } }, "localname": "RepurchaseAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r523", "r803" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and Development Expense" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r172", "r702", "r738" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash", "terseLabel": "Restricted Cash" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditDetails", "http://www.dupont.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restricted Cash and Cash Equivalents Items [Line Items]", "terseLabel": "Restricted Cash and Cash Equivalents Items [Line Items]" } } }, "localname": "RestrictedCashAndCashEquivalentsItemsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring and Related Activities [Abstract]", "terseLabel": "Restructuring and Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "auth_ref": [ "r348" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.", "label": "Restructuring and Related Activities Disclosure [Text Block]", "terseLabel": "Restructuring and Related Activities Disclosure [Text Block]" } } }, "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedCharges" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringAndRelatedCostExpectedCost1": { "auth_ref": [ "r338", "r340", "r345", "r347" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.", "label": "Restructuring and Related Cost, Expected Cost", "terseLabel": "Restructuring and Related Cost, Expected Cost" } } }, "localname": "RestructuringAndRelatedCostExpectedCost1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of restructuring cost.", "label": "Restructuring Type [Axis]", "terseLabel": "Restructuring Type [Axis]" } } }, "localname": "RestructuringCostAndReserveAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesNarrativeDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesTables" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by individual restructuring plan.", "label": "Restructuring Plan [Axis]", "terseLabel": "Restructuring Plan [Axis]" } } }, "localname": "RestructuringPlanAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesTables" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identification of the individual restructuring plans.", "label": "Restructuring Plan [Domain]", "terseLabel": "Restructuring Plan [Domain]" } } }, "localname": "RestructuringPlanDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesTables" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [ "r339", "r343" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.", "label": "Restructuring Reserve", "periodEndLabel": "Restructuring Reserve, Ending Balance", "periodStartLabel": "Restructuring Reserve, Beginning Balance", "terseLabel": "Restructuring Reserve" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringSettlementAndImpairmentProvisions": { "auth_ref": [ "r143" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of restructuring charges, remediation cost, and asset impairment loss.", "label": "Restructuring, Settlement and Impairment Provisions", "terseLabel": "Restructuring and Asset Related Charges - Net" } } }, "localname": "RestructuringSettlementAndImpairmentProvisions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r55", "r390", "r520", "r740", "r766", "r770" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings / (accumulated deficit)" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r185", "r186", "r187", "r191", "r199", "r201", "r286", "r516", "r517", "r518", "r537", "r538", "r763", "r765" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StatementofStockholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r422", "r423", "r424", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r475", "r478", "r482", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r499", "r500", "r501", "r502", "r503", "r504", "r507", "r508", "r509", "r510" ], "lang": { "en-us": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]", "terseLabel": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofComprehensiveLossIncome", "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditDetails", "http://www.dupont.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r422", "r423", "r424", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r475", "r478", "r482", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r499", "r500", "r501", "r502", "r503", "r504", "r507", "r508", "r509", "r510" ], "lang": { "en-us": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]", "terseLabel": "Retirement Plan Type [Domain]" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofComprehensiveLossIncome", "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditDetails", "http://www.dupont.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]", "terseLabel": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r397", "r398", "r399", "r400", "r401", "r402", "r405", "r406", "r409", "r421" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue from Contract with Customer" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RevenueNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionSalesOfGoods": { "auth_ref": [ "r173" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue recognition for the sale of goods, which is a transaction between an entity delivering a tangible good to a purchaser. The entity also may disclose its treatment of any unearned or deferred revenue that arises from the transaction.", "label": "Revenue Recognition, Sales of Goods [Policy Text Block]", "terseLabel": "Revenue Recognition, Sales of Goods" } } }, "localname": "RevenueRecognitionSalesOfGoods", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RevenueRevenueRecognitionPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionServicesLicensingFees": { "auth_ref": [ "r173" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue recognition for licensing fees, which is consideration paid to the entity (licensor) by another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, or trademark.", "label": "Revenue Recognition, Services, Licensing Fees [Policy Text Block]", "terseLabel": "Revenue Recognition, Licenses of Intellectual Property" } } }, "localname": "RevenueRecognitionServicesLicensingFees", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RevenueRevenueRecognitionPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r403" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Revenue, Remaining Performance Obligation, Amount" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "auth_ref": [ "r404" ], "lang": { "en-us": { "role": { "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RevenueNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r128", "r176", "r230", "r231", "r244", "r250", "r251", "r258", "r259", "r262", "r285", "r621", "r726" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Net Sales" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofOperations", "http://www.dupont.com/role/RevenueDisaggregationofRevenueGeographyDetails", "http://www.dupont.com/role/RevenueDisaggregationofRevenuePrincipalProductGroupsDetails", "http://www.dupont.com/role/SegmentReportingSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": { "auth_ref": [ "r88" ], "lang": { "en-us": { "role": { "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]", "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/AccountsandNotesReceivableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [ "r88" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]", "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/AccountsandNotesReceivableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r116", "r632", "r633" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.", "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]", "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]" } } }, "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r217" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EarningsPerShareNarrativeDetails", "http://www.dupont.com/role/EarningsPerShareShareCountInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Securities, Available-for-sale [Line Items]", "terseLabel": "Debt Securities, Available-for-sale [Line Items]" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsAFSInvestingResultsDetails", "http://www.dupont.com/role/FinancialInstrumentsContractualMaturitiesofDebtSecuritiesDetails", "http://www.dupont.com/role/FinancialInstrumentsDebtSecuritiesGrossUnrealizedLossesAggregatedbyInvestmentCategoryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r596" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.", "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "After-Tax Effect of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r102" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.", "label": "Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Tax (Expense) Benefit of Other Comprehensive (Loss) Income" } } }, "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r81", "r181", "r384", "r387", "r388", "r389", "r635", "r636", "r637", "r731" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of Long-term Debt Instruments [Table Text Block]" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r590", "r598", "r604" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "terseLabel": "Effect of Derivatives" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r592" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.", "label": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]", "terseLabel": "Fair Value of Derivatives Instruments" } } }, "localname": "ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": { "auth_ref": [ "r1", "r12", "r13", "r14", "r15", "r16", "r17", "r20", "r23", "r24", "r25", "r330", "r331" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]", "terseLabel": "Discontinued Operations [Table Text Block]" } } }, "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/DivestituresandOtherTransactionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r215" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock": { "auth_ref": [ "r209", "r215", "r221" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the effect of income (loss) on basic earnings per share.", "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block]", "terseLabel": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block]" } } }, "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock": { "auth_ref": [ "r209", "r215", "r221" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share.", "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block]", "terseLabel": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block]" } } }, "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r612", "r613" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Fair Value of Assets and Liabilities Measured on Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r311", "r315", "r684" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGuaranteeObligationsTable": { "auth_ref": [ "r368" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure about the type or nature of guarantees, for example performance, indemnification, payment and other guarantees, and related information such as term, origin and purpose, triggering event, maximum exposure, and carrying value. Represents the guarantor's disclosures which include the information about each guarantee, or each group of similar guarantees, even if the likelihood of the guarantor's need to make any payments under the guarantee is remote. This excludes disclosures for product warranties.", "label": "Schedule of Guarantor Obligations [Table]", "terseLabel": "Schedule of Guarantor Obligations [Table]" } } }, "localname": "ScheduleOfGuaranteeObligationsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Held-to-maturity Securities [Line Items]", "terseLabel": "Schedule of Held-to-maturity Securities [Line Items]" } } }, "localname": "ScheduleOfHeldToMaturitySecuritiesLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfHeldToMaturitySecuritiesTable": { "auth_ref": [ "r276", "r277", "r278" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-maturity [Table]", "terseLabel": "Debt Securities, Held-to-maturity [Table]" } } }, "localname": "ScheduleOfHeldToMaturitySecuritiesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r35", "r63", "r64", "r65" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of Inventory, Current [Table Text Block]" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "auth_ref": [ "r461" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.", "label": "Schedule of Net Benefit Costs [Table Text Block]", "terseLabel": "Schedule of Net Benefit Costs [Table Text Block]" } } }, "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": { "auth_ref": [ "r582" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.", "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]", "terseLabel": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]" } } }, "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.", "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]", "terseLabel": "Schedule of Other Nonoperating Income (Expense)" } } }, "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/SupplementaryInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r70", "r326" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRealizedGainLossTableTextBlock": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the proceeds from sales of available-for-sale securities and the gross realized gains and gross realized losses that have been included in earnings as a result of those sales.", "label": "Schedule of Realized Gain (Loss) [Table Text Block]", "terseLabel": "Schedule of Realized Gains (Losses)" } } }, "localname": "ScheduleOfRealizedGainLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r179", "r643", "r645" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EIDRelatedPartyTransactionsDetails", "http://www.dupont.com/role/EIDRelatedPartyTransactionsNotes", "http://www.dupont.com/role/RelatedPartyTransactionsDowIntercompanyTransactionsDetails", "http://www.dupont.com/role/RelatedPartyTransactionsTransactionswithDowDuPontDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable": { "auth_ref": [ "r39", "r172", "r702", "r738" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about cash and cash equivalents restricted as to withdrawal or usage.", "label": "Restrictions on Cash and Cash Equivalents [Table]", "terseLabel": "Restrictions on Cash and Cash Equivalents [Table]" } } }, "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": { "auth_ref": [ "r39", "r172", "r702", "r738" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.", "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Restrictions on Cash and Cash Equivalents" } } }, "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/SupplementaryInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r341", "r342", "r344" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]", "terseLabel": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesNarrativeDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesTables" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "auth_ref": [ "r339", "r346" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "terseLabel": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]" } } }, "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedChargesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r239", "r242", "r248", "r308" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNNotes", "http://www.dupont.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/EIDSegmentFNTables", "http://www.dupont.com/role/SegmentReportingSegmentInformationDetails", "http://www.dupont.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails", "http://www.dupont.com/role/SegmentReportingTables" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r239", "r242", "r248", "r308" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table Text Block]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/SegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r75" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-term Debt [Table]", "terseLabel": "Schedule of Short-term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShortTermDebtTextBlock": { "auth_ref": [ "r75" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-term Debt [Table Text Block]", "terseLabel": "Schedule of Short-term Debt [Table Text Block]" } } }, "localname": "ScheduleOfShortTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r85", "r174", "r224", "r225", "r377", "r380", "r381", "r384", "r385", "r386", "r387", "r388", "r389", "r390" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]", "terseLabel": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityCommonStockDetails", "http://www.dupont.com/role/StockholdersEquityPreferredStockDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTextBlock": { "auth_ref": [ "r49", "r50", "r51", "r378", "r380", "r381", "r384", "r385", "r386", "r387", "r388", "r389", "r390" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.", "label": "Schedule of Stock by Class [Table Text Block]", "terseLabel": "Schedule of Stock by Class [Table Text Block]" } } }, "localname": "ScheduleOfStockByClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMember": { "auth_ref": [ "r620" ], "lang": { "en-us": { "role": { "documentation": "The securities that an institution sells and agrees to repurchase (the identical or substantially the same securities) as a seller-borrower at a specified date for a specified price, also known as a repurchase agreement, or repo. Most repos involve obligations of the federal government or its agencies, but other financial instruments, such as commercial paper, banker's acceptances, and negotiable certificates of deposit, are sometimes used in repos.", "label": "Securities Sold under Agreements to Repurchase [Member]", "terseLabel": "Securities Sold under Agreements to Repurchase [Member]" } } }, "localname": "SecuritiesSoldUnderAgreementsToRepurchaseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentContinuingOperationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Component of an entity expected to operate in the foreseeable future.", "label": "Continuing Operations [Member]", "terseLabel": "Continuing Operations [Member]" } } }, "localname": "SegmentContinuingOperationsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsFutureAmortizationExpenseDetails", "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditDetails", "http://www.dupont.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentDiscontinuedOperationsMember": { "auth_ref": [ "r2", "r3", "r4", "r5" ], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of or classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.", "label": "Discontinued Operations [Member]", "terseLabel": "Discontinued Operations [Member]" } } }, "localname": "SegmentDiscontinuedOperationsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r227", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r244", "r245", "r246", "r247", "r249", "r250", "r251", "r252", "r253", "r255", "r262", "r758" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesNarrativeDetails", "http://www.dupont.com/role/RevenueDisaggregationofRevenueGeographyDetails", "http://www.dupont.com/role/RevenueDisaggregationofRevenuePrincipalProductGroupsDetails", "http://www.dupont.com/role/SegmentReportingSegmentInformationDetails", "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails", "http://www.dupont.com/role/SegmentReportingTables", "http://www.dupont.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails", "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentOperatingActivitiesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operations of an entity including continuing and discontinued operations.", "label": "Operating Activities [Domain]", "terseLabel": "Operating Activities [Domain]" } } }, "localname": "SegmentOperatingActivitiesDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows", "http://www.dupont.com/role/OtherIntangibleAssetsFutureAmortizationExpenseDetails", "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditDetails", "http://www.dupont.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r227", "r228", "r229", "r239", "r243", "r249", "r253", "r254", "r255", "r256", "r258", "r261", "r262", "r263" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment Reporting Disclosure [Text Block]" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNNotes", "http://www.dupont.com/role/SegmentReportingNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNNotes", "http://www.dupont.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/EIDSegmentFNTables", "http://www.dupont.com/role/SegmentReportingSegmentInformationDetails", "http://www.dupont.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails", "http://www.dupont.com/role/SegmentReportingTables" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r144" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, General and Administrative Expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SettledLitigationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.", "label": "Settled Litigation [Member]", "terseLabel": "Settled Litigation" } } }, "localname": "SettledLitigationMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesPFOALeachSettlementDetails", "http://www.dupont.com/role/DivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermBorrowings": { "auth_ref": [ "r42", "r705", "r737" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.", "label": "Short-term Debt", "terseLabel": "Short-term borrowings" } } }, "localname": "ShortTermBorrowings", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-term Debt [Line Items]", "terseLabel": "Short-term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r75" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-term Debt, Type [Axis]", "terseLabel": "Short-term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r72" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.", "label": "Short-term Debt, Type [Domain]", "terseLabel": "Short-term Debt, Type [Domain]" } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesRepurchaseFacilityandRevolvingCreditFacilitiesDetails", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermDebtWeightedAverageInterestRate": { "auth_ref": [ "r73" ], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of short-term debt outstanding calculated at point in time.", "label": "Short-term Debt, Weighted Average Interest Rate, at Point in Time", "terseLabel": "Short-term Debt, Weighted Average Interest Rate, at Point in Time" } } }, "localname": "ShortTermDebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesShorttermborrowingsandfinanceleaseobligationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShortTermInvestments": { "auth_ref": [ "r44", "r710", "r711", "r734" ], "calculation": { "http://www.dupont.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Short-term Investments", "terseLabel": "Marketable Securities" } } }, "localname": "ShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r184" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Significant Accounting Policies [Text Block]" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/SummaryofSignificantAccountingPoliciesNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r11", "r227", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r244", "r245", "r246", "r247", "r249", "r250", "r251", "r252", "r253", "r255", "r262", "r308", "r329", "r340", "r347", "r758" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.dupont.com/role/EIDSegmentFNSegmentreconciliationDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesNarrativeDetails", "http://www.dupont.com/role/RevenueDisaggregationofRevenueGeographyDetails", "http://www.dupont.com/role/RevenueDisaggregationofRevenuePrincipalProductGroupsDetails", "http://www.dupont.com/role/SegmentReportingSegmentInformationDetails", "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails", "http://www.dupont.com/role/SegmentReportingTables", "http://www.dupont.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails", "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r49", "r50", "r51", "r174", "r176", "r208", "r209", "r210", "r213", "r215", "r224", "r225", "r226", "r285", "r383", "r621" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets", "http://www.dupont.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.dupont.com/role/DEIDocument", "http://www.dupont.com/role/StatementofStockholdersEquityParentheticalsParentheticals", "http://www.dupont.com/role/StockholdersEquityPreferredStockDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r87", "r185", "r186", "r187", "r191", "r199", "r201", "r223", "r286", "r383", "r390", "r516", "r517", "r518", "r537", "r538", "r627", "r628", "r629", "r630", "r631", "r633", "r763", "r764", "r765" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/SegmentReportingSegmentInformationDetails", "http://www.dupont.com/role/StatementofStockholdersEquityStatement", "http://www.dupont.com/role/StockholdersEquityNoncontrollinginterestsDetails", "http://www.dupont.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.dupont.com/role/StockholdersEquityReclassificationsoutofAOCIDetails", "http://www.dupont.com/role/StockholdersEquityTaxBenefitExpenseonNetActivityDetails", "http://www.dupont.com/role/SummaryofSignificantAccountingPoliciesSummaryofAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets", "http://www.dupont.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows", "http://www.dupont.com/role/ConsolidatedStatementsofComprehensiveLossIncome", "http://www.dupont.com/role/ConsolidatedStatementsofOperations", "http://www.dupont.com/role/EIDBasisofPresentationNarrativeDetails", "http://www.dupont.com/role/StatementofStockholdersEquityParentheticalsParentheticals", "http://www.dupont.com/role/StatementofStockholdersEquityStatement", "http://www.dupont.com/role/SummaryofSignificantAccountingPoliciesSummaryofAccountingPoliciesDetails", "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOperatingActivitiesSegmentAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by continuing and discontinuing operations.", "label": "Operating Activities [Axis]", "terseLabel": "Operating Activities [Axis]" } } }, "localname": "StatementOperatingActivitiesSegmentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows", "http://www.dupont.com/role/OtherIntangibleAssetsFutureAmortizationExpenseDetails", "http://www.dupont.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditDetails", "http://www.dupont.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r185", "r186", "r187", "r223", "r683" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets", "http://www.dupont.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.dupont.com/role/ConsolidatedStatementsofCashFlows", "http://www.dupont.com/role/ConsolidatedStatementsofComprehensiveLossIncome", "http://www.dupont.com/role/ConsolidatedStatementsofOperations", "http://www.dupont.com/role/EIDBasisofPresentationNarrativeDetails", "http://www.dupont.com/role/StatementofStockholdersEquityParentheticalsParentheticals", "http://www.dupont.com/role/StatementofStockholdersEquityStatement", "http://www.dupont.com/role/SummaryofSignificantAccountingPoliciesSummaryofAccountingPoliciesDetails", "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period, Value, Other", "terseLabel": "Issuance of Corteva Stock" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StatementofStockholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Stock Repurchase Program, Authorized Amount" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "auth_ref": [ "r50", "r51", "r383", "r390" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased and retired during the period.", "label": "Stock Repurchased and Retired During Period, Shares", "verboseLabel": "Stock Repurchased and Retired During Period, Shares" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r51", "r57", "r58", "r176", "r268", "r285", "r621" ], "calculation": { "http://www.dupont.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total stockholders' equity attributable to the company" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r176", "r185", "r186", "r187", "r191", "r199", "r285", "r286", "r390", "r516", "r517", "r518", "r537", "r538", "r558", "r559", "r575", "r621", "r627", "r628", "r633", "r764", "r765" ], "calculation": { "http://www.dupont.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "totalLabel": "Total Equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedBalanceSheets", "http://www.dupont.com/role/StatementofStockholdersEquityStatement", "http://www.dupont.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r175", "r390", "r394" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Stockholders' Equity Note Disclosure [Text Block]" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityNoteSpinoffTransaction": { "auth_ref": [ "r393" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The change in equity as a result of a spin-off transaction (a regular or reverse spin-off) which is based on the recorded amounts.", "label": "Stockholders' Equity Note, Spinoff Transaction", "terseLabel": "Impact of Internal Reorganizations" } } }, "localname": "StockholdersEquityNoteSpinoffTransaction", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.", "label": "Stockholders' Equity, Other", "terseLabel": "Other-net" } } }, "localname": "StockholdersEquityOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StatementofStockholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsegmentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by business subsegments.", "label": "Subsegments [Axis]", "terseLabel": "Subsegments [Axis]" } } }, "localname": "SubsegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.dupont.com/role/SegmentReportingTables" ], "xbrltype": "stringItemType" }, "us-gaap_SubsegmentsConsolidationItemsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.", "label": "Subsegments Consolidation Items [Axis]", "terseLabel": "Subsegments Consolidation Items [Axis]" } } }, "localname": "SubsegmentsConsolidationItemsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.dupont.com/role/SegmentReportingTables" ], "xbrltype": "stringItemType" }, "us-gaap_SubsegmentsConsolidationItemsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.", "label": "Subsegments Consolidation Items [Domain]", "terseLabel": "Subsegments Consolidation Items [Domain]" } } }, "localname": "SubsegmentsConsolidationItemsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.dupont.com/role/SegmentReportingTables" ], "xbrltype": "domainItemType" }, "us-gaap_SubsegmentsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Subsegments [Domain]", "terseLabel": "Subsegments [Domain]" } } }, "localname": "SubsegmentsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.dupont.com/role/SegmentReportingTables" ], "xbrltype": "domainItemType" }, "us-gaap_TaxPeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information about the period subject to enacted tax laws.", "label": "Tax Period [Axis]", "terseLabel": "Tax Period [Axis]" } } }, "localname": "TaxPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/IncomeTaxesTaxbenefitchargeassociatedwithchangesinaccrualsforcertainprioryeartaxpositionsandreductionsinunrecognizedtaxbenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxPeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identified tax period.", "label": "Tax Period [Domain]", "terseLabel": "Tax Period [Domain]" } } }, "localname": "TaxPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/IncomeTaxesTaxbenefitchargeassociatedwithchangesinaccrualsforcertainprioryeartaxpositionsandreductionsinunrecognizedtaxbenefitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r555" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]", "terseLabel": "Trade Names [Member]" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TrademarksAndTradeNamesMember": { "auth_ref": [ "r555" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trademarks and Trade Names [Member]", "terseLabel": "Trademarks and Trade Names [Member]" } } }, "localname": "TrademarksAndTradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/OtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r276", "r277", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r659", "r660", "r661", "r662", "r664", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]", "terseLabel": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r86", "r392" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Stock [Member]" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StatementofStockholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "auth_ref": [ "r383", "r390", "r392" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.", "label": "Treasury Stock, Value, Acquired, Cost Method", "terseLabel": "Repurchase of common stock" } } }, "localname": "TreasuryStockValueAcquiredCostMethod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/StatementofStockholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfRestructuringDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identification of the types of restructuring costs.", "label": "Type of Restructuring [Domain]", "terseLabel": "Type of Restructuring [Domain]" } } }, "localname": "TypeOfRestructuringDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/RestructuringandAssetRelatedCharges2021RestructuringActivitiesDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.dupont.com/role/RestructuringandAssetRelatedChargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_USTreasurySecuritiesMember": { "auth_ref": [ "r450", "r495", "r727" ], "lang": { "en-us": { "role": { "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).", "label": "US Treasury Securities [Member]", "terseLabel": "US Treasury Securities" } } }, "localname": "USTreasurySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/FairValueMeasurementsDetails", "http://www.dupont.com/role/FinancialInstrumentsDebtSecuritiesGrossUnrealizedLossesAggregatedbyInvestmentCategoryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrealizedGainLossOnInvestments": { "auth_ref": [ "r166" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment.", "label": "Unrealized Gain (Loss) on Investments", "terseLabel": "Unrealized Gain (Loss) on Investments" } } }, "localname": "UnrealizedGainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ConsolidatedStatementsofComprehensiveLossIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnusualOrInfrequentItemAxis": { "auth_ref": [ "r146" ], "lang": { "en-us": { "role": { "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.", "label": "Unusual or Infrequent Item, or Both [Axis]", "terseLabel": "Unusual or Infrequent Item, or Both [Axis]" } } }, "localname": "UnusualOrInfrequentItemAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails", "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UnusualOrInfrequentItemDomain": { "auth_ref": [ "r146" ], "lang": { "en-us": { "role": { "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.", "label": "Unusual or Infrequent Item, or Both [Domain]", "terseLabel": "Unusual or Infrequent Item, or Both [Domain]" } } }, "localname": "UnusualOrInfrequentItemDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/SegmentReportingSignificantItemsDetails", "http://www.dupont.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UtilityPlantDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plant owned by a utility entity used in the operations of the entity.", "label": "Utility Plant [Domain]", "terseLabel": "Utility Plant [Domain]" } } }, "localname": "UtilityPlantDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/CommitmentsandContingentLiabilitiesOtherPFOAMattersFayettevilleDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesDebtTables", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesDebtTables", "http://www.dupont.com/role/ShortTermBorrowingsLongTermDebtandAvailableCreditFacilitiesLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r207", "r215" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted Average Common Shares - diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EarningsPerShareShareCountInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r205", "r215" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted Average Common Shares - basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.dupont.com/role/EarningsPerShareShareCountInformationDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226003-175313" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e526-108580" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(13))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868656-224227" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(14))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1(e))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.13)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.19)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3151-108585" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3337-108585" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r184": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721491-107759" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=d3e31137-122693" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=SL108384541-122693" }, "r204": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "http://asc.fasb.org/topic&trid=2122394" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258" }, "r222": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8475-108599" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r26": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/subtopic&trid=2122178" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r263": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(4)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r269": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/subtopic&trid=2196772" }, "r27": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269825-111563" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27337-111563" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "8B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL6284393-111563" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27357-111563" }, "r283": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "http://asc.fasb.org/topic&trid=2196928" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "79", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82922352-210448" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922890-210455" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r305": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r322": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230" }, "r332": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "410", "URI": "http://asc.fasb.org/extlink&oid=6392692&loc=d3e7535-110849" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "410", "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "410", "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13283-110859" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "410", "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13296-110859" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "410", "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13207-110859" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r348": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "420", "URI": "http://asc.fasb.org/topic&trid=2175745" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r351": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=6395460&loc=d3e13647-108346" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB TOPIC 5.Y.Q2)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r362": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121548805&loc=d3e10037-110241" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12069-110248" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12069-110248" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12069-110248" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121596127&loc=d3e13051-110250" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629" }, "r376": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(3)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21564-112644" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "60", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6406278&loc=d3e26268-112671" }, "r394": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130533-203044" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721501-107759" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(i)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r421": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(l)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(o)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(p)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2919-114920" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721503-107759" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r512": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "740" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "740" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "740" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e39076-109324" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r551": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5227-128473" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613673-111683" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "4M", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686" }, "r579": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=117331979&loc=d3e41228-113958" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(iii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "4CC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998890-113959" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "4F", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624186-113959" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121558989&loc=d3e80720-113993" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30226-110892" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r647": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107425-111719" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(1)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(2)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(3)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(4))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(6))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(7))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(20))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(5))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(5))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.3)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.2)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-06(3))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r785": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r795": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "3B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "340", "Topic": "980", "URI": "http://asc.fasb.org/extlink&oid=121557228&loc=d3e43603-110378" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "410", "Topic": "980", "URI": "http://asc.fasb.org/extlink&oid=6500910&loc=d3e48636-110399" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r804": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r805": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r806": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r807": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r808": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r809": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.23)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.27(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(4),(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" } }, "version": "2.1" } ZIP 126 0001755672-21-000012-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001755672-21-000012-xbrl.zip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�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

QO<^YDKV]%]F#&B';7*H?K]FVE'4M2<5(CT7^G)6:K58TP*' D ,9^%#Q M?Z"H/V&QXG_EC"*<)I$P35$VK:9+FQ&4M5YCKM?8ZVUSCVR\G4S UVW@' MJ[W:[*K&JK+6JRW7*SG]+V7\_RR]QGP]=W@' (P/W"?^8GK6S4OZ#J9>A/_? M^@D8AVHLYU.8*<*CY9,HQ/:IV%0?!V/%DUJY$?[/ISKZP",GV1&-/Y[0#W#U MA;P(4AQ]1C]Z/J,_.0DMF:=O6R-2)A8_5R#+/"@>Q;_,)'#8JO9CMLFVXK/2 MA)_>'?DBMBL("4Z"P =2IUY0*],8H!"CZO:'@!'F?BKMKHMU"[0AF'FNB]7Z M@DKA\[M/U2&MW6*S!W&S-:0[%">>LW7"S*!/E+ER#L=H31 +TPN%T[NFK<+FO6;: M9_/9#=/>%P:30Q48U@R")NWP5U+HVP.-B.L-_Z+,VI%&$D=Q&A# 8=)4&<(8 M2X $1 S!-(E\WY(T[#18&IGL8^L:"Z[V";0;(ZR9Q;)'C!EG.IRG9Z*!$ ]A MHV$P.68I2R7F9J]A&%U@M8$-66\HO\]*04IQHP3<5B%A*L MB[PJ7PC B*B?9) !GT2D"B.?&A4^J9=Q-+XJE'3.^A9;:LH38TWVMK [-TD M=0#1],=H4Z%CO'_H *69-OX&H&6SV=8#1.LN6=M[A]M"_5]Z0USRFN MW%_3;W:\2J8K2FR$\MT880F+?,#\) #*7PL!$50"$J,82A91$AKY;CUREL9X M2E=P2/NPT];FVD,?L+W$YPJNB=GO-5*_[#3]U:MT=8F8,1FZ0FXF1AR%H TW MFN#22I"=+\_%DB86'%&ET>-#BR/F[%_W^5J]47[X]U.V?:EJVZ_2$ 51K%Q" M+&2HG,-0+7-Q' _31$,2""#-+:KBWA1SM+XLE(*6-\):T/1;'WJ )N)R?%8 MP__IU3I>>966+@L==L+@ML;A95$SES?LM/>\LF'WXT/SY3X60A]&JZE!_;P6 M5;CJAA_G=5O!D#,1$P+2$#, ,4\ \>,02,E)&/(H$0&VRYW;+W1IS'"L8AZI>^7M%3;'-9 [W?VS4J+[/'K\*]?$IY_5.O'O1VV&Z*F"^5BW= MU8^L4M]'D$<4I"GS]14; 0B)*: <8@@)Q=2NA/-@399&6:]U]';VJ(E[9Y%W M,,FC+][)"_5C=MPVO!O-"&^6SIE^J3EEOUASY&A,71+G<&5F9=/1F)U2[/@& M1R4NNAC37C;U?P,F8QE! AB!D6)8%@ D$@P$0B$5&,9^:.7_&OCA2 M6M9H4^Q9IBDQP:$E39/3J,.[YL'G. MBGQ3[4VNOXD'P6L7\WNVKHPY%"B"BNGY3$H P#I,D3!A+[<*ZST4L M;4P?-+0O[]L!I)D3, Z>B<>T)3+6\WR[\2YG]@M29IW+VZT\G;T[GG205>G3 MAJV?>),L]6PYR5IG>5[%*?*%8"' F$D =>8T A,&4A3R M-$0P]N/8[OK8:)UL!L@\-\RT@M7$Q_0/XJ"JOEG:DO-D1+:F01UI>!@V9^=, MOU-RE/&IRF52F].:PF3?C]4/1U9-E!AJ#,"3I8X:I-3;)9<:@V%G^JE1#0^\ M3Z,O[7T3VZRHTG5V5TO3D4K-IJ9.0(VH[D>=O!*&L0\(4O_4P491%-* M^U95>$V$+LUEJW3V#DI[!ZV]2NV!F\I&'6#&I*YAG9@L'2!J?UO& B*G%V1, MY,Y[)\8"B;-K,#;O#N.E*DKJ)G]X+,2]V)39L]AE\?M>J6[&38 M#6;\Y![KU?>DZ)*G\TJ2[Q2FV)'8+9]8\9D$R(^,:4IS4\R M;.[5UWFO:@.\8PNNO,H&=_PV$#R71&>KPJR,-Q"?4^H;VLS XKADP]7B5/_/ MIP>=:*KR#'?K%S^,6)"F'%!,4P#3. 4XI#Z($QRG) TC/[*J8=0I;6G\IK6L MMGBJ'X[U';AD[,;:C,&<(3@Q7XT!S[YHK@DH3@OG=@JUG!72-7AJ8 M9&Y7[;'.*Z7%9(3J&KV94!*(KKS&;S??=%&(0GD.==Z%8O=/36IE73Z:Z9 ! MBB5@H2[/C1-=00U!D$(_2(2(9$JM;L4YTVQI3'4H<*H3EC3J5J/O6/]AU;W= M=:<9P;U))TU,AH[ZQSY%GFLLG6;3\%_7_?MJ<9/1:293ZW ]C0"1C '(2*E^117J##H8,A7'( MK KM]$I<&@N=IJZS#4KK ]B,=)S"-C'C['3U?MEI^ZM.!F\,Y( 8-D-PW(:T M]0F=.<+-$(/S@#?3%^>M^/5%;&_E#_+SJRBJ_;CO>N][A<*(2YQ2H"A)'Q6D MBHD@#]72-65J-5OH%?'U=YE:%O7P^N$_\E5(6[K.!_B]IPG=BZJA#7+61H^B:Z M_;0IMT65X*^YU083EF .F X,@&F0 N0G*< \\I,884B%U0G9N8BES=;5)L=! MQ6$5A<^!-*334?!,S8EVR S(KM1FO-M<2F=29LZ9ZDUB>MT]F^>RJS MC2C+F_R!9IN*0?8;L=^WXO&OC[?RFOW[*2MT<81G)2\O7JX?] *D$"R_VV3_ M)7A6!5+F\K<\YV69K_D*"PZ%$!!$5-?_)20&B,H42!0C&4>IZ;;$9!HNC5V. MT,]?:67GFUK=[!V*IKE;GZ Z@,]K3%;]W1QIF$ MW[[#9\I!_-8=;Y/&>-I.:4V /)'8N5(G3XO:4=+EB079E_$04NG#W]7YG[^J MSUZGR*@.7_7 ^E35:OSK1K4EG]1_^7ML-[98A76^(=F>+5MI@7PAC66;TS]_1= M,/F*9+GHFUQ6481"EUFA &(: )R0"# H QR&6$T\ M5I=\^P0N;H9YI:_V'!N-O7]HG;U*:=O]J3[0C3?_G4$Y_7[^&!2'[,L;0>-X MJ[U;YMR[YT8(7-@0-WMO&-_X]C(5@044 2C@!,U2Q $Q(" MZ2.)N4^0%,*&9"Y*61JS5$KJH5"I.8).+F-JQB&CD9J8.(: 9,T6G2"XI(C+ M@F;EA4Y;3\F@^^%A#/"CJ'R:EZK1.A*Y67CKU?7O8GN?\Q64(0LH3T#*=86W M(-"%>6,*?)HP+G B!++R.DR$+HT?OHE'U=2]#B$;==?5"' SMG -X\3DL5.W M)H^KW1V)G$,!"2$./(%Z$01E<-+C6^-&;1"GJ-AI:732]B MU[O3-0J1B4G"-1C&&T^C0)EI3\D.')O-HE;K6_>!SM^8:XNG5=>CW9OV9X8& M Q79L^K=9W%T/VM%TR -$4H!QDD,()(!H!1*$//$]QE6BZ78,A[H@I2ET=5! M26^GY4L5WV<;%70)4<.MEK$X3;X3?PZ1R\B@#NO=!@==$C1S?%"'K>V_ZP:N-ME=:R3-_- +742&@$BF$YEAM5*"&$.8C\5"5?T2+%1B,_EYI&K8 MA-ULE.J(X1M=UHNP[=^R[?W-DUJR/XCBFI;5[U8\DC@D. ;Z!@> %/DZ_8TN MQZ5^2Q'R V95?\M0[M)&^F[_OXKAWRGN_:$T]W:JJV^]4=YR0]2T*\SF_@D MGI@S'&%K[2=8(N72!43;";C%+8Z5:4^](U0'G,CW(]NR6 M.,-K8I(9"I7Y)H$1$@<2*7:.G\7EV%HP,W.\Q MF#T]U'G9G35(XRCADB#/ ,4D 9%P 1&(?)#@E*4Z(GZ16:;+:12V- M#(X.8 ZJ#DS.UP&PJ1?B K;)'8]!B UP-/K <.M;M$J;V9WHL_K<@^A]8U2A MX>8ZY.;NFFVSYVKWHTG]K:@ABFB" 0\D S!@$A#*)4A92$+IIT',P@%5AEL% M+HT[]HIZ!TT')EOOQ=J,0%PB.#&-# -O:%GA7D0FJ"G<+O,M"@KW(M!23;C_ MO8'59];K_ ^B+/B8%^_S)[J53^M=.I9O@HGL66=D^2J*+.>GB5M628RBD/I$ M@2]\ #'G ',6 L2CF#&N$V=8I5$?H\SB6*FJ7,"%KMY8U>HF=ZJWRJU'=D9: M5JD9TU%FM#47_!-3VC[MTT'G*V]OFZ<<>N^F$#S;>CKM0)6Q0AGD74@BY;#J MC0-HG5;#&://O%5R'"!W5CW'19O6@3 _R$]:7S@HZMQZVUQQ1%;=-1N MMEOR8YHNKZ",\VKK=*1?;9^G#/24A=[>1'U[ MM3'2>V6E<;"*N\[NV<-ZHRZ%7 M[B3-%;;E')NC<"_W;0\LL)+K2^VZ\3NQ86H!]N[E"]D^%>)6'G[]4@5"H-@/ M(/,3$ >0 H@P C0-*>#Z#A],4B@2:E5MQ5CTTJ9AK;EWI*-7ZSTHUY1%!Y@M M>*:!=>*I<2"B]J58K,%Q6I?%7/J\15JL43FKV&+?PM"#IE*HEW3%XO?B6:SS M1TV-'WX^BDTI5@Q'/L)I!.)0\12D20A('"<@C"43.M-50*S2;'=*6QHK[92M M*G<LU^MH>.'4!;7KFY B^R8^=!B(WX.#) !&W9T]= F<^?C*P_?P$RN0E MRTC9[6.QNOWS*DA3&L:**&B8I@!RI-@B2'S ".H'F#FU.<\71::1[*^MJLC($0_J:P+4/43T#\=QZTV[2;?0<7U7N^2%^;M\I)?ZU(GX0<3_& M +(X!) ( K"(.4!!*BBC"*5V)6=-!2]MJ.WTKA-3U)I[6O6R3C4MRO9M]W$] M8'AV.P&N$X_M5DAWR;OKUMVKE'=YLFN)E],37E/9\Y[T6B)R=N)K^_[@ MY<&V>&)JY:&6'#H%4A/B$ @_C%FLP.8X4&R%):!,_<1I@J @"$=V]]Y:Y"R- MEUZI62?T&A9#TH:K\3I@+%K3KP"L@1KB_'?!X-CMORAJ;H>_R]X+KG[GXP.< M_"]_7TF6Z/I:,< !44X^@A' "#,0TH@3)C$. W,G_\O?ES;"OWSXF_?WVV__ MV\+15Z 8./IVIDX\/'NMM'/V#[:-<_95._,Y^P>E7SG[1[^V/KRO2N/]3NH1 M%_J1W[!Z$D4D(8$/ C^6RJW7%=83*0$/H!I%G-*8&J73:A>QN&%4E7?EI M12UGR@XXNT>;&Y"F'H!3XF-\G.P IYD.AP?A97-NVP-%ZRELVWMSG:GVZ'UT M0MKWY-!2G8I.E*-1E^C9!Z"N9,)B'R<04))2 &,=?92$(> ,)DPBDD8PLBO0 M>5'.TGAOIZ8N6Z'TM*W*>1E+LT6! X0F)KT].+6*5]Y>29=%-SM1<%MJ\[*H MF0ML=MI[7E:S^_%A)+#;>KC=O,_*Q[S,ZE2E=47S8,7C-$IBGX%88!] J: D MB< @A*$(4\QCPJRJAG>+6QHE'.^QY1OO2&6]%5ESR3.RM=FUI_2MN%;P]C[8[;)MN*S&BM<30_JP\CH6M1-'Y?G M:LZ(_RY(\5%]>BL($58T(X"H*N%B'P.=+*#6_DWHKYBY*XR.-SD#X^%N%?N MI7)"ZZU5K=)7_8M\<[WAU5-?QO94_R,^50"S0 M'B:(0Q("Z"<,8*S\2P)Q+-*(QI#'JXVN"B6XV?IZ(DV-1CJN1_JQOM,-](.. MI;XJNKM3^JCUMUM\3]6Y9JOSM^RPF>+-J_0GKTST?JF-_+7)NW&IB.:51Z1F M936B=3VD3&:LWFXW 682M59MPDFQOMT'V%J<6XGF+]N MBI/ W]O-(?U]>5UDI9KKWM?!?U62DG="WW?6_,-YC!$,&9 <0P 3C 'E,E'_ M@4% 942X;Q6].X&.2UMS-;7K<^G]LJX.2G2BII-2]K88&K[FO.N*^]@J'=Z#G8PUVOL]=XW N_S+EM M_9?3@7?Z:^MMZYN\V(IGHF])/WW--]OOVX*\["LY_5#@E/?YFG_,BZ\?K[^O M?.4]4>0G@*N%N7*H: RP9!@DH0@1#B(1,=, ;SO)2QMXC?;UQ?]*?T\717CQ MUCL+O.W.A"K)HC;">-_3LE=Z-Y^GPWKB<;\HF(TWE*>#>Z8MY&810%^\/^XS M=K^#7O?"KD?^R-9KK[PGRBO41GA,K13+/WG7U6[$H4^RTA,_F1!<5[U5KL C MV>B!NHWM3:_NLEC M-JRO6G>E+9N;:Q]ZF)5'.\\#&["_622V>L&9;TJR5A^TU%^'*+8O]$EYB$)? MB%?&EODZXWJ#=?]!J6\CV^@8R&HW=!5&//0EB0 .D,XQ0# @G"$0D"26(>,I MAHGI/207"BUM]E)&>7IU[_VB;:L6@95Y>M#M#%2+OKV)>N@>C#R,XZMJ4!X9 M:GZEQTD_]TY\L_?>U'ZPZKAJ0^:_:X^97]F:N^=FFEKKO9=Z:ZTJDZ;M4^SH M\2K@E:QUCQ+5P<6=,JB)JU1_SC9;<5=4G5F*:G^.'$H4_*)='_&3/#SJ[-[T M:>MML3BZJ>MU[),5VH[CE/GO4[;&\4--NU?ROGMCD6JWJEF<]7L MKYFVMV[F)1Z- 'X#5 MSHKX]U/V6!^39(>@R;JY_0/*AU0:J#7?4U&CJ2263[14*)"B^G>Q>^ZAJO[> M#!\AW'@@3K_T]OM[3J3,=MO/)2;'=P.=MCLP29+ZMNHR%KLZ*A F<1B& 8@2 M'6,94+T_)7T0)PG#/ I3B:15-J13"4OS/XX4'%J;Y@Q$LV. 4=!,/+E;H6*? MFJC-)6,2\W?S0K3 MC@:Z<#H?B6%DV@^"[A<\DF7N%F9Q<#N4XXQ M><5Z?^3#I_??ZKSOJF>W+S\*HER9.J'[OKITS&.$61"#Q$>*<'Q) ?8E 8GR M,F() XF84>8B,W%+\RV4RA[P&JV]2FWO6&_KXMZ&J/?N13C&2L8C3<( M',,YT_+?!:PVBTL+E%J7CB9MS+4PM+#G:-EG\Y9EG$&Q75V7&?E*F [/W)4N M%DBF F$0!K%V^20'%$4"D%#@F'(4(HF-H@XNM;XTPM4*>HV&AE$(%T'KB4D8 M"\7$?'F,@L/"PYUF=WA:ZKTC+TO]Z]3#NMSP/+$,73;M(QLZ'[+TFT2VNLFV M+]>%(# MULYPGCX%J\>Q&0'!U(LF,^O-I],64SLBB-0K]3!4/YR.P+/FYIE#6XS8SY9M M?[ZT@H+D] GT#>:%2^T MO;2!5ZGGU?I957>ZA%O_ !R!QL1CT 8(JX'88O*(L7C:XFS#L<64XQ'9]LC0 M7(9Z,^('^7G]M+W/B]UWACA/_&I6A H*PF'LA#8!J0U+ +!;UYQD- M.Y^VGY[?-SL>=<#]APU_KQ;(JX0D&$7S#SK45.EI/E]?!K)_UAX-S\1#WAH9JPF\T_H1T_CE=F>; MS#O-.I[2NQ\<6L7D66R>Q#>ACS3KNS0R+QYTN16 M?E>_+66]'?8YVXA/6_%0KB*68B8@!USZREGG(@&$I!C &"5!A(@?"*-(?_>J M+8U &LNNO+UMWI%QWL&ZHSQMM8'ZU.[81.\?VDBOLM*ZSHJSGC=S6-ZF/R=F MO+F[HNRT>XTR[F>O-N$;UO$2-\SU;E!I!S 6!%_$(0@2A-)88A]%!LEL3:6N#0^ MK[76 WJOMUUKU_BW^@?#WN(U3@#HQJ;XMGL;GR>YQG>E(V1&^-J?* M=EBU'BP;-C/7V;*=54?'RY8O#O/MOXCMIWT,\I\%OU-S1/.-ASR*$8H10'&J M*#O$ :#,]P%-TR2-N"00&Z6/[!>U-*[6H6\'5;U&5TLR,4#8S"=V@]O$=#P4 M,FM?M1\-E[YGA[19?KB]%E\ZN#T M/C^Z&-L^E=BGC2X%7=WK4FZ5$KPE/UTSSH[36*7WD'U;U: M=\LKY8;]8,9>$Z [] MI;7#PTXKE%SRAYG@6:G%"HM3UK%[>6B8].MZ2A^5"=>,/3T\53D"VJH8W#P5 MQ3Y@>Y]FB"@7-R2)4,ZO]E-0C-6*7#DK01S2 *G?I=*H0.X4RBV-WNKE1WE4 MT$HM*:LLF$<6>I>*F>AIR#8BVF4G,QH$A% 0$ZA3ZOA">>XL!A&6G/B$0RR9 MG3/Z5MT\CSO[W[:CS>;$M^J\B:?.LSIS1CU6VW;E-=;M:P8=TI*YC']W#[S; M"'B'^LT< ^\>V?,H^ ED#-QT9_>"/ZW%K=0!FC_RW\E6I_]]^;Y/ _QY?R$F M90A2"0GPU4H$P BF .$X!&$2,L81D8&PVK:QD+VT"7RGNA[86GFPS<%#H[YW MT'_$12:;CC'-WW,B^]D+0X2?BN4E_6M*EYY6M.! M"?5;<#7CI?%H34Q PX"R9IIN'%Q22HND6;FCV]I3DNAY>G D@BXN5^J5Y#?Q M2%ZJR*Q;^?T^+[8_&FDK$D9!&F *6)+& ;*R<&^\F_\B& 8)6DHH14Y&$E= M&E?H[1AVKWY3%?&A>5'D?V2;N]+[92W4[+M5?_*P[W'R,N#PV: 3C,^EW4([ M,;'L]*VWRGXYJ*S6;;]ZE=8'WG%Z)FT.D^/C:@/!B"=B9]N4-V0QVRKZX?]?!0;GJGUL>WBJQ]R0SIR M@N!,5+1CGFWN-=IZ!W6]6E^'%&0*C5/ZZ14Z+_688G!&.\8OCO>+=K+4XJS: M8?^8;E] <.5#/PD9AH ($BH/B3. 9;VG/6#(O?FW.%O<&>-?]H(_RFRR@F\J# M,E'AS7PI"WRZO"J;9JSS'-S9'_OO[S]_%=KL66G!S M0SW +$Q@Y(,0RPA 3"0@/@P QB2!89A$,36Z!&@C=&FTME/<.]9]/ZVWV/M-UI=GVLYHCZFC0YJ-/4"I" MGPK@0XH E(0"&B$."!:<)"$*(66&5&XJI#G:Z>P?E[:G' MN!-Z&7T*:*=V3]\<56,^GP+=F>C<&EVFOM5?H:<]'0+NDE_!F GIC_ M=Q9X1R9<>,)X<9NB)F>:*TZ^^/&#/M,KZSNSZB8OR\,^G M*N636AT\%OIAH3>7JG?9.B^%M[T7WN^BN!/%E?>HW@'U/]2;!TG5N4.I&JU> MZVQ8-Z>5W'#UM_WW<\"W_)/WXUXHN74SCT7V0(IL_:+^O2D5W>KPSF:?D:P] MPI^S,B]>KI2\*C]XO=(1['Z3K_,[]?NU+@1UY1'&] 6+;'-W5;6DV5OO4RI] M\VH;[;'(I=)$O7[4K">%-JHL? MG,S&(S_0ULEY:+MSS=4C[3Z:NL>VY"15#5=ROHEMIL;%^Z>B3FN?Y;Q.A[PB MC$FM#'";,*\-MWRWS*YC1$R/1ENS-H8 MQG9M]Y%T'.L[H>9G<7JAJ=S?(V1$1B*(0^#SB !($P9P$C.0)F%"48 B9E;K MU($N2UO)7+I#V.3,VUTEI)5%WIE)1I<*G?>E&57.U$,3,V?[!<]]2I91G6/- MI@Y@=4FN8]29E6L=X'9*O2Z:')A!YE+^Q5UZQG#D:_<5 014UYKG <,0HX9I)2' 8T MM;KL.9_J2^/YMNRGQTE2ZY0LEE<59OP:S*A_F7T\\4SAHGOMT^S,CK337#WS M:3]OPI_9>^4L:]#\&HQ-6JXORMW*ZWHCKU0SIU!"->?X49+"--1?CX@!1 @! ME H$DC@(61#Z3*!@6+KR-I%+FSFTMCI_MM97.Y0[C;V#RD,SD[>B;L;T;K&< MF*%/LI$/07-$%O(^@*;)/]XJ]8TRC_>AT)YSO/=-Z\/8W[.2B;7Z1$2N=X\U M^Y$-WQUV;,1V%1 ?\4C'TZ0ZH5F 0H %EX#J#0L1LY03TPI1O<*61CJO%#X< M 0%/Z6I\M-\QJE/@)F:8UY@U^6OK,Z1:W2O'Z!D?@3I%<:;#SI%HVAS M&M36W\)W0\WQBLC_N;DKK :ZS6O]O; M7=]D:1ZQC@N<]EOIG6H6\P5,/$W]W]CYQC/E8CZ"F6;997P,-I/U+#W4.M%/ M*WTN)V$6#(\ MHZBG-;WRC+ ;L.-O@(G;3?HN@3/OJQO8?KX5;O*2];*F.OSE:MF4Z[#3)\'S M1]&$N#8>!U+K#RQC"<(4Q0!*%.AXOQ0$ZGM*0Y]REAB%O)@(6QIOU&$3QQI[ M!Y7M7<-^L'M]>Z<0SA)T,B-ZQLZQ4Q1G5E"-H9>RF@BF#_]^RK8O.D WW^CXI^N?6;D*%(Y0 MIGH3)U&K,AQ00!.I5F51(E :)7X:$KNJX1W2ED85M8[>04GO'UI-VY(DG0"; M<88SV*8^*K%%;,#U* ,DW-Z'ZA(X\P4H ]O/;SR9O#0TFWY9I?3)-G=BPUZ^ MZG2KF[N;-RB]/E6L;>@ZS$A D,0H^C_=O5V/W#B2+GQ_ M?H4N]L7I!HJSHD1))!8X0-EN]_K W?:Q/;,XF(L$/ZMR)RM5FU+:KOWU+RDI M,U65'R*9E$IS!AAW5:7$B'B8>A0,!B/T*B3&25&X5=8?$CDW%FG2$7LJWT2= MTE&K]4W4ZNU:<'\0>CMJ"0OHR/QR-98>-?EMX0E;GW]0ZL2U^FU1.*[;;WVG M[W84JP^)UG_J+T_7>R(6N<@YA4 E*C:=51- 6,8T$<$X3PSSV.6Z# F:&]\8 M/7MG*O0CH2_V;.MQ%ES;':GK(1M],\H++8^-J,M0A-V#.B-KXNVGRQ8?[SP- M7._=K;E+?:YNF1Z=\GI!F" IA1(@*?2JAF$*F"@*P(N<H3,N;& M"CT5M4_>*>G(!J>@M"."*P$:F0,M?;"DZKOZ3VE^K>73^CQH),\EV=M MV3V-YR_P>]>^H7IVN/QZ+^7^0&3G,"HB.4*9 IQ3\\HM$D#3PH 4(R00EX0Y MQ0'.BYK;4]II&C6J1CM=/1WR"PC;O8G#X#;R8^T+F?.;>1B-D"_H"](F?4\/ M6_WR=6UQAW-*F.GB5ZIWR\I45MQN9!,.3Y!2J=+^>)XJH=_=* 9$XA04E*B" M8LJI72/.,^//C1N:1I*EB@Y:.FTQG$/Q,A4$P&;DYW\D6*SSMJZ%9Z)4+7>8 M7+*S+H%P-B'KY$U3Y6!=TKB7=G7Q,C_'IRT&\8W^O-W6]Z7IQ]Z+E"ZXE]:V6BO[541R8M(V[E H? ; MF02O@<[9$;+!)*0K=%'>I,Z0C>4OW2&K>_R8Y$]9'\JBW=9MMQ03)_E6_JD- M,OU3RI6^_\[4Z]5?MWJ1I@02K%'.,$( F1T/IG+M-V6"T3@E7##I0B_.&LR- M2V-R5F)3MO#%Z28'^ X4Z=7C[4&[JY7\W/O8G92K?5$8762W2 M'&90, 4REF0 I2C3C%@0D$J6*AYSR7*G#'<'V7/CPKZB9JFP76\D+^_6R_^6 M(EJ9;(I?[K3VCBW;72;#COI&@GADTCM]DO$EYKU"6F,>;!P$;-QCCN?%O_*A MQT%'DF;TBV(*$3SW&Y#RTWLW*ALI[7I0"+KIK367E?7%'XKV.V8*SR8 M(Y/6'L>F?S.AVM2I_-#%XTZ;F[4:*I0G$5R;#;AAUCU, M+B"&/1%@)7GBTP$N:!R?%'"ZVSENW[I]1NLVKV^KG;Q/^X.+M^;KHU?&^LW/ M,4I5EE, 4Z;=L"PO %$Y 3E,<9I2+!5%B[JLZ6HPEF\KTXFS]I)'C^$TM5T. MFD<'U:-&]ZA1WCJX;3T#,).2IW$.J'E[(%%(0#(E $PXU9.0",(SR]V4469@ MN@#D:\W X$[,&+A.$YA\+4BM=W'&@':RQG4A(';9[7$%Z^P.D/5 4^T*N5K6 MVREROM7Q92J7B]_TN/53$R1IVN3)=[2F;SL/E$.,LB++3>H: T@I"FB&&("$ MHS1%#!>)7;G& 4%S(^U6UZBG;&2TC=ZZ>/N#Z YP[(E[_[: M% ?+\XS(-.,@H>:$'9($4,A3(+.4T%0(F25.R>RV@N=&&J>#<69?8J?\_J-? MV@7MKT$*M9V9%M^XY_5@OTK0\R3.316!'=ACQCXO@S9NX/.,[%>.>EY&9#CD M.7"_9ZT!?B_%UC0F^"+;7O%2O*75_>VZ^8\YH?R=KLSAY&_R9_U&6_B/19(D MB&4$@D(H36\8<8"ATAR'19;R& E*G3IJ>>@P-Z;;*=XL!$P'=ZUW4Z.C^:%G M@6.A H_9L6.YD3$?F?"LX>X:5D7&B*BQ(F3A W\,@Y9#\%!CVB()_C@=E4ZX M8BCO[!\S\N=-^7TI-!\__;62XL.Z6W.N[V[WG=3W!_#R(D.%(AAD2 K-CPP" MK!@&INR"HE!3)7$ZYNRNPMSHL7DLMZ9ML]F[*'>*]]K0.Z?[N$Z*'2V."_7( MK&@XI^,19$R_6OT=Z(Z&#%*(3^>*)U(_/$= MR;= E>;5^W*E[ZC:&C:F0MXA??O@C B8P+B0"6X,V%?\?T9=42:C^[.C C9NRI4S8ND>CH'SR/07#F*/$EB.<(4M MAV4K?.+26(Z8')?)+]=TS9MNHKL3\/M#E:B6-:^Y& M8CX384=G(\,[,K'MM>\U^+RYE ^TLR$7]'?-4/YU MN[Y*OMVTON)WNEP9J5J8:5WZU_5&TI7)4C9"/Y?5TH1?WM/EYF]TM95-G.7@ M9A2<9PEB"@BNIQ&)) 4X*RB .892?R92$KN6^@JDV]R(LZEW=;!-/]D[ZX!^ MLD%%S=-^L+!YQJ.=C3>1L3)JS'0O)!9JMFUW5EYE#D??? DT?:/&*D? /G1] MM%#J35Y2+3"NIZJPA1;AFQS_\%"*IF1MF]"Z:Q24T3C'W)RDSA5 B4P!X0D# M-$U01E2<*^BT(71&SMR(>Z]FM$_@]FMA<0Y7.UH-@-;(%.D#E$?"^D48PF:H MGQ8U<4KZ17N/<] O7^Z]=E[6\N/RNPDXUGK.E\9-;4Z#]$_H_-;V8?XBS7%L M/?HG]5XOX^GJ_TJZ63"5B2PE"I T3P""!08X)1IT6D@,XYSFTJF@?0"=YL8T MGS<2U/1G1/OGV+KFUC>FY6EK@CG:9I(_G9?=5\^A]3)\RID9?UFNK0&-.='! MGMVI'6.%B8$\.WQHUN:]R6KMBHQA0=?JH5 .O':_6JVIU_*A<#RQM@\VM!]Q M_W6]K;9T]6GS8:TV\K^VJAC(Z*!L9;6_,W]Z4];U7QY%+<-MQ9R 01^;$ /@Y\YT% M,B%Y[)*X2?G)PNZ7O&-SBV??$;WLO&M(ZZNLZU73WD13V5;_^X/J<<2WLNFM M^)ENZJ<%S&-!&4F I#DWQZ<+0*&* 4DHE"3ADDFKFH)>TN?&.0?EHX/V3)3ZH!6UCXJ3 M!U-?+ Y M:F[B-8CO?LEF^9V:,R9-E&V1PB1/,$X!U/\"Q L(6%Y((##1'P@6Y]BI[->+ M\>?&6P?UNLBU3Y_#9;B)X@S+Z1H U'A[A^Y-6APW!/Q'?M^45?7;3[[:FJ9MIOGLC^5JM6>AF$K6ZB1O'HE[WJT4YWQ_IZEO-@QU/AT1V9J,( ZU$" MV06GL,60K21/7!;9!8WC LE.=SO7H'K15?+C\F%92_'UGF[T7TKUN:PU42[I MZOVVWF[DQR5ERU63T-">:5W@A, B%1G $"< Q5PS&$Z.BUJJH9]9-=PS3662J&F2 MX]=KY"RV=HYW",1&?J'X@>71 /4R$F&[H)Z1-7$KU,L6'_=#';C>V47^_/[V M:Y?9B0A*4H8%2&61 E1H^B8P%P"SHBARDG%66%'!LU'G]MP;S1PS8I^C-.A' M^MD^\A-\M=G6'IJ?^1,Y6W8PN#A,Q^:>]7UZET[EQAQKU_-(3GSH3!]ORLVF M_*$]F VMI7Y^'Q8JE:C DH,X3\W6!#6%F#("] HZ2Q*826671G%J\+F1R5[! MR&@8&16MGZUCY :9Y2H\1B:8L%!8L\U5D$Q%.HT#;Y9Q]?)!1K(]AMRJ[^;T[3/N>S"]/,P"KN?<*\8+*C !(LXS@"B, 36;'9RA(DWR M-*?AU",X@ M3&F+RUGB'!Q@*AZUM:1'J]:W>)[@I-7]^U7YPXB1^]'+-_*+Y"M:54NUE,*T M*5FNO_V0J^_RCW)=WU>+E,1Y030#,T(90%(P0+ H0*QRP7*2X!PZ'0GPU&-N M[-S4FV].9JUE'=TU3\.J>1KJ,F(RVO2L:5L'W'YZ^]&X(F4DZ6:M9[J*3.F& MJ+Z7>HR?=50WYD8/C;V.QT@])]]Q4J<40M= MCL1>@J9E@',RT04!J*Q'3-W=*PY M91B "\2A;^Z1AO[M)6%<&'T25ABV;O?H6USI62"]7 M9+>_6FCU$MX.5%) 7 M2/LKA)CMS5@_Y5C '.202)X+B7#L=+[SA(RY/>%_EG7T;J]C1*MH%RPY$*UG M>:!3"-NY'U?B-O)C'P8R]_+DYT$)6G_\A)AI"XR?M_.H@OB%2YW#^;><;Q^V M*S/4<1.;ZE;\Y[:JS=0>#FCNUE^[_6^6BC9U!*VCUE?/R>"FP)1(C\Q+/5.B4ZVUJNA@SDWO%/FS@))S M LCUCXWMQL.44S71QL0T4^:RBQ$*Y+.['%<+F&H7)!02O5V28$/ZN;Q:O*DH M4!TJ,YL6'%T/4X7UZE4F$@B:)0 Q(9+.WXXWJ$1F:.O8(WT1ZG1L?N<&[( M<[B7H A[[O:DI(G/V5ZR]OA<[<6KKTR&V\73F,QS# M0)%S[%(4YWI^H!$"D M4IC&2C !O1+@YKG*?9EFY+R6.@GBX!+V6FA&?M['0<4S76VV*T%GE/Q3TRP7 M:B=O>IT4M+,+JHN7>>\+<%-JO%SIB^YV>XS[BCX9E"C%(@&2"0D0IQ+@E K M(,4X@8@7J5N3U(OBYL9PS[4][*[[5E$: -MZMR 0A*-O''BCY[-;8 %*X(V# M2Q*GWD.PL/[$=H+-79[!EWUTI_I6W@K1]#NAJ\]T*3ZLW]+'94U738G'!8>$ M0RDXR$GC-14(D )RD"*N5U,%1QDC3I$86\ES8YM#3AMOM]A+%;U;?E]6C?Z[ M6F-U&=U^_O#6,5!C/1N649LQ,!X[A'/0N0%QKW5DU(Z6IC]]H_A-6U0V8-3& M%:V@(1QKX=/&FD>]G/05RLY&B*6_9!0SB M'-,\0\2D8U" $L0!PY*!!*=ZW2LX)P6WS3!<%1"]DB\U4^5UM>Q;V%/VX7_+[ M:*DBV<*VK")M3_GCQI3T>*>71.8AC5)X8SHAXAMSL%:OO^^E'F!31:;&;?1 M_R&C+/[_FC(A]S(2\M&TS:TBNA;1N^WG4DLR/[XM-[7\3O6:_DXVS6 NW[W6 MPJN*;II(B@EXE1O97,%:6')DS&6O_V9QSXDLA=_F3),WR3!1Z@0UYK@DXS8$IV*@=6Y@HR;") M(EI2\?'H?//DM6) M6Z:BJO/:]HCJPD5^@<+/]*F)1KXO-U^D6?;S>FLJV2X(885,10Q$PK7S*&@! M,-9NI%Z=0T0+[3P2IPV.:NH7_S@(K."UBJ!!(BT2_"FB& M 4E0 D@,44X1I7%.%FMY9Q*0OTV$+VGQ/9+Z3PRS760UQ+=RY->'!U+.L=,A M&$+&2\_*FC1&.F3QR[CHX/77MOD[!%VKW7F"?KF0]]J"WLF$3V\_?%C7Y8^=R_:>L%VDJ]>(?(I#D7 &D< H(Y0S$><8R#/.8,J=3LF,I.C?Z M?[N2=+-;4=TWI7ST\-M5N_VZJZODVXPP\"3;[AZ]_M2-ON.T;X_8L_'FV0FL M+\?ULGH'N[2Q;>FLUMQG54A:BV\B;?,871?'F95QVC<&UO65^D".@_CYAI(C MR7,,3,CEXEVWI/NF*:YJ<@^^R$<]\$(4"1,)T]X^2A! 1!& %2^ ?O)XQN*$ M<3MO_Y*0N5']3L_HH&C4:FJY.+\$Z$#((A!,8].J.T+VZW,+" X<5NU(3"]_ M_W)7?O]7?7O+7_J'E[1U<>AIEO,6QNU7]3;7CI$%U)9+HGE,,D5!+-($(,01 MH(59DBJ(")8YHHG3V:]AD;.C 9ML%8=R2@[@V_IO(2$=W1.[&LW F3^6Y9@" MY_U,5Z;)'06WG)\ 99R,@*^2ZP6S:81U^YTN5^9K!E.8,N&E&!Y.N+*V>Z:@UQ9W_QIMT>^J< MQ51.P;H'0V^BO:E E1M047/P_V#NR_F.=A:?G/:;9POEBZ6!O*A[] D*S?KC M*3SY"V-T[$^]:\87ZMX^35.M2<1?KO]SNWGBM-IOMB(!)2.*@SC#"B"69X!! M24'"U8$Y5 E:19+UTV&%S+F MQAG["/I>3^\MAI=HVN\P7('15!L,UO!X[2^< 2# ]L++D2??73ACVJG-A7.7 M.B^6=AGON]QFBE&F6 I@(B5 N,@!$Y(#A&*8"_U'GE'+%=+SD>?V,.\S_9U] M_!>(#2Y__'$8^8$-!H'UVL8?BHD6-/:0N*QA3IM]=N'RXO*I5BNGM>PM4*VWD2+T>>&^48 M[4PFVO_^F_L3]P*S0=+Q1V)DT@D(@C7M^(,Q$>VX@.)"/*<-/TL\+RZ?BGA. M:]DCGC,7^):;JV5UNQ8?2[H^738ZCA-&C)M(4:()*3<]3&.2@(S'29XG.$\E M7GR7&U;:UYP;D.GRG>Q+'N\KV:AL^I)>59Y[&&R[T$A0 ,<.D"S7=,U-O;G7 MK=1MC5G8FG1#0B)P7%E.ML;?8O3[ M^;2]!5'/A.A@0_1W8T74F.$8UG6?*#M&&Q7^D1DN./(>]>P\T0M;U\Y5B8GK MVWEB=%SGSG<@S][SS6OQ/>7+U;)^ZHJKL2SCK,@*((A0 *6I CA-"I#+3"G$ ME4J@536I2T+FQG"=?[!3TK-VW4DX[4CJ6I#&#F"YXN/>?/T" $$[JY^2,VW; M] N6'O5$OW2MYZI,[BIVM-7%U_I'WC1D,E[8VWL][;+ZL.Y?L]1,]+B2U>'- MFW,(H<)ZI28S"5"B!&!40J"4H#%)\Q1+MVZB 92:&Z<87W9=1P>=H]^W2V%? M2"CHA%DN_B:>AK&]IP/T7VNZ%G0CJNBOCX+6LJTFU!ADJ@'WKMR;-))#%1+C MH.O)$'I-N^0,B.31JC3DV,YQ>[WXO=-,7ZY-"G)5*K:MEFMI,LSUU[8TA:^H M_J6N%BI+]**4)B 6A.4PX(Y!RH7,9,TSE*A=69TDM"YD;>!STCHZCCNOLBG)?I M.!1((_.O,S[6#& #P 7W4M_>[J1;VBUY NF8IZD.0=%01 P^PV %$4*L,@*E"8\S813$XF34N;VM#=* M[:L!18_ZA5899-1H>!,U M.H9;CUZ$(.0"\[2@25>,%VU]N02\?+'SFL[L/9=**UJ9DC3;7;/'O$AI3&4" MN$@I0 AJ#H"Q 64&>4*TAA:-=T[*V%N)-"^)V>[NE)9[ <7(%=C]#8 M[_OQP+%>2%T/TD3+)A^P7%9(EX$XNQXZ<]M4JY_+6O?6.@,7NA]@^6U=+^NG M]\N5_'/;IK@GD))<$I 5!0,H@PI@F2B08H1X2A1,XUFS6JY- M=\G;M6A:Y7TNJWHCZ^6FB6J_DVJYEN*-7.L?ZL]Z0JN/2\K,MN-25J9[:)=% MJ! NB#FVDK=]SU,$:"IS4#"%*8(%8['32=8@6LV-##JC>H&[1VU7)!\>5V53 M$#=BK4E5!*+UW@S'&LY!YM-NG33Y+(T>5VGU>[J).NVC3OW(Z'\3_3D\*>[E MHD."&+2V=!#%IBU$'1++HZK500=W;_>W7F_IJFVN\JYM9?-%FDB4OON3:LN+ M+;A0VHM*#?$B!1 5$A"]8 0Y)QDJ&$UP;-WSST+>W!BVU3GJ&C5U6M]$FYW> M9EWPV&ANW\3.!O;!)69H,$ZE:V#=T6!82*$>W;PY@4^L62 M*\!PG *5Q46M_!(!SY;7(% M>N[>M!4H0=WDRQ*G]7^MK#]R;.WN\N.5#YJC'M9+M>3-N_7WK>D(4DO9Q9\+ M"J4L8 QXK'* 8BH!5C$%L5(X,6G#66ZUT6$G;FZ\\D+;Z%:_5)OEA&<-K &P M[7@E'(0C\\H5Z#GSBATH(7EE0.*DO&)G_4M>L;S+EU=,1P^S6V$Z?IA#4&VY M4RD^Z95)([#Z4]:?U#?Z<\$E+;#B*>!8:I;!. 6XR+C^E4N)A,P1LRIQX2-\ M?IQC=-_EQ3:]>T3/@*C<6]"=F5ZV-]3TIW3LU>0T1[;D- [RHU-5"_K' ^A] MW:.#\DUG)+,:U :8 G^[%5_7LB:ZK>O-DFWKIB: 7GF9T)(>1ANQ,I=]T ^8 M:6DEQ>@U)%W]OBFWC]7^ M.W9:>JOAUUJO]ROIV+0YG4P_G4'L'C!1,6,+3 M D)0!Q# &) M\QPD,BF25$(N8J=#\Z]@P]SX^PQO1'__UE""]T'[U_AZV''^S"=]Y%?'SN:H M-;K_3@CP57!^';SB9(1\J[R&&9.^G%YQGEZ^XUY3%<\>.\OO2R'7HGK;Y!\W M<9%%7&!,2$( ;O;6)(, 0TP 2?,$D+F];%K5HKVJT2__\A>8 M'G*T?W5L8W,*5[N7P+5HC<[2G7JF-4R#V=>+.>ONS5TNV!^T)\LI.=.V4KE@ MZ5$'E$O7.F^Q__93\FTMZ_(_ENO/FU)L3;/09?VD?[[;T(==)10J$B%E!CB+ M-0]@E ."E0)2<)P*!0N.K'C 5N#<.*%3VBP^M=I17^^H4]SQQ)8U](/[[,$! M'9DV7A%+Z[WVX)A.M-D>!%N7[6HGH,[N5]N-,M6&M9--O1UKM_L\:_@=&E;] M*>M#DZL/Z^^RJLTW;-<@NMO_B"F#&$MI8A 90 (+0(LT!H@4*:=8X2013B7\ M'!68&Y/W.M?]_KQ6PL$"QY"O\YP0E&9(%ARH(A, T:0 &,<,,$X)SS 4),[< MBKV..2O3U'[MSOOA>1O&]LO?Q.9-YJ]% M^\?/=#/./J,OKD'K*KKJ,&U914^$CJHJ^H[CGKG+^69+5_K;\]OZ^W)3KAOG M9V6&;GLTWLDUUU^USV6M/UC2U6\_'YMXQG+]VT\NS7FL;HA%"N-<)B(&&%$, M$(PI8(01D E5Q"P1"56VYT+#:36WUUJG5E/B^9EM;7_69];I1WEG7[0ST.0X MMB::?;AN-/M$UW"S/;C<>9TY')N?_U^9/OMLYE>9QHF68=-.IU-Z<7#8SRGIV>4:-HM-,T^KO1U7%'^2RV=DN,$(B-_*KR \MY M43"$1$CG_ZRL29W\(8M?.O.#U_NQP^]E*7XL5ZO;M5X6U'KFEWH9>-O4>COL M.MZRJMY07B]4BBA/LP0P*4PH(\T!2W@&LH*)(F,X9XG3(6@GZ7/CD9WRS?FB M@_I1J_^S#@4[$QSIQ6UR[#AG-,A')J*@:#OSDQ=J(4G+38%)F'Y3.7KRB/,L>J9Q3P5J^ 3PT35_A=3QJ6;C=-+Y M9-(]NQ"5#P]R8YH=?:9ZW%V].J+B+"889%1F *5% 0AG"""("J02*HK$JGC8 M12ES8_F#DE&CI>?IP-.(VG'RU3B-3*'N$+GW(KH$0=!F1"<%3=N-Z)*M1^V( M+EY\[6&5KIE&U72$;-I!:H[:]_@\M(8\G"H0),:J%:L #)NY3:D=2$TW4 MR%0VT1Q=X/6XJ?V$5UQ.>$Y.@_A>:)+LOK#6@_5I#PT;\E% MC*5@JL@!E3$%*(8,T"0N $L40[A($B*=#B>?D#$W'NK[%A_+]1W00A_:E,># MYKL#I(Z\= IB._ZY$K@)_;$K,',_\74>E: 'ODZ(F?:\UWD[CXY[7;C4CQ<^ M+M?:BWK>4/>C-'7UNF,RJ5DPQHR 7')#$@4"#,82X)AK_F $"N:TJ3LD<&Z, M8?0UW_P7O9[U2J11VK,G]B#L=L01$LR16>1J')WYPQ:3+4",[6F8X\OWY4I_E:K_&?WV7UMS5''R@D_G K) M$T<%&7-[^AL56R>:[95T#"6?0-(R1'P=/F,3P $:X^H& MC-V>-SMH3/:$F&ECK>?M/(JA7KC4OU*C]YUN44_?FVC_5Y=T)1ND+_- M8/Q&YH/KH'/JHV4)RA5MM88D3-9ER]+4?M,MVUO\'(,_9?V65O>?-Z6I9B/> M//VU,N=0VY.HFIANV^()2UGM _N2("PRB@##YB H8S$@1'*0L%S_%[($VA6A M\5=A;C1CU(\>._TC]A3]LM4FF&-GOW:GYXV[3/=VN'D<'E-DYY","_S(_&1* MU3:X?^[C;BS0D/\:[8V(#E:,LD7C#V)([\=#BTF=(W^47OI.5XSD7I3KP[M= M[A]2BE*5 465"9-D#- 4,\"S.(UCSC05QK:%MW:#SHW%M&+NO7T/$ TX/YZ& MC\PB5]IL7\C*Q_:IBE798.!4C.JEL><+3NVOG*RHU$O=^H6CCCZ;ZS$6$R7^ MH$>O%EEA>@@HT\$P4R9L[L9(0# M+$0.\BR.1).NW?!M2"-3-K.^'BD/YP' M(&S*PPDY$ZOFE<-4>MI7B[HLN'ZL]MNT#+BSQ6 M3 *8T1R@-"> %8B#.&:4%D(6!;/* [<5.#LN>%[GZNDF.N@=M8K?1*WJULM? M.^0'PP'!\1R;-EX-2NLH0W!()XI A(#6)4#AA-/9X(7=*%,%-IQLZ@4]W.[S M#HCH42OY3K;__;#>G1TZG!):9*J0E*@$Y(RD .$X 2R%.9!)FE..DEA"IY1X M&Z%SH^N=ALW"<6W.546;O;+.(8)AS*W7]D&1'']1WJ@9_;)3V.S"[<\S]LXL M!EU!6T,4>.D[+'?J-:LU$B<6F_;W>B;"[5:RGU2[M-6K6',4:"/OY;I:?I?= M7_>;W:G@"B$*"I8Q@&1& "%9 53*4DJQR$CA5(O14?[<"&JO?I-/WM<[ZF)A MOD<+72?&CKI&A'MD%@N"M'NRGA]>01/Y'%68-LG/#Y^C!$#/87PC8Y29@P1F M3WPM^IG>;9[W@L-8%$F: 24ATJMDK NH 2JH%31/,TPB1=U::KD6@: +@MT M8K6]V#$C0GM]&\^KU=(U7C8 LFWL+!QTH\?1G%#SB*+901$VHC8@<^+HFAT" MQY$VR_L\^>1EJ>S#9F$F:"R5)"!.DPP@7J2 RLRLG26",<8\(VY'%L^*FIMG M=%Q1_HK]W0L(6])($-RFC:A90^;.)(-H!.60\]*F98]!JX]X8_B.J]NE?:KO MY>:$KV-D[[K-+VBB$DFR%$@LM4.2J!3@-%. J"*'@N0ISY"+0^(H?V[^2;]A M5>C_BS!8'IU.7=FLMJ0N(XXXA3!;0[*#6OXP)@F6( N62Q6E#QITENW?#B-B/_,((#_LU3=)!%HZ\V((/"-OPGABYQG^MYE2,+GVYV1 M]PH))8K'2/BLH,FS*^- "T#2'@.8\%DRJ MN"#",[IVD#(WE_6;D1&M]_I%JX/6WH&U'JC.T30_J*8+H=U$!PU'B:$= S!2 MX*PGZ+6B9<>V7@B1G;C8M]#?9OF=UHV'LB_.MNOD^N;IWZ6X:PJCKMK$U_OE M8Y-4620QA G42URSSD4<84 8D4 E#*4L)B+-'6L!^J@Q-]>C4S/JZ^F5R.HY M*W8$,S[6(S.0#\P>Y02O02ELQ4$O328N2G@-6L=U"Z\:S3DO]_VVUAY5?&V^U&G9'TSL=K?-! M3X!WF8>NAF1D>@F-AG4J['6H3)3WVJ'#F_(1G9K11K8!KKJ,3.&OS9;KBPQ% M/V[*NPU]")(!>QZ>L^FN)VZ9*K?UO+:]1-8+%SF3V-=[JK%?KG_<+_E]5UA MJ]D>=JI^2%,INEX064 4J\SDAL4 %3@'+$]3('+*$)&4(VY;%,!*X-RHKE7: MY%8V:D>[BAL'Q2.C>:15MW[F[9 ?),7@>([,DZ\'I36C!H=T(I(- :T+M3KA M=)9M[4:9BH"=;.IQLMM]SC3]AZSO2U&J=\N*WMUMY%U7':LIXTSBF,B84""S MC&BO$PF]P!8$0(H1%:H@B;0K>W=9SMQ(N=75['L]U]:Q6O80NH,,' JSD8EW M(KBL6384;!.1ZPXE4^LL.H]EJ&*!=OB<)=6+-T_%I386]"C4ZO* #0CVB68I M9TA2R4&N4TWA=D<)4ZBVD?F5_# MS_C.WJAG\ QFVWJ1/8M9GVB%_LJS[[*V'WU:S@8&QI,\551A=.QZ(8GQ9?FM M/=XOU\M:?EQ^-P7!:_T0+-E*WE:5K/]:2;5=?5PJO0R!10II#@%1>0P0(S' MG%" 4)H0*0C+,J>"#C9"Y^8#M#J#1NGHH'74J'T3M8I'1G.WU8K5!-@M7$+# M.G:>P_6(.J]G7" *N;2QDCOI*L<%B9<+'J=[_7BI/71MCK"4:]-@NMT22 J, M*4X8R%/* ((B!C0A*8@99A 5L:*8N!#122ES8YZNL>!>2\\>KJ<1M6.6JW$: MF4K<(7)FCHL0A*2*TX(FY8:+MKXD@\L7^SW]GS?EH]S43Y_U+)N:R4;&HW'\ M_Y3U@F8Q2]), (Q,BV>",T 2_1.E7$!.E,1%XD("EX3-C0MVNMY$CT;;IH:( MW.D;@29B6JJ(]@Y]"OFXD<:+-+N*O_RAY^(^2N%-9/QY?<>_I#>X0/\6O9.\ MZ>.P^RSN/LN*?XN>W=1]@.+\?)S1?5*9$E#@O PE692$00TDPAD2E^%K333WMU+X4_,\RP8>Y.II@2-K/TB1_/L'M!\D-*>*0$VSWH@DU M82._;PZS]'D_2WM5FT/4X5X\-I"$?/]BSH, #\2D0\(VMJ?JBYA3=U K-*[H#7IY_,DZ@UJ9V>\+:G># M\V[=[>;.#+>6G_4WY9W\3E?;9MQ=QS/- RJA&A./#E!X0=3=&G9YO#0NMXLV;8V9;O-GN/;@ MM%MY>0,T,AT:;)[5J(IN7T#TF8:M_W 2B<"-AWL"INXI?&S;B7;!)R[RC.1U MYPJ_E7\LU^5&>U_-^9:NM.HB$1D7""9 ,<0!0DD!:,YRH(I$XIAF,DV==A8O MBYN;?[33MCD)0+E>JE;-*1\3X:FVK%J*)=T\_<^J33N051V9&6T2"M;E&IC& M<%K7E4DZ^-!=X9@K.3 ]ED&;8*"/';;9X:U9P^3K.>'G'KBQ@B5HZ.:RQ&F# M-U;6'X5O[.[R+5GW78]=;IY.55)C<<8(3A 06:(7:4)2P&0&M?^A5(IR1#AR MVE6X)&QN/+37-53%N@LXVU%**/1&)A1_X#P*U@TC$K9@W05Y$Q>L&[;\N&"= MQ3U^+/)M0X7\TWPINE5T5G I%2T 8KEF#J@@8(@1@.)$$&4QV/4R:?K]?Q[.K)ZG*C6S>OKT8RW%U_TBOPUBF3]N3#VY MW7+TK;[^3E:?]9S?TTJ:UE?M!V^Z.Q8XQRI)80%89KK',"X!Y@H!Q9)$ \XY MB:V8:SJ5Y\:)SRR^B8S-4:V-B%JKH\;LZ&#W31=QC/:F[Z,'-U%GO;ZFL]_$ M./N,TTU52"]T JTG]6NGFX67GO*$ MDMWKG98;N;Q;OVTJ2/.GWW[R1M:NPNHWL[-SB!C%,%>B(#G )->+;%,%E2A( M =2O/L%2DA,J;$NAN@B>VWNJ4S[::1_MU(^,_MWNF'VA4*Z-_Y!P1=<;9OE;K6'A/5<8U-.Y.E5Q]P#M?Y-5IM,GJO_K8V"\-ZW6_ M>SE"NOF';+;ROTJ^W33-!;J@8"H%+6*"0 YA"A"*&< B3DQ#\5Q*A5F>6?7% MO"AE;B1_T#0ZJ.J>^'4!UD$J#P/6R+P]/D[VY0>#X#41[WKBYE1NW[A0:'+W8_:]!2;OU^67&Z^K^2;GY;BW>TE@LE,ZR2 H,D-6%7NN>"D+GQ8:=GU"H:&4TCK6ID=+4_77 6T@$R# 34 MV($*'XR#XN:SJC:R7IN+SNNY?T1W>3A'1/E#"3*5F#$PY0$!C1@&A%*=%GNNEL=7. M\W5JS(TR.E.B3M/FB%[5'-%KJ^8]M^?%9U_O>A/7#"GB+135Y7O:B*3&7#)D=UT_75?GP^?>;HU=6IA]]E7 =?.6'0&OF-,@%0UJ^",(!-Q/2^P+D0\S @9WGW MPJU3T>JP]CW6M+C8+W'DW^5*?"O_H*8.8/UT""XL8,83D28"*%Y0@"B/ 8-, M:)J,69JFB-'<*=GTG*"Y4:/1$]0E>.@TC:J]JFZY%&>1MCQ]N#_5_&A_-E-_:R'OCFINF MI;O#>Q_WS3(P88PAXTHIB/0_B /M6%$ $G?K4*? M6?#BR*E_"Q/GB;*CH3'A'YF>1D#>F;=\X0O)9\XZ3,ISO@B]Y#_O<7S;R7^7 MJ_)1BF^2WZ_+57GW]&5Y=U_OS^J(K)!*+R8A0<2<\C/M1^,4,,&3A(B8Y\HJ ME\A2WMQ8;Z]N=- W:A7V/,HS!+@=G06$<73GZ@H$/9K 6^$2MMO[99$3MW6W MLO^X?[O=;9Y)_;2ZOUT+\Q]37>Y[4[J]NF55O:&\7N0BRQ%+,%"F7@FB,09Z M909!%G,H):,)RIP\KR_W M&OS*PL$V-]A _-^[YLUP#4_V3-KVJ=_M4 MYF$Z;%1%\N%Q5;:ASUV+%]Y8<\4&X_!$>>ST!H7_%79X;[K5G2G@M+-A?X&Q M(OJEM<,^9]T'^2NV=(/.P%2%[Q[*[;HI$5WN6R@^[M#??^$;]-NO_:_-IN^+ M7=YFG_8O9BF^V@I9-=6&#D]6JME8ILVQS)N(/I2;NNN:9JS=KC>2EW?KY7_K>TS/R.-+'C4* MFZB2F^]++G?B _1*O.Z[X[ '/3SFZ^T]6]M[<<_9?I0K.JU^D5SJUS9;R4J+ MZC*Z%I@RH1@2@"=Q#E":IH 24@!9J+P@A4SCF#JW6CTI:FZOS493CQ:KIW&T M\\?#H#/R6ZU]?_6T;"J[WW1G5@*>U1Q&(WB;U=/2IN^S>M'JDXU6+]_A['9_ MD735S)!^2Y3JKBS%C^5JU46O$$.0RKP '&=Q5]HGPQ!@'*>4"I;)S*K?T("< MN3%"7U?SYMQIZWZ^XB*Z@TYQ*,Q&YHF)X++V9$/!-I'+Z@^?BXMF \I97^SB MS5,Y7386]+PKJ\O]W*A=&\K;0\G2YL>-E%TB;:X4%)AA0%26 :0R_9-D.1 8 M$UI(GB,>NWA3@Q+G1J'[AJ\]C6^BG+=R&<;?SOH*B.3*Y7@NDLS-F#4Y( MGVQ8Z*2NF34&+STT^QM]2[CN=HS?:Z5-<Q:53;PU-MQY6M.Z,C4^CS3YO*4_MGVG=-&7C^] M'K5OQYF#L/5R ^LX<8W=<1 ^KLL[DASG=;_1X6TC_,[4MVA;0)5JUS^N+8>T MP+A(,30N;!,5U*\$@&6,@$!I(A+!($16KP=;@7.C>Z-TU-/ZIFM39KA@IWE7 M[\QZD6N'_&!P(#B>([/MZT%I'3@(#NE$$800T+K$$IQP.AM4L!MEJNB"DTV] M,(/;?8';07_I,ZCZ^\1"M:]?X_O#,Q# MW_1X702NR$1,3?>8F*0"&/8!E%$("N0/O<,^:K@Y3 M<"T5S;!>;C!, _+2F&VP+*3.A)6&6F(YW'E%XCA/BEQRECLGUAV)F1OW[$^V[M3T]'C.@&K'+-=#-3*; M>*#DEUQW%H3@B77'DJ9/JCMK[&"M$D)8MCJER1A<8NG+]*L29?KNS?E9E/^T#^\I?H[I#]9\((J7&1Z M)8F2!" 5%P"S& ,9BSS1*TW]H=-RTDW\W'C):&]\B%;_:&? 3;0W(=K;$.V, M<",EQ_FQXZCQ4!][5RXHX,X,YH=;2$)SU&!2?O-#YR7=>8[BG(WZIZP//'K[ MG2Y7QH^K2Q.;*]=?ZY+_X[YQJ\BBIT@LOR^%7(NJJ<.BWR!RHRDQJHSYS3J>3N;MNL_\E2IO%?;WDOO MO7XLOY7 >_V&K663\O1!/QAMSE.3\E3]OM&J++*8YH4B$E"6,X"RC ""]*\X M2U/"2";UGQ;?Y8:5MM[_D$B7)[HO>+P'NM6X2PP[Z-RFANG'ME';S<,?Q-W. MIP^)YZL.:P,^DQW^(HS7. SIA1(Q9V^= MKD#,D/;/RL,,7NS,H]\V5,A>?:ZOVC-"\S(I#D&)M8T>2TV$Q&D(T8N MK'8)@;-\=O*FJ9CLDL8]#KMXF??!BN]+4[GV?;EY5VY9K;:K6\[-RZM::!J# M2B0YP)P2@#@O $E( 6 19QE3&$KI5"/TDK"Y\9J)[#WN]&U*_K;U@YMBNZZ9 MC!=1MEMAAL)N9.K;J=1[LF]V&T;-L?4N.R#ZY8O\KJ>1K@)4)';!*/!AB?/R MICXF,6CYB0,2P_/842P;"-WR.FVAM/;$0D,ZD6<6!EH7A\T%J+,.G-4@4SET+A;U'#RG MVZ[NI/E./FXD7S9?)_WS2C;E"]?BMM=(X.PIND6>4HK.*I7M$]S[IOFW5OSNJE+<,YD2C)0 M*"8!PC$"1*$4H S#G*D"93S93=TWKQZI4\_?MPG>VC.;1+MEPZ1S,GU#U;Y- M-]'>JF:/OF_73?3B(/?-\Y/OUVQ$%3%-H2P A#@&*!$:O&,;8"Y\9*G;Y1HW#4 MU]B[#^P@YG;T%!+)D;GI.A ]SH#:(1/VF.> S(E/)UG*4R3E;8.8^N':$$P6QD)O&#RYE!!J$(21WGA4W*&8,VOR2+X1N<]YB^RCNS MX/HB'\VRS(QME%^N3*'\6CZ\+3?Z \U0W5YCM8BE9()A!E*,]&J)000(XAQ M7E#!4IS#W+:OG:OLN3')7L'=3JQ]$I\S[(.;3F.".3+%=*I'>]VCGO)-J>1H M2JBM-Z7&A'RB#:JPT+ML5/F"=W;3RGG J3:P?"WM;69Y#^'9I(]6RZJI&6(R M&+20S^5JR9_:?P\U2DF,,H44 XJ;5T'&$< T%B!-F) R29(BMTK/=!,[M[= MHW57@*?3^R9J=8[^WOW7NU*LY4S8N9OA\1WYQ1 *6O=&?DY(!>WF9R=YVI9^ M3F@<]?5SN]N/L?Y#+N_N]3KZ]KO6[(^WAF,P+M9"$YJ; I+SFAO,; MQ(WEJDV]:+LAZ17_[<]EM2@P3E@1QX!DJ:F!2U) B':**8XQD51E*K.JHW8T M\MS8::]<]'>CGJ7[= S898ZY"H:1^<,: 6MN.&OMA>=>W]-[YO5O+Y_WXT$G M>9;/VK)[3L]?X!@KD\O%NVY1_F&MRLU#LS3_N.]DE4E!82(98(CJU5 A"6"" M*X H9:E,%$X2NVHZ X+F]H3N=(UZRGKT#!O$=R "%A"UD1]H?\#LXRN6:!P> M^&KWQ%>2_^6N_/ZO>HCV@=<_O'S6!X>?)K1B:>0^CF)[O6?2$:WNWZ_*'UV0 MOJNNGBUVCP9+ ML#M :K=44--8- :(\1S07"@@LU2B\_+5O@E^W^5Z*TV3^E/9 MA(>@O"Y<46G=UO7Y712K6NZ MG^4,V-'(&+B.3"P6D&JF&6/GQ!6LL!F!EK(GS@QT0^0X0]#Q?N<J=O!:*NO')37/?=KO+R9[EIMJ/>F<9 &U/" MF@@59R@'/&8I0((RP&2NWZ=2*..2&IIW*T9D)7=N;+Y7NZTJ?A/M-8^TZNWN MK#D)VVKO6J;(;BKL7- 1 !Z9UP-AZU&WR FIL"6,[$1/7,W("8_CPD9NM_N& MSM9WW^3FX9UD]7NZW/R-KK9R@9B@*<3$5%5@ /$BUBPE", D2;(DQ7$BG [" MG90R-TXR2@(MZ"$R:MY$1M&HT=0U<'8*4MNXV95 C1XV<\;((VQV 8.P4;-3 M@B8.FEVP]3AF=NEBSXK]SVOU],[![+?5FU7QKT?^TJBXX] M"W:OTY&0'?DE>U2ZKJ=WOWK=3<0:[<.VV/3 +&C7"P?QTS; <,?EJ!>&QQ!^ MK_5=6^&?W;&DKJWM(D4QEJGVY FG,4 2(\!XRO7+)*:<446$8"ZO\#-RYO:Z M_ORL!'+7V4J_0V33&HLW^Y!;DPA2.C;/&,+;CJ8"H#@R)77=X4R'Y'WIXT[+ M@)6/!W (23/G1$U**0/VOJ2/HJRNGD)<\ PGA&I?/RL 0I0 MEB00%+#(B%X.)-KW]*MR?%+>W*CCXLO8J.U8P,(6]L$-I]!@OJ93,R*.OG6. MK\9SHCVF'6K-F\T"Y$ '&1P!LZUW?'J05ZIW?-&B\_6.+]_FG^%L_F_*-'ZG M*_VUJK[(JMXL>2V%^>!V+9[_H7?E0B02(JC9.\T2!A!-"T"PT.M6F""%$1$2 M.W5\F:G*">UJVE54/1D3=90=7T;7/6IBIM',H)YN@D5\:Y^;F MQ;R)7XW=J73RZP?U(V43A_^Z;YJ\;[.K7P=? M]?AMNC05&*HTYT#Q- $(2VAJW7) E(!YD2>;0W-Q MH'T64&F]_3+4;?"WX\O J([,BB$ =68^!XA"\IN-V$E9S &'EUSEX'_0_RPW;U>T MJO[47[(N=I/%J, RER"!9L,[*5* 89$#)'#&I4E]CYV2)3UTF)LS=3 !K(P- MT<&(MOJ]=@<:.Z+&D,A8XEEBUV?&;/<[1IV'T?="QI@"C\T2;Q##;J2XJS'Q M)HLW3L<;,/Y#.6_.O"TWM?Q.]?KUW?9SN:Z_UAOZM$M;?S(YH*:@F]1?:JW& MG?$B/[^__;J(DQQF,4X -:VQ4)I1P/(\!02F'!89BB&SXDQO#>;&F(W6T6JG M=E2U>D>/>\6;T+E1W7KGP7-N!O=TQD=\[(!=:T 3D&M-B*KYX&^]%S3^/$RT M.S32?+AL$UV'Y=F-(\]AI]I*NL[JWN;2E0-Y9@4OUZ9QTD>IE\1[6;N&4EF: MD1CS%/#4%,#+H0D?$ *49!PR$C-*$Z?[6:/2+&@6[DK/VA?B. M@!MP&J^$8^3'W@$)IPI[YTR^HJK>T9"35=([9TR_>M[9:WPKY7"S3EVJ)6\\ M4%/BHM=!M#TI73X\;N2]7%=ZL=OF'G:\H-V-92D.R?@J5PQR)@$1,@4H(0Q0 M21#($,4D+A*<4L>^>0&UFQLYO#2NK133;P?;W9&Y[IJ)]9I1CPI!(R ?MHQ02 4GKC4T K;'!8G&$.*;_;)9 M?M=:&"%5O6FB&95>IG:%'6^Y_JC9.'JWK/BJK+8;N6_Z23-<2"H5$) V'1#U M"R,1%*B"\@)C1F'JM+%SA2YS>ST<3(EZMC0!G%VUTH,YT<$>[PZMU\RC'>%/ M-#LCT_N8$^.1C7,UI&&S=/S5F3A[YVK7/H7?FC*Z.%&60R+3A0 M"=6^=Q8+0"!4(,UAPBG-$XBMBMSV!YT=)Y8_W.N0'2 :W';Q,GQLNKG.9NNM M#B_;)]J]L,+ 92_BR-BSVPN'*Z?:,3C2K;<)Y;&R^R M:W/XK7Q;KJMRM11MYMVN7&N1TYP)F8$X4=IARS,,,$0%B%FAV281.61.I;1] M%9D;,SVWH^F7UUC2KOUV+3[K,NI;TR7G^K(94Y;J"=DS(TI>\LG]PY%E[!T78-Z(33=VC)L-R(+\\=9!WZ\X22#"ALNI.P3 %73?[O;EKMXOPIZQWY:B,<_1.5LN[=;.]L/D_6I.E>M)" M^VV<#ET*:)%!23F(8Z9]FS1%@$&5ZU^%2@3!3"BG56((I>;&>:?#R,[L=OUD M63/?I%,P/BON=V--#<]>-;VN8\NSWG"RBF[K>K-DV_84FUXP?J;--FWXCG$A MD0Y,J]?K-37E!D/R!!V'&]N_[,"!.M[2S<8(NGTHM^MZ 1'F$NM%99+F$""9 M4H!3B@%-8\D5BZ&"CBO+\\+F1JTOBU/_OM%3XUY2X"RVMBO-,(B-S(1N8'F5 M"QA"(72=@+/R)B\0,&3YJH9%!\MNHIUM46N<"5'WS?.KB!)HLFVW"::>PM$W M#2:;/=_F?H' 'J'UW[6:O49CP$!HGFD;&&IT/][_RN^EV*[D)_7^_(GEKD^R M@!@I1$!&L4DAX1G 1.8@AS*5.4\)5T[E >U%SXV_=YJ;Y[G5'7P\?<3?CY\= M)L6.@\>!>F2>#8BR,X^Z Q:2*QVD3\J'[JB\Y#R/$3P;5BW76LC;C13+^CWE MS7&U/^C/YU2AH#HKT%TC:) M^#M-70M=#0!M1U8AX1N9H/:JZK7N61"#QP1M 0I;GFI YL2UJ.P0."X\97F? M;XRP7R!Y(07/L#0%/I1I 9KQ&#"189!D@B.&),2)4WK*\^%GQR+/ZX:[!MR> M(6<;.//%8_0 F!T4'M&K4Q:'C4(]DS!Q-.F4=<=1H9-7^3ZQ-=6>B/B-;DR$ M:;>G+SC$,58%$%Q*@)*< XH4!3R+,Y[0)$:I8Y3^E)CY/<&MEM%.3<>#,P.@ MVC[4UT(U^L/MC)+'$ MF&14 I:DYKR.R@#C5($,PB3E,8R9XDXAW=-RYL8$C9K]76V/QE)#T%H&9J\' M;.PHK!]6[A'7RT@$#:^>$35M+/6RO4>!TX'+K]W]^5/679_ MV75A6 /!\)8 M7""2IBE(T@P")%(*J.EM7- \4S"&0E(WGK"3.SO>Z.U(F+3 3O.H4?WJXWJV MD^&ZY1,,X@GW>ZY"]XK='BNLQMGJN2SZE?9YK/ XO\EC=[LG=RWOUDV%FW5] MR[E)@3)[Z.5J:=+<>T>2"1.:O1# ">, 92P'5*$48$4)AX4DF#I%*>S$SHZY M#EI'![6CG=[ZZ?)F+;MIL"2MX.".S5DA<'7G*R>8@M*5G>1IV,Y82I #,J:8LR"%@,HT!0@06"6)QDMJV M?N\-.S<7JE-MJ#7V): N$XF_^2.31 #+'5IJ>"$P69\,*R3<^EX<&7RAF<7A MVNDZ5!SI]ZSMQ/&GSES2U57Y(A_+C>&G#^LF#[HIOV)*E>Z6D/=TNO-->\:BG>5>$>1>#^J75_M>1,+:FQ]&PGHA @V+N0K->P)TE8K?1IJ)J M+QM[9.YW_[4[#TW"PY;76].A2/\B-]_EFR>SQ?%)F:CA(884YP5,)$2 "K,T MCK7'B9%*0,H4PG&60YH+OUT(:QUF]Q+HQ2I_RY<6=?_>B@?]L$L;,@:DWPKYKO.$5V3#DB\".S9&#,W>M-^"$7 MM 2%HPK35J7PP^>H4(7G,'X\^'E3:AGUT^>5V<19B]_^:[M\-)[LH93^P1% MM[OH-#=V[#<6XB-37UBPG9G/![60M.%YC>%[LKGN:D-\K6F] MK;I\4X32(N8P!@HR"!"D!+"TD""/14H5Q3(IK#9A+HN9&X,=M(Q:-3VS>,^ M:D=(UT,U,O5XH.1QGO@2"&%/#I^4-/$9X4O6'I\&OGBU\X;)GV5=;=E_2E[7 MY7(MY,-ZW^JM.XRB.,P4A@@DB)@2JUPO]3C2;$!(B@11>2ZMO!P;87/C!*UP MU&EL*G&^T-F]6\XPVH-;)$$Q')DLIH?/>OFQ;M!DE;4'MKZG'MU[;=5[E(!2&*%(#R7 (D: 9(7!! M*>2%R"D3V.V@Q)#$N9'O0=-^>,?OH.4PW)8;"R%!')E]/?%SWR"PQ23H=L"@ MT&F#_[88'(7ZK6_TXYG=V<_/&3"73W( )X! +@+!* -5+ M0T!3&">8(T:9DT,R)'!NO-'IV\1<'2/70]!:1JL# C9VA+J'U0@NART20:/. M0S*GC31;(G 47;:]S[=31']((^6VJK8/CXU#8\X.O*4K;II9: ;K+CH4*&ZV M^K;K^@NMY0+I[Y@@>080RO3R)RX8P+$B0+$\ERQ#&6).&5K!-)L;+>UTBXQR MKKTG0LV6'8&]RAR,S'2=3?M44V/53=2S*VJ.0/4LVU_:+^]N-XL>33$"(QZV M@T8HY29NMQ$8T^/>'*$%^)'Y^^6:KOF2KGIMPT[F01")*4D@*'*.33*M!"0A M#"0)3*4HTD1F3ON%EG+G1L1[M?MMUL*D/MC.A!T-CX#OR"0;!EIG]G0$*B0W MVHJ>E/D<\7C):ZZW.V]FOENNMJ;/H51*\KI4\K^VR_J)EP^/VNMMV/'1^+V+ M.*4IB54&"*,<("8AP#@E(%&,%@@S1I!5&6-[D7/CJIW:4:NW221O-8_ZJD>- M[M;;<[;P#^YQC@#JV%[@:^)IO>DY JX3;7T&P==E_],1JK.[H+;C3+47ZFA7 M;T?4]4X_G_/W+=W0=2U[?8NJC[MNZ8L"<2Z)I$!!JCU-+!A@D H0QPGG*N8% M+9SJSU^4-C?.[I0M-[V%8Q7]W>C;GMIU="HO0VWG2@8#<&1^O@([9Z_1"I.0 MON)E@9-ZB%:VO_0+[6[RS+.HM4?Y02^?I7C7'*+Z+#?+4OR-KK:R.8FZR 6% M2FW6!SFG!3R^\T:HQP M3+$81-J.4H+B-S*M-+I&K;)1JVW4JGL3-0K?M ?1 R9;V*(3--EB4.BTR1:V M&!PE6UC?Z-L_1[M#\AO]V:9SW,DU?VI[ZTFD$JY0 53!$X"4P$ 3"P42HQ0G M4D !G4CFK*39D4NC:*0UC7JJ^O4R/ ^O';,$ 6UD1O'$RZ,SS@ 685OBG!,V M<2^< 9N/F^ ,W>!;P_%'KT#DIESK'[ELXF%-N)L".:,>$= MF7^TZL^JSSY3_J:M1JOIJ/OO*%%W7_3"5G1TU&'BNHY^"!U7=_0ES(W 6DV/ M5ESN1V(N #L89@\#U]A+K F0LJ^9%@2QJ0JD^2+G5 QM$)'SE<_.WSI9F;-! M[?LUS88O]HU1T;IAW::5=;M%^KFLEN;KL2_G(K)"))G*0,)Q#% F,:"4QH"B MF*9YEL<46]&DB]#9L>9.YZZ/>Y<3L%/;N[2.U0381J_"PCIZ .MJ1#U"6/80 MA8UB6VK*J/9Y4-967F<0\YS !2&0I0$BO1XDB$'#) ML@P6'*O%7GTIE+LU,3HA M9&Y/\A]T\P]9-R4ROTJ^W7CT^#B)I>43?25"HR^P]ET9>PJ.T(WQA/FCM&+L MRWF=/HPG+#W;A/'4M><>]_ZD?-0__:__L?N+_H?12OZO__'_ U!+ P04 M" !O@Z52]JZ\MO,X 0"<-@X $P &1D+3(P,C$P,S,Q7W!R92YX;6SLO5F7 M&T>2+OC>OT)3\SHF^;[4Z>I[*%*JX1F5F)=D==^9%QQ?S)/H @%> $F)]>O' M'$"N1&9BB4 XJ'J0F LRPI;/S<+\:SZ5_^Q+]G?_H. MIVF6Q]/+O_SI[^]_!O>G__$?__9O__Y_ /RO']_^\MVK6;KZB-/E=R_G&):8 MO_MMO/SPW7]E7/SCNS*???SNOV;S?XP_!X#_6/W1R]FG+_/QY8?E=X()_O"W M\S\C5UC01PC%25!)9X@Y1XA&2(9692S\_[K\LW!:H58);.$(2BH/3BH.'E64 MW#(3HUP]=#*>_N//]7\Q+/ [8FZZ6'W[ES]]6"X__?F''W[[[;?O?X_SR?>S M^>4/@C'YP_6G_[3Y^.]???XWN?HT]][_L/KMS4<7XVT?I,?R'_[7WWYYES[@ MQP#CZ6(9IJF^8#'^\V+UPU]F*2Q7,G^6KN\>_43]#JX_!O5'P 5(_OWOB_RG M__BW[[Y;BV,^F^!;+-_5?__^]O6]5^:K3[/I\OLT^_A#_?4/KWYZ?:UB(G?U MY\LOG_ O?UJ,/WZ:X/7//LRQ_.5/.4/5*I/K5_Z?=__XA]OW?YKC@GZTXO<7 M^L'F&?5]A]&"OR]QFG'-X_5;)K-T[T.3*N'9_/HO)R'B9/734&:?YI MNAPOO[R>EMG\XXK$%W&QG(>T'+%BM. E D-O0:EBP2LKP&LMDY 1O4Y/"V3' M-ZV%=0 C.+YY_IW'O@]Q@B.7 QI%>,B"*5!9>_ A"+!"21Y\1&[%?>JK*A:D MBQ7(%IB^OYQ]_H'>06 3K'Y1F6/ .%RS]\3[[_-T%P(OYNF[V3SCG.S--0%A MGKZ"PWVL;S[QPZY.N_KH:G/]4N9QU+>ZU68NA/WY%<"L[GF']9 M:_51]E>\+\E.X^J3QR#F%[P,D[5H7OP^7HQDLB8)'\AV1)*%B8)L*]?@H^8H MI!/2Y@Z \N"U ^&C,QW.NA'HP%A84_UJ]C&,IZ/$F C<(61O."B!!9P)&;QU M)62>7?2Z R#=P*#A*:;,.)#BDYO.(MM:_X<>(\U%)7C!I.;#L"?6H$!PO M'B1AWXNH;;+^V5WNYG'#*?1P1F>CM^KK17V]IDM8Q!71FQ>M%S9. MEHOKGSQMXUJG 6X#,[./'V73%P,9L>NE,R20 JXEL9;V!&)4! M7GC@Z%,4KA_$/*1D6, P< MA"03[=21@T/C@1M9I/$ZZE">=3^>>A\ 21$7_4Q1]@3?! M0W$8'.VP2;"N@Q+5OJ8/D\_ *88M7O?UCU8N5(XVN)@L(*/X2H5,+A1Q!RED MPT5!$;/K)T]YEXQAC$$OZ:@N!=X(=C;+QD3-N>(9BA%DR9 )B(6^LB[X5(P7 MH<0.H3)TBJI316X!R %2;00/=R3RRWB*KRDZ6XQX#L$'6B^H-<5BI03P*4<0 MWB$G\QJD]/T8DAL:AMEH3F5%#A-U(Y!Y3Y\=):^5J=Q'AQ0V9?K*A9Q 6-HX MDP^6\]0A1.H[FS(?!VIP"RSV%F8N?9O/EB$RDY4&6:C0S M.<>F@+,A@4M2)!'(+/HN#K\>>7U3N=#NP'&,D!O!R07%4[/\TS2_"DL=_!61LP9]O%R=C6ES?EF7:'D<,%/#!"7A#UN7+P\R1< MCCS!6F9,D#61JT+@X+5%T#$;PYW5K),=Y=Y+F_(RCD?$X0)MQ%:\GX?I8ER% ML;%WV@GC;19!(T>/QEHMNS07#]^_$S[TV>"C$S$W46?Q\WB" MOUZM$C@"4XE)D3 ,DP1SD2!PY@!53*B\RB9T5VMQ^]Z=H&'.!AI'B;4)2+S% MRW&M29LN?PT?<:12ZI&)-!>5H",?$,2'Y8U)IIX;MSAK=1L!MFSB=3 MVY&L!T9,M8\OYAA6="N/4ELM(>J@0:52(&:;( 7'N(TU;50ZP,C==^Z&BO/) MUAXLSZ%OO=%O)Q.]N>#B?[.Q1HLD6K"PAE;+UF7NORF(,<8M$A MT%[H; >8>/C>W3!Q/FG9H^0Z,";>ST-M?O#NR\^EN:#B?3.SA$FW$//ST>_H0II>X2B%G+GCQ:* $)/H= MLQ!J995V27TM-"6HX_ MXZNP#!NV1HX[511J0%0>5,1(SK7A8)AS(6BO>>BBH.0I&G:K2CNWU&H'\FX" M-_6T>_XR+/%R-O\RR@J9"4758R?RK&),$ I#$-$%13NM"[:[-/R]5^^&DG/+ MJAXNW2; \=-'G%^24?SK?/;;\L/+V<=/8?IE9#T*&11MHJ6&9$CJ#9HG,-*K M:)636G=1Y/H$";N!Y=SRJ<=+NPG0O/N D\DU]9EDD$O.4*0GZI/1%+YCAIAR M]D7J(#I,OM]]\VX0.;?TZ<&R;0(9=RZ>O_M 8ER\N5K67G8UGAOE3&%[<0I\ MJ9&=7%Q[WE*=D/.^:18.Y9]6XTB+L+\S7QU I7_,TRN M\ +G*_9&R427%3>0BY:UFI/,)F,,9 AHA2\QBBVIEDY;1SQ&VVX .X^<;5\J M:<->D:3F8?)ZFO'W_P>_C!@7Y*X910X;K1#E!4)TJ7KX3A=;K-&NN]*F!R_? M#33GD]0]7L)#GP2N([Z?QXL4)O\OAOGUY1.GLY2B6)!1$P^\5O(Q)T%DS6V) M)0G%.D#)8^_?#2CGD^_M1,Z-7.VX9>)G^LEB)'DT+ L'6J*LOGT!EQ2"+"(8 M\N*2C%U Y9'7[X:4\TD =R'EIH"ROM2V9L)J13Y]H+A/! 8J.P[>> NV9!]Y M4 )-%WO/HP3L!I;SR?YV(^DFW)1W'\-D\N/5@F2R6-3^"\SJB.!8TF06"R.O MOM946"Z<##(&W]U)P;U7[W:U]-P2O8=+MPEP_#)>U&.-5[A(\_&G*IB1EIES MD1"R9 Z4BAD\)@Y,6Q&=%QYE=Y'VU^_?#2;GEND]4LZ=8>7??_A*K,3B/PYK MW_]R-EW,)N-<8[F;KI6+67GS"=?76!;WZ=^EJ_\.S^R@V?^^E!\Y ^ Z#*YW M?#[BS0MO&L1+IA)M(HPV$8;D@G +44@#3CG!):,?;BO\.#X;\0@]G?4'WC2% M"5[[G IP5CUQ)3QX4;VL&%3*CAD9MM3*=M@4>, 1 5UJ_M%FP/N+>>CRR(?M MT(-7#(4%E@/95N,S1*\U6)-CY-PHD;N8'M'$4( NM/?4.( ]1-F$![+I"X8Q M&6D,@Z03\1\BKS,R H0L0F1!Y*2Z@,#==S8T#F ?I3TV#F ?";;2>9.<8LF1 M0B@N#)F_1#;0YZS)?59>:&\C_?NTO]#@.("]%+&MW^8^4FG@O.7&DMTZR\H9 M[Z6)D!)F"I)+(D-&^(Y9.D'&3.=M5Q\ZW/)O2!FV&W,'1KXC*3> D[?X&:=7 MN!A9'TM0#H'\&TYT$\FN]I,-60K-6$"F>^G;?DU (QO_@8J<=2#5!M#P.O!><]"6.6=2 H;>D!R+@ ['QBI;!9/:I2NFGWS_A=(&K;=096\B-*A:4 M8+06=#%@D2=N:Z4NWW)\TH69>8*J8?O =VY[NI)_ V!ZAY-)+:_#*<[#A%AZ MD3^.IZN&/K6,]YHKLJ39"EU N^J#LQ<=ZE>"?*Z6\*:_K[,C+,7F'+Q8+7"Y&CO;I9&J=53*U.26% M@=X43=MX*-SQH.+#"6G=X.MILH;I\M<3KCK4P+"!--G?Y?PJ+:_FM$SJ^J@, MO,5)36N__!#FE[CX%9%U\+>U#G1ZT_]L29>_V MKF%:_G6,DWXDVX#I^74VG:U/.*:7ZXSTS5Z=9>;&*K#".5 V1(A2.$B_& MF,A[L3J/4C1,@\">#$XW3U$9UGWLX[^KF\;J-%A][Y^+^(] M'#&S99B<:-.E3TRNZA6OBQH0D^*6R_DX7BWK8=7[V6,VUTNE4F'@0JPYXB@@ M,IF (V:,-1!R/18K=U=Y<\!_-5ZDM2 PW\J!HOPFX 3OUO/=X M@?,?PV*L%,-K.T6*AVA+AB 51=#9>&VYL(+WF+;8FUX@3> FIU,_JOQY*K>9ESWTO&R@K^ UTC+(B0$7Y0& M5,*:H(0SV$L%[=Z4#M3]<\B]^6!%-8#$#HSW/?8=A4=22 LV1%=G=6L(/ C@ MT07C7' Q;^D5V<3^O#^*6S\*:4')#6#\X9:QX66D,CG21GM:JHI1J%\G>>8H M(&@=O)/2<+6E5V7WN_2&GH&:G)YHGSY$Z.?:)&'T@(-NVB2,^&D:)3RD_J95 MP@_=RJNV-9WC!YPNQI]7=FAMD;H3W6,OZ%&*._'44>^)F_?6BN?ZEA?3?._] MFY]>=R:P-DKNL@.NZ\192U\YDPO8S(.I\HS;)IQU>(5S-SH[[E4ALC7>&3(U MP=:AE[QV>4$+.AJE%.U8DO5SNZ.A7A5](N69'A;[B+^Q'A:L#H ('@%U[0LF M/6U\)460D:O,=38V=]&!K>4>%GMI[XD>%ON(LJ4>%H5^5TI,@*X84,@$1",5 ML.3)Z2V:2=U=YZS6>ECLI;3'>ECL(\%6>EBD>J1CR+XR91>3,'U/?[4"-<\B9TOQ1O(UI+$J M@"OH('/&-$K,V-<5XFWD-'(+_7!CWZ&TF\3,9O$HQY10Q0'SM(*4R!0(DU! M&N<+1E1,]U+Y\QA!PSH)72C[6?P<(/D&$'11_>G9M#*Q>(5E/,6\J4[?6%'G M&8\A).!*.E":7&LRG))<:Y^L=RZ@ZZ4.Z#G"6D/4(>I_6%[6I2X:P-:;Y0>< MUT':\QMI;?AYG$7I3(K");",_J=4"1"8)&]%.TOA>#_]8_RGR\ MCGH?R390G[@RD%LRD:M3R=D3M<+R?U\M MEE6:-U<,M':9!R5!QJ0H5*6-/7*2J,N8&>/2Q&USV#O:]3IGIY$@L1NL-J#Q M!FSA4U+8N*W$\C/NPQ8Q*,M%**+.CJSM*)WFX(-3$)R+/"4=O>VE^J(G?AK9 MO?M'_JETOC_T_1KZ4[RL1YV=@/_OTSF&R?B?F/]*#G9E_\WT]?0SKOE:C+B+ MM4! @7#U4FXJ$H)2&F(1.;CBE=TV;O9X$#]#5W.-V(X!8YOL+Y^/.J MO=SB?UX1S^5+;0"U^+\QKUL^K5>1X#DGY0/D2&RJ2%N)4SX#>F64\8G;;=-( M^[6<.U'>7!^WOFQD]WIL'+BW%EYQF]%8\N+#ZCB>0T"R\)B$Y3$(+71_29QG MB&NN/5Q?\#M(&PT@; L[UZP]$P$PKMAG#ASG"FA#B+FZV4ST$KMW MS$=SW>B.P>V0.FX@B_ $^SNQ2P(O7-?NZI'B1I4XISU#%HA6D#>M:K?U7D[W MCJ2[N:YX/4&XH+:7K+OS/+U5IW^8YB$:<)W'[ V?+Y']KYUU?0?BZ[#7PY)0($1*K5T]CW?9R4:"=RQE+3-+UXF?O0ES'5=$R1^-T M]*#DJLTB-^3$DOZE+,7$F'CIY^I+HU71W6#BF5+H?63>P!:UZ8U]$>;+NZGX MQ8]?[OYF5?F#.7C)10'%-07=Z!"BIO#;,EFL:ZUB1+B(6<1%5[";O$ZY1GI@S)P;&'=YVVE'#?>V0[ M"#A$-;,.Y-38]9RH&/,"#5B#9$I5D!0,* %2>5]HC[8J;#$.)[F>LY>2GMTQ.P>$FSE M>HZVCBOROL$'ZVNO%T[4)P.2C)ZM]1Y?:?T,KN?LI8AMUW/VD4H#WMZ-)7LY M"8O%F_)N.4O_6.':2]I\"E'NLI!U^)RGXZB#Q*42-5*,?' M#MW(O 'PW*5_LWX<.2O<"(K.:XBNA*ZC"0.#%&70C(?,9R. M'Z9,CQ/XL#O'"_6]9N]P/L;%Q?7;5YQ<6TY'-$=:33FX2'&3%."CIHU4:F-U MQ&C9\_O),R\9%A3'JF_6BRP'1H5\FA-AD1N;*)X*C,(KAA$BMXFBZ>@"N:*\1ZXUV0\N2D0?4BT(20?2A31B%ZN M[1UXHZ7_,L0.O9'#I-P 3EZ&11V47/_YZ7]?C3^'2:V=?+%\&>;S6ISVGV%R MA>392YD"%B@.&:B2';GHM T;GWD2J'SA_1SG[D)=(\[*@1!XZ*5TKH\&0/;N MPVR^?(_SCW?+=9AA"%!ATY;;RHBG/]7+#;0DPC&;%N('2T MM!M S%M,2. G^UR+%M>W:98CSAEMMS&"1)5 HJDJV4M-( M2-T-9HZ7=P.@J7B?TD>^U"'(R25EO14DB-KJ)1221HP!C!+2Q>P3USV- ;@E MHA$_IQN('"S=!I"Q*HI>#U*_QK:3CEF6)&17>QQ[GL!K+\&(R+1BS'K9BRWY MFI3F;C\<@Y(C)=T 5NX3GYE5.08.!>N@BGH-(Q#=D'+.VO*@\&$?K6Y@LC]" M3GE!X1B$'"[?!LJTJT^^_/(W7'Z8Y;ONE=&*'.\/91NP39 M,PLJ!P,Q.P9::4"$".2%47CG!=?@,6D66"@H>KGT<4U W)A=B&MOL/MQ85+' MZF@ 8J\VK[T96G_#VHCD(Q,%LZ647AR?QTEJ;P+\ M,7#J2/0-@.A.9%COOUW[_UEI6@V"3*PC8TO>/GV5.;!$9I@7954_AU);J6EO M['I'H?B! F\ -6OZ1QZ#5D$'$/4(5HE22T!XAD1^6RH%+>L')NO7MS?I_/@ M?"^1-A!YO\)XDY=.2L8BT8,V3H/RD=4CV]HX*SBR>@X%[VG3B7ME_T\ZQ?RX M7>8PX;9@(%*:74V7BXOPI1Y?7'-18N08.8,D5"8NM(9@98:8,+$4T'/72_I_ M.SGM#20_RH <+_(V@#._NN-8X4U.DB(\6[)5P&,=D"VY@:B, -18K)?>&M_/ M9O,81>U-(S\2/AT(O@$$7?OF;_$S3J]P5))D)C*2@HF%%H#1X'R(9$BS5\$' M+X+N9UNZ1T=[D\6["( .$7)[&+E&.B)+6J$!(4+-70L)CIL K 0NBF<>I2B]H9S=[ ]'2GX!A"TA0/N1)2^)##:U;I!Q2!J"OXSABBE<86Y M7CI$'HB9DX[8/@8S1XJZ@?#ZE]GTLM8,UDAP57_Z:5P?C6&!;^)D?+D9J^JY MQ2B\@VBX )4M[;[69 C,&)NB0!2]V)[=R&MOXO51H.I>)4T,V_AUML3KV/%. M3P!:.W?2E%J6HHQ1% #4'A"^3FRNA_LJ1N,C@C4L@M=-9YJB][ 5=S]"U&[#.)<_< MI1(:P-23_>WOCT%:M;F_R^WM0D)-MME*2TZCQKJ0_+K'(X\E,@I$E-S6\:.# M0I\NJ-\-G^>2]#Z]0AM \8K5[9R8P'UD,D'M,5Z;<03B)$1 6I2,\2"3Z,4H M/D[2;G@[E[1Y1Z)O $3;F6 NAAB"@5PLR48Q"H]][>.!2O&$4EO5BVD[ CKG MDC(_7N -A)CWKU6O+S*:E%W*Z*%(IS;C*[4BCJ2P+MKD/5.];(=?T[(;8LXE M;7ZLL!NP,B]G'S_.IG?H%\D[+C717\^CE9 "R#P&8#8)Y[43LI_$YT-"=D/* MN:3+CQ)S S!YD?.JW6V87(0Q!1N;/,DHKUI.B02Z, I9K5;U\J(&H[5G(CBE M3"_NS"/T[ ::LTF2=R#T!K#S%I>ANOD_A?ET/+UW8@7D556! ,;R0L,3(!7+(,(7&%1G ?12Y7*UZ3LAJ1SR:,?*>H& MP/*W\70V)[IO!M(PI46(44)TF8$R1+KCJLZETXYLL?7D(/8!E8>$[ :4<\F+ M'R7F!O:UKX%^T("N8(1E1=)JT,;42Y>>%H<0H /7$7-@R?0R<*$;\G>#Y+FD MP@=0:0/V[DY6[<4T;['?GJ$@NA.H59NM)$M=F ZT53&XE%AB?6J1K.;*#5Q4K@'W Y3F'2Y7BK!P_N<]C54SR<':C MK_;!Q#.CK_:1>6-C1F0D$ZRX!"9" *5< 4\N)Z2234PDH**W=!4+8T949;"B!A)7PQK[HP7"$)%$,XS&YW!M&TV_#%*+T=>_X&QHPD)J M#$1RL0$%.6;6&@K$>]E>#APS7"T7RS"MYZ CY44PS"!(K'.B1+UB:WT$)W460I7$92^EZD\1 MU<@.UQ.0#I5^ TBZ[]O].B-#NRZN+IJ;=DI,X(1)8 U3)F&61I_@ MPL,M0/.RG MR6INC$EW2#I* XWBZ?5B<46AMYCQXZ>54C[67I C$Z4NSG% PSFHD M$K2AJ8,(&%.3G ML5[Z;3Y-5G-S4+K#TE$:: !/]^YW$!%IO-(+?3W!Y?I:/C$V7X[_N?KYH_,[ M1IEQGSRM(Y:QMB:I18?.)Q H%$6I,DK?RV[8%0/-C5DY!J.#:'5_-/LUFJ=X M62D]1=7?C9P7LU*'N_X\F?UV9+W?]D=V7.FW ]W=U_C=O.BFCHO+7 <<:!"2 M!U LLWK5/8$W1:LB4\FEETKVD!<&C)\\ #7@O%MB+ #?#U#6"/ ZA(-#Q'7I6J&K29X7R]: MD*_Q*4R_; Z]T7**5&P!\B]K3T%)48M.&5Q6&H/PLG#WM%^T];D#PZ)3EFVI*Q1T*:.M18S8H"0R"J;NB(\8R6)+8[=24K33U:G>,!.=*PH6RI- MS]:9I+T"84NE6Q#_P2,8@1I-4#X_+"K[ADK3]U+:8Z7I^TBPE=)T4V0VJ[GQ M=5",LKK4>9LU!RJ2=BF7DI\O&FNM-'TO16PK3=]'*BUXC%]GCUAP67(502KK M0+D@(&*Q$!E'GY*MP\7^B.5?780;ATFY 9S\BLL:SU_,9Y_'&?./7_Z^J'V! MM_A&-]$^^I*D2H1_(T0]'DE S_5 /U9!<&$8[^5 87]2&XD^#@3'PV[@_6JJ M 2P2:V6\K$U]1D[*>O+OR&\6&6@1*MI\E0627:;0K#C73XNX6Q*&Q4[?ROYZ M!OLADF\ ,[N<98R,,KK01@\&DZ]1F(%@; ;.37+<.FGZ&H7\/''#!CPGQEGG MVAK69_ZJC_Y/OW_"Z0(WO M_3,NEJNBBE&41?E0*$S#X&HE:8:H&7W%O50B).85>W8_[H248>LN3[<1GUYO MP^+T+=$\OTK+JWD5(WG!Q.)R,^CKY8PB:[:)&\<@+4SNW$*1E%(8:,3(%0-J4H. ME:4"V0M-$;Z1+O0W0&@;1<.65IYX.^U&+PT C(B?UR&7KW#][^OIBY1JB?/B M+2V%\>=5/MT4ADX1'%QFJAKA*C->D^JNY&2+4KJ7JM]=B-L)=KU->C@Q[#K7 M5I,(?$U;_Y3^B*0V*EDZRV,&&[VAK9^8\746/9(A%\%Q74PO <.35.V62.YM M&,3@H#M404VB[7H%;::RCAR7Q@B,8)*KHD+R%6HS>4-.IC>TFDP_?=B?I6PW MU'TKYQ?=*JI)Y%UG*6O&9WI%KH,I7JMZ<=9F6X^MZV!"(<.YG&#VKK@%0[B[(D??:^" MA%#+]IQC$(2H@P]<,%FIX%DO M=G%W$G<#Y;=R7M&3ZAH84O$(9Z]7N^E\DJ^Y/:2!WV+WV63G6EJ08,)+FYJ^SW^]F+]+^OQG,D7O-590M7N4V2 M'Q.Q)!*=C9+6,$:2GQ$&I$\ZJ^ASR?VTMWF.LB8+K3J#QL.3M4[U=.SUZO== MG&(0!PDQ+ZILR=VH9S?;CF["-&\]O9GBG?POP?N!JN]0[3U7SM MJ6!R0I4ZM\35X4?>$5.!UBP+ IU,VMO8RSZ^$W5-UFV=S* >K:_AC>J=JMS5 M6OR9A/R.%N*+:?Y;J&>6RR]ORE8^I3-61:M)?EA[\84,D4?RI8E-C=)QQ'YP MN2^E399L]8;17O78D-'\>3:_R^LJ^[!%J",3:!MPG@-ZI#69C 79026#,-Z M$9L8[--\[DAGDS5??1O2/G38CDG=7:@C+KP1A>2(QA50VNLU@_7'R6EMLNOE M:&=W$INL"^L+GSUIKMT\TF9TWE9!,D8NM)(6#)I:BZD]."F0O@TV8-*%YUXR M[_N3VLA5SU[S2%UIJH6=_([I?XN?-GO"F_+NPVR^)#/\\15&6L*,1O$5)L5JFI=139^_G2&LRW7,*>]>! MIAHS=O?XX%IZ]+7AC"7AJ,(3>)(;K:R869!69]%+FX7'"&HR97,*(W>P5AHR M<+?!/7%V-4\?PH+6S9VY'J/DDQ,Z!4#ZZX+XE#TK7 MTQ8&/BE:@\S+R+2/LI^DRNXD-GESKR]@]J2Y!LXZ?BH%T[)V*R''=GJ);\DJ MOYE69NM_=_E,*0'7IJ;^7?,:0:.C"M'!D'T<_7ZM&PV-\[PF$72,$+.??W/%IM@B3O\YG5Y]>/-JZ36F'7 8.+A8)BB<$5[("Y84M-NAB3"_]D4_)9',C M' =;.WVBX^"5\VFUH$E,\^7YK1\49$!43I QLMH@C%Q100XPIT#)>5]DSKTT M"6QN_9QR;.79K)]]T''D^OEIVMO@P!L-S,HJ.?IA-B&5+ZI.-"5J\)@M"%68#F@SM[TXL3M1 MU_%D0<==XN@$,%>[=%(@#TYS8C@F^AJ39+J70JI&)PMVA(IG1@SN(_3&9C)Y MKZ)S%/EZ5C.0L@AP4A8@^TFQK\S!;+O:#KB7]IZ8R;2/*%N:R821 M(VV5"K@6Y(<*K6L[$0>"6Y6,T2+E+:>DW\A,IKV4]MA,IGTDV,I,)I$CMW4^ M38[)$..20\Q10)$4D^B043^\O7T&,YGV4L2VF4S[2*6!;,:-)5OO;2]G'\DU MJ[[T"MM9*&JW.(F(2H>($H,,9H/;.VES.8)ZEJI W$X::_>]DW *0' M/&R64U(RG%]U6:AKQ&8[7]L-#C:-%WP!^ M+J[?NW*X-\:4>YYU;7:L9?"TNF0 GZ-9W120DHRI=;VD/[<1,RQZ.M#Q5Y4& M1PJ\ =#<*4'<,*!UX-*C I%EW;_))?-1"_K6:F+!)**H]U;:7:QX.3_V\CT 9N M &M8$8M/Y"?V$EFYQME M[1-$#7L0WCV&.E- V#:4B80,9D@M0'+#!E02:+Q+E/ R8I'DHOAHI<++XW/ M?N\DHWB8E)O RC_;OD9&W@HK.6W.+*K:X3%$ M"*;F\ED13BN>#,O]8*L+\AM)5!X(HJ\P>7*--E/K=F>&>>+22%ZGG;(80"FN MP(>4P C/8R(YAGXVS#VGQY^R??8QJ#I0L@ MA]]'*O&L"-R@E:W3$!3Q5XJ$D@12Z%$L8;X/O.Q"7"/[93=(ZEP;36#LYB[K MW5OZT@5D10:P(I//Z*V#@)I<2)*:BU'&6'KII["-F.:N%1V#H:.EW8KG5?O7 M8'ZUFD&ZOLGQGV%RA:LU,G(DG%S/1SB%@)'I/C5"E>D4!3,]N94/459 M<[=OCO:7.M-# \"Z61SW3QPI-(Y.EKIEAU CV-HS)"!%.];QVB_)"=>+1_0( M/-NF0 MX\K_OMJ,#W\_>^3@[-T'PE8,"\S5?R'G9077MTA1UF*\Q'_C W;+J+C==P4"AHP M"/?2ZBL.-B,6B/>:&EU^F.617;6AHM EBU5P\"-HU\XW4O3IEV( M&[9G1,?H[%P;#2#LZW35>J/).<:4M(58A\XI5R(M&8Q09!(*;7;2]U)8] @] M T]P[CU'N+_0F\3.0:G.+#T+=9UP9CDH5D=B5G&2BR9S$"5&TY]/[V/2L_TING%2CT?<#E.8;*X_]U]UHZ^?/KDJ_J^C[H[GZ>]HNJ208K]H0CC M*;+C"8)2 :S5)@1">/2]Y(N'N*(:T2@?)'&H);D4V5L(*4J0UCLODA0VQEYY M/9\KJGN@XIDKJOL(O;4KJL9:P5 !\\[1!H 9B.(,VK%"[H5G:MLUIF_JBNI> MVGOJBNH>HFSIBJJ/C,=:HNXP49P;=*9XQ!FHMVL\%UK3+MP!!!J]HKJ/TAZ[ MHKJ/!%NYHAJ+S58XBA^*(]1SXCXPSH!;)UB2BFFCG_9#&KRBNI/HEP^XL':*B0UDVL+ULR39:3%I(JX'E5;;1DHA"3?7)J(*++DK62^OGQLO: M._%&#I-R SBY4Q=V6YJ!\]71[2M,$_HGCV*]/R8Q06*F6L0<:GMVVG81O79& MY>Q]+X[)#L0UXJH<"(#'[[)WHXT&$';?FC[.EA?1QNK1<2GKI"8MR=2Z>G7? M*E\GR14JS MJ]IT]?)B-ADGVO%_G2WQD+.@/1[>Q>G/H;QT=-[S];MNTOE6RB 9P2-C;2Z6 MZERBLIKV8FA7=M<3?RAMT<.\++5TY7]YHY9]MU_6]?YNOF^2>S8-LYZM^( MI5RKU05% KPV>RF. G_C)&CEI8K)Y)3[ZFG1DQ'[,2S&%!X_>,&7]?]OEXIP M3'L6.'F42=?56-N[*0TB:V32<+2JE]8PNY'7K!';!R\/C5@/FCEG(W;SJ:]_ M]:IVUCFH4J>K-Y_,\.TKA8Y,XIOY99B._[EBZN5LNJ!7YO7ZFN:+.PR_*9NA M:F%R$X_,G,. MC#"UH8I0M>MR!EU8HZMZK ?(^LF\ 2-O[__"L* :* M'@2/)!XNR+/@24(P)@A;8DC82R.2LVN O)>V=VJ O(_HASU@7)6)3\/D+<[N M6//K/G/"290E@$CU1$R8 #[4I19\1%I?0F3SM(?VS!M:;&R\E^YFW0NR 7NR M)1?--3/H= (65@WDE -/&S,(Q.A1J("YW]$\^QTMGJK0J9,MZ# I-X"37:Z( M;OH&()=99@Z8L)YHZ0B>U?GV249K(T.?>KG"MC.%C>Q/!T+A@*N[^^NE <#= MML>I0^I?KN?J40Q]9[ >0RXP2 58E"53NQJ.;!!B0JN#B4[T=(:,5S= M0*QC30SK!/T\F^/X_OI$JF^,0=3+Y#XNQ"YRGJIU+?(7+>EMROLF-O/^ ;TH9U^S( M!2YF[V=_?_?J[JCJD=?*:G))(6M./#)-2\@9#2GHG$SD4JO\+,8.?GUSS;(. MQ-AIY-]FAOXM5M9O4\Y_O1KG,$T/JAEWR;@_^J0.,NB[4=GY(>'+E:87+Z;Y MI_E\-G\Y(YVEE76Y25&2%^1RG7,M:DM<96L-#BH#.7*N@_=!ZYZ/#9\G\NB6 MV_C;G3.)^6Q*7Z9-JG::-^]_/;W[F?$TC0DQ=T[D*<@5%!)1L"QJIU1)_PO> M,;#!9QTX4R[TDA7O@OA6#B$[QN-7G;U/K>?S,HF/_?SP&HR#W]2C2=V/R_[K M,F(2WBE6KX52E*"$HBW6: ,F9\6S:EI8BEGV:U>])Y?'/5NT^]Z4VTG8KZ MT\EL07J[740Q6*593)!2'7CL8@!76"VVDBQ(KHJ*O1Q0'DOXL":P3S1^W.SE ME/'$EG.=V+S);?T8)M7Y?O!]L;S]M:0LPPZ;3W]-'9N66WU4A3W#" M">\EZ)))Q+&LI$N&M_B2C LV%O&T57[DR<,BK4GMS[I315M(NFXRX%FLK5ZA M:,5!%:3@3B0'F*.PVDJ3]//]F[8_>Z!F3EUHZG&M'R"VH2O?[JVJZTJMD(3) MI$I3) -E.9*W+#QPQY$YZR*9ZAU*WK8\NAFM'Z*I68=B&U;M+\/BP\^3V6\; MPHTI.0NI06*HZ-<,O"X19-:E))9D?C@)9(N^[S]SF#J/SA5]A*"&U?#=_7%# MO(P^!"\R,F>&(2'7N><+6;]^[C#U%YUK^DB!-5,7UJ>'M-HJ M43J6A A04DJ@LK7@C3 0%")+D3'?SY6,T[ W;'U:RTYNPS!K8/'MQ>"OX>.- MM6*9[(J68$CN-3=8NX(F!,%33H:^=Z67$Z\#Z?W68\#]H7=,LOA ' SX3UKK!Y9>+^2Q?I>7B 2=:159D*< HF@:ER8,*S"9 IJR27FGO[;/P>.8E MPV[;)P9+EP)O8.OLWZK_.:%Y-G;?FY5GI[7;]U]/A#W#^^$-@["\ZS1>(>$DC76+N>XKNL[N.G0,2\[ M037'SKP.5.)!OEW0U=-3G-49]R/Q?)O]$2#XM9F&00B@YD M;)36%#7Y6"?IZ@2CWT TX!7=E<.O]1/5]6O!DM% M+YV2%HI2"10S"ESM'14X*U&'(HKHJ:/A=H*^=?_F /1\U1"Q U4V"LE-5J-Z M4"91+,9S4%!KNJ".Q:IS))+"$'C1O73(>YRD86'9C5%U8S\8DDQ$A"L7#MC$,1=ICL\LQ;VD/' M(8J<]2/5!DS-RKM_L5C@E@O*O' M*CX 04(K+"P'WTL#A.<(&[8Y29]&J"MM#(BNQ7PY>EFW8YR3/)=?ZNG?>L:C M"75L@X54[Z$IGRA^0([@="G%T0(1N,L>1L^_@R3Z[B&*'B/@CU'H=$BHUHG* M!H;<6_QT-4\?P@)O$J /6;KN].D8!BD,))/5NO6^5U%#4DE82V)C?I=N)3OA M<&>JAG')NU'\K&\M#.MAO;JZH,66\5?\.+N:7UMCAW?@-"H_2&0->,>G/#O6)C&LI9=:,0HW,W/@1+:@@F$*K0M2]9W_K@6=WD#I<)>=9H;3ZP2-M=?HJ5-KAG2>H5]J7\Z%Z>GDN M,!<-W-0Q?8J16;,4#)= L([.A2)X'X[9-UJVY+B5M#C)*AC+*0[(DNP#"39E MY3,OQ27WK[*EDW4(VP/;@W6FV0,P?XB8<3VYJ@Y2T"H!L[41L':KX<<>-(_> M\,!%L+W4FS1T(?F,/? #D#W,A>1]8-; XCOT3II@,;LJ?Y]9J.=J])5Q"K(0 M$K72*433TQ[_KPO)74"OHPO)^^!@V!!VY3SG._S,;OC9Y%I9)CNB9824,@5B MK$ZPYB&3_(*.C'O/W//]C)Y]S>#^3O]ZGO4D]-;LYC;E>/>@2\6VC=/K6^5%)VV%@B"D MJ V0*))!EFKQE<.(4?K85^?MIREKR$ >BX/=,7: 4AI V8.%?:]L76JG91T- M'!,S)*A K%1^,A8RZ;6#ZTX5(\?&6WO?.SG[X[0.@Z2#%=HN-F_:OQG!=!4- M&A)2<+3&'%?@LBV,"X\\G1*=+5B^SG2_&Z8.4$1[J.KU8,@+YX,- 62IA;%> MDFAJQ8]WEG$,3I'(SC-CM5^!0V]%R6=HD9L!7#-K\7KFZ2,A+"[?E/?A]Y'+ M%, *Z2B )6]-6:4A&BN!_"S#LI'T38^G*+L1V93];P=I3XY3[E#MYWDASH%UY%I'BV4I#(H[B.9?V$)XD7K8&RR MHA>#\XV>@GN76.%9@8FFD)_H"P3$"-P(SB,+Q9M_G8*?[!1\#VP/=0J^#V": M<69Z/R/24J3D20S$0QV'BQPC9CSCF2ZC/\XI^%[('N84?!^8-;#X M#CT58RDQ[1@#9)J!2G6J:2%>.5I;2"7P^E-("RI\[(E,: MF:_F@=!6$;T'I^E_S'HCG"@%?2]=%O_P!]X=QD,'*[1=;%XO-%ZTR0)!&TO, MH+0040CZ*GIE:R.MZ M &3%1F7!KLRV8[3D4B$KSJ2SG&&.89'R(=>M.>4,C$"\? MLK!91A0FF:*8 $D+AL*HF"!Z\B-D8D%X+HBA72X9[H; QZ@8KNM,1]J==2WJ M@;,;L\7R;Z]^>8?+Y60EG8N?W[R@6'Q1%^+KZ7]?S;^0%SK^N+AI/8=1\*!) M3,+7]BP:/(^:%I@7S);L$)_O[[CG2P?$3#<:GIU$W TX5+^0!;]<:::NMJMU M>K%X*;2W= G+5A MSK?,7+?MW0HS[H^YQ1ZJK*;"]I[^X;EL4M0XE<2@V$P\JP?LZJQ,9+;)\*E"V<%S2C8]OWD6H# MIN;K,>*2P@CEC0:=[&J,)FW?*RYBTL8E+7/II3KE?,:V'P*=;N0]N$79::1X MXMZ)( -I&FM[DEQ+H&4&'A6/7F3K'AZG?8-CVP^W+YW+N!4S\]2@\!(%9N4T M<+*/H*Q#"%PY,J!%:26%D_TT[C[;L>U'&Z&NM-$ ND[9.H\CQFI7:NU M$>3>F^:Y$X_D< 7%)?GK!D')Z-8#/VTI4EJ>'-]AJ/K!K__6^ZQTA]U>%=N M#[15?COTZOT1RVR.ZP^N.O86491W&5QPMHZ]QWI)(D**W&;KM=.LE['N'='_ MK;?<.&Y!# F6-ML[O\7/2"RN M2,O_&B\_O+Q:+$FE\YL.L]ZGXERJI\,N$KA4@5AT C.K-69THIK>+%>I MW,,WQLV?=[<);J/GQ!M>EE((@Q&,5AR4X!FBU@B,?E%G9(:L>SG /]&&1X%I MN+R[2.162AE@'QRGM&<10+:>T3 894[+/'U \ M_OS!6Q!WI+Y9U[)L$1#7W=0X"R@+ V]IK2A6.QW1(@%?DN?6:&,>=E[?&1)# M%E9VJ+OGT'" ( ?&0_COV?QB/LM7:5D3L9MJ"8L:)6<:I*=UHIQ6Q("+M6.W MUEFQPMSS1T#;G]T8!@[1V*Q+\0VI?QR/'M3@&)$EQ7&U_*;V^JQ]U$/F!8+V M.@4F69%;PIW%M;NQP/3]Y>SS#_3DM:=!7SQT,+Y^ZS!!3"^0.$ZB#<3%C^R< MMXUHZW*:DK0FN#\@=0&N3 M;N^!8)F=5G,-@/.I57S+E-!)A: Y&.$5J%(;.49;&QR7Z(T5I?33['(GZIHT M@]T L'OM-)T'_#7,:XG"9SQX[O)C#^KP6/])&D^<)0PN:4P\0E*V'I)R!B%F M 06-2JP$[MTW<2Q6W MMYQ.C4/ MW4TN3"_7O62"XIZ"*P3NA 9EG(10+X1$;8LM+.;B=CELVZU;W/5;FX#42=4] M.U;V+0!FDVK)S ATLC;JK%VU0T:*TGT +[013HG ]2ZWQW>'S-#M> [4V$.= M'R"^@;7^-UH?'Z\^7K?D"#SR)"4DK&VG?"# %T$N)?F7@7R@C+HS4W'OS0-K M_A"]S;H0XM#:#[_?(5QFYZ0G!S>A^XD6SG M@$[+P&CX%M8!_<%XEOE(LE"R)Z\A99&@-O. @)P4X:TK*B@9Y$\8DSO5$9'W6H#8:R(%NEL*;W"P2G M14[>$PS[W+D&K0?%PK6/W(&6=2E(2VZ_]A*$PA!=4JJPDY\^-;$3=XJ:O>I! M]U%) UOGHPT&C=$J"U8 8QTO8%, %SR","E%SUFRV,ODJJ/:@PY30[J7RG?M MZ;F/_!O%T?6LP^*TU*@AE9AJT1.GK9I\2ZV+%TZ(R'TOETS/KJ?G7BK?O:?G M/O(_CPY\7A?CN%9UPH D00D)/G$%W 6K&2HRX,^7JW?9@6^(#I][J77_#GS[ MR+@!^_-LSS?N=$1F+*"B;5[IFB&U#,$Z8D=:)53N93_KI /?$&U #\%7+]IH M %W/EC(Q,BTD%PE)\5K/A!F")Y_2FE_;Y M.]#6I"4Z#F-]::9QL-WNZR-1A\K7."7:P&IMFX*@78"L"\:$UO?4/V@W\H9M MEC88Y [43P.H>[5Y[494(^:+P2@5&"-,'7%)%EI@G3W@N ],\1QW&1B[OU=U MGXYAFV3WBJ-C)-X>8.ZW!_DG9CZ*Q2OA \6M7%,82TX1!"$SQ)P8SV@C5[UT M>GN6LIU I;\%4!VIE::/\.[+<78MQXOY>)K&G\)D'? M\;R>_&10Y"BC! Q*$H3:9(IZ\^MV=_,K@[:O8Z&=Q')0WLK;=M?J\6M"TL%N_PLGZ[6)U5 MI,!BX.0> *N1Y^MI"WR&RI)*(BO>2-[U'Q;"PZ5"[#W%SL*B'38F^0\RW MQ>V*"UD@E7H*58HFHF,";PR3S'J4^'P7HMOG#:SIP_4Q.U8X P_*GL\^D7NX MQ%6QX(9\+&DU+Y!0S2C69*9>6?+TK+B%;)N)O>7)PZ8:.]'RT0(; M^(;.)A9X,]_TYUS9,JD\=U)ELL?UCEIUKZ)R#OY_]MZTR:T;21O]13D7^_)1 MENU^?<-;6.J9N)\JL"0D3I=(-G=PT'*%L8!0 M)%E5'X>=H3TY+YU'QE,X*EM["%B>4S%=?=_Y@GV.DC.Y/+$)62SO]&!1AGM9 M,[Y]S=VT24&HHY +#QB#UJ:D Q)I7OR;B/I=M'0A]2[6* MR1J)%,'&0E1K2Z&*U1J(,2A]4$ZFP[[^@P].\R373L@GL&E:X?X?7,99FN7[ MC#Z196:H!$1#'HF*A% 74P2?O Y*2Z[YX>/\]*O3/)(U$?-9#)MZ>N2JQJ$/ MB4^"D;9Q$H1.J6HA!Y%%,CW,*8$\6O>T"?_.L9!/OWN4O,VKD/>93)M6XC_> MS#\\(IWGS U' 4D859.!$4(4'#3C04KKA&/NH+R??O4H:=M7(>VS&-;!K?S! M? ;7&"%=K')U5;D9H O)A)ST&>"<\34)+-PE 3G2^=XG?_D,ZH\.L#7EO[5 ME=$I*\T1M#*B]JDBDEFF$"9)J[,.3A?3 D=W!'3Y1'BB6'=7SP_C\6O,KOD' M+CXLP^>/7QLEU#S[?O,98T9(%,%Z2">32@[.8P N;(D^6^-CR MB$Z:-J.181"&0TBT;96]H]C+:3 Q)%X[;;'8I"'JZT^;&8*:06DS0T32@:5[ M^3F?J41:N-[9*$>;T4AN(0L6+/J(DGE%&NK_ILV<*/Q!:3-#)-$#K!Z_*M=2 MDHBF9LV2FU B>94VD9%++,>(P6O6I)CUU:3-#)+NRVDS UC=3=J,2$5G*Q1D MS63MX*G N81@H^+,8N8LQI<]I'[39H;(8V?:S!#F=)@VXTHJQ14$$7@B0^L+ M!&D1DHLE.8G!/6W,\AK39DZ3\MD,FS@=XEZIW04$LQ2NM[U!*#2TRD&4D12: MEQI\'?^>"]?.T@YE.4;C'Y4.L9>*CA-H3G$4QN/XU+"Y/3L/M[ ]1VBXLX;4 M'(OU/B%+"S$*4X &> C;"EGH+.:A=]#FI59NFL=AK1CGVM*6K*@)-$=3>&0(T,KR0FW1W6%. H9 MSU:?+C-H?&"7G@4=!"B26P[2E*;#%E&S-J0G<66@^SZO$(_4:Q[GY4' M\+C79^75>GF3UC?+V?Q#F.=-QYP_\)J"Q/SV8UA^P-7FC)WTHGSLIT=Y3#YI M'Z.](S]8_C_=O@D;H1,XLG1I23:!T2."48A3W6!.TDID? MY2*><"J/I/#L5YGT$?/--=8CMW/)MXO5>K7M=XA&16,B^.QJ1AAI\)BT!R2] M;3FZ;&V39_4!-$[]TMP"5\]>=QJ)K MK^&!#OU^'VZ[2*F<9E%; R 2 BBR M#Y+"G=2,_%+4BO9/S.9YPJB1S3=9\@:E] )T%H@Q2&.? EE M'>BL=?2<2%%-4ACVT-.1SCI-TH>PU,=DK7'YY$.1&9"D+[B!SQ-N*Y^BC!&LQ492; MLTM-[I*.(6[BW(HI_)XQQ-0!]/;P;KNM[[Z^I^_\5NIFWU-\_1W]TW]="8I- M9'$&6$$Z79[4;T 5-W-=LBLQTWF[8*CW$JT=&<=1 '-:]%[M/5ZW?X9@@[>.;)3"<;O5<1B__? MY8VT-C;GMML2>=>66P_T_U*=;PVQ6@2NF7F[+!DE[ M,2KKNP//-G:+4185>6WHH *Y$4@L(3: %K7)?DGJN%*R$^$S=>;E&()]$2AZBA(:7S ]H.Q1 M+87A%-$$M%"R"]7L,PA>U_E#VL84M8YM9M.]GF*Q(=)]L5AL"*N[*19+7 B! M1H+)@HA6C(Z-"0I\<$(:6:2.APN*^BP6&R2/G<5B0YC38;%8#!JC"0RXDZ02 M??7VC:K##%"J1!0$>;A/4^_%8B=*^6R&=:#IWRZ6GQ=+4FYW#>0T1\\C)W5, M3I9BSI 6TQ8X,JMEL%R*)OGZ3^B8-GWR?'2,P=X.T'%G[=ZD?]_,5K/[0>,J M^\1E\1!M?0(B*PPAYZ)T7(A#W,,872*J?K3)>+VP-D< MLBX\40S&.:CHB#\AB=K_+ 7O@F6F22[N0:WB:HRW644R:#S=.W_OY M::/X<=$P&AL[4";;C:S)D:N1[&_Q>G9;V[6QY'?EXU(8Q%3G/=06PRESB!@1 MUQ^FLW#PV%C%'EXC+:. M?"IVQC M1O!*$Y\45^ =0(.E,]/\[3XA/=O(-7DP$9VGWY),-PG!7J!I6E!=*L@?2RC]XFM[ M%K-G69BB(8E,FW&R=EDO!HKVW'H32Q;'#!@<"V$]!/JCR?XX3)T@B Y0M9G7 M]';QB=;_B//5[ O>;N\1MXS,+K+:62XQ"PH=HQ-(>V*>7$!R"ID133)YCB%N MFB$[E]9CHXOI%4!O>Z"XC+25Q$#7X8!*BT!>!O<@/'+%K8J\-+ER.HZ\:57< M^+ 8B+L39#1QANL?8?[A]J(WUN[(FFFH;U*@ BO@I:V5,0&1%1O(Q1PKI?5^ MU6FF1%TR"?HT!O> BKL.RSZ3^6>&MJM#K2:EN /)C(L2T%DA!7%F5%Q,W37T M1(D]E?D)[)M8ZK_,YK-/-W=5Q(1HPX4LH'T@/6F-A8B^#B1%7?*VHQ-$C21[88 M&L+VB=_+=Y9O+^9W56&8&"J#%K)4I%59-A"+5B!L\-P)GXQ[WZ]7\Y44Z M0\4I,EPT86AOBF5?7PF1 WJ- 8PT"*J0$8[)DNFUHG*+2\[;:YES^L7XOY41 M&T-,O4'O,<=^^.LSINW/>9W_'F+B$8HUK.XK@+<4.9;B7$E2*NW:.TTO$-B1 M?AL%&B]A;RPY33VUG7:#;\/JX^_AZZ:\\,F<2*JH MW"85=2]%TV:)-50_[OF]7Z5M/*X WW@8&. MI%^5"70L@LU@LTVD@+,(]G"U\DLK3)O"T])NC<;7#M3-KE9]5THI\L*L!21_ M"Y2R'CPO"2(/,5L34VSSJ+V+F&DS*"[K&I_"_VE5S%//?D=5P*^XOE+,;W*: MP/M AT+[ ,XZ 24+X0/W7@1^4-D\TA(NLA4VCS:(7D>1I)>E]* M7<<2% ?.UXN5*&4DTX"TF6GRQ[IHHCE(ICOSQX8PN =4W*52H&(\U3M5S6I; M'5D'X=H '%,J(GI6QIM2WEG^V"")[($2USI$/_SOEC0^2V-W]L"!.GEOZCU"?.&>-6.P@N$?03%Q!0>Y Y M.293C@E'RQKM,7_L5.F?S,0.KG9>;L3)M4?,K("(MB;%$YY#'??@"N/:FLQT MFXKVOTG_VU/\A_$%TP/*'C4 E-'H8K! ?5@!%3% 2$H!8T[F4)(PV&;PYFOI M?SM(NB_VOQW"ZF[ZW[I8@O=102*["2H85:>S!\!4='1%Y_ T$>/5]+\=)(^= M_6^',*?#_K<.C36AU&UG4HDR, B&S&W69"61#*RGJJ2?N*8@9E^4= M8.=06SOM0_965(\\6U"\YOUHBL]349%"="UT:I+<,$:OR2ZZY9[CCXXIG ZP MMK\EC!8E&\TE:%4[DS&* 'U*'&).2KB!]]N!%<2QD8V6;^3&OK-?D(&D?VVMR .M?1[\N@X+1 M44N@T0>*"GF]8XH.BE$\1LS1J\,#NL?LUS5!'\I3D-*(Q1VD[>WLK*E9"*X8 M#HE; ZH@&?E,N_'*6,RIT"EP!V%R7H/2"?I(G@B,<=C8@04ZJA>F=LZ7$B)( MAAR4K=WN=&: SE0)RUL(_T70W)0.C=-J1]D7G*:IP M$F(0'K1'+5(R7KDF"5"OJ.!\D*2/+#@?PO9I_9]#.8VW^TE"%,N- BE$+<-( M%IPB1L4<2'>CK=GV!WVAHY;J#"&GR'/1D+E]=R<0/' I2@ A-*\O_QF\KH49 M(L=L!$NF'.Z$/$9W@LM4:)X/D#$9VIL5VI>0CTYH@P9)\":#RKZ *T6#D5X7 M$9G!V&1&VVC=";KHA-SH"OHT,?4&O9>JWKD6RC*=(4CC:W\9A,!$!FF+#!0T ML,R;)$W\C;H3#(+&J=T)ALBI-_S=E9853SI:42"*MO9 0PI.7<1MU M3NU5W9#2OFD[&XR&JU/X?S*&/N-RMLCOUF&Y;EN3GG,F-X.1BTCX!Y54 *>Y M!8.LE*#(B61-^JJ<59,^;9.#U@=)=H"/_/=(E^F.?S.QYL9C[G]>P3TE_"3XLO M&.KY6%TEJX,)N7;FT]6WTPZB(4WK*3+6D>L MOHI6&#'%I&0V4&+5F)JKVDA(@M'&>A>+\^+PO?6(K3":=6=N"YC1>=V;=7J' MZ_7UQMS2_G[Z]#G,EO47OR\77V:K>A][)5-Q-D0)7@4!*K)8;6\")NF U(&& M(C;)0!M&YK3=52]KT<:5V:MMSO)K6"YIE2_8L@W+LT4NTW#EY;U=O+6*X#Q8 MD0NDG*J-]([<)IW!^.!X<2RA:J\#>FFM0@J^.%='GOQ?4L;Z2U,1R;7(V,M9+<:_!"J_K, MZLAX< O9NE!2$9F9T?HJ[";A]31=&23MQ:BL[PX\V^?THABKAPVL1%E'?6:* M;Z*K ZB=C+0)Q&,*GTZ$SY0)+F,)]D6U2FBK1S:U6M4+6,8N40P!=EP49M M$07Z&)K<@KZ:S@V#I/MBYX8AK.X )W?<>)/^?4-A[/WD5MJ]"B%&,"(10ZP6 MX+/0X+SE)8L<@FSB;N^AY_74ZIZC@<801J>82IM+8-P>$L6E+B[8VEN+-I3( M$2"3'6J17W ANI)\DQ[4!RF;5D>-(O\C,'6Z,#I UZ'"9A8*]]YDR)X%TL*. M-I:$!9-+=-S03[&)YAJCVT 7Q2WG:+ QA=,!UEXH+\NYV$QABS:.;+T1&0*W M";BP3!F?/ ]---@K[38P2.['=QL8((1IWP\WP^P?WCAOBPBCDS[5-%.#QM(. M)(=8AV#+PH3T7"*:PRVS]GR\VZX!0Z2V&)6%':B4G^9I\0GOHY&?ZS^XL_-. MYUA\+. 1B3-U#HW/2,8> Z])7);+)M5S+]#T>BH4SC%;8PFE7WS=%?A$$X)0 M$8HJ""KP4@OC$>JHVR*+9(%?$F$]F*[19'\HVBC?MXM/M/Y'G*]F M7_!V>X^X121+1XL#MRZ"0N,A.H90D@L8M0XE'=.'>#"XCB%NVMR[2^FQT<7T M"J#WX-ZM6.WI+-4?N&<0LN!0,D;%12B!-ZE6.(Z\:57<^+ 8B+L39-0!\H[* M+Q*9":M* ,6C3 )+3313M"TO(@2& M"8*SS",OV>LG"0J[JFD&K-CM-<.)HEZTYWMOFNQP(J.3F%@HME M%N+8DNOP=0%&D@?FF=#)M&_"W#*9].!"W\]6Z7JQNEGB>^+^=_1O_W55HLG* M;O8;G^ M^GX9YJMPVY;GU\7Z-*7WTN=&47='TSN:HMN]XCWJ5-',&LWK@ 6*('3*X%FA MYYB0S!#K>YB2_3-CY:FWW]W<=!&]#R9%B)RUJ 0IYJ! ,.:E9=/9PNL,EMNG&!Z- M]8P3HVJ7,MI![9!O!7#T=?Y+$:555\RGI/2I\\X5^@O8.D$"T[Y(D*.SS;4* MF>MH?087"@/ER5%SS$K0VB5FO37,'YY1S M#+*5Z(C:+%@=!F4#!%<29,:+P!0YJ2[>E\FE*^.+OZ&3^$ MZQ_FZ]E6>XF0G"ZO@=R_93.=C6ASB7XQ.#Y9;JNWH0^I]TB" Q?FTZ@IPMB<297.G/T'ZBYG^\?I ,RX[@AW58864%%NBUXIR!F M+9@I*5MLE*WT,F']U'=.&FN>)JA^@??[S3)]#"M<_4@\?_AWKGAPTA7:51)! MT\&J;44--Y"=I+T)[V*KA]=AA/83HYP/D^,P.([,.L#DYG(>;_O\SU?X:"N: M C7)?0)IJF%P44)0SD&A:$"$J&H_I#9U$'MIZB=B&AUI8TGB=;V$/?SYG[/U MQ^\7?WY_\SO]T]'?P0ZNU/ 5;-@N+_4&9H+'F)V&6&K%O"%\!B=-D;;X$':6D'1M2.*K5RO$@ZX264W!Q^K^P-;)#0#[^!#9' Y&]@MV[- M]F(H&X00>:],<)@/X3(R0VBAO,0D1^,O.W/./]H."4\2S&(57G6F*G:%0 M4DHY43S%**S6;DL*69(+H% E996* AN-]!OA$JVSQY8&QNHT074 O+L)8+^5 M[V?D;<[BS6V$M7A3RNQZ1GNE+0669'U2EH6<3J4, R_I5-EB::.V6QC2:8#L+U):7%#6Z*MU8/X@'TS7+V]62YO:\U^7(;:76Y_W:NYO/GV]K M'\/RZT_SLEA^NIW+-OC^;.^71K@?.X[*D>Z_?EM^"/-M2?*COM@D^]\?;."W M\N-L'N9I%J[O&]%\N\I EB/G6"RC#4)02H PRF4=A$\E-M%_0RF=N-G( MQ;'Y3$DV%>WK4I(;+_N$IX8#WVNH,'=1W)7:C+IH[UT&905%Q24:\#4=$$G2 MA2)E+GR;3D,]J,UO4=ZFYP\Y&HO/M6G&;/[AMN7/]HUO(\5O!TR+H .S"6S2 MQ#B7!7BN+12*_[V0CDF6VKY #"'W[Z! AZ!T_SM%,R%/>YOWXV*)LP_S6X;"/>U^5Z;FS'(WOQ*YZ>^W+2 M*@W=U.-WUY7S*G64MEXY.><(;B(J\-$8,#E75C.M]Y=T\ED>T*6HMZO6NHZT4XD^H6>*:6^Z-%.2=M,#7"S1U M,H/K!%$OVO"]7PAMW^"9MMEK$4%';>H#::1#ICUHRUE*CHZ6;O+8_")5T\)H M--D?AZD3!#%M=/N.?,Q%^7__J[A/.PG"UN,[68YJ88.MK&UCA&U8-0!,1( MVRB13L/3R3([]<91LV=W4C!Q-LKYIF8^-6OA3BWF@(5'"3K7AS+/$P0O,R24TGN3=#)-!LF^3-:$*!I' M[HMF0N@ 4B]/WE5,2&VR)E7L-)EK7F@SRH.(J!-Y;B'P)J_JYP^\;E>./%Z8 M-![O>P#2HT'+FBMKHPV0726^U*X[D3LHD:6LLXZ\307QJYEI/4BZ+\ZT'L+J MB=L:+1>??U\NUKC)N=OJ2Y2>>YK ZMD$H"P)+D34%SHG#0Q9W?7EB MZ9\NH\5X#)LXU,7[.9"TS50\SZ ,D:JL-."R*)!]*,23K"FD.QSFXJ#IF>W" MES%D>R)S.M#T;Q?+SXLZBN77Q7S+BKMIGY@XAJ2A8*;H7A0#WI&7GI32.0OE MQ:[F1.=K_;T43>PJG(V3<5G>55K'@^SK.HWVMHFCM5D@N>7%&E??>"/XI LD M7XN3BC"!RX-:XO Z$T_[/M^!')^;/4-C>WZ\UC'S.DJX$+>42 6%B__!_,'"KO)-?JP#)^VFE!Y8QBR!-S5!CBA M/G-F8R%HC4+1F>+Q<"+8KB]WBH=3I+88CX537YW>Q-4LS\)RAGZ5+%5NOO^#ZXR+_-/^"J_7F%> J2)MC0@G16E,KS0U$0?$< M%L>#Q1UG3R=G B!9QTNQY;'M(;J5UQ_(*6\(#__FO1JB=L')ER% M>5[4U/=0)]RNKGP)06;B4F:L#LR+F;S^Y.I[@?*)U#9+AZ],CEVMDY2B\R#3 MBKL=:*7]<>*=O?\."_V=]^&O*^9,CD%;L+(FV 5!NTI(@9X*6: RDIDF[_X# M:.PD"V <#=5*-A.W9<-"W,G?X9Q^LO[].MS6Y= !^QV7LT6>I>T?U0GM;XFT MV?HJ<)V85:F66)%+Z *O'8<#Q!RB$@II$X=5U@D+=_(F<+;V:LWS:1'URVR5 M\)HVA8NJE:M9)Z6,MR5>JSFNKU+*+M&_ 5/JN&D,"%'KVA-;J&2RCJ4!T4ODW44E.PK@=*($N@ 3W?3%6X/Q6]W9^2*LYB*C0*XK]$F ML0LBB[QV877:,UV,;S(-?@\]1R'(O1($C<'SUU7-?Z OQ^AU_4>NU[#"_Y0= M=U7KKS'64042A'6U!,$9"$(KLHO*2A&1[&.3^N-):_V/;"%S);@H(0E>RT/K M/%!!)]4Z!K7I!MHHB[?BH!=_S$I_A_K^(4@:V,MGD"!ZSB&[39[247+)-)T* M2S8E4<0;3,B 5ADA)' M<%>/%8(O1D,4%KW+45G#SD3+*\@W'"+3@?F&0QC<7[:9H>.C:QG2"YRV#:YHN<7%![ 2R-Y[",+XP>D/6HG(B<>BTT5FIS?;11CG1BD5"T M0A90E!C:E&:_E@K;0=)]L<)V"*L[P,G^8C'-O2E&UB!1TT9(H9):II,5=7;) M.N=8:-*M]+SZO O5Z Z2\M'U>4-8WE50]%09?[N:)9U;RQ4I".!8N__3;H)( M"$;6=Y[HT:1TT*@LY M).^0,9.,9K@(N=$?)R1<#5X.5F"[E^K5LSX/04T8W97QV[&?-X46JINB$V UJ@26 MU6PI'1 "%@:6.U<"5X6K,=!SMUZO!O "$#J)Y:_KX?:^B=CF5XM2.]$_Z48? MYOEQP_K17W//(:+A$^]HO!GIW7?WL( '0[&XM=(;LHRYD*=/0:?3QD/*26J* M1#&V&5C],ED7'(IQ.S+6&&F)#T"ZH,Z@%I4?*0.W,3"9O)2R29K=0#JG#3Q' M1-(94RX&RZN#"./^RN<^J^<-F8POLSIA<'A+^HY-W36ZYE$Q1 VRMF3:5&E$ M5C;9]3*:S!B:-H.!#A#6R8WMF&C8?7<[CFCZ@=K;12VDOJ$-;7>VF-^]D7IO MI,-H(:&-=2I2 %?GNP6F94Y6.O:T,GU4K.VGK(OKW9& L!ME(TFE YA]%Z[# M/.&[CXCKG^O?KE*J9S$)+UST :RPF_=77_<106*AP$]:$]J,.-M'T,1UIA>T MG:.(I%-H;8\@%\D%-!)"R('8DRUXE,2H(J2/I: /34:/[B=I6ITUCLB/P-$) M_.\ 29M:QML;H_5M0;BAMAE$G@5*GSTUP!AY:<42NU]ED8EIM<:0PC M<^)Z^ N:Q8;BZP"<>^Z&UF_#&4C M1=VTRJ\E/)ZF?8PNJPX ^)A_1'TF=A@-R"KUTGD(*1B@\UM0 M!O0E8GOM-ZW3?T%(G<']#K"SXXGF&>\>_\:#OWEE4T[D,GBP+FI06B2(-8!V M ADQ@J)FWB08.(OJ:>WNA97=963; 9!O2\_#]3^6BYO//\W3]4TF?4Z_FVXO M?##?W_?L9OQ5X@8SEPY<'0:EJJ_C$VJPWK'J:7N?F\Q".)OR:3OA7!#0EY7Q MR:#^@LNX&*$9TW:W'P[O]HD-BE[(4%V7F@,&BI<,T5-TYXTJSBHTGAUNK'[R M\M.VVKD '"\FFP[4ZEDVY"%COAU<^A<[&;6ZDJZ@J7+06MO:L*B 1ZU <&X- MAJS]TX$ ';@3 S_\(0\L8?_>(3\KKVTC)27 M=?_]*LWKQ>IFB?>I-"'$5+Q*D'*5)%.D'[.B )PEI5+ J$03+^P%FL;I+OSH MT^^)D]_1W_G7E2='.@1I03H10*%3]:[!0(F.9^849M5$Y[U$U+3706.A8W=3 MX1'$T+T"N?_IKV%9->07/#D#]:BOCJMRCJ3^ KI(U0[ZT44R(S&#\BY B"J" M]CYZS&BR;E+[VT 7D<]*WTL?P_(#+O$ZD,E=+_[Y'^_^8U43?.+UAI7K\%@[T;-P_7U_AA MXS?.UE]K&[GE35K?+,E[/(H' JVI:;K #2I0T5F(JM"A+$:@CAR+T\= N UY MT]ZCM\%Q!X+L#LRT)S+'Q-=%66(B%M!IO@Y_XIQ^J^:MS6J912V_^6]BR"K/ MTNV>F:KC6 *"D)SVK(P$3U$;"8'"(8^6<7FX^_9HY$Q[M7X9L%Y 4-V!,\SQ MNHZT_K(U+C/:;%K M?\0?[L[N;X5^]>[/V:88]H]:3/WIBH6LE!<>,&*D=/6(=V)>10; E@E0L%R4&W4>&=-VH6]JI2XAF.YODK\YCK=W M3X_C\.U-T\9U7-Z$Z^H=)ERNPVS^>3E;++]B6%9/<3L2HA;_TP9O;B.BV?QF M3@'4XL-\]C^;NZOM0J?WON^$[G%OP[N1P 7NVV-A-EBRU$4K!BJ5 K%X!EDQ MC,XSQ5.3S-5+O/W=UAU^V#1.V234*RT$Z2>*DI2H"LIK\E*4 &ELS-P9$47# M::([*.KWQGP(+O:^^ITE@ ZBB_N-O+FAZ'PY6W_=E)D)K7)4Z$%*LRF\ED , M*<"#56-871(W(ZP=!YLMZ'H-,9WR5\[@:%)\$P>P>V& LJDE6-IG@0 MTK."',F!/J8M^@@ ZJ&<N%(DQ4!&W94,WBH' M&HL++EI95).+^2=T3*M;SI#H/FR/1] WTDW@TY6^7=T7U$K9#(YE4D*,6R#/XW84=2Q>4WC4).UV'T'G M:I:GW_V6=>Y8"K$&?Q3I5>_-.@A!,K"$<4R:6RF:-+W<2]&TMF@41#Q5*.-P M_W4HDXWZ'4&;;+_30)WLHK"U/BD&F>6A@&8E40 C#<04 ]FD* E9,:C4I,2F ME3[YUKKGZ0K?A=4L;:KDKF_JJV5E]@.\^\2$] J*K#TZ0YWV)IP"IZPC]D>; MHV_!AQ/I[507#4'3_E[/[237@2M]8)O??7V[^/1I,7]['5:K;YL47B'*8(#' MVC"/X6;P$@-AA,K:6E=$D]>_DZB=]GYQ"G".(+6NH;D]>7NVJ0+%PJ9FMUKB MKK*%3J!ED>"4C-9! "[4P*H :_&*+ M"X=+5/WN!9@S%/AQ$KNW3H)R7D*T9-AX%$%J%;AI,X:B?:SP9KZ>Y:HIB;7O M,-TL-XW5?_BK-MK _".=05*?GV_6VQ3'G8';%>>:HQ,(PM5!)]K42@].?JF* M+"@*PU6;AY5QM]%I9#$$>_NMX\7E/*W1K)L)\]LL#6F*#E8'X+8V<9!>0]3* M09+&ZERGN)K#QO'!!WL9^G)YD2[.YF\7J-B^1 6,R6>AP?N2*48I!IQF'E#J M+"/S5B1[+"ZF?+,[1QS/)'H";Z:6Z7*-7\*V@WEDV8?G%JFIPAD,0)W.HC*SU1PW]X'70ZDW:0':P+MVR8)SE&0 MD(J1G)N@,V_BGXRU@5Y&I4QF<29%1 P\]TWI&TX#C:7_#$23U2NX1<'V;E5$6 MRZ=_]C9^COY1%4EK=?+621U4._[ M%K\NYK6#*,F55OCP4VT\A*OU%?=>\&@+Y$!X5-D*\"*YVK=?28F9]$23BY\V MV^GTAF,(%GQP M+()QUOA81!*I25KCN-OH]#'V'+1/*.=)^][?[?_WNY4W#M;WLR^S3%9R]6:> M-TT?WN3_OEEM^L:LKM!J:[.D<^OK*Q\%N!!TD8!,!!>RQ]@FB>YX$CM]C3T' MGXWD,^T-TZ-#5_98F3=?R(>K1VV]V(8 E:D?%]&OZ-\XR+2]UB;'\>BR[@#KCXS-?A;I^[2=6] MW^,F%9MX2BG6KA7D)O'HZ6?:@DW1%B>\B.%P9]23EY^V]5Q3)[:9%%['>\/! M&_717A:.7JG!&\)INVS]6I"C\5F53.98Y=L6FKXH#DY+Y9E#95R3"\'I7@MH MQ0V[-\M>L62<85&"SBAKZ7*&6+0$+RPO)06M5),\_X%T=GJ_/P0]P^_W3Y=4 M%U>:.WV)(]R-.W?Z\?:C3KX%@XA>PE!:W(P%'+%6DVK'6\7G5[< MGP/CZ:31'&I;()1,7HQ2EL)%:0 1Z^M81#H]D_F;#RGMU.,<@J"3 M/,Z3I=6%.1[!&WG$ .]]Y,('4OV5W:@-&1S4X+631EN>"C8)#T?>1Z=^YSE@ MGE+274#]>'_F_IF7?)A0# ?#"71TFCWMSE@PQ;#BC4I.-LFI'DQII][G.7!M M*ZW7X7_NK$H?S>-\\>L-?,SC=]/:JPS%E:!+!.8*X5(*5U.//)#Z2BIFY?S3 M@:Y]>Y4CE^4889,LB5P73 64XQ%^%]1PST$>XUKN(?( M>>K*SF]%K4%SK'6.$$QE8/(.HC 26' F).NC$\?4=?X]:[@'B71W#?<0_G:! MBFU9K!0F>Y0%HDYU!DS*X)-/8+(5.AO+%:IC<=%1#?<@<>RKX1["FZEE^K!* M67*)$H,$;6N5LA*\%CTCE$"*4ALED1\CT_YJN <)9%\-]Q#N3"C5U7)]]8YX MC#7;^UW">5C.%AMLNV =LX6!#581%QQQP? $@>LL8BS!'=4SFQ9XX&30KYXZ M&'LI^%M54Y^B^\>1S=3@VM+]S_GJ,Z99F>%=AWE6"O>."V"(&121#<'9##8* MTIO94S1ZS.7I<0#;1\4T*F1&.,B^8-&9L>')Y3[.)):C,:V#O)R1VL)$%BAO:("9HP ME;,#%U0$K[/.(0F#;2HB+]I!I-E=80 MU./\6[GM4?';S7JU#O-:2WK[JF]-SCZ&VF0.B<-14B0BC0-)ZH*Y*"UYFBW@ M/HC*OTFWD4% 6EQ*JM-:[.^WC,52,*T7!?]],UM_3<10G*\V'/U\'>8K,D?1 MR9@UUQGSVD:M4^"'KX6.7&S:L&%2N#622+]J\>&;Y\-S="64 MCDIS1?M1"113M#W)/<3:<#];'@QK4H,VD,YIS7W/JG$4R4[<$+P^@RX^;U)1 M-I/;5^OE+-&F5O4/;N:S]0JWO*ZR^>'W=U=8N'9(T5\Q]954BP#!2TD_D\AR MX F+.*@GAZ\[;47YU"JSL9PZT)[/FIUM1X;^#^:KH*4LC--6>.TMDC+QJY3: M08=\]U"*0=Y$4[Y T[0%Y%UHQ;$DUL%(A-5L_N?'6?KXANB#(^1_#:+YS)0OTCW[E_LV/X$T2V1%0D2" ME1)H(4:;(/0H8CQ\1W!XG7,5SL\+"I\WWWZ_#!GO6F9]6VA5$W6O%ZN; MA\,JL[6>28% _R^@N"_@:G91BHIEDT3BK,F]]$G43O8,/S)*GFJ@]J)[;?KI MU(FC![_85$,UF$)Z'/@"D\PDEH!;&4&9@N"#C\#1,2-%3E8<;IG17D4]>,;9 MKK59: -_ OV/LWF8)S+P#SCZ;2!@RU970Q#S0D)I4S%VX,7?;? !!Z^O%W_2_O#'Q?(M$31;UU*#)T/?9%9, M!669 J>PAF"PI'/8LQ614S$U&C9]&[C0/$^UQ>@'AO3:[>G(9R.%/-K6L M+0H^C@,@3Y')3(X<4X845F*2(DMDP+U/H?I;)AYNM=JE:=VD0A154A%*@$F& MP"X+N:U\DS*LC='(@[5-VL6=2&_/)G4(4D8PJ8/%UX$YW80U];YE=MO$>9-9 M:'FM^%.U#ZZD.,9$!(>)E'T(MDAMDI>\!01W$=--64<[%"Q&%DF'L-JF+7I9 MDA$,P6A-M$=A(2A&/V2!:'P6_&G-3QM@39G0.YZ8#^#F!)Y/^P;T(^GLQ9). MTYL/2]SD.V]35$NF.$0+ ]HI.DVN, B.U8=\I9"EDH0X_-:][^M]H> 4H2W& MY6 'ZN.1LB4]N]&WWW3LMU<&PYG#$A/IV9!!H=+@N+8@B\I&L'KM_>+*L(FKB7-HF,#AXG7"B3#K UQY&/=@0XQ2QU!C&2HV@ZN3!X'V$G!37VHDB M0Y/[UH.439Q&>PFDC2N=+MKH/'W0>K@7E1-Q*X-6T8+*)4(PGDZ29S:%6+)2 M3?IJ["=IXNS72T!L)'ETH,IV;T($+IA%!M+4#J?2(7B6+?#H4/"BDO!-TFQ. MQU.[--9+X.E\*70 I8?/ ]\O;N*ZW%P_M_IWFXN.HU>NNJQ,T _)08Q"0"B* M++_,==I.$S=L")43IZQ>Q"]K)K4.(/G]#=8TN#>ES*YG@;A(IE])D;@&6HV" MI&)C'6HC0=3!=\B9=[S)C?TS2B9.6KT$M,[C_K3W6YM4H@=J^=WB.E\YQI0R MR4(2@H-RD4%D5D,T$0/GQI7T!#P[[K9V?7GB/-*68!B#ESUH$EQB6GR8UU3] M-ZL5KE=W&;?T&[\M-[\50_H7?KNI>;-[;\@UKZ9?]WXCMN_%*YO M_^27, \?,+]??,#ZI[\O9_2'G^E/-\7_#^NDG#4, ^E>)WT 10XE>%[(1=#& M4R"3G7>JB?[J8__3SA>ZC-;L@].#D-;! ?U'F,UK.LIO\W?AX2WJ-_%<*2%2 M8!R!;U)33)W\Q4P"G5!%I:/TJDEKV<.D'05K_ZIA/;)\7EOJT+V;_ES#$Y;IFF*T='[&ZG/[ -WXCZ%1)? DZM%PUZ&BA\#3FUJB'G*2BM5 M0NM;B[$2DH9%9 MV#Q$0"=KML^XG"WRNW58KD>QJ+\O%U]F*Y+/CBU>.:>0!T6A6TRDJ[.@'9%3 M (64=-0A6VN;O**]1-2T;QMC(VPT]G?@G!UW6OZ+G%SR#,KJ"K7)6FN*"T5] MH#%%UT)\#YD5Y"G1^<$FCQH#Z9SVI6,:E7::D#K X(X,BMT)[1NW9O$%EU^O MB&.)G$X#UM36?=)9B,I+VB*SB,KY9)I<4I] Z[2O)&-CL;6P.L#C<EAA6^#W>_O?*NF2+]0Q4B?2#U09B$<3@F%V67CIAFEQCGT/TM(\ITVC+ M$<3W:J!ZY^RFE%32=1)A*0HH;M^$\0A6:TDQK,7B)S3>0Z*19L\OTT8C0P1T M9C3RPSRWNFOY:?Z%/K)8SDZI='[XCT>X%]E+RTBW'7??__JMDOT>-\:I[',1 M@)H1;JS3-0V]@ O9<)$S+[))6NT+-)T_L?'9IQ\4&"I/YISH<=*&^G#$(3"T MP#)BEM*7%)N8OI>(FO9N8RQT/!_%.)(8^KRL?7!H3VV8\/P3XRJ3!BT1C@$- M2F:$C0C%^0C*UV[U21-HG"J,%1VE:#*,JJ%*^99>?[_(UAP^J5]FJ93@"<@V M\]J&K4811I/<75$18PS2-Q[$]3*!_:J:(:C97\$YHGBZ5SMWNUY\V_7);T+' M?79<]70L_1=065:13^M23;MU];4Z20A>26#,Q\@X5THVN8^^A!?T\"1<>>.C M"=X#BW&3@2? ^1*!"\DM,AED::N;'U+3KS(:@H>]?L_)C.\@9O_N9C6;XVKU M)OW[9K;:-(.\K5IEC(5$&E-G4M!*._+@$!$,1L7(H8O)-$F"V$-/)P@Z7=*+ M\=G>*7KJ3Y>(VZI7S40QP1!79.V0K#*",TF##)@R!1:J42OV@Y1-BZA1Y'\$ MIDX7QK1YM;_@\@,N_YRM/WZ_^'-;\!S1F* PUV;OG'A#T:JO+J1/R$6X;PJ91^1TXLF<*.1]F#F=XSWAYK\6RW_]-/]]N4BDD*^,#"6D M8J$D4UN_ZJHG:3^9C+1R7C#=^ ;Y$3F=J)N1<7,ZQWO"S1_ASU\"?7<6KFMB M]+N;SY^O9[BZPNBT4S:!E;5YL.<- MBNYBA;>+3W$VW[#_QS!;_F>XOL%W:_S\S\^U8&(3/.3[35X5ZS)#)6NOE#J+ MG Y!5&220Y09,U,^JL/--4]:>MI4GI%01Z$S1 M7'H(JI9?)XKI/*DST-ZIF"/S23=Y1CI(V0A5*[L7V)7$$E"Q$%QE@*Q3)R/% MLXDY$$YP7DJ.*C?QP880.>V]PKA(VE'CTD98KTQWG9I_=.B#+;57P]RDPZ K MQK!D(ATL\KEJ);(CUSX*X 9-]DK%E)N\/DVGOKZ= ^^TYMXA.!5TO8234 65F\5M^V0O\ M.3%?;HQ%6YK74_=^,1,LG&,Q"/*_C*/ -B+I/<8R\,B%HJ#6>]LDD:BY"?Z6 MB[I?YV\>9;/1R)) \GPE!=,V!7!<:!#U&8PE="[Z%APXEL#>S?$0!.U/&!Y1 M2!T\$NS=S7=?W],G-KE$6065;7!D7E*=X%RG:\7:B5%+SZ)E7+7I?0^U/E^M_?OKT>;GXLFE=M]KFLDE)7#+> Q=Q4PCK M(#!F &+5'6*L5,Q\'2$\F@"Z0!=W]T0+V?S#UOJO2!W@I8A MP@.G'XA#+GL-R)U+GF5DI4FVSV,R.HU;1\+/&2SO #"_!&+?')=?'W)FNQ61 M:MZV*]4S=?7YKA;D!PG),4,[*5[E)N\D+] T;9)/:RB-)8P.RPU<8"9H@I$P6J5B9;@DB!+G;(H2EJ=VG2X/<-G:I8E= F?Z4P1= "D MMXM/GV_H<^\69?TG\?6G>L7X85;[;=5^T=M-J51L--E!MMY0_$(ZU[&000KI MO; NYV]SQ,=55D=0-VW*3WNM-;: )D3=:KF^^J.V*M]$Q3SY6&2,$*.J+402 M!R^4AJ2,,4$8R9X^)>U$%7WT :+H5T_1]&C57J8\-KBA.IV[/4!BBV0MO8P^ M!\"0:Q<_2898$=G<26]TM#[C,9?JQX-BROC^#(D]E?D)[)M8ZK_,YK-/-Y^V MA+O 60[, XKZ<,IT N^+!U/0![*9F1\UF.6+)GR*WQ1A,G%KZX:\' MA$?)K.(5ZU@8*"P!HB0C9GDV*=?*,G5,F'V<]!^N/(TY&$WZ)S.Q ]=SKP7\ M^3YYNOB2"C(#S"8!*I,S'9% S8QCGBGCR*&^Z*/#SX.*A)M=PDS[T'6:?'I& MW&V]$$O<)N=3'6E'Y\CFY_B^XY?JB4OF^O1'_%]97+DL=< M)!AO/:AHKYA'9<\4*""MK(J@K0-$PQ<"NN&"<+!0$O\I4XHB48!>5@TF#@)"<\'IY[([#ZUT&9ZZY/7 MGA/4S>[/C*!7CJ!O) 52R]?_G%U?$V*>KK>C\ZN0A9 B- 1).%*:[ _]FCR? MHHH)BFD=FG0%&T3EV=-NCUGL6XT0[9PSEQ!"$)F.%?/@Z2 )B=$$D)&UZ1< MD2H[M>;YI8^U4FL-:YV'P2[F5)PV!70@OUU% F"4 M-H.+T;LB;2IMNNY>1+GE?/6MZJTV'EQCS;$A)I?-+WZ>?<%GRS^IALQ68Q3% M0]"YAKPEUP8GH5;C=GW[< M>]R^^_I+^._%\NUU6-V>O"L;E3"U0HX;4,IS<#DZ4+EX MCBCJ6-<+HW07G=,BM1E>CL?EV<*;MFW//W!)/F-8W25\,8ZL^%I'G&K"5Y$* M8MC,/+*:<3K82:>#PE4*,(J-0E0^1C RV2!A2!X0FF)14V*-HZA;MH,D4O K)VP.D#@]_@%KQ>? M:UY)^CA?7"\^?/UC]N'C_79T2+7,!8'KRB8;./A(>S*:IYK19:)OTBWB %W3 MIH)<$G5C"J@#O+U?AHR?PO)?=0# YA>53W>;\9(4-/<:"E.DOB4Y"E$[TN98 M=$G$*Z6;W(J^2-6TB2"7Q-IXPIG6O?HQ?%DL:UBTF3#Q]>UBO@GLM_L(PA6T MM>%[G=NFZDQM9\DY91KKO"T6=3$'G:T7EYBV7O9"KM=X3.Y +>V\%;VKQ5'* M6@IC:LH!\4?+!#$G \X(QXOF-LPE5=)8@ND 8P>>59Z%SK6B M&$5-(RXB$K.4!A!1U4\^@O"S@QA=87\\" M/**G0T/^B'.50;;.)\/*)12I<"^5>])"8Z1G@8:3)2^#D#.9V8$R>ODNAFN= M6:301VR\5QLDP;DFL1*/3) 4>9LF2JCCB[))K-TH NH ;2^%V2GXX%TBLUTS MEI5$TI]"2=H48\GXY% WP=JY]Q\-QU9>%FEC":<#G!T.TE<_WQ(>-*EX MV(SB"CEY%MPCE% 9&+ 0 S'5NW#)K-5%MQD>-YS4:6/2'E YA@S[UHNU285B M*2EF% BCJI^3R!5A7(+U1L10C!%MZC5?)FM: ]T#^H;*I@N->,#'_N&O='U3 M!Q7<9?9?&9F0.:8@Z^IE:U2T0^] H^9:*9ND:3)+:2BATP;)%\-C4_EUH MW M.A[/=V5%E$YI!\742RL,]AKQIP^@+8G%T676(0%+S MS_<4-0:;.",GF"=0R1OP+F?@Y X7G8P3R5P"?[N(FS:)93+TG2VG/NSSI\]A MMJRO++^5ISO\IONO*UN?[S8GZ4.T"-9H07ZO0/#9)C"FE)Q"DAF;Q,_G$'T4 M6NWK1^NEY#KM2]MQV_QYYS;?%"+A??CKB@L>G(@)2FW-IP1+$%7AQ'9O0S91 M%/4DX-GQ/#<&)4=AT[U:;$XAKPX,_'Y^/FC2YZOAP))!8KW_CZQV7U .LLDL M1.3TBKID_'BSKI7S#RZUMK/MQ^V4<7"95MTRANUO MDHX9%!\[)TT"IHH%58R&H#5"LLB]P)AB#"TTP$0=,UXXSK>O6J[V)K7D?^A" MYTO%VLN+%P-!)?4R^,(>C:WPMC5*%U8)K?D;@VP^)^^XQ+ MDMS\PYNTGGV9K6>X>HFEX,2X\GJ*P@:QZ@. MZ3LVM<5.'+P0/)AH;?60J MM1D]<(BPB4'7 @U/$3>F:/J!6JWPF\UO:$/;G2WF]UE(6N7LA(6$M;,E)RL1 M41M(1IM4,F?D/S?$VG[*)@;;J$#8C;*1I-(!S(X*U(00#.G\04A!J %='IKG4Q-L=+1?L I5P3ZGMMO>15/@]10)ODZ8$N[PRCM?6!8*N,UE&_[%*( %5Z+@T:;<)/?G1'J[ M;9HT&50'2_%5@O7'QF@NI@&;Y.I-+?O3+,D6O5I$7A:>1.F[76 M(U*'RK#/9(QW'VEW[W'YZ;O%)$Y_D)1PV3:Y M"]U#S[27H",@X7F[W_/Y_K=36?7/3YTR-\ZRTZJQ??MOK-""3T5I"<+;3/X< M1$Y8]EZ7PHSPKTRA_32G;]W45]/;=S#),C,L6RC!LSI;UD*(+H(.RC&1 M5 JET2#?9[3TJ<@&(&"7(CN'WQU$"/5XKK?'\SW]F]O$$-2B6"4A\LV0NRS M^UBGHA=DD0*@K)K4F>XB9GK0G"7AQ-X!=!FS!43HPH<1)8U+2+2/@+SP'T2.8N@ M=6@R/G,?03U9J.&"?A$W)W*] _3\9UC.ZB'Z(ZQOM2\FD1BKLX)1N'J82%5F MYB!Z$476(F)NTK?[*2'3OJZ/K6;.8G-G,-D"W2N!G!L'B)QVH V9:60&LN?* MQJ0Y*TTNOY^3,JUB.4^T+^#D!#YW@)3')^?_9^];N]S(=6M_$1*^'Q\]]LS) M9'G&OO:<9-U/O?@ ;27MEJ^D]AF?7W]!M=0OJUM5I2H5>Y* M%(EI?9N35=$\N'8;AB,M2: %@4Q2_%"Y6WQD8)TJ3#+GE)F$*K3+Y%KR@4X' M1"^\#=#.C(A;KS87'\+5IQN3GECQ1BB$[)*L%*D%?""3')D,(@57N.P"*?KH M/3C1?SV&TH-1YTV"&A(6B_* MTZRE#),$3L>GUI)W,A !3](.C**.I@!V^XB\O>R^70^%FB5*Q\&7NAZOD7ZG M-20OI2X88S23O"\(EA MCQ",!$5 MF^0]?)HLD:?V]];583(ZBXX<',ZQ]EI)M&C%P6IN$]D4%^4DCRO/36K^X_M$ M3'2UL+TU,',H>4LT\C'A55@MEMO(2LND%-<>G/,4%=E84P-K$S):AA!]8E Z ;7)Z:Q7PW$B-H=CFVF!O!RB_+%::PWO>X)+>5*4=^ MII,ND-MI&42)&4Q0!GE@'&.76K]>0'DXA1E1,HY>#R#E!"$W$#7^%"ZKC_CQ M,^+F;?W;51?;#22BMMQK8"S40BU1( AOH B;Z=AVF,LDCR5/3:@5WIR1SJ11 MY=\HCO;OU!)]D"6#K6Q"RJ.%6+2BR)H%8QQ3^+A![71(:N&Q;1R5=\#1 /G/ M2[C^*J7E]=6FQJZ_+S>X_H )%]_J'ML95X/6H1$<6%!D7*5GX%3FP',QR15E MU>-J@P-DZL=&:0\=0Q2YG$:J#9B:!Y48"<>8VNNT,!0^ MD<\V"5'@H!D@[7D/H@_X;7GY;7'UZ?%%:[Y&4JG:^_JJ$G-& M#\71,:V2I2#3T-*"];(HGJQ$=O0XZC962^@8HL[EE+)M&BQBMR!I#&IG$B1? M\YM<(?,K(Y)U4#E;SWV2_%2PB!Y@F2Q6.B-8ALBV@;/H WZ]7J7/88VO/JUP M>WFUI^-EUCKNN #O3*08H.8(%[+!1G-*]',QJ81I9] RAZ MZ.+MB^2T-CE91MB7RI*7)SU$IPJ@C4X:SY&':1C=#\UFWK3IR;SATR7?(GSV M=4I9)L$* ^-%;4(4 GE\$B&9D 2Y?E9A/ N 6G"+1]#T,>P,$'L#Z'F]_/(% M5VD1+M^'K[C:WR3D[ I+!HHG?TTYA1 P6]*V42P*XXR8I(#CX&P:0\X0/3^. MJDX6>@/(^8CI>G63M;*\S'^O#,=W)_$?R[OS>;<\;J/ Z!UD69*3J5 MLPXDN2!EFJAM1*]YSOP^,0':IE34O!';MHO;Y3)F660 T45*I=,@:?S8(1,*6-D7!Q)0.LRS,R7A2-B9G2AOHB07M5 PTL) M1F:2E(X:HA46LF,B%R@3B;>!@^R4L5O\1+J_QI^^W MO_VW!:YH4I^_O\5O>+EK&I53*+R 0<,KN0 YCSI*\)85*:/QJE/)4._SK-OT MYJTMFRQBFT W+2'N-PPUMW)[,O^XOMUFU<)SD9,#9H( )3@')[0&P1TOD8L@ M39D4>%UF.7/#F@E@\A021]=92X#\]>KK]6:]E=C>FB-M4R9I 2QJ$IHGS] 5 M+:%PEH5 )XR9AKW[Z3DU K;QD? 4YDY42P,(>W NO+TM!=,L9BNS.8BR_JH[06($-C-4[?7 MN;93L-DDQEV>AGKOP%P:NK4:J.*G4#-0W@U YGX9UNMM5+NYP$0[Q9&UE-*3 M2) B%*_K0U3.12A?A!23I(X3< F5]N:N_>UMJ[MXL0M\^7 M^[7$@,Y$)T$K7Q/NF*,S-QE2>50R.X<!601'[J%0/&6?)ZNE[(.5\UQ&C8.5H?)M !H/I/&?N/CT M>8/YU3<*'CZ1NT_CX'I32>,NBG1>%C [A/S#Q'M?^A\>\\'1VX*>1#2@&RR,IB% M@H'/-SU4TA+0.ET HRT)*\M>T)64G%Q1\)4U3S*5$C*M"ILF:/SK/=_T@;7DCH\7S3 M1RT-(.Q F1DS,F6KTTV?!24I\/$Y![!%29O1*S=-Q+*-GLI> N)9M]I#UORMZV MM/VWL+E>4:Q-.M3[6J%DO9,F@$G52DJ7(/IZ?R!KCR?MA0F/2&\.Y.@]\?&6 M]#]$84_B7;T\H+O/JO](P+3Y=W=SBI^]O:R+RSD=*,5CIR*K+HL@T1BW!RUA .TO_SSLO M'V<>'8# T]]OL$!R( I&DF$#KL/!_H'12>^8\>!$Y8MV.@ 9L!K\D422MDR[ M2:J3!G?E/&L7JU-\S9/%W2!D]GEWR@6>& -G) /%K 4G"X(.T2 S]:YTDG3M M%].5LY>:NW7E["/S>4^=CWBU6*ZVI^>;;>V"WL?E3")/4@&=(K2$4"CR9UH# M:I^-ML$PI8^>.4]]O2T4#%':/F-W+;K+_4]^,;WOEE$5D+$FIG+ M@ZR<2[Z"OFCP,3CZ"?."3W+)?W V\_HH$Z#F=)FW==I(MB^]I<#-H,DV(#U.-"T."$&SDD80M;S4O, M,0@#@KQW0=8OHI\DOVM@(_"S-LL\);8Y4=3-@>5>2^H0>"2C)R!E0:#7R0$! MGX+ZJ*.U0C$>S]!OM>%&X+T4W;41>!^I-X">']H8<\VTM_5IH90,JCXW1"T2 ML*PTRERLG<;0#&H$?M8VF*>8F9/$W!A,=D"/5FJ,V4!1IH"*+(.GHQ1LRLFZ MB JGB7^:;P3>2[7'&X'WD7,#2.G0;)B[Y+,OY-.5H$A ->V:[#"PF%R4VI%? MWJ6ER8D'T^!&X&?MK3F>;W.R*IH'USX91XGBN"%!Q503[H6F-9'(8I$FHNOT:P1N6S=&PP79@O9W]PT@C< MM6X?QA1Z ]@Y5-RNZ%A+M>Z/9$$>O)!TIKJ@:U)O%%XD9M)DF0E#R 3.WNJ[ MEXX[L GT$7ACF+G-!K^0%/,QFTD*I3I*M5@K&%I.3EXYR3RY8I.E)OPPFY:2 MI\?'S3"A-X"AH WOUWN^>*W[7A@BE"!061#I26B0++7 !UEE9* MC3E.TJ^@X_Q:>LL:SZR-K9@&\/905*_#:O5]\3M>EO/\F"/ <- MQK 9SDN4,8)4IZ72T!3-!I25KE-Z4"HBH3]:R#*KE!QB[-29?9#9&9]*HQJ) M=^5AO<%-5*\E^>=!%N1&:PUWDYRG_[DC.8/8D]$PP^']BBR MG_F^=.O2UJ-AWSI]>WV8L]0IH@"11*KI$!DBX_5**!H93)*RDP/8K2O]H1G, MG$T]CF:78XIY;ISLYOWWJ_573(NRP/W3$(\4 ?&L )VH3T,Q@2?'!)R*% O% M6&3I8FBZ8>6I6C\K1CD.6:N.4=.$[Z MC4(PGXH5AH]G5 Y.84:4C*/7 T@Y0<@-1(B'.JO?-#KFSH9 2S#6&%#!&PBI MTO$5E(RY+%RDKS>C;CJ+P#C@;(?]XZCEU>+9., M*B2K"QB-JK(%*7!,!F"HC4Q8>-+'ZSF.C=(>.H8HSLMA99W*R8MX"<4:S M>()HDX/J&-I<$X6GN9%Z0VFZ8W/?/F)O 3T].W]Z4;(*P@'F;6\&$R#D M$$%X2;95Z"SC)-R 4[1H/7M#X%[8.+%%:Q]%O8P.G-)R3") X96?W9(88^(% M=')%L1B<#OZHHS1B!\ZS-_@=@IYIQ-N W3KD$&QMNC0IJUA2[9O&ZJMF!L^B M VVBYM[E$N(TS7J>F-#,)=63^$VC"+]1$+VMCX2KW993M@CO"X)3O/9;+Q:" M*F13HY/"Z>% E2(IS M X.<6; \B,CT)+=& XW29 DITQBE$P7>'&1VL&?,Z2*"@Y(3P3Z[#$$Z!GU!)ZAJA[.8GLFXZ]U&Y!6BO)A?.@':L\%DQ!C().]XC, M95F8P./,RMW&:I!H=PA*II%MTV#91Y*<>9^9%U#S$>J;CP:7G 61-$IKT=L. M+QHC!NKGY>.=!BQ#9-O ^730J;]+0+8,,6DZ1;:=.;/2$"I/CI6*!R<3DVD2 M?_C96'V8&AK U*$FTT(KM,5+*$:KVA%A2^FG:Z56D J%MWZ2RI+F MFGJ/J.D.O;W[B'W>H^NNN&I9EM>;=4TVIR6$;<'".FZ7A/EZ0P+[)^:P3LO+ MRT CA\N+5 R7'B5@H7-*I4CG?WGVX,"84*[4 G1(')80%ERE"X$4[+9ACXG&5 MT@%0/3M$>^_U)^-F/)$V<(R]O\3\"?--Z_)%N+RKIEK_OMQ\1)(S+?/R.X69 M9'AI>I4&^2[/9??/7ZU?WVT.)'-,AM<"B[4ED$$!WN0(W 8>E6%HTB3)C>,O MI;U'DW$.T9F5W@#L#\GVM_#GXLOUG6/Q.GREGVR^7] *-+FU#G)-.%:ROB<$ MGK9UA<;(DGV9ABNCQR3;NTH?!ZJ3*:H!$#ZBJR&G]H(ERY-2&61&I&U$!T?P MY-D:\FR+\"R5QL#))?\MC$YN7/&XZ2(VJD 8 M=E]2%UA4-"$P0%Y/8EY6L?,<;KT$W1A(]E+Y M@/7NF4[D'X]F*:),J5#T2+^AB#FXVNT@0HD^EB2\E>5LEZQ/3[,3T/S+!MK( MRIKW>N-V[C5@J1PS%ZIHSR/3@,+5-AV51 8-!W(!T=CDE.;'[\E^^&RWZU3V M(;WF.SRB:@EK75CL)*!$EQ@2\4*XCZ)%8TLW*: M)+I>L^R&LQ=X;S^=KAH XOO5,B'F]2\DT%_7Z^M:9O:NW">5N8A92*TM&5)7 M\YJ#EA DIQ@C1T$+P/DO]/]*_^^X(5I4)R M#C#% DHC@A>$HER,SS%A$--8KG[3G#EG=#*4_9",/)WR7JS1V^8]36/Z=I\^ MCP$\M(Y9S"#3GH!(3E M6#IL[)=DWOJ@YWX;UNF5\F(MW-^NPRI01(Z_A]4JU%!\,!_L2:.=QPYV7.TL MIC'0Z2G1,)#6>U F5GXS3:XWXKORJTJWL7+Q:>MLF\V MX 6%XC:'4*^DE2%H37.V6%DFLRKD;"2$Y)'9['D*C_F!#Z5:__CA M>9 PHJ:6HXEM7J7O>C*]7ZZJ\/?,(SS0<8^T=+UMT,0K"Y/1X)VPW+$D4CFN M]4-?GDWM)RMI.9[$&K@]/V0 ?_K^>]C4$[/N!>5-2C)'V@$8*;0@$[AMM.0* M[07-K;9NDG9$QR8V,P_01"?()&II%&8WJ]EMP>"4P\QI 5+1>CBMQQFO(2,7 MNC!1LCP;S.Y/;%Y'95P8=,#88)W,>W;]0G[] MV\1)<#$P\,PR$;VQVA^OY7GJZ^UA8[CZEN/*_Y-A6XSJF91H^]M[=O[LY;@\@<4+"10:F,X,EE@$*N@@[, M.QXG>>9[=E;SUB;.X5<-4TBCZ-J5 ?W\Y]?MI1<)BQN%EH-C0H**F(%BG0)> M(F,BH+/>G MCC^;6WO$Y$ D=,':*6AI VI[3_:[<\7?<7$2KF=)E2Z5D*YV* M@IBR I8LLUY9'RQ.@:V#LVGOO!P'3:>+_L4^P;W^C%^6UZOAC1@'C'&>Y[9G M5W;B(UN]X_KEW:O=IV]?/80O.5)$"%A[+2B6% 2'$H2Q00AIO>;':<(.?/CT M!L6''ILO*("E.):V?_),D($LH3[24+!1BLD\>\UPHJ;JAZ8SWVWEB9K\L>OP MR=*>,[3#Q<5;_!0N?Z85[&DF XN^GJ3>N,JZ)9&D(<@P%N\"Q2*YF ,8R- \/.S"0T@A:7XXAT9C3.$WYU/M<)4LQY#/S(JMY"K?PF[>*)Q!KC0H M7CWG4JM2T#.(44E13/(:PW&]WO_D/''":&H=+)UYM?KF^CV=5YEBE_NHY*;$ MY 6"$"Z!\M63D81/*Y5PFO[G'W=\/*#=@Y^>YQ9K+"V?+JV9V\&^KB$KKDA: MF^^_AR^[CDY,2::)TB"PN! ,7*P71B#.C6#/32!F=GZQO/9 M1I'PS @YP-#]>$F[/922%D%S"4E7#F9)$HK1%1"%.8NI&)<.>'7#8--Y5O.U M%3Y=\2B0P93 Y[AA/IZTFWL M([P6'0PT&'*.'&*JR5B.7"7/212Z\H#7!61[O'QDN(,Q^F%R%@R<+LH&7BR> M['KL#2.O.">(/BM0V7"*DZTB4QF=*CS5XWB*B\63NHQ/5Q0^GETZ(X$ITP'Q!&Z/G(4]"__7B6HSW4GF?%N/=Y=]XB_'H?1(R M)& QUM1C*4A"B5%D%[GPT21G.J0:O=P6XST4V:/%>!^I-F!JWFT^X^K5>HVW M78H4]S)&'H'S*AA$.G=IS]2E6)9$J='_%!;FAYG,&S2/#)UQY#V[15E=8R;H M;U>QJT&X][:\6Y'TB:R$K =WI"-<9@>.60-&"&>XR[4E;1?#TF6P>7V82>S+ MZ#)NQZ/;]XJH^9*L5P@65ZM+46G(0F$)$F61BE?_"11=MPG_A4W]UF_7EYO%F\5ZLUHD,M6;78[G_F4N*JY- MI1 0&$!900$O*[RRL002$SJ6^5%?J^MH+0'H!,TNIQ5S,\AYLZ(?D[3^L_:$ M>95NLL'WQ2S>TY82P$K!FK)3P-=T7JMD0"&5+V'_[.,%!0X^@=F2@04*3:,J"6RPL>1H0^1= MHKAN@'EJ%O.]D8ZDW>78HI[Y1%JN-[^]>?L1-YO+K72J!7U/7UY>U59G_W6] M^O[Z,BR^K'J,CIF WU%YZBEM8Z%8]?'_4<=$;,C*/AY5G$ MW4+,=>N:U=UVO=YN+Z0%6$_NF=-%DWLF/82<''".1OM$B\(#F?AC=#/Y<3(S M-^J:('X_5>(-HF:_Q82F;20"8"T@5[6#K"_HP-""M/(>(Y/GP$T3\?G):CZ" MFP$RG_?@VE>$Y[)<45@8+O>WHYDG*TV"PK>IM4J#\YY#XBB]="AH84NI;@EKA"RT8O"^"J.2;$=.86.B/^-,.TRV M"Q5F)Q_WQ^%G[MDW;C1THG2;PL8?]"_VVT5I;4L@%RJ&2L,N(T13(O#"L\V& M&=03(>1N$O,YM*VI,_3P>J5\:!Y]'S M'*0Q_/BQ]5C0\5"W+4V4T=QE!(".XA;=3GJ<2/7A1&36D(O-74H"@7+!9 M"R>Q2R_%;F4"^U%G[L$Y[D$P3)8M &!/4(8E^Q@1I*^I.\77%&6CH92$%*\' MK]"."H&Y;;3)N"D0J*3%I)3D!S(!"A1 \(_/@-;>9_H\.B5E3(*9YDD\.50C,4CR[ M]79)Z2Y1\&Q)'EED%='D#G[>D"?Y$<#\]I8ZRNJ@*J-B[29%FYN.= B,&P*O MR5D)6F29A&/KZ2G-W?7W#+E1P\0_;XSS:+^]77Q9;#!__!PJE>NRO%]N2+B+ MN;((C(Q[XP2P:CC_L*)DVBL%'0^^ W020,AR?W6 MVF\6E<_Z*N]*TS!?9,9\J>UDF&2T&"%)AK[60]+VLM*S*!^?K^,XYC5IOUYE_'*U*(M=0>VV7NV7Y>J>GW#[5S#_=&>UHPB:.8S ',E- M!5]O@%T (XS5S.2([#CEQ=#1&\L4/-F(G44+C0"-!KU;59/T;(.';RS)9SRH3:J'!D[*>QD.MPERK[[4DNY7_PBD MMOS'_(2Z+;W4W/J]6J/M=LVP[BZLN%]U@HCG$@8O"T49BO M_"@"R$\HGNGZ+M&!K/;)[W?"AG\AV!A/DO/"X?]0_+L]M3]^)5B_NLH_KTFJ M_]@QF52!K1;QNBKI#U+Y^O/R,E\8ZY2JHM(ZD[RLJCPZPH*4R@E7@F7N^)W8 M@(%;N^$_&4%3"W]N2[.]+J%EW3"W?=RLPO>]R_A]MW/>XRI5+7Y"\B=KKL\% MLYEK'RLWK7.UC0#MG<@12LK22!N1VP[$B(/&[@:P%W31?P85S'R]NKW N]DV M;_#K.13J+C03M=522T^'\..WBT)7ICQ_NAHZ7= U_ MHO":4_T'K,_XI(=W9?=2I30*(TB_4LG:,3L7PC293)E48,I:5;JP#748J1LX M7M(E^=CBG1!!^-E%&"296K7DI-T6&I3?PL]YF7(,UQ:_'4 MU[NAXJ5<9(\EQGF1\,#'VG$H7<2,.EJEP*,B(#,*X@)7'(+4*9HLG$W'"7D/ M?;D; E[0O?/)XFM(^SL(WSE %Z:P5#C/8(V,H+2MGH_*8+2P.7N-^G$O@&,X M^&&,;HAX0=?#(XITYE2E\(_U]6*S#I>7^(GD\W57%[W8UD67Q27F"\V5#$)S MB*HV.%3" )D^!.LI^$HR.BN.'Q<=!NJ&DI=R<3N!<%N.;6^C]7U 17%Y9A$# MD(TLM# *J#Q& 2EC1,=DUKISNZ".8W8#T$NYBIU6Y#,',EL/*M&8-0MOL\20 M/J?EEZ_AZOMZ2I\/CI$R=ANJ&G!=T M43N^@&QKOX7AO$J_N3:(" M\\UBG2ZWS=5O&^6J8AD=3@Q0EFV3=4(1%@[8NIN9,"?-$*L@V.8RS>V/,4/M*I+%P!_G1==9_B7;*_?2XC/ME?N(M*7VREX7IDQDD -Z4.@K MQ4!]$:43NZ;-:I+!"%"X/V8[[95[*>VI]LI])-A$W+UO Y>T#3X52*4VFV7* M@=<"@3ORUV\J0=Q11[=_%][IFROW4LA377C[2*?%)GDBRT1G6ZR&K#;Y(Y!' M9S@@RAQE$LQY%'S7MI[]@YU$>437'T;;=*1BW(X@I(9&%)%$[0[)D *;QBT7%7](&P\JS\C>?N MN3KT##I1NDUAXQZ-'2M&&TV;A?'*?5!OE@,0E)K7"XGB7'E%_'?[&7DKM MPM_81\+-\#>N\W;T(-@F"Q; M , .MSX5XX6/$'1-)7"<%IX0@;P<88*.WH_G%#3&W]A+8T_P-_81W]S\C8NK M^]2#W@FM.=GI8&LN?.T!I9U,ED$$]3C7ZP3^QOLCM\'?V$MORS&$.+?V M'Q!/>BF$- +!,8RUSV#E&!)D^+CWP1:#_G&5VSG9.T>_B1I-^X.%.'?CJGU_ MIH\)K\)JL;RY.TD1F3(%K&5(8L@%R.19*"%*G9RE&'DT[MZ#,VB,M^0T5^!T M&<\-DMV\_WZU_HII6[NY#3,9L4-N<"@CM':U$ M>W#.>. 60X[%)11=XHYS<^R>NWW9D,-H9.FWE ]\E]$L(PJ?C 461;VQB0J" MK0EDPB#W5AFICS^@/_'QQC*A!JKMJ?3?83)\"64$2HDL731 6P8K[;HF"TP. M?E!<9>:E5KP#G^AH901S5,L/1,CX\FW):OR8\$[8QLK17RMZ:U?SVJ^'D=1J M]VLI8@X:CY?$CE%%,$?1_"A6Y#29SOQ.CE_J-<[B?H%,U+DDKR&P"NU4H,51Q-R]LQ17S\0/F?00,L0^Z&.,T3-B],(1LK*150X.6!:@' Q*JLM M'N&$2G+'M[9KCSU,!U7>\L!7'9 M)D580\A.$>)0.Z!/,E"9;%H6F6O^*%#]ZQ3$R<)]"E*#SI%=-M*T M2?3GKH_KI=1C2?1])#QW"DOG!&!I"[,N%BB&Q*1XH/A$2 O,LF1+*73\CP:; MEYI$WTOQ@Y+H^VAA9A?^\\.4;Q\JR;4$EL@:JX(27%8U7X"V5XDR%RV.N^B? M7UK:?"]]+<<07HO/54_W-V5),\]M :\TR0<30J E 5,\&HTII'"&#I_=^YO. M?D4]_+B:6#O-X>YA*]F8K1?*13"5'D$IGB'*I,":Q!SWAL=.J1?3M9*=W1$: M"0;/]T48K).YD_COFNGNDM9\,LI[!2@SF619"H3:OX9I*P/+4,TM^LZ,L$BV.!(5L)C-9T%D#D?M;/>^ [N;;]!9\3,.!I> MGD7<316];S<6G:RX X!,X9&"D,.N,RF>.Q+,Y 0H1SU\$./9M. ME&Y3V+A?%VXE@=IIB+Q4TYL3!(.10!YRH!^6Z$9S8EX$(4(OI78B1.@AX;ES M>[Y\Q:MU_0O?<_@2/N$^TD,CB]?) 282A2+;"M[3 6UEX%(R1"4ZO!$\]?E6 M]#]4:T'4*M9\JM3;>@Q]T+%T>6A/61F!9>N Q*,*Q1(C>%1!DP*(TQH7' M+(_//!4?'6X>]W&28V$2";= Q?=FSQ^WS?C:)JH>7R2+Z%74DE85R!QF+BAJ M(U$*YRFH$CQF<[QP=OCX\^2<3X&K,^F@A0?D6\G56Z3K]0V]C8Z6$$$V-0E: M0W06G*+(SK+B?!8V6S?-R_&!R316R#!",L*I$F\0-?O4'XU)BU3(M-;=5L@- M=]FXVA%&>#*TLN1).G@3^6YKA;S7=FF;.US<-8?,.'BVSZ3ZX\5AFVMUD4NGOE"$BR6 M[+1*,I&SIS4(HV-@.7OR^CI=[ Z=04O9;6@;]2R]U5]Q/]R6[%\8;3V KD#3X7"VI!'@BR M?1E#AC.?9^$?Z^O%9ATN+_'3#?G8-C%QL4U,+(M+I-,YE(2B1!#;C,0M/;=1 M"GA2#KFR*I7CC[ =!NJ$#OMRT#&V;!LX5 X=J#=$AZ_^$4A!^8_EN\UG7+VO MM<\7)M&?D \'W!A&H85G$ HM$V..TG KV30\+;UFV0EU[H6@;GH]M0#"A^'N M>]S>K-PD4=_$OA>.?#3C@X*DM*_O206\M ZX3,(C8U$=:O<]>HGO@:EU@IM_ M:7 ;5R/S'HF_7F7\XV9-8>P]=JS;OX+YI^_[7)L+;8L3*#,$ M:3F=^K4O8BD".*=U>\U$8L<3%H>.WNV^E+T08)U+#8T@K;X^W:ZJTQJ3*S94 MCU)Z67>3 R=H-XF S@FRVBK+[E#K.WPWK+V@R_GS***I*_MZ^49ARQ7F!V:: M*V5MY *DUX8$R#)$7DG,F!>Y-.)XIUVFH;B!ZN;?P(PBX/5_K9BF[%_/] MR4X13''2@$C%U7T@P+'MVSMR6;ASEIV#3N7 U+I![*7!,1WA!*_A.\D ORVN+S$*;E^NXQ['M+?WA*8A?TWJ5*\K/Y]"+XV M%@[@?"A@G#=SM:%2"'8),6)9!@SI+) M]>+8?_N@IB/[;Q]EM'#*7L?+1?K[9OLLO\VZ5L:$Q*0"Q*A!U=L9CQK!IQ2< MR49;QR8Y6Q_/I+%DKP'J?7R8GB3K!L"RF_K[RW"UV9<,(1/.)0F>UU!7H(2 ML?9W3[[V='?%3(*6'ZI)ER:1@1;$*>#UN M51$:0BH4-C@;HA+1.-6%T?<,?&7G)NT=0B#.<'^JJO]]!88_J73\MO_UH_1_/C;OL[J+^[#XN;P5HD M'^NEKN5PVU"L:&VNK;*B>ELL8?3S<[S760@7("I$.&%G.6XL %YB#C_GH^VI4IC'L_V37%_GA# MN9MCT$'6$-:(2DE6B8:X!EN2T R=M['+U?64S*#G9JT>&@6>*-VFL'&/D\@G M8[G3 FJ/8U"ZV-I(M#;/2CDZIZSR71YV_CK,H+V4VH49M(^$9R:I?I KGV@9 MMPVP4LS12)*'JD(1PD.U?V""<20F(9PX7CW\Y.=;T?]0I2U'EF #3Q$'"8.R MU,PA)[=C":K51T[X8FN+#2%@FH MR)%7F50?ZWDM1*D%GU+P<(;4QY-;%IZ;)? DVS2-=IK#WR4,W)*/GV+[(EH6]8-"C96$?G333C.R9YFI1JKK]$FCM M8VVN5MU"%:%8IYT3TFISG-EIO.YUL[0V[*73OMWK^@AX7L!L91(N/^!Z>;U* MN'[SH+- ULF8R#V$;&OAB^ 0E5!DOKDS05E4^?@%_;-#M/1F/PI QA-HJZ\V MJ"4O0JG:SIJ!LC3]Z&0"QNA 3U*$J(Z'Y8V]VDP(B'$$.2\8?EG0F(M/GZM< M?EF&?>\)'72('@U8YQ-)Q$EP(06P:*R(R:#NT+?C\+=;BK1'@<$((FS <_W; M=5B%JPWBNWBY"P!O_;&;]!4I3 FI=DV3A&F?R07S-H(LV1AE>;!BDG+\8Q-K MC(_F].AH5$TTBJP'^RZ$C"9+VFU19W+N'4(H,8&QH4C+M%+3E(<=F]B\+NZX M,.B L<$ZF?D$"^F& ^Z6C'5O@%GQWA4#(B()257#[K4'DV,0QDC).A!%/O7U M]K Q7'W+<679@,EYIKQ26>=R=IFVB3>@F+3@-/WB41@>M _"=LEG/C>/]ODH MLR:XWALF_>9P=) 3A_#OK&82?,BT,VIU6K0V0:*-5]_B?& MLQ3-0?#1"P3] M68KZ:*0I.H^;^2_+^]7R*ZXVW]_]XXI&N;"L,N%H77G$:QI!;2:<# =$9W2V M+BBGCYYCG89JZ M/U]]6ZR65_7OA,LI*3L.#G0>CH[C:YR%E$-PZ5DTL?9TU&3&R'OR22G(+(C( MBPDF3U(&F8FZ^[UX4HX^J.E(RM%' M&0V96Y=>4S1B3\9%I*#6K27E%,I(%@0LI/$]:2WXEV))DCE(:.FTID ./'(-S/JH M*-#CJ(^'+0,';QYI0U"P/*M*&KARV=%^U(O.K?&_QOR.(KMPOPA$,QN8E0R* MJ.]]C@L*ZSB=\C88SKWA)4[2B+/#W.8)H,X#PJE4-*^IVQ*VYWMK(24MON&: M]EB\7B^N<+V^M]=VRV.EH!:YOBU*!4I[2Y+C!HQ#:YF)O.#Q2HTA(\_CDYW- MR$VNC(;!#F/K?SF>U7/S<_V>RYRXZ4Q M@"72GBLIUA:$ 8SRAC0@52G'#]])ISA/ZL#9T-N.>F^N<(7N.K/;,,0&\MQJ\LIA-?G,^NNS) ME7^"\&9G2BS+U9=PE;"NH7+-WA*.V. R)ZRRH&@1M'PRD4S4K!6DLY?I$(Y7 MXC_]_?FHM"='PTA";>!.L@=14O':"BT,^&V+M( Q4EJJ5\X MF]DI28<3::H6O!)=*>B:SFH0O[_EI MM02R$[2_G$P5#0#KN1HMHS *5MNQ56:F3+]$*\FKT#PD]%ZKV"4T/W?Y_[GY M:T8]#X=)?UZ/_-&&>+5>X^8"R0GEC,+(*"O'6_0!*IT&:%WSQP1+)1Y_X#CT MY9:,RG"%+<>37@-&Y%5*J^MP^ V_0=A7:!BBGLE0%4"=H7(('AAP7O! M'4O+<+DO#%Y<_?QGJB_3 M9?>)"UJJRI6N)T=;0!7%P66!8#!PPU,0FA\O_A]O/HTEH4%.9URO2[G.11K#WQ\<;>OTX& MSA@R;,\O6E]P+Z0S=$I95EF1 U,UD9[P;)RP,1DIS7$,'/QT8[=%DWA&_>37 MB/YIT+L\ CJ&[_W7O;_ST_?7R]4&OX4+G9SEQM/">'WO*RI"T!16"!^*R$$Q M_;B/]',0Z3EZ8S'6>"B:4@MM4HA\W"S3?U>C28/\_/^NR8P^G&\7=I #WQB! M^./8S$;B]+CY]"W] H\I*9<4T!%1DP^3!L>MAE+?OHI+//A)B'H>3N/DK.L? M9/<[^4YW;!-_D/!^HG_PWQ>_-(D%N;0+*>Q,\'X;(31M"_JC2 / MA5Q4:\!F'31Z6RR?Y)9C9#N3/F.^OL1W92M+.A@OPWI]AV34,8LD'912>6XM M^\(1P#:?=AJXMK[;8:]2NOYRO;1]8IS$0DZO MOZ;@VFUY14M12B+[%V+MT5(*A$)HXAAB8A%Y-)/0M_>M-IXSU:=48AC* (*\;:<-5)49M_!5"*21%8-,I.XC:.,_UY M[UA'!.L,VGPIX6SE]*SU7_3G@TEU.WUUDC#WV.RG"7DQ&&,E;;Q@E"+M)P\^ M1PW9HBQ%!IB@TWN?G%NG M0Q2R'$$Z#80LKY=7W^ACU;W=6ZZ_7RW^WS6^P75:+;YNE;#MF9X+FN1=)1'C MM0=2H$,A;!D4CWM MH&AK!R4AP9A$)E3M0O:\ M2C8GYUP!6V(E9_'YC$!FJO>78HFP##V^6_[BI MY;\7^_\;7N9;5D%OHH@2M(]T\@=%)S^C]6D>;!+&\L1M9VP\/]:\Y]2$.!E1 MQ"T<4/7\WLGH[6V"'9WBUF!$D$94:J,@(7!-5I9G'R5#D?PDSUD'9S/O(]5D M'L_)@I^9%._/]#E!EI3]'DG6.6(@R764@8BSE^R?'@ MDS.?,Z=K9SF"J%HP$'=6[GU8O5M]W-0W@?\(E]?X'E=;HWB1">Z)3D2PW"E0 M261P66K(G,>"B?DH0@T.8A+R'0!BHTJ\=E8>, [?C4YDUY&!]C(ROCI60U M/$SN7.R3.T?,<#@RPB39#GU6-5+FP^$LV=MW<&LMIA(]6%FKE.N+N')+UO4=9 M*\!'ED$'R85;1WI)7@ MT#I0HGB(+"D041FO&44'CSF QT#*PTG,>_DTE5$Y0= -@F4'^>!RJD6_(+6@ M52AN(8K:L%1I'PR3/(K1R.>?GD8+IN44]1[!RP!9SXR8=_^XHN]\7GS=RH)[ M[RT3D4) U#4=+H#SVD"1W!E54N+&C062!R//>Z,XKB$9+M)6L+!O>5ZYL /Z M2CHDR9&7M#-*G7]*T;EBD@M=\G?ZH6%N.W&"]@YA8( H&[C$VSZZU)NCVSJ+ MK\NK>I&T%0IY89A2;5J?@JS<>63>=*85B60YF3>;^"3W=\_.:M[KX?$LR/@J M: !/C]:PVQ1:68$9R>V6NMYLIE07D:%PPRT:;<64W!&/9C-SU<%XVEZ.+?H& M\'-3CWN=L]P'*2W)!!F9;LDAVIH\D##E8HTUBIWCV>!M&[SRX]NF M<43?((9N0XCWN$I51Y_PIT=O@#=_Y<);Y66B;>B\KXV0L@1?7X@=G>(\ZL2+ MZW(3>#+&.L^XK;>(@8@Y@L-IU-< 3O)D;MGJHO?&!<56ZNK..6 M2E2 BUO>AI2=3U:J,HD[]ORTVKJH'@=Q(RJB 5@]EM&O5_^^7%QM_H-6>%W3 M[AACKO)O@,3 07E3>[/%")89PT)A,NNS&+E'\VKKXG(:4W:**AI UIO=L'^$ M/^_Q(%]8ZZTH.8((*9"?2=YEH-E#,C&JP$0P=I);K,/3:>OZ:APSW \\?KN%[D15A]?[^5]>W!OQ?FZVUMQ/K];?K= M_@<_[?[%A?!"E) MF0_9-$?,Q3S\X4E2,#NL81K.*8V86:WAS,;(6E-5($;GZ 060<7,LU23Y.:? MCW,J:<&XK"T(G/-0>S.!XT\IYSHI+ODN&7/]'I1?".=4' 7TXI_K(?6[R MFCO>GA*#4B4@L$K9HV(B^TUS!1F]5\9DJ_3Q3E8O@G.JEWX.H=EHI&[,G5 L!2M+4/>,>BO3"*&%Y,@<\E/7^ %]C^I=/RV__2I^^.;OI M-X^/[ /#MDL6->+@_YDR6X%2E+4>0X,Q4&;^^V1FP0.&S$)$6+K%6YM>,-Z95?<$M4KB" M\G%%V"&:C/WGYE/H<$4L3Y1* S=>MX_R]PM2;WC)%$4@QB%$73D1 T;"M4'@ M5O*D#=-IFDOX)V?4+G7.$/L_K@(:0-+]^>\VDP@AEA 25!H84#1GD@NY3=&8 MPG-"IN0D[X,_3J61C+_3=/P,Z=( @<_1 M)4UT_!K,7,>8G9N&06DXM]]D[[I3.2BG"WY>FW+[)+=GT5AC%'AR84SC)WK+X93T( ^/RTVCF63H/2!$IH%%*_KM?7 MM!)$9#G4W<#K.6O)V0\Q5?)E[J75G#$^39+DDU-JD=)O;"@-$'YS,/J &;_< M$,5O^>$N3!1,F4H0SZ4%Y84&CR(!8XF+K+&(/ F3\?/3:I&L;SPXG:2$EY*O M\UQST1&S=[H,,TDN3^_U39/98W3.R3)!-JB0->*JO@:[""BY%%:4P#I1+LR< MV=.G*>T%<]Z1=[@M%J.-F.B7H ,%G:%(Q[4@&SQ)JD^?23:5^],'(X\MUV2: MF9FLXO;^]&/"J[!:+&^8HC*OW3DU",1M0XL OJ8:ATAAA_"&Q3P:*=+!&[O!YZE9S,=],H)FEV.+>=Z+HFUF]E6X_(#T\7"U^.=6#[O;4B5,<%IX MX*742]@@@+Q(!3HJP6VTP<7C^6G/C3 C$L;1W7)\0380D3U/UD'&5$FC$(3+ MM3K*<0HX.$4%QBDO18S!3].*_F1VG,ENBB8_EL;73 ,P.\S<0M))6FA'LS8: ME(@&@O,&?$I2*68M/DZ*_1]*FM-+VYU(<_J(O@'\W-MU?ZS"U?KR1C'YOZ[7 MFRJU?3\OA]X%66N?LB3CZR0XX5BM-1(ETYJEFH2%J=OT6HC#3L+!T^'86$II M"VJ_X^9O)*1JSW\A>;[!]>+3U=;RK_[/=;A/+SGJ^3PO0\"FT.Q'^_ M6B&M[I^8?[WZAC>;\+,]E-PU?6>8;S MO@--"KT153-KFS *SM]@65QA_@FOZ#>;]Y?DEX2KFP6^7ZXWJVTOM+JO[O^- M&_)L$U.L-]->D9U7A3/R4WPAG]MYZ2B0#_)X6\S!P\]KV":/:L^FF7GOV :M M<;>751'HG$[ C*9=YC!!9,A QJQ#]"';QSWKQL+?S 6E9P+&B4@(TN40D-0M65 L84V,VHH&!.K2YV(J^#8Q%X6&H> XW%: MQIB::@!YQR1V:(E(YTC0=+)P#*HZ&A)<2!S(V0@VZ")2[O)FU1N, ^8Z3Y0\ M(SZGUF<3_64[^D%O;Q.QO-7912/!UTA,14?A6%*BEE>R0G&:CV'JBYY.$YTW M>#G;H\FD^FO J/Z8^D6+NKS.M;'SRD"('6JL?%Y]#T;YUYO.XINPVHSG M0#PAW9^P+%?X 5/-CEV4Q0WA^OIWW+PK?X0_+U KQIB)X$I=,"\9 L8(F:>8 M2I:^L$E8"$^8\XMXUAX'U>?2; ,&^_%"ZK-#!UF_OEY5K;W?;JG;M0>1O>:F M7N^96H>D#) W1Q% XLD):YDJD[C'8R[B1=QSC0/SV73? .Z?D^[MFIS#:(J* M$&JK=N4=@A=6 =-."^Y]S&42Y[G+Y%Z$PSR].1ZDJR9"N4--YS?X\>OB:EG* M-E\AI*K."ZE0H+$:F$)%L"AV$*1L4AT&MB$D!CZ2)Y\E&62^IHSAFV3=>MYD6%;#WV?&+;] M?)7/>8%V>ZQDF;RN74BSK,=*3 I\[4P: _DZ/&'H5J4PU?U9+V_ _B6P.Z4& M7TJ]**UK=Y']\Y]?:>6XO*+UOJ*SYUNETANO8K3;0)/4C Y8XT1\\%R$C*@A M&QYJ_T[R+&,P$+QGUC"'ADU29#!CU:C.)E?K#9@=IST3-;CL,U"(QXS*2I

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
  •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end
  •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�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